PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Graham, DJ; Drinkard, CR; Shatin, D; Tsong, Y; Burgess, MJ				Graham, DJ; Drinkard, CR; Shatin, D; Tsong, Y; Burgess, MJ			Liver enzyme monitoring in patients treated with troglitazone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATIC-FAILURE	Context Soon after initial marketing in March 1997, troglitazone, the first thiazolidinedione antidiabetic agent, was found to cause life-threatening acute liver failure. The drug was removed from the market in March 2000. Objective To evaluate the effect of US Food and Drug Administration (FDA) risk management efforts, including repeated labeling changes and "Dear Healthcare Professional" letters, on periodic liver enzyme monitoring of patients taking troglitazone. Design, Setting, and Participants Claims data from a large, multistate managed care organization were used to establish 4 cohorts of patients (N = 7603) with at least 90 days of health plan enrollment before first troglitazone prescription during 4 consecutive periods spanning April 1997 to September 1999 and representing 4 progressively stringent liver monitoring recommendations. Main Outcome Measures Percentage of eligible troglitazone users in each cohort with baseline, monthly (for up to 6 months of continuous use), and complete (baseline and monthly) enzyme monitoring, based on computerized records of laboratory claims. Results Baseline testing increased from 15% before any FDA monitoring recommendations (cohort 1) to 44.6% following 4 separate FDA interventions (cohort 4; P<.001). In cohort 4, 33.4% of users had follow-up testing after 1 month of therapy, falling to 13% after 5 months of continuous use. in all cohorts, less than 5% received all recommended liver enzyme tests by the third month of continuous use. Conclusions The FDA risk management efforts did not achieve meaningful or sustained improvement in liver enzyme testing. Evaluation of the impact of regulatory actions is needed before such actions can be regarded as effective or sufficient.	US FDA, Off Postmarketing Drug Risk Assessment, Rockville, MD 20857 USA; US FDA, Off Biostat, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; United Hlth Grp, Ctr Hlth Care Policy & Evaluat, Minneapolis, MN USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); UnitedHealth Group Incorporated	Graham, DJ (corresponding author), US FDA, Off Postmarketing Drug Risk Assessment, 5600 Fishers Ln,HFD-400,Room 15B-32, Rockville, MD 20857 USA.				FDA HHS [FD-U-000149, FD-U-0001643-01/02] Funding Source: Medline	FDA HHS		ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; GRAHAM DJ, 1999, FDA MET END DRUGS AD; Herrine SK, 1999, ANN INTERN MED, V130, P163, DOI 10.7326/0003-4819-130-2-199901190-00021; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Jagannath S, 2000, ANN INTERN MED, V132, P677, DOI 10.7326/0003-4819-132-8-200004180-00021; Murphy EJ, 2000, DIGEST DIS SCI, V45, P549, DOI 10.1023/A:1005405526283; Neuschwander-Tetri BA, 1998, ANN INTERN MED, V129, P38, DOI 10.7326/0003-4819-129-1-199807010-00009; REZULIN, 1998, PHYSICIANS DESK REFE, P2218; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; SIGMUND WR, 1998, IMPORTANT DRUG WARNI; SIGMUND WR, 1997, IMPORTANT DRUG WARNI; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Stolberg Sheryl Gay, 1999, N Y Times Web, pA9; Walker A M, 1995, Arch Fam Med, V4, P24, DOI 10.1001/archfami.4.1.24	16	104	106	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					831	833		10.1001/jama.286.7.831	http://dx.doi.org/10.1001/jama.286.7.831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497537	Bronze			2022-12-01	WOS:000170429600031
J	Hofbauer, LC; Schoppet, M				Hofbauer, LC; Schoppet, M			Osteoprotegerin: a link between osteoporosis and arterial calcification?	LANCET			English	Editorial Material							BONE LOSS; LIGAND; OSTEOCLASTOGENESIS; DESTRUCTION; CELLS		Univ Marburg, Dept Med, Div Gastroenterol & Endocrinol, D-35033 Marburg, Germany; Univ Marburg, Dept Med, Div Cardiol, D-35033 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Hofbauer, LC (corresponding author), Univ Marburg, Dept Med, Div Gastroenterol & Endocrinol, D-35033 Marburg, Germany.		Hofbauer, Lorenz C/G-2490-2010	Hofbauer, Lorenz C/0000-0002-8691-8423				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; Hofbauer LC, 2001, BIOCHEM BIOPH RES CO, V280, P334, DOI 10.1006/bbrc.2000.4130; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518	16	100	111	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					257	259		10.1016/S0140-6736(01)05494-0	http://dx.doi.org/10.1016/S0140-6736(01)05494-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498208				2022-12-01	WOS:000170114400005
J	Minor, PD				Minor, PD			Biosafety consequences of eradication of wild-type polioviruses	LANCET			English	Editorial Material									Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	National Institute for Biological Standards & Control	Minor, PD (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England.							Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; DOWDLE WR, 1997, J INFECT DIS S1, V109, P1; *HOUS COMM, 1980, REP INV CAUS 1978 BI; Kelly H, 2000, Commun Dis Intell, V24, P207; Mulders MN, 1997, J INFECT DIS, V176, P617, DOI 10.1086/514081; *WHO, 1999, WER, V74, P165; *WHO VACC ASS MON, 1999, WHOVB9932 VAC ASS MO; Wood D. J., 2000, Biologicals, V28, P199, DOI 10.1006/biol.2000.0257; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347	9	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					166	168		10.1016/S0140-6736(01)05399-5	http://dx.doi.org/10.1016/S0140-6736(01)05399-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476828				2022-12-01	WOS:000169967100004
J	Perutz, MF; Windle, AH				Perutz, MF; Windle, AH			Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats	NATURE			English	Article							HUNTINGTONS-DISEASE; INTRANUCLEAR INCLUSIONS; CELL-DEATH; DYSFUNCTION; MODEL	Neurodegenerative diseases resulting from expanded repeat sequences of glutamine residues are associated with the formation of protein aggregates in the cell nuclei of the affected neurons, but whether these are pathogenic is controversial. Recent observations indicate that the ages of onset of these diseases are exponential functions of the repeat lengths and that the probability of neural death is constant with time. The only process known to us that could give rise to such behaviour is nucleation of the aggregates.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	MRC Laboratory Molecular Biology; University of Cambridge	Perutz, MF (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; KAZANTSEV A, UNPUB CELL; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Mullins J. W., 1972, CRYSTALLISATION; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	17	161	167	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					143	144		10.1038/35084141	http://dx.doi.org/10.1038/35084141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449262				2022-12-01	WOS:000169778700040
J	Grimes, DA				Grimes, DA			Intrauterine devices and infertility: sifting through the evidence	LANCET			English	Editorial Material							PELVIC INFLAMMATORY DISEASE		Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.							Bastianelli C, 1998, Minerva Ginecol, V50, P231; BUCHAN H, 1990, BRIT J OBSTET GYNAEC, V97, P780, DOI 10.1111/j.1471-0528.1990.tb02571.x; CATES W, 2000, WOMEN HLTH, P381; Doll H, 2001, BRIT J OBSTET GYNAEC, V108, P304, DOI 10.1111/j.1471-0528.2001.00075.x; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; HUBACHER D, 2000, INT J GYNECOL OBSTET; *ROYAL COLL OBST G, INT INV MAN INF COUP; VESSEY MP, 1981, BRIT MED J, V282, P855, DOI 10.1136/bmj.282.6267.855; *WHO, 2001, IMPR ACC QUAL CAR FA; World Health Organization (Who), 1987, 753 WHO	10	16	16	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					6	7		10.1016/S0140-6736(00)05299-5	http://dx.doi.org/10.1016/S0140-6736(00)05299-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454367				2022-12-01	WOS:000169710900006
J	Merila, J; Kruuk, LEB; Sheldon, BC				Merila, J; Kruuk, LEB; Sheldon, BC			Cryptic evolution in a wild bird population	NATURE			English	Article							NESTLING COLLARED FLYCATCHERS; DIRECTIONAL SELECTION; NATURAL-SELECTION; BODY-SIZE; VARIANCE; MASS	Microevolution is expected to be commonplace, yet there are few thoroughly documented cases of microevolution in wild populations(1,2). In contrast, it is often observed that apparently heritable traits under strong and consistent directional selection fail to show the expected evolutionary response(3,4). One explanation proposed for this paradox is that a genetic response to selection may be masked by opposing changes in the environment(5,6). We used data from a 20-year study of collared flycatchers (Ficedula albicollis) to explore selection on, and evolution of, a heritable trait: relative body weight at fledging ('condition'). Despite consistent positive directional selection, on both the phenotypic and the additive genetic component (breeding values, estimated from an animal model) of condition, the mean phenotypic value of this trait in the population has declined, rather than increased, over time. Here we show that, despite this decline, the mean breeding value for condition has increased over time. The mismatch between response to selection at the levels of genotype and phenotype can be explained by environmental deterioration, concealing underlying evolution. This form of cryptic evolution may be common in natural environments.	Uppsala Univ, Evolutionary Biol Ctr, Dept Populat Biol, SE-75236 Uppsala, Sweden; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden	Uppsala University; University of Edinburgh; University of Oxford; Uppsala University	Merila, J (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Populat Biol, Norbyvagen 18d, SE-75236 Uppsala, Sweden.		Sheldon, Ben C/A-8056-2010; Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012; Merila, Juha/A-4061-2008	Sheldon, Ben C/0000-0002-5240-7828; Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123; Merila, Juha/0000-0001-9614-0072				ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; BLAIR HT, 1984, J ANIM SCI, V58, P878, DOI 10.2527/jas1984.584878x; Boltnev AI, 1998, CAN J ZOOL, V76, P843, DOI 10.1139/cjz-76-5-843; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; COOKE F, 1990, AM NAT, V136, P261, DOI 10.1086/285095; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; FRANK SA, 1992, TRENDS ECOL EVOL, V7, P92, DOI 10.1016/0169-5347(92)90248-A; *GENST, 1998, GENST 5 REL 4 1; Gilchrist AS, 1999, GENETICS, V153, P1775; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; GROENEVELD E, 1992, ARCH ANIM BREED, V15, P399; GROENEVELD E, 1995, REML VCE MULTIVARIAT; GUSTAFSSON L, 1988, IBIS, V130, P11, DOI 10.1111/j.1474-919X.1988.tb00951.x; HOCHACHKA W, 1991, J ANIM ECOL, V60, P995, DOI 10.2307/5427; LEWONTIN RC, 1978, SCI AM, V239, P212, DOI 10.1038/scientificamerican0978-212; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Lynch M., 1998, AM J HUM GENET; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1997, MOL ECOL, V6, P1167, DOI 10.1046/j.1365-294X.1997.00295.x; MERILA J, UNPUB J EVOL BIOL; MEYER K, 1989, GENET SEL EVOL, V21, P317, DOI 10.1051/gse:19890308; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Roff D.A., 2012, EVOLUTIONARY QUANTIT; Sheldon BC, 1998, ECOLOGY, V79, P1939, DOI 10.2307/176700; Sorci G, 1999, EVOL ECOL RES, V1, P303; SOUTHWOOD OI, 1991, J ANIM SCI, V69, P3177; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	30	169	172	0	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					76	79		10.1038/35083580	http://dx.doi.org/10.1038/35083580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452309				2022-12-01	WOS:000169644900046
J	Parrish, J; Li, LL; Klotz, K; Ledwich, D; Wang, XD; Xue, D				Parrish, J; Li, LL; Klotz, K; Ledwich, D; Wang, XD; Xue, D			Mitochondrial endonuclease G is important for apoptosis in C-elegans	NATURE			English	Article							PROGRAMMED CELL DEATHS; DNA FRAGMENTATION; PROTEIN; INTERFERENCE; GENE; RNA	Programmed cell death (apoptosis) is a tightly regulated process of cell disassembly in which dying cells and their nuclei shrink and fragment and the chromosomal DNA is degraded into internucleosomal repeats(1-3). Here we report the characterization of the cps-6 gene, which appears to function downstream of, or in parallel to, the cell-death protease CED-3 of Caenorhabditis elegans in the DNA degradation process during apoptosis. cps-6 encodes a homologue of human mitochondrial endonuclease G(4,5), and its protein product similarly localizes to mitochondria in C. elegans. Reduction of cps-6 activity caused by a genetic mutation or RNA-mediated interference (RNAi) affects normal DNA degradation, as revealed by increased staining in a TUNEL assay, and results in delayed appearance of cell corpses during development in C. elegans. This observation provides in vivo evidence that the DNA degradation process is important for proper progression of apoptosis. CPS-6 is the first mitochondrial protein identified to be involved in programmed cell death in C. elegans, underscoring the conserved and important role of mitochondria in the execution of apoptosis.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136; Wang, Xiaodong/0000-0001-9885-356X				BRENNER S, 1974, GENETICS, V77, P71; Chalfie M, 1995, PROG BRAIN RES, V105, P179; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; CLARK SG, 1994, GENETICS, V137, P987; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Horvitz HR, 1999, CANCER RES, V59, p1701S; HSU DR, 1995, DEVELOPMENT, V121, P3323; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Riddle DL, 1997, C ELEGANS; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wu YC, 2000, GENE DEV, V14, P536; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	30	329	343	10	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					90	94		10.1038/35083608	http://dx.doi.org/10.1038/35083608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452313				2022-12-01	WOS:000169644900050
J	Outten, CE; O'Halloran, TV				Outten, CE; O'Halloran, TV			Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis	SCIENCE			English	Article							ESCHERICHIA-COLI; REGULATOR ZUR; UPTAKE SYSTEM; HIGH-AFFINITY; METALLOTHIONEIN; IONS; ZNTR; SMTB; FLUORESCENCE; TRANSPORTER	Intracellular zinc is thought to be available in a cytosolic pool of free or Loosely bound Zn(II) ions in the micromolar to picomolar range. To test this, we determined the mechanism of zinc sensors that control metal uptake or export in Escherichia coli and calibrated their response against the thermodynamically defined free line concentration. Whereas the cellular line quota is millimolar, free Zn(II) concentrations that trigger transcription of zinc uptake or efflux machinery are femtomolar, or six orders of magnitude Less than one atom per cell. This is not consistent with a cytosolic pool of free Zn(II) and suggests an extraordinary intracellular zinc-binding capacity. Thus, cells exert tight control over cytosolic metal concentrations, even for relatively Low-toxicity metals such as zinc.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.		O'Halloran, Thomas/ABE-6125-2021; Outten, Caryn E./I-9433-2019	O'Halloran, Thomas/0000-0001-8732-5059; Outten, Caryn E./0000-0003-0335-6531	NIDDK NIH HHS [DK52627] Funding Source: Medline; NIGMS NIH HHS [R01 GM38784, R01 GM038784, T32 GM08382] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382, R01GM038784] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Ausubel FM, 1995, CURRENT PROTOCOLS MO, V1; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Binet MRB, 2000, FEBS LETT, V473, P67, DOI 10.1016/S0014-5793(00)01509-X; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Granger J, 1999, LIMNOL OCEANOGR, V44, P541, DOI 10.4319/lo.1999.44.3.0541; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HITOMI Y, UNPUB; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kar SR, 1997, BIOCHEMISTRY-US, V36, P15343, DOI 10.1021/bi971690v; Martell A.E., 1998, NIST STANDARD REFERE, V46; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Neidhardt F.C., 1990, PHYSL BACTERIAL CELL; OUTTEN C, UNPUB; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; OUTTEN FW, UNPUB; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Sensi SL, 1997, J NEUROSCI, V17, P9554; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; VALLEE B L, 1988, Biofactors, V1, P31; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	36	1109	1132	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2488	2492		10.1126/science.1060331	http://dx.doi.org/10.1126/science.1060331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11397910				2022-12-01	WOS:000169658200041
J	Orr, A; McVean, RJ; Webb, AK; Dodd, ME				Orr, A; McVean, RJ; Webb, AK; Dodd, ME			Questionnaire survey of urinary incontinence in women with cystic fibrosis	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE		S Manchester Univ Hosp Trust, NW Lung Ctr, Adult Cyst Fibrosis Unit, Manchester M23 9LT, Lancs, England		Orr, A (corresponding author), S Manchester Univ Hosp Trust, NW Lung Ctr, Adult Cyst Fibrosis Unit, Manchester M23 9LT, Lancs, England.							Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Dolan LR, 1999, BJU INT, V83, P760; Gunnarsson M, 1999, NEUROUROL URODYNAM, V18, P613, DOI 10.1002/(SICI)1520-6777(1999)18:6<613::AID-NAU11>3.0.CO;2-B; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243	4	40	40	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2001	322	7301					1521	1521		10.1136/bmj.322.7301.1521	http://dx.doi.org/10.1136/bmj.322.7301.1521			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446UF	11420273	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000169532000018
J	Wallis, JD; Anderson, KC; Miller, EK				Wallis, JD; Anderson, KC; Miller, EK			Single neurons in prefrontal cortex encode abstract rules	NATURE			English	Article							ORBITOFRONTAL CORTEX; NEURAL ACTIVITY; FRONTAL-CORTEX; WORKING-MEMORY; UNIT-ACTIVITY; PRIMATE; REWARD; MACAQUE; MONKEY	The ability to abstract principles or rules from direct experience allows behaviour to extend beyond specific circumstances to general situations. For example, we learn the 'rules' for restaurant dining from specific experiences and can then apply them in new restaurants. The use of such rules is thought to depend on the prefrontal cortex (PFC) because its damage often results in difficulty in following rules(1). Here we explore its neural basis by recording from single neurons in the PFC of monkeys trained to use two abstract rules. They were required to indicate whether two successively presented pictures were the same or different depending on which rule was currently in effect. The monkeys performed this task with new pictures, thus showing that they had learned two general principles that could be applied to stimuli that they had not yet experienced. The most prevalent neuronal activity observed in the PFC reflected the coding of these abstract rules.	MIT, Ctr Learning & Memory, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, Ctr Learning & Memory, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA.		Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958; Wallis, Joni/0000-0001-7262-7417				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; FUSTER JM, 1997, PREFRONTAL CORTEX; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller EK, 1996, J NEUROSCI, V16, P5154; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; NIKI H, 1974, BRAIN RES, V68, P197, DOI 10.1016/0006-8993(74)90389-8; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1999, J NEUROSCI, V19, P5493; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1990, J NEUROPHYSIOL, V64, P1055, DOI 10.1152/jn.1990.64.4.1055; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	26	684	694	1	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					953	956		10.1038/35082081	http://dx.doi.org/10.1038/35082081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418860				2022-12-01	WOS:000169386200046
J	Moscicki, AB; Hills, N; Shiboski, S; Powell, K; Jay, N; Hanson, E; Miller, S; Clayton, L; Farhat, S; Broering, J; Darragh, T; Palefsky, J				Moscicki, AB; Hills, N; Shiboski, S; Powell, K; Jay, N; Hanson, E; Miller, S; Clayton, L; Farhat, S; Broering, J; Darragh, T; Palefsky, J			Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED-DISEASE; NATURAL-HISTORY; CIGARETTE-SMOKING; HPV INFECTION; TYPE-16; ASSOCIATION; BEHAVIOR; CANCER; E6; PREVALENCE	Context Low-grade squamous intraepithelial lesions (LSILs) have been described as a benign cytological consequence of active human papillomavirus (HPV) replication. Several studies have reported that certain behavioral and biological risks exist for LSIL, suggesting that HPV alone is not sufficient for the development of LSIL. However, because most of these studies have been cross-sectional, it is not known whether behavioral and biological risks are simply risks for HPV infection itself. Objective To prospectively examine risks of incident HPV infection in HPV-negative females and of incident LSIL development in females with HPV infection. Design Prospective cohort study conducted between 1990-2000, with a median follow-up of 50 months. Setting and Participants Females aged 13 to 21 years who attended 2 family planning clinics in the San francisco bay area; 496 had prevalent HPV infection and 105 were HPV-negative. Main Outcome Measure Incident development of HPV infection and LSIL, analyzed by various demographic, behavioral, and clinical risk factors. Results Fifty-four incident HPV infections occurred in the 105 females who were HPV-negative at study entry (median duration of follow-up for those who remained HPV-negative was 26 months). Multivariable analysis showed that risks of HPV included sexual behavior (relative hazard [RH], 10.10; 95% confidence interval [CI], 3.24-31.50 per new partner per month), history of herpes simplex virus (RH, 3.54; 95% CI, 1.37-9.10), and history of vulvar warts (RH, 2.73; 95% CI, 1.27-5.87). Current use of oral contraceptives had a significantly protective effect (RH, 0.49; 95% CI, 0.28-0.86). Among the 496 individuals who were HPV-positive at baseline or in follow-up, there were 109 incident cases of LSIL during the follow-up interval, with a median follow-up time of 60 months for those who never developed LSIL. Human papillomavirus infection was the most significant risk factor for development of LSIL, The multivariable model showed the following risks for LSIL: HPV infection for less than 1 year(RH, 7.40; 95% CI, 4.74-11.57); HPV infection for 1 to 2 years (RH, 10.27; 95% CI, 5.64-18.69); HPV infection for 2 to 3 years (RH, 6.11; 95% CI, 1.86-20.06); and daily cigarette smoking (RH, 1.67; 95% CI, 1.12-2.48). Conclusion Our results indicate distinct risks for HPV and LSIL. In addition, most women with HPV infection in our study did not develop LSIL within a median follow-up period of 60 months. These findings underscore the hypothesis that certain biological risks thought to be associated with LSIL are, in fact, risks for acquisition of HPV. Cigarette smoking was a risk specific to LSIL, supporting the role of tobacco in neoplastic development.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Moscicki, AB (corresponding author), 3333 Calif St,Suite 245, San Francisco, CA 94118 USA.	annam@itsa.ucsf.edu	Moscicki, Anna-Barbara/AAP-3806-2021	Broering, Jeanette/0000-0002-7580-8931	NATIONAL CANCER INSTITUTE [R37CA051323, R01CA054053, R01CA051323] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA54053, R01CA51323, R37 CA051323] Funding Source: Medline; NCRR NIH HHS [M01 RR01271] Funding Source: Medline; PHS HHS [P01A121912, MCJ000978] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMBROS RA, 1990, SEMIN DIAGN PATHOL, V7, P158; Arany I, 1996, J INTERF CYTOK RES, V16, P453, DOI 10.1089/jir.1996.16.453; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BARTON SE, 1988, LANCET, V2, P652; BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472; CLARKE EA, 1985, AM J OBSTET GYNECOL, V151, P612, DOI 10.1016/0002-9378(85)90149-8; COPPLESON M, 1979, COLPOSCOPY SCI PRACT; COX JT, 1992, OBSTET GYNECOL, V80, P389; Daling JR, 1996, CANCER EPIDEM BIOMAR, V5, P541; DEVET HCW, 1993, INT J EPIDEMIOL, V22, P798, DOI 10.1093/ije/22.5.798; Ferenczy A, 1996, OBSTET GYN CLIN N AM, V23, P759, DOI 10.1016/S0889-8545(05)70276-X; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; HARAHAP RE, 1986, CANCER DETECT PREV, V9, P237; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; HOLMES KK, 1981, SCAND J INFECT DIS, P110; IRWIN KL, 1988, JAMA-J AM MED ASSOC, V259, P59, DOI 10.1001/jama.259.1.59; Kadish AS, 1997, J NATL CANCER I, V89, P1285, DOI 10.1093/jnci/89.17.1285; Kurman R.J., 1994, BETHESDA SYSTEM REPO; LAVECCHIA C, 1986, CANCER, V58, P935, DOI 10.1002/1097-0142(19860815)58:4<935::AID-CNCR2820580422>3.0.CO;2-O; LORINCZ A, 1996, HUMAN PAPILLOMAVIRUS, V1; MOSCICKI AB, 1993, OBSTET GYNECOL, V82, P578; MOSCICKI AB, 1993, J ADOLESCENT HEALTH, V14, P74, DOI 10.1016/1054-139X(93)90088-7; MOSCICKI AB, 1989, J PEDIATR-US, V115, P487, DOI 10.1016/S0022-3476(89)80863-7; MOSCICKI AB, 1990, PEDIATR RES, V28, P507, DOI 10.1203/00006450-199011000-00018; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Nakagawa M, 2000, J INFECT DIS, V182, P595, DOI 10.1086/315706; Nakagawa M, 1996, CLIN DIAGN LAB IMMUN, V3, P205, DOI 10.1128/CDLI.3.2.205-210.1996; NASH JD, 1987, OBSTET GYNECOL, V69, P160; NEVINS JR, 1992, SCIENCE, V258, P424; Roberts S, 1997, J VIROL, V71, P3554, DOI 10.1128/JVI.71.5.3554-3562.1997; ROSENFELD WD, 1989, AM J DIS CHILD, V143, P1443, DOI 10.1001/archpedi.1989.02150240065018; SCHACHTER J, 1982, JAMA-J AM MED ASSOC, V248, P2134, DOI 10.1001/jama.248.17.2134; SCHIFFMAN MH, 1987, CANCER RES, V47, P3886; Scott M, 1999, CLIN DIAGN LAB IMMUN, V6, P751, DOI 10.1128/CDLI.6.5.751-755.1999; Smith PJ, 1997, STAT MED, V16, P485, DOI 10.1002/(SICI)1097-0258(19970315)16:5&lt;485::AID-SIM422&gt;3.0.CO;2-#; STONE KM, 1995, EPIDEMIOLOGY, V6, P409, DOI 10.1097/00001648-199507000-00014; Svare EI, 1998, INT J CANCER, V75, P1, DOI 10.1002/(SICI)1097-0215(19980105)75:1&lt;1::AID-IJC1&gt;3.0.CO;2-1; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WINKELSTEIN W, 1984, AM J EPIDEMIOL, V119, P1	41	402	419	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2001	285	23					2995	3002		10.1001/jama.285.23.2995	http://dx.doi.org/10.1001/jama.285.23.2995			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442AR	11410098	Bronze			2022-12-01	WOS:000169263200022
J	Premawardhena, A; Fisher, CA; Fathiu, F; de Silva, S; Perera, W; Peto, TEA; Olivieri, NF; Weatherall, DJ				Premawardhena, A; Fisher, CA; Fathiu, F; de Silva, S; Perera, W; Peto, TEA; Olivieri, NF; Weatherall, DJ			Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia	LANCET			English	Article							UDP-GLUCURONOSYLTRANSFERASE-1	Chronic hyperbilirubinaemia, gallstone formation, and bladder disease are unusually common in people with haemoglobin E beta thalassaemia in Sri Lanka. To determine whether this has a genetic basis we compared the bilirubin levels and frequency of gallstones in patients with different alleles of the UGT*1 gene. There was a significantly higher bilirubin level in those with the 7/7 genotypes compared with 6/6 and 6/7 genotype (p=0.032 and 0.0015 respectively), who also appeared more prone to gallstone formation. These results suggest that the UGT*1 genotpe is of importance in the genesis of gallstones in this population of patients.	Univ Oxford, Weatherall Inst Mol Med, Oxford, England; Gen Hosp, Thalassaemia Unit, Kurunegala, Sri Lanka; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Toronto Gen Hosp, Toronto, ON, Canada	University of Oxford; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Weatherall, DJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.		Premawardhena, Anuja/GLN-5388-2022; Olivieri, Nancy/AAI-2250-2020	Premawardhena, Anuja/0000-0003-0605-9081; 				Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; del Giudice EM, 1999, BLOOD, V94, P2259, DOI 10.1182/blood.V94.7.2259.419k42_2259_2262; Sampietro M, 1999, HAEMATOLOGICA, V84, P150	5	57	58	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2001	357	9272					1945	1946		10.1016/S0140-6736(00)05082-0	http://dx.doi.org/10.1016/S0140-6736(00)05082-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425418				2022-12-01	WOS:000169431000016
J	Zaslavskaia, LA; Lippmeier, JC; Shih, C; Ehrhardt, D; Grossman, AR; Apt, KE				Zaslavskaia, LA; Lippmeier, JC; Shih, C; Ehrhardt, D; Grossman, AR; Apt, KE			Trophic obligate conversion of an photoautotrophic organism through metabolic engineering	SCIENCE			English	Article							SELECTABLE MARKER; TRANSFORMATION; REPORTER; OCEANOGRAPHY; MICROALGAE; CHLORELLA; GLUCOSE; GLUT1; IRON	Most microalgae are obligate photoautotrophs and their growth is strictly dependent on the generation of photosynthetically derived energy. We show that the microalga Phaeodactylum tricornutum can be genetically engineered to thrive on exogenous glucose in the absence of light through the introduction of a gene encoding a glucose transporter (glut1 or hup1). This demonstrates that a fundamental change in the metabolism of an organism can be accomplished through the introduction of a single gene. This also represents progress toward the use of fermentation technology for large-scale commercial exploitation of algae by reducing limitations associated with light-dependent growth.	Martek Biosci Corp, Columbia, MD 21045 USA; Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Apt, KE (corresponding author), Martek Biosci Corp, 6480 Dobbin Rd, Columbia, MD 21045 USA.	kirkapt@martekbio.com		Lippmeier, J./0000-0002-8157-1491				Apt KE, 1999, J PHYCOL, V35, P215, DOI 10.1046/j.1529-8817.1999.3520215.x; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/BF02172403; ASANO T, 1991, J BIOL CHEM, V266, P24632; Borowitzka MA, 1999, J BIOTECHNOL, V70, P313, DOI 10.1016/S0168-1656(99)00083-8; Boyle E, 1998, NATURE, V393, P733, DOI 10.1038/31585; Chen F, 1996, TRENDS BIOTECHNOL, V14, P421, DOI 10.1016/0167-7799(96)10060-3; Chisholm SW, 2000, NATURE, V407, P685, DOI 10.1038/35037696; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; COOKSEY KE, 1974, J PHYCOL, V10, P253, DOI 10.1111/j.0022-3646.1974.00253.x; Droop M.R., 1974, ALGAL PHYSL BIOCH, P530; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; Hallmann A, 1996, P NATL ACAD SCI USA, V93, P669, DOI 10.1073/pnas.93.2.669; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hellebust J.A., 1977, BIOL DIATOMS, V13, P169; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Lu LL, 1997, J CHROMATOGR A, V776, P81, DOI 10.1016/S0021-9673(97)00151-9; Mueckler M, 1997, BIOCHEM SOC T, V25, P951, DOI 10.1042/bst0250951; RADMER RJ, 1994, J APPL PHYCOL, V6, P93, DOI 10.1007/BF02186062; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; ROESSLER PG, 1987, J PHYCOL, V23, P494, DOI 10.1111/j.1529-8817.1987.tb02536.x; RUNNING JA, 1994, J APPL PHYCOL, V6, P99, DOI 10.1007/BF02186063; SAUER N, 1989, FEBS LETT, V259, P43, DOI 10.1016/0014-5793(89)81489-9; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; ZASLAVSKAIA LA, UNPUB	28	212	260	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2073	2075		10.1126/science.160015	http://dx.doi.org/10.1126/science.160015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408656				2022-12-01	WOS:000169284700046
J	Kuroda, M; Ohta, T; Uchiyama, I; Baba, T; Yuzawa, H; Kobayashi, I; Cui, LZ; Oguchi, A; Aoki, K; Nagai, Y; Lian, JQ; Ito, T; Kanamori, M; Matsumaru, H; Maruyama, A; Murakami, H; Hosoyama, A; Mizutani-Ui, Y; Takahashi, NK; Sawano, T; Inoue, R; Kaito, C; Sekimizu, K; Hirakawa, H; Kuhara, S; Goto, S; Yabuzaki, J; Kanehisa, M; Yamashita, A; Oshima, K; Furuya, K; Yoshino, C; Shiba, T; Hattori, M; Ogasawara, N; Hayashi, H; Hiramatsu, K				Kuroda, M; Ohta, T; Uchiyama, I; Baba, T; Yuzawa, H; Kobayashi, I; Cui, LZ; Oguchi, A; Aoki, K; Nagai, Y; Lian, JQ; Ito, T; Kanamori, M; Matsumaru, H; Maruyama, A; Murakami, H; Hosoyama, A; Mizutani-Ui, Y; Takahashi, NK; Sawano, T; Inoue, R; Kaito, C; Sekimizu, K; Hirakawa, H; Kuhara, S; Goto, S; Yabuzaki, J; Kanehisa, M; Yamashita, A; Oshima, K; Furuya, K; Yoshino, C; Shiba, T; Hattori, M; Ogasawara, N; Hayashi, H; Hiramatsu, K			Whole genome sequencing of meticillin-resistant Staphylococcus aureus	LANCET			English	Article							PENICILLIN-BINDING PROTEINS; NUCLEOTIDE-SEQUENCE; GENE; CLONING; IDENTIFICATION; EXPRESSION; VIRULENCE; REGULATOR; ELEMENT; ENCODES	Background Staphylococcus aureus is one of the major causes of community-acquired and hospital-acquired infections. It produces numerous toxins including superantigens that cause unique disease entities such as toxic-shock syndrome and staphylococcal scarlet fever, and has acquired resistance to practically all antibiotics. Whole genome analysis is a necessary step towards future development of countermeasures against this organism. Methods Whole genome sequences of two related S aureus strains (N315 and Mu50) were determined by shot-gun random sequencing. N315 is a meticillin-resistant S aureus (MRSA) strain isolated in 1982, and Mu50 is an MRSA strain with vancomycin resistance isolated in 1997. The open reading frames were identified by use of GAMBLER and GLIMMER programs, and annotation of each was done with a BLAST homology search, motif analysis, and protein localisation prediction. Findings The Staphylococcus genome was composed of a complex mixture of genes, many of which seem to have been acquired by lateral gene transfer. Most of the antibiotic resistance genes were carried either by plasmids or by mobile genetic elements including a unique resistance island. Three classes of new pathogenicity islands were identified in the genome: a toxic-shock-syndrome toxin island family, exotoxin islands, and enterotoxin islands. in the latter two pathogenicity islands, clusters of exotoxin and enterotoxin genes were found closely linked with other gene clusters encoding putative pathogenic factors. The analysis also identified 70 candidates for new virulence factors. Interpretation The remarkable ability of S aureus to acquire useful genes from various organisms was revealed through the observation of genome complexity and evidence of lateral gene transfer. Repeated duplication of genes encoding superantigens explains why S aureus is capable of infecting humans of diverse genetic backgrounds, eliciting severe immune reactions. Investigation of many newly identified gene products, including the 70 putative virulence factors, will greatly improve our understanding of the biology of staphylococci and the processes of infectious diseases caused by S aureus.	Juntendo Univ, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan; Univ Tsukuba, Coll Med Technol & Nursing, Tsukuba, Ibaraki 305, Japan; Okazaki Natl Res Inst, Res Ctr Computat Sci, Okazaki, Aichi, Japan; Univ Tokyo, Inst Med Sci, Div Basic Med Sci, Tokyo, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; Natl Inst Technol & Evaluat, Tokyo, Japan; Kyushu Univ, Fac Agr, Fukuoka 812, Japan; Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; Kitasato Univ, Sch Sci, Kanagawa, Japan; RIKEN Genom Sci Ctr, Human Genome Res Grp, Kanagawa, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan	Juntendo University; University of Tsukuba; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo; University of Tokyo; Kyushu University; Kyoto University; Kitasato University; RIKEN; Nara Institute of Science & Technology; University of Tsukuba	Hiramatsu, K (corresponding author), Juntendo Univ, Dept Bacteriol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.		Kaito, Chikara/W-1815-2019; Kanehisa, Minoru/R-3081-2018; Ogasawara, Naotake/B-7971-2011; Kaito, Chikara/G-1248-2017; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Hattori, Masahira/0000-0001-9467-0344; Uchiyama, Ikuo/0000-0002-9197-5000; cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885				ABE J, 1992, P NATL ACAD SCI USA, V89, P4066, DOI 10.1073/pnas.89.9.4066; AGATA N, 1995, MICROBIOL-UK, V141, P983, DOI 10.1099/13500872-141-4-983; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; AMAKO K, 1979, MICROBIOL IMMUNOL, V23, P329, DOI 10.1111/j.1348-0421.1979.tb00470.x; BISSETT DL, 1974, J BACTERIOL, V119, P698, DOI 10.1128/JB.119.3.698-704.1974; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chesney P.J., 1997, STAPHYLOCOCCI HUMAN, P509; CHEUNG AL, 1994, J BACTERIOL, V176, P4168, DOI 10.1128/JB.176.13.4168-4172.1994; Cramton SE, 2000, INFECT IMMUN, V68, P2344, DOI 10.1128/IAI.68.4.2344-2348.2000; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; FLANNAGAN SE, 1994, PLASMID, V32, P350, DOI 10.1006/plas.1994.1077; FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; HAYS JB, 1973, J BIOL CHEM, V248, P941; Hiramatsu K, 1999, BAILLIERE CLIN INF D, V5, P221; HIRAMATSU K, 1997, LANCET, V350, P1668; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; KIL KS, 1994, INFECT IMMUN, V62, P2440, DOI 10.1128/IAI.62.6.2440-2449.1994; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Manganelli R, 1999, INFECT IMMUN, V67, P50, DOI 10.1128/IAI.67.1.50-56.1999; Manna A, 2001, INFECT IMMUN, V69, P885, DOI 10.1128/IAI.69.2.885-896.2001; MARSHALL JH, 1981, J BACTERIOL, V147, P900, DOI 10.1128/JB.147.3.900-913.1981; MARTIN C, 1992, J BACTERIOL, V174, P4517, DOI 10.1128/JB.174.13.4517-4523.1992; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; PARK W, 1984, J BACTERIOL, V157, P538, DOI 10.1128/JB.157.2.538-544.1984; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; PROJAN SJ, 1997, STAPHYLOCOCCI HUMAN, P55; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Wada A, 1998, J BACTERIOL, V180, P2759, DOI 10.1128/JB.180.10.2759-2765.1998; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Yamaguchi T, 2000, MOL MICROBIOL, V38, P694, DOI 10.1046/j.1365-2958.2000.02169.x; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001	43	1511	3575	11	496	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1225	1240		10.1016/S0140-6736(00)04403-2	http://dx.doi.org/10.1016/S0140-6736(00)04403-2			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418146				2022-12-01	WOS:000168323300008
J	Saurin, AJ; Shao, ZH; Erdjument-Bromage, H; Tempst, P; Kingston, RE				Saurin, AJ; Shao, ZH; Erdjument-Bromage, H; Tempst, P; Kingston, RE			A Drosophila Polycomb group complex includes Zeste and dTAFII proteins	NATURE			English	Article							HISTONE; CHROMATIN; BINDING; IDENTIFICATION; EXPRESSION; TRITHORAX; SITES; TAFS	A goal of modern biology is to identify the physical interactions that define 'functional modules'(1) of proteins that govern biological processes. One essential regulatory process is the maintenance of master regulatory genes, such as homeotic genes, in an appropriate 'on' or 'off' state for the lifetime of an organism. The Polycomb group (PcG) of genes maintain a repressed transcriptional state, and PcG proteins form large multiprotein complexes(2,3), but these complexes have not been described owing to inherent difficulties in purification. We previously fractionated a major PcG complex, PRC1, to 20-50% homogeneity from Drosophila embryos. Here, we identify 30 proteins in these preparations, then further fractionate the preparation and use western analyses to validate unanticipated connections. We show that the known PcG proteins Polycomb, Posterior sex combs, Polyhomeotic and dRING1 exist in robust association with the sequence-specific DNA-binding factor Zeste and with numerous TBP (TATA-binding-protein)-associated factors that are components of general transcription factor TFIID (dTAFIIs). Thus, in fly embryos, there is a direct physical connection between proteins that bind to specific regulatory sequences, PcG proteins, and proteins of the general transcription machinery.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@frodo.mgh.harvard.edu		Saurin, Andrew/0000-0001-5162-003X; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; DeRubertis F, 1996, NATURE, V384, P589; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Kal AJ, 2000, GENE DEV, V14, P1058; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; LOCKE J, 1988, GENETICS, V120, P181; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mollaaghababa R, 2001, P NATL ACAD SCI USA, V98, P3958, DOI 10.1073/pnas.061497798; Nakatani Y, 1996, J BIOL CHEM, V271, P6575, DOI 10.1074/jbc.271.12.6575; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Tie F, 2001, DEVELOPMENT, V128, P275; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	29	311	328	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					655	660		10.1038/35088096	http://dx.doi.org/10.1038/35088096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493925				2022-12-01	WOS:000170318000045
J	Zehr, JP; Waterbury, JB; Turner, PJ; Montoya, JP; Omoregie, E; Steward, GF; Hansen, A; Karl, DM				Zehr, JP; Waterbury, JB; Turner, PJ; Montoya, JP; Omoregie, E; Steward, GF; Hansen, A; Karl, DM			Unicellular cyanobacteria fix N-2 in the subtropical North Pacific Ocean	NATURE			English	Article							NITROGEN-FIXATION; ATLANTIC OCEAN; NIFH GENES; TRICHODESMIUM; SEA; MICROORGANISMS; PHYTOPLANKTON; VARIABILITY; EXPRESSION; STRAIN	Fixed nitrogen (N) often limits the growth of organisms in terrestrial and aquatic biomes(1,2), and N availability has been important in controlling the CO2 balance of modern and ancient oceans(3,4). The fixation of atmospheric dinitrogen gas (N-2) to ammonia is catalysed by nitrogenase and provides a fixed N for N-limited environments(2,5). The filamentous cyanobacterium Trichodesmium has been assumed to be the predominant oceanic N-2-fixing microorganism since the discovery of N-2 fixation in Trichodesmium in 1961 (ref. 6). Attention has recently focused on oceanic N-2 fixation because nitrogen availability is generally limiting in many oceans, and attempts to constrain the global atmosphere-ocean fluxes of CO2 are based on basin-scale N balances(7-9). Biogeochemical studies and models have suggested that total N-2-fixation rates may be substantially greater than previously believed(7,8) but cannot be reconciled with observed Trichodesmium abundances(8,9). It is curious that there are so few known N-2-fixing microorganisms in oligotrophic oceans when it is clearly ecologically advantageous. Here we show that there are unicellular cyanobacteria in the open ocean that are expressing nitrogenase, and are abundant enough to potentially have a significant role in N dynamics.	Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Woods Hole Oceanographic Institution; University System of Georgia; Georgia Institute of Technology; University of Hawaii System	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.		Montoya, Joseph/C-3115-2013; Steward, Grieg F./D-9768-2011; Zehr, Jonathan P/B-3513-2014; Karl, David/AFP-3837-2022	Montoya, Joseph/0000-0001-7197-4660; Steward, Grieg F./0000-0001-5988-0522; Zehr, Jonathan P/0000-0002-5691-5408; Karl, David/0000-0002-6660-6721; Omoregie, Enoma/0000-0002-7701-4182				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BRASS S, 1994, APPL ENVIRON MICROB, V60, P2575, DOI 10.1128/AEM.60.7.2575-2583.1994; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; DUGDALE RC, 1961, DEEP-SEA RES, V7, P298; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; HAWSER SP, 1992, J APPL PHYCOL, V4, P79, DOI 10.1007/BF00003963; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2000, TRENDS MICROBIOL, V8, P301, DOI 10.1016/S0966-842X(00)01774-1; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Letelier RM, 1996, MAR ECOL PROG SER, V133, P263, DOI 10.3354/meps133263; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Neveux J, 1999, J GEOPHYS RES-OCEANS, V104, P3311, DOI 10.1029/98JC02000; PAERL HW, 1990, ADV MICROB ECOL, V11, P305; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wasmund N, 2001, MAR ECOL PROG SER, V214, P1, DOI 10.3354/meps214001; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	28	551	575	4	142	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					635	638		10.1038/35088063	http://dx.doi.org/10.1038/35088063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493920				2022-12-01	WOS:000170318000040
J	Lee, PY; Alexander, KP; Hammill, BG; Pasquali, SK; Peterson, ED				Lee, PY; Alexander, KP; Hammill, BG; Pasquali, SK; Peterson, ED			Representation of elderly persons and women in published randomized trials of acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; THROMBOLYTIC THERAPY; CLINICAL-TRIALS; AGE; MORTALITY; OLDER	Context Elderly persons and women were underrepresented in randomized controlled trials (RCTs) prior to 1990. Since then, efforts have been made to correct these biases, but their effect is unclear. Objective To determine whether the percentage of elderly persons and women in published clinical trials of acute coronary syndromes has increased and how this enrollment compared with disease prevalence. Data Sources The MEDLINE and Cochrane databases were searched for English-language articles from January 1966 to March 2000 regarding myocardial infarction, unstable angina, or acute coronary syndromes. Additional data sources included meta-analyses, review articles, and cardiology textbooks. Estimates of community-based myocardial infarction rates came from the National Registry of Myocardial Infarction and the Worcester Heart Study. Study Selection Published RCTs of acute coronary syndrome patients were included and trials enrolling 50 patients or fewer, those without clinical end points, papers published in a language other than English, and unpublished manuscripts were excluded. Of 7645 studies identified, 593 RCTs were selected for review. Data Extraction The RCTs were abstracted by 2 of the authors for year of publication, source of support (ie, funding), pharmacotherapy, study phase, number of study sites, trial location, number of patients, mean age of the study population, and any age exclusion criteria for enrollment. Data Synthesis The number of published RCTs with explicit age exclusions has declined from 58% during 1966-1990 to 40% during 1991-2000. Trial enrollment of patients aged 75 years or older increased from 2% for studies published during 1966-1990 to 9% during 1991-2000, but remains well below their representation among all patients with myocardial infarction (37%) in the United States. Enrollment of women has risen from 20% for studies published between 1966-1990 to 25% during 1991-2000, but remains well below their proportion of all patients with myocardial infarction (43%) in the United States. Conclusions Attempts at making cardiovascular RCTs more inclusive appear to have had limited success; thus, women and elderly persons remain underrepresented in published trial literature relative to their disease prevalence. Because safety and efficacy can vary as a function of sex and age, these enrollment biases undermine efforts to provide evidence-based care to all cardiac patients.	Duke Univ, Med Ctr, Dept Med, Outcomes Res & Assessment Grp, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, Dept Med, Outcomes Res & Assessment Grp, Box 3236, Durham, NC 27710 USA.		Peterson, Eric David/ABF-5033-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T35GM008679] Funding Source: NIH RePORTER; NIGMS NIH HHS [T35-GM-08679] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; DOUGLAS PS, 1986, CIRCULATION, V74, P917, DOI 10.1161/01.CIR.74.5.917; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.268.11.1417; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; JECKER NS, 1991, JAMA-J AM MED ASSOC, V266, P3012, DOI 10.1001/jama.266.21.3012; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; MACDONALD ET, 1982, DRUG TREATMENT ELDER, P217; National Institutes of Health, 1994, FED REGISTER, V59, P11146; *NIH, 1990, PUBL NIH; RICH MW, 1992, AM J MED, V92, P7, DOI 10.1016/0002-9343(92)90008-Y; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; *US FDA, 1989, GUID STUD DRUGS LIK; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; VOGT TM, 1986, CONTROL CLIN TRIALS, V7, P118, DOI 10.1016/0197-2456(86)90028-0; [No title captured]	21	625	642	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					708	713		10.1001/jama.286.6.708	http://dx.doi.org/10.1001/jama.286.6.708			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495621	Bronze			2022-12-01	WOS:000170271500027
J	Wilkinson, DM				Wilkinson, DM			At cross purposes - How do we cope with scientific terms that have two different definitions?	NATURE			English	Editorial Material									Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	Liverpool John Moores University	Wilkinson, DM (corresponding author), Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England.							Douglas A.E., 1994, SYMBIOTIC INTERACTIO; Margulis L., 1998, SYMBIOTIC PLANET	2	30	33	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					485	485		10.1038/35087676	http://dx.doi.org/10.1038/35087676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484028				2022-12-01	WOS:000170202900022
J	Tewksbury, JJ; Nabhan, GP				Tewksbury, JJ; Nabhan, GP			Seed dispersal - Directed deterrence by capsaicin in chillies	NATURE			English	Article							FRUIT; PAIN		Univ Montana, Dept Biol Sci, Missoula, MT 59812 USA; No Arizona Univ, Ctr Sustainable Environm, Flagstaff, AZ 86011 USA	University of Montana System; University of Montana; Northern Arizona University	Tewksbury, JJ (corresponding author), Univ Florida, Dept Zool, Box 118525, Gainesville, FL 32611 USA.			Tewksbury, Joshua/0000-0002-9786-1477				Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; CORDELL GA, 1993, ANN PHARMACOTHER, V27, P330, DOI 10.1177/106002809302700316; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; JANSEN DH, 1969, EVOLUTION, V23, P1; MASON JR, 1991, J CHEM ECOL, V17, P2539, DOI 10.1007/BF00994601; McKey D., 1975, COEVOLUTION ANIMALS, P158; NORMAN DM, 1992, WILSON BULL, V104, P549; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x	11	200	211	5	94	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					403	404		10.1038/35086653	http://dx.doi.org/10.1038/35086653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473305				2022-12-01	WOS:000170068200035
J	Drummond, PD				Drummond, PD			Mechanism of complex regional pain syndrome: no longer excessive sympathetic outflow?	LANCET			English	Editorial Material							PERIAQUEDUCTAL GRAY; LOCUS-COERULEUS; DYSTROPHY; RESPONSES; RATS		Murdoch Univ, Sch Psychol, Murdoch, WA 6150, Australia	Murdoch University	Drummond, PD (corresponding author), Murdoch Univ, Sch Psychol, Murdoch, WA 6150, Australia.							Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; ARNOLD JMO, 1993, ANN INTERN MED, V118, P619, DOI 10.7326/0003-4819-118-8-199304150-00008; Bajic D, 1999, J COMP NEUROL, V405, P359; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Butler SH, 2000, PROG PAIN RES MANAG, V16, P657; HODGE CJ, 1983, BRAIN RES, V288, P325, DOI 10.1016/0006-8993(83)90111-7; JONES SL, 1991, PROG BRAIN RES, V88, P381; Ochoa JL, 1999, J NEUROL, V246, P875, DOI 10.1007/s004150050476; Perl ER, 1999, P NATL ACAD SCI USA, V96, P7664, DOI 10.1073/pnas.96.14.7664; Rommel O, 1999, PAIN, V80, P95, DOI 10.1016/S0304-3959(98)00202-4; SATO J, 1993, NEUROSCI LETT, V164, P225, DOI 10.1016/0304-3940(93)90897-T; TRACEY DJ, 1995, INFLAMM RES, V44, P407, DOI 10.1007/BF01757696; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Zhang C, 1998, BRAIN RES, V784, P116, DOI 10.1016/S0006-8993(97)01197-9; Zhang YH, 1997, J PHYSIOL-LONDON, V503, P177, DOI 10.1111/j.1469-7793.1997.177bi.x	15	31	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					168	170		10.1016/S0140-6736(01)05400-9	http://dx.doi.org/10.1016/S0140-6736(01)05400-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476829				2022-12-01	WOS:000169967100005
J	Tettelin, H; Nelson, KE; Paulsen, IT; Eisen, JA; Read, TD; Peterson, S; Heidelberg, J; DeBoy, RT; Haft, DH; Dodson, RJ; Durkin, AS; Gwinn, M; Kolonay, JF; Nelson, WC; Peterson, JD; Umayam, LA; White, O; Salzberg, SL; Lewis, MR; Radune, D; Holtzapple, E; Khouri, H; Wolf, AM; Utterback, TR; Hansen, CL; McDonald, LA; Feldblyum, TV; Angiuoli, S; Dickinson, T; Hickey, EK; Holt, IE; Loftus, BJ; Yang, F; Smith, HO; Venter, JC; Dougherty, BA; Morrison, DA; Hollingshead, SK; Fraser, CM				Tettelin, H; Nelson, KE; Paulsen, IT; Eisen, JA; Read, TD; Peterson, S; Heidelberg, J; DeBoy, RT; Haft, DH; Dodson, RJ; Durkin, AS; Gwinn, M; Kolonay, JF; Nelson, WC; Peterson, JD; Umayam, LA; White, O; Salzberg, SL; Lewis, MR; Radune, D; Holtzapple, E; Khouri, H; Wolf, AM; Utterback, TR; Hansen, CL; McDonald, LA; Feldblyum, TV; Angiuoli, S; Dickinson, T; Hickey, EK; Holt, IE; Loftus, BJ; Yang, F; Smith, HO; Venter, JC; Dougherty, BA; Morrison, DA; Hollingshead, SK; Fraser, CM			Complete genome sequence of a virulent isolate of Streptococcus pneumoniae	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; MICROBIAL GENE IDENTIFICATION; HAEMOPHILUS-INFLUENZAE; MARKOV-MODELS; TRANSFORMATION; ELEMENT; LIPOPROTEINS; COMPETENCE; CHROMOSOME; EXPRESSION	The 2,160,837-base pair genome sequence of an isolate of Streptococcus pneumoniae, a Cram-positive pathogen that causes pneumonia, bacteremia, meningitis, and otitis media, contains 2236 predicted coding regions; of these, 1440 (64%) were assigned a biological role. Approximately 5% of the genome is composed of insertion sequences that may contribute to genome rearrangements through uptake of foreign DNA. Extracellular enzyme systems for the metabolism of polysaccharides and hexosamines provide a substantial source of carbon and nitrogen for S. pneumoniae and also damage host tissues and facilitate colonization. A motif identified within the signal peptide of proteins is potentially involved in targeting these proteins to the cell surface of low-guanine/cytosine (GC) Gram-positive species. Several surface-exposed proteins that may serve as potential vaccine candidates were identified. Comparative genome hybridization with DNA arrays revealed strain differences in S. pneumoniae that could contribute to differences in virulence and antigenicity.	Inst Genome Res TIGR, Rockville, MD 20850 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; George Washington Univ, Med Ctr, Washington, DC 20037 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA; Univ Illinois, Chicago, IL 60607 USA; Univ Alabama, Birmingham, AL 35294 USA	J. Craig Venter Institute; Johns Hopkins University; George Washington University; Bristol-Myers Squibb; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alabama System; University of Alabama Birmingham	Fraser, CM (corresponding author), Inst Genome Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven L/F-6162-2011; Nelson, William C/E-9263-2016; Read, Timothy/E-6240-2011; Eisen, Jonathan A./H-2706-2019; Paulsen, Ian T/K-3832-2012; Angiuoli, Samuel V/H-7340-2014; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Paulsen, Ian T/0000-0001-9015-9418; Salzberg, Steven/0000-0002-8859-7432; Fraser, Claire/0000-0003-1462-2428; loftus, brendan/0000-0001-8871-8356; Heidelberg, John/0000-0003-0673-3224; Read, Timothy/0000-0001-8966-9680; Angiuoli, Samuel/0000-0001-9525-4350	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040645] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI40645-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BANERJEI L, COMMUNICATION; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENSON G, 1994, NUCLEIC ACIDS RES, V22, P4828, DOI 10.1093/nar/22.22.4828; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; CHANDLER M, 1993, MOL MICROBIOL, V7, P497, DOI 10.1111/j.1365-2958.1993.tb01140.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DAVIES J, 1995, INFECT IMMUN, V63, P2485, DOI 10.1128/IAI.63.7.2485-2492.1995; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Garcia E, 2000, RES MICROBIOL, V151, P429, DOI 10.1016/S0923-2508(00)00173-X; Garcia JL, 2000, STREPTOCOCCUS PNEUMO, P231; GASC AM, 1991, J BACTERIOL, V173, P7361, DOI 10.1128/jb.173.22.7361-7367.1991; Gill SI, COMMUNICATION; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3; HUMBERT O, 1995, P NATL ACAD SCI USA, V92, P9052, DOI 10.1073/pnas.92.20.9052; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; PACE NR, 1995, J BACTERIOL, V177, P1919, DOI 10.1128/jb.177.8.1919-1928.1995; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; PEARCE BJ, 1994, MOL MICROBIOL, V12, P881, DOI 10.1111/j.1365-2958.1994.tb01076.x; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; SMITH MD, 1979, J BACTERIOL, V137, P735, DOI 10.1128/JB.137.2.735-739.1979; Sutton G.G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; TOMASZ A, 1995, NEW ENGL J MED, V333, P514, DOI 10.1056/NEJM199508243330810; VIDGREN G, 1992, J BACTERIOL, V174, P7419, DOI 10.1128/jb.174.22.7419-7427.1992; WEISER JN, 2000, STREPTOCOCCUS PNEUMO, P245; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; WOOD WB, 1949, J EXP MED, V90	60	1056	1658	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					498	506		10.1126/science.1061217	http://dx.doi.org/10.1126/science.1061217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463916				2022-12-01	WOS:000169966700049
J	Hermankova, M; Ray, SC; Ruff, C; Powell-Davis, M; Ingersoll, R; D'Aquila, RT; Quinn, TC; Siliciano, RF; Persaud, D				Hermankova, M; Ray, SC; Ruff, C; Powell-Davis, M; Ingersoll, R; D'Aquila, RT; Quinn, TC; Siliciano, RF; Persaud, D			HIV-1 drug resistance profiles in children and adults with viral load of < 50 copies/mL receiving combination therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; LATENT RESERVOIR; GENOTYPIC RESISTANCE; PROTEASE INHIBITOR; CONFERS RESISTANCE; INFECTED PATIENTS; PLASMA VIREMIA; IN-VIVO	Context The continued release of human immunodeficiency virus type 1 (HIV-1) into plasma at very low levels during highly active antiretroviral therapy (HAART) can be detected using specialized techniques, but the nature and significance of this low-level viremia, especially as related to acquisition of drug resistance mutations, are unclear. Objective To determine genetic resistance profiles of low-level plasma HIV-1 in patients with prolonged viral suppression (<50 copies/mL of plasma HIV-1 RNA) while receiving HAART. Design and Setting Cross-sectional study conducted at a US academic hospital from November 1999 to February 2001 using a novel method for amplification of low levels of viral genomes in plasma. Patients Eighteen HIV-1-infected patients (7 children and 11 adults), enrolled in a longitudinal study of HIV-1 reservoirs, who had suppression of viral replication while receiving protease inhibitor-containing combination therapy. Two patients (1 adult and 1 child) with less optimal suppression of viral replication were included to assess virus predominating when plasma HIV-1 RNA levels are low but detectable (<1000 copies/mL). Follow-up analyses were conducted in 3 patients. Main Outcome Measure Detection of drug resistance mutations in clones amplified from low-level plasma virus. Results Viral sequences were amplified from 8 of the 18 patients with simultaneous plasma HIV-1 measurements of less than 50 copies/mL and from 2 patients with 231 and 50 copies/mL. Clones from 3 treatment-naive patients with less than 50 copies/mL of plasma HIV-1 RNA showed continued release, for as long as 42 months, of wild-type drug-sensitive virus. The 7 patients with prior nonsuppressive therapy, with viral loads below 50 copies/mL and during "blips" to 231 and 64 copies/mL, had only resistance mutations consistent with pre-HAART therapy (although reverse transcriptase inhibitor mutations may have continued to occur), New HAART-related mutations were seen in a control patient with prior viral load levels of about 400 to 1000 copies/mL. For phylogenetic analysis, sequences were available for both resting CD4(+) T cells and plasma HIV for 7 of 10 patients and showed patient-specific clustering of sequences and a close relationship between virus in the plasma and the latent reservoir. Conclusions Based on the samples that could be amplified, low-level viremia in children and adults receiving HAART with prolonged suppression of viremia to less than 50 copies/mL of HIV-1 RNA may result primarily from archival, pre-HAART virus, reflecting earlier treatment conditions, and does not appear to require development of new, HAART-selected mutations reflecting partial resistance to therapy. Low-level viremia below 50 copies/mL may represent less of a concern regarding impending drug failure of current HAART regimens, However, the archival drug-resistant virus may be relevant regarding future treatment strategies.	Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Genet, Baltimore, MD USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; NIAID, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Persaud, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, 600 N Wolfe St,256 Pk Bldg, Baltimore, MD 21287 USA.		Ray, Stuart C./B-7527-2008; Quinn, Thomas/A-2494-2010	Ray, Stuart C./0000-0002-1051-7260; , Roxann/0000-0002-4266-613X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD027799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, R01AI029193, Z01AI000361] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29193, AI43222] Funding Source: Medline; NICHD NIH HHS [P30HD27799] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Atkinson B, 2000, J INFECT DIS, V182, P420, DOI 10.1086/315726; Brown AJL, 1997, NAT MED, V3, P268, DOI 10.1038/nm0397-268; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; de Mendoza C, 2000, J ACQ IMMUN DEF SYND, V23, P279; Demeter LM, 2000, ANTIMICROB AGENTS CH, V44, P794, DOI 10.1128/AAC.44.3.794-797.2000; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Felsenstein J., 1985, EVOLUTION 1985, V39, P783; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Grossman Z, 1998, IMMUNOL TODAY, V19, P528, DOI 10.1016/S0167-5699(98)01353-X; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 1999, J VIROL, V73, P9404; Gunthard HF, 1998, J VIROL, V72, P2422; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hertogs K, 2000, ANTIMICROB AGENTS CH, V44, P568, DOI 10.1128/AAC.44.3.568-573.2000; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Ho DD, 2000, NAT MED, V6, P736, DOI 10.1038/77447; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; MARKOWITZ M, 1995, J VIROL, V69, P701, DOI 10.1128/JVI.69.2.701-706.1995; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; Melvin AJ, 1999, J ACQ IMMUN DEF SYND, V20, P468, DOI 10.1097/00042560-199904150-00009; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Patick AK, 1998, ANTIMICROB AGENTS CH, V42, P2637, DOI 10.1128/AAC.42.10.2637; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Rouzine IM, 1999, P NATL ACAD SCI USA, V96, P10758, DOI 10.1073/pnas.96.19.10758; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Smith DB, 1997, J GEN VIROL, V78, P1511, DOI 10.1099/0022-1317-78-7-1511; SWOFFORD DL, 2000, PAUP ASTERISK PHYLOG; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Winters MA, 1998, J CLIN INVEST, V102, P1769, DOI 10.1172/JCI4948; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2000, AIDS, V14, P243, DOI 10.1097/00002030-200002180-00006; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	47	178	184	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					196	207		10.1001/jama.286.2.196	http://dx.doi.org/10.1001/jama.286.2.196			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448283	Bronze			2022-12-01	WOS:000169798700025
J	Lowenfels, AB; Maisonneuve, P; Whitcomb, DC; Lerch, MM; DiMagno, EP				Lowenfels, AB; Maisonneuve, P; Whitcomb, DC; Lerch, MM; DiMagno, EP			Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									New York Med Coll, Dept Surg & Community & Prevent Med, Valhalla, NY 10595 USA; European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; Univ Pittsburgh, Ctr Genom Sci, Pittsburgh, PA USA; Univ Munster, Dept Med B, D-4400 Munster, Germany; Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN 55905 USA	New York Medical College; IRCCS European Institute of Oncology (IEO); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Munster; Mayo Clinic	Lowenfels, AB (corresponding author), New York Med Coll, Dept Surg & Community & Prevent Med, Valhalla, NY 10595 USA.		Lerch, Markus M./E-2206-2016; Lowenfels, Albert/ABD-8388-2021; Maisonneuve, Patrick/U-9789-2018	Lerch, Markus M./0000-0002-9643-8263; Maisonneuve, Patrick/0000-0002-5309-4704	NIDDK NIH HHS [DK54709] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054709] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DEMESQUITA HBB, 1991, INT J CANCER, V49, P816, DOI 10.1002/ijc.2910490604; Efthimiou E, 2001, GUT, V48, P143, DOI 10.1136/gut.48.2.143; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Schenk M, 2001, JNCI-J NATL CANCER I, V93, P640, DOI 10.1093/jnci/93.8.640; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	5	205	219	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					169	170		10.1001/jama.286.2.169	http://dx.doi.org/10.1001/jama.286.2.169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448279				2022-12-01	WOS:000169798700020
J	McNamara, P; Seo, SB; Rudic, RD; Sehgal, A; Chakravarti, D; FitzGerald, GA				McNamara, P; Seo, SB; Rudic, RD; Sehgal, A; Chakravarti, D; FitzGerald, GA			Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: A humoral mechanism to reset a peripheral clock	CELL			English	Article							CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; DIURNAL-VARIATION; RETINOIC ACID; MESSENGER-RNA; EXPRESSION; LOOP; TISSUES; TRANSCRIPTION; OSCILLATORS	Circadian clock genes are expressed in the suprachiasmatic nucleus and in peripheral tissues to regulate cyclically physiological processes. Synchronization of peripheral oscillators is thought to involve humoral signals, but the mechanisms by which these are mediated and integrated are poorly understood. We report a hormone-dependent interaction of the nuclear receptors, RAR alpha and RXR alpha, with CLOCK and MOP4. These interactions negatively regulate CLOCK/MOP4: BMAL1-mediated transcriptional activation of clock gene expression in vascular cells. MOP4 exhibits a robust rhythm in the vasculature, and retinoic acid can phase shift Per2 mRNA rhythmicity in vivo and in serum-induced smooth muscle cells in vitro, providing a molecular mechanism for hormonal central of clock gene expression. We propose that circadian or periodic availability of nuclear hormones may play a critical role in resetting a peripheral vascular clock.	Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010; Rudic, Dan/B-3432-2016	Rudic, Dan/0000-0001-9122-3127; Chakravarti, Debabrata/0000-0001-8446-8599	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, P50HL054500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057079] Funding Source: NIH RePORTER; NHLBI NIH HHS [1P50HL54500, P01 HL62250-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK057079, R01-DK57079-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi M, 2000, GENE DEV, V14, P645; Amir S, 1998, NEUROSCIENCE, V86, P345, DOI 10.1016/S0306-4522(98)00172-9; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glass CK, 2000, GENE DEV, V14, P121; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HOSSMANN V, 1980, CARDIOVASC RES, V14, P125, DOI 10.1093/cvr/14.3.125; Ishida N, 1999, P NATL ACAD SCI USA, V96, P8819, DOI 10.1073/pnas.96.16.8819; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; MILLARCRAIG MW, 1978, LANCET, V1, P795; Muller JE, 1999, AM J HYPERTENS, V12, p35S, DOI 10.1016/S0895-7061(98)00278-7; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Rajendran RR, 1996, J EXP BIOL, V199, P2775; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; RIDKER PM, 1990, CIRCULATION, V82, P897, DOI 10.1161/01.CIR.82.3.897; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schulman IG, 1996, MOL CELL BIOL, V16, P3807; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; TSEMENTZIS SA, 1985, NEUROSURGERY, V17, P901, DOI 10.1227/00006123-198512000-00005; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Westin S, 2000, ADV PHARMACOL, V47, P89; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	49	363	375	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2001	105	7					877	889		10.1016/S0092-8674(01)00401-9	http://dx.doi.org/10.1016/S0092-8674(01)00401-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439184	Bronze			2022-12-01	WOS:000169664300008
J	Takayama, S; Ostuni, E; LeDuc, P; Naruse, K; Ingber, DE; Whitesides, GM				Takayama, S; Ostuni, E; LeDuc, P; Naruse, K; Ingber, DE; Whitesides, GM			Laminar flows - Subcellular positioning of small molecules	NATURE			English	Article									Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Takayama, S (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	gwhitesides@gmwgroup.harvard.edu	Ingber, Donald E/AAC-5894-2019; Sokabe, Masahiro/I-1565-2012; NARUSE, Keiji/B-1620-2011	naruse, keiji/0000-0003-4100-6444				Ayscough K, 1998, METHOD ENZYMOL, V298, P18, DOI 10.1016/S0076-6879(98)98004-1; BALL EH, 1982, P NATL ACAD SCI-BIOL, V79, P123, DOI 10.1073/pnas.79.1.123; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	10	428	455	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1016	1016		10.1038/35082637	http://dx.doi.org/10.1038/35082637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429594	Green Published, Bronze			2022-12-01	WOS:000169528500037
J	Pearson, DL; Dawling, S; Walsh, WF; Haines, JL; Christman, BW; Bazyk, A; Scott, N; Summar, ML				Pearson, DL; Dawling, S; Walsh, WF; Haines, JL; Christman, BW; Bazyk, A; Scott, N; Summar, ML			Neonatal pulmonary hypertension - Urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYALINE-MEMBRANE DISEASE; L-ARGININE; RELAXING FACTOR; BIOLOGICAL-FLUIDS; VASCULAR TONE; END-PRODUCTS; NEWBORN; NITRATE; ENDOTHELIN-1; CIRCULATION	Background: Endogenous production of nitric oxide is vital for the decrease in pulmonary vascular resistance that normally occurs after birth. The precursor of nitric oxide is arginine, a urea-cycle intermediate. We hypothesized that low concentrations of arginine would correlate with the presence of persistent pulmonary hypertension in newborns and that the supply of this precursor would be affected by a functional polymorphism (the substitution of asparagine for threonine at position 1405 [T1405N]) in carbamoyl-phosphate synthetase, which controls the rate-limiting step of the urea cycle. Methods: Plasma concentrations of amino acids and genotypes of the carbamoyl-phosphate synthetase variants were determined in 65 near-term neonates with respiratory distress. Plasma nitric oxide metabolites were measured in a subgroup of 10 patients. The results in infants with pulmonary hypertension, as assessed by echocardiography, were compared with those in infants without pulmonary hypertension. The frequencies of the carbamoyl-phosphate synthetase genotypes in the study population were assessed for Hardy-Weinberg equilibrium. Results: As compared with infants without pulmonary hypertension, infants with pulmonary hypertension had lower mean (+/-SD) plasma concentrations of arginine (20.2+/-8.8 vs. 39.8+/-17.0 micromol per liter, P<0.001) and nitric oxide metabolites (18.8+/-12.7 vs. 47.2+/-11.2 micromol per liter, P = 0.05). As compared with the general population, the infants in the study had a significantly skewed distribution of the genotypes for the carbamoyl-phosphate synthetase variants at position 1405 (P<0.005). None of the infants with pulmonary hypertension were homozygous for the T1405N polymorphism. Conclusions: Infants with persistent pulmonary hypertension have low plasma concentrations of arginine and nitric oxide metabolites. The simultaneous presence of diminished concentrations of precursors and breakdown products suggests that inadequate production of nitric oxide is involved in the pathogenesis of neonatal pulmonary hypertension. Our preliminary observations suggest that the genetically predetermined capacity of the urea cycle - in particular, the efficiency of carbamoyl-phosphate synthetase - may contribute to the availability of precursors for nitric oxide synthesis. (N Engl J Med 2001;344:1832-8.) Copyright (C) 2001 Massachusetts Medical Society.	Vanderbilt Univ, Med Ctr, Div Med Genet, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Internal Med, Div Pulm Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Summar, ML (corresponding author), Vanderbilt Univ, Med Ctr, Div Med Genet, Dept Pediat, DD 2205 Med Ctr N, Nashville, TN 37232 USA.	marshall.summar@mcmail.vanderbilt.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Summar, Marshall/0000-0001-8920-0110	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009915] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES-09915] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABMAN SH, 1990, AM J PHYSIOL, V259, pH1921, DOI 10.1152/ajpheart.1990.259.6.H1921; [Anonymous], 1997, NEW ENGL J MED, V337, P434; BAIG MMA, 1992, PEDIATR RES, V31, P143, DOI 10.1203/00006450-199202000-00010; CASTILLO L, 1995, PEDIATR RES, V38, P17, DOI 10.1203/00006450-199507000-00004; Christou H, 1997, J PEDIATR-US, V130, P603, DOI 10.1016/S0022-3476(97)70245-2; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; CORNFIELD DN, 1992, AM J PHYSIOL, V262, pH1474, DOI 10.1152/ajpheart.1992.262.5.H1474; Diaz J, 1998, CLIN BIOCHEM, V31, P513, DOI 10.1016/S0009-9120(98)00051-4; DOLLBERG S, 1995, PEDIATR RES, V37, P31, DOI 10.1203/00006450-199501000-00007; Endo A, 1996, BIOL NEONATE, V70, P15; EVANS NJ, 1991, ARCH DIS CHILD-FETAL, V66, P6, DOI 10.1136/adc.66.1_Spec_No.6; FINEMAN JR, 1994, J CLIN INVEST, V93, P2675, DOI 10.1172/JCI117281; FINEMAN JR, 1995, ANNU REV PHYSIOL, V57, P115; GRANGER DL, 1990, J CLIN INVEST, V85, P264, DOI 10.1172/JCI114422; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; HECKER M, 1990, P NATL ACAD SCI USA, V87, P8612, DOI 10.1073/pnas.87.21.8612; Lepage N, 1997, CLIN CHEM, V43, P2397; Lipsitz EC, 1996, J PEDIATR SURG, V31, P137, DOI 10.1016/S0022-3468(96)90336-X; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NELIN LD, 1994, PEDIATR RES, V35, P20, DOI 10.1203/00006450-199401000-00006; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; RAIHA NCR, 1968, ACTA PAEDIATR SCAND, V57, P121, DOI 10.1111/j.1651-2227.1968.tb04663.x; RIVERA A, 1989, J PEDIATR-US, V115, P465, DOI 10.1016/S0022-3476(89)80858-3; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; SHAUL PW, 1992, AM J PHYSIOL, V262, pH355, DOI 10.1152/ajpheart.1992.262.2.H355; SKINNER JR, 1992, ARCH DIS CHILD-FETAL, V67, P366, DOI 10.1136/adc.67.4_Spec_No.366; Stork E, 1997, NEW ENGL J MED, V336, P597; Summar ML, 1999, AM J HUM GENET, V65, pA25; VOSATKA RJ, 1994, BIOL NEONATE, V66, P65; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Xie LJ, 2000, SEMIN PERINATOL, V24, P42, DOI 10.1016/S0146-0005(00)80054-3	33	157	168	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2001	344	24					1832	1838		10.1056/NEJM200106143442404	http://dx.doi.org/10.1056/NEJM200106143442404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441LC	11407344				2022-12-01	WOS:000169231000004
J	Drab, M; Verkade, P; Elger, M; Kasper, M; Lohn, M; Lauterbach, B; Menne, J; Lindschau, C; Mende, F; Luft, FC; Schedl, A; Haller, H; Kurzchalia, TV				Drab, M; Verkade, P; Elger, M; Kasper, M; Lohn, M; Lauterbach, B; Menne, J; Lindschau, C; Mende, F; Luft, FC; Schedl, A; Haller, H; Kurzchalia, TV			Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice	SCIENCE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; IN-VIVO; PROTEIN; TRANSPORT; CHOLESTEROL; CELLS; VIP21-CAVEOLIN; COMPONENT; MUSCLE	Caveolae are plasma membrane invaginations that may play an important role in numerous cellular processes including transport, signaling, and tumor suppression. By targeted disruption of caveolin-1, the main protein component of caveolae, we generated mice that lacked caveolae. The absence of this organelle impaired nitric oxide and calcium signaling in the cardiovascular system, causing aberrations in endothelium-dependent relaxation, contractility, and maintenance of myogenic tone. In addition, the lungs of knockout animals displayed thickening of alveolar septa caused by uncontrolled endothelial cell proliferation and fibrosis, resulting in severe physical limitations in caveolin-1-disrupted mice. Thus, caveolin-1 and caveolae play a fundamental role in organizing multiple signaling pathways in the cell.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Humboldt Univ, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Hannover Med Sch, D-30625 Hannover, Germany; Tech Univ Dresden, Inst Anat, D-01307 Dresden, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Hannover Medical School; Technische Universitat Dresden	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 108, D-01307 Dresden, Germany.		Drab, Marek/AAQ-1892-2020; Verkade, Paul/N-7240-2014; Lindschau, Carsten/AAE-6721-2020; Drab, Marek/J-5196-2013; Lindschau, Carsten/G-1798-2011; Schedl, Andreas/GOP-3427-2022; Schedl, Andreas/F-8823-2015; Eckhardt, Erik/G-1567-2010	Verkade, Paul/0000-0002-2497-1026; Drab, Marek/0000-0002-2771-1692; Lindschau, Carsten/0000-0003-1960-099X; Schedl, Andreas/0000-0001-9380-7396; Luft, Friedrich/0000-0002-8635-1199				Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; HALLER H, 1995, CIRC RES, V76, P21, DOI 10.1161/01.RES.76.1.21; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; PALADE GE, 1960, ANAT REC, V136, P254; PALADE GE, 1953, J APPL PHYS, V24, P1424; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427	25	1247	1287	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2449	2452		10.1126/science.1062688	http://dx.doi.org/10.1126/science.1062688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11498544				2022-12-01	WOS:000171237200046
J	Munshi, N; Agalioti, T; Lomvardas, S; Merika, M; Chen, GY; Thanos, D				Munshi, N; Agalioti, T; Lomvardas, S; Merika, M; Chen, GY; Thanos, D			Coordination of a transcriptional switch by HMGI(Y) acetylation	SCIENCE			English	Article							IFN-BETA ENHANCEOSOME; GENE-EXPRESSION; RECRUITMENT; ACTIVATION; INDUCTION	Dynamic control of interferon-beta (IFN-beta) gene expression requires the regulated assembly and disassembly of the enhanceosome, a higher-order nucleoprotein complex formed in response to virus infection. The enhanceosome activates transcription by recruiting the histone acetyltransferase proteins CREB binding protein (CBP) and (p) under bar 300/(C) under bar BP-(a) under bar ssociated (f) under bar actors (PCAF)/GCN5, which, in addition to modifying histones, acetylate HMGI(Y), the architectural component required for enhanceosome assembly. We show that the accurate execution of the IFN-P transcriptional switch depends on the ordered acetylation of the high-mobility group I protein HMGI(Y) by PCAF/GCN5 and CBP, which acetylate HMGI(Y) at distinct lysine residues on endogenous promoters. Whereas acetylation of HMGI(Y) by CBP at lysine-65 destabilizes the enhanceosome, acetylation of HMGI(Y) by PCAF/GCN5 at lysine-71 potentiates transcription by stabilizing the enhanceosome and preventing acetylation by CBP.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Munshi, Nikhil/ABE-2338-2021; Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026; Agalioti, Theodora/0000-0002-5898-2751	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367, R01GM054605] Funding Source: NIH RePORTER; NIGMS NIH HHS [1RO1GM54605, 5-T32-GM07367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074	10	182	188	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1133	1136		10.1126/science.293.5532.1133	http://dx.doi.org/10.1126/science.293.5532.1133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498590				2022-12-01	WOS:000170432600059
J	Kaptchuk, TJ; Eisenberg, DM				Kaptchuk, TJ; Eisenberg, DM			Varieties of healing. 2: A taxonomy of unconventional healing practices	ANNALS OF INTERNAL MEDICINE			English	Review							FOLK MEDICINE; ALTERNATIVE MEDICINE; HEALTH; RELIGION; CARE; TRANSFUSION; BELIEFS; THERAPY; CULTURE; FAITH	The first of two essays in this issue demonstrated that the United States has had a rich history of medical pluralism. This essay seeks to present an overview of contemporary unconventional medical practices in the United States. No clear definition of "alternative medicine" is offered because it is a residual category composed of heterogeneous healing methods. A descriptive taxonomy of contemporary unconventional healing could be more helpful. Two broad categories of unconventional medicine are described here: a more prominent, "mainstream" complementary and alternative medicine (CAM) and a more culture-bound, "parochial" unconventional medicine. The CAM component can be divided into professional groups, layperson-initiated popular health reform movements, New Age healing, alternative psychological therapies, and non-normative scientific enterprises. The parochial category can be divided into ethno-medicine, religious healing, and folk medicine. A topologic examination of U.S. health care can provide an important conceptual framework through which health care providers can understand the current situation in U.S. medical pluralism.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kaptchuk, TJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,W-K-400, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Albanese Catherine L., 1990, NATURE RELIG AM ALGO; ALBRECHT GL, 1982, RES SOCIOLOGY HLTH C, V2; AMUNDSEN DW, 1982, B HIST MED, V56, P326; ANDERSON J, 1997, NEWSDAY         1105, pB10; [Anonymous], 2000, LANCET, V356, P2023; [Anonymous], 1982, CRUSADERS FITNESS HI; Baer H A, 1992, Med Anthropol, V13, P369; Barnes LL, 1998, CULT MED PSYCHIAT, V22, P413, DOI 10.1023/A:1005403825213; BARRETT S, 1985, JAMA-J AM MED ASSOC, V254, P1041, DOI 10.1001/jama.254.8.1041; Braden, 1987, SPIRITS REBELLION RI; Brown Karen McCarthy, 2001, M LOLA VODOU PRIESTE; BURROUGHS H, 1993, ALTERNATIVE HEALING; Cassileth BR, 1996, CANCER INVEST, V14, P396, DOI 10.3109/07357909609012168; CAVENDER AP, 1992, SOUTH MED J, V85, P170, DOI 10.1097/00007611-199202000-00012; Chopra Deepak, 1989, QUANTUM HEALING EXPL; COHEN C, 1992, PRIMARY CARE, V19, P87; COOK C, 1986, SOUTH MED J, V79, P1098, DOI 10.1097/00007611-198609000-00014; COOTER R, 1987, MED FRINGE MED ORTHO; COULEHAN JL, 1985, SOC SCI MED, V21, P383, DOI 10.1016/0277-9536(85)90218-7; Csordas Thomas J., 1994, SACRED SELF CULTURAL; CURRY P, 1987, ASTROLOGY SCI SOC HI; Deutsch RM, 1977, NEW NUTS BERRIES; DICK HG, 1946, J HIST MED, V13, P300; Dossey L., 1991, MEANING MED; DOWLING SJ, 1984, J ROY SOC MED, V77, P634, DOI 10.1177/014107688407700803; Easthope G, 1986, HEALERS ALTERNATIVE; EISENBERG DM, 1993, ANN INTERN MED, V118, P964, DOI 10.7326/0003-4819-118-12-199306150-00009; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; Eisenberg DM, 2000, JAMA-J AM MED ASSOC, V283, P885; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ellwood Robert S, 1979, ALTERNATIVE ALTARS U; English-Lueck JuneAnne., 1990, HLTH NEW AGE STUDY C; Ernst E, 1996, ARCH INTERN MED, V156, P2162, DOI 10.1001/archinte.156.19.2162; Ernst E, 1997, CIRCULATION, V96, P1031; Ernst E, 1999, FORSCH KOMPLEMENTMED, V6, P7, DOI 10.1159/000021201; Fadiman A, 1997, SPIRIT CATCHES YOU Y; FERNGREN GB, 1992, B HIST MED, V66, P1; FISCH S, 1968, MILBANK FUND Q, V46, P377, DOI 10.2307/3349335; Fox M, 1984, Med Anthropol, V8, P292; FUCHS M, 1975, MED CARE, V13, P915, DOI 10.1097/00005650-197511000-00004; Fuller Robert C, 1982, MESMERISM AM CURE SO; Furnham A, 2000, COMPLEMENT THER MED, V8, P82, DOI 10.1054/ctim.2000.0355; FYE WB, 1986, CIRCULATION, V73, P21, DOI 10.1161/01.CIR.73.1.21; GEBHARD B, 1976, AM FOLK MED; GEVITZ N, 1995, MT SINAI J MED, V62, P127; Gevitz N., 1988, OTHER HEALERS UNORTH, P124; Gevitz Norman, 1982, DOS OSTEOPATHIC MED; GLIK DC, 1988, SOC SCI MED, V27, P1197, DOI 10.1016/0277-9536(88)90349-8; GOLDMAN B, 1991, CAN MED ASSOC J, V144, P218; GOLDSTEIN MS, 1987, J HEALTH SOC BEHAV, V28, P103, DOI 10.2307/2137125; GOOD BJ, 1981, 8 PUBL REG HLTH CAR; Gordon JS., 1996, MANIFESTO NEW MED; GORT EH, 1988, SOC SCI MED, V26, P1061, DOI 10.1016/0277-9536(88)90224-9; HAFNER AW, 1993, READERS GUIDE ALTERN; HAFNER AW, 1992, GUIDE AM MED ASS HIS; HAND W D, 1971, Journal of the History of Medicine and Allied Sciences, V26, P263; Harrell David E., 1978, ALL THINGS ARE POSSI; Harwood A, 1977, Cult Med Psychiatry, V1, P69; Harwood A, 1981, ETHNICITY MED CARE; HELMAN C G, 1978, Culture Medicine and Psychiatry, V2, P107, DOI 10.1007/BF00054580; HERINK R, 1980, PSYCHOTHERAPY HDB; HEXHAM I, 1992, PERSPECTIVES NEW AGE; Hufford DJ, 1997, PRIMARY CARE, V24, P723, DOI 10.1016/S0095-4543(05)70307-9; Jacobs C F, 1990, Med Anthropol, V12, P349; JOHNSON DM, 1986, SOCIOL ANAL, V47, P66, DOI 10.2307/3711279; JOHNSON KP, 1998, E CAYCE CONTEXT; Johnson Shirley M., 1997, Journal of the American Osteopathic Association, V97, P80; JONES RK, 1970, SOCIOLOGY, V4, P181, DOI 10.1177/003803857000400203; JUDAH JS, 1967, HIST PHILOS METAPHYS; KANDEL RF, 1976, THESIS STATE U NEW Y; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; Kaptchuk TJ, 1998, ARCH INTERN MED, V158, P2215, DOI 10.1001/archinte.158.20.2215; Kaptchuk TJ, 1998, NUTRITION, V14, P471; KAPTCHUK TJ, 2001, FUNDAMENTALS COMPLEM; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; KAPTCHUK TJ, 1986, HEALING ARTS JOURNEY; KARASU TB, 1986, AM J PSYCHIAT, V143, P687; Kaufman Martin, 1971, HOMEOPATHY AM RISE F; Kelsey Morton T., 1973, HEALING CHRISTIANITY; Kemper K J, 1996, Pediatr Rev, V17, P279, DOI 10.1542/pir.17-8-279; Kerr H., 1983, OCCULT AM NEW HIST P; KING DE, 1988, J FAM PRACTICE, V27, P505; Kirmayer L. J, 1988, BIOMEDICINE EXAMINED; KIRSCHNER HE, 1991, LIVE FOOD JUICES; KLEINMAN AM, 1973, INQUIRY, V16, P206, DOI 10.1080/00201747308601685; KNAPP JE, 1990, NATL STUDY PROFESSIO; Ko CY, 1997, ARCH SURG-CHICAGO, V132, P829; KOENIG HG, 1988, J AM GERIATR SOC, V36, P362, DOI 10.1111/j.1532-5415.1988.tb02365.x; Kohl L, 1989, TAOIST MEDITATION LO; KRIEGER D, 1979, AM J NURS, V79, P660, DOI 10.2307/3462338; LAETZ T, 1991, JAMA-J AM MED ASSOC, V266, P2996, DOI 10.1001/jama.266.21.2996; LEIBOWITZ J, 1990, ALEXANDER TECHNIQUE; LERNER M, 1994, CHOICES HEALING INTE; LEVIN JS, 1986, SOC SCI MED, V23, P889, DOI 10.1016/0277-9536(86)90217-0; Levine HD, 1941, NEW ENGL J MED, V224, P487, DOI 10.1056/NEJM194103202241201; Linden Wolfgang, 1994, Annals of Behavioral Medicine, V16, P35; MANN MC, 1992, ANN INTERN MED, V117, P1042, DOI 10.7326/0003-4819-117-12-1042; MARTINEZ C, 1966, J AMER MED ASSOC, V196, P161, DOI 10.1001/jama.196.2.161; MATHEWS HF, 1987, SOUTHERN MED J, V80, P885, DOI 10.1097/00007611-198707000-00019; MCGUIRE MB, 1983, CULT MED PSYCHIAT, V7, P221, DOI 10.1007/BF00049311; McGuire Meredith, 1988, RITUAL HEALING SUBUR; Melton J.G., 1990, NEW AGE ENCY; MITCHELL BB, 1997, ACUPUNCTURE ORIENTAL; *NAT CTR HLTH STAT, 1975, OFF VIS OST PHYS JAN; National Institutes of Health, 1994, ALT MED EXP MED HOR; Numbers Ronald L., 1986, CARING CURING HLTH M; OConnor BB, 1995, STUDIES HLTH ILLNESS, Vxxiv; OPENHEIM J, 1988, OTHER WORLD SPIRITUA; OSHERSON S, 1981, SOCIAL CONTEXTS HLTH; PACHTER LM, 1994, JAMA-J AM MED ASSOC, V271, P690, DOI 10.1001/jama.271.9.690; *PAN DEF DESCR, 1997, ALTERN THER HEALTH M, V3, P49; Parker Gail Thain, 1973, MIND CURE NEW ENGLAN; PIETRONI PC, 1992, BRIT MED J, V305, P564, DOI 10.1136/bmj.305.6853.564; RINZLER CA, 1991, FEED COLD STARVE FEV; ROTHSTEIN W, 1972, AM PHYSICIANS 19 CEN; RYWERANT Y, 1983, FELDENKRAIS METHOD; SAKETKHOO K, 1978, CHEST, V74, P408, DOI 10.1378/chest.74.4.408; SAKS M, 1992, ALTERNATIVE MED BRIT; SCHOEPFLIN RB, 1988, OTHER HEALERS UNORTH; SCOTT CS, 1974, PUBLIC HEALTH REP, V89, P524; Segen J. C., 1998, DICT ALTERNATIVE MED; SINGELENBERG R, 1990, SOC SCI MED, V31, P515, DOI 10.1016/0277-9536(90)90048-W; Snow L F, 1978, Cult Med Psychiatry, V2, P69, DOI 10.1007/BF00052450; TAPPEN FM, 1988, HEALING MASSAGE TECH; TROTTER R, 1981, CURANDERISMO MEXICAN; TURNER R, 1998, COMPLEMENTARY THERAP, V6, P141; *US C OFF TECHN AS, 1990, UNC CANC TREATM; Uva J L, 1991, JAMA, V266, P3065; VANPRAAG J, 1997, TALKING HEAVEN MEDIU; WARDWELL W, 1992, CHIROPRACTIC HIST EV; WARDWELL WI, 1994, PERSPECT BIOL MED, V37, P595; Weil A., 1995, SPONTANEOUS HEALING; YAHN G, 1979, JAMA-J AM MED ASSOC, V242, P2202, DOI 10.1001/jama.242.20.2202; YATES JW, 1981, MED PEDIATR ONCOL, V9, P121, DOI 10.1002/mpo.2950090204; Yuasa Yasuo., 1993, BODY SELF CULTIVATIO; Zefron L J, 1975, Nurs Forum, V14, P350, DOI 10.1111/j.1744-6198.1975.tb00596.x; [No title captured]	137	100	100	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					196	204		10.7326/0003-4819-135-3-200108070-00012	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487487				2022-12-01	WOS:000170298500006
J	Schoups, A; Vogels, R; Qian, N; Orban, G				Schoups, A; Vogels, R; Qian, N; Orban, G			Practising orientation identification improves orientation coding in V1 neurons	NATURE			English	Article							DISCRIMINATION TASK; FREQUENCY-DISCRIMINATION; DIRECTION DISCRIMINATION; SPATIAL-FREQUENCY; OWL MONKEYS; CORTEX; SPECIFICITY; REORGANIZATION; REPRESENTATION; PERFORMANCE	The adult brain shows remarkable plasticity, as demonstrated by the improvement in fine sensorial discriminations after intensive practice. The behavioural aspects of such perceptual learning are well documented, especially in the visual system(1-8). Specificity for stimulus attributes clearly implicates an early cortical site, where receptive fields retain fine selectivity for these attributes; however, the neuronal correlates of a simple visual discrimination task remained unidentified. Here we report electrophysiological correlates in the primary visual cortex (V1) of monkeys for learning orientation identification. We link the behavioural improvement in this type of learning to an improved neuronal performance of trained compared to naive neurons. Improved long-term neuronal performance resulted from changes in the characteristics of orientation tuning of individual neurons. More particularly, the slope of the orientation tuning curve that was measured at the trained orientation increased only for the subgroup of trained neurons most likely to code the orientation identified by the monkey. No modifications of the tuning curve were observed for orientations for which the monkey had not been trained. Thus training induces a specific and efficient increase in neuronal sensitivity in V1.	Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, B-3000 Louvain, Belgium; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	KU Leuven; Columbia University; Columbia University	Schoups, A (corresponding author), Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, B-3000 Louvain, Belgium.			Orban, Guy/0000-0002-8179-9584				Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Matthews N, 1999, VISION RES, V39, P3692, DOI 10.1016/S0042-6989(99)00069-3; Nudo RJ, 1996, J NEUROSCI, V16, P785; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Qian N., 1999, Society for Neuroscience Abstracts, V25, P1316; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SOMERS DC, 1995, J NEUROSCI, V15, P5448; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; VOGELS R, 1990, J NEUROSCI, V10, P3543; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; ZOHARY E, 1994, INVEST OPHTH VIS SCI, V35, P1663	30	602	621	2	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					549	553		10.1038/35087601	http://dx.doi.org/10.1038/35087601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484056	Green Published			2022-12-01	WOS:000170202900048
J	Threlfall, AG; Woodman, CBJ				Threlfall, AG; Woodman, CBJ			Risk of breast cancer in women who attend the NHS breast screening programme: cohort study	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY		Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England	University of Manchester	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.							Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Moss S, 1998, J EPIDEMIOL COMMUN H, V52, P111, DOI 10.1136/jech.52.2.111; Prior P, 1996, J Med Screen, V3, P119; QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391; Richardson A, 1997, J Med Screen, V4, P16	5	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					140	140		10.1136/bmj.323.7305.140	http://dx.doi.org/10.1136/bmj.323.7305.140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463682	Bronze, Green Published			2022-12-01	WOS:000170106200016
J	Longnecker, MP; Klebanoff, MA; Zhou, HB; Brock, JW				Longnecker, MP; Klebanoff, MA; Zhou, HB; Brock, JW			Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth	LANCET			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; HUMAN-MILK; ORGANOCHLORINE PESTICIDES; RESIDUE LEVELS; PREMATURE; P,P'-DDE; DELIVERY; MALARIA; BLOOD; WOMEN	Background DDT (1,1,1-trichloro-2.2-bis(p-chlorophenyl) ethane) is highly effective against most malaria-transmitting mosquitoes and is being widely used in malaria-endemic areas. The metabolite, DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene), has been linked to preterm birth in small studies, but these findings are inconclusive. Our aim was to investigate the association between DDE exposure and preterm birth. Methods Our study was based on the US Collaborative Perinatal Project (CPP). From this study we selected a subset of more than 44 000 eligible children born between 1959 and 1966 and measured the DDE concentration in their mothers' serum samples stored during pregnancy. Complete data were available for 2380 children, of whom 361 were born preterm and 221 were small-for-gestational age. Findings The median maternal DDE concentration was 25 mug/L (range 3-178)-several fold higher than current US concentrations. The adjusted odds ratios (OR) of preterm birth increased steadily with increasing concentrations of serum DDE (ORs=1, 1.5, 1.6, 2.5, 3.1; trend p<0.0001). Adjusted odds of small-for-gestational-age also increased, but less consistently (ORs=1, 1.9, 1.7, 1.6, 2.6; trend p=0.04). After excluding preterm births, the association of DDE with small-for-gestational-age remained. Interpretation The findings strongly suggest that DDT use increases preterm births, which is a major contributor to infant mortality. If this association is causal, it should be included in any assessment of the costs and benefits of vector control with DDT.	NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; NICHHD, Div Epidemiol Stat & Prevent Res, Rockville, MD USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Longnecker, MP (corresponding author), NIEHS, Epidemiol Branch, POB 12233 MD A3-05, Res Triangle Pk, NC 27709 USA.			Longnecker, Matthew/0000-0001-6073-5322	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100490, ZIAES049016, Z01ES049016, Z01ES101170] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; *ATSDR, 1994, TOX PROF DDT DDE DDD; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Berkowitz GS, 1996, ARCH ENVIRON CON TOX, V30, P139, DOI 10.1007/BF00211340; BOUWMAN H, 1991, J TOXICOL ENV HEALTH, V33, P141, DOI 10.1080/15287399109531514; BRACKBILL Y, 1978, LANCET, V2, P520; Brock JW, 1996, J ANAL TOXICOL, V20, P528, DOI 10.1093/jat/20.7.528; DELONG RL, 1973, SCIENCE, V181, P1168, DOI 10.1126/science.181.4105.1168; HART MM, 1971, ARCH INT PHARMACOD T, V192, P286; Jeong SY, 2000, BIOCHEM BIOPH RES CO, V267, P262, DOI 10.1006/bbrc.1999.1916; JUBERG DR, 1992, TOXICOLOGY, V74, P161, DOI 10.1016/0300-483X(92)90136-3; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Klotz DM, 1997, MOL CELL ENDOCRINOL, V129, P63, DOI 10.1016/S0303-7207(96)04041-5; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Longnecker MP, 1999, ARCH ENVIRON HEALTH, V54, P110, DOI 10.1080/00039899909602244; Lunden A, 1998, ARCH ENVIRON CON TOX, V34, P414, DOI 10.1007/s002449900338; LUNDHOLM CE, 1992, ARCH TOXICOL, V66, P387, DOI 10.1007/BF02035127; LYON MF, 1980, PROC R SOC SER B-BIO, V208, P1, DOI 10.1098/rspb.1980.0040; NARAHASHI T, 1997, COMPREHENSIVE TOXICO, V11; Niswander K.R., 1972, WOMEN THEIR PREGNANC; Noren K, 1999, ARCH ENVIRON CON TOX, V37, P408, DOI 10.1007/s002449900532; NOREN K, 1988, CHEMOSPHERE, V17, P39, DOI 10.1016/0045-6535(88)90042-2; OLEARY JA, 1970, AM J OBSTET GYNECOL, V106, P939, DOI 10.1016/0002-9378(70)90499-0; POLLIOTTI B, 1994, PLACENTA, V15, P477, DOI 10.1016/S0143-4004(05)80417-5; PROCIANOY RS, 1981, ACTA PAEDIATR SCAND, V70, P925, DOI 10.1111/j.1651-2227.1981.tb06252.x; Quensen JF, 1998, SCIENCE, V280, P722, DOI 10.1126/science.280.5364.722; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; ROGAN WJ, 1986, AM J PUBLIC HEALTH, V76, P172, DOI 10.2105/AJPH.76.2.172; Sames WJ, 1996, J AM MOSQUITO CONTR, V12, P487; SAXENA MC, 1981, J ANAL TOXICOL, V5, P6, DOI 10.1093/jat/5.1.6; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Smith AG, 2000, LANCET, V356, P267, DOI 10.1016/S0140-6736(00)02497-1; STEHRGREEN PA, 1989, J TOXICOL ENV HEALTH, V27, P405, DOI 10.1080/15287398909531312; Ware G W, 1975, Residue Rev, V59, P119; WASSERMANN M, 1982, ENVIRON RES, V28, P106, DOI 10.1016/0013-9351(82)90158-X; *WHO, 1995, WHO TECHN REP SER, V857; WWF, 1999, HAZ EXP ASS DDT SYNT	38	331	339	1	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					110	114		10.1016/S0140-6736(01)05329-6	http://dx.doi.org/10.1016/S0140-6736(01)05329-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463412				2022-12-01	WOS:000169837700011
J	Dann, CE; Hsieh, JC; Rattner, A; Sharma, D; Nathans, J; Leahy, DJ				Dann, CE; Hsieh, JC; Rattner, A; Sharma, D; Nathans, J; Leahy, DJ			Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains	NATURE			English	Article							PROTEIN-PROTEIN INTERFACES; RECEPTOR TYROSINE KINASES; SECRETED PROTEINS; CRD DOMAIN; CLASSIFICATION; PURIFICATION; DIFFRACTION; ANTAGONIST; FAMILY	Members of the Frizzled family of seven-pass transmembrane proteins serve as receptors for Wnt signalling proteins(1). Wnt proteins have important roles in the differentiation and patterning of diverse tissues during animal development(2,3), and inappropriate activation of Wnt signalling pathways is a key feature of many cancers(4). An extracellular cysteine-rich domain (CRD) at the amino terminus of Frizzled proteins binds Wnt proteins(1), as do homologous domains in soluble proteins-termed secreted Frizzled-related proteins(5) - that function as antagonists of Wnt signalling(6-8). Recently, an LDL-receptor-related protein has been shown to function as a co-receptor for Wnt proteins and to bind to a Frizzled CRD in a Wnt-dependent manner(9-11). To investigate the molecular nature of the Wnt signalling complex, we determined the crystal structures of the CRDs from mouse Frizzled 8 and secreted Frizzled-related protein 3. Here we show a previously unknown protein fold, and the design and interpretation of CRD mutations that identify a Wnt-binding site. CRDs exhibit a conserved dimer interface that may be a feature of Wnt signalling. This work provides a framework for studies of homologous CRDs in proteins including muscle-specific kinase and Smoothened, a component of the Hedgehog signalling pathway(12,13).	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	leahy@groucho.med.jhmi.edu	Dann, Charles E/C-2747-2018	Nathans, Jeremy/0000-0001-8106-5460; Rattner, Amir/0000-0001-9542-6212				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Sparks AB, 1998, CANCER RES, V58, P1130; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; YONG K, 1990, ACTA CRYSTALLOGR A, V46, P41	30	362	419	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					86	90		10.1038/35083601	http://dx.doi.org/10.1038/35083601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452312				2022-12-01	WOS:000169644900049
J	Nguyen, VQ; Co, C; Li, JJ				Nguyen, VQ; Co, C; Li, JJ			Cyclin-dependent kinases prevent DNA re-replication through multiple mechanisms	NATURE			English	Article							CELL-CYCLE; S-PHASE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-LOCALIZATION; CHROMOSOME-REPLICATION; CDK PHOSPHORYLATION; DISTINCT MODES; NUCLEAR EXPORT; MAMMALIAN CDC6; BUDDING YEAST	The stable propagation of genetic information requires that the entire genome of an organism be faithfully replicated once and only once each cell cycle. In eukaryotes, this replication is initiated at hundreds to thousands of replication origins distributed over the genome, each of which must be prohibited from re-initiating DNA replication within every cell cycle. How cells prevent reinitiation has been a long-standing question in cell biology. In several eukaryotes, cyclin-dependent kinases (CDKs) have been implicated in promoting the block to re-initiation(1), but exactly how they perform this function is unclear. Here we show that B-type CDKs in Saccharomyces cerevisiae prevent re-initiation through multiple overlapping mechanisms, including phosphorylation of the origin recognition complex (ORC), downregulation of Cdc6 activity, and nuclear exclusion of the Mcm2-7 complex. Only when all three inhibitory pathways are disrupted do origins re-initiate DNA replication in G2/M cells. These studies show that each of these three independent mechanisms of regulation is functionally important.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, JJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.							BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BREWER BJ, 1993, COLD SPRING HARB SYM, V58, P425, DOI 10.1101/SQB.1993.058.01.049; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MUZIFALCONI M, 1996, P NATL ACAD SCI USA, V93, P1666; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Pelizon C, 2000, GENE DEV, V14, P2526, DOI 10.1101/gad.176300; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; SAUER K, 1995, GENE DEV, V9, P1327, DOI 10.1101/gad.9.11.1327; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; VAS A, 2001, IN PRESS MOL CELL BI; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460	30	353	356	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1068	1073		10.1038/35082600	http://dx.doi.org/10.1038/35082600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429609				2022-12-01	WOS:000169528500052
J	Bao, SD; Tibbetts, RS; Brumbaugh, KM; Fang, YN; Richardson, DA; Ali, A; Chen, SM; Abraham, RT; Wang, XF				Bao, SD; Tibbetts, RS; Brumbaugh, KM; Fang, YN; Richardson, DA; Ali, A; Chen, SM; Abraham, RT; Wang, XF			ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses	NATURE			English	Article							SLIDING CLAMP; DNA; ATR; FAMILY	Genotoxic stress triggers the activation of checkpoints that delay cell-cycle progression to allow for DNA repair(1). Studies in fission yeast implicate members of the Rad family of checkpoint proteins, which includes Rad17, Rad1, Rad9 and Hus1, as key early-response elements during the activation of both the DNA damage and replication checkpoints(2-5). Here we demonstrate a direct regulatory linkage between the human Rad17 homologue (hRad17) and the checkpoint kinases, ATM and ATR. Treatment of human cells with genotoxic agents induced ATM/ATR-dependent phosphorylation of hRad17 at Ser 635 and Ser 645. Overexpression of a hRad17 mutant (hRad17(AA)) bearing Ala substitutions at both phosphorylation sites abrogated the DNA-damage-induced G(2) checkpoint, and sensitized human fibroblasts to genotoxic stress. In contrast to wild-type hRad17, the hRad17(AA) mutant showed no ionizing-radiation-inducible association with hRad1, a component of the hRad1-hRad9-hHus1 checkpoint complex. These findings demonstrate that ATR/ATM-dependent phosphorylation of hRad17 is a critical early event during checkpoint signalling in DNA-damaged cells.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	wang0011@mc.duke.edu		Fang, Yanan/0000-0002-1112-9569; Tibbetts, Randal/0000-0003-2245-2297				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 1998, CELL GROWTH DIFFER, V9, P961; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Caspari T, 1999, BIOCHIMIE, V81, P173, DOI 10.1016/S0300-9084(99)80050-9; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Parker AE, 1999, J BIOL CHEM, V274, P24438; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Sekulic A, 2000, CANCER RES, V60, P3504; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Weinert T, 1997, CANCER SURV, V29, P109; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	19	220	233	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					969	974		10.1038/35082110	http://dx.doi.org/10.1038/35082110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418864				2022-12-01	WOS:000169386200050
J	Kane, B				Kane, B			Medical marijuana: The continuing story	ANNALS OF INTERNAL MEDICINE			English	Article																			0	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1159	1162		10.7326/0003-4819-134-12-200106190-00035	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412075				2022-12-01	WOS:000169313200025
J	Farmer, A				Farmer, A			10-minute consultation - Prostatic symptoms	BRITISH MEDICAL JOURNAL			English	Article									Inst Hlth Sci, Oxford OX3 7LF, England	University of Oxford	Farmer, A (corresponding author), Inst Hlth Sci, Oxford OX3 7LF, England.								0	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2001	322	7300					1468	1468		10.1136/bmj.322.7300.1468	http://dx.doi.org/10.1136/bmj.322.7300.1468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408305	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000169389200032
J	Dong, YH; Wang, LH; Xu, JL; Zhang, HB; Zhang, XF; Zhang, LH				Dong, YH; Wang, LH; Xu, JL; Zhang, HB; Zhang, XF; Zhang, LH			Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase	NATURE			English	Article							AERUGINOSA VIRULENCE GENES; PSEUDOMONAS-AERUGINOSA; ERWINIA-CAROTOVORA; EXOENZYME PRODUCTION; AUTOINDUCER; SIGNAL; EXPRESSION; BINDING; DETERMINANTS; SPECIFICITY	Bacterial cells sense their population density through a sophisticated cell-cell communication system and trigger expression of particular genes when the density reaches a threshold. This type of gene regulation, which controls diverse biological functions including virulence, is known as quorum sensing(1,2). Quorum-sensing signals, such as acyl-homoserine lactones (AHLs), are the essential components of the communication system. AHLs regulate virulence gene expression in a range of plant and animal (including human) bacterial pathogens(3-9). AHL-producing tobacco restored the pathogenicity of an AHL-negative mutant of Erwinia carotovora(10). Different bacterial species may produce different AHLs, which vary in the length and substitution of the acyl chain but contain the same homoserine lactone moiety. Here we show that the acyl-homoserine lactonase (AHL-lactonase), a new enzyme from Bacillus sp.(11), inactivates AHL activity by hydrolysing the lactone bond of AHLs. Plants expressing AHL-lactonase quenched pathogen quorum-sensing signalling and showed significantly enhanced resistance to E. carotovora infection. Our results highlight a promising potential to use quorum-sensing signals as molecular targets for disease control, thereby broadening current approaches for prevention of bacterial infections.	Natl Univ Singapore, Inst Mol Agrobiol, Lab Biosignals & Bioengn, Singapore 117604, Singapore	National University of Singapore	Zhang, LH (corresponding author), Natl Univ Singapore, Inst Mol Agrobiol, Lab Biosignals & Bioengn, 1 Res Link, Singapore 117604, Singapore.		Wang, Lianhui/D-6826-2016					Beaujean A, 1998, J EXP BOT, V49, P1589, DOI 10.1093/jexbot/49.326.1589; Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; Costa JM, 1997, CAN J MICROBIOL, V43, P1164, DOI 10.1139/m97-165; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dunphy G, 1997, J BACTERIOL, V179, P5288, DOI 10.1128/jb.179.17.5288-5291.1997; Fray RG, 1999, NAT BIOTECHNOL, V17, P1017, DOI 10.1038/13717; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gallois P., 1995, PLANT GENE TRANSFER, P39, DOI 10.1385/0-89603-321-X:39; Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Robson ND, 1997, TRENDS BIOTECHNOL, V15, P458, DOI 10.1016/S0167-7799(97)01102-5; von Bodman SB, 1998, P NATL ACAD SCI USA, V95, P7687, DOI 10.1073/pnas.95.13.7687; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832	28	717	826	20	267	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					813	817		10.1038/35081101	http://dx.doi.org/10.1038/35081101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459062				2022-12-01	WOS:000169246400053
J	Prior, P				Prior, P			A tale of seven surgeons	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1433	1433		10.1136/bmj.322.7299.1433	http://dx.doi.org/10.1136/bmj.322.7299.1433			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397766	Green Published			2022-12-01	WOS:000169284600058
J	Olesen, AB; Juul, S; Birkebaek, N; Thestrup-Pedersen, K				Olesen, AB; Juul, S; Birkebaek, N; Thestrup-Pedersen, K			Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study	LANCET			English	Article							PARTY DIAGNOSTIC-CRITERIA; INTERFERON-GAMMA; CLINICAL ASPECTS; NATURAL-HISTORY; TRANSGENIC MICE; EXPRESSION; CHILDREN; ECZEMA; IL-4	Background Up to two-thirds of children with atopic dermatitis have IgE-mediated allergic reactions and a Th2 immune reactivity pattern with low production of interferon gamma and high production of interleukin 4 after allergen stimulation of T lymphocytes. Insulin-dependent diabetes mellitus (IDDM) seems to be associated with a Th1 immune reactivity pattern. We therefore postulated that these diseases may be inversely associated. Methods We designed a case-control study including 920 children with IDDM, registered in the Danish Registry for Childhood Diabetes, and a sample of 9732 non-diabetic children registered in the Danish Medical Birth Registry. The children were aged 3-15 years. Information on atopic dermatitis was obtained by questionnaires. Findings The cumulative incidence of atopic dermatitis up to age 15 years was 13.1% among children with IDDM and 19.8% in non-diabetic children (p<0.0001). Among children who developed IDDM, the incidence of atopic dermatitis was significantly lower than in the controls before onset of IDDM (73 cases in 5314 person-months vs 1375 in 57 432 person-months; odds ratio 0.49 [0.39-0.63]). After onset of IDDM, diabetic and non-diabetic groups did not differ in incidence of atopic dermatitis (1.36 [0.89-2.07]). Interpretation Our findings may be explained by different acquired or inherited reactivity patterns associated with atopic dermatitis (Th2) and IDDM (Th1). The results do not allow us to find out whether early development of atopic dermatitis reduces the risk of IDDM, or a propensity for IDDM reduces the risk of early-onset atopic dermatitis.	Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Parasitol, DK-8000 Aarhus C, Denmark; Univ Aarhus, Dept Epidemiol & Social Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Olesen, AB (corresponding author), Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark.	Annebraae@dadlnet.dk		Birkebaek, Niels/0000-0001-6268-6464				Cameron MJ, 1997, J IMMUNOL, V159, P4686; Dahlquist G, 2000, J PEDIATR-US, V137, P470, DOI 10.1067/mpd.2000.109109; de Longueville M, 1997, PEDIATR ALLERGY IMMU, V8, P177; DELPRETE G, 1992, ALLERGY, V47, P450; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DOTTERUD LK, 1995, ACTA DERM-VENEREOL, V75, P50; GREWE M, 1994, LANCET, V343, P25, DOI 10.1016/S0140-6736(94)90879-6; Knudsen LB, 1998, DAN MED BULL, V45, P320; Mandrup-Poulsen T, 1998, BMJ-BRIT MED J, V316, P1221, DOI 10.1136/bmj.316.7139.1221; MEERWALD R, 1998, HORM RES, V50, P125; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; RAJKA G, 1986, CLIN REV ALLERG, V4, P3; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; STROMBERG LGE, 1995, J ALLERGY CLIN IMMUN, V96, P188, DOI 10.1016/S0091-6749(95)70007-2; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams HC, 1998, BRIT J DERMATOL, V139, P834; WILLIAMS HC, 1996, SO I DEFINE ATOPIC E; WOGENSEN L, 1993, J EXP MED, V178, P175, DOI 10.1084/jem.178.1.175; Wuthrich B, 1999, ANN ALLERG ASTHMA IM, V83, P464, DOI 10.1016/S1081-1206(10)62852-9	23	82	84	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2001	357	9270					1749	1752		10.1016/S0140-6736(00)04896-0	http://dx.doi.org/10.1016/S0140-6736(00)04896-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403811				2022-12-01	WOS:000169156200012
J	Said, G				Said, G			Value of nerve biopsy?	LANCET			English	Editorial Material							NEUROPATHY		Hop Bicetre, Serv Neurol, F-94275 Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Said, G (corresponding author), Hop Bicetre, Serv Neurol, F-94275 Le Kremlin Bicetre, France.							ARGOV Z, 1989, ACTA NEUROL SCAND, V79, P243, DOI 10.1111/j.1600-0404.1989.tb03745.x; Collins MP, 2000, NEUROLOGY, V55, P636, DOI 10.1212/WNL.55.5.636; De Freitas MRG, 1998, ARQ NEURO-PSIQUIAT, V56, P585, DOI 10.1590/S0004-282X1998000400011; Dyck PJ GC, 1993, PERIPHERAL NEUROPATH, P514; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; HELLMANN DB, 1988, MEDICINE, V67, P145, DOI 10.1097/00005792-198805000-00001; RAPPAPORT WD, 1993, AM J SURG, V166, P252, DOI 10.1016/S0002-9610(05)80968-7; Said G, 1999, MUSCLE NERVE, V22, P1617, DOI 10.1002/(SICI)1097-4598(199912)22:12<1617::AID-MUS1>3.0.CO;2-L; SAID G, 1988, ANN NEUROL, V23, P461, DOI 10.1002/ana.410230506; THOMAS PK, 1995, PERIPHERAL NERVE DIS, V2, P281	10	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1220	1221		10.1016/S0140-6736(00)04449-4	http://dx.doi.org/10.1016/S0140-6736(00)04449-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418142				2022-12-01	WOS:000168323300004
J	Hammond, SM; Boettcher, S; Caudy, AA; Kobayashi, R; Hannon, GJ				Hammond, SM; Boettcher, S; Caudy, AA; Kobayashi, R; Hannon, GJ			Argonaute2, a link between genetic and biochemical analyses of RNAi	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; MESSENGER-RNA; INTERFERENCE; ARABIDOPSIS; POLYMERASE; HELICASE; NEUROSPORA; TRANSGENE; PROTEINS	Double-stranded RNA induces potent and specific gene silencing through a process referred to as RNA interference (RNAi) or posttranscriptional gene silencing (PTGS). RNAi is mediated by RNA-induced silencing complex (RISC), a sequence-specific, multicomponent nuclease that destroys messenger RNAs homologous to the silencing trigger. RISC is known to contain short RNAs (similar to 22 nucleotides) derived from the double-stranded RNA trigger, but the protein components of this activity are unknown. Here, we report the biochemical purification of the RNAi effector nuclease from cultured Drosophila cells. The active fraction contains a ribonucleoprotein complex of similar to 500 kilodaltons. Protein microsequencing reveals that one constituent of this complex is a member of the Argonaute family of proteins, which are essential for gene silencing in Caenorhabditis elegans, Neurospora, and Arabidopsis. This observation begins the process of forging links between genetic analysis of RNAi from diverse organisms and the biochemical model of RNAi that is emerging from Drosophila in vitro systems.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Genet Inc, Cambridge, MA 02138 USA	Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.		Hannon, Gregory/AAB-3568-2019	Caudy, Amy/0000-0001-6307-8137	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM62534] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; KETTING R, UNPUB; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	26	1097	1237	8	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1146	1150		10.1126/science.1064023	http://dx.doi.org/10.1126/science.1064023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498593				2022-12-01	WOS:000170432600063
J	Robert, F				Robert, F			Isotope geochemistry - The origin of water on Earth	SCIENCE			English	Editorial Material							DEUTERIUM; METEORITE; HYDROGEN		CNRS, Museum Minerol, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Robert, F (corresponding author), CNRS, Museum Minerol, 61 Rue Buffon, F-75005 Paris, France.	robert@mnhn.fr						Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; BROWN PD, 1989, MON NOT R ASTRON SOC, V237, P661, DOI 10.1093/mnras/237.3.661; DELOULE E, 1995, GEOCHIM COSMOCHIM AC, V59, P4695, DOI 10.1016/0016-7037(95)00313-4; Deloule E, 1998, GEOCHIM COSMOCHIM AC, V62, P3367, DOI 10.1016/S0016-7037(98)00232-4; DHENDECOURT L, 2001, C DEUT U OBS MEUD FR; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; Geiss J, 1998, SPACE SCI REV, V84, P239, DOI 10.1023/A:1005039822524; Glassgold A. E., 2000, Protostars and planets 4, P429; HALBOUT J, 1990, GEOCHIM COSMOCHIM AC, V54, P1453, DOI 10.1016/0016-7037(90)90168-K; Lecuyer C, 1998, CHEM GEOL, V145, P249, DOI 10.1016/S0009-2541(97)00146-0; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Malfait K, 1999, ASTRON ASTROPHYS, V345, P181; Morbidelli A, 2000, METEORIT PLANET SCI, V35, P1309, DOI 10.1111/j.1945-5100.2000.tb01518.x; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Teixeira TC, 1999, ASTRON ASTROPHYS, V347, pL19	16	88	90	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1056	1058		10.1126/science.1064051	http://dx.doi.org/10.1126/science.1064051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498566				2022-12-01	WOS:000170432600034
J	Pockley, P				Pockley, P			Commission plots transgenic future	NATURE			English	News Item																		Pockley P, 2000, NATURE, V404, P914, DOI 10.1038/35010234	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					573	573		10.1038/35088195	http://dx.doi.org/10.1038/35088195			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493883	Bronze			2022-12-01	WOS:000170318000007
J	Marin, O; Yaron, A; Bagri, A; Tessier-Lavigne, M; Rubenstein, JLR				Marin, O; Yaron, A; Bagri, A; Tessier-Lavigne, M; Rubenstein, JLR			Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions	SCIENCE			English	Article							NEURONS; MIGRATION; RECEPTORS; GUIDANCE; ORIGIN; GENES	Most striatal and cortical interneurons arise from the basal telencephalon, later segregating to their respective targets. Here, we show that migrating cortical interneurons avoid entering the striatum because of a chemorepulsive signal composed at least in part of semaphorin 3A and semaphorin 3F. Migrating interneurons expressing neuropilins, receptors for semaphorins, are directed to the cortex; those lacking them go to the striatum. Loss of neuropilin function increases the number of interneurons that migrate into the striatum. These observations reveal a mechanism by which neuropilins mediate sorting of distinct neuronal populations into different brain structures, and provide evidence that, in addition to guiding axons, these receptors also control neuronal migration in the central nervous system.	Univ Calif San Francisco, Langley Porter Psychiat Inst, Nina Ireland Lab Dev Neurobiol, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rubenstein, JLR (corresponding author), Univ Calif San Francisco, Langley Porter Psychiat Inst, Nina Ireland Lab Dev Neurobiol, Dept Psychiat, San Francisco, CA 94143 USA.	jlrr@cgl.ucsf.edu	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [R01MH49428-01, R01MH51561-01A1, K02MH01046-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046, R01MH049428, R01MH051561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Marin O, 2000, J NEUROSCI, V20, P6063; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	13	323	329	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					872	875		10.1126/science.1061891	http://dx.doi.org/10.1126/science.1061891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486090				2022-12-01	WOS:000170241000047
J	Johnston, SD; Smye, M; Watson, RGP				Johnston, SD; Smye, M; Watson, RGP			Intestinal permeability and morphometric recovery in coeliac disease	LANCET			English	Editorial Material							CELIAC-DISEASE; PERSISTENT DEFECT; ABSORPTION TEST		Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland; Royal Victoria Hosp, Dept Clin Chem, Belfast BT12 6BA, Antrim, North Ireland; Queens Univ Belfast, Dept Med, Belfast BT7 1NN, Antrim, North Ireland	Belfast City Hospital; Queens University Belfast	Johnston, SD (corresponding author), Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland.							BJARNASON I, 1983, LANCET, V1, P323; BJARNASON I, 1994, SCAND J GASTROENTERO, V29, P630, DOI 10.3109/00365529409092484; BJARNASON I, 1984, GUT, V25, P145, DOI 10.1136/gut.25.2.145; CHADWICK VS, 1977, GASTROENTEROLOGY, V73, P247; Cummins AG, 2001, CLIN SCI, V100, P379, DOI 10.1042/CS20000193; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; HAMILTON I, 1982, GUT, V23, P202, DOI 10.1136/gut.23.3.202; JUBY LD, 1987, J CLIN PATHOL, V40, P714, DOI 10.1136/jcp.40.7.714; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; Uil JJ, 1996, EUR J GASTROEN HEPAT, V8, P219, DOI 10.1097/00042737-199603000-00006	10	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					259	260		10.1016/S0140-6736(01)05495-2	http://dx.doi.org/10.1016/S0140-6736(01)05495-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498209				2022-12-01	WOS:000170114400006
J	Ghigo, JM				Ghigo, JM			Natural conjugative plasmids induce bacterial biofilm development	NATURE			English	Article								Horizontal gene transfer is a principal source of evolution leading to change in the ecological character of bacterial species(1). Bacterial conjugation(2), which promotes the horizontal transfer of genetic material between donor and recipient cells by physical contact, is a phenomenon of fundamental evolutionary consequence(3). Although conjugation has been studied primarily in liquid, most natural bacterial populations are found associated with environmental surfaces in complex multispecies communities called biofilms(4). Biofilms are ideally suited to the exchange of genetic material of various origins, and it has been shown that bacterial conjugation occurs within biofilms(5,6). Here I investigate the direct contribution of conjugative plasmids themselves to the capacity of the bacterial host to form a biofilm. Natural conjugative plasmids expressed factors that induced planktonic bacteria to form or enter biofilm communities, which favour the infectious transfer of the plasmid. This general connection between conjugation and biofilms suggests that medically relevant plasmid-bearing strains are more likely to form a biofilm. This may influence both the chances of biofilm-related infection risks and of conjugational spread of virulence factors.	Inst Pasteur, Unite Membranes Bacteriennes, CNRS, URA 2172, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghigo, JM (corresponding author), Inst Pasteur, Unite Membranes Bacteriennes, CNRS, URA 2172, 25 Rue Dr Roux, F-75724 Paris 15, France.	jmghigo@pasteur.fr	GHIGO, Jean-Marc/AAP-4011-2021	GHIGO, Jean-Marc/0000-0001-6528-118X				Bergstrom CT, 2000, GENETICS, V155, P1505; BRADLEY DE, 1980, J BACTERIOL, V143, P1466, DOI 10.1128/JB.143.3.1466-1470.1980; BUKHARI AI, 1977, DNA INSERTION ELEMEN, P601; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Frost LS., 1993, BACTERIAL CONJUGATIO, P189; Hausner M, 1999, APPL ENVIRON MICROB, V65, P3710; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LUNDQUIST PD, 1986, GENETICS, V113, P483; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pratt LA, 1999, CURR OPIN MICROBIOL, V2, P598, DOI 10.1016/S1369-5274(99)00028-4; RIED G, 1987, FEBS LETT, V223, P387, DOI 10.1016/0014-5793(87)80324-1; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000	19	475	505	4	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					442	445		10.1038/35086581	http://dx.doi.org/10.1038/35086581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473319				2022-12-01	WOS:000170068200049
J	Baralle, D				Baralle, D			Chromosomal aberrations, subtelomeric defects, and mental retardation	LANCET			English	Editorial Material									Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 5AQ, England	Addenbrooke's Hospital; University of Cambridge	Baralle, D (corresponding author), Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 5AQ, England.			Baralle, Diana/0000-0003-3217-4833				Antonarakis SE, 2001, NAT GENET, V27, P230, DOI 10.1038/85769; Castellvi-Bel S, 2001, MOL GENET METAB, V72, P104, DOI 10.1006/mgme.2000.3128; De Vries BBA, 2001, J MED GENET, V38, P175, DOI 10.1136/jmg.38.3.175; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Doheny KF, 1997, J MED GENET, V34, P640, DOI 10.1136/jmg.34.8.640; Hamerton JL, 1999, LANCET, V354, P1659, DOI 10.1016/S0140-6736(99)00246-9; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; PHELAN MC, 1996, P GREENWOOD GENET CT, V15, P45; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; *WHO, 1968, 392 WHO; *WHO, 1986, WHO OFFS PUBL, V86; WINTER RM, 1998, LONDON DYSMORPHOLOGY	13	12	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					7	8		10.1016/S0140-6736(00)05300-9	http://dx.doi.org/10.1016/S0140-6736(00)05300-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449WV	11454368				2022-12-01	WOS:000169710900007
J	Loreau, M; Hector, A				Loreau, M; Hector, A			Partitioning selection and complementarity in biodiversity experiments	NATURE			English	Article							GRASSLAND ECOSYSTEMS; SPECIES-DIVERSITY; PLANT DIVERSITY; PRODUCTIVITY; COVARIANCE	The impact of biodiversity loss on the functioning of ecosystems and their ability to provide ecological services has become a central issue in ecology. Several experiments have provided evidence that reduced species diversity may impair ecosystem processes such as plant biomass production(1-5). The interpretation of these experiments, however, has been controversial(6-12) because two types of mechanism may operate in combination(6,13-15). In the 'selection effect', dominance by species with particular traits affects ecosystem processes. In the 'complementarity effect', resource partitioning or positive interactions lead to increased total resource use. Here we present a new approach to separate the two effects on the basis of an additive partitioning analogous to the Price equation in evolutionary genetics(16-19). Applying this method to data from the pan-European BIODEPTH experiment(4) reveals that the selection effect is zero on average and varies from negative to positive in different localities, depending on whether species with lower- or higher-than-average biomass dominate communities. In contrast, the complementarity effect is positive overall, supporting the hypothesis that plant diversity influences primary production in European grasslands through niche differentiation or facilitation.	Ecole Normale Super, Ecol Lab, UMR 7625, F-75230 Paris 05, France; Imperial Coll, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Loreau, M (corresponding author), Ecole Normale Super, Ecol Lab, UMR 7625, 46 Rue Ulm, F-75230 Paris 05, France.		Hector, Andrew/H-4199-2011	Hector, Andrew/0000-0002-1309-7716				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Frank SA, 1997, EVOLUTION, V51, P1712, DOI 10.1111/j.1558-5646.1997.tb05096.x; FRANK SA, 1995, J THEOR BIOL, V175, P373, DOI 10.1006/jtbi.1995.0148; Garnier E, 1997, ACTA OECOL, V18, P657, DOI 10.1016/S1146-609X(97)80049-5; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HECTOR A, 2000, SCIENCE, V289, P1255; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; PRICE GR, 1995, J THEOR BIOL, V175, P389, DOI 10.1006/jtbi.1995.0149; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; van der Heijden MGA, 1999, OIKOS, V87, P408, DOI 10.2307/3546758; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	25	1862	1942	77	1104	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					72	76		10.1038/35083573	http://dx.doi.org/10.1038/35083573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452308				2022-12-01	WOS:000169644900045
J	Holland, PC; Hancock, SW; Hodge, D; Thompson, D; Shires, S; Evans, S				Holland, PC; Hancock, SW; Hodge, D; Thompson, D; Shires, S; Evans, S			Degradation of albumin in meningococcal sepsis	LANCET			English	Article								We postulate that the proteolytic degradation of albumin into fragments could link the rapidity of the shock, rash, and hypocalcaemia associated with meningococcal sepsis, We examined urine of children with meningococcal disease and urine from control children with no sepsis and found albumin fragments of about 45 kDa, 25 kDa, and less than 20 kDa only in the urine of children with meningococcal sepsis and associated purpura, Exogenous or endogenous proteases, or both, may be released in severe meningococcal sepsis and, in association with an inadequate antiprotease response, result In albumin degradation. This may be a contributory factor to the rapid shock, hypocalcaemia, and rash seen in meningococcal sepsis.	Gen Infirm, Dept Paediat, Leeds LS2 9NS, W Yorkshire, England; Gen Infirm, Dept Clin Biochem & Immunol, Leeds LS2 9NS, W Yorkshire, England; Univ Leeds, Mol Epidemiol Unit, Leeds, W Yorkshire, England	Leeds General Infirmary; Leeds General Infirmary; University of Leeds	Holland, PC (corresponding author), Gen Infirm, Dept Paediat, Clarendon Wing, Leeds LS2 9NS, W Yorkshire, England.							Baines PB, 2000, ARCH DIS CHILD, V83, P510, DOI 10.1136/adc.83.6.510; KLEIN NJ, 1992, J CELL SCI, V102, P821; NETTER A, 1917, BRIT J CHILD DIS, V14, P101; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; SELYE H, 1962, CALCIFYLAXIS	5	16	17	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2102	2104		10.1016/S0140-6736(00)05200-4	http://dx.doi.org/10.1016/S0140-6736(00)05200-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445107				2022-12-01	WOS:000169586600017
J	Kolber, ZS; Plumley, FG; Lang, AS; Beatty, JT; Blankenship, RE; VanDover, CL; Vetriani, C; Koblizek, M; Rathgeber, C; Falkowski, PG				Kolber, ZS; Plumley, FG; Lang, AS; Beatty, JT; Blankenship, RE; VanDover, CL; Vetriani, C; Koblizek, M; Rathgeber, C; Falkowski, PG			Contribution of aerobic photoheterotrophic bacteria to the carbon cycle in the ocean	SCIENCE			English	Article							ROSEOBACTER-DENITRIFICANS; BACTERIOCHLOROPHYLL ALPHA; PROTEIN COMPLEXES; ELECTRON-TRANSFER; CYTOCHROME; WATERS	The vertical distribution of bacteriochlorophyll a, the numbers of infrared fluorescent cells, and the variable fluorescence signal at 880 nanometers wavelength, all indicate that photosynthetically competent anoxygenic phototrophic bacteria are abundant in the upper open ocean and comprise at Least 11% of the total microbial community. These organisms are facultative photoheterotrophs, metabolizing organic carbon when available, but are capable of photosynthetic Light utilization when organic carbon is scarce. They are globally distributed in the euphotic zone and represent a hitherto unrecognized component of the marine microbial community that appears to be critical to the cycling of; both organic and inorganic carbon in the ocean.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; Rutgers State Univ, Dept Geol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; University of Alaska System; University of Alaska Fairbanks; University of British Columbia; Arizona State University; Arizona State University-Tempe; William & Mary; University of Manitoba; Rutgers State University New Brunswick	Kolber, ZS (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, 71 Dudley Rd, New Brunswick, NJ 08901 USA.		Koblizek, Michal/H-2851-2014	Lang, Andrew/0000-0002-4510-7683				Cogdell R. J., 1995, ANOXYGENIC PHOTOSYNT, P315; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia D, 1998, PHOTOSYNTH RES, V55, P331, DOI 10.1023/A:1005941031263; HARASHIMA K, 1980, PLANT CELL PHYSIOL, V21, P1283, DOI 10.1093/oxfordjournals.pcp.a076127; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P158; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; MOREL A, 1994, J PHYS OCEANOGR, V24, P1652, DOI 10.1175/1520-0485(1994)024<1652:HRWTUO>2.0.CO;2; NISHIMURA Y, 1989, ARCH MICROBIOL, V152, P1, DOI 10.1007/BF00447002; NOGUCHI T, 1992, PHOTOSYNTH RES, V31, P21, DOI 10.1007/BF00049533; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Schwarze C, 2000, EUR J BIOCHEM, V267, P422, DOI 10.1046/j.1432-1327.2000.01018.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; SHIBA T, 1984, J GEN APPL MICROBIOL, V30, P1313; Shimada K., 1995, ANOXYGENIC PHOTOSYNT, P105; TAKEMOTO J, 1977, J BACTERIOL, V129, P1102, DOI 10.1128/JB.129.2.1102-1109.1977; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1999, J BACTERIOL, V181, P4517, DOI 10.1128/JB.181.15.4517-4525.1999; YURKOV VV, 1993, ARCH MICROBIOL, V159, P84, DOI 10.1007/BF00244268; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	25	323	360	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2492	2495		10.1126/science.1059707	http://dx.doi.org/10.1126/science.1059707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431568				2022-12-01	WOS:000169658200042
J	O'Brien, SJ; Eizirik, E; Murphy, WJ				O'Brien, SJ; Eizirik, E; Murphy, WJ			Genomics - On choosing mammalian genomes for sequencing	SCIENCE			English	Editorial Material							PLACENTAL MAMMALS; PROJECT		NCI, Lab Genom Divers, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@ncifcrf.gov	Eizirik, Eduardo/K-8034-2012; OBRIEN, STEPHEN/ABD-1346-2020	Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757				Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Gibbons A, 2000, SCIENCE, V289, P1267; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W.H., 1997, MOL EVOLUTION; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McConkey EH, 2000, SCIENCE, V289, P1295; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; MURPHY WJ, IN PRESS GENOME BIOL; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Paabo S, 2001, SCIENCE, V291, P1219, DOI 10.1126/science.1056972; Pennisi E, 2000, SCIENCE, V287, P1179, DOI 10.1126/science.287.5456.1179; Pennisi E, 2001, SCIENCE, V291, P1204, DOI 10.1126/science.291.5507.1204; Rettie JC, 1951, CORONET, V29, P21; Rubin GM, 2001, NATURE, V409, P820, DOI 10.1038/35057277; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; VandeBerg JL, 2000, SCIENCE, V290, P1504, DOI 10.1126/science.290.5496.1504; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	22	46	49	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2264	2266		10.1126/science.1059393	http://dx.doi.org/10.1126/science.1059393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423643				2022-12-01	WOS:000169455900037
J	Picco, MF; Goodman, S; Reed, J; Bayless, TM				Picco, MF; Goodman, S; Reed, J; Bayless, TM			Methodologic pitfalls in the determination of genetic anticipation: The case of Crohn disease	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ONSET ANTICIPATION; AFFECTED PARENT; AGE; BIAS; PREVALENCE; DISORDER; COUNTY; COHORT	Background: The term genetic anticipation is used when genetically transmitted disease manifests at increasingly younger ages with each succeeding generation: that is, if the offspring of patients develop the disease, they will tend to do so at an earlier age than their parents. In some monogenetic disorders, genetic anticipation has a biological basis in expanded genetic triplet repeats; however, some have claimed that it occurs in polygenic disorders, such as Crohn disease, in which its mechanism cannot be explained. Objective: To show how apparent changes in age at diagnosis of Crohn disease between generations, which could suggest genetic anticipation, can be an artifact of inadequate analysis based on age at diagnosis in cohorts that have not been followed for a sufficiently long time. Design: Comparison of ages at diagnosis of Crohn disease among different birth cohorts, before and after adjustment for observation time. Setting: Meyerhoff Center for Inflammatory Bowel Disease, Johns Hopkins Hospital, Baltimore, Maryland. Patients: 928 consecutive outpatients with Crohn disease. Measurements: Trends in age at diagnosis of Crohn disease among birth cohorts were determined by calculating Pearson correlation coefficients and performing Kaplan-Meyer analysis before and after adjustment for observation time. Adjustment for observation time was performed by ensuring that the time during which all included patients were at risk for Crohn disease was equal and that all patients had developed disease by the end of the risk period. Results: Mean age at diagnosis decreased by approximately 5 years with each subsequent 10-year birth cohort on the basis of crude cross-sectional data that could suggest genetic anticipation between generations. However, after adjustment for observation time, the age at diagnosis decreased minimally, if at all, with each successive generation. Conclusions: Apparent genetic anticipation can be explained by observational biases without invoking any additional genetic influences. Claims for genetic anticipation must be based on methods that properly account for the duration of observation in all persons being studied.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; St Lukes Hosp, Res Inst, Bethlehem, PA 18105 USA	Mayo Clinic; Johns Hopkins University	Picco, MF (corresponding author), Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.							Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Bayless TM, 1998, AM J GASTROENTEROL, V93, P2322, DOI 10.1111/j.1572-0241.1998.02322.x; BINDER V, 1982, GASTROENTEROLOGY, V83, P563; CHILDS B, 1986, PERSPECT BIOL MED, V29, P437; Fresko I, 1998, ANN RHEUM DIS, V57, P45, DOI 10.1136/ard.57.1.45; Frisch M, 1996, LANCET, V347, P1551, DOI 10.1016/S0140-6736(96)90703-5; Grandbastien B, 1998, GUT, V42, P170, DOI 10.1136/gut.42.2.170; Heiman GA, 1996, PSYCHIAT GENET, V6, P61, DOI 10.1097/00041444-199622000-00005; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Inskip H, 1996, LANCET, V347, P1551; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KILDEBO S, 1989, SCAND J GASTROENTERO, V24, P1265, DOI 10.3109/00365528909090797; Lashner B, 2000, INFLAMM BOWEL DIS, P305; Lee JCW, 1999, GUT, V44, P808, DOI 10.1136/gut.44.6.808; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Marx G, 1999, CURR OPIN GASTROEN, V15, P322, DOI 10.1097/00001574-199907000-00008; McDermott E, 1996, ANN RHEUM DIS, V55, P475, DOI 10.1136/ard.55.7.475; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; Munkholm P, 1997, DAN MED BULL, V44, P287; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Polito JMII, 1996, LANCET, V347, P798, DOI 10.1016/S0140-6736(96)90870-3; Post S, 1996, ANN SURG, V223, P253, DOI 10.1097/00000658-199603000-00005; Rabinowitz D, 1999, BIOMETRICS, V55, P834, DOI 10.1111/j.0006-341X.1999.00834.x; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Rosner B., 2011, FUNDAMENTALS BIOSTAT, P352; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Tsai YY, 1997, GENET EPIDEMIOL, V14, P435, DOI 10.1002/(SICI)1098-2272(1997)14:4<435::AID-GEPI8>3.0.CO;2-1; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517	31	42	42	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1124	1129		10.7326/0003-4819-134-12-200106190-00013	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00013			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412053				2022-12-01	WOS:000169313200006
J	Lewis, S; Clarke, M				Lewis, S; Clarke, M			Forest plots: trying to see the wood and the trees	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BETA		Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Neurosci Trials Unit, Edinburgh EH4 2XU, Midlothian, Scotland; UK Cochrane Ctr, NHS Res & Dev Programme, Oxford OX2 7LG, England	University of Edinburgh; Cochrane Centre	Lewis, S (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Neurosci Trials Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	steff.lewis@ed.ac.uk		Lewis, Steff/0000-0003-1210-2314				[Anonymous], 1988, BRIT MED J, V296, P320; BIJNENS L, 1996, P 4 COCHR C AD AUSTR; *COCHR COLL, 2001, COCHR LIB; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Lewis, 1982, PRIMARY CARDIOLOGY S, P31; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Sindhu F, 1996, J ADV NURS, V24, P1152, DOI 10.1111/j.1365-2648.1996.tb01020.x; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	10	449	453	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2001	322	7300					1479	1480		10.1136/bmj.322.7300.1479	http://dx.doi.org/10.1136/bmj.322.7300.1479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408310	Green Published, Green Submitted			2022-12-01	WOS:000169389200036
J	Ribo, JM; Crusats, J; Sagues, F; Claret, J; Rubires, R				Ribo, JM; Crusats, J; Sagues, F; Claret, J; Rubires, R			Chiral sign induction by vortices during the formation of mesophases in stirred solutions	SCIENCE			English	Article							ABSOLUTE ASYMMETRIC-SYNTHESIS; RESONANCE LIGHT-SCATTERING; SYMMETRY-BREAKING; PORPHYRIN; WATER	Achiral diprotonated porphyrins, forming homoassociates in aqueous solution, lead to spontaneous chiral symmetry breaking. The unexpected result is that the chirality sign of these homoassociates can be selected by vortex motion during the aggregation process. This result is confirmed by means of circular dichroism spectra. These experimental findings are rationalized in terms of the asymmetric influence of macroscopic forces on bifurcation scenarios and by considering the specific binding characteristics of the porphyrin units to form the homoassociates.	Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Catalonia, Spain; Univ Barcelona, Dept Phys Chem, E-08028 Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona	Ribo, JM (corresponding author), Univ Barcelona, Dept Organ Chem, Marti & Franques 1, E-08028 Barcelona, Catalonia, Spain.	jmr@qo.ub.es	Crusats, Joaquim/K-7367-2017; Sagues, Francesc/K-6414-2015; Ribó, Josep M./K-2052-2017	Sagues, Francesc/0000-0002-2956-5676; Ribó, Josep M./0000-0001-6258-1726; Crusats, Joaquim/0000-0003-3511-4676				Avalos M, 1998, CHEM REV, V98, P2391, DOI 10.1021/cr970096o; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BARRON LD, 1986, CHEM SOC REV, V15, P189, DOI 10.1039/cs9861500189; Berlepsch H., 2000, J PHYS CHEM B, V104, P5255, DOI DOI 10.1021/JP000220Z; Bersuker G, 1999, J CHEM PHYS, V110, P10907, DOI 10.1063/1.479003; BUSTAMANTE C, 1983, P NATL ACAD SCI-BIOL, V80, P3568, DOI 10.1073/pnas.80.12.3568; Collings PJ, 1999, J PHYS CHEM B, V103, P8474, DOI 10.1021/jp991610s; Feringa BL, 1999, ANGEW CHEM INT EDIT, V38, P3419; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; Harada N., 1983, CIRCULAR DICHROISM S; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V5; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V1; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V6; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V2; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V10; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V7; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V8; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V9; HELMCHEN G, 1996, HOUBENWEYL METHODS O, V4; Jacques J., 1981, ENANTIOMERS RACEMATE; Katzenelson O, 1996, CHEM-EUR J, V2, P174, DOI 10.1002/chem.19960020209; Kondepudi DK, 1999, J AM CHEM SOC, V121, P1448, DOI 10.1021/ja983418u; KONDEPUDI DK, 1984, PHYSICA A, V125, P465, DOI 10.1016/0378-4371(84)90065-7; KONDEPUDI DK, 1993, J AM CHEM SOC, V115, P10211, DOI 10.1021/ja00075a041; KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975; KONDEPUDI DK, 1998, MODERN THERMODYNAMIC, P436; MASON SF, 1984, NATURE, V311, P19, DOI 10.1038/311019a0; Micali N, 2000, J PHYS CHEM B, V104, P5897, DOI 10.1021/jp991909a; Misawa K, 1999, J CHEM PHYS, V110, P5844, DOI 10.1063/1.478483; OHNO O, 1993, J CHEM PHYS, V99, P4128, DOI 10.1063/1.466109; PASTERNACK RF, 1995, SCIENCE, V269, P935, DOI 10.1126/science.7638615; QIU X, 1991, PHYS REV LETT, V67, P703, DOI 10.1103/PhysRevLett.67.703; Ribo JM, 2000, MAT SCI ENG C-BIO S, V11, P107, DOI 10.1016/S0928-4931(00)00147-8; Rubires R, 1999, NEW J CHEM, V23, P189, DOI 10.1039/a808943d; Rubires R, 2001, CHEM-EUR J, V7, P436, DOI 10.1002/1521-3765(20010119)7:2<436::AID-CHEM436>3.3.CO;2-9; SCHWARTZ DK, 1993, PHYS REV LETT, V70, P1267, DOI 10.1103/PhysRevLett.70.1267; Seddon J.M., 1995, HDB BIOL PHYS A&B, V1, P97	37	548	556	1	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2063	2066		10.1126/science.1060835	http://dx.doi.org/10.1126/science.1060835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408653				2022-12-01	WOS:000169284700043
J	Wang, XQ; Ullah, H; Jones, AM; Assmann, SM				Wang, XQ; Ullah, H; Jones, AM; Assmann, SM			G protein regulation of ion channels and abscisic acid signaling in Arabidopsis guard cells	SCIENCE			English	Article							HETEROTRIMERIC G-PROTEIN; INWARD K+ CHANNEL; PLASMA-MEMBRANE; STOMATAL CLOSURE; ALPHA-SUBUNIT; CYTOPLASMIC CALCIUM; POTASSIUM CHANNELS; CYTOSOLIC CALCIUM; ANION CHANNELS; VICIA-FABA	The phytohormone abscisic acid (ABA) promotes plant water conservation by decreasing the apertures of stomatal pores in the epidermis through which water loss occurs. We found that Arabidopsis thaliana plants harboring transferred DNA insertional mutations in the sole prototypical heterotrimeric GTP-binding (G) protein a subunit gene, GPA1, lack both ABA inhibition of guard cell inward K+ channels and pH-independent ABA activation of anion channels. Stomatal opening in gpa1 plants is insensitive to inhibition by ABA, and the rate of water loss from gpa1 mutants is greater than that from wild-type plants. Manipulation of G protein status in guard cells may provide a mechanism for controlling plant water balance.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.			Wang, Xi-Qing/0000-0003-4477-9557				Aharon GS, 1998, FEBS LETT, V424, P17, DOI 10.1016/S0014-5793(98)00129-X; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; ARMSTRONG F, 1995, PLANT J, V8, P187, DOI 10.1046/j.1365-313X.1995.08020187.x; ASSMANN SM, 1996, SIGNAL TRANSDUCTION, P39; BLATT MR, 1990, PLANTA, V180, P445, DOI 10.1007/BF00198799; BLATT MR, 1993, PLANTA, V191, P330, DOI 10.1007/BF00195690; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; FAIRLEYGRENOT K, 1991, PLANT CELL, V3, P1037; Gelli A, 1997, PLANT PHYSIOL, V113, P269, DOI 10.1104/pp.113.1.269; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; Grabov A, 1997, PLANT J, V12, P203, DOI 10.1046/j.1365-313X.1997.12010203.x; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; IRVING HR, 1992, P NATL ACAD SCI USA, V89, P1790, DOI 10.1073/pnas.89.5.1790; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; KELLY WB, 1995, PLANT J, V8, P479, DOI 10.1046/j.1365-313X.1995.8040479.x; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; LEE HJ, 1993, PLANT PHYSIOL, V102, P95, DOI 10.1104/pp.102.1.95; Lee YS, 1996, PLANT PHYSIOL, V110, P987, DOI 10.1104/pp.110.3.987; LEMTIRICHLIEH F, 1994, J MEMBRANE BIOL, V137, P99; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leymarie J, 1998, AUST J PLANT PHYSIOL, V25, P785, DOI 10.1071/PP98031; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; MacRobbie EAC, 2000, P NATL ACAD SCI USA, V97, P12361, DOI 10.1073/pnas.220417197; MacRobbie EAC, 1997, J EXP BOT, V48, P515, DOI 10.1093/jxb/48.Special_Issue.515; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Romano LA, 1998, PLANT CELL PHYSIOL, V39, P1133, DOI 10.1093/oxfordjournals.pcp.a029314; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; SHEPHERD GM, 1991, CELL, V67, P845, DOI 10.1016/0092-8674(91)90358-6; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; WANG X, UNPUB; Wang XQ, 1998, PLANT PHYSIOL, V118, P1421, DOI 10.1104/pp.118.4.1421; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WU WH, 1994, P NATL ACAD SCI USA, V91, P6310, DOI 10.1073/pnas.91.14.6310	41	376	437	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2070	2072		10.1126/science.1059046	http://dx.doi.org/10.1126/science.1059046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408655	Green Submitted			2022-12-01	WOS:000169284700045
J	Zeng, X; Goetz, JA; Suber, LM; Scott, WJ; Schreiner, CM; Robbins, DJ				Zeng, X; Goetz, JA; Suber, LM; Scott, WJ; Schreiner, CM; Robbins, DJ			A freely diffusible form of Sonic hedgehog mediates long-range signalling	NATURE			English	Article							LIMB-PATTERNING ACTIVITY; INDUCTION; PROTEIN; TRANSDUCTION; CYCLOPAMINE; INHIBITION; CLEAVAGE; PRODUCT; CELLS; CHICK	The secreted protein Sonic hedgehog (Shh) exerts many of its patterning effects through a combination of short- and long-range signalling(1-3). Three distinct mechanisms, which are not necessarily mutually exclusive, have been proposed to account for the long-range effects of Shh: simple diffusion of Shh, a relay mechanism in which Shh activates secondary signals, and direct delivery of Shh through cytoplasmic extensions, termed cytonemes. Although there is much data (using soluble recombinant Shh (ShhN)) to support the simple diffusion model of long-range Shh signalling(1,2), there has been little evidence to date for a native form of Shh that is freely diffusible and not membrane-associated. Here we provide evidence for a freely diffusible form of Shh (s-ShhNp) that is cholesterol modified, multimeric and biologically potent. We further demonstrate that the availability of s-ShhNp is regulated by two functional antagonists of the Shh pathway, Patched (Ptc) and Hedgehog-interacting protein (Hip)(4-6). Finally, we show a gradient of s-ShhNp across the anterior-posterior axis of the chick limb, demonstrating the physiological relevance of s-ShhNp.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Robbins, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.							Bell SM, 2000, METH MOL B, V136, P219; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1999, DEV BIOL, V211, P323, DOI 10.1006/dbio.1999.9311; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Incardona JP, 1998, DEVELOPMENT, V125, P3553; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; MARTI E, 1995, DEVELOPMENT, V121, P2537; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tickle C, 1999, SEMIN CELL DEV BIOL, V10, P345, DOI 10.1006/scdb.1999.0294; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393	28	353	363	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					716	720		10.1038/35079648	http://dx.doi.org/10.1038/35079648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395778				2022-12-01	WOS:000169112500052
J	Lee, C; Murray, MF; Miron, PM; Marsden, D; Irons, M; Wilkins-Haug, LE; Morton, CC				Lee, C; Murray, MF; Miron, PM; Marsden, D; Irons, M; Wilkins-Haug, LE; Morton, CC			Clinical picture: multicolour karyotyping	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lee, C (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2001	357	9264					1240	1240		10.1016/S0140-6736(00)04472-X	http://dx.doi.org/10.1016/S0140-6736(00)04472-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11458963				2022-12-01	WOS:000168323300009
J	Rubin, C; Turner, AS; Bain, S; Mallinckrodt, C; McLeod, K				Rubin, C; Turner, AS; Bain, S; Mallinckrodt, C; McLeod, K			Anabolism - Low mechanical signals strengthen long bones	NATURE			English	Article							STRAIN; MAGNITUDE		SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA; Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; Skeletech Inc, Bothell, WA 98021 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Colorado State University	Rubin, C (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA.	clinton.rubin@sunysb.edu						BAIN SD, 1990, J BONE MINER RES, V5, P1069; Blob RW, 1999, J EXP BIOL, V202, P1023; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; CARTER DR, 1981, MECHANICAL PROPERTIE, V45, P81; Fritton JC, 1997, ANN BIOMED ENG, V25, P831, DOI 10.1007/BF02684167; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; Hylander WL, 1998, AM J PHYS ANTHROPOL, V107, P257, DOI 10.1002/(SICI)1096-8644(199811)107:3<257::AID-AJPA3>3.0.CO;2-6; RUBIN CT, 1995, J BONE MINER RES, V10, P488; RUBIN CT, 1982, J EXP BIOL, V101, P187; SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F; Wolff J., 1986, LAW BONE REMODELLING	13	512	567	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					603	604		10.1038/35088122	http://dx.doi.org/10.1038/35088122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493908				2022-12-01	WOS:000170318000028
J	Snyder, L; Sulmasy, DP				Snyder, L; Sulmasy, DP		Ethics Human Rights Comm Amer C	Physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT REQUESTS; EUTHANASIA; OREGON; DEATH; PAIN; LIFE; GUIDELINES; ATTITUDES; MANAGEMENT; END	Medical professional codes have long prohibited physician involvement in assisting a patient's suicide. However, despite ethical and legal prohibitions, calls for the liberalization of this ban have grown in recent years. The medical profession should articulate its views on the arguments for and against changes in public policy and decide whether changes are prudent. In addressing such a contentious issue, physicians, policymakers, and society must fully consider the needs of patients, the vulnerability of particular patient groups, issues of trust and professionalism, and the complexities of end-of-life health care. Physician-assisted suicide is prominent among the issues that define our professional norms and codes of ethics. The American College of Physicians-American Society of Internal Medicine (ACP-ASIM) does not support the legalization of physician-assisted suicide. The routine practice of physician-assisted suicide raises serious ethical and other concerns. Legalization would undermine the patient-physician relationship and the trust necessary to sustain it; after the medical profession's role in society; and endanger the value our society places on life, especially on the lives of disabled, incompetent, and vulnerable individuals. The ACP-ASIM remains thoroughly committed to improving care for patients at the end of life.	Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA 19106 USA	American College of Physicians	Snyder, L (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Abrahm JL, 1999, ANN INTERN MED, V131, P37, DOI 10.7326/0003-4819-131-1-199907060-00009; ALPERS A, 1995, JAMA-J AM MED ASSOC, V274, P483, DOI 10.1001/jama.274.6.483; Angell M, 1997, NEW ENGL J MED, V336, P50, DOI 10.1056/NEJM199701023360108; ANNAS GJ, 1994, NEW ENGL J MED, V331, P1240, DOI 10.1056/NEJM199411033311822; Annas GJ, 1996, NEW ENGL J MED, V335, P683, DOI 10.1056/NEJM199608293350924; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BAILE WF, 1993, CANCER, V72, P2786, DOI 10.1002/1097-0142(19931101)72:9<2786::AID-CNCR2820720942>3.0.CO;2-2; Baron CH, 1996, HARVARD J LEGIS, V33, P1; BATTIN MP, 1995, ACAD MED, V70, P583; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; BOSCHERT S, 1992, INTERNAL MED NE 1201, P3; BOSCHERT S, 1992, INTERNAL MED NE 1201, P20; BROCK DW, 1992, YALE J BIOL MED, V65, P121; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; BUCHAN ML, 1995, J CLIN ETHIC, V6, P53; BYOCK I, 1997, DYING WELL PROSPECT, P245; Byock IR, 1997, MED ETHIC S, P107; CAIN C, 1998, DETROIT NEWS    1104, pA1; Callahan D, 1997, MED ETHIC S, P69; CALLAHAN D, 1992, HASTINGS CENT REP, V22, P52, DOI 10.2307/3562566; Caplan AL, 2000, ANN INTERN MED, V132, P476, DOI 10.7326/0003-4819-132-6-200003210-00009; CAPRON AM, 1992, HASTINGS CENT REP, V22, P30, DOI 10.2307/3562562; CASSEL CK, 1990, NEW ENGL J MED, V323, P750, DOI 10.1056/NEJM199009133231110; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Coleman CH, 1996, J LAW MED ETHICS, V24, P217, DOI 10.1111/j.1748-720X.1996.tb01855.x; CONWELL Y, 1991, NEW ENGL J MED, V325, P1100, DOI 10.1056/NEJM199110103251511; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel Ezekiel, 1997, Atl Mon, V279, P73; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; Field MJ, 1997, APPROACHING DEATH IM; Fohr S A, 1998, J Palliat Med, V1, P315, DOI 10.1089/jpm.1998.1.315; Foley K, 1999, HASTINGS CENT REP, V29, P37, DOI 10.2307/3528194; FOLEY KM, 1991, J PAIN SYMPTOM MANAG, V6, P289, DOI 10.1016/0885-3924(91)90052-6; FRIED TR, 1993, ARCH INTERN MED, V153, P722, DOI 10.1001/archinte.153.6.722; GAYLIN W, 1988, JAMA-J AM MED ASSOC, V259, P2139; GERT B, 1994, HASTINGS CENT REP, V24, P13, DOI 10.2307/3562837; GILLESPIE M, 1999, KEVORKIAN FACE MURDE; Glick SM, 1997, AM J MED, V102, P294, DOI 10.1016/S0002-9343(97)00016-8; GOAD M, 2000, PORTLAND PRESS  1108, pA1; GROSS J, 1991, NY TIMES        1107, pB16; Hardwig J, 1997, HASTINGS CENT REP, V27, P34, DOI 10.2307/3527626; Heilig S, 1997, WESTERN J MED, V166, P370; Hendin H, 1999, J CLIN PSYCHIAT, V60, P46; Jochemsen H, 1999, J MED ETHICS, V25, P16, DOI 10.1136/jme.25.1.16; JONES WH, 1923, HIPPOCRATES, V1, P289; Jones WHS, 1923, HIPPOCRATES, P193; KAMISAR Y, 1993, HASTINGS CENT REP, V23, P32, DOI 10.2307/3563366; KAMISAR Y, 1958, MINN LAW REV, V42, P969; KASS LR, 1989, PUBLIC INTEREST, P25; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lynn J, 1997, J AM GERIATR SOC, V45, P489, DOI 10.1111/j.1532-5415.1997.tb05176.x; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; Miller FG, 2000, ANN INTERN MED, V132, P470, DOI 10.7326/0003-4819-132-6-200003210-00008; MILLER FG, 1994, NEW ENGL J MED, V331, P119, DOI 10.1056/NEJM199407143310211; Nuland SB, 2000, NEW ENGL J MED, V342, P583, DOI 10.1056/NEJM200002243420811; *NY STAT TASK FORC, 1994, DEATH IS SOUGHT ASSI; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V270, P874, DOI 10.1001/jama.270.7.874; PELLEGRINO ED, 1995, ANN INTERN MED, V122, P377, DOI 10.7326/0003-4819-122-5-199503010-00010; Phillips RS, 2000, J AM GERIATR SOC, V48, pS1, DOI 10.1111/j.1532-5415.2000.tb03118.x; PIJNENBORG L, 1993, LANCET, V341, P1196, DOI 10.1016/0140-6736(93)91014-D; PRATT DA, 1999, ALBANY LAW J SCI TEC, V9, P161; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; SHAPIRO RS, 1994, ARCH INTERN MED, V154, P575, DOI 10.1001/archinte.154.5.575; Simons M, 2000, N Y Times Web, pA3; SIMONS M, 1995, NY TIMES        0909; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; SNYDER L, 1990, ANN INTERN MED, V112, P802, DOI 10.7326/0003-4819-112-11-802; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; Sulmasy DP, 1998, J LAW MED ETHICS, V26, P55, DOI 10.1111/j.1748-720X.1998.tb01906.x; *TASK FORC IMPR CA, 1998, OR DEATH DIGN ACT GU; TOLLE SW, 1996, ETHICAL CHOICES CASE; TROLLOPE A, 1990, FIXED PERIOD NOVEL; van Delden JJM, 1999, J MED ETHICS, V25, P22, DOI 10.1136/jme.25.1.22; VANDELDEN JJM, 1993, HASTINGS CENT REP, V23, P24, DOI 10.2307/3562919; VANDERMAAS PJ, 1992, EUTHANASIA OTHER MED, P43; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wolf S M, 1996, Duquesne Law Rev, V35, P455; Young EWD, 1997, WESTERN J MED, V166, P381; [No title captured]	98	37	37	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					209	216		10.7326/0003-4819-135-3-200108070-00015	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487490				2022-12-01	WOS:000170298500009
J	Eichhorst, ST; Krammer, PH				Eichhorst, ST; Krammer, PH			Derangement of apoptosis in cancer	LANCET			English	Editorial Material							GENE; LYMPHOMA; CELLS		Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany; German Canc Res Ctr, Div Immunogenet, Tumorimmunol Program, D-69120 Heidelberg, Germany	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Eichhorst, ST (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Catlett IM, 2001, J IMMUNOL, V166, P6019, DOI 10.4049/jimmunol.166.10.6019; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eichhorst ST, 2000, MOL CELL BIOL, V20, P7826, DOI 10.1128/MCB.20.20.7826-7837.2000; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; Krammer P H, 1999, Adv Immunol, V71, P163; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489	14	11	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					345	346		10.1016/S0140-6736(01)05584-2	http://dx.doi.org/10.1016/S0140-6736(01)05584-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502308				2022-12-01	WOS:000170235100003
J	de Gennes, PG				de Gennes, PG			Ultradivided matter	NATURE			English	Editorial Material									Ecole Super Phys & Chim Ind, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	de Gennes, PG (corresponding author), Ecole Super Phys & Chim Ind, 10 Rue Vauquelin, F-75231 Paris 05, France.							CABANE B, 2001, COLLECTION ECOLE PHY; ISRAELASHVILI J, 1985, INTERMOLECULAR SURFA; Morawetz H., 1985, POLYM ORIGIN GROWTH; 2001, P 1 LAV SEM COLL EC	4	24	24	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					385	385		10.1038/35086662	http://dx.doi.org/10.1038/35086662			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473291				2022-12-01	WOS:000170068200023
J	Erickson, GM; Rogers, KC; Yerby, SA				Erickson, GM; Rogers, KC; Yerby, SA			Dinosaurian growth patterns and rapid avian growth rates	NATURE			English	Article							HISTOLOGY; BIRDS	Did dinosaurs grow in a manner similar to extant reptiles, mammals or birds, or were they unique(1)? Are rapid avian growth rates an innovation unique to birds, or were they inherited from dinosaurian precursors(2)? We quantified growth rates for a group of dinosaurs spanning the phylogenetic and size diversity for the clade and used regression analysis to characterize the results. Here we show that dinosaurs exhibited sigmoidal growth curves similar to those of other vertebrates, but had unique growth rates with respect to body mass. All dinosaurs grew at accelerated rates relative to the primitive condition seen in extant reptiles. Small dinosaurs grew at moderately rapid rates, similar to those of marsupials, but large species attained rates comparable to those of eutherian mammals and precocial birds. Growth in giant sauropods was similar to that of whales of comparable size. Non-avian dinosaurs did not attain rates like those of altricial birds. Avian growth rates were attained in a stepwise fashion after birds diverged from theropod ancestors in the Jurassic period.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; Sci Museum Minnesota, St Paul, MN 55102 USA; Macalester Coll, St Paul, MN 55102 USA; Stanford Univ, Dept Biomech Engn, Stanford, CA 94305 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Macalester College; Stanford University	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.							ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; APPENZELLER T, 1994, SCIENCE, V266, P1805, DOI 10.1126/science.266.5192.1805; Bakker R.T., 1986, DINOSAUR HERESIES; Calder W. A, 1984, SIZE FUNCTION LIFE H; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; CASTANET J, 1990, ANN SCI NAT ZOOL, V11, P191; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; DERICQLES A, 1983, COLD LOOK WARM BLOOD, P103; DERICQLES A, 1990, MOD GEOL, V15, P19; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; NORELL MA, IN PRESS SPECIAL PUB; Reid R.E.H., 1997, P449; RICQLES A, 1991, BONE MATRIX BONE SPE, V3, P1; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sussman M., 1964, GROWTH DEV; Thompson D.W., 1943, GROWTH FORM; Varricchio D. J., 1997, ENCY DINOSAURS, P282, DOI DOI 10.1016/J.CUB.2016.10.043; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	29	194	200	0	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					429	433		10.1038/35086558	http://dx.doi.org/10.1038/35086558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473315				2022-12-01	WOS:000170068200045
J	Gill, JA; Norris, K; Potts, PM; Gunnarsson, TG; Atkinson, PW; Sutherland, WJ				Gill, JA; Norris, K; Potts, PM; Gunnarsson, TG; Atkinson, PW; Sutherland, WJ			The buffer effect and large-scale population regulation in migratory birds	NATURE			English	Article							CONSEQUENCES; NUMBERS; COMPETITION; FECUNDITY; ARRIVAL	Buffer effects occur when sites vary in quality and fluctuations in population size are mirrored by large changes in animal numbers in poor-quality sites but only small changes in good-quality sites. Hence, the poor sites `buffer' the good sites(1,2,) a mechanism that can potentially drive population regulation if there are demographic costs of inhabiting poor sites. Here we show that for a migratory bird this process can apply on a country-wide scale with consequences for both survival and timing of arrival on the breeding grounds (an indicator of reproductive success(3,4)). The Icelandic population of the black-tailed godwit, Limosa limosa islandica, wintering in Britain has increased fourfold since the 1970s (ref. 5) but rates of change within individual estuaries have varied from zero to sixfold increases. In accordance with the buffer effect, rates of increase are greater on estuaries with low initial numbers, and godwits on these sites have lower prey-intake rates, lower survival rates and arrive later in Iceland than godwits on sites with stable populations. The buffer effect can therefore be a major process influencing large-scale population regulation of migratory species.	Univ E Anglia, Sch Biol Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Iceland, Inst Biol, IS-108 Reykjavik, Iceland; Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; British Trust Ornithol, Thetford IP24 2PU, England	University of East Anglia; University of Reading; University of Iceland; University of East Anglia; British Trust for Ornithology	Gill, JA (corresponding author), Univ E Anglia, Sch Biol Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England.	j.gill@uea.ac.uk	Sutherland, William/B-1291-2013; Gill, Jennifer A/A-7759-2008; Atkinson, Philip/B-8975-2009; Gunnarsson, Tomas G/L-9783-2015	Atkinson, Philip/0000-0002-0838-557X; Sutherland, William/0000-0002-6498-0437; Gunnarsson, Tomas Gretar/0000-0001-7692-0637				BROWN JL, 1969, AM NAT, V103, P347, DOI 10.1086/282607; Currie D, 2000, IBIS, V142, P389, DOI 10.1111/j.1474-919X.2000.tb04435.x; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; FRASER DF, 1980, ECOLOGY, V61, P790, DOI 10.2307/1936749; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gill JA, 2001, P ROY SOC B-BIOL SCI, V268, P369, DOI 10.1098/rspb.2000.1386; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; HALAMA KJ, 1994, OIKOS, V69, P107, DOI 10.2307/3545289; KAY DG, 1975, J MAR BIOL ASSOC UK, V55, P811, DOI 10.1017/S0025315400017732; KLUYVER H. N., 1953, ARCH NEERLAND ZOOL, V10, P265; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; KREBS JR, 1970, J ZOOL, V162, P317; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; MOSER ME, 1988, J APPL ECOL, V25, P473, DOI 10.2307/2403838; POLLITT MS, 2000, WETLAND BIRD SURVEY; Sandercock BK, 1999, J AVIAN BIOL, V30, P460, DOI 10.2307/3677018; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; UNDERHILL LG, 1994, J APPL ECOL, V31, P463, DOI 10.2307/2404443; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	20	236	247	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					436	438		10.1038/35086568	http://dx.doi.org/10.1038/35086568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473317				2022-12-01	WOS:000170068200047
J	Hale, P; Makgoba, MW; Merson, MH; Quinn, TC; Richman, DD; Vella, S; Wabwire-Mangen, F; Wain-Hobson, S; Weiss, RA				Hale, P; Makgoba, MW; Merson, MH; Quinn, TC; Richman, DD; Vella, S; Wabwire-Mangen, F; Wain-Hobson, S; Weiss, RA			Success hinges on support for treatment	NATURE			English	Editorial Material									Fac Med Necker Enfants Malad, Inst Necker, F-75015 Paris, France; MRC S Africa, Congella, South Africa; Yale Univ, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ist Super Sanita, Int AIDS Soc, I-00161 Rome, Italy; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Pasteur, Paris, France; UCL, London WC1E 6BT, England	UDICE-French Research Universities; Universite Paris Cite; Yale University; Johns Hopkins University; University of California System; University of California San Diego; Istituto Superiore di Sanita (ISS); Makerere University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Hale, P (corresponding author), Fac Med Necker Enfants Malad, Inst Necker, 156 Rue Vaugirard, F-75015 Paris, France.		VELLA, STEFANO/V-8440-2019; VELLA, STEFANO/ABI-3368-2020; Vella, Stefano/GZM-0519-2022	VELLA, STEFANO/0000-0003-2347-5984; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, Z01AI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					272	272		10.1038/35085656	http://dx.doi.org/10.1038/35085656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460135	Bronze			2022-12-01	WOS:000169918200020
J	Perrier, A; Howarth, N; Didier, D; Loubeyre, P; Unger, PF; de Moerloose, P; Slosman, D; Junod, A; Bounameaux, H				Perrier, A; Howarth, N; Didier, D; Loubeyre, P; Unger, PF; de Moerloose, P; Slosman, D; Junod, A; Bounameaux, H			Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP VENOUS THROMBOSIS; VENTILATION-PERFUSION SCINTIGRAPHY; SPIRAL CT; D-DIMER; MEDICAL LITERATURE; VEIN THROMBOSIS; DIAGNOSTIC-TEST; USERS GUIDES; LUNG-SCAN; ANGIOGRAPHY	Background: Helical computed tomography (CT) is commonly used to diagnose pulmonary embolism, although its operating characteristics have been insufficiently evaluated. Objective: To assess the sensitivity and specificity of helical CT in suspected pulmonary embolism. Design: observational study. Setting: Emergency department of a teaching and community hospital. Patients: 299 patients with clinically suspected pulmonary embolism and a plasma D-dimer level greater than 500 mug/L. Intervention: Pulmonary embolism was established by using a validated algorithm that included clinical assessment, lower-limb compression ultrasonography, lung scanning, and pulmonary angiography. Measurements: Sensitivity, specificity, and likelihood ratios of helical CT and interobserver agreement. Helical CT scans were withheld from clinicians and were read 3 months after acquisition by radiologists blinded to all clinical data. Results: 118 patients (39%) had pulmonary embolism, In 12 patients (4%), 2 of whom had pulmonary embolism, results of helical CT were inconclusive, For patients with conclusive results, sensitivity of helical CT was 70% (95% CI, 62% to 78%) and specificity was 91% (CI, 86% to 95%), Interobserver agreement was high (kappa = 0.823 to 0,902). The false-negative rate was lower for helical CT used after initial negative results on ultrasonography than for helical CT alone (21% vs, 30%). Use of helical CT after normal results on initial ultrasonography and nondiagnostic results on lung scanning had a false-negative rate of only 5% and a false-positive rate of only 7%. Conclusion: Helical CT should not be used alone for suspected pulmonary embolism but could replace angiography in combined strategies that include ultrasonography and lung scanning.	Univ Hosp Geneva, Dept Internal Med, Med Clin 1, CH-1211 Geneva 14, Switzerland	University of Geneva	Perrier, A (corresponding author), Univ Hosp Geneva, Dept Internal Med, Med Clin 1, Rue Micheli Du Crest 24, CH-1211 Geneva 14, Switzerland.	Arnaud.Perrier@medecine.unige.ch	Perrier, Arnaud/M-2263-2014					BECKER DM, 1989, ARCH INTERN MED, V149, P1731, DOI 10.1001/archinte.149.8.1731; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Bounameaux H, 1997, QJM-INT J MED, V90, P437, DOI 10.1093/qjmed/90.7.437; Cham MD, 2000, RADIOLOGY, V216, P744, DOI 10.1148/radiology.216.3.r00se44744; deMoerloose P, 1996, THROMB HAEMOSTASIS, V75, P11; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369, DOI 10.2214/ajr.164.6.7754875; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Loud PA, 2000, AM J ROENTGENOL, V174, P61, DOI 10.2214/ajr.174.1.1740061; Mayo JR, 1997, RADIOLOGY, V205, P447, DOI 10.1148/radiology.205.2.9356627; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sostman HD, 1996, JMRI-J MAGN RESON IM, V6, P275, DOI 10.1002/jmri.1880060203; SOSTMAN HD, 1994, RADIOLOGY, V193, P103, DOI 10.1148/radiology.193.1.8090877; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; vanRossum AB, 1996, THORAX, V51, P23, DOI 10.1136/thx.51.1.23; vanRossum AB, 1996, RADIOLOGY, V201, P467, DOI 10.1148/radiology.201.2.8888242; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Woodard PK, 2000, RADIOLOGY, V215, P325, DOI 10.1148/radiology.215.2.r00ma48325; 1990, JAMA, V263, P2753	34	232	238	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					88	97		10.7326/0003-4819-135-2-200107170-00008	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453707				2022-12-01	WOS:000169842300002
J	Rajagopal, MR; Joranson, DE; Gilson, AM				Rajagopal, MR; Joranson, DE; Gilson, AM			Medical use, misuse, and diversion of opioids in India	LANCET			English	Article							TRENDS; CANCER; CARE	In less-developed countries, opioids such as morphine are often not available for pain relief because of excessive regulations imposed to prevent their misuse and diversion. We describe the effect that these draconian measures have had on the availability of drugs for medical use in Kerala, India, and present results of a study, which we did to ascertain whether or not the misuse and diversion of opioids is as prevalent as the government reaction would suggest. We followed 1723 patients in Calicut, India, who were being treated for pain with oral morphine on an -outpatient home-care basis. Over 2 years, we did not identify any instances of misuse or diversion. These results suggest that, in the context of India as a less-developed country, oral morphine can be dispensed safely to patients for use at home. We recommend that palliative care programmes talk to concerned governmental authorities, to make them aware of the medical need for opioids, and communicate with local news media to increase awareness of palliative care and the use of these analgesics. Our project has overcome regulatory barriers that had interrupted availability of morphine and Its use in pain relief in India.	Coll Med, Pain & Palliative Care Clin, Calicut, Kerala, India; Pain & Policy Studies Grp, Madison, WI USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Rajagopal, MR (corresponding author), Coll Med, Pain & Palliative Care Clin, Calicut, Kerala, India.	pain@vsnl.com						Ajithakumari K, 1997, PALLIATIVE MED, V11, P451, DOI 10.1177/026921639701100604; [Anonymous], 2000, ACH BAL NAT OP CONTR; *I MED, 1997, APPR DEATH IMPR CAR; *INT NARC CONTR BO, 2000, NARC DRUGS EST WORLD; *INT NARC CONTR BO, 1999, NARC DRUGS EST WORLD; *INT NARC CONTR BO, 2000, REP INT NARC CONTR B; *INT NARC CONTR BO, 1989, NARC DRUGS EST WORLD; International Narcotics Control Board, 1996, REP INT NARC CONTR B; International Narcotics Control Board, 1999, REP INT NARC CONTR B; *JAP MIN HLTH WELF, 1999, REP ADM MEAS NARC ST; JORANSON DE, 1993, J PAIN SYMPTOM MANAG, V8, P353, DOI 10.1016/0885-3924(93)90052-W; Joranson DE, 2000, JAMA-J AM MED ASSOC, V283, P1710, DOI 10.1001/jama.283.13.1710; Kumar KS, 2000, PALLIATIVE MED, V14, P183, DOI 10.1191/026921600670697351; SIKORA K, 1998, WHO PROGRAMME CANC C; Sureshkumar K, 1996, PALLIATIVE MED, V10, P293, DOI 10.1177/026921639601000404; TEOH N, 1991, Palliative Medicine, V5, P185, DOI 10.1177/026921639100500302; *WHO, 1990, TECHN REP SER WHO, V804; *WHO, 1998, TECHN REP SER WHO, V882; *WHO COLL CTR POL, 2000, IMPR CANC PAIN REL W; World Health Organization, 1986, CANC PAIN REL; World Health Organization, 1996, CANC PAIN REL GUID O, V2nd	21	57	59	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					139	143		10.1016/S0140-6736(01)05322-3	http://dx.doi.org/10.1016/S0140-6736(01)05322-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463435				2022-12-01	WOS:000169837700033
J	Facinelli, B; Spinaci, C; Magi, G; Giovanetti, E; Varaldo, PE				Facinelli, B; Spinaci, C; Magi, G; Giovanetti, E; Varaldo, PE			Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci	LANCET			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING-PROTEIN; EPITHELIAL-CELLS; PYOGENES; INVASION; INTERNALIZATION; PHENOTYPES; STRAINS; GENE	Background An increase in erythromycin resistance rates among group A streptococci has been reported in some European countries. These bacteria, long thought to be extracellular pathogens, can be efficiently internalised by, and survive within, human cells of respiratory-tract origin. Macrolide antibiotics enter eukaryotic cells, whereas beta -lactams are essentially confined to the extracellular fluid. A protein encoded by gene prtF1 is required for efficient entry of group A streptococci into epithelial cells. We investigated isolates of group A streptococci from children with pharyngitis in Italy for the presence of prtF1 and cell-invasion efficiency. Methods We investigated 74 erythromycin-resistant and 52 erythromycin-susceptible isolates collected throughout Italy in 1997-98 from children with pharyngitis. Erythromycin-resistance phenotypes (constitutive, inducible, and M) were assessed by the triple-disc test and resistance determinants (ermB, ermTR, and mefA) by PCR. All strains were examined for the presence of prtF1 by PCR and for their ability to enter cultured human respiratory cells. Findings The proportion of prtF1-positive strains was significantly higher among erythromycin-resistant than susceptible strains (66 [89%] vs 11 [21%]; difference 68% [95% CI 52-84]). All erythromycin-resistant strains without prtF1 were of the M phenotype. The proportion of highly cell-invasive isolates (invasion efficiency >10%) was significantly higher among erythromycin-resistant than among susceptible strains (59 [80%] vs five [10%]; difference 70% [57-83]). Interpretations The unsuspected association between erythromycin resistance and cell invasiveness in group A streptococci raises serious concern. Strains combining erythromycin resistance and ability to enter human respiratory-tract cells may be able to escape both p-lactams by virtue of intracellular location and macrolides by virtue of resistance.	Univ Ancona, Sch Med, Inst Microbiol, I-60131 Ancona, Italy	Marche Polytechnic University	Facinelli, B (corresponding author), Univ Ancona, Sch Med, Inst Microbiol, Via Ranieri, I-60131 Ancona, Italy.			VARALDO, Pietro/0000-0002-4131-487X; GIOVANETTI, Eleonora/0000-0002-9427-8091				Cue DR, 1997, INFECT IMMUN, V65, P2759, DOI 10.1128/IAI.65.7.2759-2764.1997; Gillespie SH, 1998, LANCET, V352, P1954, DOI 10.1016/S0140-6736(05)61327-X; Giovanetti E, 1999, ANTIMICROB AGENTS CH, V43, P1935, DOI 10.1128/AAC.43.8.1935; HSUEH PR, 1995, ANTIMICROB AGENTS CH, V39, P2239, DOI 10.1128/AAC.39.10.2239; KAPLAN EL, 1997, CLIN INFECT DIS    S, V24, P89; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Medina E, 1999, J IMMUNOL, V163, P3396; MITSUHASHI S, 1982, MICROBIOLOGY 1982, P151; Molinari G, 1998, J INFECT DIS, V177, P1600, DOI 10.1086/515310; Molinari G, 1999, CURR OPIN MICROBIOL, V2, P56, DOI 10.1016/S1369-5274(99)80010-1; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; SCHITO GC, 1998, 39 INT C ANT AG CHEM; SEPPALA H, 1993, J ANTIMICROB CHEMOTH, V32, P885, DOI 10.1093/jac/32.6.885; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Varaldo PE, 1999, CLIN INFECT DIS, V29, P869, DOI 10.1086/520451; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577	24	78	78	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					30	33		10.1016/S0140-6736(00)05253-3	http://dx.doi.org/10.1016/S0140-6736(00)05253-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454374				2022-12-01	WOS:000169710900013
J	Ducros, A; Denier, C; Joutel, A; Cecillon, M; Lescoat, C; Vahedi, K; Darcel, F; Vicaut, E; Bousser, M; Tournier-Lasserve, E				Ducros, A; Denier, C; Joutel, A; Cecillon, M; Lescoat, C; Vahedi, K; Darcel, F; Vicaut, E; Bousser, M; Tournier-Lasserve, E			The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CACNA1A GENE MUTATION; DE-NOVO MUTATION; HETEROGENEITY; PREVALENCE; NYSTAGMUS; LOCUS; COMA; AURA; MAPS	Background: Familial hemiplegic migraine, an autosomal dominant disorder characterized by attacks of transient hemiparesis followed by a migraine headache, is divided into pure familial hemiplegic migraine (affecting 80 percent of families) and familial hemiplegic migraine with permanent cerebellar signs (affecting 20 percent of families). Mutations in CACNA1A, which encodes a neuronal calcium channel, are present in 50 percent of families with hemiplegic migraine, including all those with cerebellar signs. We studied the various clinical manifestations associated with mutations in CACNA1A in 28 families with hemiplegic migraine with and without cerebellar signs. Methods: CACNA1A was analyzed and nine mutations were detected in 15 of 16 probands of families affected by hemiplegic migraine and cerebellar signs, in 2 of 3 subjects with sporadic hemiplegic migraine and cerebellar signs, and in 4 of 12 probands of families affected by pure hemiplegic migraine. Genotyping of probands and relatives identified a total of 117 subjects with mutations whose clinical manifestations were assessed in detail. Results: Eighty-nine percent of the subjects with mutations had attacks of hemiplegic migraine. One third had severe attacks with coma, prolonged hemiplegia, or both, with full recovery. All nine mutations, including five newly identified ones, were missense mutations. Six mutations were associated with hemiplegic migraine and cerebellar signs, and 83 percent of the subjects with these six mutations had nystagmus, ataxia, or both. Three mutations were associated with pure hemiplegic migraine. Conclusions: Hemiplegic migraine in subjects with mutations in CACNA1A has a broad clinical spectrum. This clinical variability is partially associated with the various types of mutations. (N Engl J Med 2001;345:17-24.) Copyright (C) 2001 Massachusetts Medical Society.	Fac Med Lariboisiere, INSERM, E9921, Paris, France; Hop Lariboisiere, Dept Neurol, F-75475 Paris 10, France; Hop Lariboisiere, Genet Lab, F-75475 Paris 10, France; CHU, Dept Neurol, Rennes, France; Hop Fernand Widal, Biophys Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Ducros, A (corresponding author), Hop Lariboisiere, Dept Neurol, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	anne.ducros@lrb.ap-hop-paris.fr	DUCROS, Anne/D-1899-2010; Joutel, Anne/K-5601-2017; Tournier-Lasserve, Elisabeth/N-7134-2017	DUCROS, Anne/0000-0001-5560-5013; Joutel, Anne/0000-0003-3963-3860; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677				Battistini S, 1999, NEUROLOGY, V53, P38, DOI 10.1212/WNL.53.1.38; BLAU JN, 1955, LANCET, V2, P1115; Carrera P, 1999, NEUROLOGY, V53, P26, DOI 10.1212/WNL.53.1.26; Clarke JM, 1910, BMJ-BRIT MED J, V1910, P1534; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Elliott MA, 1996, ANN NEUROL, V39, P100, DOI 10.1002/ana.410390115; FITZSIMONS RB, 1985, BRAIN, V108, P555, DOI 10.1093/brain/108.3.555-a; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Friend KL, 1999, HUM GENET, V105, P261, DOI 10.1007/s004390051099; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Gervil M, 1999, NEUROLOGY, V53, P995, DOI 10.1212/WNL.53.5.995; Geschwind DH, 1997, NEUROLOGY, V49, P1247, DOI 10.1212/WNL.49.5.1247; Hans M, 1999, J NEUROSCI, V19, P1610; HENRY S, 1990, IEEE SOFTWARE, V7, P36, DOI 10.1109/52.50772; Hollander M., 1973, NONPARAMETRIC STAT M; JOUTEL A, 1994, AM J HUM GENET, V55, P1166; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; LANCE JW, 1982, MECH MANAGEMENT HEAD; OHTA M, 1967, NEUROLOGY, V17, P813, DOI 10.1212/WNL.17.8.813; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Terwindt GM, 1998, NEUROLOGY, V50, P1105, DOI 10.1212/WNL.50.4.1105; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Vahedi K, 2000, NEUROLOGY, V55, P1040, DOI 10.1212/WNL.55.7.1040; WHITTY CWM, 1953, J NEUROL NEUROSUR PS, V16, P172, DOI 10.1136/jnnp.16.3.172; Yue Q, 1998, AM J MED GENET, V77, P298, DOI 10.1002/(SICI)1096-8628(19980526)77:4<298::AID-AJMG9>3.0.CO;2-J; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZIFKIN B, 1980, ANN NEUROL, V8, P329, DOI 10.1002/ana.410080319	36	373	387	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2001	345	1					17	U5		10.1056/NEJM200107053450103	http://dx.doi.org/10.1056/NEJM200107053450103			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449QJ	11439943				2022-12-01	WOS:000169697600003
J	Clover, BP; McHenry, CS				Clover, BP; McHenry, CS			The DNA polymerase III holoenzyme: An asymmetric dimeric replicative complex with leading and lagging strand polymerases	CELL			English	Article							ESCHERICHIA-COLI; INITIATION COMPLEX; EPSILON-SUBUNIT; GENE-PRODUCT; CLAMP LOADER; TAU-SUBUNIT; PURIFICATION; PROTEIN; GAMMA; TEMPLATE	The DNA Polymerase III holoenzyme forms initiation complexes on primed DNA in an ATP-dependent reaction. We demonstrate that the nonhydrolyzable ATP analog, ATP gammaS, supports the formation of an isolable leading strand complex that loads and replicates the lagging strand only in the presence of ATP, beta, and the single-stranded DNA binding protein. The single endogenous DnaX complex within DNA polymerase III holoenzyme assembles beta onto both the leading and lagging strand polymerases by an ordered mechanism. The dimeric replication complex disassembles in the opposite order from which it assembled. Upon ATP gammaS-induced dissociation, the leading strand polymerase is refractory to disassembly allowing cycling to occur exclusively on the lagging strand. These results establish holoenzyme as an intrinsic asymmetric dimer with distinguishable leading and lagging strand polymerases.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McHenry, CS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695, R01GM036255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35695, GM36255] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HAWKER JR, 1987, J BIOL CHEM, V262, P12722; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; JOHANSON KO, 1984, J BIOL CHEM, V259, P4589; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kim S, 1996, J BIOL CHEM, V271, P4315; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KODAIRA M, 1983, MOL GEN GENET, V192, P80, DOI 10.1007/BF00327650; Kornberg A., 1992, DNA REPLICATION; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; MAKI H, 1988, J BIOL CHEM, V263, P6570; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1988, BIOCHIM BIOPHYS ACTA, V951, P240, DOI 10.1016/0167-4781(88)90092-9; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; MULLIN DA, 1983, MOL GEN GENET, V192, P73, DOI 10.1007/BF00327649; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; ONRUST R, 1993, J BIOL CHEM, V268, P11766; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; REEMS JA, 1994, J BIOL CHEM, V269, P33091; Schulenberg B, 1999, J BIOL CHEM, V274, P34233, DOI 10.1074/jbc.274.48.34233; SHRIMANKAR P, 1992, J BACTERIOL, V174, P7689, DOI 10.1128/JB.174.23.7689-7696.1992; SINHA NK, 1980, J BIOL CHEM, V255, P4290; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	38	52	65	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					925	934		10.1016/S0092-8674(01)00400-7	http://dx.doi.org/10.1016/S0092-8674(01)00400-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439188	Bronze			2022-12-01	WOS:000169664300012
J	Veasy, LG				Veasy, LG			Time to take soundings in acute rheumatic fever	LANCET			English	Editorial Material							DOPPLER-ECHOCARDIOGRAPHIC FINDINGS; VALVULAR REGURGITATION; MITRAL REGURGITATION; INTERMOUNTAIN AREA; UNITED-STATES; CARDITIS; DIAGNOSIS		Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84113 USA	Utah System of Higher Education; University of Utah	Veasy, LG (corresponding author), Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84113 USA.							ABERNETHY M, 1994, AUST NZ J MED, V24, P530, DOI 10.1111/j.1445-5994.1994.tb01753.x; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; DASILVA CH, 1999, REV HOSP CLIN FAC ME, V54, P85; Elevli M, 1999, ACTA PAEDIATR, V88, P1074, DOI 10.1080/08035259950168117; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; FOLGER GM, 1992, BRIT HEART J, V67, P434; FOLGER GM, 1989, AM J CARDIOL, V63, P1278, DOI 10.1016/0002-9149(89)90192-6; Minich LD, 1997, CLIN CARDIOL, V20, P924, DOI 10.1002/clc.4960201105; MORSI MR, 1994, ALEXANDRIA J PEDIAT, V3, P341; STEINFELD L, 1986, CIRCULATION, V74, P385; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q; YOSHIDA K, 1988, CIRCULATION, V78, P840, DOI 10.1161/01.CIR.78.4.840	14	28	28	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					1994	1995		10.1016/S0140-6736(00)05134-5	http://dx.doi.org/10.1016/S0140-6736(00)05134-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438128				2022-12-01	WOS:000169509200005
J	Di Cristo, G; Berardi, N; Cancedda, L; Pizzorusso, T; Putignano, E; Ratto, GM; Maffei, L				Di Cristo, G; Berardi, N; Cancedda, L; Pizzorusso, T; Putignano, E; Ratto, GM; Maffei, L			Requirement of ERK activation for visual cortical plasticity	SCIENCE			English	Article							CRITICAL-PERIOD; MAP KINASE; EXPERIENCE; CORTEX; PHOSPHORYLATION; NEUROTROPHINS; CASCADE	Experience-dependent plasticity in the developing visual cortex depends on electrical activity and molecular signals involved in stabilization or removal of inputs. Extracellular signal-regulated kinase 1,2 (also called p42/44 mitogen-activated protein kinase) activation in the cortex is regulated by both factors. We show that two different inhibitors of the ERK pathway suppress the induction of two forms of long-term potentiation (LTP) in rat cortical slices and that their intracortical administration to monocularly deprived rats prevents the shift in ocular dominance towards the nondeprived eye. These results demonstrate that the ERK pathway is necessary for experience-dependent plasticity and for LTP of synaptic transmission in the developing visual cortex.	CNR, Ist Neurofisiol, I-56100 Pisa, Italy; Scuola Normale Super Pisa, I-56126 Pisa, Italy; Univ Florence, Dipartimento Psicol, I-50123 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Scuola Normale Superiore di Pisa; University of Florence	Berardi, N (corresponding author), CNR, Ist Neurofisiol, Via Moruzzi 1, I-56100 Pisa, Italy.	berardi@in.pi.cnr.it	Ratto, Gian Michele/AAX-8514-2020; Ratto, Gian Michele/AAB-8719-2021; Pizzorusso, Tommaso/D-1399-2013	Ratto, Gian Michele/0000-0001-9632-7769; Pizzorusso, Tommaso/0000-0001-5614-0668; Cancedda, Laura/0000-0003-0566-057X; Putignano, Elena/0000-0002-4313-408X	Telethon [934] Funding Source: Medline	Telethon(Fondazione Telethon)		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Berman DE, 1998, J NEUROSCI, V18, P10037; BIRCH D, 1979, VISION RES, V19, P933, DOI 10.1016/0042-6989(79)90029-4; Blum S, 1999, J NEUROSCI, V19, P3535; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Lodovichi C, 2000, J NEUROSCI, V20, P2155; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Schafe GE, 2000, J NEUROSCI, V20, P8177; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127	24	161	164	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2337	2340						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423664				2022-12-01	WOS:000169455900060
J	Royer, DL; Wing, SL; Beerling, DJ; Jolley, DW; Koch, PL; Hickey, LJ; Berner, RA				Royer, DL; Wing, SL; Beerling, DJ; Jolley, DW; Koch, PL; Hickey, LJ; Berner, RA			Paleobotanical evidence for near present-day levels of atmospheric CO2 during part of the tertiary	SCIENCE			English	Article							CARBON-DIOXIDE; CLIMATE; MARINE; RECORD; END; RESPONSES; PCO(2); L.	Understanding the Link between the greenhouse gas carbon dioxide (CO2) and Earth's temperature underpins much of paleoclimatology and our predictions of future global warming. Here, we use the inverse relationship between Leaf stomatal indices and the partial pressure of CO2 in modern Ginkgo biloba and Metasequoia glyptostroboides to develop a CO2 reconstruction based on fossil Ginkgo and Metaseguoia cuticles for the middle Paleocene to early Eocene and middle Miocene. Our reconstruction indicates that CO2 remained between 300 and 450 parts per million by volume for these intervals with the exception of a single high estimate near the Paleocene/Eocene boundary. These results suggest that factors in addition to CO2 are required to explain these past intervals of global warmth.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Ctr Palynol, Sheffield S3 7HF, S Yorkshire, England; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Sheffield; University of Sheffield; University of California System; University of California Santa Cruz	Royer, DL (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	dana.royer@yale.edu	Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314; Royer, Dana/0000-0003-0976-953X; Wing, Scott/0000-0002-2954-8905				Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; Beerling DJ, 2000, PALAEOGEOGR PALAEOCL, V161, P395, DOI 10.1016/S0031-0182(00)00095-X; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; CHANEY RALPH W., 1951, TRANS AMER PHIL SOC, V40, P171; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; DICKENS GR, IN PRESS GEOPHYS MON, V124; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Huber M, 1999, J GEOPHYS RES-ATMOS, V104, P16633, DOI 10.1029/1999JD900272; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kothavala Z, 1999, GEOPHYS RES LETT, V26, P209, DOI 10.1029/1998GL900275; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; ROYER DL, IN PRESS EARTH SCI R; Rundgren M, 1999, HOLOCENE, V9, P509, DOI 10.1191/095968399677717287; SAVIN SM, 1975, GEOL SOC AM BULL, V86, P1499, DOI 10.1130/0016-7606(1975)86<1499:TMP>2.0.CO;2; SINHA A, 1994, GLOBAL PLANET CHANGE, V9, P297, DOI 10.1016/0921-8181(94)00010-7; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; Stott LD, 1992, PALEOCEANOGRAPHY, V7, P395, DOI 10.1029/92PA01183; Tajika E, 1998, EARTH PLANET SC LETT, V160, P695, DOI 10.1016/S0012-821X(98)00121-6; THIRY M, 1998, MEM SCI TERRE, V34, P21; TRALAU H, 1968, LETHAIA, V1, P63, DOI 10.1111/j.1502-3931.1968.tb01728.x; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; WALLMANN K, IN PRESS GEOCHIM COS; WING SL, 2000, WARM CLIMATES EARTH, P197; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; WOODWARD FI, 1988, J EXP BOT, V39, P1771, DOI 10.1093/jxb/39.12.1771	34	262	291	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2310	2313		10.1126/science.292.5525.2310	http://dx.doi.org/10.1126/science.292.5525.2310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423657				2022-12-01	WOS:000169455900052
J	Teasley, S; Wolinsky, S				Teasley, S; Wolinsky, S			Policy forum: Communication - Scientific collaborations at a distance	SCIENCE			English	Article									Univ Michigan, Sch Informat, Collab Res Elect Work, Ann Arbor, MI 48109 USA; Northwestern Univ, Dept Med, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; Northwestern University	Teasley, S (corresponding author), Univ Michigan, Sch Informat, Collab Res Elect Work, Ann Arbor, MI 48109 USA.	steasley@umich.edu	Wolinsky, Steven/B-2893-2012	Wolinsky, Steven/0000-0002-9625-6697	NATIONAL CANCER INSTITUTE [P30CA079458] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA79458-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Finholt TA, 1997, PSYCHOL SCI, V8, P28, DOI 10.1111/j.1467-9280.1997.tb00540.x; FINHOLT TA, 2001, ANN REV INF SCI TECH, V36; HESSE BW, 1993, COMMUN ACM, V36, P90, DOI 10.1145/163381.163409; National Research Council, 1993, NAT COLL APPL INF TE; Schatz B. R., 1991, Journal of Management Information Systems, V8, P87; Star SL, 1994, P C COMP SUPP COOP W, P253, DOI DOI 10.1145/192844.193021; Uncapher K., 1989, NATL COLLABORATORY R; WEINBERG AM, 1961, SCIENCE, V134, P161, DOI 10.1126/science.134.3473.161; WULF WA, 1993, SCIENCE, V261, P854, DOI 10.1126/science.8346438	9	53	56	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2254	2255		10.1126/science.1061619	http://dx.doi.org/10.1126/science.1061619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423638				2022-12-01	WOS:000169455900029
J	Charatan, F				Charatan, F			Fake prescription drugs are flooding the United States	BRITISH MEDICAL JOURNAL			English	News Item																			0	6	6	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2001	322	7300					1443	1443						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408295				2022-12-01	WOS:000169389200011
J	Baur, JA; Zou, Y; Shay, JW; Wright, WE				Baur, JA; Zou, Y; Shay, JW; Wright, WE			Telomere position effect in human cells	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE DEACETYLASE; CELLULAR SENESCENCE; EXPRESSION; GENE; FIBROBLASTS; REPRESSION; SEQUENCE; RB	In yeast, telomere position effect (TPE) results in the reversible silencing of genes near telomeres. Here we demonstrate the presence of TPE in human cells. HeLa clones containing a luciferase reporter adjacent to a newly formed telomere express 10 times less luciferase than do control clones generated by random integration. Luciferase expression is restored by trichostatin A, a histone deacetylase inhibitor. Overexpression of a human telomerase reverse transcriptase complementary DNA results in telomere elongation and an additional 2- to 10-fold decrease in expression in telomeric clones but not control clones. The dependence of TPE on telomere length provides a mechanism for the modification of gene expression throughout the replicative life-span of human cells.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shay, JW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Baur, Joseph A/D-8163-2011; Shay, Jerry W/F-7878-2011	Baur, Joseph/0000-0001-8262-6549	NIA NIH HHS [AG07792] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAUR J, UNPUB; BAYNE RAL, 1994, HUM MOL GENET, V3, P539; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; COOKE H, 1995, TELOMERES, P238; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HAYFLICK L, 1980, ANN REV GERONTOLOGY, V1, P26; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McChesney Patricia A., 2000, Molecular Cell Biology Research Communications, V3, P312, DOI 10.1006/mcbr.2000.0229; Ofir R, 1999, P NATL ACAD SCI USA, V96, P11434, DOI 10.1073/pnas.96.20.11434; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sprung CN, 1996, NUCLEIC ACIDS RES, V24, P4336, DOI 10.1093/nar/24.21.4336; Tresini M, 1999, J CELL PHYSIOL, V179, P11, DOI 10.1002/(SICI)1097-4652(199904)179:1<11::AID-JCP2>3.3.CO;2-Z; WILEY EA, 1995, GENETICS, V139, P67; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S; Yamano T, 2000, MOL THER, V1, P574, DOI 10.1006/mthe.2000.0074	22	350	364	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2075	2077		10.1126/science.1062329	http://dx.doi.org/10.1126/science.1062329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408657				2022-12-01	WOS:000169284700047
J	Lohmann, JU; Hong, RL; Hobe, M; Busch, MA; Parcy, F; Simon, R; Weigel, D				Lohmann, JU; Hong, RL; Hobe, M; Busch, MA; Parcy, F; Simon, R; Weigel, D			A molecular link between stem cell regulation and floral patterning in Arabidopsis	CELL			English	Article							HOMEOTIC GENE; FLOWER DEVELOPMENT; ORGAN IDENTITY; SYNERGISTIC ACTIVATION; NEGATIVE REGULATION; ECTOPIC EXPRESSION; SHOOT MERISTEMS; LEAFY; PLANTS; TRANSCRIPTION	The homeotic gene AGAMOUS (AG) has dual roles in specifying organ fate and limiting stem cell proliferation in Arabidopsis flowers. We show that the floral identity protein LEAFY (LPI), a transcription factor expressed throughout the flower, cooperates with the homeodomain protein WUSCHEL (WUS) to activateAG in the center of flowers. WUS was previously identified because of its role in maintaining stem cell populations in both shoot and floral meristems. The unsuspected additional role of WUS in regulating floral homeotic gene expression supports the hypothesis that floral patterning uses a general meristem patterning system that was present before flowers evolved. We also show that AG represses WUS at later stages of floral development, thus creating a negative feedback loop that is required for the determinate growth of floral meristems.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Salk Institute; University of California System; University of California San Diego; University of Cologne; Max Planck Society	Weigel, D (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.		Weigel, Detlef/C-1418-2008; Parcy, François/G-9177-2011; parcy, francois/A-6031-2009; Weigel, Detlef/AAR-3312-2021; Lohmann, Jan/T-3776-2019; Weigel, Detlef/GSJ-0799-2022; Simon, Rudiger/T-6755-2018	Weigel, Detlef/0000-0002-2114-7963; Parcy, François/0000-0003-2191-500X; Lohmann, Jan/0000-0003-3667-187X; Weigel, Detlef/0000-0002-2114-7963; Simon, Rudiger/0000-0002-1317-7716	NIGMS NIH HHS [GM07240-24] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bechtold N, 1998, METH MOL B, V82, P259; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Byzova MV, 1999, GENE DEV, V13, P1002, DOI 10.1101/gad.13.8.1002; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CLARK SE, 1993, DEVELOPMENT, V119, P397; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GOLEMIS EA, 1996, CURRENT PROTOCOLS MO; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Irish VF, 1999, DEV BIOL, V209, P211, DOI 10.1006/dbio.1999.9226; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Laux T, 1996, DEVELOPMENT, V122, P87; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MIZUKAMI Y, 1995, PLANT MOL BIOL, V28, P767, DOI 10.1007/BF00042064; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; OLIVIERO S, 1991, P NATL ACAD SCI USA, V88, P224, DOI 10.1073/pnas.88.1.224; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; SAUER F, 1995, SCIENCE, V270, P1783, DOI 10.1126/science.270.5243.1783; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Sieburth LE, 1998, DEVELOPMENT, V125, P4303; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; von Goethe J. W., 1790, VERSUCH METAMORPHOSE; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	54	498	554	5	73	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					793	803		10.1016/S0092-8674(01)00384-1	http://dx.doi.org/10.1016/S0092-8674(01)00384-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440721	Bronze, Green Published			2022-12-01	WOS:000169375100012
J	Heames, RM; Sado, D; Deakin, CD				Heames, RM; Sado, D; Deakin, CD			Do doctors position defibrillation paddles correctly? Observational study	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England		Deakin, CD (corresponding author), Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England.							[Anonymous], 2000, RESUSCITATION, V46, P109; [Anonymous], 2000, RESUSCITATION, V46, P73; *EM CARD CAR COMM, 1992, JAMA-J AM MED ASSOC, V268, P2199; LAROSE D, 1993, ANN EMERG MED, V22, P1925, DOI 10.1016/S0196-0644(05)80429-9; Robertson C, 1998, RESUSCITATION, V37, P81, DOI 10.1016/S0300-9572(98)00035-5	5	27	28	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1393	1394		10.1136/bmj.322.7299.1393	http://dx.doi.org/10.1136/bmj.322.7299.1393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397743	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000169284600016
J	Alroy, J				Alroy, J			A multispecies overkill simulation of the end-Pleistocene megafaunal mass extinction	SCIENCE			English	Article							MAMMALS; HUNTER	A computer simulation of North American end-Pleistocene human and Large herbivore population dynamics correctly predicts the extinction or survival of 32 out of 41 prey species. Slow human population growth rates, random hunting, and Low maximum hunting effort are assumed; additional parameters are based on published values. Predictions are close to observed values for overall extinction rates, human population densities, game consumption rates, and the temporal overlap of humans and extinct species. Results are robust to variation in unconstrained parameters. This fully mechanistic model accounts for megafaunal extinction without invoking climate change and secondary ecological effects.	Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Alroy, J (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	alroy@nceas.ucsb.edu	Alroy, John/B-4585-2009	Alroy, John/0000-0002-9882-2111				ADAMS RHM, 1986, HUM TOXICOL, V5, P5, DOI 10.1177/096032718600500102; ALBERDI MT, 1995, BIOL J LINN SOC, V54, P349, DOI 10.1111/j.1095-8312.1995.tb01042.x; Alroy John, 1999, P105; Beck MW, 1996, PALEOBIOLOGY, V22, P91, DOI 10.1017/S0094837300016043; BELOVSKY GE, 1987, J ANTHROPOL ARCHAEOL, V6, P29, DOI 10.1016/0278-4165(87)90016-X; BELOVSKY GE, 1988, J ANTHROPOL ARCHAEOL, V7, P329, DOI 10.1016/0278-4165(88)90002-5; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; BUDYKO MI, 1967, SOV GEOGR, V8, P783, DOI 10.1080/00385417.1967.10770945; Choquenot D, 1998, GLOBAL ECOL BIOGEOGR, V7, P167, DOI 10.1046/j.1466-822X.1998.00285.x; Damuth J., 1990, BODY SIZE MAMMALIAN; Diamond J.M., 1984, QUATERNARY EXTINCTIO, P354; Fiedel SJ, 1999, AM ANTIQUITY, V64, P95, DOI 10.2307/2694348; Graham R.W., 1984, P223; Graham RW, 1996, SCIENCE, V272, P1601; Guthrie R.D., 1984, P259; HARVEY PH, 1991, AM NAT, V137, P556, DOI 10.1086/285183; Hassan FA, 1981, DEMOGRAPHIC ARCHAEOL; Haynes Gary, 1999, P71; HENNEMANN WW, 1983, OECOLOGIA, V56, P104, DOI 10.1007/BF00378224; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Keesing F, 1998, OECOLOGIA, V116, P381, DOI 10.1007/s004420050601; MacPhee Ross D.E., 1997, P169; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; MARTIN PS, 1973, SCIENCE, V179, P969, DOI 10.1126/science.179.4077.969; Martin PS, 1967, PREHISTORIC EXTINCTI; MOSIMANN JE, 1975, AM SCI, V63, P304; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Silva M, 1997, J ANIM ECOL, V66, P327, DOI 10.2307/5979; Webster D., 1981, P556; WHITLEY DS, 1993, AM ANTIQUITY, V58, P626, DOI 10.2307/282199; Whittington S.L., 1984, P451; Wilkie DS, 1998, CONSERV BIOL, V12, P137, DOI 10.1046/j.1523-1739.1998.96156.x; WINTERHALDER B, 1988, J ANTHROPOL ARCHAEOL, V7, P289, DOI 10.1016/0278-4165(88)90001-3	34	349	367	14	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1893	1896		10.1126/science.1059342	http://dx.doi.org/10.1126/science.1059342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397940				2022-12-01	WOS:000169200700043
J	Young, D				Young, D			Leprosy and the genome - not yet a burnt-out case	LANCET			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Young, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England.							Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; *WHO, 2000, GLOB TUB CONTR; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P226	8	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2001	357	9269					1639	1640		10.1016/S0140-6736(00)04861-3	http://dx.doi.org/10.1016/S0140-6736(00)04861-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425365				2022-12-01	WOS:000168901600006
J	Wilke, CO; Wang, JL; Ofria, C; Lenski, RE; Adami, C				Wilke, CO; Wang, JL; Ofria, C; Lenski, RE; Adami, C			Evolution of digital organisms at high mutation rates leads to survival of the flattest	NATURE			English	Article							SELECTION BALANCE; POPULATION	Darwinian evolution favours genotypes with high replication rates, a process called 'survival of the fittest'. However, knowing the replication rate of each individual genotype may not suffice to predict the eventual survivor, even in an asexual population. According to quasi-species theory, selection favours the cloud of genotypes, interconnected by mutation, whose average replication rate is highest(1-5). Here we confirm this prediction using digital organisms that self-replicate, mutate and evolve(6-9). Forty pairs of populations were derived from 40 different ancestors in identical selective environments, except that one of each pair experienced a 4-fold higher mutation rate. In 12 cases, the dominant genotype that evolved at the lower mutation rate achieved a replication rate >1.5-fold faster than its counterpart. We allowed each of these disparate pairs to compete across a range of mutation rates. In each case, as mutation rate was increased, the outcome of competition switched to favour the genotype with the lower replication rate. These genotypes, although they occupied lower fitness peaks, were located in flatter regions of the fitness surface and were therefore more robust with respect to mutations.	CALTECH, Digital Life Lab, Pasadena, CA 91125 USA; Michigan State Univ, Ctr Biol Modeling, E Lansing, MI 48824 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; Michigan State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Wilke, CO (corresponding author), CALTECH, Digital Life Lab, Mail Code 136-93, Pasadena, CA 91125 USA.	wilke@caltech.edu	Adami, Chris/A-9675-2011; Wilke, Claus O./B-4643-2008; Adami, Christoph/A-5181-2009	Adami, Chris/0000-0002-2915-9504; Lenski, Richard/0000-0002-1064-8375; Ofria, Charles/0000-0003-2924-1732; Wilke, Claus/0000-0002-7470-9261				Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Adami C., 1998, INTRO ARTIFICIAL LIF; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Eigen M., 1979, HYPERCYCLE PRINCIPLE; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Freeland SJ, 1998, P ROY SOC B-BIOL SCI, V265, P2111, DOI 10.1098/rspb.1998.0547; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Johnson T, 1999, P ROY SOC B-BIOL SCI, V266, P2389, DOI 10.1098/rspb.1999.0936; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; RAY TS, 1991, ARTIF LIFE, V2, P372; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x; WIKE CO, IN PRESS B MATH BIOL	28	420	428	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					331	333		10.1038/35085569	http://dx.doi.org/10.1038/35085569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460163				2022-12-01	WOS:000169918200046
J	Hale, RC; La Guardia, MJ; Harvey, EP; Gaylor, MO; Mainor, TM; Duff, WH				Hale, RC; La Guardia, MJ; Harvey, EP; Gaylor, MO; Mainor, TM; Duff, WH			Flame retardants - Persistent pollutants in land-applied sludges	NATURE			English	Article									Virginia Inst Marine Sci, Dept Environm Sci, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Hale, RC (corresponding author), Virginia Inst Marine Sci, Dept Environm Sci, POB 1346, Gloucester Point, VA 23062 USA.	hale@vims.edu	Hale, Robert C/D-7601-2013	La Guardia, Mark/0000-0003-4866-4992				de Boer J, 1998, NATURE, V394, P28, DOI 10.1038/27798; DICARLO FJ, 1978, ENVIRON HEALTH PERSP, V23, P351, DOI 10.1289/ehp.7823351; *NAT AC SCI, 1996, US RECL WAT SLUD FOO; Renner R, 2000, ENVIRON SCI TECHNOL, V34, p452A, DOI 10.1021/es003482n; Renner R, 2000, ENVIRON SCI TECHNOL, V34, p222A, DOI 10.1021/es003269r; Sellstrom U, 1999, ORGANOHALOGEN COMPD, V40, P383; Strandberg B, 2001, ENVIRON SCI TECHNOL, V35, P1078, DOI 10.1021/es001819f; *US EPA, 1999, EPA530R99009; World Health Organization: Brominated diphenylethers, 1994, ENV HLTH CRIT	9	200	209	7	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					140	141		10.1038/35084130	http://dx.doi.org/10.1038/35084130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449259				2022-12-01	WOS:000169778700037
J	Sharma, L; Song, J; Felson, DT; Cahue, S; Shamiyeh, E; Dunlop, DD				Sharma, L; Song, J; Felson, DT; Cahue, S; Shamiyeh, E; Dunlop, DD			The role of knee alignment in disease progression and functional decline in knee osteoarthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIOGRAPHIC ASSESSMENT; MEDICAL CONDITIONS; CLINICAL-TRIALS; JOINT LOAD; MALALIGNMENT; ARTHRITIS; LAXITY; MENISCECTOMY; STABILITY; DYNAMICS	Context Knee osteoarthritis (OA) is a leading cause of disability in older persons. Few risk factors for disease progression or functional decline have been identified. Hip-knee-ankle align ment influences load distribution at the knee; varus and valgus alignment increase medial and lateral load, respectively. Objective To test the hypotheses that (1) varus alignment increases risk of medial knee OA progression during the subsequent 18 months, (2) valgus alignment increases risk of subsequent lateral knee OA progression, (3) greater severity of malalignment is associated with greater subsequent loss of joint space, and (4) greater burden of malalignment is associated with greater subsequent decline in physical function. Design and Setting Prospective longitudinal cohort study conducted March 1997 to March 2000 at an academic medical center in Chicago, ill. Participants A total of 237 persons recruited from the community with primary knee OA, defined by presence of definite tibiofemoral osteophytes and at least some difficulty with knee-requiring activity; 230 (97%) completed the study. Main Outcome Measures Progression of OA, defined as al-grade increase in severity of joint space narrowing on semiflexed, fluoroscopically confirmed knee radiographs; change in narrowest joint space width; and change in physical function between baseline and 18 months, compared by knee alignment at baseline. Results Varus alignment at baseline was associated with a 4-fold increase in the odds of medial progression, adjusting for age, sex, and body mass index (adjusted odds ratio [OR], 4.09; 95% confidence interval [CI], 2.20-7.62). Valgus alignment at baseline was associated with a nearly 5-fold increase in the odds of lateral progression (adjusted OR, 4.89; 95% CI, 2.13-11.20). Severity of varus correlated with greater medial joint space loss during the subsequent 18 months (R=0.52; 95% CI, 0.40-0.62 in dominant knees), and severity of valgus correlated with greater subsequent lateral joint space loss (R=0.35; 95% CI, 0.21-0.47 in dominant knees). Having alignment of more than 5 degrees (in either direction) in both knees at baseline was associated with significantly greater functional deterioration during the 18 months than having alignment of 5 degrees or less in both knees, after adjusting for age, sex, body mass index, and pain. Conclusion This is, to our knowledge, the first demonstration that in primary knee OA varus alignment increases risk of medial OA progression, that valgus alignment increases risk of lateral OA progression, that burden of malalignment predicts decline in physical function, and that these effects can be detected after as little as 18 months of observation.	Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Boston Univ, Boston, MA 02215 USA	Northwestern University; Boston University	Sharma, L (corresponding author), Northwestern Univ, Sch Med, 303 E Chicago Ave,Ward Bldg 3-315, Chicago, IL 60611 USA.			Felson, David/0000-0002-2668-2447; Sharma, Leena/0000-0002-5571-1622	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR030692] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00048] Funding Source: Medline; NIAMS NIH HHS [AR-30692] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALLEN PR, 1984, J BONE JOINT SURG BR, V66, P666, DOI 10.1302/0301-620X.66B5.6548755; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; ALTMAN RD, 1987, ARTHRITIS RHEUM-US, V30, P1214, DOI 10.1002/art.1780301103; ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395; BOE S, 1986, J BONE JOINT SURG BR, V68, P707, DOI 10.1302/0301-620X.68B5.3782228; BRAGE ME, 1994, CLIN ORTHOP RELAT R, P184; Bruns J, 1993, ARCH ORTHOP TRAUMA S, V133, P12; Buckland-Wright JC, 1999, J RHEUMATOL, V26, P2664; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; BUCKLANDWRIGHT JC, 1995, ANN RHEUM DIS, V54, P872, DOI 10.1136/ard.54.11.872; BUCKLANDWRIGHT JC, 1994, ANN RHEUM DIS, V53, P268, DOI 10.1136/ard.53.4.268; BUCKLANDWRIGHT JC, 1995, ANN RHEUM DIS, V54, P263, DOI 10.1136/ard.54.4.263; BUCKLANDWRIGHT JC, 1995, OSTEOARTHRITIC DISOR, P51; CHAO EYS, 1994, ORTHOP CLIN N AM, V25, P379; COOKE TDV, 1994, ORTHOP CLIN N AM, V25, P387; CUSHNAGHAN J, 1990, ANN RHEUM DIS, V49, P768, DOI 10.1136/ard.49.10.768; Dieppe P, 1995, OSTEOARTHRITIC DISOR, P481; DIEPPE P, 2001, STEPP OA SCI C PREV; DIEPPE P, 1995, OSTEOARTHRITIC DISOR, P7; DOUGADOS M, 1992, J RHEUMATOL, V19, P378; ETTINGER WH, 1994, J CLIN EPIDEMIOL, V47, P809, DOI 10.1016/0895-4356(94)90178-3; FLECKENSTEIN SJ, 1988, J BIOMECH, V21, P915, DOI 10.1016/0021-9290(88)90129-7; GOLDBERG VM, 1992, OSTEOARTHRITIS DIAGN, P599; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; HARRINGTON IJ, 1983, J BONE JOINT SURG AM, V65, P247, DOI 10.2106/00004623-198365020-00016; HILDING MB, 1995, ACTA ORTHOP SCAND, V66, P317, DOI 10.3109/17453679508995552; HSU RWW, 1990, CLIN ORTHOP RELAT R, P215; JOHNSON F, 1980, J BONE JOINT SURG BR, V62, P346, DOI 10.1302/0301-620X.62B3.7410467; KUETTNER KE, 1995, OSTEOARTHRITIC DISOR, pR21; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Lequesne M., 1995, OSTEOARTHRITIC DISOR, P427; MARKOLF KL, 1981, J BONE JOINT SURG AM, V63, P570, DOI 10.2106/00004623-198163040-00007; MARKOLF KL, 1978, J BONE JOINT SURG AM, V60, P664, DOI 10.2106/00004623-197860050-00014; Mazzuca SA, 1997, OSTEOARTHR CARTILAGE, V5, P217, DOI 10.1016/S1063-4584(97)80017-9; Mazzuca SA, 1999, RHEUM DIS CLIN N AM, V25, P467, DOI 10.1016/S0889-857X(05)70079-X; MCKELLOP HA, 1994, ORTHOP CLIN N AM, V25, P415; MESSIEH SS, 1990, J BONE JOINT SURG BR, V72, P639, DOI 10.1302/0301-620X.72B4.2380220; MILLER R, 1973, J BONE JOINT SURG AM, VA 55, P956, DOI 10.2106/00004623-197355050-00004; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; *NAT I ARTHR MUSC, 2001, OST IN; NEYRET P, 1993, J BONE JOINT SURG BR, V75, P36, DOI 10.1302/0301-620X.75B1.8421030; NOYES FR, 1991, AM J SPORT MED, V19, P163, DOI 10.1177/036354659101900212; OGILVIE-HARRIS D J, 1991, Arthroscopy, V7, P151, DOI 10.1016/0749-8063(91)90101-3; PAI YC, 1991, ARCH PHYS MED REHAB, V72, P881, DOI 10.1016/0003-9993(91)90004-3; PAI YC, 1994, ARTHRITIS RHEUM-US, V37, P1297, DOI 10.1002/art.1780370905; PELLETIER JP, 1997, ARTHRITIS ALLIED CON, P1969; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Ravaud P, 1996, J RHEUMATOL, V23, P1756; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; SCHOUTEN JSAG, 1992, ANN RHEUM DIS, V51, P932, DOI 10.1136/ard.51.8.932; SCHULTZ AB, 1992, J BIOMECH, V25, P1383, DOI 10.1016/0021-9290(92)90052-3; SEEMAN TE, 1994, J GERONTOL MED SCI, V49, P97; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Sharma L, 1999, ARTHRITIS RHEUM-US, V42, P25, DOI 10.1002/1529-0131(199901)42:1<25::AID-ANR3>3.0.CO;2-G; TETSWORTH K, 1994, ORTHOP CLIN N AM, V25, P367; Wada M, 1996, BRIT J RHEUMATOL, V35, P560; YASUDA K, 1992, CLIN ORTHOP RELAT R, P186	61	960	1042	1	73	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					188	195		10.1001/jama.286.2.188	http://dx.doi.org/10.1001/jama.286.2.188			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448282				2022-12-01	WOS:000169798700024
J	Verlinsky, Y; Rechitsky, S; Schoolcraft, W; Strom, C; Kuliev, A				Verlinsky, Y; Rechitsky, S; Schoolcraft, W; Strom, C; Kuliev, A			Preimplantation diagnosis for fanconi anemia combined with HLA matching	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-GENE DISORDERS; POLAR BODY ANALYSIS; AMPLIFICATION; POLYMORPHISM; FACC	Context The advent of single-cell polymerase chain reaction (PCR) has presented the opportunity for combined preimplantation genetic diagnosis (PCD) and HLA antigen testing, This is a novel and useful way to preselect a potential donor for an affected sibling requiring stem cell transplantation. Objective To perform in vitro fertilization (IVF) and preimplantation HLA matching combined with PGD for Fanconi anemia (FA), Design DNA analysis for the IVS 4+4 A -->T (adenine to thymine) mutation in the FA complement C (FANCC) gene in single blastomeres, obtained by biopsy of embryos, to identify genetic status and HLA markers of each embryo before intrauterine transfer. Setting In vitro fertilization programs at large medical centers in Chicago, ill, and Denver, Colo. Participants A couple, both carriers of the IVS 4+4 A -->T mutation in the FANCC gene with an affected child requiring an HLA-compatible donor for cord blood transplantation. Main Outcome Measures DNA analysis of single blastomeres to preselect unaffected embryos representing an HLA match for the affected sibling. Results Of 30 embryos tested in 4 IVF attempts, 6 were homozygous affected and 24 were unaffected. Five of these embryos were also found to be HLA-compatible, of which 2 were transferred in the first and 1 in each of the other 3 cycles, resulting in a pregnancy and birth of an unaffected child in the last cycle. Conclusion To our knowledge, this is the first PGD with HLA matching, demonstrating feasibility of preselecting unaffected embryos that can also be an HLA-compatible source for stem cell transplantation for a sibling.	Inst Reprod Genet, Chicago, IL USA; Colorado Ctr Reprod Med, Denver, CO USA		Verlinsky, Y (corresponding author), 2825 N Halsted St, Chicago, IL 60657 USA.		Kuliev, Anver/P-5666-2018	Kuliev, Anver/0000-0002-2486-9339				BLASCZYK R, 1995, TISSUE ANTIGENS, V46, P86, DOI 10.1111/j.1399-0039.1995.tb02483.x; Foissac A, 1998, TISSUE ANTIGENS, V52, P318, DOI 10.1111/j.1399-0039.1998.tb03054.x; Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; GLUCKMAN E, 1980, BRIT J HAEMATOL, V45, P557, DOI 10.1111/j.1365-2141.1980.tb07178.x; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HANDYSIDE AH, 1992, NEW ENGL J MED, V327, P905, DOI 10.1056/NEJM199209243271301; *INT WORK GROUP PR, 2001, J ASSIST REPROD GEN, V18, P66; *INT WORK GROUP PR, 2000, J ASSIST REPROD GEN, V17, P75; Mitsunaga S, 1998, EUR J IMMUNOGENET, V25, P15, DOI 10.1046/j.1365-2370.1998.00093.x; Munne S, 1998, J ASSIST REPROD GEN, V15, P290, DOI 10.1023/A:1022544511198; Rechitsky S, 1999, J ASSIST REPROD GEN, V16, P192, DOI 10.1023/A:1020312823155; Sermon K, 1997, PRENATAL DIAG, V17, P925, DOI 10.1002/(SICI)1097-0223(199710)17:10<925::AID-PD178>3.0.CO;2-4; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; VELRINSKY Y, 2000, ATLAS PREIMPLANTATIO; Verlinsky Y, 1999, GENET TEST, V3, P185, DOI 10.1089/gte.1999.3.185; VERLINSKY Y, 1990, HUM REPROD, V5, P826, DOI 10.1093/oxfordjournals.humrep.a137192; Verlinsky Y, 1999, J ASSIST REPROD GEN, V16, P161, DOI 10.1023/A:1020327804500; Verlinsky Yury, 2001, Reprod Biomed Online, V2, P102; WAGNER JE, 1999, HEMATOPOIETIC CELL T, P1204; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202; Xu KP, 1999, JAMA-J AM MED ASSOC, V281, P1701, DOI 10.1001/jama.281.18.1701; YOSHIDA M, 1992, HUM IMMUNOL, V34, P257, DOI 10.1016/0198-8859(92)90025-I	24	244	271	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2001	285	24					3130	3133		10.1001/jama.285.24.3130	http://dx.doi.org/10.1001/jama.285.24.3130			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FF	11427142	Bronze			2022-12-01	WOS:000169388900027
J	Smith, GCS; Pell, JP; Walsh, D				Smith, GCS; Pell, JP; Walsh, D			Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births	LANCET			English	Article							MYOCARDIAL-INFARCTION; YOUNG-WOMEN; CIGARETTE-SMOKING; WEIGHT; HYPERTENSION; ASSOCIATION; MORTALITY; SCOTLAND; PREECLAMPSIA; PROGNOSIS	Background Individuals who are small at birth are at increased risk of ischaemic heart disease (IHD) in later life. One hypothesis to explain this association is fetal adaptation to a suboptimum intrauterine environment. We investigated whether pregnancy complications associated with low birthweight are related to risk of subsequent IHD in the mother. Methods Routine discharge data were used to identify all singleton first births in Scotland between 1981 and 1985. Linkage to the mothers' subsequent admissions and deaths provided 15-19 years of follow-up. The mothers' risks of death from any cause or from IHD and admission for or death from IHD were related to adverse obstetric outcomes in the first pregnancy. Hazard ratios were adjusted for socioeconomic deprivation, maternal height and age, and essential hypertension. Findings Complete data were available on 129 920 (95.6%) eligible deliveries. Maternal risk of IHD admission or death was associated with delivering a baby in the lowest birthweight quintile for gestational age (adjusted hazard ratio 1.9 [95% CI 1.5-2.4]), preterm delivery (1.8 [1.3-2.5]), and pre-eclampsia (2.0 [1.5-2.5]). The associations were additive; women with all three characteristics had a risk of IHD admission or death seven times (95% CI 3.3-14.5) greater than the reference category. Interpretation Complications of pregnancy linked to low birthweight are associated with an increased risk of subsequent IHD in the mother. Common genetic risk factors might explain the link between birthweight and risk of IHD in both the individual and the mother.	Univ Glasgow, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Med Cardiol, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Glasgow	Smith, GCS (corresponding author), Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G3 8SJ, Lanark, Scotland.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035; Walsh, David/0000-0002-3390-5039				Barker D. J. P., 1994, MOTHERS BABIES DIS L; CHESLEY LC, 1980, KIDNEY INT, V18, P234, DOI 10.1038/ki.1980.131; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Dunn NR, 2000, J EPIDEMIOL COMMUN H, V54, P293, DOI 10.1136/jech.54.4.293; Erhardt E, 2000, BIOL NEONATE, V78, P145, DOI 10.1159/000014263; Gurevitz O, 2000, AM J CARDIOL, V85, P806, DOI 10.1016/S0002-9149(99)00871-1; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hosmer DW, 1999, APPL SURVIVAL ANAL R; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; MARMOT MG, 1984, INT J EPIDEMIOL, V13, P160, DOI 10.1093/ije/13.2.160; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Melander O, 1999, J HYPERTENS, V17, P1557, DOI 10.1097/00004872-199917110-00008; Morris JA, 1998, MED HYPOTHESES, V51, P285, DOI 10.1016/S0306-9877(98)90048-2; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Smith GCS, 2000, AM J EPIDEMIOL, V151, P614, DOI 10.1093/oxfordjournals.aje.a010249; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Smith GD, 1997, BRIT MED J, V315, P1189, DOI 10.1136/bmj.315.7117.1189; Smith GD, 2000, BRIT MED J, V320, P839, DOI 10.1136/bmj.320.7238.839; SUSSER M, 1991, AM J CLIN NUTR, V53, P1384, DOI 10.1093/ajcn/53.6.1384; vandenElzen HJ, 1996, BRIT J OBSTET GYNAEC, V103, P117; ZHANG XQ, 2001, J SOC GYNECOL INVEST, V8	27	703	716	1	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					2002	2006		10.1016/S0140-6736(00)05112-6	http://dx.doi.org/10.1016/S0140-6736(00)05112-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438131				2022-12-01	WOS:000169509200008
J	Karnath, HO; Ferber, S; Himmelbach, M				Karnath, HO; Ferber, S; Himmelbach, M			Spatial awareness is a function of the temporal not the posterior parietal lobe	NATURE			English	Article							RIGHT-HEMISPHERE STROKE; SUNNYBROOK STROKE; VISUAL NEGLECT; LESIONS; MONKEYS; CORTEX; SULCUS; REPRESENTATION; ATTENTION; BEHAVIOR	Our current understanding of spatial behaviour and parietal lobe function is largely based on the belief that spatial neglect in humans (a lack of awareness of space on the side of the body contralateral to a brain injury) is typically associated with lesions of the posterior parietal lobe. However, in monkeys, this disorder is observed after lesions of the superior temporal cortex(1), a puzzling discrepancy between the species. Here we show that, contrary to the widely accepted view, the superior temporal cortex is the neural substrate of spatial neglect in humans, as it is in monkeys. Unlike the monkey brain, spatial awareness in humans is a function largely confined to the right superior temporal cortex, a location topographically reminiscent of that for language on the left(2). Hence, the decisive phylogenetic transition from monkey to human brain seems to be a restriction of a formerly bilateral function to the right side, rather than a shift from the temporal to the parietal lobe. One may speculate that this lateralization of spatial awareness parallels the emergence of an elaborate representation for language on the left side.	Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Karnath, HO (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.			Himmelbach, Marc/0000-0002-7771-2968				Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Darling WG, 2001, NEUROPSYCHOLOGIA, V39, P237, DOI 10.1016/S0028-3932(00)00113-5; ETTLINGER G, 1962, J NEUROL NEUROSUR PS, V25, P256, DOI 10.1136/jnnp.25.3.256; FAUGIERGRIMAUD S, 1978, NEUROPSYCHOLOGIA, V16, P151, DOI 10.1016/0028-3932(78)90103-3; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Heilman K. M, 1983, LOCALIZATION NEUROPS, P471; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; LAMOTTE RH, 1978, BRAIN RES, V139, P309, DOI 10.1016/0006-8993(78)90931-9; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Leibovitch FS, 1999, HUM BRAIN MAPP, V7, P244, DOI 10.1002/(SICI)1097-0193(1999)7:4<244::AID-HBM3>3.0.CO;2-K; LUH KE, 1986, NEUROPSYCHOLOGIA, V24, P461, DOI 10.1016/0028-3932(86)90091-6; LYNCH JC, 1989, J NEUROPHYSIOL, V61, P74, DOI 10.1152/jn.1989.61.1.74; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MOTOMURA N, 1986, ACTA NEUROL SCAND, V74, P190, DOI 10.1111/j.1600-0404.1986.tb07854.x; Perenin M.-T., 1997, PARIETAL LOBE CONTRI, P289; RORDEN C, IN PRESS BEHAV NEURO; Samuelsson H, 1997, CORTEX, V33, P271, DOI 10.1016/S0010-9452(08)70004-2; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Ungerleider L, 1982, ANAL VISUAL BEHAV, P549; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; WATSON RT, 1994, ARCH NEUROL-CHICAGO, V51, P1014, DOI 10.1001/archneur.1994.00540220060015; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71	28	596	608	2	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					950	953		10.1038/35082075	http://dx.doi.org/10.1038/35082075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418859				2022-12-01	WOS:000169386200045
J	Baker, AC				Baker, AC			Ecosystems - Reef corals bleach to survive change	NATURE			English	Article							ZOOXANTHELLAE; DIVERSITY; ECOLOGY; FUTURE		Wildlife Conservat Soc, Osborn Labs Marine Sci, New York Aquarium, Brooklyn, NY 11224 USA	Wildlife Conservation Society	Baker, AC (corresponding author), Wildlife Conservat Soc, Osborn Labs Marine Sci, New York Aquarium, Surf Ave & W 8th St, Brooklyn, NY 11224 USA.			Baker, Andrew/0000-0002-7866-2587				Baker AC., 1999, SYMBIOSIS ECOLOGY RE; Brown BE, 1997, CORAL REEFS, V16, P129; Buddemeier RW, 1999, AM ZOOL, V39, P1; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; GLYNN PW, 1992, AM ZOOL, V32, P707; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; TOLLER WW, IN PRESS BIOL B MAR; Wilkinson C, 1999, AMBIO, V28, P188	14	360	379	3	161	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					765	766		10.1038/35081151	http://dx.doi.org/10.1038/35081151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459046				2022-12-01	WOS:000169246400036
J	Chamoun, Z; Mann, RK; Nellen, D; von Kessler, DP; Bellotto, M; Beachy, PA; Basler, K				Chamoun, Z; Mann, RK; Nellen, D; von Kessler, DP; Bellotto, M; Beachy, PA; Basler, K			Skinny Hedgehog, an acyltransferase required for palmitoylation and activity of the Hedgehog signal	SCIENCE			English	Article							DROSOPHILA; POLARITY; PROTEIN; IDENTIFICATION; MUTATIONS; GENES; CHROMOSOME; WINGLESS; PATTERN; RNA	One of the most dominant influences in the patterning of multicellular embryos is exerted by the Hedgehog (Hh) family of secreted signaling proteins. Here, we identify a segment polarity gene in Drosophila, melanogaster, Skinny hedgehog (ski), and show that its product is required in Hh-expressing cells for production of appropriate signaling activity in embryos and in the imaginal precursors of adult tissues. The ski gene encodes an apparent acyltransferase, and we provide genetic and biochemical evidence that Hh proteins from ski mutant cells retain carboxyl-terminal cholesterol modification but lack amino-terminal palmitate modification. Our results suggest that ski encodes an enzyme that acts within the secretory pathway to catalyze amino-terminal palmitoylation of Hh, and further demonstrate that this lipid modification is required for the embryonic and larval patterning activities of the Hh signal.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; Johns Hopkins University; University of Zurich; University of Zurich	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	pbeachy@jhmi.edu; basler@molbio.unizh.ch		Basler, Konrad/0000-0003-3534-1529				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chou TB, 1996, GENETICS, V144, P1673; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Deak P, 1997, GENETICS, V147, P1697; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kawakami Y, 2001, J IMMUNOL, V166, P2871, DOI 10.4049/jimmunol.166.4.2871; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; WAHI M, 1995, GENETICS, V140, P79; WOHLWILL AD, 1991, GENETICS, V128, P763	28	325	339	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2080	2084		10.1126/science.1064437	http://dx.doi.org/10.1126/science.1064437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11486055				2022-12-01	WOS:000171028700072
J	Lawrance, RA; Dorsch, MF; Sapsford, R; Mackintosh, AF; Greenwood, DC; Jackson, BM; Morrell, C; Robinson, MB; Hall, AS				Lawrance, RA; Dorsch, MF; Sapsford, R; Mackintosh, AF; Greenwood, DC; Jackson, BM; Morrell, C; Robinson, MB; Hall, AS		EMMACE Study Grp	Use of cumulative mortality data in patients with acute myocardial infarction for early detection of variation in clinical practice: observational study	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC-SURGERY; HEART-SURGERY; TRIAL	Objectives Use of cumulative mortality adjusted for case mix in patients with acute myocardial infarction for early detection of variation in clinical practice. Design Observational study. Setting 20 hospitals across the former Yorkshire region. Participants All 2153 consecutive patients with confirmed acute myocardial infarction identified during three months. Main outcome measures Variable life-adjusted displays showing cumulative differences between observed and expected mortality of patients; expected mortality calculated from risk model based on admission characteristics of age. heart rate, and systolic blood pressure. Results The performance of two individual hospitals over three months was examined as an example. One, the smallest district hospital in the region, had a series of 30 consecutive patients but had five more deaths than predicted. The variable life-adjusted display showed minimal variation from that predicted for the first 15 patients followed by a run of unexpectedly high mortality. The second example was the main tertiary referral centre for the region, which admitted 188 consecutive patients. The display showed a period of apparently poor performance followed by substantial improvement, where the plot rose steadily from a cumulative net lives saved of - 4 to 7. These variations in patient outcome are unlikely to have been revealed during conventional audit practice. Conclusions Variable life-adjusted display has been integrated. into surgical care as a graphical display of risk-adjusted survival for individual surgeons or centres. In combination with a simple risk model, it may have a role in monitoring performance and outcome in patients with acute myocardial infarction.	Leeds Gen Infirm, BHF Heart Res Ctr, Leeds LS2 9JT, W Yorkshire, England; St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England	Leeds General Infirmary; University of Leeds; Saint James's University Hospital; University of Leeds	Hall, AS (corresponding author), Leeds Gen Infirm, BHF Heart Res Ctr, Leeds LS2 9JT, W Yorkshire, England.		Greenwood, Darren C/C-3220-2008; Hall, Alistair/K-1953-2019	Greenwood, Darren C/0000-0001-7035-3096; Hall, Alistair/0000-0003-0306-7887				ANDERSON RG, 1996, FEDERAL RESERVE BANK, V0078; BIRKHEAD J, 2000, EHEART, V84; de Mol BA, 1998, LANCET, V351, P144, DOI 10.1016/S0140-6736(05)78110-1; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DORSCH MF, IN PRESS HEART; Ecochard E, 2000, HEART, V84, P5, DOI 10.1136/heart.84.1.5; IEZZONI LI, 1992, MED CARE, V30, P347, DOI 10.1097/00005650-199204000-00005; LAWRANCE RA, 2000, EHEART, V84; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lovegrove J, 1997, LANCET, V350, P1128, DOI 10.1016/S0140-6736(97)06507-0; NASHEF SAM, 1992, BRIT MED J, V305, P1066, DOI 10.1136/bmj.305.6861.1066; Nashef SAM, 1998, LANCET, V351, P143, DOI 10.1016/S0140-6736(05)78111-3; PARSONNET V, 1989, CIRCULATION 2, V76, P3; Poloniecki J, 1998, BRIT MED J, V316, P1697, DOI 10.1136/bmj.316.7146.1697; Sergeant P, 1997, LANCET, V350, P1114, DOI 10.1016/S0140-6736(97)22042-8; Sherlaw-Johnson C, 2000, HEART, V84, P79, DOI 10.1136/heart.84.1.79; WILLIAMS SM, 1992, BRIT MED J, V304, P1359, DOI 10.1136/bmj.304.6838.1359	18	39	39	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					324	327		10.1136/bmj.323.7308.324	http://dx.doi.org/10.1136/bmj.323.7308.324			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498491	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000170470900022
J	Wakioka, T; Sasaki, A; Kato, R; Shouda, T; Matsumoto, A; Miyoshi, K; Tsuneoka, M; Komiya, S; Baron, R; Yoshimura, A				Wakioka, T; Sasaki, A; Kato, R; Shouda, T; Matsumoto, A; Miyoshi, K; Tsuneoka, M; Komiya, S; Baron, R; Yoshimura, A			Spred is a Sprouty-related suppressor of Ras signalling	NATURE			English	Article							DROSOPHILA SPROUTY; KINASE-ACTIVITY; RAF-1; EXPRESSION; ACTIVATION; DIFFERENTIATION; PHOSPHORYLATION; INHIBITOR; CLONING; HOMOLOG	Cellular proliferation, and differentiation of cells in response to extracellular signals, are controlled by the signal transduction pathway of Ras, Raf and MAP (mitogen-activated protein) kinase. The mechanisms that regulate this pathway are not well known. Here we describe two structurally similar tyrosine kinase substrates, Spred-1 and Spred-2. These two proteins contain a cysteine-rich domain related to Sprouty (the SPR domain) at the carboxy terminus. In Drosophila, Sprouty inhibits the signalling by receptors of fibroblast growth factor (FGF) and epidermal growth factor (EGF) by suppressing the MAP kinase pathway(2-7). Like Sprouty, Spred inhibited growth-factor-mediated activation of MAP kinase. The Ras-MAP kinase pathway is essential in the differentiation of neuronal cells and myocytes. Expression of a dominant negative form of Spred and Spred-antibody microinjection revealed that endogenous Spred regulates differentiation in these types of cells. Spred constitutively associated with Ras but did not prevent activation of Ras or membrane translocation of Raf. Instead, Spred inhibited the activation of MAP kinase by suppressing phosphorylation and activation of Raf. Spred may represent a class of proteins that modulate Ras-Raf interaction and MAP kinase signalling.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Kagoshima Univ, Fac Med, Dept Orthopaed, Kagoshima 899, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Kyushu University; Kagoshima University; Kurume University; Yale University	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan.		Yoshimura, Akihiko/K-5515-2013	Sasaki, Atsuo/0000-0003-2963-4501				Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; DeMille MMC, 1996, GENE, V183, P103, DOI 10.1016/S0378-1119(96)00506-9; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Reich A, 1999, DEVELOPMENT, V126, P4139; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROSE DW, 1992, J CELL BIOL, V119, P1405, DOI 10.1083/jcb.119.6.1405; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163	23	343	360	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					647	651		10.1038/35088082	http://dx.doi.org/10.1038/35088082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493923				2022-12-01	WOS:000170318000043
J	Klemperer, W				Klemperer, W			Astronomy - The complex story of H-2	SCIENCE			English	Editorial Material							MOLECULAR-HYDROGEN; CHEMISTRY; LINES		Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Klemperer, W (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.							Biham O, 2001, ASTROPHYS J, V553, P595, DOI 10.1086/320975; de Lange A, 2001, PHYS REV LETT, V86, P2988, DOI 10.1103/PhysRevLett.86.2988; GEBALLE TR, 1993, ASTR SOC P, V41, P147; HERBST E, 1995, ANNU REV PHYS CHEM, V46, P27, DOI 10.1146/annurev.pc.46.100195.000331; MAHAN BH, 1970, ACCOUNTS CHEM RES, V8, P55; McCall BJ, 1999, ASTROPHYS J, V522, P338, DOI 10.1086/307637; MORTON DC, 1975, ASTROPHYS J, V197, P85, DOI 10.1086/153490; Rychlewski J, 1999, ADV QUANTUM CHEM, V31, P173; SPITZER L, 1974, ASTROPHYS J SUPPL S, V28, P373, DOI 10.1086/190323; STARK J, 1927, WIEN HARMS HDB EXPT, V21, P442	10	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					815	816		10.1126/science.1062991	http://dx.doi.org/10.1126/science.1062991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486077				2022-12-01	WOS:000170241000031
J	de Leon, MSP; Zollikofer, CPE				de Leon, MSP; Zollikofer, CPE			Neanderthal cranial ontogeny and its implications for late hominid diversity	NATURE			English	Article							PALEOANTHROPOLOGY; MORPHOLOGY; MANDIBLES; GROWTH; SHAPE; BASE; FACE	Homo neanderthalensis has a unique combination of craniofacial features that are distinct from fossil and extant anatomically modern' Homo sapiens (modern humans). Morphological evidence, direct isotopic dates(1) and fossil mitochondrial DNA from three Neanderthals(2,3) indicate that the Neanderthals were a separate evolutionary lineage for at least 500,000 yr. However, it is unknown when and how Neanderthal craniofacial autapomorphies (unique, derived characters) emerged during ontogeny. Here we use computerized fossil reconstruction(4) and geometric morphometrics (5,6) to show that characteristic differences in cranial and mandibular shape between Neanderthals and modern humans arose very early during development, possibly prenatally, and were maintained throughout postnatal ontogeny. Postnatal differences in cranial ontogeny between the two taxa are characterized primarily by heterochronic modifications of a common spatial pattern of development. Evidence for early ontogenetic divergence together with evolutionary stasis of taxon-specific patterns of ontogeny is consistent with separation of Neanderthals and modern humans at the species level.	Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; Univ Zurich Irchel, Inst Informat MultiMedia Lab, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Zollikofer, CPE (corresponding author), Univ Zurich Irchel, Inst Anthropol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	zolli@ir.unizh.ch						Bookstein F.L., 1991, MORPHOMETRIC TOOLS L, DOI [10.1017/CBO9780511573064, DOI 10.1017/CBO9780511573064]; De Leon MSP, 1999, ANAT REC, V254, P474; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DELEON MSP, 2000, THESIS U ZURICH; Enlow D. H., 1990, FACIAL GROWTH; FRANCISCUS RG, 1995, J HUM EVOL, V28, P577, DOI 10.1006/jhev.1995.1043; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lieberman Daniel E., 2000, Linnean Society Symposium Series, V20, P85; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Maureille B, 1999, J HUM EVOL, V37, P137, DOI 10.1006/jhev.1999.0312; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; RAK Y, 1986, J HUM EVOL, V15, P151, DOI 10.1016/S0047-2484(86)80042-2; RAK Y, 1994, J HUM EVOL, V26, P313, DOI 10.1006/jhev.1994.1019; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, V8, P131; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Schwartz JH, 1996, P NATL ACAD SCI USA, V93, P10852, DOI 10.1073/pnas.93.20.10852; STRINGER CB, 1990, MG PRIMATOL, V14, P115; Stringer Christopher, 1993, SEARCH NEANDERTHALS; Tattersall I, 1998, ANAT RECORD, V253, P113; TILLIER AM, 1989, HUMAN REVOLUTION, P286; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; Ubelaker D.H., 1978, HUMAN SKELETAL REMAI; WILLIAMS FL, 2000, NEANDERTHALS EDGE, P257; Zollikofer CPE, 1998, EVOL ANTHROPOL, V6, P41, DOI 10.1002/(SICI)1520-6505(1998)6:2<41::AID-EVAN2>3.0.CO;2-Z; ZOLLIKOFER CPE, 1995, IEEE COMPUT GRAPH, V15, P48, DOI 10.1109/38.469515; ZOLLIKOFER CPE, 1995, NATURE, V375, P283, DOI 10.1038/375283b0	30	226	236	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					534	538		10.1038/35087573	http://dx.doi.org/10.1038/35087573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484052				2022-12-01	WOS:000170202900044
J	Ellner, SP; McCauley, E; Kendall, BE; Briggs, CJ; Hosseini, PR; Wood, SN; Janssen, A; Sabelis, MW; Turchin, P; Nisbet, RM; Murdoch, WW				Ellner, SP; McCauley, E; Kendall, BE; Briggs, CJ; Hosseini, PR; Wood, SN; Janssen, A; Sabelis, MW; Turchin, P; Nisbet, RM; Murdoch, WW			Habitat structure and population persistence in an experimental community	NATURE			English	Article							PREDATOR-PREY SYSTEM; METAPOPULATION PERSISTENCE; LOCAL EXTINCTION; DYNAMICS; MODELS; STABILITY; DISPERSAL	Understanding spatial population dynamics is fundamental for many questions in ecology and conservation(1-4). Many theoretical mechanisms have been proposed whereby spatial structure can promote population persistence, in particular for exploiter-victim systems (host-parasite/pathogen, predator-prey) whose interactions are inherently oscillatory and therefore prone to extinction of local populations(5-11). Experiments have confirmed that spatial structure can extend persistence(11-16), but it has rarely been possible to identify the specific mechanisms involved. Here we use a model-based approach to identify the effects of spatial population processes in experimental systems of bean plants (Phaseolus lunatus), herbivorous mites (Tetranychus urticae) and predatory mites (Phytoseiulus persimilis). On isolated plants, and in a spatially undivided experimental system of 90 plants, prey and predator populations collapsed; however, introducing habitat structure allowed long-term persistence. Using mechanistic models, we determine that spatial population structure did not contribute to persistence, and spatially explicit models are not needed. Rather, habitat structure reduced the success of predators at locating prey outbreaks, allowing between-plant asynchrony of local population cycles due to random colonization events.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Univ Calgary, Dept Biol Sci, Div Ecol, Calgary, AB T2N 1N4, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ St Andrews, Sch Math & Comp Sci, St Andrews KY16 9SS, Fife, Scotland; Inst Biodivers & Ecosyst Dynam, NL-1090 GB Amsterdam, Netherlands; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	Cornell University; University of Calgary; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; University of St Andrews; University of Amsterdam; University of Connecticut	Ellner, SP (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	spe2@cornell.edu	Briggs, Cheryl/F-7456-2013; Wood, Simon N/B-3058-2010; Janssen, Arne/B-2657-2009; Kendall, Bruce/C-1871-2008; Nisbet, Roger M/B-6951-2014; Hosseini, Parviez/F-8439-2010	Wood, Simon N/0000-0002-2034-7453; Janssen, Arne/0000-0001-5075-5303; Kendall, Bruce/0000-0003-1782-8106; 				[Anonymous], 1997, SPATIAL ECOLOGY ROLE; Caswell H., 2001, MATRIX POPULATION MO, V2nd; de Roos AM, 1998, THEOR POPUL BIOL, V53, P108, DOI 10.1006/tpbi.1997.1345; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; Hanski I., 1997, METAPOPULATION BIOL; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HASSELL MP, 1988, ANN ZOOL FENN, V25, P55; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; Helle W., 1985, SPIDER MITES THEIR B; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; HUFFAKER C. B., 1963, HILGARDIA, V34, P305; Janssen A, 1997, EXP APPL ACAROL, V21, P415, DOI 10.1023/A:1018479828913; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; McCauley E, 2000, ECOLOGY, V81, P3350, DOI 10.1890/0012-9658(2000)081[3350:ICPFPD]2.0.CO;2; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; NISBET RM, 1982, MODELLING FLUCTUATIN, pCH10; Pels B, 1999, OIKOS, V86, P573, DOI 10.2307/3546662; SABELIS MW, 1991, BIOL J LINN SOC, V42, P267, DOI 10.1111/j.1095-8312.1991.tb00563.x; SABELIS MW, 1990, OECOLOGIA, V82, P289, DOI 10.1007/BF00317473; SABELIS MW, 1988, THEOR POPUL BIOL, V34, P169, DOI 10.1016/0040-5809(88)90040-8; SABELIS MW, 1987, NETH J ZOOL, V37, P117; VANDEKLASHORST G, 1992, EXP APPL ACAROL, V14, P185, DOI 10.1007/BF01200563; Wright S, 1943, GENETICS, V28, P114; [No title captured]	29	163	181	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					538	543		10.1038/35087580	http://dx.doi.org/10.1038/35087580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484053				2022-12-01	WOS:000170202900045
J	Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF				Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF		European Grp Blood & Marrow Transp	Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey	LANCET			English	Article							TOTAL-BODY IRRADIATION; CHRONIC MYELOID-LEUKEMIA; RADIATION WORKERS; LYMPHOMA; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; FERTILITY; CHILDREN; FAILURE; EMBRYOS	Background Some patients treated by transplantation of haemopoietic stem cells (peripheral blood or bone marrow) become permanently infertile, but others retain or recover fertility. We assessed the outcome of conception in women, and partners of men previously treated by autologous or allogeneic stem cell transplantation (SCT). Methods We sent questionnaires to 229 centres of the European Group for Blood and Marrow Transplantation. We sought details about the original disease, transplant procedure, and outcome of conception for both male and female patients. Findings 199 centres gave information relating to 19 412 allogeneic and 17 950 autologous transplant patients. 232 (0.6%) patients conceived after SCT. Crude annual birth rate for 4-month survivors of SCT was lower than the national average for England and Wales at 1.7 per 1000 patients. 312 conceptions were reported in 113 patients (74 allograft) and partners of 119 patients (93 allograft). Most pregnancies were uncomplicated and resulted in 271 livebirths. 28 (42%) of 67 allograft recipients had caesarean section compared with 16% in the normal population (difference=26% [95% CI 15-38]), 12 (20%) of 59 had preterm delivery compared with a normal rate of 6% (14% [4-24]), and 12 (23%) of 52 had low birthweight singleton offspring compared with a normal rate of 6% (17% [6-29]). Interpretation Pregnancy after SCT is likely to have a successful outcome. Pregnancies in allograft patients who have received total body irradiation should be treated as high risk for maternal and fetal complications.	Hammersmith Hosp, Imperial Coll Sci & Med, Dept Haematol, London W12 0NN, England; Hop St Louis, Dept Hematol BMT, Paris, France; Hop Hotel Dieu, Serv Hematol, Paris, France; UCL Hosp, Dept Haematol, London, England; Huddinge Univ Hosp, Dept Hematol, S-14186 Huddinge, Sweden; Osped San Martino Genova, Dept Hematol, Genoa, Italy; Royal Marsden Hosp, Leukaemia Myeloma Units, Surrey, England; Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Donauspital, L Boltzmann Inst, Dept Internal Med 2, Vienna, Austria; Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany	Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University College London Hospitals NHS Foundation Trust; University of London; University College London; Karolinska Institutet; University of Genoa; IRCCS AOU San Martino IST; Royal Marsden NHS Foundation Trust; Newcastle University - UK; Donauspital; University of Munich	Apperley, JF (corresponding author), Hammersmith Hosp, Imperial Coll Sci & Med, Dept Haematol, Du Cane Rd, London W12 0NN, England.	j.apperley@ic.ac.uk	Szydlo, Richard/C-6678-2012; Ljungman, Per/M-4946-2019	Szydlo, Richard/0000-0003-1102-8298; 				APPERLEY JF, 1995, BLOOD REV, V9, P93, DOI 10.1016/S0268-960X(95)90030-6; ATKINSON HG, 1994, LANCET, V344, P199, DOI 10.1016/S0140-6736(94)92804-5; Blondel B., 1997, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V26, P770; BorgnaPignatti C, 1996, BONE MARROW TRANSPL, V18, P235; CHATTERJEE R, 1994, BONE MARROW TRANSPL, V13, P519; CHATTERJEE R, 1994, BONE MARROW TRANSPL, V13, P511; Deeg HJ, 1998, BLOOD, V91, P3637; *DEP HLTH, 1997, B DEP HLTH, V28; Draper GJ, 1997, BRIT MED J, V315, P1181, DOI 10.1136/bmj.315.7117.1181; *EUROCAT, 1997, 7 EUROCAT; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; GARDNER MJ, 1992, BRIT MED J, V305, P715, DOI 10.1136/bmj.305.6855.715; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; Gulati SC, 1998, J CLIN ONCOL, V16, P1978, DOI 10.1200/JCO.1998.16.5.1978; Jackson GH, 1997, LEUKEMIA LYMPHOMA, V28, P127, DOI 10.3109/10428199709058338; LEE S, 1995, J ASSIST REPROD GEN, V12, P294, DOI 10.1007/BF02212935; Letendre L, 1997, MED PEDIATR ONCOL, V28, P147; Lipton JH, 1997, J CLIN ONCOL, V15, P3347, DOI 10.1200/JCO.1997.15.11.3347; NEEL JV, 1990, AM J HUM GENET, V46, P1053; *NORD MED COMM, 1993, BRITHS INF MORT NORD; *OFF NAT STAT, 1998, SER MB3, V12; *OFF NAT STAT, 1997, SER FMI, V24; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; RIO B, 1994, BONE MARROW TRANSPL, V13, P487; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; Sankila R, 1998, NEW ENGL J MED, V338, P1339, DOI 10.1056/NEJM199805073381902; Singhal S, 1996, BONE MARROW TRANSPL, V18, P1049; TANBO T, 1995, OBSTET GYNECOL, V86, P188, DOI 10.1016/0029-7844(95)00159-O	28	237	247	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					271	276		10.1016/S0140-6736(01)05482-4	http://dx.doi.org/10.1016/S0140-6736(01)05482-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498213				2022-12-01	WOS:000170114400010
J	Faergemann, J				Faergemann, J			Treatment of seborrhoeic dermatitis with oral terbinafine?	LANCET			English	Editorial Material							PITYROSPORUM-OVALE; MALASSEZIA-FURFUR		Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Faergemann, J (corresponding author), Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden.							Bergbrant I M, 1991, Acta Derm Venereol Suppl (Stockh), V167, P1; Camera E, 1999, BRIT J DERMATOL, V140, P640, DOI 10.1046/j.1365-2133.1999.02762.x; Faergemann J, 1996, BRIT J DERMATOL, V134, P12, DOI 10.1111/j.1365-2133.1996.tb15652.x; FAERGEMANN J, 1986, BRIT J DERMATOL, V114, P695, DOI 10.1111/j.1365-2133.1986.tb04878.x; Faergemann J, 2000, Am J Clin Dermatol, V1, P75, DOI 10.2165/00128071-200001020-00001; Faergemann J, 2001, BRIT J DERMATOL, V144, P549, DOI 10.1046/j.1365-2133.2001.04082.x; Faergemann J, 1999, ALLERGY, V54, P413, DOI 10.1034/j.1398-9995.1999.00089.x; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; KESEVAN S, 1997, J INVEST DERMATOL, V108, pA389; Leeming JP, 1997, BRIT J DERMATOL, V137, P764, DOI 10.1111/j.1365-2133.1997.tb01115.x; Neuber K, 1996, ARCH DERMATOL RES, V288, P532, DOI 10.1007/s004030050098; Rosen T, 1997, INT J DERMATOL, V36, P788, DOI 10.1046/j.1365-4362.1997.00309.x; Scaparro E, 2001, BRIT J DERMATOL, V144, P854, DOI 10.1046/j.1365-2133.2001.04144.x; SHUSTER S, 1984, BRIT J DERMATOL, V111, P235, DOI 10.1111/j.1365-2133.1984.tb04050.x; VILLARS V, 1989, CLIN EXP DERMATOL, V14, P124, DOI 10.1111/j.1365-2230.1989.tb00908.x	15	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					170	170		10.1016/S0140-6736(01)05401-0	http://dx.doi.org/10.1016/S0140-6736(01)05401-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476831				2022-12-01	WOS:000169967100006
J	Davis, GL; Rodrigue, JR				Davis, GL; Rodrigue, JR			Treatment of chronic hepatitis C in active drug users	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS-INFECTION; UNITED-STATES; INTERFERON; RISK; PREVALENCE; MORTALITY; RIBAVIRIN; THERAPY; ALCOHOL; DISEASE		Univ Florida, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Coll Hlth Profess, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Davis, GL (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32610 USA.							Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231; [Anonymous], 1999, J Hepatol, V30, P956; BELL J, 1990, MED J AUSTRALIA, V153, P274, DOI 10.5694/j.1326-5377.1990.tb136900.x; Brown K, 1998, AUST NZ J PUBL HEAL, V22, P384, DOI 10.1111/j.1467-842X.1998.tb01396.x; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Davis GL, 1998, HEPATOLOGY, V28, p390A; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Fontana RJ, 2000, DIGEST DIS, V18, P107, DOI 10.1159/000051384; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GONZALEZPERALTA RP, 1994, J HEPATOL, V21, P255, DOI 10.1016/S0168-8278(05)80405-2; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Ho SB, 2001, AM J GASTROENTEROL, V96, P157; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; JOE GW, 1982, AM J PUBLIC HEALTH, V72, P703, DOI 10.2105/AJPH.72.7.703; Johnson ME, 1998, AM J GASTROENTEROL, V93, P785; LAI ME, 1994, LANCET, V343, P388, DOI 10.1016/S0140-6736(94)91224-6; Leal P, 1999, J MED SCREEN, V6, P124, DOI 10.1136/jms.6.3.124; Manns MP, 2000, HEPATOLOGY, V32, p297A; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; MEYER RA, 1991, AM J GASTROENTEROL, V86, P1224; Muir AJ, 1999, HEPATOLOGY, V30, p190A; *NIH CONS DEV C, 1997, HEPATOLOGY S, V1, pS2; Ohnishi K, 1996, AM J GASTROENTEROL, V91, P1374; Ono K, 1996, ALCOHOL CLIN EXP RES, V20, P1560, DOI 10.1111/j.1530-0277.1996.tb01699.x; Rosenthal R. N., 1999, ADDICTIONS COMPREHEN, P439; Schiff Eugene R., 1999, American Journal of Medicine, V107, p95S; Sherman M, 1997, CAN J GASTROENTEROL, V11, P407, DOI 10.1155/1997/454278; Stein MD, 2001, DRUG ALCOHOL DEPEN, V61, P211, DOI 10.1016/S0376-8716(00)00144-7; Stephenson J, 2001, JAMA-J AM MED ASSOC, V285, P1003, DOI 10.1001/jama.285.8.1003; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	36	95	96	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					215	217		10.1056/NEJM200107193450312	http://dx.doi.org/10.1056/NEJM200107193450312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453JM	11463020				2022-12-01	WOS:000169912800012
J	Sam, M; Vora, S; Malnic, B; Ma, WD; Novotny, MV; Buck, LB				Sam, M; Vora, S; Malnic, B; Ma, WD; Novotny, MV; Buck, LB			Neuropharmacology - Odorants may arouse instinctive behaviours	NATURE			English	Article							NEURONS; ODORS		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; Indiana Univ, Dept Chem, Inst Pheromone Res, Bloomington, IN 47405 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington	Sam, M (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	lbuck@hms.harvard.edu	Malnic, Bettina/A-4905-2008	Malnic, Bettina/0000-0002-5877-4784				BINDER BF, 1995, J CHEM ECOL, V21, P1315, DOI 10.1007/BF02027564; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Dobson HEM, 1996, AM J BOT, V83, P877, DOI 10.2307/2446264; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Kielty JP, 1996, J INSECT BEHAV, V9, P237, DOI 10.1007/BF02213868; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; NOVOTNY M, 1990, CHEM SIGNAL, V5, P1; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; Wysocki C.J., 1987, P125	10	180	186	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					142	142		10.1038/35084137	http://dx.doi.org/10.1038/35084137			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449261	Bronze			2022-12-01	WOS:000169778700039
J	Broza, M; Halpern, M				Broza, M; Halpern, M			Pathogen reservoirs - Chironomid egg masses and Vibrio cholerae	NATURE			English	Article							CLIMATE		Univ Haifa, Fac Sci & Sci Educ, Dept Biol, IL-36006 Tivon, Israel	University of Haifa	Broza, M (corresponding author), Univ Haifa, Fac Sci & Sci Educ, Dept Biol, IL-36006 Tivon, Israel.	broza@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019	Halpern, Malka/0000-0002-3407-2198				Armitage P.D., 1995, THE CHIRONOMIDAE; Broza M, 2000, WATER SCI TECHNOL, V42, P71, DOI 10.2166/wst.2000.0293; Colwell Rita R., 1994, P117; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Colwell RR, 1999, J APPL MICROBIOL, V85, p134S, DOI 10.1111/j.1365-2672.1998.tb05292.x; ECHOLS H, 1961, J MOL BIOL, V3, P425, DOI 10.1016/S0022-2836(61)80055-7; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Lewin S. M., 1996, P228; NOLTE U, 1993, ENT SCAND S, V43, P5; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987	11	93	100	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					40	40		10.1038/35083691	http://dx.doi.org/10.1038/35083691			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452294	Bronze			2022-12-01	WOS:000169644900031
J	Corten, GP; Veldkamp, HF				Corten, GP; Veldkamp, HF			Aerodynamics - Insects can halve wind-turbine power	NATURE			English	Article									Energy Ctr Netherlands, Unit Wind Energy, NL-1755 ZG Petten, Netherlands; NEG Micon AS, DK-8900 Randers, Denmark	Vestas Wind Systems	Corten, GP (corresponding author), Energy Ctr Netherlands, Unit Wind Energy, POB 1, NL-1755 ZG Petten, Netherlands.							Bak C., 1999, WIND ENERGY, V2, P195; Corten G. P, 1999, 13 IEA EXP M AER WIN; Corten GP., 2001, THESIS U UTRECHT; DYRMOSE SZ, 1998, DOUBLE STALL PHENOME; Madsen H. A., 1991, AERODYNAMICS HORIZON; Snel H., 1999, PROGR JOULE PROJECT	6	73	81	2	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					41	42		10.1038/35083698	http://dx.doi.org/10.1038/35083698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452297				2022-12-01	WOS:000169644900034
J	Goldie, SJ; Kuhn, L; Denny, L; Pollack, A; Wright, TC				Goldie, SJ; Kuhn, L; Denny, L; Pollack, A; Wright, TC			Policy analysis of cervical cancer screening strategies in low-resource settings - Clinical benefits and cost-effectiveness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; HIGH-RISK; HIV-INFECTION; SOUTH-AFRICA; DEVELOPING-COUNTRIES; VISUAL INSPECTION; UTERINE CERVIX	Context Cervical cancer is a leading cause of cancer-related death among women in developing countries. In such low-resource settings, cytology-based screening is difficult to implement, and less complex strategies may offer additional options. Objective To assess the cost-effectiveness of several cervical cancer screening strategies using population-specific data. Design and Setting Cost-effectiveness analysis using a mathematical model and a hypothetical cohort of previously unscreened 30-year-old black South African women. Screening tests included direct visual inspection (DVI) of the cervix, cytologic methods, and testing for high-risk types of human papillomavirus (HPV) DNA, Strategies differed by number of clinical visits, screening frequency, and response to a positive test result. Data sources included a South African screening study, national surveys and fee schedules, and published literature. Main Outcome Measures Years of life saved (YLS), lifetime costs in US dollars, and incremental cost-effectiveness ratios (cost per YLS). Results When analyzing all strategies performed as a single lifetime screen at age 35 years compared with no screening, HPV testing followed by treatment of screen-positive women at a second visit, cost $39/YLS (27% cancer incidence reduction); DVI, coupled with immediate treatment of screen-positive women at the first visit was next most effective (26% cancer incidence reduction) and was cost saving; cytology, followed by treatment of screen-positive women at a second visit was least effective (19% cancer incidence reduction) at a cost of $81/YLS, For any given screening frequency, when strategies were compared incrementally, HPV DNA testing generally was more effective but also more costly than DVI, and always was more effective and less costly than cytology. When comparing all strategies simultaneously across screening frequencies, DVI was the nondominated strategy up to a frequency of every 3 years (incremental cost-effectiveness ratio, $460/YLS), and HPV testing every 3 years (incremental cost-effectiveness ratio, $11 500/YLS) was the most effective strategy. Conclusion Cervical cancer screening strategies that incorporate DVI or HPV DNA testing and eliminate colposcopy may offer attractive alternatives to cytology-based screening programs in low-resource settings.	Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Dept Hlth Policy & Management, Boston, MA 02115 USA; Univ Cape Town, Dept Obstet & Gynecol, ZA-7925 Cape Town, South Africa; Columbia Univ, Joseph L Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY USA; EngenderHlth, New York, NY USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Cape Town; Columbia University; Columbia University; Columbia University	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Dept Hlth Policy & Management, 718 Huntington Ave,Suite 2, Boston, MA 02115 USA.							ANDERSEN ES, 1992, GYNECOL ONCOL, V45, P240, DOI 10.1016/0090-8258(92)90297-V; Bailie RS, 1996, INT J EPIDEMIOL, V25, P488, DOI 10.1093/ije/25.3.488; BALLEGOOLJEN M, 1992, EUR J CANCER, V28, P1703; *CENTR STAT SERV, 1997, S AFR LIV STAND DEV; *CENTR STAT SERV, 1997, 1994 HOUS SURV; *CENTR STAT SERV, 1997, CONS PRIC IND; Clavel C, 1999, BRIT J CANCER, V80, P1306, DOI 10.1038/sj.bjc.6690523; CREASMAN WT, 1984, OBSTET GYNECOL, V63, P145; Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; CUZICK J, 1999, HEALTH TECHNOL ASSES, V3, P1; Denny L, 2000, AM J OBSTET GYNECOL, V183, P383, DOI 10.1067/mob.2000.105871; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; DENNY L, 2000, THESIS U CAPE TOWN; DORRINGTON R, 1999, ESTIMATES LEVEL SHAP; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Enger C, 1996, JAMA-J AM MED ASSOC, V275, P1329, DOI 10.1001/jama.275.17.1329; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Gaffikin L, 1999, LANCET, V353, P869; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Gold MR., 1996, COST EFFECTIVENESS H; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Grant A D, 1997, AIDS, V11 Suppl B, pS43; Harper DM, 1999, J FAM PRACTICE, V48, P531; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; Hillemanns P, 1999, LANCET, V354, P1970, DOI 10.1016/S0140-6736(99)04110-0; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; Jenkins D, 1996, INT J CANCER, V65, P768; Kitchener HC, 1999, LANCET, V353, P856, DOI 10.1016/S0140-6736(98)00417-6; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; Londesborough P, 1996, INT J CANCER, V69, P364; LONGINI IM, 1989, STAT MED, V8, P831, DOI 10.1002/sim.4780080708; LOPEZ A, 2001, LIFETABLES 191 COUNT; Mandelblatt JS, 1997, J GEN INTERN MED, V12, P551, DOI 10.1046/j.1525-1497.1997.07107.x; MATHERS C, 2001, 16 WHO GLOB PROGR EV; MCCRORY D, 1999, AHCPR PUB; *MED ASS S AFR, 1999, 1999 GUID FEES MED S; Mitchell MF, 1998, OBSTET GYNECOL, V92, P737, DOI 10.1097/00006250-199811000-00001; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Nene BM, 1996, INT J CANCER, V68, P770, DOI 10.1002/(SICI)1097-0215(19961211)68:6<770::AID-IJC14>3.0.CO;2-4; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; OLATUNBOSUN OA, 1992, INT J GYNECOL OBSTET, V38, P305, DOI 10.1016/0020-7292(92)91023-H; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; Pecorelli S, 1999, INT J GYNECOL OBSTET, V65, P243, DOI 10.1016/S0020-7292(99)00070-3; Peters DH, 2000, B WORLD HEALTH ORGAN, V78, P761; PETTERSSON F, 1985, INT J EPIDEMIOL, V14, P521, DOI 10.1093/ije/14.4.521; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; ROGO KO, 1990, INT J GYNECOL OBSTET, V33, P249, DOI 10.1016/0020-7292(90)90010-I; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Sankaranarayanan R, 1998, IARC Sci Publ, P135; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0; SCHIFFMAN M, 2000, JAMA-J AM MED ASSOC, V28, P2525; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; Serwadda D, 1999, J INFECT DIS, V180, P1316, DOI 10.1086/315026; SherlawJohnson C, 1997, INT J CANCER, V72, P210, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;210::AID-IJC2&gt;3.0.CO;2-U; Sitas F, 1997, BRIT J CANCER, V75, P1704, DOI 10.1038/bjc.1997.290; SITAS F, 1994, S AFR MED J, V84, P344; SOLOMON D, 1989, JAMA-J AM MED ASSOC, V262, P931; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; *U CAP TOWN, 1993, COST COMP STUD SEV M; *US DHHS, 2001, CANC STAT REV; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Womack SD, 2000, INT J CANCER, V85, P206, DOI 10.1002/(SICI)1097-0215(20000115)85:2%3C206::AID-; *WORLD BANK, 1997, CONFR AIDS PUBL PRIO; *WORLD BANK AIDS E, 2000, PUBL PRIOR GLOB EP C; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	79	228	241	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2001	285	24					3107	3115		10.1001/jama.285.24.3107	http://dx.doi.org/10.1001/jama.285.24.3107			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FF	11427139	Bronze			2022-12-01	WOS:000169388900024
J	Galarreta, M; Hestrin, S				Galarreta, M; Hestrin, S			Spike transmission and synchrony detection in networks of GABAergic interneurons	SCIENCE			English	Article							CAT VISUAL-CORTEX; LAYER-V NEURONS; SOMATOSENSORY CORTEX; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; PRINCIPAL NEURONS; CORTICAL-NEURONS; RAT HIPPOCAMPUS; SYNAPSES; RECEPTORS	The temporal pattern and relative timing of action potentials among neocortical neurons may carry important information. However, how cortical circuits detect or generate coherent activity remains unclear. Using paired recordings in rat neocortical slices, we found that the firing of fast-spiking cells can reflect the spiking pattern of single-axon pyramidal inputs. Moreover, this property allowed groups of fast-spiking cells interconnected by electrical and gamma -aminobutyric acid (GABA)-releasing (GABAergic) synapses to detect the relative timing of their excitatory inputs. These results indicate that networks of fast-spiking cells may play a role in the detection and promotion of synchronous activity within the neocortex.	Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Galarreta, M (corresponding author), Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA.		Hestrin, Shaul/F-4410-2010		NATIONAL EYE INSTITUTE [R01EY012114, R01EY009120] Funding Source: NIH RePORTER; NEI NIH HHS [EY09120, EY12114] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Chow A, 1999, J NEUROSCI, V19, P9332; COPE TC, 1987, J PHYSIOL-LONDON, V390, P161, DOI 10.1113/jphysiol.1987.sp016692; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P244, DOI 10.1152/jn.1984.52.2.244; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097	40	286	289	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2295	2299		10.1126/science.1061395	http://dx.doi.org/10.1126/science.1061395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423653				2022-12-01	WOS:000169455900047
J	Hampe, J; Cuthbert, A; Croucher, PJP; Mirza, MM; Mascheretti, S; Fisher, S; Frenzel, H; King, K; Hasselmeyer, A; MacPherson, AJS; Bridger, S; van Deventer, S; Forbes, A; Nikolaus, S; Lennard-Jones, JE; Foelsch, UR; Krawczak, M; Lewis, C; Schreiber, S; Mathew, CG				Hampe, J; Cuthbert, A; Croucher, PJP; Mirza, MM; Mascheretti, S; Fisher, S; Frenzel, H; King, K; Hasselmeyer, A; MacPherson, AJS; Bridger, S; van Deventer, S; Forbes, A; Nikolaus, S; Lennard-Jones, JE; Foelsch, UR; Krawczak, M; Lewis, C; Schreiber, S; Mathew, CG			Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; LARGE EUROPEAN COHORT; FACTOR KAPPA-B; SUPPORTS LINKAGE; CHROMOSOME-16; ACTIVATION; FAMILIES; COLITIS; LOCUS; CELLS	Background Genetic predisposition to inflammatory bowel disease (IBD) has been shown by epidemiological and linkage studies. Genetic linkage of IBD to chromosome 16 has been previously observed and replicated in independent populations. The recently identified NOD2 gene is a good positional and functional candidate gene since it is located in the region of linkage on chromosome 16q12, and activates nuclear factor (NF) KB in response to bacterial lipopolysaccharides. Methods We sequenced the coding region of the NOD2 gene and genotyped an insertion polymorphism affecting the leucine-rich region of the protein product in 512 individuals with IBD from 309 German or British families, 369 German trios (ie, German patients with sporadic IBD and their unaffected parents), and 272 normal controls. We then tested for association with Crohn's disease and ulcerative colitis. Findings Family-based association analyses were consistently positive in 95 British and 99 German affected sibling pairs with Crohn's disease (combined p<0.0001); the association was confirmed in the 304 German trios with Crohn's disease. No association was seen in the 115 sibling pairs and 65 trios with ulcerative colitis. The genotype-specific disease risks conferred by heterozygous and homozygous mutant genotypes were 2.6 (95% CI 1.5-4.5)and 42.1(4.3-<infinity>), respectively. Interpretation The insertion mutation in the NOD2 gene confers a substantially increased susceptibility to Crohn's disease but not to ulcerative colitis.	Univ Kiel, Dept Gen Internal Med, Kiel, Germany; Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England; Guys Kings & St Thomas Sch Med, Div Med, London, England; AMC Amsterdam, Dept Gastroenterol, Amsterdam, Netherlands; St Marks Hosp, Harrow, Middx, England; Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	University of Kiel; University of London; King's College London; University of London; King's College London; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Cardiff University	Schreiber, S (corresponding author), Univ Kiel, Dept Med 1, Schittenhelmstr 12, D-24105 Kiel, Germany.	S.Schreiber@mucosa.de	Krawczak, Michael/A-8964-2010; Lewis, Cathryn M/A-5225-2010; Mathew, Christopher G/G-3434-2015; Hampe, Jochen/A-2555-2010; Lewis, Cathryn/M-8766-2019	Krawczak, Michael/0000-0003-2603-1502; Lewis, Cathryn M/0000-0002-8249-8476; Mathew, Christopher G/0000-0003-4178-1838; Hampe, Jochen/0000-0002-2421-6127; Lewis, Cathryn/0000-0002-8249-8476; Forbes, Alastair/0000-0001-7416-9843	Medical Research Council [G9800001] Funding Source: Medline; MRC [G9800001] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Fleiss J.L., 1981, STAT METHODS RATES P; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1998, INT J COLORECTAL DIS, V13, P260, DOI 10.1007/s003840050173; HAMPE J, IN PRESS BIOINFORMAT; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P77; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2000, J BIOL CHEM, V275, P27823; INOHARA N, 2000, J BIOL CHEM, V31, P31; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nikolaus S, 2000, LANCET, V356, P1475, DOI 10.1016/S0140-6736(00)02871-3; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Olavesen MG, 2000, IMMUNOGENETICS, V51, P1, DOI 10.1007/s002510050001; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SCHREIBER S, 1991, GASTROENTEROLOGY, V101, P1020, DOI 10.1016/0016-5085(91)90729-5; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Thompson NP, 1996, BRIT MED J, V312, P95; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990	30	905	947	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2001	357	9272					1925	1928		10.1016/S0140-6736(00)05063-7	http://dx.doi.org/10.1016/S0140-6736(00)05063-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425413				2022-12-01	WOS:000169431000011
J	Bayer, KU; De Koninck, P; Leonard, AS; Hell, JW; Schulman, H				Bayer, KU; De Koninck, P; Leonard, AS; Hell, JW; Schulman, H			Interaction with the NMDA receptor locks CaMKII in an active conformation	NATURE			English	Article							PROTEIN-KINASE-II; NR2B SUBUNIT; CALMODULIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; TRANSLOCATION; NEUROSCIENCE; SYNAPSES; ISOFORM; DENSITY	Calcium- and calmodulin-dependent protein kinase II (CaMKII) and glutamate receptors are integrally involved in forms of synaptic plasticity that may underlie learning and memory. In the simplest model for long-term potentiation(1), CaMKII is activated by Ca2+ influx through NMDA (N-methyl-D-aspartate) receptors and then potentiates synaptic efficacy by inducing synaptic insertion(2,3) and increased single-channel conductance(4) of AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors. Here we show that regulated CaMKII interaction with two sites on the NMDA receptor subunit NR2B provides a mechanism for the glutamate-induced translocation of the kinase to the synapse in hippocampal neurons. This interaction can lead to additional forms of potentiation by: facilitated CaMKII response to synaptoc Ca2+; suppression of inhibitory autophosphorylation of CaMKII; and, most notably, direct generation of sustained Ca2+/calmodulin (CaM)-independent (autonomous) kinase activity by a mechanism that is independent of the phosphorylation state. Furthermore, the interaction leads to trapping of CaM that may reduce down-regulation of NMDA receptor activity(5). CaMKII-NR2B interaction may be prototypical for direct activation of a kinase by its targeting protein.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison	Bayer, KU (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ulli.bayer@stanford.edu; schulman@cmgm.stanford.edu	Hell, Johannes W./P-5085-2019					Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 1996, MOL CELL BIOL, V16, P29; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Gardoni F, 1998, J NEUROCHEM, V71, P1733; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199	30	510	542	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					801	805		10.1038/35081080	http://dx.doi.org/10.1038/35081080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459059				2022-12-01	WOS:000169246400050
J	Tranel, D				Tranel, D			Combs, ducks, and the brain	LANCET			English	Editorial Material							RETRIEVAL; NOUNS; VERBS; SYSTEMS; KNOWLEDGE		Univ Iowa Hosp & Clin, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA	University of Iowa	Tranel, D (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA.			Tranel, Daniel/0000-0002-1338-1389				CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; DAMASIO AR, 1993, P NATL ACAD SCI USA, V90, P4957, DOI 10.1073/pnas.90.11.4957; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; Federmeier KD, 2000, BRAIN, V123, P2552, DOI 10.1093/brain/123.12.2552; GOODGLASS H, 1994, NEUROPSYCHOLOGY, V8, P598, DOI DOI 10.1037/0894-4105.8.4.598; HILLIS AE, 1995, J COGNITIVE NEUROSCI, V7, P396, DOI 10.1162/jocn.1995.7.3.396; HUMPHREYS GW, IN PRESS BEHAV BRAIN; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; MCCARTHY R, 1985, NEUROPSYCHOLOGIA, V23, P709, DOI 10.1016/0028-3932(85)90079-X; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; TRANEL D, 1991, BRAIN COGNITION, V15, P187, DOI 10.1016/0278-2626(91)90025-4; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; TRANEL D, IN PRESS COGN NEUROP; WARRINGTON EK, 1994, NEUROPSYCHOLOGIA, V32, P1465, DOI 10.1016/0028-3932(94)90118-X; ZINGESER LB, 1990, BRAIN LANG, V39, P14, DOI 10.1016/0093-934X(90)90002-X	16	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2001	357	9271					1818	1819		10.1016/S0140-6736(00)05010-8	http://dx.doi.org/10.1016/S0140-6736(00)05010-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440DN	11410186				2022-12-01	WOS:000169160800006
J	Fridkin, SK; Edwards, JR; Courval, JM; Hill, H; Tenover, FC; Lawton, R; Gaynes, RP; McGowan, JE				Fridkin, SK; Edwards, JR; Courval, JM; Hill, H; Tenover, FC; Lawton, R; Gaynes, RP; McGowan, JE		Intensive Care Antimicrobial Resis	The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIMICROBIAL RESISTANCE; NOSOCOMIAL INFECTIONS; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE; HOSPITALS; SEVERITY; FAECIUM; IMPACT; RISK	Background: Patient-specific risk factors for acquisition of vancomycin-resistant enterococci (VRE) among hospitalized patients are becoming well defined. However, few studies have reported data on the institutional risk factors, including rates of antimicrobial use, that predict rates of VRE. Identifying modifiable institutional factors can advance quality-improvement efforts to minimize hospital-acquired infections with VRE. Objective: To determine the independent importance of any association between antimicrobial use and risk factors for nosocomial infection on rates of VRE in intensive care units (ICUs). Design: Prospective ecologic study. Setting: 126 adult ICUs from 60 U.S. hospitals from January 1996 through July 1999. Patients: All patients admitted to participating ICUs. Measurements: Monthly use of antimicrobial agents (defined daily doses per 1000 patient-days), nosocomial infection rates, and susceptibilities of all tested enterococci isolated from clinical cultures. Results: Prevalence of VRE (median, 10%; range, 0% to 59%) varied by type of ICU and by teaching status and size of the hospital. Prevalence of VRE was strongly associated with VRE prevalence among inpatient non-ICU areas and outpatient areas in the hospital, ventilator-days per 1000 patient-days, and rate of parenteral vancomycin use. In a weighted linear regression model controlling for type of ICU and rates of VRE among non-ICU inpatient areas rates of vancomycin use (P < 0.001) and third-generation cephalosporin use (P = 0.02) were independently associated with VRE prevalence. Conclusions: Higher rates of vancomycin or third-generation cephalosporin use were associated with increased prevalence of VRE, independent of other ICU characteristics and the endemic VRE prevalence elsewhere in the hospital. Decreasing the use rates of these antimicrobial agents could reduce rates of VRE in ICUs.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Fridkin, SK (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, MS A-35,1600 Clifton Rd, Atlanta, GA 30333 USA.	skf0@cdc.gov	mcgowan, john e/G-5404-2011					[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105; [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; BOYCE JM, 1994, J CLIN MICROBIOL, V32, P1148, DOI 10.1128/JCM.32.5.1148-1153.1994; CULLEN DJ, 1984, CRIT CARE MED, V12, P155, DOI 10.1097/00003246-198403000-00001; Duncan RA, 1997, INFECT CONT HOSP EP, V18, P260; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Evans ME, 1996, INFECT CONT HOSP EP, V17, P356; Fridkin SK, 1999, CLIN INFECT DIS, V28, P1119, DOI 10.1086/514752; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; FRIDKIN SK, IN PRESS CLIN INFECT; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hamilton C. Dukes, 1997, Clinical Infectious Diseases, V25, P425; HANDWERGER S, 1993, CLIN INFECT DIS, V16, P750, DOI 10.1093/clind/16.6.750; JOHNSON SV, 1995, PHARMACOTHERAPY, V15, P579, DOI 10.1002/j.1875-9114.1995.tb02866.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Montecalvo MA, 1996, ARCH INTERN MED, V156, P1458, DOI 10.1001/archinte.156.13.1458; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; PETROFSKY MV, 1997, INFECT CONT HOSP EP, V18, pP33; Quale J, 1996, CLIN INFECT DIS, V23, P1020, DOI 10.1093/clinids/23.5.1020; Salemi C, 1998, Clin Perform Qual Health Care, V6, P12; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; Singer MV, 1998, INFECT CONT HOSP EP, V19, P248; Steward CD, 2000, DIAGN MICR INFEC DIS, V38, P59, DOI 10.1016/S0732-8893(00)00161-9; Stroud L, 1996, INFECT CONT HOSP EP, V17, P576; Watanakunakorn C, 1997, INFECT CONT HOSP EP, V18, P767; Wenzel RP, 1999, CLIN INFECT DIS, V28, P1126, DOI 10.1086/514753	29	201	216	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					175	183		10.7326/0003-4819-135-3-200108070-00009	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487484				2022-12-01	WOS:000170298500003
J	Goodman, S				Goodman, S			Pressure grows over US blood ban	NATURE			English	News Item																		2001, NATURE, V412, P7	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					467	467		10.1038/35087718	http://dx.doi.org/10.1038/35087718			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484010	Bronze			2022-12-01	WOS:000170202900007
J	Fox, NC; Crum, WR; Scahill, RI; Stevens, JM; Janssen, JC; Rossor, MN				Fox, NC; Crum, WR; Scahill, RI; Stevens, JM; Janssen, JC; Rossor, MN			Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images	LANCET			English	Article							PRECLINICAL PHASE; APOLIPOPROTEIN-E; ATROPHY; RISK; MRI; REGISTRATION; MICROSCOPY; PATTERNS; ALLELE	Background Early diagnosis and monitoring of the progression of Alzheimer's disease is important for the development of therapeutic strategies. To detect the earliest structural brain changes, individuals need to be studied before symptom onset. We used an imaging technique known as voxel-compression mapping to localise progressive atrophy in patients with preclinical Alzheimer's disease. Methods Four symptom-free individuals from families with early-onset Alzheimer's disease with known autosomal dominant mutations underwent serial magnetic resonance imaging (MRI) over 5-8 years. All four became symptomatic during follow-up. 20 individuals with a clinical diagnosis of probable Alzheimer's disease and 20 control participants also underwent serial MR imaging. A non-linear fluid matching algorithm was applied to register repeat scans onto baseline imaging. Jacobian determinants were used to create the voxel-compression maps. Findings Progressive atrophy was revealed in presymptomatic individuals, with posterior cingulate and neocortical temporoparietal cortical losses, and medial temporal-lobe atrophy. In patients with known Alzheimer's disease, atrophy was widespread apart from in the primary motor and sensory cortices and cerebellum, reflecting the clinical phenomenology. Interpretation Voxel-compression maps confirmed early involvement of the medial temporal lobes, but also showed posterior cingulate and temporoparietal cortical losses at presymptomatic stage. This technique could be applied diagnostically and used to monitor the effects of therapeutic intervention.	UCL, Inst Neurol, Dept Clin Neurol, Dementia Res Grp, London, England; Imperial Coll Sch Med, Div Neurosci, London, England	University of London; University College London; Imperial College London	Fox, NC (corresponding author), Natl Hosp Neurol & Neurosurg, Dementia Res Grp, 8-11 Queen Sq, London WC1N 3BG, England.	nfox@dementia.ionl.ucl.ac.uk	Rossor, Martin/C-1598-2008; Fox, Nick C/AAE-1849-2021; Crum, William R/C-4891-2008; Fox, Nick C/B-1319-2009	Fox, Nick C/0000-0002-6660-657X; Crum, William R/0000-0001-9369-2197; Fox, Nick C/0000-0002-6660-657X; Scahill, Rachael/0000-0002-1832-106X; Rossor, Martin/0000-0001-8215-3120				Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Fabrigoule C, 1998, BRAIN, V121, P135, DOI 10.1093/brain/121.1.135; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; Fox NC, 1997, J MAGN RESON IMAGING, V7, P1069, DOI 10.1002/jmri.1880070620; Fox NC, 1998, BRAIN, V121, P1631, DOI 10.1093/brain/121.9.1631; Fox NC, 2000, NAT MED, V6, P20, DOI 10.1038/71481; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Freeborough PA, 1996, J COMPUT ASSIST TOMO, V20, P1012, DOI 10.1097/00004728-199611000-00030; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NEWMAN SK, 1994, J NEUROL NEUROSUR PS, V57, P967, DOI 10.1136/jnnp.57.8.967; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Warrington EK., 1984, RECOGNITION MEMORY T; WHITWELL JL, IN PRESS AM J NEUROR	24	341	349	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					201	205		10.1016/S0140-6736(01)05408-3	http://dx.doi.org/10.1016/S0140-6736(01)05408-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476837				2022-12-01	WOS:000169967100013
J	Dalton, R				Dalton, R			Action urged to combat killer algae	NATURE			English	News Item																			0	4	4	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					260	260		10.1038/35085712	http://dx.doi.org/10.1038/35085712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460123	Bronze			2022-12-01	WOS:000169918200010
J	Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R				Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R			Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas	NATURE			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; HODGKINS-LYMPHOMA; BURKITT-LYMPHOMA; BCL-6 MUTATIONS; BINDING PROTEIN; IG GENES; TRANSLOCATIONS	Genomic instability promotes tumorigenesis and can occur through various mechanisms, including defective segregation of chromosomes or inactivation of DNA mismatch repair(1). Although B-cell lymphomas are associated with chromosomal translocations that deregulate oncogene expression(2), a mechanism for genome-wide instability during lymphomagenesis has not been described. During B-cell development, the immunoglobulin variable (V) region genes are subject to somatic hypermutation in germinal-centre B cells(3). Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres. Mutations are distributed in the 5' untranslated or coding sequences, are independent of chromosomal translocations, and share features typical of V-region-associated somatic hypermutation. In contrast to mutations in V regions, however, these mutations are not detectable in normal germinal-centre B cells or in other germinal-centre-derived lymphomas, suggesting a DLCL-associated malfunction of somatic hypermutation. Intriguingly, the four hypermutable genes are susceptible to chromosomal translocations in the same region, consistent with a role for hypermutation in generating translocations by DNA double-strand breaks(4-6). By mutating multiple genes, and possibly by favouring chromosomal translocations, aberrant hypermutation may represent the major contributor to lymphomagenesis.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Mem Sloan Kettering Canc Ctr, Canc Genet Lab, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Columbia University; Columbia University; University of Cologne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.			Kuppers, Ralf/0000-0002-6691-7191				Akasaka H, 2000, CANCER RES, V60, P2335; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; CUYPERS HT, 1984, CELL, V37, P141; DALLAFAVERA R, 2001, CANC PRINCIPLES PRAC, P2215; Dang CV, 1999, MOL CELL BIOL, V19, P1; Gamberi B, 1997, BLOOD, V89, P975; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Klein U, 1998, IMMUNOL REV, V162, P261; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2000, CANCER RES, V60, P5644; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Raffeld M, 1995, Curr Top Microbiol Immunol, V194, P265; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Storb U, 1998, IMMUNOL REV, V162, P153; Zan H, 1999, J IMMUNOL, V162, P3437	30	737	767	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					341	346		10.1038/35085588	http://dx.doi.org/10.1038/35085588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460166				2022-12-01	WOS:000169918200049
J	Richmond, JE; Weimer, RM; Jorgensen, EM				Richmond, JE; Weimer, RM; Jorgensen, EM			An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming	NATURE			English	Article							MUNC13-1; EXPRESSION; FUSION; FAMILY; GENE	The priming step of synaptic vesicle exocytosis is thought to require the formation of the SNARE complex, which comprises the proteins synaptobrevin, SNAP-25 and syntaxin(1-3). In solution syntaxin adopts a default, closed configuration that is incompatible with formation of the SNARE complex(4). Specifically, the amino terminus of syntaxin binds the SNARE motif and occludes interactions with the other SNARE proteins. The N terminus of syntaxin also binds the presynaptic protein UNC-13 (ref. 5). Studies in mouse, Drosophila and Caenorhabditis elegans suggest that UNC-13 functions at a post-docking step of exocytosis, most likely during synaptic vesicle priming(6-8). Therefore, UNC-13 binding to the N terminus of syntaxin may promote the open configuration of syntaxin(9). To test this model, we engineered mutations into C. elegans syntaxin that cause the protein to adopt the open configuration constitutively(4). Here we demonstrate that the open form of syntaxin can bypass the requirement for UNC-13 in synaptic vesicle priming. Thus, it is likely that UNC-13 primes synaptic vesicles for fusion by promoting the open configuration of syntaxin.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NIMH NIH HHS [R03 MH059820-02, R03 MH059820-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1997, J BIOL CHEM, V272, P2520; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Nonet ML, 1998, J NEUROSCI, V18, P70; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; THOMAS JH, 1990, GENETICS, V124, P855; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	21	305	315	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					338	341		10.1038/35085583	http://dx.doi.org/10.1038/35085583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460165	Green Accepted			2022-12-01	WOS:000169918200048
J	Tahaoglu, K; Torun, T; Sevim, T; Atac, G; Kir, A; Karasulu, L; Ozmen, I; Kapakli, N				Tahaoglu, K; Torun, T; Sevim, T; Atac, G; Kir, A; Karasulu, L; Ozmen, I; Kapakli, N			The treatment of multidrug-resistant tuberculosis in Turkey	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MDR-TB; CHEMOTHERAPY; RIFAMPIN	Background: We evaluated the results of treatment in 158 consecutive patients with multidrug-resistant tuberculosis who were treated at our center in Istanbul, Turkey. Methods: A total of 21 female patients and 137 male patients (age range, 15 to 68 years) received treatment for multidrug-resistant tuberculosis between March 1992 and October 1999. The patients had previously received a mean of 5.7 antituberculosis drugs and were infected with organisms that were resistant to a mean of 4.4 drugs. All patients received at least three drugs thought to be active; the treatment was continued for at least 18 months after the conversion to a negative culture and for at least 24 months in the absence of first-line drugs. Results: The mean number of drugs given during the study was 5.5 (range, 3 to 9). Surgical resection was performed in 36 patients. Adverse effects led to discontinuation of one or more drugs in 62 patients (39 percent). Cultures became negative in 150 patients (95 percent) after a mean of 1.9 months (range, 1 to 9). The overall success rate of treatment was 77 percent, with cures in 78 patients (49 percent) and probable cures in 43 (27 percent). Treatment failed in 13 patients (8 percent). Seven patients died (4 percent). Seventeen patients (11 percent) did not complete the treatment regimen. Thirty-eight percent of the patients with unsuccessful outcomes were infected with organisms that were resistant to more than five drugs. In a step-down logistic-regression analysis, a successful outcome was independently associated with a younger age (P=0.013) and the absence of previous treatment with ofloxacin (P=0.005). Conclusions: Most patients with multidrug-resistant tuberculosis can be cured with the use of appropriate, intensive treatment regimens. (N Engl J Med 2001;345:170-4.) Copyright (C) 2001 Massachusetts Medical Society.	Sureyyapasa Ctr Chest Dis & Thorac Surg, Dept Pulm Dis, Istanbul, Turkey; Sureyyapasa Ctr Chest Dis & Thorac Surg, Dept Thorac Surg, Istanbul, Turkey; Univ Istanbul, Istanbul Fac Med, Dept Chest Dis, Istanbul, Turkey	Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital; Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital; Istanbul University	Tahaoglu, K (corresponding author), Ekin Tibbi Yayincilik, Osmanaga Mah Nuzhet Efendi Sok 49-3, TR-81320 Istanbul, Turkey.		Ozmen, Ipek/I-3449-2018	Ozmen, Ipek/0000-0002-3448-3675				Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Farmer P, 1999, INT J TUBERC LUNG D, V3, P643; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Farmer P, 1999, MULTIDRUG RESISTAN 5; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; ISEMAN MD, 1991, AM REV RESPIR DIS, V143, P697, DOI 10.1164/ajrccm/143.4_Pt_1.697; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; RIEDER HL, 1994, TUBERCLE LUNG DIS, V75, P321, DOI 10.1016/0962-8479(94)90075-2; TAHAOGLU K, 1994, TUBERCLE LUNG DIS, V75, P324, DOI 10.1016/0962-8479(94)90076-0; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404	12	205	216	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					170	174		10.1056/NEJM200107193450303	http://dx.doi.org/10.1056/NEJM200107193450303			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463011				2022-12-01	WOS:000169912800003
J	Binder, GK; Griffin, DE				Binder, GK; Griffin, DE			Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; VIRAL-INFECTIONS; VIRUS-INFECTION; EXPRESSION; MICE; NEUROVIRULENCE; ENCEPHALITIS; CYTOKINES; MOUSE	Recovery from viral encephalomyelitis requires immune-mediated noncytolytic clearance from neurons by mechanisms assumed to be the same for all neurons. In alphavirus encephalomyelitis, antibody clears infectious virus from neurons in all regions of the central nervous system (CNS), but CD8 T cells contribute to elimination of viral RNA. To understand the role of T cells in clearance, we infected antibody knockout mice with Sindbis virus. Virus was cleared from spinal cord and brain stem neurons, but not from cortical neurons, and required both CD4 and CD8 T cells. Infection with cytokine-expressing recombinant viruses suggested that T cells used interferon-gamma, but not tumor necrosis factor alpha, in clearing virus and that populations of neurons differ in responsiveness to this effector pathway.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Griffin, DE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038932] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038932] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BINDER GK, UNPUB; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; GRIFFIN DE, 1977, J IMMUNOL, V118, P1070; Guidotti LG, 2000, VIROLOGY, V273, P221, DOI 10.1006/viro.2000.0442; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; JACKSON AC, 1988, LAB INVEST, V58, P503; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kelly J. P., 1991, PRINCIPLES NEURAL SC, P273; Kelly JP., 1991, PRINC NEURAL SCI, V1, P283; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KUNDIG TM, 1993, J IMMUNOL, V150, P2316; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Lin MT, 1998, ADV EXP MED BIOL, V440, P431; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0; PEARCE BD, 1994, J VIROL, V68, P5483, DOI 10.1128/JVI.68.9.5483-5495.1994; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; Ramshaw IA, 1997, IMMUNOL REV, V159, P119, DOI 10.1111/j.1600-065X.1997.tb01011.x; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; TUCKER PC, 1991, J VIROL, V65, P1551, DOI 10.1128/JVI.65.3.1551-1557.1991; WESSELINGH SL, 1994, J IMMUNOL, V152, P1289; Will A, 1996, J IMMUNOL, V157, P4576; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	25	199	203	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					303	306		10.1126/science.1059742	http://dx.doi.org/10.1126/science.1059742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452126				2022-12-01	WOS:000169875200060
J	Bao, SW; Chan, WT; Merzenich, MM				Bao, SW; Chan, WT; Merzenich, MM			Cortical remodelling induced by activity of ventral tegmental dopamine neurons	NATURE			English	Article							AUDITORY-CORTEX; SOMATOSENSORY CORTEX; BASAL FOREBRAIN; CEREBRAL-CORTEX; PLASTICITY; RECEPTORS; SYSTEMS; REORGANIZATION; PREDICTION; INDUCTION	Representations of sensory stimuli in the cerebral cortex can undergo progressive remodelling according to the behavioural importance of the stimuli(1,2). The cortex receives widespread projections from dopamine neurons in the ventral tegmental area (VTA)(3-5), which are activated by new stimuli or unpredicted rewards(6,7), and are believed to provide a reinforcement signal for such learning-related cortical reorganization(8). In the primary auditory cortex (AI) dopamine release has been observed during auditory learning that remodels the sound-frequency representations(9,10). Furthermore, dopamine modulates longterm potentiation(11,12), a putative cellular mechanism underlying plasticity(13). Here we show that stimulating the VTA together with an auditory stimulus of a particular tone increases the cortical area and selectivity of the neural responses to that sound stimulus in AI. Conversely, the AI representations of nearby sound frequencies are selectively decreased. Strong, sharply tuned responses to the paired tones also emerge in a second cortical area, whereas the same stimuli evoke only poor or non-selective responses in this second cortical field in naive animals. In addition, we found that strong long-range coherence of neuronal discharge emerges between AI and this secondary auditory cortical area.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Merzenich, MM (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	merz@phy.ucsf.edu						Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; DIAMOND DM, 1986, BRAIN RES, V372, P357, DOI 10.1016/0006-8993(86)91144-3; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Goldsmith SK, 1996, NEUROSCIENCE, V74, P435, DOI 10.1016/0306-4522(96)00132-7; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; HARING JH, 1986, BRAIN RES, V366, P152, DOI 10.1016/0006-8993(86)91290-4; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; PANDYA DN, 1982, TRENDS NEUROSCI, V5, P386, DOI 10.1016/0166-2236(82)90219-3; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stark H, 1997, J NEUROCHEM, V68, P691; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1212, DOI 10.1152/jn.1990.64.4.1212; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	30	426	447	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					79	83		10.1038/35083586	http://dx.doi.org/10.1038/35083586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452310				2022-12-01	WOS:000169644900047
J	Furlong, EEM; Andersen, EC; Null, B; White, KP; Scott, MP				Furlong, EEM; Andersen, EC; Null, B; White, KP; Scott, MP			Patterns of gene expression during Drosophila mesoderm Development	SCIENCE			English	Article							DORSAL VENTRAL POLARITY; TWIST GENE; MYOBLAST FUSION; PROTEIN; INDUCTION; EMBRYO; PATHWAY; COMPLEX; CELLS; TOLL	The transcription factor Twist initiates Drosophila mesoderm development, resulting in the formation of heart, somatic muscle, and other cell types. Using a Drosophila embryo sorter, we isolated enough homozygous twist mutant embryos to perform DNA microarray experiments. Transcription profiles of twist loss-of-function embryos, embryos with ubiquitous twist expression, and wild-type embryos were compared at different developmental stages. The results implicate hundreds of genes, many with vertebrate homologs, in stage-specific processes in mesoderm development. One such gene, gleeful, related to the vertebrate Gli genes, is essential for somatic muscle development and sufficient to cause neural cells to express a muscle marker.	Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Scott, MP (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Andersen, Erik/0000-0003-0229-9651; Furlong, Eileen/0000-0002-9544-8339	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000045] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [K22 HG00045-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARMAND P, 1994, MOL CELL BIOL, V14, P4145, DOI 10.1128/MCB.14.6.4145; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; Campos-Ortega J.A., 1997, EMBRYONIC DEV DROSOP, V2nd, P9; Cann GM, 1999, ANAT EMBRYOL, V200, P239, DOI 10.1007/s004290050276; Casal J, 1996, P NATL ACAD SCI USA, V93, P10327, DOI 10.1073/pnas.93.19.10327; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LAKEY A, 1993, EMBO J, V12, P2863, DOI 10.1002/j.1460-2075.1993.tb05948.x; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; LEVINE M, 1988, CELL, V52, P785, DOI 10.1016/0092-8674(88)90418-7; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; REUTER R, 1993, DEVELOPMENT, V119, P1135; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Spring J, 2000, DEV BIOL, V228, P363, DOI 10.1006/dbio.2000.9956; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Taylor MV, 2000, CURR BIOL, V10, pR646, DOI 10.1016/S0960-9822(00)00664-3; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yin ZZ, 1997, DEVELOPMENT, V124, P4971	35	207	210	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1629	1633		10.1126/science.1062660	http://dx.doi.org/10.1126/science.1062660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11486054				2022-12-01	WOS:000170802900054
J	Luecke, H; Schobert, B; Lanyi, JK; Spudich, EN; Spudich, JL				Luecke, H; Schobert, B; Lanyi, JK; Spudich, EN; Spudich, JL			Crystal structure of sensory rhodopsin II at 2.4 angstroms: Insights into color tuning and transducer interaction	SCIENCE			English	Article							MOLECULAR-MECHANISM; NATRONOBACTERIUM-PHARAONIS; PROTON TRANSLOCATION; BACTERIORHODOPSIN; PROTEIN; PHOBORHODOPSIN; PHOTOCYCLE; RECEPTOR; MODEL; TEMPERATURE	We report an atomic-resolution structure for a sensory member of the microbial rhodopsin family, the phototaxis receptor sensory rhodopsin II (NpSRII), which mediates blue-light avoidance by the haloarchaeon Natronobacterium pharaonis. The 2.4 angstrom structure reveals features responsible for the 70- to 80-nanometer blue shift of its absorption maximum relative to those of haloarchaeal transport rhodopsins, as well as structural differences due to its sensory, as opposed to transport, function. Multiple factors appear to account for the spectral tuning difference with respect to bacteriorhodopsin: (i) repositioning of the guanidinium group of arginine 72, a residue that interacts with the counterion to the retinylidene protonated Schiff base; (ii) rearrangement of the protein near the retinal ring; and (iii) changes in tilt and slant of the retinal polyene chain. Inspection of the surface topography reveals an exposed polar residue, tyrosine 199, not present in bacteriorhodopsin, in the middle of the membrane bilayer. We propose that this residue interacts with the adjacent helices of the cognate NpSRII transducer NpHtrII.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Univ Texas, Sch Med, Struct Biol Ctr, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas System	Luecke, H (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	hudel@uci.edu; jlanyi@orion.oac.uci.edu; john.l.spudich@uth.tmc.edu	Lanyi, Janos/C-3808-2011; Luecke, Hartmut/F-4712-2012	Luecke, Hartmut/0000-0002-4938-0775	NIGMS NIH HHS [R01 GM029498, R01 GM027750, R01-GM27750, R01-GM59970, R01-GM29498, R01 GM059970] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029498, R01GM027750, R01GM059970] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Brown LS, 1998, BIOPHYS J, V75, P1455, DOI 10.1016/S0006-3495(98)74064-0; Brown LS, 1998, BIOCHEMISTRY-US, V37, P3982, DOI 10.1021/bi9728396; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRAYAMA J, 1992, BIOCHEMISTRY-US, V31, P2093, DOI 10.1021/bi00122a029; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; KAMO N, IN PRESS BIOCHEMISTR; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kunji ERS, 2001, J MOL BIOL, V308, P279, DOI 10.1006/jmbi.2001.4565; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2000, J PHYS CHEM B, V104, P11441, DOI 10.1021/jp0023718; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MILLER A, 1990, BIOCHIM BIOPHYS ACTA, V1020, P57, DOI 10.1016/0005-2728(90)90093-J; NAKANISHI K, 1979, PHOTOCHEM PHOTOBIOL, V29, P657, DOI 10.1111/j.1751-1097.1979.tb07745.x; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Schmies G, 2000, BIOPHYS J, V78, P967, DOI 10.1016/S0006-3495(00)76654-9; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; SPUDICH JL, 1986, BIOPHYS J, V49, P479, DOI 10.1016/S0006-3495(86)83657-8; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; SUDO Y, 2000, BIOPHYS J, V78, P959; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; YAN B, 1995, J BIOL CHEM, V270, P29668; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Zhang WS, 1996, P NATL ACAD SCI USA, V93, P8230, DOI 10.1073/pnas.93.16.8230; Zhang XN, 1999, P NATL ACAD SCI USA, V96, P857, DOI 10.1073/pnas.96.3.857	43	311	321	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1499	1503		10.1126/science.1062977	http://dx.doi.org/10.1126/science.1062977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11452084	Green Accepted			2022-12-01	WOS:000170616000047
J	Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA				Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA			Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; ENVELOPE GLYCOPROTEIN; GP120; INFECTION; LIBRARIES; EFFICIENT; PROTEINS; RECEPTOR; EPITOPE	We present the crystal structure at 2.7 angstrom resolution of the human antibody lgG1 b12. Antibody b12 recognizes the CD4-binding site of human immunodeficiency virus-1 (HIV-1) gp120 and is one of only two known antibodies against gp120 capable of broad and potent neutralization of primary HIV-1 isolates. A key feature of the antibody-combining site is the protruding, finger-like long CDR H3 that can penetrate the recessed CD4-binding site of gp120. A docking model of b12 and gp120 reveals severe structural constraints that explain the extraordinary challenge in eliciting effective neutralizing antibodies similar to b12. The structure, together with mutagenesis studies, provides a rationale for the extensive cross-reactivity of b12 and a valuable framework for the design of HIV-1 vaccines capable of eliciting b12-like activity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Oxford	Burton, DR (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Morris, Garrett Matthew/F-2465-2019; Stanfield, Robyn/AAH-3190-2019; Saphire, Erica/A-7055-2009	Morris, Garrett Matthew/0000-0003-1731-8405; Parren, Paul/0000-0002-4365-3859; Saphire, Erica Ollmann/0000-0002-1206-7451	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033292, R29AI040377, R01AI033292] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33292, AI40377] Funding Source: Medline; NIGMS NIH HHS [GM46192] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MENENDEZ A, UNPUB; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MICHAELSEN TE, 1994, P NATL ACAD SCI USA, V91, P9243, DOI 10.1073/pnas.91.20.9243; Mo HM, 1997, J VIROL, V71, P6869, DOI 10.1128/JVI.71.9.6869-6874.1997; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parren PWHI, 1999, AIDS, V13, pS137; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; SANNA PP, 1995, P NATL ACAD SCI USA, V92, P6439, DOI 10.1073/pnas.92.14.6439; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SANZ I, 1991, J IMMUNOL, V147, P1720; Saphire EO, 2001, ACTA CRYSTALLOGR D, V57, P168, DOI 10.1107/S0907444900017376; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; ZWICK MBV, UNPUB	44	731	801	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1155	1159		10.1126/science.1061692	http://dx.doi.org/10.1126/science.1061692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498595				2022-12-01	WOS:000170432600065
J	Griffitts, JS; Whitacre, JL; Stevens, DE; Aroian, RV				Griffitts, JS; Whitacre, JL; Stevens, DE; Aroian, RV			Bt toxin resistance from loss of a putative carbohydrate-modifying enzyme	SCIENCE			English	Article							PESTICIDAL CRYSTAL PROTEINS; BACILLUS-THURINGIENSIS; CAENORHABDITIS-ELEGANS; AMINOPEPTIDASE-N; IDENTIFICATION; RECEPTOR; LECTIN; FOLD	The development of resistance is the main threat to the long-term use of toxins from Bacillus thuringiensis (Bt) in transgenic plants. Here we report the cloning of a Bt toxin resistance gene, Caenorhabditis elegans bre-5, which encodes a putative beta -1,3-galactosyltransferase. Lack of bre-5 in the intestine led to resistance to the Bt toxin Cry5B. Wild-type but not bre-5 mutant animals were found to uptake toxin into their gut cells, consistent with bre-5 mutants lacking toxin-binding sites on their apical gut. bre-5 mutants displayed resistance to Cry14A, a Bt toxin lethal to both nematodes and insects; this indicates that resistance by loss of carbohydrate modification is relevant to multiple Bt toxins.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.							Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GRIFFITTS JS, UNPUB; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Kostich M, 2000, J CELL SCI, V113, P2595; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; MARROQUIN L, UNPUB; Marroquin LD, 2000, GENETICS, V155, P1693; MCGAUGHEY WH, 1998, ISRAEL J ENTOMOL, V2, P1; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; PAYNE J, 1995, Patent No. 5589382; PAYNE JM, 1994, Patent No. 9416079; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; TABASHNIK BE, 1994, P ROY SOC B-BIOL SCI, V255, P7, DOI 10.1098/rspb.1994.0002; WHITACRE JF, UNPUB; Yochem J, 1998, GENETICS, V149, P1323	24	165	197	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					860	864		10.1126/science.1062441	http://dx.doi.org/10.1126/science.1062441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486087				2022-12-01	WOS:000170241000044
J	Galibert, F; Finan, TM; Long, SR; Puhler, A; Abola, P; Ampe, F; Barloy-Hubler, F; Barnett, MJ; Becker, A; Boistard, P; Bothe, G; Boutry, M; Bowser, L; Buhrmester, J; Cadieu, E; Capela, D; Chain, P; Cowie, A; Davis, RW; Dreano, S; Federspiel, NA; Fisher, RF; Gloux, S; Godrie, T; Goffeau, A; Golding, B; Gouzy, J; Gurjal, M; Hernandez-Lucas, I; Hong, A; Huizar, L; Hyman, RW; Jones, T; Kahn, D; Kahn, ML; Kalman, S; Keating, DH; Kiss, E; Komp, C; Lalaure, V; Masuy, D; Palm, C; Peck, MC; Pohl, TM; Portetelle, D; Purnelle, B; Ramsperger, U; Surzycki, R; Thebault, P; Vandenbol, M; Vorholter, FJ; Weidner, S; Wells, DH; Wong, K; Yeh, KC; Batut, J				Galibert, F; Finan, TM; Long, SR; Puhler, A; Abola, P; Ampe, F; Barloy-Hubler, F; Barnett, MJ; Becker, A; Boistard, P; Bothe, G; Boutry, M; Bowser, L; Buhrmester, J; Cadieu, E; Capela, D; Chain, P; Cowie, A; Davis, RW; Dreano, S; Federspiel, NA; Fisher, RF; Gloux, S; Godrie, T; Goffeau, A; Golding, B; Gouzy, J; Gurjal, M; Hernandez-Lucas, I; Hong, A; Huizar, L; Hyman, RW; Jones, T; Kahn, D; Kahn, ML; Kalman, S; Keating, DH; Kiss, E; Komp, C; Lalaure, V; Masuy, D; Palm, C; Peck, MC; Pohl, TM; Portetelle, D; Purnelle, B; Ramsperger, U; Surzycki, R; Thebault, P; Vandenbol, M; Vorholter, FJ; Weidner, S; Wells, DH; Wong, K; Yeh, KC; Batut, J			The composite genome of the legume symbiont Sinorhizobium meliloti	SCIENCE			English	Article							MOLECULAR-BASIS; RHIZOBIUM; AGROBACTERIUM; GENES	The scarcity of usable nitrogen frequently limits plant growth. A tight metabolic association with rhizobial bacteria allows legumes to obtain nitrogen compounds by bacterial reduction of dinitrogen (N-2) to ammonium (NH4+). We present here the annotated DNA sequence of the alpha -proteobacterium Sinorhizobium meliloti, the symbiont of alfalfa. The tripartite 6.7-megabase (Mb) genome comprises a 3.65-Mb chromosome, and 1.35-Mb pSymA and 1.68-Mb pSymB megaplasmids. Genome sequence analysis indicates that all three elements contribute, in varying degrees, to symbiosis and reveals how this genome may have emerged during evolution. The genome sequence will be useful in understanding the dynamics of interkingdom associations and of life in soil environments.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Fac Med, Lab Genet & Dev, CNRS, UMR 6061, F-35043 Rennes, France; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; Univ Bielefeld, D-33615 Bielefeld, Germany; Stanford Ctr DNA Sequencing & Technol, Stanford, CA 94305 USA; INRA, Lab Biol Mol Relat Plantes Microorganisms, CNRS, UMR 215, F-31326 Castanet Tolosan, France; GATC Biotech AG, D-78467 Constance, Germany; Univ Catholique Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium; Fac Sci Agron Gembloux, Unite Biol Anim & Microbienne, B-5030 Gembloux, Belgium; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; McMaster University; University of Bielefeld; Stanford University; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Catholique Louvain; Washington State University	Long, SR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Yeh, Kuo-Chen/AAG-4485-2021; Chain, Patrick/O-4140-2019; Kahn, Daniel/B-9393-2013; chain, patrick/B-9777-2013; Thébault, Patricia/AAD-1105-2020; BATUT, Jacques/B-6506-2008; Albers, Pieter/I-2563-2017; Kiss, Ernö/B-4836-2008; Gouzy, Jerome/AAH-4977-2020	Yeh, Kuo-Chen/0000-0002-3791-3423; Chain, Patrick/0000-0003-3949-3634; Kahn, Daniel/0000-0001-8093-0854; Thébault, Patricia/0000-0003-2276-4573; Gouzy, Jerome/0000-0001-5695-4557; Wong, Kim/0000-0002-0984-1477; Barloy-Hubler, Frederique/0000-0002-8277-6034; Kiss, Erno/0000-0002-7344-1750; Boutry, Marc/0000-0002-2315-6900; Kahn, Michael/0000-0002-5204-561X; Puhler, Alfred/0000-0003-4723-2960; Barnett, Melanie/0000-0003-3350-278X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030962, R01GM030962] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30962] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNETT MJ, IN PRESS P NATL ACAD; CAPELA D, IN PRESS P NATL ACAD; FINAN T, IN PRESS P NATL ACAD; FLORES M, 1987, J BACTERIOL, V169, P5782, DOI 10.1128/jb.169.12.5782-5788.1987; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gottfert M, 2001, J BACTERIOL, V183, P1405, DOI 10.1128/JB.183.4.1405-1412.2001; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Matthysse AG, 1996, J BACTERIOL, V178, P5302, DOI 10.1128/jb.178.17.5302-5308.1996; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Oresnik IJ, 2000, J BACTERIOL, V182, P3582, DOI 10.1128/JB.182.12.3582-3586.2000; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; RENALIER MH, 1987, J BACTERIOL, V169, P2239; SCHWEDOCK JS, 1992, GENETICS, V132, P899; SCHWEDOCK JS, 1994, MOL PLANT MICROBE IN, V11, P1119; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Viprey V, 2000, Subcell Biochem, V33, P437; Viprey V, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-6-research0014	17	909	1838	1	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					668	672		10.1126/science.1060966	http://dx.doi.org/10.1126/science.1060966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474104				2022-12-01	WOS:000170204600047
J	Otterbein, LR; Graceffa, P; Dominguez, R				Otterbein, LR; Graceffa, P; Dominguez, R			The crystal structure of uncomplexed actin in the ADP state	SCIENCE			English	Article							I-BINDING LOOP; F-ACTIN; SUBDOMAIN 2; DIVALENT-CATION; CONFORMATION; MECHANISM; PHOSPHATE; MOVEMENT; GELSOLIN; COMPLEX	The dynamics and polarity of actin filaments are controlled by a conformational change coupled to the hydrolysis of adenosine S'-triphosphate (ATP) by a mechanism that remains to be elucidated. Actin modified to block polymerization was crystallized in the adenosine 5'-diphosphate (ADP) state, and the structure was solved to 1.54 angstrom resolution. Compared with previous ATP-actin structures from complexes with deoxyribonuclease I, profilin, and gelsotin, monomeric ADP-actin is characterized by a marked conformational change in subdomain 2. The successful crystallization of monomeric actin opens the way to future structure determinations of actin complexes with actin-binding proteins such as myosin.	Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Dominguez, R (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	dominguez@bbri.org	ID, IMCACAT/D-5867-2014		NCRR NIH HHS [RR07707] Funding Source: Medline; NIAMS NIH HHS [R01 AR046524, R01 AR46524, P01 AR41637] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046524, P01AR041637] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allen PG, 1996, J BIOL CHEM, V271, P4665; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Borovikov YS, 2000, BBA-PROTEIN STRUCT M, V1478, P138, DOI 10.1016/S0167-4838(00)00005-4; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Graceffa P, 2000, J BIOL CHEM, V275, P17143, DOI 10.1074/jbc.M001979200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; Moraczewska J, 1999, BIOPHYS J, V77, P373, DOI 10.1016/S0006-3495(99)76896-7; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sheterline P, 1998, ACTIN	28	409	415	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					708	711		10.1126/science.1059700	http://dx.doi.org/10.1126/science.1059700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474115				2022-12-01	WOS:000170204600058
J	Cook-Deegan, RM; McCormack, SJ				Cook-Deegan, RM; McCormack, SJ			Intellectual property - Patents, secrecy, and DNA	SCIENCE			English	Editorial Material							ACADEMIC RESEARCH; TECHNOLOGY		Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA; Stanford Washington Program, Washington, DC 20008 USA; AlleCure Corp, Valencia, CA 91355 USA	Georgetown University; Stanford University	Cook-Deegan, RM (corresponding author), Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA.			Cook-Deegan, Robert/0000-0002-8251-4237				Cockburn I, 1996, P NATL ACAD SCI USA, V93, P12725, DOI 10.1073/pnas.93.23.12725; Gambardella A., 1995, SCI INNOVATION US PH; HASELTINE W, 1994, WORKSH OFF TECHN ASS; Henderson R, 1998, REV ECON STAT, V80, P119, DOI 10.1162/003465398557221; *INT COMM INT PROP, 1999, TRAD KNOWL FOLKL, P10; JACOBS P, 2000, LA TIMES        0228, pA1; JORDA KF, 1999, INTELLECTUAL PROPERT; MANSFIELD E, 1991, RES POLICY, V20, P1, DOI 10.1016/0048-7333(91)90080-A; MANSFIELD E, 1995, REV ECON STAT, V77, P55, DOI 10.2307/2109992; NARIN F, 1992, RES POLICY, V21, P237, DOI 10.1016/0048-7333(92)90018-Y; NARIN F, 1988, RES POLICY, V17, P139, DOI 10.1016/0048-7333(88)90039-X; National Academy of Engineering, 1992, TIME HORIZONS TECHNO; *OTA, 1988, MAPP OUR GEN GEN PRO, P167; *USPTO, 2000, FED REGISTER, V65, P57024; 2000, Patent No. 6025154	15	25	25	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					217	217		10.1126/science.1058032	http://dx.doi.org/10.1126/science.1058032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	452TK	11452101				2022-12-01	WOS:000169875200027
J	Dupuis, S; Dargemont, C; Fieschi, C; Thomassin, N; Rosenzweig, S; Harris, J; Holland, SM; Schreiber, RD; Casanova, JL				Dupuis, S; Dargemont, C; Fieschi, C; Thomassin, N; Rosenzweig, S; Harris, J; Holland, SM; Schreiber, RD; Casanova, JL			Impairment od mycobacterial but not viral immunity by a germline human STAT1 mutation	SCIENCE			English	Article							INTERFERON-GAMMA-RECEPTOR; CALMETTE-GUERIN INFECTION; TARGETED DISRUPTION; DEFICIENCY; SUSCEPTIBILITY; MICE; GENE; DEFENSE; CHILD; CHAIN	Interferons (IFN) alpha/beta and gamma induce the formation of two transcriptional activators: gamma-activating factor (CAF) and interferon-stimulated gamma factor 3 (ISGF3). We report a natural heterozygous germline STAT1 mutation associated with susceptibility to mycobacterial but not viral disease. This mutation causes a loss of CAF and ISGF3 activation but is dominant for one cellular phenotype and recessive for the other. It impairs the nuclear accumulation of GAF but not of ISGF3 in heterozygous cells stimulated by IFNs. Thus, the antimycobacterial, but not the antiviral, effects of human IFNs are principally mediated by GAF.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM,UMR550, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Paris 06, CNRS, Inst Jacques Monod, F-75005 Paris, France; Univ Paris 07, CNRS, UMR 7592, F-75005 Paris, France; Ctr Hosp Gen, F-58000 Nevers, France; NIAID, Host Def Lab, Bethesda, MD 20892 USA; Univ San Francisco, Dept Pediat, San Francisco, CA 94117 USA; Washington Univ, Dept Pathol, St Louis, MO 63110 USA; Hop Necker Enfants Malad, Unite Hematol Immunol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of San Francisco; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM,UMR550, Lab Genet Humaine Malad Infect, F-75015 Paris, France.		Schreiber, Robert D/A-1276-2013; Boisson-Dupuis, Stephanie/AAF-5066-2021; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis, Stéphanie/I-2040-2017; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Casanova, Jean-Laurent/0000-0002-7782-4169; Schreiber, Robert/0000-0003-1590-2341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000647, ZIAAI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Casanova JL, 1996, PEDIATRICS, V98, P774; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; de Jong R, 1998, SCIENCE, V280, P1435; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VERLIAC F, 1972, INFECT OSSEUSES BACT	24	358	366	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					300	303		10.1126/science.1061154	http://dx.doi.org/10.1126/science.1061154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452125				2022-12-01	WOS:000169875200059
J	Carr, MH; Garvin, J				Carr, MH; Garvin, J			Mars exploration	NATURE			English	Editorial Material								An international flotilla of spacecraft are to be sent to Mars over the next decade in an effort to understand the planet's geology and climate history, and to determine whether some form of life ever started there. At least two spacecraft will be sent at each launch opportunity, and at times up to four spacecraft may be operating simultaneously at the planet.	US Geol Survey, Menlo Park, CA 94025 USA; NASA Headquarters, Washington, DC 20546 USA	United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA)	Carr, MH (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Park, CA 94025 USA.			Garvin, James/0000-0003-1606-5645				Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Haberle RM, 1998, J GEOPHYS RES-PLANET, V103, P28467, DOI 10.1029/98JE01396; McKay C.P., 1992, MARS, P1234; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	9	6	7	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					250	253		10.1038/35084200	http://dx.doi.org/10.1038/35084200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449287				2022-12-01	WOS:000169778700065
J	Lorenz, MC; Fink, GR				Lorenz, MC; Fink, GR			The glyoxylate cycle is required for fungal virulence	NATURE			English	Article							YEAST YARROWIA-LIPOLYTICA; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; ISOCITRATE LYASE; GENE; EXPRESSION; DISRUPTION; MUTATIONS; CLONING	Candida albicans, a normal component of the mammalian gastrointestinal flora, is responsible for most fungal infections in immunosuppressed patients. Candida is normally phagocytosed by macrophages and neutrophils, which secrete cytokines and induce hyphal development in this fungus(1,2). Neutropenic patients, deficient in these immune cells, are particularly susceptible to systemic candidiasis(3,4). Here we use genome-wide expression profiles of the related yeast Saccharomyces cerevisiae to obtain a signature of the events that take place in the fungus on ingestion by a mammalian macrophage. Live S. cerevisiae cells isolated from the phagolysosome are induced for genes of the glyoxylate cycle, a metabolic pathway that permits the use of two-carbon compounds as carbon sources. In C. albicans, phagocytosis also upregulates the principal enzymes of the glyoxylate cycle, isocitrate lyase (ICL1) and malate synthase (MLS1). Candida albicans mutants lacking ICL1 are markedly less virulent in mice than the wild type. These findings in fungi, in conjunction with reports that isocitrate lyase is both upregulated and required for the virulence of Mycobacterium tuberculosis(5,6), demonstrate the wide-ranging significance of the glyoxylate cycle in microbial pathogenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	fink@wi.mit.edu		Lorenz, Michael/0000-0002-7881-8027				ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; CANNON RD, 1992, MOL GEN GENET, V235, P453, DOI 10.1007/BF00279393; FONZI WA, 1993, GENETICS, V134, P717; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; KUJAU M, 1992, YEAST, V8, P193, DOI 10.1002/yea.320080305; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MINARD KI, 1991, MOL CELL BIOL, V11, P370, DOI 10.1128/MCB.11.1.370; MORTIMER RK, 1986, GENETICS, V113, P35; SEDIVY JM, 1985, J MOL BIOL, V186, P307, DOI 10.1016/0022-2836(85)90107-X; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Tzschoppe K, 1999, YEAST, V15, P1645, DOI 10.1002/(SICI)1097-0061(199911)15:15<1645::AID-YEA491>3.0.CO;2-G; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wright WL, 1997, INFECT DIS CLIN N AM, V11, P411, DOI 10.1016/S0891-5520(05)70363-9	18	555	576	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					83	86		10.1038/35083594	http://dx.doi.org/10.1038/35083594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452311				2022-12-01	WOS:000169644900048
J	Navarro-Gonzalez, R; McKay, CP; Mvondo, DN				Navarro-Gonzalez, R; McKay, CP; Mvondo, DN			A possible nitrogen crisis for Archaean life due to reduced nitrogen fixation by lightning	NATURE			English	Article							EARTHS EARLY ATMOSPHERE; NITRIC-OXIDE; EVOLUTION; CARBON; ENERGY; OXYGEN	Nitrogen is an essential element for life and is often the limiting nutrient for terrestrial ecosystems(1,2). As most nitrogen is locked in the kinetically stable form(3), N-2, in the Earth's atmosphere, processes that can fix N-2 into biologically available forms-such as nitrate and ammonia-control the supply of nitrogen for organisms. On the early Earth, nitrogen is thought to have been fixed abiotically, as nitric oxide formed during lightning discharge(4-6). The advent of biological nitrogen fixation suggests that at some point the demand for fixed nitrogen exceeded the supply from abiotic sources, but the timing and causes of the onset of biological nitrogen fixation remain unclear(7-11). Here we report an experimental simulation of nitrogen fixation by lightning over a range of Hadean (4.5-3.8 Gyr ago) and Archaean (3.8-2.5 Gyr ago) atmospheric compositions, from predominantly carbon dioxide to predominantly dinitrogen (but always without oxygen). We infer that, as atmospheric CO2 decreased over the Archaean period, the production of nitric oxide from lightning discharge decreased by two orders of magnitude until about 2.2 Gyr. After this time, the rise in oxygen (or methane) concentrations probably initiated other abiotic sources of nitrogen. Although the temporary reduction in nitric oxide production may have lasted for only 100 Myr or less, this was potentially long enough to cause an ecological crisis that triggered the development of biological nitrogen fixation.	Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estud Planetarios, Mexico City 04510, DF, Mexico; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	Universidad Nacional Autonoma de Mexico; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Navarro-Gonzalez, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estud Planetarios, Circuito Exterior,Ciudad Univ,Apartado Postal 70-, Mexico City 04510, DF, Mexico.		Navarro-González, Rafael/D-1748-2009	Navarro-González, Rafael/0000-0002-6078-7621; NNA MVONDO, Delphine/0000-0001-7107-4988				Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; CLOUD PE, 1968, SCIENCE, V160, P729, DOI 10.1126/science.160.3829.729; Golubic S, 1995, LETHAIA, V28, P285, DOI 10.1111/j.1502-3931.1995.tb01817.x; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; JEBENS DS, 1992, GEOPHYS RES LETT, V19, P273, DOI 10.1029/91GL02937; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KNIPOVICH OM, 1988, RUSS J PHYS CHEM, V62, P867; LEVINE JS, 1982, GEOPHYS RES LETT, V9, P893, DOI 10.1029/GL009i008p00893; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; POSTGATE J, 1987, NITROGEN FIXATION, P73; Raven JA, 1998, NEW PHYTOL, V139, P205, DOI 10.1046/j.1469-8137.1998.00168.x; Rosswall T., 1981, SOME PERSPECTIVES MA; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Schopf JW, 2000, PROKARYOTIC DEVELOPMENT, P105; Schopf JW, 1983, EARTHS EARLIEST BIOS; The National Institute of Standards and Technology, NIST STAND REF DAT 1; Walker J. C. G., 1977, EVOLUTION ATMOSPHERE; Wang Y, 1998, J GEOPHYS RES-ATMOS, V103, P19149, DOI 10.1029/98JD01356; YOUNG JPW, 1992, BIOL NITROGEN FIXATI, P43; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819	30	180	184	4	91	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					61	64		10.1038/35083537	http://dx.doi.org/10.1038/35083537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452304	Green Submitted			2022-12-01	WOS:000169644900041
J	Weeks, AR; Marec, F; Breeuwer, JAJ				Weeks, AR; Marec, F; Breeuwer, JAJ			A mite species that consists entirely of haploid females	SCIENCE			English	Article							RIBOSOMAL DNA; NO EVIDENCE; EVOLUTION; REPRODUCTION; ARTHROPODS; DIPLOIDY	The dominance of the diploid state in higher organisms, with haploidy generally confined to the gametic phase, has Led to the perception that diploidy is favored by selection. This view is highlighted by the fact that no known female organism within the Metazoa exists exclusively (or even for a prolonged period) in a haploid state. We used fluorescence microscopy and variation at nine microsatellite Loci to show that the false spider mite, Brevipalpus phoenicis, consists of haploid female parthenogens. We show that this reproductive anomaly is caused by infection by an undescribed endosymbiotic bacterium, which results in feminization of haploid genetic males.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, NL-1098 SM Amsterdam, Netherlands; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Evolutionary Biol, NL-1098 SM Amsterdam, Netherlands; Acad Sci Czech Republ, Inst Entomol, CZ-37005 Ceske Budejovice, Czech Republic	University of Amsterdam; University of Amsterdam; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Weeks, AR (corresponding author), Monash Univ, Dept Biol Sci, Ctr Environm Stress & Adaptat Res, Clayton, Vic 3168, Australia.		Marec, Frantisek/G-7943-2014; Weeks, Andrew/ABC-3048-2020	Marec, Frantisek/0000-0002-6745-5603; Weeks, Andrew/0000-0003-3081-135X				Blackman RL, 1996, CHROMOSOME RES, V4, P314, DOI 10.1007/BF02263684; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; *GENB, AF350221 GENB; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; HELLE W, 1980, GENETICA, V54, P45, DOI 10.1007/BF00122407; HELLE W, 1972, EXPERIENTIA, V28, P707, DOI 10.1007/BF01944992; Kennedy JS, 1996, J APPL ENTOMOL, V120, P493, DOI 10.1111/j.1439-0418.1996.tb01641.x; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; MARTIN G, 1990, GEN COMP ENDOCR, V80, P349, DOI 10.1016/0016-6480(90)90183-M; Norton Roy A., 1993, P8; ORR HA, 1995, GENETICS, V139, P1441; PerrotMinnot MJ, 1997, CAN ENTOMOL, V129, P691, DOI 10.4039/Ent129691-4; PIJNACKER LP, 1980, GENETICA, V51, P211, DOI 10.1007/BF00121613; PIJNACKER LP, 1981, ACAROLOGIA, V22, P157; Rigaud T, 1997, BIOESSAYS, V19, P409, DOI 10.1002/bies.950190508; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suomalainen E., 1987, CYTOLOGY EVOLUTION P; Weeks AR, 2000, EXP APPL ACAROL, V24, P775, DOI 10.1023/A:1006486400800; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wenseleers T, 2000, J EVOLUTION BIOL, V13, P277, DOI 10.1046/j.1420-9101.2000.00168.x; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Wrensch Dana L., 1994, P282; ZCHORIFEIN E, COMMUNICATION	29	200	215	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2479	2482		10.1126/science.1060411	http://dx.doi.org/10.1126/science.1060411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431565				2022-12-01	WOS:000169658200038
J	Thomas, GL; Thorne, RE				Thomas, GL; Thorne, RE			Night-time predation by Steller sea lions	NATURE			English	Article									Prince William Sound Sci Ctr, Cordova, AK 99574 USA		Thomas, GL (corresponding author), Prince William Sound Sci Ctr, POB 705, Cordova, AK 99574 USA.							CASTELLINI M, 1993, AKSG9301, P4; Loughlin TR, 1998, BIOSPHERE CONSERV, V1, P91; MacLennan D.N., 1992, SPRINGER SCI BUS MED, V5, P54; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Merrick RL, 1997, CAN J FISH AQUAT SCI, V54, P1342, DOI 10.1139/cjfas-54-6-1342; MERRICK RL, 1994, POLAR RES, V13, P105, DOI 10.1111/j.1751-8369.1994.tb00441.x; National Research Council, 1996, BER SEA EC; Thomas G. L., 1997, DEV SUSTAINING WORLD, P606; THORNE RE, 1983, FAO FISH REP, V300, P217	9	53	53	2	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1013	1013		10.1038/35082745	http://dx.doi.org/10.1038/35082745			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429591				2022-12-01	WOS:000169528500033
J	Bernhardt, TG; Wang, IN; Struck, DK; Young, R				Bernhardt, TG; Wang, IN; Struck, DK; Young, R			A protein antibiotic in the phage Q beta virion: Diversity in lysis targets	SCIENCE			English	Article							ESCHERICHIA-COLI; CELL-LYSIS; ELEMENTS; STRAINS	A(2), a capsid protein of RNA phage Q beta, is also responsible for host Lysis. A(2) blocked synthesis of murein precursors in vivo by inhibiting MurA, the catalyst of the committed step of murein biosynthesis. An A(2)-resistance mutation mapped to an exposed surface near the substrate-binding cleft of MurA. Moreover, purified Q beta virions inhibited wild-type MurA, but not the mutant MurA, in vitro. Thus, the two small phages characterized for their Lysis strategy, Q beta and the small DNA phage phi X174, effect host Lysis by targeting different enzymes in the multistep, universally conserved pathway of cell wall biosynthesis.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Young, R (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.			Young, Ry/0000-0001-8001-2914	NIGMS NIH HHS [R01 GM027099] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berlyn MKB, 1998, MICROBIOL MOL BIOL R, V62, P814, DOI 10.1128/MMBR.62.3.814-984.1998; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; BERNHARDT TM, UNPUB; Chaplin MF, 1986, CARBOHYDRATE ANAL PR; KOZAK M, 1971, NATURE-NEW BIOL, V234, P209, DOI 10.1038/newbio234209a0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MARQUARDT JL, 1992, J BACTERIOL, V174, P5748, DOI 10.1128/JB.174.17.5748-5752.1992; Miller JH., 1972, EXPT MOL GENETICS; PARANCHYCH W, 1975, RNA PHAGES, pCH4; ROOF W, UNPUB; Sektas M, 1999, BIOTECHNIQUES, V27, P911, DOI 10.2144/99275bm07; SINGER M, 1989, MICROBIOL REV, V53, P1; STRAUSS JH, 1963, J MOL BIOL, V7, P43, DOI 10.1016/S0022-2836(63)80017-0; VANDUIN J, 1988, BACTERIOPHAGES, V1, pCH4; WANG IC, UNPUB; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WINTER RB, 1983, CELL, V33, P877, DOI 10.1016/0092-8674(83)90030-2; WITTE A, 1990, BIOCHIMIE, V72, P191, DOI 10.1016/0300-9084(90)90145-7; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4	20	100	108	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2326	2329		10.1126/science.1058289	http://dx.doi.org/10.1126/science.1058289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423662				2022-12-01	WOS:000169455900057
J	Hines, PJ; Marx, J				Hines, PJ; Marx, J			The endless race between plant and pathogen	SCIENCE			English	Editorial Material																			0	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2269	2269		10.1126/science.292.5525.2269	http://dx.doi.org/10.1126/science.292.5525.2269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423645				2022-12-01	WOS:000169455900039
J	Honein, MA; Paulozzi, LJ; Mathews, TJ; Erickson, JD; Wong, LYC				Honein, MA; Paulozzi, LJ; Mathews, TJ; Erickson, JD; Wong, LYC			Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRENATAL-DIAGNOSIS; BIRTH-DEFECTS; ELECTIVE TERMINATION; FOLATE LEVELS; PREVENTION; PREVALENCE; CERTIFICATES; HOMOCYSTEINE; DECISION; GRAIN	Context Daily consumption of 400 mug of folic acid before conception and during early pregnancy dramatically reduces the occurrence of neural tube defects (NTDs), Before food fortification, however, only an estimated 29% of US reproductive-aged women were taking a supplement containing 400 mug of folic acid daily. The US Food and Drug Administration authorized addition of folic acid to enriched grain products in March 1996, with compliance mandatory by January 1998. Objective To evaluate the impact of food fortification with folic acid on NTD birth prevalence. Design, Setting, and Population National study of birth certificate data for live births to women in 45 US states and Washington, DC, between January 1990 and December 1999, Main Outcome Measure Birth certificate reports of spina bifida and anencephaly before fortification (October 1995 through December 1996) compared with after mandatory fortification (October 1998 through December 1999). Results The birth prevalence of NTDs reported on birth certificates decreased from 37.8 per 100000 live births before fortification to 30.5 per 100000 live births conceived after mandatory folic acid fortification, representing a 19% decline (prevalence ratio [PR], 0.81; 95% confidence interval [CI], 0.75-0.87), During the same period, NTD birth prevalence declined from 53.4 per 100000 to 46.5 per 100000 (PR, 0.87; 95% CI, 0.64-1.18) for women who received only third-trimester or no prenatal care. Conclusions A 19% reduction in NTD birth prevalence occurred following folic acid fortification of the US food supply. However, factors other than fortification may have contributed to this decline.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Vital Stat, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Mailstop F-45,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	MHonein@cdc.gov						Adams T, 1996, AM J PUBLIC HEALTH, V86, P593, DOI 10.2105/AJPH.86.4.593; Allen WP, 1996, PRENATAL DIAG, V16, P531, DOI 10.1002/(SICI)1097-0223(199606)16:6<531::AID-PD914>3.0.CO;2-1; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; *CDC, 2000, TRENDS SPIN BIF AN U; *CDC, 2000, MMWR-MORBID MORTAL W, V49, P962; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P325; COHEN SA, 1998, GUTTMACHER REP PUBLI, V1, P6; Committee on Medical Aspects of Food and Nutrition Policy, 2000, FOL AC PREV DIS; Cornel MC, 1997, TERATOLOGY, V55, P134; CROWDER SV, 1987, J QUAL TECHNOL, V19, P161, DOI 10.1080/00224065.1987.11979055; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; Daly S, 1998, CURR OPIN OBSTET GYN, V10, P85, DOI 10.1097/00001703-199804000-00002; Forrester MB, 1998, AM J EPIDEMIOL, V148, P1206; FREEDMAN MA, 1988, AM J PUBLIC HEALTH, V78, P168, DOI 10.2105/AJPH.78.2.168; Freire WB, 2000, EUR J PEDIATR SURG, V10, P42; Gregory JF, 1997, EUR J CLIN NUTR, V51, pS54; GREVENGOOD C, 1994, FETAL DIAGN THER, V9, P273, DOI 10.1159/000263947; Hook EB, 1997, LANCET, V350, P513, DOI 10.1016/S0140-6736(97)01342-1; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Lawrence JM, 1999, LANCET, V354, P915, DOI 10.1016/S0140-6736(99)03227-4; Mulinare J, 1997, TERATOLOGY, V56, P17, DOI 10.1002/(SICI)1096-9926(199707/08)56:1/2<17::AID-TERA5>3.0.CO;2-Z; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; Olsen CL, 1996, PAEDIATR PERINAT EP, V10, P161, DOI 10.1111/j.1365-3016.1996.tb00040.x; PIPER JM, 1993, AM J EPIDEMIOL, V137, P758, DOI 10.1093/oxfordjournals.aje.a116736; PRYDE PG, 1992, OBSTET GYNECOL, V80, P52; Rader JI, 2000, FOOD CHEM, V70, P275, DOI 10.1016/S0308-8146(00)00116-3; ROBERTS HE, 1995, PEDIATRICS, V96, P880; ROMANO PS, 1995, AM J PUBLIC HEALTH, V85, P667, DOI 10.2105/AJPH.85.5.667; ROSENFIELD A, 1993, AM J OBSTET GYNECOL, V169, P128, DOI 10.1016/0002-9378(93)90146-A; Skeaff M, 1998, NEW ZEAL MED J, V111, P417; TAFFEL SM, 1989, BIRTH-ISS PERINAT C, V16, P188, DOI 10.1111/j.1523-536X.1989.tb00896.x; TOLSON GC, 1991, VITAL HLTH STAT 4, V28, P1; Turner LA, 1998, CAN MED ASSOC J, V158, P773; Velie EM, 1996, AM J EPIDEMIOL, V144, P473; Ventura SJ., 2000, BIRTHS FINAL DATA 19, V48; Wald NJ, 1998, LANCET, V351, P834, DOI 10.1016/S0140-6736(05)78966-2; Wald NJ, 2001, AM J MED GENET, V98, P204, DOI 10.1002/1096-8628(20010115)98:2<204::AID-AJMG1032>3.0.CO;2-D; Watkins ML, 1996, AM J PUBLIC HEALTH, V86, P731, DOI 10.2105/AJPH.86.5.731; Watkins ML, 1999, NEW ENGL J MED, V341, P923; Wynn Margaret, 1998, Nutrition and Health (Bicester), V12, P147; 1996, FED REG, V61, P8781	44	708	730	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2001	285	23					2981	2986		10.1001/jama.285.23.2981	http://dx.doi.org/10.1001/jama.285.23.2981			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	442AR	11410096				2022-12-01	WOS:000169263200020
J	Roper, NA; Bilous, RW; Kelly, WF; Unwin, NC; Connolly, VM				Roper, NA; Bilous, RW; Kelly, WF; Unwin, NC; Connolly, VM			Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; SOCIOECONOMIC-STATUS; SOCIAL DEPRIVATION; RISK-FACTORS; MELLITUS; COHORT; PEOPLE; PREVALENCE; DISEASE; ADULTS	Objectives To establish the age and sex specific mortality for people with diabetes in comparison with local and national background populations; to investigate the relationship between mortality and material deprivation in an unselected population with diabetes. Design Longitudinal study, using a population based district diabetes register. Setting South Tees, United Kingdom. Participants All people known to have diabetes living in Middlesbrough and Redcar and Cleveland local authorities on 1 January 1994. Main outcome measure Death, from any cause, between 1 January 1994 and 31 December 1999. Results Over the six years of the study 1205 (24.9%) of 4842 participants died. All cause standardised mortality ratios for type 1 diabetes were 641 (95% confidence interval 406 to 962) in women and 294 (200 to 418) in men, and those for type 2 diabetes were 160 (147 to 174) in women and 141 (130 to 152) in men. Cause specific standardised mortality ratios were increased for ischaemic heart disease, cerebrovascular disease, and renal disease; no reductions in mortality from other causes were seen. The risk of premature death increased significantly with increasing material deprivation (P < 0.001). Conclusions Diabetes is associated with excess mortality, even in an area with high background death rates from cardiovascular disease. This excess mortality is evident in all age groups, most pronounced in young people with type 1 diabetes, and exacerbated by material deprivation. Aggressive approaches to the management of cardiovascular risk factors could reduce the excess mortality in people with diabetes.	Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Diabet & Epidemiol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Roper, NA (corresponding author), Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough TS5 5AZ, Cleveland, England.			Unwin, Nigel/0000-0002-1368-1648				Chaturvedi N, 1998, BMJ-BRIT MED J, V316, P100; Connolly VM, 1996, DIABETES CARE, V19, P419, DOI 10.2337/diacare.19.5.419; CROXSON SCM, 1994, DIABETIC MED, V11, P250, DOI 10.1111/j.1464-5491.1994.tb00267.x; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Devis T, 1990, POPUL TRENDS, V60, P23; Diabetes care and research in Europe, 1990, DIABETIC MED, V7, P360; *DOC GEIG, 1970, SCI TABL; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Gatling W, 1997, DIABETIC MED, V14, P316, DOI 10.1002/(SICI)1096-9136(199704)14:4<316::AID-DIA328>3.0.CO;2-0; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; KELLY WF, 1993, BRIT MED J, V307, P1115, DOI 10.1136/bmj.307.6912.1115; Koskinen SVP, 1998, AM J PUBLIC HEALTH, V88, P765, DOI 10.2105/AJPH.88.5.765; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; MUGGEO M, 1995, DIABETOLOGIA, V38, P318, DOI 10.1007/s001250050288; *OFF POP CENS SURV, 1994, SER DH2, V2126; *OFF POP CENS SURV, 1994, SER DH1, V2730; PHILLIMORE P, 1994, BRIT MED J, V308, P1125, DOI 10.1136/bmj.308.6937.1125; Raymond NT, 1995, J EPIDEMIOL COMMUN H, V49, P570, DOI 10.1136/jech.49.6.570; Robinson N, 1998, DIABETIC MED, V15, P205, DOI 10.1002/(SICI)1096-9136(199803)15:3<205::AID-DIA519>3.0.CO;2-#; Townsend P, 1988, HLTH DEPRIVATION INE; Unwin N, 1996, DIABETIC MED, V13, P72, DOI 10.1002/(SICI)1096-9136(199601)13:1<72::AID-DIA21>3.3.CO;2-K; WAUGH NR, 1989, DIABETOLOGIA, V32, P103, DOI 10.1007/BF00505181; WONG JSK, 1991, DIABETIC MED, V8, P135, DOI 10.1111/j.1464-5491.1991.tb01559.x	25	230	233	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1389	1393		10.1136/bmj.322.7299.1389	http://dx.doi.org/10.1136/bmj.322.7299.1389			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397742	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000169284600015
J	Bartolazzi, A; Gasbarri, A; Papotti, M; Bussolati, G; Lucante, T; Khan, A; Inohara, H; Marandino, F; Orlandi, F; Nardi, F; Vecchione, A; Tecce, R; Larsson, O				Bartolazzi, A; Gasbarri, A; Papotti, M; Bussolati, G; Lucante, T; Khan, A; Inohara, H; Marandino, F; Orlandi, F; Nardi, F; Vecchione, A; Tecce, R; Larsson, O		Thyroid Canc Study Grp	Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions	LANCET			English	Article							FINE-NEEDLE-ASPIRATION; HASHIMOTO THYROIDITIS; EXPRESSION; GALECTIN-3; CD44; CARCINOMA; MARKER; CYTOLOGY; FUSION; TUMORS	Background Thyroid cancer is the most common endocrine malignant disease, but preoperative diagnosis remains a challenge. Fine-needle aspiration cytology has greatly improved the clinical management of thyroid nodules, but the preoperative characterisation of follicular lesions is very difficult. Many patients are thus referred to surgery more for diagnosis than for therapeutic necessity. We undertook an international multicentre study to assess the usefulness of immunohistocytochemical staining for two potential markers of malignant thyrocytes. Methods Expression of galectin-3 and CD44v6 was tested on 1009 thyroid lesions (tissue specimens and cytological cell-blocks) and 226 fresh cytological samples obtained preoperatively by ultrasound-guided fine-needle aspiration of thyroid nodules (prospective analysis). The test used monoclonal antibodies specific for CD44v6 and galectin-3, the indirect avidin-biotin complex immunoperoxidase method, and 3-amino-9-ethylcarbazole as substrate. Findings The sensitivity, specificity, positive predictive value, and diagnostic accuracy of this test method (for coexpression of the two markers) in the prospective analysis were 88%, 98%, 91%, and 97%, respectively. The sensitivity and specificity of galectin-3 immunodetection alone in discriminating benign from malignant thyroid lesions were more than 99% and 98% respectively, and the positive predictive value and diagnostic accuracy were 92% and 99%. Interpretation The integration of galectin-3 immunostaining with conventional cytomorphological and clinical diagnostic procedures represents a sensitive and reliable diagnostic approach for preoperative identification of thyroid carcinomas. This test method improves the diagnostic accuracy of conventional cytology and provides the molecular basis for a new nosological assignation of the not yet classified thyroid neoplasms of indeterminate malignant behaviour.	Karolinska Hosp, Canc Ctr Karolinska, Dept Oncol Pathol Cellular & Mol Tumor Pathol, S-17176 Stockholm, Sweden; Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; Regina Elena Inst Canc Res, Dept Immunol, Rome, Italy; Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; Univ Turin, Dept Biol & Clin Sci, I-10124 Turin, Italy; Univ Roma La Sapienza, Policlin Umberto I, Dept Pathol & Expt Med, I-00161 Rome, Italy; Univ Roma La Sapienza, Policlin Umberto I, Dept Cytopathol, I-00161 Rome, Italy; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Div Anat Pathol, Worcester, MA 01605 USA; Osaka Univ, Grad Sch Med, Dept Otolaryngol, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Sensory Organ Surg, Osaka, Japan	Karolinska Institutet; Karolinska University Hospital; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Turin; University of Turin; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Osaka University; Osaka University	Bartolazzi, A (corresponding author), Karolinska Hosp, Canc Ctr Karolinska, Dept Oncol Pathol Cellular & Mol Tumor Pathol, S-17176 Stockholm, Sweden.	Armando.Bartolazzi@cck.ki.se	MARANDINO, FERDINANDO/AAB-2537-2019; Bartolazzi, Armando/K-9708-2016	Bartolazzi, Armando/0000-0001-7820-5127				Baloch ZW, 1998, THYROID, V8, P565, DOI 10.1089/thy.1998.8.565; Bartolazzi A, 2000, LANCET, V355, P1661, DOI 10.1016/S0140-6736(00)02233-9; CARAWAY NP, 1993, DIAGN CYTOPATHOL, V9, P345, DOI 10.1002/dc.2840090320; CHIARIOTTI L, 1992, ONCOGENE, V7, P2507; EISENBERG BL, 1989, ARCH SURG-CHICAGO, V124, P1045; ERMAK G, 1995, CANCER RES, V55, P4594; Fernandez PL, 1997, J PATHOL, V181, P80; Gasbarri A, 1999, J CLIN ONCOL, V17, P3494, DOI 10.1200/JCO.1999.17.11.3494; Gu J, 1998, PATHOL INT, V48, P184, DOI 10.1111/j.1440-1827.1998.tb03891.x; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HALL TL, 1989, CANCER, V63, P718, DOI 10.1002/1097-0142(19890215)63:4<718::AID-CNCR2820630420>3.0.CO;2-N; HEDINGER CE, 1993, SCHWEIZ MED WSCHR, V123, P1673; Inohara H, 1999, CANCER, V85, P2475, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2475::AID-CNCR25>3.3.CO;2-T; Kini SR, 1987, GUIDE CLIN ASPIRATIO, V3; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; NUNEZ C, 1989, PATHOL ANNU, V24, P161; Orlandi F, 1998, CANCER RES, V58, P3015; Ponta H., 1998, FRONT BIOSCI, V3, P650; Raber W, 1997, WIEN KLIN WOCHENSCHR, V109, P116; Rosai J., 1992, ATLAS TUMOR PATHOL, P1; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; SCLAFANI AP, 1993, LARYNGOSCOPE, V103, P845; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sidawy MK, 1997, CANCER CYTOPATHOL, V81, P253, DOI 10.1002/(SICI)1097-0142(19970825)81:4<253::AID-CNCR7>3.0.CO;2-Q; SILVERMAN JF, 1986, CANCER-AM CANCER SOC, V57, P1164, DOI 10.1002/1097-0142(19860315)57:6<1164::AID-CNCR2820570617>3.0.CO;2-S; TAKASHIMA S, 1992, RADIOLOGY, V185, P125, DOI 10.1148/radiology.185.1.1523294; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377; Wirtschafter A, 1997, LARYNGOSCOPE, V107, P95, DOI 10.1097/00005537-199701000-00019; XU XC, 1995, AM J PATHOL, V147, P815	30	318	346	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1644	1650		10.1016/S0140-6736(00)04817-0	http://dx.doi.org/10.1016/S0140-6736(00)04817-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425367				2022-12-01	WOS:000168901600008
J	Witmer, LM				Witmer, LM			Nostril position in dinosaurs and other vertebrates and its significance for nasal function	SCIENCE			English	Article								Many dinosaurs have enormous and complicated bony nasal apertures. Functional interpretation requires knowledge of the Location of the external opening in the skin. Traditionally, the fleshy nostril of dinosaurs has been placed in the back of the bony opening, but studies of extant dinosaur relatives suggest that it is located far forward. Narial blood supply and cavernous tissue corroborate the rostra[ position in dinosaurs. A rostra[ nostril was, and remains, a virtually invariant rule of construction among Amniota, which has consequences for (I) nasal airstreaming, and hence various physiological parameters, and (ii) the collection of behaviorally relevant circumoral odorants.	Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Witmer, LM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	witmer@exchange.oucom.ohiou.edu						Aas-Hansen O, 2000, AM J PHYSIOL-REG I, V279, pR1190; BAKKER RT, 1971, NATURE, V229, P172, DOI 10.1038/229172a0; BANG B G, 1971, Acta Anatomica, V79, P1; BAUMEL JJ, 1983, ZOOMORPHOLOGY, V102, P215, DOI 10.1007/BF00310349; BELLAIRS AD, 1949, J ANAT, V83, P116; BELLAIRS AD, 1953, J ANAT, V87, P367; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; Cope ED, 1878, AM NAT, V12, P71, DOI [10.1086/272033., DOI 10.1086/272033]; DAWES J D K, 1952, J Laryngol Otol, V66, P583, DOI 10.1017/S0022215100048143; DAWES JDK, 1953, J ANAT, V87, P311; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; HUNTLEY AC, 1984, J EXP BIOL, V113, P447; LAURENT RS, 1994, J EXP BIOL, V194, P329; MALAN M. E., 1946, ANN UNIV STELLENBOSCH REEKS A, V24A, P69; Marsh O., 1883, AM J SCI, V26, P81; Marsh O. C., 1884, AM J SCI 3, V158, P161, DOI DOI 10.2475/AJS.S3-27.158.161; OSBORN HF, 1898, B AM MUS NAT HIST, V10, P219; OSTROM JH, 1961, AM MUSEUM NATURAL HI, V122, P33; Owen R., 1875, PALAEONTOGRAPHICAL S, V29, P15; PARSONS TS, 1970, BIOLOGY REPTILIA, V2, P99; PRATT CWM, 1948, P ZOOL SOC LOND, V118, P171; REHOREK SJ, 2001, 2001 ANN M AM SOC IC; Ruben JA, 1996, ANIMALS TEMPERATURE, P347; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Sedlmayr Jayc C., 1999, Journal of Vertebrate Paleontology, V19, p74A; STEBBINS RC, 1948, AM J ANAT, V83, P183, DOI 10.1002/aja.1000830202; Walker WF, 1959, COPEIA, V1959, P257, DOI [10.2307/1440406, DOI 10.2307/1440406]; Ward S, 1999, J EXP BIOL, V202, P1589; Witmer L. M., 1999, Journal of Vertebrate Paleontology, V19, p85A; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 1999, J ZOOL, V249, P249, DOI 10.1017/S0952836999009991; Witmer LM, 2001, NAT HIST, V110, P64; WITMER LM, 1997, MEM SOC VERTEBR PALE, V17, P173	35	37	37	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					850	853		10.1126/science.1062681	http://dx.doi.org/10.1126/science.1062681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486085				2022-12-01	WOS:000170241000041
J	Tercero, JA; Diffley, JFX				Tercero, JA; Diffley, JFX			Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint	NATURE			English	Article							CEREVISIAE CHROMOSOME-VI; SACCHAROMYCES-CEREVISIAE; S-PHASE; BUDDING YEAST; ORIGINS; ACTIVATION; INITIATION; SEQUENCES; TELOMERES; PROTEIN	The checkpoint kinase proteins Mec1 and Rad53 are required in the budding yeast, Saccharomyces cerevisiae, to maintain cell viability in the presence of drugs causing damage to DNA or arrest of DNA replication forks(1-3). It is thought that they act by inhibiting cell cycle progression, allowing time for DNA repair to take place. Mec1 and Rad53 also slow S phase progression in response to DNA alkylation(4), although the mechanism for this and its relative importance in protecting cells from DNA damage have not been determined. Here we show that the DNA-alkylating agent methyl methanesulphonate (MMS) profoundly reduces the rate of DNA replication fork progression; however, this moderation does not require Rad53 or Mec1. The accelerated S phase in checkpoint mutants(4), therefore, is primarily a consequence of inappropriate initiation events(5-7). Wild-type cells ultimately complete DNA replication in the presence of MMS. In contrast, replication forks in checkpoint mutants collapse irreversibly at high rates. Moreover, the cytotoxicity of MMS in checkpoint mutants occurs specifically when cells are allowed to enter S phase with DNA damage. Thus, preventing damage-induced DNA replication fork catastrophe seems to be a primary mechanism by which checkpoints preserve viability in the face of DNA alkylation.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England		Diffley, JFX (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.		Tercero, José Antonio/D-7489-2016	Diffley, John/0000-0001-5184-7680; Tercero, Jose Antonio/0000-0003-4829-3570				Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Longhese MP, 2000, GENETICS, V155, P1577; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; SCHWARTZ JL, 1989, MUTAT RES, V216, P111, DOI 10.1016/0165-1161(89)90011-3; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	22	547	557	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					553	557		10.1038/35087607	http://dx.doi.org/10.1038/35087607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484057				2022-12-01	WOS:000170202900049
J	Tochio, H; Tsui, MMK; Banfield, DK; Zhang, MJ				Tochio, H; Tsui, MMK; Banfield, DK; Zhang, MJ			An autoinhibitory mechanism for nonsyntaxin SNARE proteins revealed by the structure of Ykt6p	SCIENCE			English	Article							N-TERMINAL DOMAIN; MEMBRANE-FUSION; COMPLEX; NMR; EXOCYTOSIS; PROGRAM; TRANSPORT; SYNTAXIN; YEAST; SSO1P	Ykt6p is a nonsyntaxin SNARE implicated in multiple intracellular membrane trafficking steps. Here we present the structure of the NH2-terminal domain of Ykt6p (Ykt6pN, residues 1 to 140). The structure of Ykt6pN differed entirety from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin. Like some syntaxins, Ykt6p adopted a folded back conformation in which Ykt6pN bound to its COOH-terminal core domain. The NH2-terminal domain plays an important biological rote in the function of Ykt6p, which in vitro studies revealed to include influencing the kinetics and proper assembly of SNARE complexes.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Banfield, DK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.		Tochio, Hidehito/GWV-0429-2022; Tochio, Hidehito/F-6109-2011; Tsui, Man-kin/E-9612-2010	Tochio, Hidehito/0000-0003-3843-3330; Zhang, Mingjie/0000-0001-9404-0190				BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GOLEMIS E, 1996, INTERACTION TRAP 2 H; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson M, 2000, NAT STRUCT BIOL, V7, P894; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOCHIO H, UNPUB; Tsui MMK, 2000, J CELL SCI, V113, P145; Tsui MMK, 2001, MOL BIOL CELL, V12, P521, DOI 10.1091/mbc.12.3.521; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435	33	106	108	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					698	702		10.1126/science.1062950	http://dx.doi.org/10.1126/science.1062950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474112				2022-12-01	WOS:000170204600055
J	Wadsworth, JDF; Joiner, S; Hill, AF; Campbell, TA; Desbruslais, M; Luthert, PJ; Collinge, J				Wadsworth, JDF; Joiner, S; Hill, AF; Campbell, TA; Desbruslais, M; Luthert, PJ; Collinge, J			Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay	LANCET			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; FATAL FAMILIAL INSOMNIA; BLOOD-TRANSFUSION; STRAIN VARIATION; TRANSGENIC MICE; TONSIL BIOPSY; BSE AGENT; SCRAPIE; INFECTIVITY	Background Variant Creutzfeldt-Jakob disease (vCJD) has a pathogenesis distinct from other forms of human prion disease: disease-related prion protein (PrP(Sc)) is readily detectable in lymphoreticular tissues. Quantitation of risk of secondary transmission, and targeting of risk reduction strategies, is limited by lack of knowledge about relative prion titres in these and other peripheral tissues, the unknown prevalence of preclinical vCJD, and a transmission barrier which limits the sensitivity of bioassay. We aimed to improve immunoblotting methods for high sensitivity detection of PrP(Sc) to investigate the distribution of PrP(Sc) in a range of vCJD tissues. Methods We obtained tissues at necropsy from four patients with neuropathologically confirmed vCJD and from individuals without neurological disease. Tissues were analysed by sodium phosphotungstic acid precipitation of PrP(Sc) and western blotting using high sensitivity enhanced chemiluminescence. Findings We could reliably detect PrP(Sc) in the equivalent of 50 nL 10% vCJD brain homogenate, with a maximum limit of detection equivalent to 5 nl. PrP(Sc) could be detected in tissue homogenates when present at concentrations 10(4)-10(5) fold lower than those reported in brain. Tonsil, spleen, and lymph node were uniformly positive for PrP(Sc) at concentrations in the range of 0.1-15% of those found in brain: the highest concentrations were consistently seen in tonsil. PrP(Sc) was readily detected in the retina and proximal optic nerve of vCJD eye at levels of 2.5 and 25%, respectively of those found in brain. Other peripheral tissues studied were negative for PrP(Sc) with the exception of low concentrations in rectum, adrenal gland, and thymus from a single patient with vCJD. vCJD appendix and blood (Buffy coat fraction) were negative for PrP(Sc) at this level of assay sensitivity. Interpretation We have developed a highly sensitive immunoblot method for detection of PrP(Sc) in vCJD tissues that can be used to provide an upper limit on PrP(Sc) concentrations in peripheral tissues, including blood, to inform risk assessment models. Rectal and other gastrointestinal tissues should be further investigated to assess risk of iatrogenic transmission via biopsy instruments. Ophthalmic surgical instruments used in procedures involving optic nerve and the posterior segment populations; of the eye, in particular the retina, might represent a potential risk for iatrogenic transmission of vCJD. Tonsil is the tissue of choice for diagnostic biopsy and for population screening of surgical tissues to assess prevalence of preclinical vCJD infection within the UK and other populations.	Imperial Coll Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England; Imperial Coll Sch Med St Marys, Dept Neurogenet, London W2 1PG, England; UCL, Inst Ophthalmol, Dept Pathol, London EC1V 9EL, England	Imperial College London; Imperial College London; University of London; University College London	Collinge, J (corresponding author), Imperial Coll Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England.	pacollinge@ic.ac.uk	Hill, Andrew F./AAH-2854-2020; Hill, Andrew/GZL-4124-2022; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew/0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Wadsworth, Jonathan/0000-0002-4797-2259; Luthert, Philip/0000-0001-7276-6898	Medical Research Council [MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*ADV COMM DANG PAT, 1998, TRANSM SPONG ENC AG; Barbara J, 1998, BRIT MED J, V316, P717, DOI 10.1136/bmj.316.7133.717; BERNOULLI C, 1977, LANCET, V1, P478; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUDKA H, 1995, BRAIN PATHOL, V5, P319, DOI 10.1111/j.1750-3639.1995.tb00609.x; BUELER H, 1993, CELL, V73, P1399; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fraser JR, 1996, J GEN VIROL, V77, P2663, DOI 10.1099/0022-1317-77-10-2663; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill DP, 1997, DEV BRAIN RES, V102, P53, DOI 10.1016/S0165-3806(97)00076-X; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; Wells GAH, 1999, VET REC, V144, P292, DOI 10.1136/vr.144.11.292; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	47	558	583	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					171	180		10.1016/S0140-6736(01)05403-4	http://dx.doi.org/10.1016/S0140-6736(01)05403-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476832				2022-12-01	WOS:000169967100008
J	Calzada, A; Sacristan, M; Sanchez, E; Bueno, A				Calzada, A; Sacristan, M; Sanchez, E; Bueno, A			Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ANAPHASE-PROMOTING COMPLEX; BUDDING YEAST; DNA-REPLICATION; MCM PROTEINS; S-PHASE; PROTEOLYSIS; GENES; CDK; ORIGINS	Exit from mitosis requires the inactivation of mitotic cyclin-dependent kinases (CDKs). In the budding yeast, Saccharomyces cerevisiae, inactivation of CDKs during late mitosis involves degradation of B-type cyclins as well as direct inhibition of cyclin-CDK complexes by the CDK-inhibitor protein Sic1 (refs 1-3). Several striking similarities exist between Sic1 and Cdc6, a DNA replication factor essential for the formation of pre-replicative complexes at origins of DNA replication(4-9). Transcription of both genes is activated during late mitosis by a process dependent on Swi5 (ref. 10). Like Sic1, Cdc6 binds CDK complexes in vivo(11,12) and downregulates them in vitro(11). Here we show that Cdc6, like Sic1, also contributes to inactivation of CDKs during late mitosis in S. cerevisiae. Deletion of the CDK-interacting domain of Cdc6 does not inhibit the function of origins of DNA replication during S phase, but instead causes a delay in mitotic exit; this delay is accentuated in the absence of Sic1 or of cyclin degradation. By contributing to mitotic exit and inactivation of CDKs, Cdc6 helps to create the conditions that are required for its subsequent role in the formation of pre-replicative complexes at origins of DNA replication.	Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Dept Genet & Microbiol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bueno, A (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Campus Miguel de Unamuno, Salamanca, Spain.		Sacristan, Maria/Y-4923-2019; Sacristán, María P/A-9587-2016; Bueno, Avelino/A-9505-2016; Calzada, Arturo/M-1168-2014; Sánchez, Elisa/Z-3780-2019	Sacristan, Maria/0000-0003-2314-8430; Sacristán, María P/0000-0003-2314-8430; Bueno, Avelino/0000-0002-0362-4391; Calzada, Arturo/0000-0002-3190-688X; 				Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; Detweiler CS, 1997, J CELL SCI, V110, P753; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Mizushima T, 2000, GENE DEV, V14, P1631; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pichler S, 1997, EMBO J, V16, P5988, DOI 10.1093/emboj/16.19.5988; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; ZWERSCHKE W, 1994, J BIOL CHEM, V269, P23352	26	60	62	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					355	358		10.1038/35085610	http://dx.doi.org/10.1038/35085610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460169				2022-12-01	WOS:000169918200052
J	Lindgren, E; Gustafson, R				Lindgren, E; Gustafson, R			Tick-borne encephalitis in Sweden and climate change	LANCET			English	Article							IXODES-SCAPULARIS ACARI; TEMPERATURE; IXODIDAE; DISEASE; RICINUS	Background The incidence of tick-borne encephalitis (TBE) in Sweden has substantially increased since the mid-1980s. During the same period the climate has become milder and ticks have become more abundant. We investigated whether there is a link between the change in climate and the increase in incidence of TEE. Methods Since the late 1950s all cases of encephalitis admitted in Stockholm County have been serologically tested for TEE. We analysed the period 1960-98 with multiple regressions. The number of days per season with temperatures of known importance for tick prevalence and pathogen transmission were studied. 2 years of temperature data were related to each TEE incidence rate to account for the tick's long life-span. Findings Increases in disease incidence was significantly related (R-2=0.58; p<0.0001) to a combination of two consecutive mild winters, temperatures favouring spring development (8-10<degrees>C) and extended autumn activity (5-8 degreesC) in the year prior to the incidence year, and temperatures allowing tick activity (5-8 degreesC) early in the incidence year. Interpretations The findings indicate that the increase in TBE incidence since the mid-1980s is related to the period's change towards milder winters and early arrival of spring. Other factors may have influenced TBE incidence such as more people in endemic locations, and increases in host animal populations; factors which are partly climate related. Access to TBE vaccination since 1986 and increased awareness of ticks might have caused an underestimation of the links found. Our findings also suggest that the incidence of other tick-borne zoonoses might have been affected by the milder climate.	Stockholm Univ, Dept Syst Ecol Nat Resources Management, SE-10691 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Div Clin Immunol, Dept Immunol Microbiol Pathol & Infect Dis, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Lindgren, E (corresponding author), Stockholm Univ, Dept Syst Ecol Nat Resources Management, SE-10691 Stockholm, Sweden.							Balashov Y.S., 1972, MISC PIB ENTOMOL SOC, V8, P161; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Berry MO, 1981, HDB SNOW, P32; Bjoersdorff A, 1999, SCAND J INFECT DIS, V31, P51, DOI 10.1080/00365549950161880; DANIEL M, 1993, ACAROLOGIA, V34, P105; DUFFY DC, 1994, J MED ENTOMOL, V31, P178, DOI 10.1093/jmedent/31.1.178; FUJIMOTO K, 1994, JPN J SANIT ZOOL, V1, P333; GUSTAFSON R, 1994, SCAND J INFECT DI S1, V24, pS181; KAISER R, 1995, LANCET, V345, P463, DOI 10.1016/S0140-6736(95)90452-2; Lindblom U, 1998, EUR J PAIN-LONDON, V2, P1, DOI 10.1016/S1090-3801(98)90040-4; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; *WORLD MET ORG, 1999, STAT STAT GLOB CLIM; Zinyovera MC, 1998, IPCC REGIONAL IMPACA, P149	15	251	262	2	57	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					16	18		10.1016/S0140-6736(00)05250-8	http://dx.doi.org/10.1016/S0140-6736(00)05250-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454371				2022-12-01	WOS:000169710900010
J	Li, LY; Luo, L; Wang, XD				Li, LY; Luo, L; Wang, XD			Endonuclease G is an apoptotic DNase when released from mitochondria	NATURE			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; CASPASE ACTIVATION; MICE LACKING; PROTEIN; FRAGMENTATION; BAX; PATHWAYS; BINDING; BRAIN	Nucleosomal fragmentation of DNA is a hallmark of apoptosis (programmed cell death)(1), and results from the activation of nucleases in cells undergoing apoptosis. One such nuclease, DNA fragmentation factor (DFF, a caspase-activated deoxyribonuclease (CAD) and its inhibitor (ICAD)), is capable of inducing DNA fragmentation and chromatin condensation after cleavage by caspase-3 (refs 2-4). However, although transgenic mice lacking DFF45 or its caspase cleavage site have significantly reduced DNA fragmentation(5,6), these mice still show residual DNA fragmentation and are phenotypically normal(5-7). Here we report the identification and characterization of another nuclease that is specifically activated by apoptotic stimuli and is able to induce nucleosomal fragmentation of DNA in fibroblast cells from embryonic mice lacking DFF. This nuclease is endonuclease G (endoG), a mitochondrion-specific nuclease that translocates to the nucleus during apoptosis. Once released from mitochondria, endoG cleaves chromatin DNA into nucleosomal fragments independently of caspases. Therefore, endoG represents a caspase-independent apoptotic pathway initiated from the mitochondria.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu		Wang, Xiaodong/0000-0001-9885-356X				Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Ikeda S, 1997, BIOCHEM BIOPH RES CO, V235, P291, DOI 10.1006/bbrc.1997.6786; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McIlroy D, 2000, GENE DEV, V14, P549; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	30	1271	1347	10	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					95	99		10.1038/35083620	http://dx.doi.org/10.1038/35083620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452314				2022-12-01	WOS:000169644900051
J	Ergon, T; Lambin, X; Stenseth, NC				Ergon, T; Lambin, X; Stenseth, NC			Life-history traits of voles in a fluctuating population respond to the immediate environment	NATURE			English	Article							DENSITY-DEPENDENCE; SMALL MAMMALS; IN-FIELD; CYCLES; PREDATION; DYNAMICS; PATTERNS	Life-history traits relating to growth and reproduction vary greatly among species and populations(1,2) and among individuals within populations(3). In vole populations, body size and age at maturation may vary considerably among locations and among years within the same location(4-8). Individuals in increasing populations are typically larger and start reproduction earlier in the spring than those in declining populations(6-8). The cause of such life-history variation within populations has been subject of much discussion(7,9,10). Much of the controversy concerns whether the memory of past conditions, leading to delayed effects on life-history traits, resides in the environment (for example, predators(11,12), pathogens(13) or food(14,15)) or intrinsically within populations or individuals (age distribution(16,17), physiological state(3), genetic(18) or maternal effects(19,20)). Here we report from an extensive field transplant experiment in which voles were moved before the breeding season between sites that differed in average overwintering body mass. Transplanted voles did not retain the characteristics of their source population, and we demonstrate an over-riding role of the immediate environment in shaping life-history traits of small rodents.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway; Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Oslo; University of Aberdeen	Stenseth, NC (corresponding author), Univ Oslo, Dept Biol, Div Zool, POB 1050 Blindern, N-0316 Oslo, Norway.	x.lambin@abdn.ac.uk; n.c.stenseth@bio.uio.no	Lambin, Xavier/E-8284-2011; Stenseth, Nils Chr./G-5212-2016	Lambin, Xavier/0000-0003-4643-2653; Stenseth, Nils Chr./0000-0002-1591-5399				AGRELL J, 1995, P ROY SOC B-BIOL SCI, V262, P65, DOI 10.1098/rspb.1995.0177; AGRELL J, 1992, CAN J ZOOL, V70, P494, DOI 10.1139/z92-074; Batzli G.O., 1992, WILDLIFE 2001 POPULA; BOONSTRA R, 1994, EVOL ECOL, V8, P196, DOI 10.1007/BF01238250; BOONSTRA R, 1987, EVOLUTION, V41, P929, DOI 10.1111/j.1558-5646.1987.tb05868.x; Burnham K.P., 2002, MODEL SELECTION INFE, DOI DOI 10.1007/B97636; CHITTY D, 1952, PHILOS T ROY SOC B, V236, P505, DOI 10.1098/rstb.1952.0009; Chitty D., 1967, Proceedings of the Ecological Society of Australia, V2, P51; Inchausti P, 1998, J ANIM ECOL, V67, P180, DOI 10.1046/j.1365-2656.1998.00189.x; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Krebs C.J., 1974, ADV ECOL RES, V8, P267, DOI DOI 10.1016/S0065-2504(08)60280-9; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lambin X, 2000, J ANIM ECOL, V69, P106, DOI 10.1046/j.1365-2656.2000.00380.x; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Littell R. C, 1996, SAS SYSTEM MIXED MOD; Mappes T, 1998, OIKOS, V82, P365, DOI 10.2307/3546977; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; NELSON RJ, 1987, AM NAT, V130, P350, DOI 10.1086/284715; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; Roff Derek A., 1992; Soveri T, 2000, COMP IMMUNOL MICROB, V23, P73, DOI 10.1016/S0147-9571(99)00057-0; Stearns S.C., 1992, pi; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; TAST J, 1984, WINTER ECOLOGY SMALL, P59; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042; [No title captured], DOI DOI 10.1016/J.FORECO.2007.08.005	28	98	100	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1043	1045		10.1038/35082553	http://dx.doi.org/10.1038/35082553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429603				2022-12-01	WOS:000169528500046
J	Ochsenbein, AF; Sierro, S; Odermatt, B; Pericin, M; Karrer, U; Hermans, IF; Hemmi, S; Hengartner, H; Zinkernagel, RM				Ochsenbein, AF; Sierro, S; Odermatt, B; Pericin, M; Karrer, U; Hermans, IF; Hemmi, S; Hengartner, H; Zinkernagel, RM			Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction	NATURE			English	Article							ANTIGEN-PRESENTING CELLS; IMMUNE-RESPONSES; LYMPHOID ORGANS; BONE-MARROW; IN-VIVO; LYMPHOCYTES; COSTIMULATION; MICE; REJECTION; MATURATION	The vertebrate immune system has evolved to protect against infections that threaten survival before reproduction. Clinically manifest tumours mostly arise after the reproductive years and somatic mutations allow even otherwise antigenic tumours to evade the attention of the immune system(1-3). Moreover, the lack of immunological co-stimulatory molecules on solid tumours could result in T-cell tolerance(4-8); that is, the failure of T cells to respond. However, this may not generally apply(9,10). Here we report several important findings regarding the immune response to tumours, on the basis of studies of several tumour types. First, tumour-specific induction of protective cytotoxic T cells (CTLs) depends on sufficient tumour cells reaching secondary lymphatic organs early and for a long enough duration. Second, diffusely invading systemic tumours delete CTLs. Third, tumours that stay strictly outside secondary lymphatic organs, or that are within these organs but separated from T cells by barriers, are ignored by T cells but do not delete them. Fourth, co-stimulatory molecules on tumour cells do not influence CTL priming but enhance primed CTL responses in peripheral solid tumours. Last, cross priming of CTLs by tumour antigens, mediated by major histocompatibility complex (MHC) class I molecules of antigen-presenting host cells, is inefficient and not protective. These rules of T-cell induction and maintenance not only change previous views but also rationales for anti-tumour immunotherapy(1,2).	Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Malaghan Inst Med Res, Wellington, New Zealand	University of Zurich; University Zurich Hospital; University of Zurich; Malaghan Institute; Victoria University Wellington	Zinkernagel, RM (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.	adrian.ochsenbein@insel.ch; rolf.zinkernagel@pty.usz.ch	Hermans, Ian/I-3961-2013	Ochsenbein, Adrian/0000-0003-1773-5436				BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; CHEN YM, 1993, MOL CRYST LIQ CRYS B, V4, P71; HAHN H, 1981, REV INFECT DIS, V3, P1221; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HELLSTROM KE, 1995, IMMUNOL REV, V145, P123, DOI 10.1111/j.1600-065X.1995.tb00079.x; Hermans IF, 1998, CANCER RES, V58, P3909; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Maric M, 1998, CANCER RES, V58, P3376; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OLD LJ, 1992, CURR OPIN IMMUNOL, V4, P603, DOI 10.1016/0952-7915(92)90034-C; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Toes REM, 1996, CANCER RES, V56, P3782; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; WU TC, 1995, J EXP MED, V182, P1415, DOI 10.1084/jem.182.5.1415; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	30	420	449	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1058	1064		10.1038/35082583	http://dx.doi.org/10.1038/35082583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429607				2022-12-01	WOS:000169528500050
J	Yu, QY; Geng, Y; Sicinski, P				Yu, QY; Geng, Y; Sicinski, P			Specific protection against breast cancers by cyclin D1 ablation	NATURE			English	Article							TRANSGENIC MICE; CELL-PROLIFERATION; SIGNALING PATHWAY; NEU ONCOGENE; EXPRESSION; RAS; OVEREXPRESSION; TRANSFORMATION; PROGRESSION; GENE	Breast cancer is the most common malignancy among women. Most of these cancers overexpress cyclin D1, a component of the core cell-cycle machinery. We previously generated mice lacking cyclin D1 using gene targeting. Here we report that these cyclin D1-deficient mice are resistant to breast cancers induced by the neu and ras oncogenes. However, animals lacking cyclin D1 remain fully sensitive to other oncogenic pathways of the mammary epithelium, such as those driven by c-myc or Wnt-1. Our analyses revealed that, in mammary epithelial cells, the Neu-Ras pathway is connected to the cell-cycle machinery by cyclin D1, explaining the absolute dependency on cyclin D1 for malignant transformation in this tissue. Our results suggest that an anti-cyclin D1 therapy might be highly specific in treating human breast cancers with activated Neu-Ras pathways.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.							ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; DICKINSON AJ, 1990, OPHTHALMIC PAED GEN, V11, P1, DOI 10.3109/13816819009012942; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; FILMUS J, 1994, ONCOGENE, V9, P3627; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; JANES PW, 1994, ONCOGENE, V9, P3601; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; LUKAS J, 1995, ONCOGENE, V10, P2125; MCINTOSH GG, 1995, ONCOGENE, V11, P885; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257	31	782	818	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1017	1021		10.1038/35082500	http://dx.doi.org/10.1038/35082500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429595				2022-12-01	WOS:000169528500038
J	Brown, CE; Howe, L; Sousa, K; Alley, SC; Carrozza, MJ; Tan, S; Workman, JL				Brown, CE; Howe, L; Sousa, K; Alley, SC; Carrozza, MJ; Tan, S; Workman, JL			Recruitment of HAT complexes by direct activator interactions with the ATM-related tra1 subunit	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; IN-VIVO; TRANSCRIPTIONAL ADAPTER; BASAL TRANSCRIPTION; ESSENTIAL COFACTOR; C-MYC; YEAST; PROTEIN; DOMAIN; BINDING	Promoter-specific recruitment of histone acetyltransferase activity is often critical for transcriptional activation. We present a detailed study of the interaction between the histone acetyltransferase complexes SAGA and NuA4, and transcription activators. We demonstrate by affinity chromatography and photo-cross-linking Label transfer that acidic activators directly interact with Tra1p, a shared subunit of SAGA and NUA4. Mutations within the COOH-terminus of Tra1p disrupted its interaction with activators and resulted in gene-specific transcriptional defects that correlated with Lowered promoter-specific histone acetylation. These data demonstrate that the essential Tra1 protein serves as a common target for activators in both SAGA and NuA4 acetyltransferases.	Penn State Univ, Howard Hughes Med Inst, Althouse Lab 306, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 306, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, Althouse Lab 306, University Pk, PA 16802 USA	Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Workman, JL (corresponding author), Penn State Univ, Howard Hughes Med Inst, Althouse Lab 306, University Pk, PA 16802 USA.			Brown, Christine/0000-0003-4915-8207	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019492] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM19492] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Alley SC, 2000, J AM CHEM SOC, V122, P6126, DOI 10.1021/ja000591t; BALASUBRAMANIAN R, UNPUB; BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; BROWN CM, UNPUB; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Candau R, 1996, J BIOL CHEM, V271, P5237; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Jia MH, 2000, PHYSIOL GENOMICS, V3, P83, DOI 10.1152/physiolgenomics.2000.3.2.83; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; SELLECK W, IN PRESS NATURE STRU; SELLECK W, UNPUB; Sil AK, 1999, MOL CELL BIOL, V19, P7828; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	32	284	288	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2333	2337		10.1126/science.1060214	http://dx.doi.org/10.1126/science.1060214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423663				2022-12-01	WOS:000169455900059
J	Ullah, H; Chen, JG; Young, JC; Im, KH; Sussman, MR; Jones, AM				Ullah, H; Chen, JG; Young, JC; Im, KH; Sussman, MR; Jones, AM			Modulation of cell proliferation by heterotrimeric G protein in Arabidopsis	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; EXPANSION; THALIANA; PATHWAYS; DIVISION; GROWTH; LEAVES	The alpha subunit of a prototypical heterotrimeric GTP-binding protein (G protein), which is encoded by a single gene (GPA 1) in Arabidopsis, is a modulator of plant cell proliferation. gpa1 null mutants have reduced cell division in aerial tissues throughout development. Inducible overexpression of GPA1 in Arabidopsis confers inducible ectopic cell division. GPA1 overexpression in synchronized BY-2 cells causes premature advance of the nuclear cycle and the premature appearance of a division wall, Results from loss of function and ectopic expression and activation of GPA1 indicate that this subunit is a positive modulator of cell division in plants.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Wisconsin, Cell & Mol Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201				Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dhanasekaran N, 1998, ONCOGENE, V17, P1383, DOI 10.1038/sj.onc.1202242; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; FRANCIS D, 1998, PORTLAND PRESS RES M; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HABER AH, 1962, AM J BOT, V49, P583, DOI 10.2307/2439715; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Kim GT, 1999, P NATL ACAD SCI USA, V96, P9433, DOI 10.1073/pnas.96.16.9433; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LAMORTE VJ, 1992, J BIOL CHEM, V267, P691; Liebmann C, 2000, CURR MED CHEM, V7, P911, DOI 10.2174/0929867003374589; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5	28	277	311	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2066	2069		10.1126/science.1059040	http://dx.doi.org/10.1126/science.1059040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408654	Green Submitted			2022-12-01	WOS:000169284700044
J	Yoo, BC; Lubec, G				Yoo, BC; Lubec, G			Neurobiology - p25 protein in neurodegeneration	NATURE			English	Article							ALZHEIMERS-DISEASE; P35; ACTIVATOR; CALPAIN; CDK5; CLEAVAGE		Univ Vienna, Dept Pediat, A-1090 Vienna, Austria	University of Vienna	Yoo, BC (corresponding author), Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.			Lubec, Gert/0000-0002-6333-9461				Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359	7	74	80	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					763	764		10.1038/35081146	http://dx.doi.org/10.1038/35081146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459045				2022-12-01	WOS:000169246400034
J	Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Cobbe, SM				Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Cobbe, SM			Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study	BRITISH MEDICAL JOURNAL			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; EMERGENCY MEDICAL TECHNICIANS; AMERICAN-HEART-ASSOCIATION; HEALTH-PROFESSIONALS; CLINICAL-EXPERIENCE; UTSTEIN STYLE; MANAGEMENT; STATEMENT; SCOTLAND; EFFICACY	Objectives To determine the association between ambulance response time and survival from out of hospital cardiopulmonary arrest and to estimate the effect of reducing response times. Design Cohort study. Setting Scottish Ambulance Service. Subjects All out of hospital cardiopulmonary arrests due to cardiac disease attended by the Scottish Ambulance Service during May 1991 to March 1998. Main outcome measures Survival rate to hospital discharge and potential improvement from reducing response times. Results Of 13 822 arrests not witnessed by ambulance crews but attended by them within 15 minutes, complete data were available for 10 554 (76%). Of these patients, 653 (6%) survived to hospital discharge. After other significant covariates were adjusted for, shorter response time was significantly associated with increased probability of receiving defibrillation and survival to discharge among those defibrillated. Reducing the 90th centile for response time to 8 minutes increased the predicted survival to 8%, and reducing it to 5 minutes increased survival to 10-11% (depending on the model used). Conclusions Reducing ambulance response times to 5 minutes could almost double the survival rate for cardiac arrests not witnessed by ambulance crews.	Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Cobbe, SM (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.		Ford, Ian/ABE-6145-2020	Pell, Jill/0000-0002-8898-7035				BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; COBB LA, 1992, CIRCULATION, V85, P98; COBBE SM, 1991, BRIT MED J, V302, P1517, DOI 10.1136/bmj.302.6791.1517; CUMMINS RO, 1987, JAMA-J AM MED ASSOC, V257, P1605, DOI 10.1001/jama.257.12.1605; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1989, ANN EMERG MED, V18, P1269, DOI 10.1016/S0196-0644(89)80257-4; Dracup K, 1997, ANN INTERN MED, V126, P645, DOI 10.7326/0003-4819-126-8-199704150-00010; Evans T, 1998, BMJ-BRIT MED J, V316, P1031; Kuisma M, 1996, HEART, V76, P18, DOI 10.1136/hrt.76.1.18; *NHS, 1996, REV AMB PERF STAND F; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Norris RM, 1998, BMJ-BRIT MED J, V316, P1065; Rayner M, 1998, CORONARY HEART DIS S; SEDGWICK ML, 1992, RESUSCITATION, V24, P73, DOI 10.1016/0300-9572(92)90175-C; STULTS KR, 1986, CIRCULATION, V73, P701, DOI 10.1161/01.CIR.73.4.701; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; WEAVER WD, 1986, AM J CARDIOL, V57, P1017, DOI 10.1016/0002-9149(86)90667-3; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101	19	164	165	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1385	1388		10.1136/bmj.322.7299.1385	http://dx.doi.org/10.1136/bmj.322.7299.1385			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397740	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-01	WOS:000169284600014
J	Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV				Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV			Strategies to decrease tuberculosis in US homeless populations - A computer simulation model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; DIRECTLY OBSERVED THERAPY; UNITED-STATES; ISONIAZID PROPHYLAXIS; HIV; SHELTER; TRANSMISSION; PREVENTION; RESISTANT	Context The rate of tuberculosis (TB) among US homeless persons maybe 20 times that of the general adult population. Studies suggest that the majority of urban homeless TB cases are attributable to ongoing transmission of TB. Optimal TB-control strategies in both chronically and transiently homeless populations are not known. Objective To examine the effects of TB-control strategies on projected TB cases and deaths in US homeless populations using a computer-based simulation model. Design, Setting, and Population The US general population and a theoretical population of 2 million homeless individuals in 1995 were divided into 18 clinical states based on the risk for or presence of TB and human immunodeficiency virus (HIV) infection in a semi-Markov model. Main Outcome Measures Prevalence of transiently and chronically homeless individuals with active TB and deaths from TB as a function of public health measures taken to control and eliminate TB, including improvement of treatment effectiveness, improvement in access to treatment, and vaccination with BCG. Results A 10% increase in access to treatment among homeless persons with active TB produced larger declines in predicted TB cases and deaths after 10 years (cases and deaths among chronically homeless persons decreased 12.5% and 19.8% and among transiently homeless persons dropped 35.9% and 32.4%, respectively) than improvements in the effectiveness of treatment programs (cases and deaths among chronically homeless per-sons declined 7.2% and 3.1% and among transiently homeless persons dropped 10.9% and 4.1%, respectively). A 10% increase in access to treatment among homeless persons with latent TB infection led to a 6.7% decline in TB among chronically homeless persons and a 5.7% decline among transiently homeless persons, while a 10% improvement in effectiveness of treatment for latent TB infection was associated with declines of 3.0% and 3.3%, respectively. When treatment for latent TB infection was modeled to be the same in vaccinated and nonvaccinated populations, BCG vaccination led to TB case declines of 15.4% and 21.5% in chronically and transiently homeless populations, respectively. Conclusions Overcoming barriers faced by homeless individuals in accessing TB treatment programs will be crucial to reducing the burden of TB in this high-risk group. Increased treatment access, improvement in the effectiveness of treatment programs, and BCG vaccination of HIV-negative homeless individuals have the best chance to markedly decrease TB morbidity and mortality.	Channing Labs, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Off Provost, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University	Brewer, TF (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	timothy.brewer@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Heymann, Jody/0000-0003-0008-4198	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001444] Funding Source: NIH RePORTER; NIAID NIH HHS [1K08 AI01444-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P13; Barnes PF, 1996, JAMA-J AM MED ASSOC, V275, P305, DOI 10.1001/jama.275.4.305; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bock NN, 1998, INT J TUBERC LUNG D, V2, P124; Brewer TF, 1996, JAMA-J AM MED ASSOC, V276, P1898, DOI 10.1001/jama.276.23.1898; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Burman WJ, 1997, CHEST, V111, P1168, DOI 10.1378/chest.111.5.1168; BURT MR, 1999, HOMELESSNESS PROGRAM; CDC, 1999, REP TUB US 1998, P1; *CDCP, 1992, MMWR-MORBID MORTAL W, V41; *CDCP, 2001, NAT IMM SURV Q3 1999; *CDCP, 1996, REP TUB US 1995, P26; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; COMSTOCK GW, 1976, PUBLIC HEALTH REP, V91, P276; COUNTS GW, 1984, REV INFECT DIS, V6, P640; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Diez E, 1996, TUBERCLE LUNG DIS, V77, P420, DOI 10.1016/S0962-8479(96)90114-8; ElSadr W, 1996, AM J PUBLIC HEALTH, V86, P1146, DOI 10.2105/AJPH.86.8_Pt_1.1146; Etkind S, 1991, Semin Respir Infect, V6, P273; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gallagher TC, 1997, MED CARE, V35, P814, DOI 10.1097/00005650-199708000-00007; GEITER L, 2000, ENDING NEGLECT ELIMI; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gelberg L, 1996, J GEN INTERN MED, V11, P156, DOI 10.1007/BF02600268; Gelberg L, 1997, J GEN INTERN MED, V12, P25, DOI 10.1007/s11606-006-0004-4; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Gordin FM, 1996, AM J RESP CRIT CARE, V154, P1478, DOI 10.1164/ajrccm.154.5.8912768; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; HOBBY GL, 1974, AM REV RESPIR DIS, V110, P95; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P613; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; LeBaron CW, 1998, ARCH PEDIAT ADOL MED, V152, P327; LINK B, 1995, AM J ORTHOPSYCHIAT, V65, P347, DOI 10.1037/h0079653; LoBue PA, 1999, CHEST, V115, P218, DOI 10.1378/chest.115.1.218; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; NAZARSTEWART V, 1992, AM REV RESPIR DIS, V146, P57, DOI 10.1164/ajrccm/146.1.57; NOLAN CM, 1991, AM REV RESPIR DIS, V143, P257, DOI 10.1164/ajrccm/143.2.257; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Pilote L, 1996, ARCH INTERN MED, V156, P161, DOI 10.1001/archinte.156.2.161; Polesky A, 1996, AM J RESP CRIT CARE, V154, P1473, DOI 10.1164/ajrccm.154.5.8912767; Rendleman NJ, 1999, AM J PREV MED, V17, P108, DOI 10.1016/S0749-3797(99)00052-5; ROSE DN, 1992, J GEN INTERN MED, V7, P589, DOI 10.1007/BF02599196; SALOMON N, 1995, CLIN INFECT DIS, V21, P1245, DOI 10.1093/clinids/21.5.1245; Salomon N, 1997, INT J TUBERC LUNG D, V1, P397; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; SELWYN PA, 1992, JAMA-J AM MED ASSOC, V268, P504, DOI 10.1001/jama.268.4.504; Shlay JC, 1996, SEX TRANSM DIS, V23, P304, DOI 10.1097/00007435-199607000-00011; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; STLAWRENCE JS, 1995, AIDS EDUC PREV, V7, P22; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404; TORRES RA, 1990, ARCH INTERN MED, V150, P2030, DOI 10.1001/archinte.150.10.2030; Tulsky JP, 2000, ARCH INTERN MED, V160, P697, DOI 10.1001/archinte.160.5.697; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; *US C MAYORS, 2001, STAT REP HUNG HOM AM; *WHO, 2000, WHO VACC PREV DIS M; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	72	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					834	842		10.1001/jama.286.7.834	http://dx.doi.org/10.1001/jama.286.7.834			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	462PU	11497538	Bronze			2022-12-01	WOS:000170429600032
J	Vanclay, JK				Vanclay, JK			The effectiveness of parks	SCIENCE			English	Editorial Material									So Cross Univ, POB 157, Lismore, NSW 2480, Australia	Southern Cross University	Vanclay, JK (corresponding author), So Cross Univ, POB 157, Lismore, NSW 2480, Australia.	Jvanclay@scu.edu.au	Vanclay, Jerome/B-9266-2009	Vanclay, Jerome/0000-0002-5639-5481				Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125	1	36	38	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1007	1007		10.1126/science.293.5532.1007a	http://dx.doi.org/10.1126/science.293.5532.1007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498547				2022-12-01	WOS:000170432600001
J	Schwetz, BA				Schwetz, BA			New device for procedures on diseased bypass grafts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-01	WOS:000170188300004
J	McLeod, A				McLeod, A			Changing patterns of teenage pregnancy: population based study of small areas	BRITISH MEDICAL JOURNAL			English	Article								Objectives To measure the impact of socioeconomic deprivation on rates of teenage pregnancy and the extent of local variation in pregnancy rates in Scotland, and to examine how both have changed over time. Design Population study using routine data from hospital records, aggregated for small areas. Subjects Female teenagers resident in Scotland who were treated for pregnancy in an NHS hospital mi either 1981-5 (62 338 teenagers) or 1991-5 (48 514) and who were aged 13-19 at the time of conception. Main outcome measures Pregnancy rates per 1000 in age group and the proportions of pregnancies resulting in a maternity (live birth or stillbirth) in teenagers aged 13-15, 16-17, and 18-19. Results From the 1980s to the 1990s pregnancy rates increased differentially according to levels of local deprivation, as measured by the Carstairs index. Among teenagers aged less than 18 the annual pregnancy rate increased in the most deprived areas (from 7.0 to 12.5 pregnancies per 1000 13-15 year olds and from 67.6 to 84.6 per 1000 16-17 year olds), but there was no change, on average, among teenagers in the most affluent areas (3.8 per 1000 13-15 year olds and 28.9 per 1000 16-17 year olds). Among 18-19 year olds the pregnancy rate decreased in the most affluent areas (from 60.0 to 46.3 per 1000) and increased in the most deprived areas (from 112.4 to 116.0 per 1000). The amount of local variation explained by deprivation more than doubled from the 1980s to the 1990s. The proportion of pregnancies resulting in a maternity was positively associated with level of deprivation, but the effect remained similar over time. Conclusion From the 1980s to the 1990s the difference in rates of teenage pregnancy between more affluent and more deprived areas widened. This has implications for allocating resources to achieve government targets and points to important social processes behind the general increase in the number of teenage pregnancies in Scotland.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	McLeod, A (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.							Carstairs V., 1991, DEPRIVATION HLTH SCO; Churchill D, 2000, BRIT MED J, V321, P486, DOI 10.1136/bmj.321.7259.486; Coory M, 1998, STAT MED, V17, P2625, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2625::AID-SIM957>3.0.CO;2-4; *DEP HLTH, 1992, HLTH NAT; Diamond I, 1999, J ROY STAT SOC A STA, V162, P273, DOI 10.1111/1467-985X.00135; *INF STAT DIV, 1995, SCOTT HLTH STAT 1995; *INF STAT DIV, 1984, SCOTT HLTH STAT 1984; *ISD, 1998, TEEN PREGN SCOTL 15; Rigsby D C, 1998, J Pediatr Adolesc Gynecol, V11, P115; *SCOTT OFF, 1999, TOW HLTH SCOTL; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; *SOC EXCL UN, 1999, TEEN PREGN; StevensSimon C, 1996, J ADOLESCENT HEALTH, V19, P48, DOI 10.1016/1054-139X(95)00281-V	13	46	48	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					199	203		10.1136/bmj.323.7306.199	http://dx.doi.org/10.1136/bmj.323.7306.199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473910	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000170270200017
J	Brooks, CL; Onuchic, JN; Wales, DJ				Brooks, CL; Onuchic, JN; Wales, DJ			Statistical thermodynamics - Taking a walk on a landscape	SCIENCE			English	Editorial Material							TRANSITION-STATE; KINETICS; LIQUIDS; MECHANISMS; PROTEINS; GLASSES		Scripps Res Inst, Dept Mol Biol, Glebe, NSW 2037, Australia; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of California System; University of California San Diego; University of Cambridge	Brooks, CL (corresponding author), Scripps Res Inst, Dept Mol Biol, Glebe, NSW 2037, Australia.	brooks@scripps.edu						ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; BERRY RS, 1987, NATO ASI SER B, V158, P185; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dugourd P, 1997, CHEM PHYS LETT, V267, P186, DOI 10.1016/S0009-2614(97)00062-6; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Finke JM, 2000, BIOCHEMISTRY-US, V39, P15633, DOI 10.1021/bi001307d; Gruebele M, 1999, ANNU REV PHYS CHEM, V50, P485, DOI 10.1146/annurev.physchem.50.1.485; Hardin C, 2000, P NATL ACAD SCI USA, V97, P14235, DOI 10.1073/pnas.230432197; Hirst JD, 1999, PROTEIN ENG, V12, P721, DOI 10.1093/protein/12.9.721; Hummer G, 2001, PROTEINS, V42, P77, DOI 10.1002/1097-0134(20010101)42:1<77::AID-PROT80>3.0.CO;2-#; Klimov DK, 2000, P NATL ACAD SCI USA, V97, P2544, DOI 10.1073/pnas.97.6.2544; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Lacroix E, 1999, CURR OPIN STRUC BIOL, V9, P487, DOI 10.1016/S0959-440X(99)80069-4; Pillardy A, 2001, P NATL ACAD SCI USA, V98, P2329, DOI 10.1073/pnas.041609598; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sciortino F, 2000, J PHYS-CONDENS MAT, V12, P6525, DOI 10.1088/0953-8984/12/29/324; Shea JE, 2000, J CHEM PHYS, V113, P7663, DOI 10.1063/1.1313792; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shimada J, 2001, J MOL BIOL, V308, P79, DOI 10.1006/jmbi.2001.4586; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Skolnick J, 2000, NAT BIOTECHNOL, V18, P283, DOI 10.1038/73723; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Wales DJ, 2000, ADV CHEM PHYS, V115, P1, DOI 10.1002/9780470141748.ch1; Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990	27	154	156	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					612	613		10.1126/science.1062559	http://dx.doi.org/10.1126/science.1062559			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474087				2022-12-01	WOS:000170204600029
J	Sanderson, SL; Cheer, AY; Goodrich, JS; Graziano, JD; Callan, WT				Sanderson, SL; Cheer, AY; Goodrich, JS; Graziano, JD; Callan, WT			Crossflow filtration in suspension-feeding fishes	NATURE			English	Article							FLOW MICROFILTRATION; MEMBRANE FILTRATION; PARTICLE RETENTION; PERMEATE FLUX; MECHANISMS; FILTER; ULTRAFILTRATION; DEPOSITION; TRANSPORT; MIGRATION	Rows of comb-like or tufted gill rakers in the oral cavity of suspension-feeding fishes (for example, herring, anchovies and tilapia) have been thought to serve as (1) non-porous barriers that direct particle-laden water to the sticky oral roof, where particles are retained as water exits from the oral cavity, (2) conventional dead-end filters that sieve particles from water exiting between rakers, or (3) sticky filters that retain particles encountered by a hydrosol filtration mechanism(1-6). Here we present data from computational fluid dynamics and video endoscopy in suspension-feeding fish indicating that the rakers of three distantly related species function instead as a crossflow filter(7,8.) Particles are concentrated inside the oral cavity as filtrate exits between the rakers, but particles are not retained on the rakers. Instead, the high-velocity crossflow along the rakers carries particles away from the raker surfaces and transports the particles towards the oesophagus. This crossflow prevents particles from clogging the gaps between the rakers, and solves the mystery of particle transport from the rakers to the oesophagus.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA; Univ Calif Davis, Inst Theoret Dynam, Davis, CA 95616 USA	William & Mary; University of California System; University of California Davis; University of California System; University of California Davis	Sanderson, SL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	slsand@wm.edu						BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; BOWEN WR, 1995, ADV COLLOID INTERFAC, V56, P141, DOI 10.1016/0001-8686(94)00232-2; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; Chellam S, 1997, ENVIRON SCI TECHNOL, V31, P819, DOI 10.1021/es9605228; Cheryan M, 1998, ULTRAFILTRATION MICR; DREW DA, 1991, CHEM ENG SCI, V46, P3219, DOI 10.1016/0009-2509(91)85023-Q; Gerking SD, 1994, FEEDING ECOLOGY FISH; GIBSON RN, 1988, J FISH BIOL, V32, P949, DOI 10.1111/j.1095-8649.1988.tb05438.x; Goodrich JS, 2000, J FISH BIOL, V56, P858; GREEN G, 1980, DESALINATION, V35, P129, DOI 10.1016/S0011-9164(00)88607-5; HOOGENBOEZEM W, 1991, CAN J FISH AQUAT SCI, V48, P7, DOI 10.1139/f91-002; Kardong K. V, 1998, VERTEBRATES COMP ANA; Koehl M.A.R., 1995, Symposia of the Society for Experimental Biology, V49, P157; LABARBERA M, 1984, AM ZOOL, V24, P71; LANGELAND A, 1995, J FISH BIOL, V47, P719, DOI 10.1006/jfbi.1995.0174; LAUDER GV, 1980, J EXP BIOL, V88, P49; Li H, 1998, J MEMBRANE SCI, V149, P83, DOI 10.1016/S0376-7388(98)00181-1; MUMMERT JR, 1986, T AM FISH SOC, V115, P522, DOI 10.1577/1548-8659(1986)115<522:EOFSOT>2.0.CO;2; NORTON SF, 1993, J EXP BIOL, V176, P11; PORTER MC, 1972, IND ENG CHEM PROD RD, V11, P234, DOI 10.1021/i360043a002; SANDERSON SL, 1991, SCIENCE, V251, P1346, DOI 10.1126/science.251.4999.1346; SANDERSON SL, 1996, J EXP BIOL, V199, P1743; SANDERSON SL, 1993, FLUID DYNAMICS BIOL, P135; Sethi S, 1997, J MEMBRANE SCI, V136, P191, DOI 10.1016/S0376-7388(97)00168-3; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; Tardieu E, 1998, J MEMBRANE SCI, V147, P1, DOI 10.1016/S0376-7388(98)00091-X; Vogel S., 1994, LIFE MOVING FLUIDS P, V2nd ed.; Wiesner MR, 1999, J ENVIRON ENG-ASCE, V125, P1124, DOI 10.1061/(ASCE)0733-9372(1999)125:12(1124); Zeman L. J., 1996, MICROFILTRATION ULTR	29	104	106	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					439	441		10.1038/35086574	http://dx.doi.org/10.1038/35086574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473318				2022-12-01	WOS:000170068200048
J	Gachet, Y; Tournier, S; Millar, JBA; Hyams, JS				Gachet, Y; Tournier, S; Millar, JBA; Hyams, JS			A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; ATF1 TRANSCRIPTION FACTOR; ASYMMETRIC CELL-DIVISION; SCHIZOSACCHAROMYCES-POMBE; BIPOLAR SPINDLE; PROTEIN-KINASE; CYCLE; PROTEOLYSIS; PATHWAY; LOCALIZATION	The accurate segregation of chromosomes at mitosis depends on a correctly assembled bipolar spindle that exerts balanced forces on each sister chromatid(1,2). The integrity of mitotic chromosome segregation is ensured by the spindle assembly checkpoint (SAC) that delays mitosis in response to defective spindle organisation or failure of chromosome attachment(2,3). Here we describe a distinct mitotic checkpoint in the fission yeast, Schizosaccharomyces pombe, that monitors the integrity of the actin cytoskeleton and delays sister chromatid separation, spindle elongation and cytokinesis until spindle poles have been properly oriented. This mitotic delay is imposed by a stress-activated mitogen-activated protein (MAP) kinase pathway but is independent of the anaphase-promoting complex (APC)(4,5).	Natl Inst Med Res, Div Yeast Genet, London NW7 1AA, England; UCL, Dept Biol, London WC1E 6B, England	MRC National Institute for Medical Research; University of London; University College London	Millar, JBA (corresponding author), Natl Inst Med Res, Div Yeast Genet, Ridgeway,Mill Hill, London NW7 1AA, England.	jmillar@nimr.mrc.ac.uk	Gachet, Yannick/AAK-5363-2021	Millar, Jonathan/0000-0002-9930-3989	MRC [MC_U117531948] Funding Source: UKRI; Medical Research Council [MC_U117531948] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALFA CE, 1990, NATURE, V347, P680, DOI 10.1038/347680a0; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703, DOI 10.1074/jbc.270.13.7703; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hagan IM, 1996, CELL MOTIL CYTOSKEL, V34, P69; Hardwick KG, 1999, GENETICS, V152, P509; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	28	135	139	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					352	355		10.1038/35085604	http://dx.doi.org/10.1038/35085604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460168				2022-12-01	WOS:000169918200051
J	Lu, QX; Lemke, G				Lu, QX; Lemke, G			Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family	SCIENCE			English	Article							EXPRESSION ANALYSIS; PROTEIN-S; C-MER; LIGANDS; AXL; ANTIBODIES; SELECTION; CLONING; GAS6	Receptor tyrosine kinases and their Ligands mediate cell-cell communication and interaction in many organ systems, but have not been known to actin this capacity in the mature immune system. We now provide genetic evidence that three closely related receptor tyrosine kinases, Tyro 3, Axl, and Mer, play an essential immunoregulatory role. Mutant mice that lack these receptors develop a severe Lymphoproliferative disorder accompanied by broad-spectrum autoimmunity. These phenotypes are cell nonautonomous with respect to Lymphocytes and result from the hyperactivation of antigen-presenting cells in which the three receptors are normally expressed.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.							Bokarewa MI, 1997, SEMIN HEMATOL, V34, P235; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Daeron M, 1999, CURR TOP MICROBIOL, V244, P1; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; GREVES M, 1999, HAEMATOLOGICA, V84, P32; Hahn BH, 1997, DUBOIS LUPUS ERYTHEM, P69; HESS DC, 1993, J RHEUMATOL, V20, P610; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LU Q, UNPUB; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.iy.10.040192.001455; NEUBAUER A, 1994, BLOOD, V84, P1931; Neubauer A, 1997, LEUKEMIA LYMPHOMA, V25, P91, DOI 10.3109/10428199709042499; Nousari HC, 1999, LANCET, V354, P667, DOI 10.1016/S0140-6736(99)03007-X; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; STUART JM, 1984, ANNU REV IMMUNOL, V2, P199, DOI 10.1146/annurev.iy.02.040184.001215	25	505	553	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					306	311		10.1126/science.1061663	http://dx.doi.org/10.1126/science.1061663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452127				2022-12-01	WOS:000169875200061
J	Kelley, DS; Karson, JA; Blackman, DK; Fruh-Green, GL; Butterfield, DA; Lilley, MD; Olson, EJ; Schrenk, MO; Roe, KK; Lebon, GT; Rivizzigno, P				Kelley, DS; Karson, JA; Blackman, DK; Fruh-Green, GL; Butterfield, DA; Lilley, MD; Olson, EJ; Schrenk, MO; Roe, KK; Lebon, GT; Rivizzigno, P		AT3-60 Shipboard Party	An off-axis hydrothermal vent field near the Mid-Atlantic Ridge at 30 degrees N	NATURE			English	Article							FRACTURE-ZONE; ULTRAMAFIC ROCKS; ENDEAVOR SEGMENT; SERPENTINIZATION; SYSTEMS; CH4; INTERSECTION; CHEMISTRY; HYDROGEN; OFFSETS	Evidence is growing that hydrothermal venting occurs not only along mid-ocean ridges but also on old regions of the oceanic crust away from spreading centres. Here we report the discovery of an extensive hydrothermal field at 30 degrees N near the eastern intersection of the Mid-Atlantic Ridge and the Atlantis fracture zone. The vent field-named 'Lost City'-is distinctly different from all other known sea-floor hydrothermal fields in that it is located on 1.5-Myr-old crust, nearly 15 km from the spreading axis, and may be driven by the heat of exothermic serpentinization reactions between sea water and mantle rocks. It is located on a dome-like massif and is dominated by steep-sided carbonate chimneys, rather than the sulphide structures typical of 'black smoker' hydrothermal fields. We found that vent fluids are relatively cool (40-75 degrees C) and alkaline (pH 9.0-9.8), supporting dense microbial communities that include anaerobic thermophiles. Because the geological characteristics of the Atlantis massif are similar to numerous areas of old crust along the Mid-Atlantic, Indian and Arctic ridges, these results indicate that a much larger portion of the oceanic crust may support hydrothermal activity and microbial life than previously thought.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; ETH Zentrum, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland; Univ Washington, NOAA, Pacific Marine Environm Lab, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Kelley, DS (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.		Matthew, Schrenk/AAH-5682-2020; Butterfield, David/H-3815-2016	Butterfield, David/0000-0002-1595-9279; Schrenk, Matthew/0000-0002-5623-8558				ALLEN DA, 1998, EOS T AM GEOPHYS UN, V79, P58; BARNES I, 1972, CONTRIB MINERAL PETR, V35, P263, DOI 10.1007/BF00371220; BARRIGA FJA, 1998, EOS, V79, P67; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Blackman DK, 1998, J GEOPHYS RES-SOL EA, V103, P21315, DOI 10.1029/98JB01756; BONATTI E, 1980, GEOCHIM COSMOCHIM AC, V44, P1207, DOI 10.1016/0016-7037(80)90074-5; Bougault H, 1998, EARTH PLANET SC LETT, V161, P1, DOI 10.1016/S0012-821X(98)00094-6; BUTTERFIELD DA, 1994, J GEOPHYS RES-SOL EA, V99, P9561, DOI 10.1029/93JB03132; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; Charlou JL, 1998, GEOCHIM COSMOCHIM AC, V62, P2323, DOI 10.1016/S0016-7037(98)00138-0; COLEMAN RG, 1971, GEOL SOC AM BULL, V82, P897, DOI 10.1130/0016-7606(1971)82[897:PAGNOS]2.0.CO;2; Donval J. P., 1997, EOS T AM GEOPHYS UN, V78, P832; DOUVILLE E, 1997, EOS T AM GEOPHYS UN, V78, P832; FORNARI DJ, 1995, AM GEOPHYSICAL UNION, V91, P1; FOUQUET Y, 1977, EOS, V78, P832; Fruh-Green G. L., 1996, P ODP SCI RESULTS, V147, P255, DOI DOI 10.2973/0DP.PR0C.SR.147.016.1996; Fryer P, 1990, P OCEAN DRILLING PRO, V125, P69, DOI DOI 10.2973/ODP.PROC.IR.125.1990; German CR, 1996, EARTH PLANET SC LETT, V138, P93, DOI 10.1016/0012-821X(95)00224-Z; Gracia E, 2000, EARTH PLANET SC LETT, V177, P89, DOI 10.1016/S0012-821X(00)00034-0; HAGGERTY JA, 1987, AM GEOPHYSICAL MONOG, V47, P175; HANNINGTON MD, 1995, AM GEOPHYSICAL UNION, V91, P115; JAMES RH, 1995, GEOCHIM COSMOCHIM AC, V59, P651, DOI 10.1016/0016-7037(95)00003-I; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Karson J. A., 1997, P OCEAN DRILLING PRO, V153, P5; Krasnov S.G., 1995, GEOL SOC LOND SPEC P, V87, P43, DOI 10.1144/GSL.SP.1995.087.01.05; Lagabrielle Y, 1998, GEOPH MONOG SERIES, V106, P153; LILLEY MD, 1993, NATURE, V364, P45, DOI 10.1038/364045a0; MACLEOD G, 1994, ORIGINS LIFE EVOL B, V24, P19, DOI 10.1007/BF01582037; NEAL C, 1983, EARTH PLANET SC LETT, V66, P315, DOI 10.1016/0012-821X(83)90144-9; NEAL C, 1984, MINERAL MAG, V48, P237, DOI 10.1180/minmag.1984.048.347.07; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; RONA PA, 1992, GEOLOGY, V20, P783, DOI 10.1130/0091-7613(1992)020<0783:HCSADA>2.3.CO;2; RUSSELL MJ, 1996, J GEOL SOC LONDON, V153, P1; SAKAI R, 1990, EARTH PLANET SC LETT, V100, P291, DOI 10.1016/0012-821X(90)90192-Z; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, P1; SEEWALD JS, 1990, EARTH PLANET SC LETT, V101, P388, DOI 10.1016/0012-821X(90)90168-W; Shock EL, 1998, J GEOPHYS RES-PLANET, V103, P28513, DOI 10.1029/98JE02142; Tivey MK, 1999, J GEOPHYS RES-SOL EA, V104, P22859, DOI 10.1029/1999JB900107; VANDOVER CL, 2000, ECOLOGY DEEP SEA HYD, P63; VONDAMM KL, 1995, AM GEOPHYSICAL UNION, V91, P222; Wetzel LR, 2000, J GEOPHYS RES-SOL EA, V105, P8319, DOI 10.1029/1999JB900382	42	819	878	7	263	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					145	149		10.1038/35084000	http://dx.doi.org/10.1038/35084000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449263				2022-12-01	WOS:000169778700041
J	Davare, MA; Avdonin, V; Hall, DD; Peden, EM; Burette, A; Weinberg, RJ; Horne, MC; Hoshi, T; Hell, JW				Davare, MA; Avdonin, V; Hall, DD; Peden, EM; Burette, A; Weinberg, RJ; Horne, MC; Hoshi, T; Hell, JW			A beta(2) adrenergic receptor signaling complex assembled with the Ca2+ channel Ca(v)1.2	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; NEURONAL CLASS-C; CALCIUM CHANNELS; HIPPOCAMPAL-NEURONS; ADENYLYL-CYCLASE; ALPHA-1 SUBUNIT; GAMMA-SUBUNITS; ION CHANNELS; PHOSPHORYLATION; LOCALIZATION	The existence of a large number of receptors coupled to heterotrimeric guanine nucleotide binding proteins (G proteins) raises the question of how a particular receptor selectively regulates specific targets. We provide insight into this question by identifying a prototypical macromolecular signaling complex. The beta (2) adrenergic receptor was found to be directly associated with one of its ultimate effecters, the class C L-type calcium channel Ca(v)1.2. This complex also contained a C protein, an adenylyl cyclase, cyclic adenosine monophosphate-dependent protein kinase, and the counterbalancing phosphatase PP2A. Our electrophysiological recordings from hippocampal neurons demonstrate highly localized signal transduction from the receptor to the channel. The assembly of this signaling complex provides a mechanism that ensures specific and rapid signaling by a G protein-coupled receptor.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill	Hell, JW (corresponding author), Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.		Hell, Johannes W./P-5085-2019; Weinberg, Richard/AAC-1898-2020; Hall, Duane/ACD-6815-2022	Hall, Duane/0000-0003-2228-0966; Horne, Mary/0000-0002-2799-3212; Peden, Erik/0000-0002-8436-3217; Davare, Monika/0000-0003-1802-7597	NHLBI NIH HHS [HL61645] Funding Source: Medline; NIA NIH HHS [AG17502, AG00213] Funding Source: Medline; NIGMS NIH HHS [GM08688, GM56900] Funding Source: Medline; NINDS NIH HHS [NS39444, NS35563] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056900, T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039444, R01NS035563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017502, R56AG017502] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARSINAI A, 1992, EUR J BIOCHEM, V207, P703, DOI 10.1111/j.1432-1033.1992.tb17098.x; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Horne MC, 1996, IMMUNITY, V4, P145, DOI 10.1016/S1074-7613(00)80679-2; MONS N, 1995, P NATL ACAD SCI USA, V92, P8473, DOI 10.1073/pnas.92.18.8473; Porter NM, 1997, J NEUROSCI, V17, P5629; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; STRADER CD, 1983, P NATL ACAD SCI-BIOL, V80, P1840, DOI 10.1073/pnas.80.7.1840; Taylor JM, 1996, J BIOL CHEM, V271, P3336; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Xiao RP, 1999, CIRC RES, V85, P1092; Ye CI, 2000, BIOPHYS J, V79, P2547, DOI 10.1016/S0006-3495(00)76495-2	27	414	425	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					98	101		10.1126/science.293.5527.98	http://dx.doi.org/10.1126/science.293.5527.98			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441182				2022-12-01	WOS:000169780300037
J	Waelti, P; Dickinson, A; Schultz, W				Waelti, P; Dickinson, A; Schultz, W			Dopamine responses comply with basic assumptions of formal learning theory	NATURE			English	Article							LONG-TERM DEPRESSION; RAT PREFRONTAL CORTEX; BEHAVIORAL REACTIONS; CONDITIONED-STIMULI; MONKEY MIDBRAIN; NEURONS; REWARD; PREDICTION; MECHANISMS; MODEL	According to contemporary learning theories, the discrepancy, or error, between the actual and predicted reward determines whether learning occurs when a stimulus is paired with a reward. The role of prediction errors is directly demonstrated by the observation that learning is blocked when the stimulus is paired with a fully predicted reward. By using this blocking procedure, we show that the responses of dopamine neurons to conditioned stimuli was governed differentially by the occurrence of reward prediction errors rather than stimulus-reward associations alone, as was the learning of behavioural reactions. Both behavioural and neuronal learning occurred predominantly when dopamine neurons registered a reward prediction error at the time of the reward. Our data indicate that the use of analytical tests derived from formal behavioural learning theory provides a powerful approach for studying the role of single neurons in learning.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland; Univ Fribourg, Program Neurosci, CH-1700 Fribourg, Switzerland; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Fribourg; University of Fribourg; University of Cambridge	Schultz, W (corresponding author), Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland.		schultz, wolfram/H-8958-2016	schultz, wolfram/0000-0002-8530-4518				Barto A, 1998, REINFORCEMENT LEARNI, V1st; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Dickinson A., 1980, CONT ANIMAL LEARNING; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; GARCIAMUNOZ M, 1992, NEUROREPORT, V3, P357, DOI 10.1097/00001756-199204000-00017; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Kalman R.E., 1960, T ASME J BASIC ENG, V82, P35, DOI DOI 10.1115/1.3662552; Kamin L, 1969, FUNDAMENTAL ISSUES A, P42; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Mackintosh N.J., 1983, CONDITIONING ASS LEA; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARTIN I, 1991, Q J EXP PSYCHOL-B, V43, P233; Mikhael, 2019, UNIFIED FRAMEWORK DO; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otani S, 1999, J NEUROSCI, V19, P9788; Pavlov IP, 1927, CONDITIONAL REFLEXES; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rauhut AS, 1999, J EXP PSYCHOL ANIM B, V25, P45, DOI 10.1037/0097-7403.25.1.45; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Sutton R.S., 1990, LEARNING COMPUTATION, P497; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; THOMPSON RF, 1991, PERSPECTIVES COGNITI, P25; Thorndike EL, 1911, ANIMAL INTELLIGENCE; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; WIDROW G, 1985, ADAPTIVE SIGNAL PROC; WIDROW G, 1960, I RADIO ENG W ELEC 4, P96; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; [No title captured]	50	690	698	2	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					43	48		10.1038/35083500	http://dx.doi.org/10.1038/35083500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448TB	11452299	Green Submitted			2022-12-01	WOS:000169644900036
J	Kirkham, FJ; Hewes, DKM; Prengler, M; Wade, A; Lane, R; Evans, JPM				Kirkham, FJ; Hewes, DKM; Prengler, M; Wade, A; Lane, R; Evans, JPM			Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease	LANCET			English	Article							OBSTRUCTIVE SLEEP-APNEA; CHILDREN; STROKE; ABNORMALITIES; ANEMIA; RISK; ERYTHROPOIETIN; HEMOGLOBIN; ACTIVATION; PLATELET	Background Central-nervous-system (CNS) events, including strokes, transient ischaemic attacks, and seizures are common in sickle-cell disease. Stroke can be predicted by high velocities in the internal-carotid or middle-cerebral arteries on transcranial doppler ultrasonography. We tested the hypothesis that nocturnal hypoxaemia can predict CNS events better than clinical or haematological features, or transcranial doppler sonography. Methods We screened 95 hospital-based patients with sickle-cell disease (median age 7.7 years [range 1.0-23.1]), but without previous stroke, with transcranial doppler and overnight pulse oximetry. Follow-up continued for a median of 6.01(0.11-8.54) years. Findings 19 patients had CNS events (six ischaemic and one haemorrhagic stroke, eight transient ischaemic attacks, and four seizures). Mean overnight oxygen saturation ([SaO(2)] hazard ratio 0.82 per 1% increase [95% CI 0.71-0.93]; p=0.003) and higher internat-carotid or middle-cerebral artery velocity (1.02 for every increase of 1 cm/s [1.004-1.03]; p=0.009) were independently associated with time to CNS event. After accounting for mean SaO(2), artery velocity, and haemoglobinopathy, high haemoglobin concentration was also associated with an increased risk of CNS event (1.7 per g/dL, [1.18-2.43]; p=0.004). Dips suggestive of obstructive sleep apnoea did not predict CNS events, and adenotonsillectomy seemed to have no effect, although the CI were wide and clinically important effects cannot be excluded. Interpretation Screening for, and appropriate management of, nocturnal hypoxaemia might be a safe and effective alternative to prophylactic blood transfusion for primary prevention of CNS events in sickle-cell disease.	UCL, Inst Child Hlth, Neurosci Unit, London, England; UCL, Inst Child Hlth, Paediat Epidemiol & Biostat Unit, London, England; UCL, Inst Child Hlth, Portex Unit Anaesthesia Intens Care & Resp Med, London, England; UCL, Inst Child Hlth, Dept Haematol, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Kirkham, FJ (corresponding author), Wolfson Ctr Magnet Technol, Mecklenburgh Sq, London WC1N 2AP, England.	F.Kirkham@ich.ucl.ac.uk	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958				Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Appenzeller O, 1998, ARCH NEUROL-CHICAGO, V55, P1007, DOI 10.1001/archneur.55.7.1007; Armstrong FD, 1996, PEDIATRICS, V97, P864; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; Britton TC, 1997, J NEUROL NEUROSUR PS, V63, P808, DOI 10.1136/jnnp.63.6.808; Collett, 2014, MODELLING SURVIVAL D; Dale GL, 1998, LANCET, V352, P566, DOI 10.1016/S0140-6736(97)11506-9; DAVIES SC, 1989, LANCET, V2, P283; Earley CJ, 1998, NEUROLOGY, V51, P169, DOI 10.1212/WNL.51.1.169; Eisensehr I, 1998, NEUROLOGY, V51, P188, DOI 10.1212/WNL.51.1.188; EMBURY SH, 1984, NEW ENGL J MED, V311, P291, DOI 10.1056/NEJM198408023110504; Gadian DG, 2000, J CHILD NEUROL, V15, P279, DOI 10.1177/088307380001500502; GILLARD JH, 1986, J NEUROL NEUROSUR PS, V49, P1025, DOI 10.1136/jnnp.49.9.1025; Inwald DP, 2000, BRIT J HAEMATOL, V111, P474, DOI 10.1046/j.1365-2141.2000.02353.x; Kinney TR, 1999, PEDIATRICS, V103, P640, DOI 10.1542/peds.103.3.640; Kirkham FJ, 2001, ANN NEUROL, V49, P477; LIU JE, 1994, J NEUROL SCI, V123, P6, DOI 10.1016/0022-510X(94)90196-1; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Ohene-Frempong K, 1998, BLOOD, V91, P288; PARTINEN M, 1985, LANCET, V2, P1325; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; RACKOFF WR, 1993, BLOOD, V81, P3422; ROBERTSON PL, 1988, ANN NEUROL, V23, P614, DOI 10.1002/ana.410230615; ROTHMAN SM, 1986, ANN NEUROL, V20, P684, DOI 10.1002/ana.410200606; SAMUELS MP, 1992, ARCH DIS CHILD, V67, P925, DOI 10.1136/adc.67.7.925; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Steen RG, 1999, ANN NEUROL, V45, P279, DOI 10.1002/1531-8249(199903)45:3<279::AID-ANA2>3.0.CO;2-7; Wang WC, 1998, J PEDIATR-US, V132, P994, DOI 10.1016/S0022-3476(98)70397-X	30	183	189	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1656	1659		10.1016/S0140-6736(00)04821-2	http://dx.doi.org/10.1016/S0140-6736(00)04821-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425370				2022-12-01	WOS:000168901600011
J	Packer, C; Pusey, AE; Eberly, LE				Packer, C; Pusey, AE; Eberly, LE			Egalitarianism in female African lions	SCIENCE			English	Article							REPRODUCTIVE SKEW; PANTHERA-LEO; COOPERATION; EVOLUTION; TERRITORIALITY; DOMINANCE; SOCIETIES; CONTESTS	Because most cooperative societies are despotic, it has been difficult to test models of egalitarianism. Female African lions demonstrate a unique form of plural breeding in which companions consistently produce similar numbers of surviving offspring. Consistent with theoretical predictions from models of reproductive skew, female lions are unable to control each other's reproduction because of high costs of fighting and low access to each other's newborn cubs. A female also tacks incentives to reduce her companions' reproduction, because her own survival and reproduction depend on group territoriality and synchronous breeding. Consequently, female relationships are highly symmetrical, and female lions are "free agents" who only contribute to communal care when they have cubs of their own.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.			Eberly, Lynn/0000-0003-4763-330X; Pusey, Anne/0000-0002-2280-8954				BERTRAM BCR, 1975, J ZOOL, V177, P463; Boehm Christopher, 1997, American Naturalist, V150, P100; Brown J. L., 1987, HELPING COMMUNAL BRE; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; COX DR, 1972, J R STAT SOC B, V34, P187; Creel SR, 1991, BEHAV ECOL, V2, P7, DOI 10.1093/beheco/2.1.7; De Luca DW, 2001, ANIM BEHAV, V61, P17, DOI 10.1006/anbe.2000.1559; EMLEN ST, 1982, AM NAT, V119, P40, DOI 10.1086/283889; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Hammerstein P, 1988, EVOL ECOL, V2, P115, DOI 10.1007/BF02067272; Hanby J. P., 1995, SERENGETI, P315; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; Heinsohn R, 1997, ANIM BEHAV, V53, P1143, DOI 10.1006/anbe.1996.0316; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Johnstone RA, 1999, AM NAT, V153, P315, DOI 10.1086/303169; LIMA SL, 1989, AM NAT, V134, P828, DOI 10.1086/285015; Macdonald D. W., 1982, PERSPECTIVES ETHOLOG, P433; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C., 1988, P363; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C., 1985, P173; PACKER C, 1983, ANIM BEHAV, V31, P334, DOI 10.1016/S0003-3472(83)80051-7; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Packer C., 1986, P429; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; PUSEY AE, 1994, PROTECTION ABUSE YOU, P277; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Reeve Hudson K., 1993, P45; Schaller GB., 1972, SERENGETI LION; Silk J.B., 1987, P318; Sober Elliott, 1999, OTHERS EVOLUTION PSY; Solomon N.G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Walters J.R., 1987, P306	45	146	147	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					690	693		10.1126/science.1062320	http://dx.doi.org/10.1126/science.1062320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474110				2022-12-01	WOS:000170204600053
J	von Dohlen, CD; Kohler, S; Alsop, ST; McManus, WR				von Dohlen, CD; Kohler, S; Alsop, ST; McManus, WR			Mealybug beta-proteobacterial endosymbionts contain gamma-proteobacterial symbionts	NATURE			English	Article							BACTERIAL ENDOSYMBIONTS; RIBOSOMAL-RNA; EVOLUTION; BUCHNERA; APHIDS; HOMOPTERA; HEMIPTERA; SEQUENCE; INSECTS	Some insects have cultivated intimate relationships with mutualistic bacteria since their early evolutionary history. Most ancient `primary' endosymbionts live within the cytoplasm of large, polyploid host cells of a specialized organ (bacteriome)(1). Within their large, ovoid bacteriomes, mealybugs (Pseudococcidae) package the intracellular endosymbionts into `mucus-filled' spheres, which surround the host cell nucleus and occupy most of the cytoplasm(2). The genesis of symbiotic spheres has not been determined, and they are structurally unlike eukaryotic cell vesicles. Recent molecular phylogenetic and fluorescent in situ hybridization (FISH) studies suggested that two unrelated bacterial species may share individual host cells(3,4), and that bacteria within spheres comprise these two species(5). Here we show that mealybug host cells do indeed harbour both beta- and gamma -subdivision Proteobacteria, but they are not co-inhabitants of the spheres. Rather, we show that the symbiotic spheres themselves are beta -proteobacterial cells. Thus, gamma -Proteobacteria live symbiotically inside beta -Proteobacteria. This is the first report, to our knowledge, of an intracellular symbiosis involving two species of bacteria.	Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	von Dohlen, CD (corresponding author), Utah State Univ, Dept Biol, 5305 Old Main Hill, Logan, UT 84322 USA.			von Dohlen, Carol/0000-0002-3961-251X				Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Baumann P, 2000, PROKARYOTES HDB BIOL; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; COSTA HS, 1993, PROTOPLASMA, V176, P106, DOI 10.1007/BF01378946; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; FINK R, 1962, Z MORPHOL OKOL TIERE, V41, P78; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P643, DOI 10.1128/AEM.66.2.643-650.2000; GRUNEWALDJANHO S, 1996, NONRADIOACTIVE IN SI; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Kantheti P, 1996, INSECT BIOCHEM MOLEC, V26, P997, DOI 10.1016/S0965-1748(96)00009-4; KOHLER M, 1962, Z ALLG MIKROBIOL, V2, P190; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Lambert JD, 1998, P NATL ACAD SCI USA, V95, P4458, DOI 10.1073/pnas.95.8.4458; LOUIS C, 1972, CR ACAD SCI D NAT, V274, P715; LOUIS C, 1974, B OBSERVATOIRE MER, P43; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Munson MA, 1992, MOL PHYLOGENET EVOL, V1, P26, DOI 10.1016/1055-7903(92)90032-C; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Smith D.C., 1987, BIOL SYMBIOSIS; Spaulding AW, 1998, MOL BIOL EVOL, V15, P1506, DOI 10.1093/oxfordjournals.molbev.a025878; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tremblay E., 1989, P145; Van Ham RCHJ, 2000, P NATL ACAD SCI USA, V97, P10855, DOI 10.1073/pnas.180310197; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040	30	241	250	1	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					433	436		10.1038/35086563	http://dx.doi.org/10.1038/35086563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473316				2022-12-01	WOS:000170068200046
J	Nuesch, R; Schroeder, K; Dieterle, T; Martina, B; Battegay, E				Nuesch, R; Schroeder, K; Dieterle, T; Martina, B; Battegay, E			Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study	BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE CONTROL; PATIENT COMPLIANCE; MEDICATION COMPLIANCE; MONITORING COMPLIANCE; REGIMEN; HYPERTENSION; THERAPY	Objectives To prospectively compare compliance with treatment in patients with hypertension responsive to treatment versus patients with treatment resistant hypertension. Design Prospective case control study. Setting Outpatient department in large city hospital in Switzerland, providing primary, secondary, and tertiary care. Participants 110 consecutive medial outpatients with hypertension and taking stable treatment with at least two antihypertensive drugs for at least four weeks. Main outcome measures Treatment compliance assess with MEM devices; blood pressure determined by 12 hour daytime ambulatory monitoring (pressure <135/85 mm Hg in patients age <less than or equal to>60 years and <155/90 mm Hg in patients aged >60 indicated hypertension responsive to treatment). Results Complete data were available for 103 patients, of whom 86 took greater than or equal to 80% of their prescribed doses ("compliant") and 17 took <80% ("non-compliant"). Of the 49 patients with treatment resistant hypertension, 40 (82%) were compliant, while 46 (85%) of the patients responsive to treatment were compliant. Conclusion Non-compliance with treatment was not more prevalent in patients with treatment resistant hypertension than in treatment responsive patients.	Univ Basel Hosp, Outpatient Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel	Battegay, E (corresponding author), Univ Basel Hosp, Outpatient Dept Internal Med, CH-4031 Basel, Switzerland.		Dieterle, Thomas/AAG-3619-2019; Dieterle, Thomas/CAA-2532-2022	Dieterle, Thomas/0000-0002-3740-1903				Altman DG., 1982, STATISTICS PRACTICE, P6; Andrejak M, 2000, AM J HYPERTENS, V13, P184, DOI 10.1016/S0895-7061(99)00175-2; BATTEGAY E, 1996, MED HYG, V54, P541; Black HR, 1997, ARCH INTERN MED, V157, P2413; Boissel JP, 1996, EUR J CLIN PHARMACOL, V50, P63, DOI 10.1007/s002280050070; CALDERBANK PH, 1976, FLUIDIZATION TECHNOL, V1, P115; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; EISEN SA, 1990, ARCH INTERN MED, V150, P1881, DOI 10.1001/archinte.150.9.1881; ERAKER SA, 1984, ANN INTERN MED, V100, P258, DOI 10.7326/0003-4819-100-2-258; Graves John W., 2000, Mayo Clinic Proceedings, V75, P278; GUERRERO D, 1993, AM J HYPERTENS, V6, P586, DOI 10.1093/ajh/6.7.586; KJELLGREN KI, 1995, INT J CARDIOL, V47, P257, DOI 10.1016/0167-5273(94)02203-U; Krall RL, 1991, PATIENT COMPLIANCE M, P19; KRUSE W, 1990, EUR J CLIN PHARMACOL, V38, P561, DOI 10.1007/BF00278582; Leenen FHH, 1997, CAN J CARDIOL, V13, P914; Mallion JM, 1998, J HYPERTENS, V16, pS75; Mallion JM, 1996, J HYPERTENS, V14, P137; MALLION JM, 1992, J CARDIOVASC PHARM, V19, pS41, DOI 10.1097/00005344-199219002-00011; MCKENNEY JM, 1992, J CLIN PHARMACOL, V32, P277, DOI 10.1002/j.1552-4604.1992.tb03837.x; MELNIKOW J, 1994, J GEN INTERN MED, V9, P96, DOI 10.1007/BF02600211; OBRIEN E, 1993, J HYPERTENS, V11, P673, DOI 10.1097/00004872-199306000-00012; Sackett D L, 1978, Patient Couns Health Educ, V1, P18; SETARO J, 1992, NEW ENGL J MED, V327, P534; URQUHART J, 1994, CLIN PHARMACOKINET, V27, P202, DOI 10.2165/00003088-199427030-00004; Waeber B, 1999, INT J CLIN PRACT, V53, P37; Waeber B, 1999, J HYPERTENS, V17, P1041, DOI 10.1097/00004872-199917070-00022; WRIGHT EC, 1993, LANCET, V342, P909, DOI 10.1016/0140-6736(93)91951-H	28	77	84	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					142	146		10.1136/bmj.323.7305.142	http://dx.doi.org/10.1136/bmj.323.7305.142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463685	Green Published, Bronze			2022-12-01	WOS:000170106200018
J	Jeppesen, C; Wong, JY; Kuhl, TL; Israelachvili, JN; Mullah, N; Zalipsky, S; Marques, CM				Jeppesen, C; Wong, JY; Kuhl, TL; Israelachvili, JN; Mullah, N; Zalipsky, S; Marques, CM			Impact of polymer tether length on multiple ligand-receptor bond formation	SCIENCE			English	Article								The promoters of cell adhesion are ligands, which are often attached to flexible tethers that bind to surface receptors on adjacent cells. Using a combination of Monte Carte simulations, diffusion reaction theory, and direct experiments (surface force measurements) of the biotin-streptavidin system, we have quantified polymer chain dynamics and the kinetics and spatial range of tethered ligand-receptor binding. The results show that the efficiency of strong binding does not depend solely on the molecular architecture or binding energy of the receptor-ligand pair, nor on the equilibrium configuration of the polymer tether, but rather on its "rare" extended conformations.	LDFC Inst Phys, F-67084 Strasbourg, France; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; ALZA Corp, Mt View, CA 94043 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Boston University; University of California System; University of California Davis; Johnson & Johnson; Johnson & Johnson USA	Marques, CM (corresponding author), LDFC Inst Phys, 3 Rue Univ, F-67084 Strasbourg, France.		Marques, Carlos M/B-2322-2010; Wong, Joyce Y/F-3732-2011; Wong, Joyce Y./AAF-5759-2019	Marques, Carlos M/0000-0002-3952-0498; Wong, Joyce Y/0000-0002-3526-6381; Wong, Joyce Y./0000-0002-3526-6381; Marques, Carlos/0000-0002-6526-1258	NIGMS NIH HHS [GM-17876, GM-47334] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM017876, R01GM047334] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		De Gennes P-G., 1979, SCALING CONCEPTS POL; DEGENNES PG, 1982, J CHEM PHYS, V76, P3316, DOI 10.1063/1.443328; DOI M, 1975, CHEM PHYS, V9, P455, DOI 10.1016/0301-0104(75)80083-8; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; Israelachvili J., 1992, INTERMOLECULAR SURFA; Kolb A, 1997, MACROMOL THEOR SIMUL, V6, P169, DOI 10.1002/mats.1997.040060112; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LECKBAND DE, 1994, BIOCHEMISTRY-US, V33, P4611, DOI 10.1021/bi00181a023; WILEMSKI G, 1973, J CHEM PHYS, V58, P4009, DOI 10.1063/1.1679757; Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820	14	191	205	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					465	468		10.1126/science.293.5529.465	http://dx.doi.org/10.1126/science.293.5529.465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463908				2022-12-01	WOS:000169966700039
J	Bach, PB; Cramer, LD; Schrag, D; Downey, RJ; Gelfand, SE; Begg, CB				Bach, PB; Cramer, LD; Schrag, D; Downey, RJ; Gelfand, SE; Begg, CB			The influence of hospital volume on survival after resection for lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-YORK-STATE; ADMINISTRATIVE DATA; OUTCOMES RESEARCH; PATIENT OUTCOMES; RANDOMIZED TRIAL; SURGICAL VOLUME; MORTALITY; SURGERY; QUALITY; CARE	Background: Among patients who have undergone high-risk operations for cancer, postoperative mortality rates are often lower at hospitals where more of these procedures are performed. We undertook a population-based study to estimate the extent to which the number of procedures performed at a hospital (hospital volume) is associated with survival after resection for lung cancer. Methods: We studied patients 65 years old or older who received a diagnosis of stage I, II, or IIIA non-small-cell lung cancer between 1985 and 1996, resided in 1 of the 10 study areas covered by the Surveillance, Epidemiology, and End Results Program, and underwent surgery at a hospital that participates in the Nationwide Inpatient Sample (2118 patients and 76 hospitals). Results: The volume of procedures at the hospital was positively associated with the survival of patients (P<0.001). Five years after surgery, 44 percent of patients who underwent operations at the hospitals with the highest volume were alive, as compared with 33 percent of those who underwent operations at the hospitals with the lowest volume. Patients at the highest-volume hospitals also had lower rates of postoperative complications (20 percent vs. 44 percent) and lower 30-day mortality (3 percent vs. 6 percent) than those at the lowest-volume hospitals. Conclusions: Patients who undergo resection for lung cancer at hospitals that perform large numbers of such procedures are likely to survive longer than patients who have such surgery at hospitals with a low volume of lung-resection procedures. (N Engl J Med 2001;345:181-8.) Copyright (C) 2001 Massachusetts Medical Society.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 221, New York, NY 10021 USA.			Schrag, Deborah/0000-0002-4334-5717	NCI NIH HHS [R01-CA-090226] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090226] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison PD, 1999, LOGISTIC REGRESSION, P179; Asamura H, 1996, J THORAC CARDIOV SUR, V111, P1125, DOI 10.1016/S0022-5223(96)70213-1; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg MD, 1999, BIOMETRICS, V55, P302, DOI 10.1111/j.0006-341X.1999.00302.x; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Diggle PJ, 1995, ANAL LONGITUDINAL DA; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Ellison LM, 2000, J UROLOGY, V163, P867, DOI 10.1016/S0022-5347(05)67821-4; Ettinger D S, 1996, Oncology (Williston Park), V10, P81; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hewitt M, 2000, INTERPRETING VOLUME; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hillner BE, 1998, JAMA-J AM MED ASSOC, V280, P1783, DOI 10.1001/jama.280.20.1783; Holm T, 1997, BRIT J SURG, V84, P657, DOI 10.1002/bjs.1800840520; HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004; IEZZONI LI, 1994, INQUIRY-J HEALTH CAR, V31, P40; ISHIDA T, 1990, ANN THORAC SURG, V50, P708, DOI 10.1016/0003-4975(90)90666-T; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Keller SM, 2000, NEW ENGL J MED, V343, P1217, DOI 10.1056/NEJM200010263431703; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; Percy C., 1990, INT CLASSIFICATION D; Phillips KA, 1997, INT J QUAL HEALTH C, V9, P341, DOI 10.1093/intqhc/9.5.341; POTOSKY AL, 1993, MED CARE, V31, P732; ROMANO PS, 1992, CHEST, V101, P1332, DOI 10.1378/chest.101.5.1332; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950; 1999, HOSP PAYOR ICD9CM IN	42	545	552	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					181	188		10.1056/NEJM200107193450306	http://dx.doi.org/10.1056/NEJM200107193450306			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463014				2022-12-01	WOS:000169912800006
J	Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH				Bostom, AG; Selhub, J; Jacques, PF; Rosenberg, IH			Power shortage: Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONVERTING ENZYME-INHIBITION; METAANALYSIS	Large randomized, controlled trials of total homocysteine-lowering therapy for the potential reduction of cardiovascular disease outcomes are ongoing in the United States and Canada, These trials are the Vitamin Intervention for Stroke Prevention (VISP) trial, the Women's Antioxidant Cardiovascular Disease Study (WACS), and the Heart Outcomes Prevention Evaluation (HOPE-2). However, the dramatic effect of policies mandating fortification of cereal grain flour products with folic acid may reduce the statistical power of these trials. All three trials assume that the active treatment groups will achieve the same mean effects of total homocysteine-lowering therapy as those reported in the absence of folic acid-fortified cereal grain flour. This paper examines this assumption using data from studies of total homocysteine-lowering therapy in U.S. and Canadian patients with cardiovascular disease who were exposed to products made with folic acid-fortified cereal grain flour, These data showed that the VISP trial, HOPE-2, and WACS will probably achieve only approximately 20% to 25% of the projected treatment effects of mean total homocysteine-lowering therapy (1.0 to 1.5 mu mol/L vs. 4.0 to 6.0 mu mol/L). As a result, all three trials will be substantially underpowered to test the specific hypotheses of total homocysteine- lowering therapy identified a priori. In contrast, renal transplant recipients have a persistent excess prevalence of hyperhomocysteinemia in the era of fortification but remain very responsive to supraphysiologic doses of folic acid-based supplementation (mean reduction in total homocysteine level, 5.0 to 6.0 mu mol/L). Therefore, unlike other populations with normal renal function that are at high risk for cardiovascular disease but are profoundly affected by fortification efforts, renal transplant recipients continue to merit serious consideration for a controlled trial of the "homocysteine hypothesis.".	Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA; Denver Hlth, Denver, CO 80204 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center	Bostom, AG (corresponding author), Univ Colorado, Hlth Sci Ctr, 4200 E 9th Ave,Room 6403, Denver, CO 80262 USA.	abostom@loa.com						GANSEVOORT RT, 1995, NEPHROL DIAL TRANSPL, V10, P1963; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mosconi L, 1996, KIDNEY INT, pS91; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEIDMANN P, 1995, NEPHROL DIAL TRANSPL, V10, P39	9	81	82	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					133	139		10.7326/0003-4819-135-2-200107170-00014	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453713				2022-12-01	WOS:000169842300007
J	Gundersen, L				Gundersen, L			Physician burnout	ANNALS OF INTERNAL MEDICINE			English	Article																			0	175	184	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					145	148		10.7326/0003-4819-135-2-200107170-00023	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453722				2022-12-01	WOS:000169842300013
J	Hunter, N; Kleckner, N				Hunter, N; Kleckner, N			The single-end invasion: An asymmetric intermediate at the double-strand break to double-holliday junction transition of meiotic recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; CHROMOSOME SYNAPSIS; ALLOHEXAPLOID WHEAT; SORDARIA-MACROSPORA; INITIATION SITE; GENE CONVERSION; CROSSING-OVER; MEIOSIS	We identify a novel meiotic recombination intermediate, the single-end invasion (SEI), which occurs during the transition from double-strand breaks (DSBs) to double-Holliday junction (dHJs). SEIs are products of strand exchange between one DSB end and its homolog. The structural asymmetry of SEIs indicates that the two ends of a DSB interact with the homolog in temporal succession, via structurally (and thus biochemically) distinct processes. SEIs arise surprisingly late in prophase, concomitant with synaptonemal complex (SC) formation. These and other data imply that SEIs are preceded by nascent DSB-partner intermediates, which then undergo selective differentiation into crossover and noncrossover types, with SC formation and strand exchange as downstream consequences. Late occurrence of strand exchange provides opportunity to reverse recombinational fate even after homologs are coaligned and/or synapsed. This feature can explain crossover suppression between homeologous and structurally heterozygous chromosomes.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu			NIGMS NIH HHS [GM44794] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BELMAAZA A, 1994, MUTAT RES, V314, P199, DOI 10.1016/0921-8777(94)90065-5; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; CARPENTER ATC, 1994, CELL, V77, P959, DOI 10.1016/0092-8674(94)90434-0; Cha RS, 2000, GENE DEV, V14, P493; DEMASSY B, 1995, EMBO J, V14, P4589, DOI 10.1002/j.1460-2075.1995.tb00138.x; FOSS E, 1993, GENETICS, V133, P681; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Grushcow JM, 1999, GENETICS, V153, P607; Havekes FWJ, 1994, CHROMOSOME RES, V2, P315, DOI 10.1007/BF01552725; HOBOLTH P, 1981, CARLSBERG RES COMMUN, V46, P129, DOI 10.1007/BF02910465; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; Hunter N, 2001, NAT GENET, V27, P236, DOI 10.1038/85781; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; MAGUIRE MP, 1994, GENETICS, V137, P281; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; MOSES MJ, 1984, CONTROLLING EVENTS M, P245; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; STACK SM, 1993, CHROMOSOMES TODAY, V11, P301; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Villemure JF, 1997, MOL GEN GENET, V256, P533, DOI 10.1007/s004380050598; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Worth L, 1998, J BIOL CHEM, V273, P23176, DOI 10.1074/jbc.273.36.23176; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; YAMAMOTO K, 1992, MOL GEN GENET, V234, P1; ZICKLER D, 1977, CHROMOSOMA, V61, P289, DOI 10.1007/BF00288615; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619; ZICKLER D, 1992, GENETICS, V132, P135	55	507	518	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					59	70		10.1016/S0092-8674(01)00430-5	http://dx.doi.org/10.1016/S0092-8674(01)00430-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461702	Bronze			2022-12-01	WOS:000169870300009
J	Sakuta, H; Suzuki, R; Takahashi, H; Kato, A; Shintani, T; Iemura, S; Yamamoto, TS; Ueno, N; Noda, M				Sakuta, H; Suzuki, R; Takahashi, H; Kato, A; Shintani, T; Iemura, S; Yamamoto, TS; Ueno, N; Noda, M			Ventroptin: A BMP-4 antagonist expressed in a double-gradient pattern in the retina	SCIENCE			English	Article							GANGLION-CELL AXONS; RETINOTECTAL PROJECTION; EPHRINA LIGANDS; CHICK; MAP; ELF-1	In the visual system, the establishment of the anteroposterior and dorsoventral axes in the retina ana tectum during development is important for topographic retinotectal projection. We identified chick Ventroptin, an antagonist of bone morphogenetic protein 4 (BMP-4), which is mainly expressed in the ventral retina, not only with a ventral high-dorsal low gradient but also with a nasal high-temporal Low gradient at later stages, Misexpression of Ventroptin altered expression patterns of several topographic genes in the retina and projection of the retinal axons to the tectum along both axes. Thus, the topographic retinotectal projection appears to be specified by the double-gradient molecule Ventroptin along the two axes.	Grad Univ Adv Studies, Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Natl Inst Basic Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Grad Univ Adv Studies, Natl Inst Basic Biol, Div Mol Neurobiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.		Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Sakuta, Hiraki/0000-0003-2375-0528; Ueno, Naoto/0000-0002-8375-2317; Shintani, Takafumi/0000-0002-6165-2307				Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CROSSLAND WJ, 1974, J COMP NEUROL, V155, P127, DOI 10.1002/cne.901550202; CROSSLAND WJ, 1975, BRAIN RES, V91, P1, DOI 10.1016/0006-8993(75)90463-1; Dudley AT, 1997, DEV DYNAM, V208, P349; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hyatt GA, 1996, DEVELOPMENT, V122, P195; KAHN AJ, 1974, DEV BIOL, V38, P30, DOI 10.1016/0012-1606(74)90256-5; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; MATSUNO T, 1992, NEUROSCI RES, V15, P96, DOI 10.1016/0168-0102(92)90022-5; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; Schulte D, 2000, DEVELOPMENT, V127, P5033; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Suzuki H, 1996, NUCLEIC ACIDS RES, V24, P289, DOI 10.1093/nar/24.2.289; Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	20	157	167	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					111	115		10.1126/science.1058379	http://dx.doi.org/10.1126/science.1058379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441185				2022-12-01	WOS:000169780300040
J	Javaux, EJ; Knoll, AH; Walter, MR				Javaux, EJ; Knoll, AH; Walter, MR			Morphological and ecological complexity in early eukaryotic ecosystems	NATURE			English	Article							ROCKS; MICROFOSSILS; EXAMPLE; FOSSILS; BASIN	Molecular phylogeny and biogeochemistry indicate that eukaryotes differentiated early in Earth history. Sequence comparisons of small-subunit ribosomal RNA genes suggest a deep evolutionary divergence of Eukarya and Archaea(1); C-27-C-29 steranes (derived from sterols synthesized by eukaryotes) and strong depletion of C-13 (a biogeochemical signature of methanogenic Archaea) in 2,700 Myr old kerogens independently place a minimum age on this split(2,3). Steranes, large spheroidal microfossils, and rare macrofossils of possible eukaryotic origin occur in Palaeoproterozoic rocks(4-6). Until now, however, evidence for morphological and taxonomic diversification within the domain has generally been restricted to very late Mesoproterozoic and Neoproterozoic successions(7). Here we show that the cytoskeletal and ecological prerequisites for eukaryotic diversification were already established in eukaryotic microorganisms fossilized nearly 1,500 Myr ago in shales of the early Mesoproterozoic Roper Group in northern Australia.	Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Macquarie Univ, Australian Ctr Astrobiol, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia	Harvard University; Macquarie University	Knoll, AH (corresponding author), Harvard Univ, Bot Museum, Cambridge, MA 02138 USA.	aknoll@oeb.harvard.edu						Abbott ST, 2000, AUST J EARTH SCI, V47, P637, DOI 10.1046/j.1440-0952.2000.00795.x; ANBAR AD, 1999, 1999 AM GEOPH UN FAL; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Butterfield Nicholas J., 1994, Fossils and Strata, V34, P1; BUTTERFIELD NJ, 1992, PALAEONTOLOGY, V35, P943; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; GERMAN TN, 1990, ORGANIC WORLD 1 BILL, P1; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; Jackson M.J., 1999, INTEGRATED BASIN ANA; JACKSON MJ, 1991, PRECAMBRIAN RES, V54, P81, DOI 10.1016/0301-9268(91)90070-Q; JACOBSON SR, 1979, J PALEONTOL, V53, P1197; JANKAUSKAS TV, 1989, PRECAMBRIAN MICROFOS, P5; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Knoll A.H., 1996, PALYNOLOGY PRINCIPLE, V1, P51; KRALIK M, 1982, PRECAMBRIAN RES, V18, P157, DOI 10.1016/0301-9268(82)90044-4; PEAT C J, 1978, BMR (Bureau of Mineral Resources) Journal of Australian Geology and Geophysics, V3, P1; PETROV PY, 1995, STRATIGR GEO CORREL+, V3, P435; Samuelsson J, 1999, PRECAMBRIAN RES, V96, P1, DOI 10.1016/S0301-9268(98)00123-5; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P3075, DOI 10.1016/0016-7037(87)90381-4; VEIS AF, 1992, IZV AN SSSR GEOL, V8, P114; VIDAL G, 1990, AM J SCI, V290A, P170; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xiao SH, 1997, PRECAMBRIAN RES, V84, P197, DOI 10.1016/S0301-9268(97)00029-6; Yin LM, 1997, REV PALAEOBOT PALYNO, V98, P15, DOI 10.1016/S0034-6667(97)00022-5; Zhang Zhongying, 1986, Journal of Micropalaeontology, V5, P9; ZHOU H, 1999, SEQUENCE STRATIGRAPH, P5	28	283	319	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					66	69		10.1038/35083562	http://dx.doi.org/10.1038/35083562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452306				2022-12-01	WOS:000169644900043
J	Rhode, SC; Pawlowski, M; Tollrian, R				Rhode, SC; Pawlowski, M; Tollrian, R			The impact of ultraviolet radiation on the vertical distribution of zooplankton of the genus Daphnia	NATURE			English	Article							SOLAR UV-RADIATION; ADAPTIVE SIGNIFICANCE; MIGRATION; EXPOSURE; MAGNA	The vertical migration of zooplankton into lower and darker water strata by day is generally explained by the avoidance of visually orienting predators, mainly fish(1-4); however, it is unclear why daily zooplankton migration has been maintained in fishless areas(5). In addition to predation, ultraviolet radiation-a hazardous factor for zooplankton in the surface layers of marine and freshwater environments(6-8) - has been suspected as a possible cause of daytime downward migration(9). Here we test this hypothesis by studying several Daphnia species, both in a controlled laboratory system and under natural sunlight in an outdoor system. We selected Daphnia species that differed in their pigmentation as both melanin and carotenoids have been shown to protect Daphnia from ultraviolet light(10,11). All Daphnia species escaped into significantly deeper water layers under ultraviolet radiation. The extent to which the daphnids responded to this radiation was inversely linked to their pigmentation, which reduced ultraviolet transmission. These results suggest that ultraviolet avoidance is an additional factor in explaining daytime downward migration. Synergistic benefits might have shaped the evolution of this complex behaviour.	Univ Munich, Dept Ecol, Inst Zool, D-80333 Munich, Germany	University of Munich	Tollrian, R (corresponding author), Univ Munich, Dept Ecol, Inst Zool, Karlstr 25, D-80333 Munich, Germany.	ralph.tollrian@lrz.uni-muenchen.de						BOLLENS SM, 1994, J PLANKTON RES, V16, P555, DOI 10.1093/plankt/16.5.555; CALKINS J, 1980, NATURE, V283, P563, DOI 10.1038/283563a0; CONFER JL, 1978, OIKOS, V31, P27, DOI 10.2307/3543380; DAMKAER DM, 1982, ROLE SOLAR ULTRAVIOL, P701; De Meester L, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P160; DEMEESTER L, 1995, NATURE, V378, P483; DODSON S, 1990, LIMNOL OCEANOGR, V35, P1195, DOI 10.4319/lo.1990.35.5.1195; FLEISCHMANN EM, 1989, LIMNOL OCEANOGR, V34, P1623, DOI 10.4319/lo.1989.34.8.1623; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; HEBERT PDN, 1990, FUNCT ECOL, V4, P703; HESSEN DO, 1994, ARCH HYDROBIOL BEIH, V43, P85; Kerfoot W.C., 1985, Contributions in Marine Science, V27, P91; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; MADRONICH S, 1995, AMBIO, V24, P143; Merker E., 1930, Zoologische Jahrbuecher Jena Allgemeine Zoologie, V48, P277; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; NEILL WE, 1990, NATURE, V345, P524, DOI 10.1038/345524a0; Ringelberg J., 1964, Netherlands Journal of Sea Research, V2, P319, DOI 10.1016/0077-7579(64)90001-8; Siebeck O., 1994, Advances in Limnology, V43, P197; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; WILLIAMSON CE, 1994, J PLANKTON RES, V16, P205, DOI 10.1093/plankt/16.3.205; WILLIAMSON CE, IN PRESS ECOLOGY; ZARET TM, 1976, LIMNOL OCEANOGR, V21, P804, DOI 10.4319/lo.1976.21.6.0804	29	184	199	6	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					69	72		10.1038/35083567	http://dx.doi.org/10.1038/35083567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452307				2022-12-01	WOS:000169644900044
J	Taylor, RB; Shakoor, O; Behrens, RH; Everard, M; Low, AS; Wangboonskul, J; Raid, RG; Kolawole, JA				Taylor, RB; Shakoor, O; Behrens, RH; Everard, M; Low, AS; Wangboonskul, J; Raid, RG; Kolawole, JA			Pharmacopoeial quality of drugs supplied by Nigerian pharmacies	LANCET			English	Article							SUBSTANDARD DRUGS	Background The quality of medicines available in some less-developed countries is inadequate in terms of content of active ingredient. Reasons for the poor quality of drugs include widespread counterfeiting of medicines in less-developed countries, excessive decomposition of active ingredient as a result of high temperature and humidity, and poor quality assurance during the manufacture of medicinal products. Our aim was to investigate the quality of different drugs obtained from retail pharmacies in two urban areas of Nigeria, and, in instances of poor quality, to ascertain the reason why. Methods We randomly collected 581 samples of 27 different drugs from 35 pharmacies in Lagos and Abuja in Nigeria. We analysed the medicines for drug content by validated chromatographic methods, and compared our results with pharmacopoeial requirements. Findings 279 (48%) samples did not comply with set pharmacopoeial limits, and this proportion was uniform for the various types of drugs tested. Although some preparations contained no active ingredient, most had amounts just outside the pharmacopoeial limits. We identified samples with both too much and too little active drug content. Interpretation The most probable cause of the poor quality of drugs is absence of adequate quality assurance during manufacture. Substandard drugs sold in the pharmacies of less-developed countries could contribute to global microbial resistance and therapeutic failure of infectious diseases.	Robert Gordon Univ, Sch Pharm, Aberdeen AB10 1FR, Scotland; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen, Thailand; Univ Jos, Dept Pharm, Jos, Nigeria	Robert Gordon University; University of London; London School of Hygiene & Tropical Medicine; Khon Kaen University; University of Jos	Taylor, RB (corresponding author), Robert Gordon Univ, Sch Pharm, Aberdeen AB10 1FR, Scotland.			Behrens, Ron/0000-0002-8166-2633				ABDI YA, 1995, LANCET, V346, P1161, DOI 10.1016/S0140-6736(95)91834-5; [Anonymous], 1990, ACUTE RESP INFECT CH; Arya S C, 1995, World Health Forum, V16, P269; CAMPBELL H, 1995, ARCH DIS CHILD, V73, P281, DOI 10.1136/adc.73.4.281; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HOGERZEIL HV, 1991, LANCET, V338, P754, DOI 10.1016/0140-6736(91)91470-F; KELLY JC, 1990, ANN EMERG MED, V19, P47, DOI 10.1016/S0196-0644(05)82141-9; KIBWAGE IO, 1992, E AFR MED J, V69, P577; Low AS, 1999, ANALYST, V124, P1589, DOI 10.1039/a907400g; PETRALANDA I, 1995, LANCET, V345, P1433, DOI 10.1016/S0140-6736(95)92620-8; Roy J, 1994, World Health Forum, V15, P406; Shakoor O, 1997, TROP MED INT HEALTH, V2, P839, DOI 10.1046/j.1365-3156.1997.d01-403.x; TENHAM M, 1992, ADVERSE DRUG REACT T, V11, P59; WONDEMAGEGNEHU E, 1995, COUNTERFEIT SUBSTAND; 1999, WORLD HLTH REPORT 19, P49	15	139	142	0	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2001	357	9272					1933	1936		10.1016/S0140-6736(00)05065-0	http://dx.doi.org/10.1016/S0140-6736(00)05065-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425415				2022-12-01	WOS:000169431000013
J	Dajani, R; Fraser, E; Roe, SM; Young, N; Good, V; Dale, TC; Pearl, LH				Dajani, R; Fraser, E; Roe, SM; Young, N; Good, V; Dale, TC; Pearl, LH			Crystal structure of glycogen synthase kinase 3 beta: Structural basis for phosphate-primed substrate specificity and autoinhibition	CELL			English	Article							BETA-CATENIN; PHOSPHORYLASE-KINASE; GSK-3-BETA-DEPENDENT PHOSPHORYLATION; 3-DIMENSIONAL STRUCTURE; CATALYTIC DOMAIN; AXIN; PEPTIDE; IDENTIFICATION; ACTIVATION; GSK-3	Glycogen synthase kinase 3 beta (GSK3 beta) plays a key role in insulin and Wnt signaling, phosphorylating downstream targets by default, and becoming inhibited following the extracellular signaling event. The crystal structure of human GSK3 beta shows a catalytically active conformation in the absence of activation-segment phosphorylation, with the sulphonate of a buffer molecule bridging the activation-segment and N-terminal domain in the same way as the phosphate group of the activation-segment phospho-Ser/Thr in other kinases. The location of this oxyanion binding site in the substrate binding cleft indicates direct coupling of P+4 phosphate-primed substrate binding and catalytic activation, explains the ability of GSK3 beta to processively hyperphosphorylate substrates with Ser/Thr pentad-repeats, and suggests a mechanism for autoinhibition in which the phosphorylated N terminus binds as a competitive pseudosubstrate with phospho-Ser 9 occupying the P+4 site.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Inst Canc Res, Chester Beatty Labs, CRC, Ctr Cell & Mol Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pearl, LH (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	laurence@icr.ac.uk	Dale, Trevor C/D-3749-2009; Fraser, Elizabeth/M-7049-2015	Dale, Trevor C/0000-0002-4880-9963; Fraser, Elizabeth/0000-0001-8420-3208; Pearl, Laurence/0000-0002-6910-1809; Roe, Mark/0000-0002-7371-9855				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; COX S, 1992, PROTEIN ENG, V5, P811, DOI 10.1093/protein/5.8.811; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Itoh K, 1995, DEVELOPMENT, V121, P3979; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim L, 1999, CELL, V99, P399, DOI 10.1016/S0092-8674(00)81526-3; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE A, 1995, MOSFLM USERS GUIDE; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murai H, 1996, FEBS LETT, V392, P153, DOI 10.1016/0014-5793(96)00806-X; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; WANG YH, 1993, J BIOL CHEM, V268, P23876; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Williams RSB, 2000, TRENDS PHARMACOL SCI, V21, P61, DOI 10.1016/S0165-6147(99)01428-5; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHANG JD, 1995, STRUCTURE, V3, P299, DOI 10.1016/S0969-2126(01)00160-5	55	541	575	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					721	732		10.1016/S0092-8674(01)00374-9	http://dx.doi.org/10.1016/S0092-8674(01)00374-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440715	Bronze			2022-12-01	WOS:000169375100006
J	Dodson, KW; Pinkner, JS; Rose, T; Magnusson, G; Hultgren, SJ; Waksman, G				Dodson, KW; Pinkner, JS; Rose, T; Magnusson, G; Hultgren, SJ; Waksman, G			Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor	CELL			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; SIALOSYL GALACTOSYL GLOBOSIDE; PREFERRED BINDING-RECEPTOR; URINARY-TRACT-INFECTION; CYTOKINE RESPONSES; GLYCOLIPID RECEPTOR; BACTERIAL INVASION; COMMON THEMES; PAPG ADHESIN; P-FIMBRIAE	PapG is the adhesin at the tip of the P pilus that mediates attachment of uropathogenic Escherichia coli to the uroepithelium of the human kidney. The human specific allele of PapG binds to globoside (GbO4), which consists of the tetrasaccharide GalNAc beta1-3Gal alpha1-4Gal beta1-4Glc linked to ceramide. Here, we present the crystal structures of a binary complex of the PapG receptor binding domain bound to GbO4 as well as the unbound form of the adhesin. The biological importance of each of the residues involved in binding was investigated by site-directed mutagenesis. These studies provide a molecular snapshot of a host-pathogen interaction that determines the tropism of uropathogenic E. coli for the human kidney and is critical to the pathogenesis of pyelonephritis.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Lund Univ, Lund, Sweden	Washington University (WUSTL); Washington University (WUSTL); Lund University	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu; waksman@biochem.wustl.edu		ROSE, Thierry/0000-0001-8863-0207; Pinkner, Jerome/0000-0002-7389-7440	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049950, R01AI048689, R37AI029549, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054033] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49950, AI48689, AI29549] Funding Source: Medline; NIDDK NIH HHS [DK51406] Funding Source: Medline; NIGMS NIH HHS [GM54033] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CLEGG S, 1982, INFECT IMMUN, V38, P739, DOI 10.1128/IAI.38.2.739-744.1982; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Hedlund M, 1999, MOL MICROBIOL, V33, P693, DOI 10.1046/j.1365-2958.1999.01513.x; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; HULTGREN SJ, 1989, P NATL ACAD SCI USA, V86, P4357, DOI 10.1073/pnas.86.12.4357; HULTGREN SJ, 1990, MOL MICROBIOL, V4, P1311, DOI 10.1111/j.1365-2958.1990.tb00710.x; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; Johnson JR, 1998, J INFECT DIS, V177, P97, DOI 10.1086/513824; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIHLBERG J, 1989, J AM CHEM SOC, V111, P6364, DOI 10.1021/ja00198a056; KLANN AG, 1994, J BACTERIOL, V176, P2312, DOI 10.1128/JB.176.8.2312-2317.1994; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; LEFFLER H, 1980, FEMS MICROBIOL LETT, V8, P127, DOI 10.1111/j.1574-6968.1980.tb05064.x; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; LUND B, 1987, P NATL ACAD SCI USA, V84, P5898, DOI 10.1073/pnas.84.16.5898; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASCHER I, 1992, BIOCHIM BIOPHYS ACTA, V1113, P339, DOI 10.1016/0304-4157(92)90006-V; PATTON JP, 1991, MED CLIN N AM, V75, P495, DOI 10.1016/S0025-7125(16)30466-7; Pernestig AK, 2000, ADV EXP MED BIOL, V485, P137; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; RONALD AR, 1991, MED CLIN N AM, V75, P299, DOI 10.1016/S0025-7125(16)30455-2; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Stapleton AE, 1998, INFECT IMMUN, V66, P3856, DOI 10.1128/IAI.66.8.3856-3861.1998; STRIKER R, 1995, MOL MICROBIOL, V16, P1021, DOI 10.1111/j.1365-2958.1995.tb02327.x; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; Stroud MR, 1998, BIOCHEMISTRY-US, V37, P17420, DOI 10.1021/bi9814639; Svanborg C, 1996, ANN NY ACAD SCI, V797, P177, DOI 10.1111/j.1749-6632.1996.tb52959.x; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; Thanassi DG, 2000, METHODS, V20, P111, DOI 10.1006/meth.1999.0910; Warren John W., 1996, P3; Zhang JP, 1996, SCIENCE, V273, P1234, DOI 10.1126/science.273.5279.1234	48	197	205	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					733	743		10.1016/S0092-8674(01)00388-9	http://dx.doi.org/10.1016/S0092-8674(01)00388-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440716	Bronze			2022-12-01	WOS:000169375100007
J	Orme, CA; Noy, A; Wierzbicki, A; McBride, MT; Grantham, M; Teng, HH; Dove, PM; DeYoreo, JJ				Orme, CA; Noy, A; Wierzbicki, A; McBride, MT; Grantham, M; Teng, HH; Dove, PM; DeYoreo, JJ			Formation of chiral morphologies through selective binding of amino acids to calcite surface steps	NATURE			English	Article							FREE-ENERGIES; ELECTROSTATIC POTENTIALS; CRYSTAL NUCLEATION; AQUEOUS-SOLUTION; GROWTH; CRYSTALLIZATION; INTERFACES; SOLVATION; MODEL; DIFFRACTION	Many living organisms contain biominerals and composites with finely tuned properties, reflecting a remarkable level of control over the nucleation, growth and shape of the constituent crystals(1-6). Peptides and proteins play an important role in achieving this control(1,7,8). But the general view that organic molecules affect mineralization through stereochemical recognition, where geometrical and chemical constraints dictate their binding to a mineral, seems difficult to reconcile(4) with a mechanistic understanding, where crystallization is controlled by thermodynamic and kinetic factors(9). Indeed, traditional crystal growth models emphasize the inhibiting effect of so-called 'modifiers' on surface-step growth, rather than stereochemical matching to newly expressed crystal facets. Here we report in situ atomic force microscope observations and molecular modelling studies of calcite growth in the presence of chiral amino acids that reconcile these two seemingly divergent views. We rnd that enantiomer-specific binding of the amino acids to those surface-step edges that offer the best geometric and chemical rt changes the step-edge free energies, which in turn results in macroscopic crystal shape modifications. Our results emphasize that the mechanism underlying crystal modification through organic molecules is best understood by considering both stereochemical recognition and the effects of binding on the interfacial energies of the growing crystal.	Lawrence Livermore Natl Lab, Dept Chem & Mat Sci, Livermore, CA 94551 USA; Univ S Alabama, Dept Chem, Mobile, AL 36688 USA; Virginia Polytech Inst & State Univ, Dept Geol Sci, Blacksburg, VA 24061 USA; George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of South Alabama; Virginia Polytechnic Institute & State University; George Washington University	Orme, CA (corresponding author), Lawrence Livermore Natl Lab, Dept Chem & Mat Sci, Livermore, CA 94551 USA.	orme1@llnl.gov	Dove, Patricia M/A-7911-2010; Orme, Christine A/A-4109-2009	Orme, Christine A/0000-0003-3652-3367; Noy, Aleksandr/0000-0003-4924-2652				ADDADI L, 1986, TOP STEREOCHEM, V16, P1, DOI 10.1002/9780470147252.ch1; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; AIZENBERG J, 1995, CHEM-EUR J, V1, P414, DOI 10.1002/chem.19950010705; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CRAMER CJ, 1991, J AM CHEM SOC, V113, P8305, DOI 10.1021/ja00022a017; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; CRAMER CJ, 1992, SCIENCE, V256, P213, DOI 10.1126/science.256.5054.213; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Didymus J.M., 1991, P267; DIDYMUS JM, 1994, P ROY SOC B-BIOL SCI, V258, P237, DOI 10.1098/rspb.1994.0168; FEIDENHANSL R, 1989, SURF SCI REP, V10, P105, DOI 10.1016/0167-5729(89)90002-2; Fenter P, 2000, GEOCHIM COSMOCHIM AC, V64, P1221, DOI 10.1016/S0016-7037(99)00403-2; HONESS AP, 1937, 35 PENNS STAT COLL M, P667; Land TA, 1999, NATURE, V399, P442, DOI 10.1038/20886; MADURA JD, 1994, J AM CHEM SOC, V116, P417, DOI 10.1021/ja00080a066; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; MANN S, 1990, J CHEM SOC FARADAY T, V86, P1873, DOI 10.1039/ft9908601873; MANN S, 1987, PROC R SOC SER B-BIO, V231, P477, DOI 10.1098/rspb.1987.0056; REEDER RJ, 1983, CARBONATES MINERALOG, V2, P1; Robinson IK, 1998, ACTA CRYSTALLOGR A, V54, P772, DOI 10.1107/S0108767398008125; SIKES CS, 1991, ACS SYM SER, V444, P50; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; STIPP SL, 1991, GEOCHIM COSMOCHIM AC, V55, P1723, DOI 10.1016/0016-7037(91)90142-R; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Zhao XY, 2000, LANGMUIR, V16, P9812, DOI 10.1021/la000378a	34	547	559	15	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					775	779		10.1038/35081034	http://dx.doi.org/10.1038/35081034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459051				2022-12-01	WOS:000169246400042
J	Pearce, G; Moura, DS; Stratmann, J; Ryan, CA				Pearce, G; Moura, DS; Stratmann, J; Ryan, CA			Production of multiple plant hormones from a single polyprotein precursor	NATURE			English	Article							SELF-INCOMPATIBILITY; TOMATO LEAVES; SYSTEMIN; RECEPTOR; PROTEIN; PHYTOSULFOKINE; CLAVATA3; BRASSICA; PEPTIDE; CELLS	Some animal and yeast hormone genes produce prohormone polypeptides that are proteolytically processed to produce multiple copies of hormones with the same or different functions(1). In plants, four polypeptides have been identified that can be classed as hormones(2-5) (intercellular chemical messengers(6)) but none are known to be produced as multiple copies from a single precursor. Here we describe a polyprotein hormone precursor, present in tobacco plants, that gives rise to two polypeptide hormones, as often found in animals and yeast. The tobacco polypeptides activate the synthesis of defensive proteinase-inhibitor proteins in a manner similar to that of systemin, an 18-amino-acid polypeptide found in tomato plants(2). The two tobacco polypeptides are derived from each end of a 165-amino-acid precursor that bears no homology to tomato prosystemin. The data show that structurally diverse polypeptide hormones in different plant species can serve similar signalling roles, a condition not found in animals or yeast.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Ryan, CA (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.		Moura, Daniel S/D-6673-2012; Moura, Daniel/F-3011-2010	Moura, Daniel S/0000-0003-2042-1403; 				BRYANT J, 1976, BIOCHEMISTRY-US, V15, P3418, DOI 10.1021/bi00661a004; Constabel CP, 1998, PLANT MOL BIOL, V36, P55, DOI 10.1023/A:1005986004615; DOMBROWSKI JE, 1994, PLANT MOL BIOL MANUA, V3, P1; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Karban R., 2007, INDUCED RESPONSES HE; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; Meindl T, 1998, PLANT CELL, V10, P1561, DOI 10.1105/tpc.10.9.1561; NIALL HD, 1982, ANNU REV PHYSIOL, V44, P615, DOI 10.1146/annurev.ph.44.030182.003151; PATTERSON DH, 1995, ANAL CHEM, V67, P3971, DOI 10.1021/ac00117a024; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PEARCE G, 1993, PLANT PHYSIOL, V102, P639, DOI 10.1104/pp.102.2.639; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stratmann JW, 1997, P NATL ACAD SCI USA, V94, P11085, DOI 10.1073/pnas.94.20.11085; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; VOET D, 1995, BIOCHEMISTRY-US, P1261	23	180	209	4	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					817	820		10.1038/35081107	http://dx.doi.org/10.1038/35081107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459063				2022-12-01	WOS:000169246400054
J	Beguin, P; Nagashima, K; Gonoi, T; Shibasaki, T; Takahashi, K; Kashima, Y; Ozaki, N; Geering, T; Iwanaga, T; Seino, S				Beguin, P; Nagashima, K; Gonoi, T; Shibasaki, T; Takahashi, K; Kashima, Y; Ozaki, N; Geering, T; Iwanaga, T; Seino, S			Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem	NATURE			English	Article							RAS-LIKE GTPASE; CALCIUM CHANNELS; BETA-SUBUNIT; FUNCTIONAL-CHARACTERIZATION; N-TYPE; FACILITATION; BINDING; ROLES; ACTIVATION; SIGNAL	Voltage-dependent calcium (Ca2+) channels are involved in many specialized cellular functions(1-3), and are controlled by intracellular signals such as heterotrimeric G-proteins(4), protein kinases(5,6) and calmodulin (CaM)(7,8). However, the direct role of small G-proteins in the regulation of Ca2+ channels is unclear. We report here that the GTP-bound form of kir/Gem, identified originally as a Ras-related small G-protein that binds CaM9-11, inhibits high-voltage-activated Ca2+ channel activities by interacting directly with the beta -subunit. The reduced channel activities are due to a decrease in alpha (1)-subunit expression at the plasma membrane. The binding of Ca2+/CaM to kir/Gem is required for this inhibitory effect by promoting the cytoplasmic localization of kir/Gem. Inhibition of L-type Ca2+ channels by kir/Gem prevents Ca2+ triggered exocytosis in hormone-secreting cells. We propose that the small G-protein kir/Gem, interacting with beta -subunits, regulates Ca2+ channel expression at the cell surface.	Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, Chiba 2608670, Japan; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Chiba Univ, Pathogen Fungi & Microbial Toxicoses Res Ctr, Chuo Ku, Chiba 2608673, Japan; Chiba Univ, Grad Sch Med, Dept Mol Immunol,CREST, Chuo Ku, Chiba 2608670, Japan; Hokkaido Univ, Grad Sch Vet Med, Lab Anat, Sapporo, Hokkaido 0600818, Japan	Chiba University; University of Lausanne; Chiba University; Chiba University; Japan Science & Technology Agency (JST); Hokkaido University	Seino, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		gonoi, tohru/AAC-5181-2021; , gonoi/GRS-0648-2022	gonoi, tohru/0000-0003-3655-7911; , gonoi/0000-0003-3655-7911				ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Dolphin AC, 1996, TRENDS NEUROSCI, V19, P35, DOI 10.1016/0166-2236(96)81865-0; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kawaki J, 1999, DIABETES, V48, P2001, DOI 10.2337/diabetes.48.10.2001; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	29	223	232	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					701	706		10.1038/35079621	http://dx.doi.org/10.1038/35079621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395774				2022-12-01	WOS:000169112500048
J	Tattersall, DB; Bak, S; Jones, PR; Olsen, CE; Nielsen, JK; Hansen, ML; Hoj, PB; Moller, BL				Tattersall, DB; Bak, S; Jones, PR; Olsen, CE; Nielsen, JK; Hansen, ML; Hoj, PB; Moller, BL			Resistance to an herbivore through engineered cyanogenic glucoside synthesis	SCIENCE			English	Article							BICOLOR L MOENCH; P-HYDROXYPHENYLACETALDEHYDE OXIME; SORGHUM-BICOLOR; CYTOCHROME P-450(TYR); ESCHERICHIA-COLI; L-TYROSINE; DHURRIN; BIOSYNTHESIS; EXPRESSION; PURIFICATION	The entire pathway for synthesis of the tyrosine-derived cyanogenic glucoside dhurrin has been transferred from Sorghum bicolor to Arabidopsis thaliana. Here, we document that genetically engineered plants are able to synthesize and store large amounts of new natural products. The presence of dhurrin in the transgenic A. thaliana plants confers resistance to the flea beetle Phyllotreta nemorum, which is a natural pest of other members of the crucifer group, demonstrating the potential utility of cyanogenic glucosides in plant defense.	Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Ctr Mol Plant Physiol, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Dept Chem, DK-1871 Frederiksberg C, Denmark; Univ Adelaide, Dept Hort Viticulture & Oenol, Glen Osmond, SA 5064, Australia; Australian Wine Res Inst, Glen Osmond, SA 5064, Australia	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Adelaide; Australian Wine Research Institute	Moller, BL (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, 40 Thorvaldsensvej, DK-1871 Frederiksberg C, Denmark.	blm@kvl.dk	Bak, Soren/H-4404-2014; Hoj, Peter B/E-8526-2011; Møller, Birger Lindberg/GQI-1792-2022; Olsen, Carl E/H-3031-2014; Møller, Birger Lindberg/H-2657-2014	Bak, Soren/0000-0003-4100-115X; Møller, Birger Lindberg/0000-0002-3252-3119; Olsen, Carl E/0000-0002-2275-0596; Møller, Birger Lindberg/0000-0002-3252-3119				Bak S, 1999, PLANT J, V20, P663, DOI 10.1046/j.1365-313X.1999.00642.x; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bak S, 2000, PLANT PHYSIOL, V123, P1437, DOI 10.1104/pp.123.4.1437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; FRANZL S, 1985, TISSUE CELL, V17, P267, DOI 10.1016/0040-8166(85)90093-X; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HALKIER BA, 1989, PLANT PHYSIOL, V90, P1552, DOI 10.1104/pp.90.4.1552; HALKIER BA, 1995, ARCH BIOCHEM BIOPHYS, V322, P369, DOI 10.1006/abbi.1995.1477; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; NAHRSTEDT A, 1986, PHYTOCHEMISTRY, V25, P2299, DOI 10.1016/S0031-9422(00)81683-0; Nielsen JK, 1997, ENTOMOL EXP APPL, V82, P25, DOI 10.1023/A:1002990929647; Nielsen JK, 2001, CHEMOECOLOGY, V11, P75, DOI 10.1007/PL00001835; Schappert PJ, 1999, ECOSCIENCE, V6, P511, DOI 10.1080/11956860.1999.11682560; Seigler D.S, 1991, HERBIVORES THEIR INT, V1; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; SIBBESEN O, 1994, P NATL ACAD SCI USA, V91, P9740, DOI 10.1073/pnas.91.21.9740; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; WANG P, 1992, ARCH BIOCHEM BIOPHYS, V298, P569, DOI 10.1016/0003-9861(92)90451-2	22	193	210	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1826	1828		10.1126/science.1062249	http://dx.doi.org/10.1126/science.1062249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11474068				2022-12-01	WOS:000170894400046
J	Bruce, MG; Rosenstein, NE; Capparella, JM; Shutt, KA; Perkins, BA; Collins, M				Bruce, MG; Rosenstein, NE; Capparella, JM; Shutt, KA; Perkins, BA; Collins, M			Risk factors for meningococcal disease in college students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAMPUS BAR PATRONAGE; UNITED-STATES; BACTERIAL-MENINGITIS; INFECTIONS; OUTBREAK; EPIDEMIOLOGY; ASSOCIATION; MYCOPLASMA; CHILDREN; VACCINE	Context Elevated rates of meningococcal disease were noted among 18- to 22-year-olds in the mid-1990's. However, national data on rates of meningococcal disease in US college students were not collected until 1998. Objectives To determine rates of meningococcal disease in US college students and to identify risk factors for meningococcal disease in this population. Design, Setting, and Patients Prospective surveillance study with nested case-control study of US college students with meningococcal infection from September 1, 1998, to August 31, 1999. Fifty state health departments and 231 college health centers participated. Main Outcome Measures incidence of and risk factors for meningococcal disease in US college students. Results Ninety-six cases of meningococcal disease were identified. The incidence rate for undergraduates was 0.7 per 100000 persons vs 1.4 per 100000 for the general population of 18- to 23-year-old nonstudents (P<.001). Freshmen living in dormitories had the highest incidence rate at 5.1 per 100000. Of the 79 case-patients for whom information was available, 54 (68%) had illness due to vaccine-preventable meningococcal serogroups. On multivariable analysis of case-control study data, freshmen who lived in dormitories had an elevated risk of meningococcal disease (matched odds ratio, 3.6; 95% confidence interval, 1.6-8.5; P=.003) compared with other college students. Conclusions Freshmen who live in dormitories have an independent, elevated risk of meningococcal disease compared with other college students. Use of the currently vat available quadrivalent polysaccharide vaccine among college students could substantially decrease their risk of meningococcal disease.	CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Amer Coll Hlth Assoc, Baltimore, MD USA; Univ Penn, Student Hlth Serv, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; University of Pennsylvania	Rosenstein, NE (corresponding author), CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop C-09, Atlanta, GA 30333 USA.			Shutt, Kathleen/0000-0003-3376-6152				Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P13; *AM COLL HLTH ASS, 2001, REC MEN MEN VACC; AYCOCK WL, 1950, BACTERIOL REV, V14, P115, DOI 10.1128/MMBR.14.2.115-160.1950; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BRUNDAGE JF, 1987, EVOLUTION MENINGOCOC, P5; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Douglas KA, 1997, J AM COLL HEALTH, V46, P55, DOI 10.1080/07448489709595589; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; FRANCKE EL, 1981, SURG CLIN N AM, V61, P135; Froeschle JE, 1999, CLIN INFECT DIS, V29, P215, DOI 10.1086/520166; Hall CB, 1996, PEDIATRICS, V97, P404; HANEBERG B, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P169; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; KRASINSKI K, 1987, AM J EPIDEMIOL, V125, P499, DOI 10.1093/oxfordjournals.aje.a114556; MARTONE WJ, 1999, CHANGING EPIDEMIOLOG, P1; Moodley JR, 1999, S AFR MED J, V89, P56; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Neal KR, 1999, EPIDEMIOL INFECT, V122, P351, DOI 10.1017/S0950268899002368; Nelson JD, 1996, NEW ENGL J MED, V335, P885, DOI 10.1056/NEJM199609193351210; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; SAX LJ, 1998, AM FRESHMAN NATL NOR; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; STUART JM, 1988, COMMUNITY MED, V10, P139; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; *UD DEP ED, 1999, NCES PUBL; *US CENS BUR, 1999, US CENS DAT 1998; WOODS CW, 1998, INF DIS SOC AM NOV 1; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102; Yusuf HR, 1999, AM J PUBLIC HEALTH, V89, P712, DOI 10.2105/AJPH.89.5.712; 1997, MMWR MORB MORTAL WKL, V46, P13; 1999, COMMUN DIS REP, V9, P261	40	111	114	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					688	693		10.1001/jama.286.6.688	http://dx.doi.org/10.1001/jama.286.6.688			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495618	Bronze			2022-12-01	WOS:000170271500024
J	Gahan, LJ; Gould, F; Heckel, DG				Gahan, LJ; Gould, F; Heckel, DG			Identification of a gene associated with bit resistance in Heliothis virescens	SCIENCE			English	Article							BACILLUS-THURINGIENSIS TOXINS; CADHERIN SUPERFAMILY; QUANTITATIVE TRAITS; MENDELIAN FACTORS; RECEPTOR; MEMBERS; LEPIDOPTERA; NOCTUIDAE; ENDOTOXIN; CLONING	Transgenic crops producing insecticidal toxins from Bacillus thuringiensis (Bt) are widely used for pest control. Bt-resistant insect strains have been studied, but the molecular basis of resistance has remained elusive. Here, we show that disruption of a cadherin-superfamily gene by retrotransposon-mediated insertion was linked to high levels of resistance to the Et toxin Cry1Ac in the cotton pest Heliothis virescens. Monitoring the early phases of Bt resistance evolution in the field has been viewed as crucial but extremely difficult, especially when resistance is recessive. Our findings enable efficient DNA-based screening for resistant heterozygotes by directly detecting the recessive allele.	Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	University of Melbourne; University of North Carolina; North Carolina State University; Clemson University	Heckel, DG (corresponding author), Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia.		Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150				Arkhipova IR, 1995, DROSOPHILA RETROTRAN; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; *GENB, AF367363 GENB; *GENB, AF367362 GENB; GILL SS, 1995, J BIOL CHEM, V270, P27277, DOI 10.1074/jbc.270.45.27277; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 1997, J ECON ENTOMOL, V90, P75, DOI 10.1093/jee/90.1.75; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Marillonnet S, 1998, GENETICS, V150, P1245; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Suzuki ST, 1996, J CELL BIOCHEM, V61, P531, DOI 10.1002/(SICI)1097-4644(19960616)61:4<531::AID-JCB6>3.0.CO;2-P; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; US EPA, 1998, EPA PUBL; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593	19	451	530	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					857	860		10.1126/science.1060949	http://dx.doi.org/10.1126/science.1060949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486086				2022-12-01	WOS:000170241000043
J	Kozloski, J; Hamzei-Sichani, F; Yuste, R				Kozloski, J; Hamzei-Sichani, F; Yuste, R			Stereotyped position of local synaptic targets in neocortex	SCIENCE			English	Article							RAT VISUAL-CORTEX; CEREBRAL-CORTEX; PROJECTION NEURONS; MORPHOLOGY; MONKEY; CAT; ORGANIZATION; CONNECTIONS; POTENTIALS; LAYER-5	The microcircuitry of the mammalian neocortex remains largely unknown. Although the neocortex could be composed of scores of precise circuits, an alternative possibility is that local connectivity is probabilistic or even random. To examine the precision and degree of determinism in the neocortical microcircuitry, we used optical probing to reconstruct microcircuits in layer 5 from mouse primary visual cortex. We stimulated "trigger" cells, isolated from a homogenous population of corticotectal pyramidal neurons, white optically detecting "follower" neurons directly driven by the triggers. Followers belonged to a few selective anatomical classes with stereotyped physiological and synaptic responses. Moreover, even the position of the followers appeared determined across animals. Our data reveal precisely organized cortical microcircuits.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Kozloski, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.							Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; [Anonymous], 1995, INTRO GEOLOGICAL DAT; Braitenberg VB, 1998, CORTEX STAT GEOMETRY, DOI 10.1007/978-3-662-03733-1; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; CAJAL SRY, 1923, RECUERDOS VIDA HIST; DOUGLAS RJ, 1998, SYNAPTIC ORG BRAIN, pCH12; Fairen A., 1984, CEREB CORTEX, V1, P201; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Lorente de No R., 1949, PHYSL NERVOUS SYSTEM, P274; Lorente de No R., 1922, TRAB LAB BIOL U MADR, V20, P41; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; MOUNTCASTLE VB, 1978, MINDFUL BRAIN, pCH1; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Peters A., 1984, CEREB CORTEX; Ramon y Cajal S, 1904, TEXTURA SISTEMA NERV; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rumberger A, 1998, EXP BRAIN RES, V119, P375, DOI 10.1007/s002210050353; SCHOFIELD BR, 1987, J COMP NEUROL, V261, P85, DOI 10.1002/cne.902610107; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOLNICK B, 1984, P NATL ACAD SCI-BIOL, V81, P3898, DOI 10.1073/pnas.81.12.3898; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; White E.L., 1989, CORTICAL CIRCUITS SY	32	141	143	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					868	872		10.1126/science.293.5531.868	http://dx.doi.org/10.1126/science.293.5531.868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486089				2022-12-01	WOS:000170241000046
J	Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Kaga, K; Ono, T				Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Kaga, K; Ono, T			Retrospective and prospective coding for predicted reward in the sensory thalamus	NATURE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AUDITORY THALAMUS; RECEPTIVE-FIELDS; BASAL GANGLIA; SINGLE UNITS; AMYGDALA; NEURONS; BRAIN; RAT	Reward is important for shaping goal-directed behaviour(1-4). After stimulus-reward associative learning, an organism can assess the motivational value of the incoming stimuli on the basis of past experience (retrospective processing), and predict forthcoming rewarding events (prospective processing)(1-5). The traditional role of the sensory thalamus is to relay current sensory information to cortex. Here we rnd that non-primary thalamic neurons respond to reward-related events in two ways. The early, phasic responses occurred shortly after the onset of the stimuli and depended on the sensory modality. Their magnitudes resisted extinction and correlated with the learning experience. The late responses gradually increased during the cue and delay periods, and peaked just before delivery of the reward. These responses were independent of sensory modality and were modulated by the value and timing of the reward. These observations provide new evidence that single thalamic neurons can code for the acquired significance of sensory stimuli in the early responses (retrospective coding) and predict upcoming reward value in the late responses (prospective coding).	Toyama Med & Pharmaceut Univ, Dept Physiol, Fac Med, Toyama 9300194, Japan; Univ Tokyo, Sch Med, Dept Otorhinolaryngol, Tokyo 1130033, Japan	University of Toyama; University of Tokyo	Ono, T (corresponding author), Toyama Med & Pharmaceut Univ, Dept Physiol, Fac Med, Toyama 9300194, Japan.							[Anonymous], [No title captured]; Bechara A, 1998, J NEUROSCI, V18, P428; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BOUTON ME, 1994, CURR DIR PSYCHOL SCI, V3, P49, DOI 10.1111/1467-8721.ep10769943; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dolan R.J., 2000, NEW COGNITIVE NEUROS; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; GALLISTEL CR, 1991, BEHAV NEUROSCI, V105, P901, DOI 10.1037/0735-7044.105.6.901; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Laberge D, 1990, J Cogn Neurosci, V2, P358, DOI 10.1162/jocn.1990.2.4.358; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; Linke R, 1999, J COMP NEUROL, V403, P158; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; NAKAMURA K, 1987, J NEUROPHYSIOL, V58, P1123, DOI 10.1152/jn.1987.58.5.1123; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; Rainer G, 1999, J NEUROSCI, V19, P5493; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rolls E. T., 1999, BRAIN EMOTION; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sefton Ann Jervie, 1995, P833; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; WINER JA, 1983, J NEUROSCI, V3, P2629; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; [No title captured]	30	183	186	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					546	549		10.1038/35087595	http://dx.doi.org/10.1038/35087595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484055				2022-12-01	WOS:000170202900047
J	Rogers, KC; Forster, CA				Rogers, KC; Forster, CA			The last of the dinosaur titans: a new sauropod from Madagascar	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS	The Titanosauria, the last surviving group of the giant sauropod dinosaurs, attained a near-global distribution by the close of the Cretaceous period (65 Myr ago). With the exception of a few new discoveries in Argentina(1-3), most titanosaurs are known only from fragmentary postcranial skeletons and rare, isolated skull elements(4-9). Here we describe the most complete titanosaur yet discovered. Rapetosaurus krausei gen. et sp. nov., from the Maevarano Formation of Madagascar, provides a view of titanosaur anatomy from head to tail. A total-evidence phylogenetic analysis supports a close relationship between brachiosaurids and titanosaurs (Titanosauriformes(10-13)). The inclusion of cranial data from Rapetosaurus also lays to rest questions concerning the phylogeny of the enigmatic Mongolian genera Nemegtosaurus and Quaesitosaurus(14,15). In spite of their elongated, diplodocoid-like skulls, all three taxa are now firmly nested within Titanosauria.	SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Rogers, KC (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA.							BERMAN DS, 1982, CARNEGIE MUSEUM ANN, V51, P405; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Calvo J.O., 1997, AMEGHINIANA, V34, P534; CALVO JO, 1998, ACTA GEOL LILLOANA, V13, P156; Chatterjee Sankar, 1996, Memoirs of the Queensland Museum, V39, P489; Coria RA, 1999, AMEGHINIANA, V36, P98; Coria Rodolfo A., 1999, National Science Museum Monographs, V15, P47; Curry Rogers K., 1999, 7 INT S MES TERR EC, P20; Deperet C, 1896, B SOC GEOLOGIQUE FRA, V21, P176; Gauthier J., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Gomani Elizabeth M., 1998, Journal of Vertebrate Paleontology, V18, p46A; HUENE F, 1929, CENTRALBLATT MINER B, P493; Krause D.W., 1999, GSA TODAY, V9, P1; KURZANOV SM, 1983, PALEONTOL J, V2, P90; Martinez Ruben, 1998, Journal of Vertebrate Paleontology, V18, p61A; McIntosh J.S., 1990, P345; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; POWELL JE, 1986, THESIS U NACIONALE T; Ravoavy F, 1991, U ANTANANARIVO MEMOI, VII, P55; ROGERS KC, 1999, J VERT PALEONTOL, V19, pA41; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Romer A.S., 1956, OSTEOLOGY REPTILES; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Salgado Leonardo, 1997, Ameghiniana, V34, P3; SWOFFORD DL, 1999, PAUP STAR PHYLOGENET; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; WILSON JA, 1999, EVOLUTIONARY HIST SA	31	164	173	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					530	534		10.1038/35087566	http://dx.doi.org/10.1038/35087566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484051				2022-12-01	WOS:000170202900043
J	Gustafson, P; Gomes, VF; Vieira, CS; Jensen, H; Seng, R; Norberg, R; Samb, B; Naucler, A; Aaby, P				Gustafson, P; Gomes, VF; Vieira, CS; Jensen, H; Seng, R; Norberg, R; Samb, B; Naucler, A; Aaby, P			Tuberculosis mortality during a civil war in Guinea-Bissau	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMPACT; INFECTIONS; DIAGNOSIS; DISTRICT; ABIDJAN; AFRICA; MALAWI	Context Tuberculosis (TB) is an increasing global problem, despite effective drug therapies. Access to TB therapy during conflict situations has not been studied. Objective To determine the effect of irregular TB treatment due to an armed conflict in Guinea-Bissau, West Africa. Design, Setting, and Patients Ongoing retrospective cohort study conducted in the capital city of Bissau among 101 patients with TB who received irregular or no treatment during the civil war (war cohort; June 7-December 6, 1998) and 108 patients with TB who received treatment 12 months earlier (peace cohort; June 7-December 6,1997) and comparison of an additional 42 patients who had completed treatment before June 6, 1998, and 69 patients who had completed treatment before June 6, 1997. Main Outcome Measure Mortality rates, compared by irregular (war cohort) vs regular (peace cohort) access to treatment, by intensive vs continuation phase of treatment, and by those who had previously completed treatment for TB. Results Irregular treatment was associated with an increased mortality rate among patients with TB. The mortality rate ratio (MR) was 3.12 (95% confidence interval [CI], 1.20-8.12) in the war cohort, adjusting for age, sex, human immunodeficiency virus (HIV) infection, residence, and length of treatment. Each additional week of treatment before the war started increased probability of survival by 5% (95% CI, 0%-10%). In the intensive phase of treatment, the adjusted MR was 3.30 (95% CI, 1.04-10.50) and in the continuation phase it was 2.26 (95% CI, 0.33-15.34). Increased mortality among the war cohort was most marked in HIV-positive patients, who had an adjusted MR of 8.19 (95% CI, 1.62-41.25). Mortality was not increased in HIV-positive or HIV-negative patients who had completed TB treatment when the war started. Conclusions Interruption of treatment had a profound impact on mortality among patients with TB during the war in Guinea-Bissau. Regular treatment for TB was associated with significantly improved survival for HIV-infected individuals. In emergencies, it is crucial to ensure availability of TB drugs.	Malmo Univ Hosp, Dept Infect Dis, S-20502 Malmo, Sweden; Hosp Raoul Follereau, Bissau, Guinea Bissau; State Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark; IMEA, INSERM, U88, Paris, France; Karolinska Inst, Swedish Inst Infect Dis Control, Stockholm, Sweden	Lund University; Skane University Hospital; Aarhus University; Statens Serum Institut; Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; Swedish Institute for Infectious Disease Control	Gustafson, P (corresponding author), Malmo Univ Hosp, Dept Infect Dis, S-20502 Malmo, Sweden.	Per.Gustafson@inf.mas.lu.se		Aaby, Peter/0000-0001-8331-1389				Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Andersson S, 1997, AIDS, V11, P1815, DOI 10.1097/00002030-199715000-00005; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; DATTA M, 1993, TUBERCLE LUNG DIS, V74, P180, DOI 10.1016/0962-8479(93)90008-L; DECOCK KM, 1991, BMJ-BRIT MED J, V302, P496, DOI 10.1136/bmj.302.6775.496; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; KREBS W, 1930, BEITR KLIN TUBERK, P345; LINCOLN EM, 1947, AM REV TUBERC PULM, V56, P95; LINCOLN EM, 1947, AM REV TUBERC PULM, V56, P75; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; NAUCLER A, 1991, AIDS, V5, P301, DOI 10.1097/00002030-199103000-00009; OBrien JK, 1997, CHEST, V112, P387, DOI 10.1378/chest.112.2.387; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Thompson BC, 1943, BRIT MED J, V1943, P721, DOI 10.1136/bmj.2.4326.721; THOMPSON BC, 1940, TUBERCLE, P217; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Walther-Jallow L, 1999, AIDS RES HUM RETROV, V15, P957, DOI 10.1089/088922299310467; WHO, 1997, MID IMP US ANT FOOD; Zellweger JP, 1998, INT J TUBERC LUNG D, V2, P372	27	43	46	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					599	603		10.1001/jama.286.5.599	http://dx.doi.org/10.1001/jama.286.5.599			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476664				2022-12-01	WOS:000170188300025
J	Schwetz, BA				Schwetz, BA			New oral contraceptive	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-01	WOS:000170188300003
J	Wells, PS; Anderson, DR; Rodger, M; Stiell, I; Dreyer, JF; Barnes, D; Forgie, M; Kovacs, G; Ward, J; Kovacs, MJ				Wells, PS; Anderson, DR; Rodger, M; Stiell, I; Dreyer, JF; Barnes, D; Forgie, M; Kovacs, G; Ward, J; Kovacs, MJ			Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; ANGIOGRAPHY; ULTRASONOGRAPHY; SCINTIGRAPHY; PROBABILITY; UTILITY; SCAN; CT	Background: The limitations of the current diagnostic standard, ventilation-perfusion lung scanning, complicate the management of patients with suspected pulmonary embolism. We previously demonstrated that determining the pretest probability can assist with management and that the high negative predictive value of certain D-dimer assays may simplify the diagnostic process. Objective: To determine the safety of using a simple clinical model combined with D-dimer assay to manage patients presenting to the emergency department with suspected pulmonary embolism. Design: Prospective cohort study. Setting: Emergency departments at four tertiary care hospitals in Canada. Patients: 930 consecutive patients with suspected pulmonary embolism. Interventions: Physicians first used a clinical model to determine patients' pretest probability of pulmonary embolism and then performed a D-dimer test. Patients with low pretest probability and a negative D-dimer result had no further tests and were considered to have a diagnosis of pulmonary embolism excluded. All other patients underwent ventilation-perfusion lung scanning. If the scan was nondiagnostic, bilateral deep venous ultrasonography was done. Whether further testing (by serial ultrasonography or angiography) was done depended on the patients' pretest probability and the lung scanning results. Measurements: Patients received a diagnosis of pulmonary embolism if they had a high-probability ventilation-perfusion scan, an abnormal result on ultrasonography or pulmonary angiography, or a venous thromboembolic event during follow-up. Patients for whom the diagnosis was considered excluded were followed up for 3 months for the development of thromboembolic events. Results: The pretest probability of pulmonary embolism was low, moderate, and high in 527, 339, and 64 patients (1.3%, 16.2%, and 37.5% had pulmonary embolism), respectively. Of 849 patients in whom a diagnosis of pulmonary-embolism had initially been excluded, 5 (0.6% [95% CI, 0.2% to 1.4%]) developed pulmonary embolism or deep venous thrombosis during followup. However, 4 of these patients had not undergone the proper diagnostic testing protocol. In 7 of the patients who received a diagnosis of pulmonary embolism, the physician had performed more diagnostic tests than were called for by the algorithm. In 759 of the 849 patients in whom pulmonary embolism was not found on initial evaluation, the diagnostic protocol was followed correctly. Only 1 (0.1% [CI, 0.0% to 0.7%]) of these 759 patients developed thromboembolic events during follow-up. Of the 437 patients with a negative D-dimer result and low clinical probability, only 1 developed pulmonary embolism during follow-up; thus, the negative predictive value for the combined strategy of using the clinical model with D-dimer testing in these patients was 99.5% (CI, 99.1% to 100%). Conclusion: Managing patients for suspected pulmonary embolism on the basis of pretest probability and sigma -dimer result is safe and decreases the need for diagnostic imaging.	Univ Ottawa, Ottawa, ON K1N 6N5, Canada; Univ Western Ontario, London, ON N6A 3K7, Canada; Dalhousie Univ, Halifax, NS B3H 3J5, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; Western University (University of Western Ontario); Dalhousie University; University of British Columbia	Wells, PS (corresponding author), Suite 452,737 Parkdale Ave, Ottawa, ON K1Y 1J8, Canada.		Kovacs, Michael/G-3315-2011	Rodger, Marc/0000-0001-8166-3487; Stiell, Ian/0000-0002-2583-6408; Anderson, David/0000-0003-0845-1722				Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bauld DL, 1999, AM J EMERG MED, V17, P11, DOI 10.1016/S0735-6757(99)90004-9; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; Farrell S, 2000, ANN EMERG MED, V35, P121, DOI 10.1016/S0196-0644(00)70130-2; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; FRANKEL N, 1986, J NUCL MED, V27, P366; Gupta A, 1999, RADIOLOGY, V210, P353, DOI 10.1148/radiology.210.2.r99fe53353; HEIJBOER H, 1992, ACTA RADIOL, V33, P297; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; Kember PG, 1997, BRIT J RADIOL, V70, P1109, DOI 10.1259/bjr.70.839.9536900; LENSING AWA, 1992, THROMB HAEMOSTASIS, V68, P245; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; Schluger N, 1994, J Thorac Imaging, V9, P180, DOI 10.1097/00005382-199422000-00013; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; 1990, JAMA, V263, P2753	21	931	970	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					98	107		10.7326/0003-4819-135-2-200107170-00010	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453709				2022-12-01	WOS:000169842300003
J	Eggenschwiler, JT; Espinoza, E; Anderson, KV				Eggenschwiler, JT; Espinoza, E; Anderson, KV			Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway	NATURE			English	Article							NEURAL-TUBE; OPEN BRAIN; GENE; MICE; CHOLESTEROL; SPECIFICITY; MUTATION; DEFECTS; FAMILY; DORSAL	The mouse open brain (opb) and Sonic hedgehog (Shh) genes have opposing roles in neural patterning: opb is required for dorsal cell types and Shh is required for ventral cell types in the spinal cord(1-3). Here we show that opb acts downstream of Shh. Ventral cell types that are absent in Shh mutants, including the floor plate, are present in Shh opb double mutants. The organization of ventral cell types in Shh opb double mutants reveals that Shh-independent mechanisms can pattern the neural tube along its dorsal-ventral axis. We cloned opb by a map-based approach and found that it encodes Rab23, a member of the Rab family of vesicle transport proteins. The data indicate that dorsalizing signals activate transcription of Rab23 in order to silence the Shh pathway in dorsal neural cells.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org		Anderson, Kathryn/0000-0003-1657-2161				Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; FORBES AJ, 1993, DEVELOPMENT, P115; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Liem KF, 2000, DEVELOPMENT, V127, P4855; LITINGTUNG Y, 2000, NAT NEUROSCI, V10, P979; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Methot N, 2001, DEVELOPMENT, V128, P733; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Mo R, 1997, DEVELOPMENT, V124, P113; OLKKONEN VM, 1994, GENE, V138, P207, DOI 10.1016/0378-1119(94)90809-5; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797	30	283	295	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					194	198		10.1038/35084089	http://dx.doi.org/10.1038/35084089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449277				2022-12-01	WOS:000169778700055
J	Melnick, GJ; Neufeld, DA; Ford, KES; Hollenbach, DJ; Ashby, MLN				Melnick, GJ; Neufeld, DA; Ford, KES; Hollenbach, DJ; Ashby, MLN			Discovery of water vapour around IRC+10216 as evidence for comets orbiting another star	NATURE			English	Article							WAVE-ASTRONOMY-SATELLITE; SUBMILLIMETER; MILLIMETER; MOLECULES; SPECTRUM; LINES; HCN	Since 1995, planets with masses comparable to that of Jupiter have been discovered around approximately 60 stars(1). These planets have not been seen directly, but their presence has been inferred from the small reflex motions that they gravitationally induce on the star they orbit; these motions result in small periodic wavelength shifts in the stellar spectrum. The presence of analogues of the smaller bodies in our Solar System cannot, however, be determined using this technique, because the induced reflex motions are too small-so an alternative approach is needed. Here we report the observation of circumstellar water vapour around the ageing carbon star IRC+10216; water is not expected in measurable quantities around such a star. The only plausible explanation for this water is that the recent evolution of IRC+10216, which has been accompanied by a prodigious increase in its luminosity, is causing the vaporization of a collection of orbiting icy bodies-a process considered in an earlier theoretical study(2).	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Melnick, GJ (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.							Ashby MLN, 2000, ASTROPHYS J, V539, pL115, DOI 10.1086/312842; Cernicharo J, 1999, ASTROPHYS J, V526, pL41, DOI 10.1086/312360; Cernicharo J, 1996, ASTRON ASTROPHYS, V315, pL201; DELUCIA FC, 1977, J CHEM PHYS, V67, P4262, DOI 10.1063/1.435363; Glassgold AE, 1996, ANNU REV ASTRON ASTR, V34, P241, DOI 10.1146/annurev.astro.34.1.241; Herpin F, 2000, ASTROPHYS J, V530, pL129, DOI 10.1086/312507; Hogerheijde MR, 2000, ASTRON ASTROPHYS, V362, P697; Jewitt D. C., 2000, Protostars and planets 4, P1201; Marcy GW, 2000, PUBL ASTRON SOC PAC, V112, P137, DOI 10.1086/316516; Melnick GJ, 2000, ASTROPHYS J, V539, pL77, DOI 10.1086/312856; Millar TJ, 2000, MON NOT R ASTRON SOC, V316, P195, DOI 10.1046/j.1365-8711.2000.03560.x; Neufeld DA, 1999, ASTROPHYS J, V517, pL147, DOI 10.1086/312036; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; Skinner CJ, 1999, MON NOT R ASTRON SOC, V302, P293, DOI 10.1046/j.1365-8711.1999.02113.x; STERN SA, 1990, NATURE, V345, P305, DOI 10.1038/345305a0; Willacy K, 1998, ASTRON ASTROPHYS, V330, P676; WILLIAMS PG, 1992, ASTRON ASTROPHYS, V266, P365; WOOLF NJ, 1964, ASTROPHYS J, V140, P833, DOI 10.1086/147989	18	109	110	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					160	163		10.1038/35084024	http://dx.doi.org/10.1038/35084024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449266				2022-12-01	WOS:000169778700044
J	Lilburn, TC; Kim, KS; Ostrom, NE; Byzek, KR; Leadbetter, JR; Breznak, JA				Lilburn, TC; Kim, KS; Ostrom, NE; Byzek, KR; Leadbetter, JR; Breznak, JA			Nitrogen fixation by symbiotic and free-living spirochetes	SCIENCE			English	Article							RETICULITERMES FLAVIPES; PHYLOGENETIC DIVERSITY; MICROBIAL COMMUNITY; LOWER TERMITE; GUT; GENES; ACETOGENESIS; DEPENDENCE; INHIBITION; MICROFLORA	Spirochetes from termite hindguts and freshwater sediments possessed homologs of a nitrogenase gene (nifH) and exhibited nitrogenase activity, a previously unrecognized metabolic capability in spirochetes. Fixation of 15-dinitrogen was demonstrated with termite gut Treponema ZAS-9 and free-living Spirochaeta aurantia. Homologs of nifH were also present in human oral and bovine ruminal treponemes. Results implicate spirochetes in the nitrogen nutrition of termites, whose food is typically Low in nitrogen, and in global nitrogen cycling. These results also proffer spirochetes as a Likely origin of certain nifHs observed in termite guts and other environments that were not previously attributable to known microbes.	Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; Michigan State Univ, Ribosomal Database Project, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; CALTECH, Pasadena, CA 91125 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; California Institute of Technology	Breznak, JA (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.			Leadbetter, Jared/0000-0002-7033-0844				BOLLAG DM, 1991, PROTEIN METHODS, P45; Breznak JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P209; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; CANALEPAROLA E, 1992, PROKARYOTES HDB BIOL, V4, P3524; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Dean D.R., 1992, BIOL NITROGEN FIXATI, P763; DILWORTH MJ, 1987, NATURE, V327, P167, DOI 10.1038/327167a0; Ebert A, 1997, APPL ENVIRON MICROB, V63, P4039, DOI 10.1128/AEM.63.10.4039-4046.1997; EUTICK ML, 1978, J INSECT PHYSIOL, V24, P363, DOI 10.1016/0022-1910(78)90076-8; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GARRITY GM, 2000, BERGEYS MANUAL SYSTE, P1; GRABER JR, 2000, AM SOC MICR ABSTR, P475; GUTH JH, 1983, BIOCHEMISTRY-US, V22, P5111, DOI 10.1021/bi00291a010; Kessler PS, 1997, J BACTERIOL, V179, P541, DOI 10.1128/jb.179.2.541-543.1997; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TG, 1999, ENVIRON MICROBIOL, V1, P331; MADDEN MS, 1991, J BACTERIOL, V173, P5403, DOI 10.1128/jb.173.17.5403-5405.1991; MILLER JN, 1992, PROKARYOTES, V4, P3537; MINIGAWA M, 1985, ANAL CHEM, V56, P1859; Neidhardt F.C., 1990, PHYSL BACTERIAL CELL; Noda S, 1999, APPL ENVIRON MICROB, V65, P4935; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P2747, DOI 10.1128/AEM.62.8.2747-2752.1996; Paster BJ, 1996, APPL ENVIRON MICROB, V62, P347, DOI 10.1128/AEM.62.2.347-352.1996; Postgate J.R., 1972, METHODS MICROBIOLOGY, P343, DOI [10.1016/s0580-9517(08)70604-4, DOI 10.1016/S0580-9517(08)70604-4]; RASCHE ME, 1989, PLANT PHYSIOL, V91, P663, DOI 10.1104/pp.91.2.663; SCHULTZ JE, 1978, APPL ENVIRON MICROB, V35, P930, DOI 10.1128/AEM.35.5.930-936.1978; STANTON TB, 1980, ARCH MICROBIOL, V127, P145, DOI 10.1007/BF00428018; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1111/j.1574-6941.1997.tb00430.x; Weinbauer MG, 1998, APPL ENVIRON MICROB, V64, P5000; YOUNG JPW, 1992, BIOL NITROGEN FIXATI, P43	35	175	188	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2495	2498		10.1126/science.1060281	http://dx.doi.org/10.1126/science.1060281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431569				2022-12-01	WOS:000169658200043
J	Georgellis, D; Kwon, O; Lin, ECC				Georgellis, D; Kwon, O; Lin, ECC			Quinones as the redox signal for the Arc two-component system of bacteria	SCIENCE			English	Article							SENSOR-REGULATOR PROTEIN; ESCHERICHIA-COLI; ANAEROBIC REPRESSION; IN-VITRO; TRANSDUCTION; BINDING; GENE; PHOSPHORELAY; REQUIREMENT; PROMOTER	The Arc two-component signal transduction system mediates adaptive responses of Escherichia coli to changing respiratory conditions of growth. Under anaerobic conditions, the ArcB sensor kinase autophosphorylates and then transphosphorylates ArcA, a global transcriptional regulator that controls the expression of numerous operons involved in respiratory or fermentative metabolism. We show that oxidized forms of quinone electron carriers act as direct negative signals that inhibit autophosphorylation of ArcB during aerobiosis. Thus, the Arc signal transduction system provides a link between the electron transport chain and gene expression.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lin, ECC (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	elin@hms.harvard.edu	Georgellis, Dimitris/U-2517-2017	Georgellis, Dimitris/0000-0002-6114-795X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040993] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40993] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; BRONDSTED L, 1994, J BACTERIOL, V176, P5423; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; GEORGELLIS D, UNPUB; Hoch JA, 1995, 2 COMPONENT SIGNAL T; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1992, J BACTERIOL, V174, P3972, DOI 10.1128/jb.174.12.3972-3980.1992; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; Lynch A. Simon, 1996, P361; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; LYNCH AS, 1996, ESCHERICHIA COLI SAL, V1, P1526; Magasanik B., 1996, ESCHERICHIA COLI SAL, P1344; McGuire AM, 1999, MOL MICROBIOL, V32, P219, DOI 10.1046/j.1365-2958.1999.01347.x; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Pellicer MT, 1999, MOL GEN GENET, V261, P170, DOI 10.1007/s004380050954; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; SAWERS G, 1992, J BACTERIOL, V174, P3474, DOI 10.1128/JB.174.11.3474-3478.1992; SILVERMAN PM, 1991, J MOL BIOL, V220, P271, DOI 10.1016/0022-2836(91)90012-U; Soballe B, 1998, MICROBIOL-UK, V144, P361, DOI 10.1099/00221287-144-2-361	29	364	374	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2314	2316		10.1126/science.1059361	http://dx.doi.org/10.1126/science.1059361			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423658				2022-12-01	WOS:000169455900053
J	Istre, GR; McCoy, MA; Osborn, L; Barnard, JJ; Bolton, A				Istre, GR; McCoy, MA; Osborn, L; Barnard, JJ; Bolton, A			Deaths and injuries from house fires.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Public-Health-Association	NOV 15-16, 2000	BOSTON, MASSACHUSETTS	Amer Public Hlth Assoc			FATAL RESIDENTIAL FIRES; HOMES	Background: We sought to define the factors associated with house fires and related injuries by analyzing the data from population-based surveillance. Methods: For 1991 through 1997, we linked the following data for Dallas: records from the fire department of all house fires (excluding fires in apartments and mobile homes), records of patients transported by ambulance, hospital admissions, and reports from the medical examiner of fatal injuries. Results: There were 223 injuries (91 fatal and 132 nonfatal) from 7190 house fires, for a rate of 5.2 injured persons per 100,000 population per year. Rates of injury related to house fires were highest among blacks (relative risk, 2.8; 95 percent confidence interval, 2.1 to 3.6) and in people 65 years of age or older (relative risk, 2.6; 95 percent confidence interval, 1.9 to 3.5). Census tracts with low median incomes had the highest rates of injury related to house fires (relative risk as compared with census tracts with high median incomes, 8.1; 95 percent confidence interval, 2.5 to 32.0). The rate of injuries was higher for fires that began in bedrooms or living areas (relative risk, 3.7); that were started by heating equipment, smoking, or children playing with fire (relative risk, 2.6); or that occurred in houses built before 1980 (relative risk, 6.6). Injuries occurred more often in houses without functioning smoke detectors (relative risk, 1.5; 95 percent confidence interval, 1.0 to 2.4). The prevalence of functioning smoke detectors was lowest in houses in the census tracts with the lowest median incomes (P<0.001). Conclusions: Rates of injuries related to house fires are highest in elderly, minority, and low-income populations and in houses without functioning smoke detectors. Efforts to prevent injuries and deaths from house fires should target these populations. (N Engl J Med 2001;344:1911-6.) Copyright (C) 2001 Massachusetts Medical Society.	Injury Prevent Ctr Greater Dallas, Dallas, TX 75235 USA; PID Associates, Dallas, TX USA; Dallas Fire Dept, Dallas, TX USA; Dallas Fir, Off Chief Med Examiner Dallas Cty, Dallas, TX USA; Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Istre, GR (corresponding author), Injury Prevent Ctr Greater Dallas, POB 36067, Dallas, TX 75235 USA.							Bonnie RJ, 1999, REDUCING BURDEN INJU; Dean A.G., 1994, EPI INFO VERSION 6 W; Douglas MR, 1999, AM J PUBLIC HEALTH, V89, P1112, DOI 10.2105/AJPH.89.7.1112; *FED EM MAN AG, 1997, SOC FACT INC FIR; *FIR ADM, 1999, FIR US 1987 1996; GORMAN RL, 1985, PEDIATRICS, V75, P14; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; HEMENWAY D, 1990, Q J ECON, V105, P1063, DOI 10.2307/2937886; ISTRE GR, 1992, PUBLIC HEALTH SURVEILLANCE, P42; Johnson S. W., 1996, 808338 NHTSA DOT HS; Mallonee S, 1996, NEW ENGL J MED, V335, P27, DOI 10.1056/NEJM199607043350106; Marshall SW, 1998, JAMA-J AM MED ASSOC, V279, P1633, DOI 10.1001/jama.279.20.1633; MCLOUGHLIN E, 1985, AM J PUBLIC HEALTH, V75, P858, DOI 10.2105/AJPH.75.8.858; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; MIERLEY MC, 1983, JAMA-J AM MED ASSOC, V249, P1466, DOI 10.1001/jama.249.11.1466; PICKENS S, 2000, DALLAS MED J, V86, P251; ROBERTS I, 1995, BRIT MED J, V311, P1381, DOI 10.1136/bmj.311.7017.1381; RUNYAN CW, 1992, NEW ENGL J MED, V327, P859, DOI 10.1056/NEJM199209173271207; Selvin S., 1996, STAT ANAL EPIDEMIOLO, V2nd; SHULTS R, 1996, EFFORTS INCREASE SMO; Thacker SB, 1996, FIELD EPIDEMIOLOGY, P16; WOODWARD M, 1999, EPIDEMIOLOGY STUDY D, P476	22	121	123	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2001	344	25					1911	1916		10.1056/NEJM200106213442506	http://dx.doi.org/10.1056/NEJM200106213442506			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443VJ	11419429				2022-12-01	WOS:000169362100006
J	Lutzoni, F; Pagel, M; Reeb, V				Lutzoni, F; Pagel, M; Reeb, V			Major fungal lineages are derived from lichen symbiotic ancestors	NATURE			English	Article							DISCRETE CHARACTERS; PHYLOGENY; EVOLUTIONARY; ORIGINS	About one-fifth of all known extant fungal species form obligate symbiotic associations with green algae, cyanobacteria or with both photobionts. These symbioses, known as lichens, are one way for fungi to meet their requirement for carbohydrates(1,2). Lichens are widely believed to have arisen independently on several occasions, accounting for the high diversity and mixed occurrence of lichenized and non-lichenized (42 and 58%, respectively) fungal species within the Ascomycota(3,4). Depending on the taxonomic classification chosen(2,5,6), 15-18 orders of the Ascomycota include lichen-forming taxa, and 8-11 of these orders (representing about 60% of the Ascomycota species) contain both lichenized and non-lichenized species. Here we report a phylogenetic comparative analysis of the Ascomycota, a phylum that includes greater than 98% of known lichenized fungal species 5. Using a Bayesian phylogenetic tree sampling methodology(7,8) combined with a statistical model of trait evolution(9), we take into account uncertainty about the phylogenetic tree and ancestral state reconstructions. Our results show that lichens evolved earlier than believed, and that gains of lichenization have been infrequent during Ascomycota evolution, but have been followed by multiple independent losses of the lichen symbiosis. As a consequence, major Ascomycota lineages of exclusively non-lichen-forming species are derived from lichen-forming ancestors. These species include taxa with important benefits and detriments to humans, such as Penicillium and Aspergillus(10-12).	Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	Field Museum of Natural History (Chicago); University of Reading; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lutzoni, F (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.							Alexopoulos C. J., 1996; BARINAGA M, 1995, SCIENCE, V268, P1437, DOI 10.1126/science.7770768; BERBEE ML, 1995, MYCOLOGIA, V87, P210, DOI 10.2307/3760907; BERBEE ML, 1995, CAN J BOT, V73, pS677; Berbee ML, 2000, MOL PHYLOGENET EVOL, V17, P337, DOI 10.1006/mpev.2000.0835; Bhattacharya D, 2000, MOL BIOL EVOL, V17, P1971, DOI 10.1093/oxfordjournals.molbev.a026298; COLLINS TM, 1994, SYST BIOL, V43, P482, DOI 10.2307/2413547; Elix J. A., 1996, P154; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Hafellner J., 1988, HDB LICHENOLOGY, P41; Hawksworth D.L., 1995, DICT FUNGI, V8th; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hillis DM, 1996, MOL SYSTEMATICS; Honegger R., 1996, P24; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Kranner I., 1999, PLANT RESPONSES ENV, P591; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; LUTZONI F, 1995, CRYPTOG BOT, V5, P82; Lutzoni FM, 1997, SYST BIOL, V46, P373, DOI 10.1093/sysbio/46.3.373; MADDISON DR, 1994, ANNU REV ENTOMOL, V39, P267, DOI 10.1146/annurev.en.39.010194.001411; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Rambold G., 1992, BIBLIOTHECA LICHENOL, V48, P1; SPATAFORA JW, 1995, CAN J BOT, V73, pS811, DOI 10.1139/b95-326; Suh SO, 1999, MYCOLOGIA, V91, P836, DOI 10.2307/3761537; Wilson IJ, 1998, GENETICS, V150, P499	30	378	402	12	132	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					937	940		10.1038/35082053	http://dx.doi.org/10.1038/35082053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418855				2022-12-01	WOS:000169386200041
J	Osterwalder, J				Osterwalder, J			Portal hypertension - Where is evidence for 5% dextrose and pulmonary artery catheter?	BRITISH MEDICAL JOURNAL			English	Letter									Kantonsspital, CH-9007 St Gallen, Switzerland	Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen	Osterwalder, J (corresponding author), Kantonsspital, CH-9007 St Gallen, Switzerland.							Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; DEREK A, 2001, BRIT MED J, V322, P446; Krige JEJ, 2001, BRIT MED J, V322, P348, DOI 10.1136/bmj.322.7282.348	3	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2001	322	7300					1492	1492		10.1136/bmj.322.7300.1492	http://dx.doi.org/10.1136/bmj.322.7300.1492			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11430380	Green Published			2022-12-01	WOS:000169389200065
J	Mullen, AC; High, FA; Hutchins, AS; Lee, HW; Villarino, AV; Livingston, DM; Kung, AL; Cereb, N; Yao, TP; Yang, SY; Reiner, SL				Mullen, AC; High, FA; Hutchins, AS; Lee, HW; Villarino, AV; Livingston, DM; Kung, AL; Cereb, N; Yao, TP; Yang, SY; Reiner, SL			Role of T-bet in commitment of T(H)1 cells before IL-12-dependent selection	SCIENCE			English	Article							CYTOKINE GENE-EXPRESSION; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCER; TH2 CELLS; ACTIVATION; RESPONSES; STAT6; IL-4; DIFFERENTIATION; INTERLEUKIN-4	How cytokines control differentiation of helper T (T-H) cells is controversial. We show that T-bet, without apparent assistance from interleukin 12 (IL-12)/ STAT4, specifies T(H)1 effector fate by targeting chromatin remodeling to individual interferon-gamma (IFN-gamma) alleles and by inducing IL-12 receptor beta2 expression. Subsequently, it appears that IL-12/STAT4 serves two essential functions in the development of T(H)1 cells: as growth signal, inducing survival and cell division; and as trans-activator, prolonging IFN-gamma synthesis through a genetic interaction with the coactivator, CREB-binding protein. These results suggest that a cytokine does not simply induce T-H fate choice but instead may act as an essential secondary stimulus that mediates selective survival of a lineage.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Histogenet Inc, Hawthorne, NY 10532 USA; Ctr Genet Polymorphism, Hawthorne, NY 10532 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Duke University	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Mullen, Alan/0000-0002-4096-3106; Villarino, Alejandro/0000-0001-8068-2176	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370] Funding Source: NIH RePORTER; NEI NIH HHS [EY-07131] Funding Source: Medline; NIAID NIH HHS [AI-42370] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kung AL, 2000, GENE DEV, V14, P272; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MULLEN AC, UNPUB; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Zhang WX, 2000, GENOMICS, V70, P41, DOI 10.1006/geno.2000.6361; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	28	645	691	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1907	1910		10.1126/science.1059835	http://dx.doi.org/10.1126/science.1059835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397944				2022-12-01	WOS:000169200700048
J	Boers, M				Boers, M			NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; COMPLICATIONS; MISOPROSTOL; MORTALITY; ASPIRIN; RISK		Free Univ Amsterdam Hosp, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Boers, M (corresponding author), Free Univ Amsterdam Hosp, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands.	j.wildbret@azvu.nl						Aranow C, 2000, LUPUS, V9, P166, DOI 10.1191/096120300678828208; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Chan FKL, 1998, NEW ENGL J MED, V339, P349; CLELAND JGF, 1995, BRIT HEART J, V74, P215; Dickinson JP, 1998, QJM-INT J MED, V91, P523, DOI 10.1093/qjmed/91.8.523; Hawkey CJ, 2000, BMJ-BRIT MED J, V321, P291, DOI 10.1136/bmj.321.7256.291; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Isles C, 1999, LANCET, V353, P148, DOI 10.1016/S0140-6736(05)76185-7; MUTRU O, 1989, CARDIOLOGY, V76, P71, DOI 10.1159/000174474; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445	13	45	47	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1222	1223		10.1016/S0140-6736(00)04451-2	http://dx.doi.org/10.1016/S0140-6736(00)04451-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418144				2022-12-01	WOS:000168323300006
J	Matte, TD; Bresnahan, M; Begg, MD; Susser, E				Matte, TD; Bresnahan, M; Begg, MD; Susser, E			Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; GROWTH	Objective To examine the relation between birth weight and measured intelligence at age 7 years in children within the normal range of birth weight and in siblings. Design Cohort study of siblings of the same sex. Setting 12 cities in the United States. Subjects 3484 children of 1683 mothers in a birth cohort study during the years 1959 through 1966. The sample was restricted to children born at greater than or equal to 37 weeks gestation and with birth weights of 1500-3999 g. Main outcome measure Full scale IQ at age 7 years. Results Mean IQ increased monotonically with birth weight in both sexes across the range of birth weight in a linear regression analysis of one randomly selected sibling per family (n = 1683) with adjustment for maternal age, race, education, socioeconomic status, and birth order. Within same sex sibling pairs, differences in birth weight were directly associated with differences in IQ in boys (812 pairs, predicted IQ difference per 100 g change in birth weight = 0.50, 95% confidence interval 0.28 to 0.71) but not girls (871 pairs, 0.10, - 0.09 to 0.30). The effect in boys remained after differences in birth order, maternal smoking, and head circumference were adjusted for and in an analysis restricted to children with birth weight greater than or equal to 2500 g. Conclusion The increase in childhood IQ with birth weight continues well into the normal birth weight range. For boys this relation holds within same sex sibships and therefore cannot be explained by confounding from family social environment.	New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY 10029 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, Div Biostat, New York, NY 10032 USA	New York Academy of Medicine; Columbia University; Columbia University	Matte, TD (corresponding author), New York Acad Med, Ctr Urban Epidemiol Studies, 1216 5th Ave, New York, NY 10029 USA.							[Anonymous], 1999, NATL VITAL STAT REPO; BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; BRESLAU N, 1994, ARCH PEDIAT ADOL MED, V148, P377, DOI 10.1001/archpedi.1994.02170040043007; Broman SH, 1984, HDB LONGITUDINAL RES, V1; *COLL PER PROJ EL, 1958, REC NAT I NEUR DIS S; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; HARDY JB, 1977, EPIDEMIOLOGY PREMATU; Hutchison JB, 1997, CELL MOL NEUROBIOL, V17, P603, DOI 10.1023/A:1022581902880; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; MYRIANTHOPOULOS NC, 1968, SOC SCI MED, V2, P283, DOI 10.1016/0037-7856(68)90004-8; NISWANDER NR, 1972, WOMEN THEIR PREGNANC; RECORD RG, 1969, ANN HUM GENET, V33, P71, DOI 10.1111/j.1469-1809.1969.tb01631.x; Richter CP., 1922, PSYCHOL MONOGR, V1, P1; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Stein Z., 1975, FAMINE HUM DEV DUTCH; Strauss RS, 1998, J PEDIATR-US, V133, P67, DOI 10.1016/S0022-3476(98)70180-5; Wechsler D., 2016, WECHSLER INTELLIGENC, V5th	18	217	220	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					310	314		10.1136/bmj.323.7308.310	http://dx.doi.org/10.1136/bmj.323.7308.310			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498487	Green Published, Bronze			2022-12-01	WOS:000170470900018
J	Lo, WS; Duggan, L; Emre, NCT; Belotserkovskya, R; Lane, WS; Shiekhattar, R; Berger, SL				Lo, WS; Duggan, L; Emre, NCT; Belotserkovskya, R; Lane, WS; Shiekhattar, R; Berger, SL			Snf1 - a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription	SCIENCE			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; H3 PHOSPHORYLATION; PROTEIN-KINASE; ADA-COMPLEX; YEAST; ACETYLATION; PHOSPHATASE; REPRESSION; ACTIVATION	Modification of histories is an important element in the regulation of gene expression. Previous work suggested a link between acetylation and phosphorylation, but questioned its mechanistic basis. We have purified a histone H3 serine-10 kinase complex from Saccharomyces cerevisiae and have identified its catalytic subunit as Snf1. The Snf1/AMPK family of kinases function in conserved signal transduction pathways. Our results show that Snf1 and the acetyltransferase Gcn5 function in an obligate sequence to enhance INO1 transcription by modifying histone H3 serine-10 and lysine-14. Thus, phosphorylation and acetylation are targeted to the same histone by promoter-specific regulation by a kinase/acetyltransferase pair, supporting models of gene regulation wherein transcription is controlled by coordinated patterns of histone modification.	Wistar Inst Anat & Biol, Mol Genet Program, Philadelphia, PA 19104 USA; Harvard Univ, Harvard Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	The Wistar Institute; Harvard University	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Mol Genet Program, 3601 Spruce St,Room 389, Philadelphia, PA 19104 USA.		Emre, Tolga/A-1787-2016	Emre, Tolga/0000-0001-8021-5228; Berger, Shelley/0000-0001-5398-4400				Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Berger SL, 2001, SCIENCE, V292, P64; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayes JJ, 2001, CURR OPIN GENET DEV, V11, P124, DOI 10.1016/S0959-437X(00)00168-4; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; John S, 2000, GENE DEV, V14, P1196; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roberts SM, 1997, GENETICS, V147, P451; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shirra MK, 1999, GENETICS, V152, P73; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; WOODS A, 1994, J BIOL CHEM, V269, P19509	29	287	298	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1142	1146		10.1126/science.1062322	http://dx.doi.org/10.1126/science.1062322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498592				2022-12-01	WOS:000170432600062
J	Ohman, MD; Hirche, HJ				Ohman, MD; Hirche, HJ			Density-dependent mortality in an oceanic copepod population	NATURE			English	Article							1997 SPRING BLOOM; PLANKTONIC MARINE COPEPOD; FREQUENCY TIME-SERIES; CALANUS-FINMARCHICUS; NORWEGIAN SEA; WEATHERSHIP M; DYNAMICS; PHYTOPLANKTON; PREDATION; BIOMASS	Planktonic copepods are primary consumers in the ocean and are perhaps the most numerous metazoans on earth. Secondary production by these zooplankton supports most food webs of the open sea, directly affecting pelagic fish populations and the biological pump of carbon into the deep ocean. Models of marine ecosystems are quite sensitive to the formulation of the term for zooplankton mortality(1-4), although there are few data available to constrain mortality rates in such models. Here we present the first evidence for nonlinear, density-dependent mortality rates of open-ocean zooplankton. A high-frequency time series reveals that per capita mortality rates of eggs of Calanus finmarchicus Gunnerus are a function of the abundance of adult females and juveniles. The temporal dynamics of zooplankton populations can be influenced as much by time-dependent mortality rates as by variations in 'bottom up' forcing. The functional form and rates chosen for zooplankton mortality in ecosystem models can alter the balance of pelagic ecosystems(1-3), modify elemental fluxes into the ocean's interior(5), and modulate interannual variability in pelagic ecosystems(6).	Stn Zool, F-06230 Villefranche Sur Mer, France; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ohman, MD (corresponding author), Stn Zool, F-06230 Villefranche Sur Mer, France.	mohman@ucsd.edu	Ohman, Mark D/C-8763-2009	Ohman, Mark D/0000-0001-8136-3695				Aksnes DL, 1997, SARSIA, V82, P279, DOI 10.1080/00364827.1997.10413657; CAMPBELL RG, IN PRESS MAR ECOL PR; Carlotti F., 2000, P571, DOI 10.1016/B978-012327645-2/50013-X; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; DAAN R, 1988, MAR ECOL PROG SER, V47, P45, DOI 10.3354/meps047045; Edwards AM, 2000, J PLANKTON RES, V22, P1085, DOI 10.1093/plankt/22.6.1085; FASHAM MJR, 1995, DEEP-SEA RES PT I, V42, P1111, DOI 10.1016/0967-0637(95)00054-A; FASHAM MJR, 1993, GLOBAL CARBON CYCLE, P457; Gallego A, 1999, FISH OCEANOGR, V8, P77; Hainbucher Dagmar, 1999, Fisheries Oceanography, V8, P1, DOI 10.1046/j.1365-2419.1999.00009.x; HIRCHE HJ, IN PRESS MAR ECOL PR; Irigoien X, 1998, MAR ECOL PROG SER, V172, P127, DOI 10.3354/meps172127; LANDRY MR, 1978, INT REV GES HYDROBIO, V63, P77, DOI 10.1002/iroh.19780630106; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Li M, 2000, ESTUAR COAST SHELF S, V50, P467, DOI 10.1006/ecss.2000.0593; Lynch DR, 1998, MAR ECOL PROG SER, V169, P189, DOI 10.3354/meps169189; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Niehoff B, 1999, MAR ECOL PROG SER, V176, P81, DOI 10.3354/meps176081; OHMAN MD, 1994, LIMNOL OCEANOGR, V39, P21, DOI 10.4319/lo.1994.39.1.0021; OHMAN MD, 1998, EOS T AM GEOPHYS UN, V79, pOS155; PETERSON WT, 1994, LIMNOL OCEANOGR, V39, P1594, DOI 10.4319/lo.1994.39.7.1594; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Richardson Katherine, 1999, Fisheries Oceanography, V8, P153, DOI 10.1046/j.1365-2419.1999.00007.x; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; SOLOW AR, 1995, J PLANKTON RES, V17, P1669, DOI 10.1093/plankt/17.8.1669; STEELE JH, 1992, J PLANKTON RES, V14, P157, DOI 10.1093/plankt/14.1.157; Uye S, 1998, J MARINE SYST, V15, P495, DOI 10.1016/S0924-7963(97)00052-3; WOOD SN, 1994, ECOL MONOGR, V64, P23, DOI 10.2307/2937054	29	193	195	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					638	641		10.1038/35088068	http://dx.doi.org/10.1038/35088068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493921	Green Published			2022-12-01	WOS:000170318000041
J	Craven, RB; Roehrig, JT				Craven, RB; Roehrig, JT			West Nile Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW VOLUME APPLICATIONS; HALE COUNTY; NEW-YORK; ENCEPHALITIS; MALATHION; OUTBREAK; POPULATIONS; DIAGNOSIS; MOSQUITOS; EPIDEMIC		CDCP, Arbovirus Dis Branch,Natl Ctr Infect Dis, Div Vector Borne Infect Dis, US Dept HHS,PHS, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Craven, RB (corresponding author), CDCP, Arbovirus Dis Branch,Natl Ctr Infect Dis, Div Vector Borne Infect Dis, US Dept HHS,PHS, POB 2087,Foothills Campus, Ft Collins, CO 80522 USA.	rbc1@cdc.gov		Roehrig, John/0000-0001-7581-0479				Anderson JF, 1999, SCIENCE, V286, P2331, DOI 10.1126/science.286.5448.2331; ANDIS MD, 1987, J AM MOSQUITO CONTR, V3, P125; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P944; *CDCP, 1993, GUID ARB SURV US; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P820; CECCHINE G, 1996, REV SCI LIT IT PERTA, V8; Centers for Disease Control and Prevention, 1999, MMWR MORB MORTAL WKL, V48, P890; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P178; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; CRAVEN RB, 1991, TXB HUMAN VIROLOGY, P645; CRAVEN RB, 1991, TXB HUMAN VIROLOGY, P649; Hayes CG, 1989, ARBOVIRUSES EPIDEMIO, VV, P59; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; LEISER LB, 1982, MOSQ NEWS, V42, P617; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MITCHELL CJ, 1969, J MED ENTOMOL, V6, P155, DOI 10.1093/jmedent/6.2.155; MITCHELL CJ, 1970, J MED ENTOMOL, V7, P85, DOI 10.1093/jmedent/7.1.85; MONATH TP, 1991, TROPICAL MED, P206; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; REISEN WK, 1985, J AM MOSQUITO CONTR, V1, P154; ROEHRIG JT, 2000, CLIN VIROLOGY MANUAL, P356; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Tardei G, 2000, J CLIN MICROBIOL, V38, P2232; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7	32	28	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					651	653		10.1001/jama.286.6.651	http://dx.doi.org/10.1001/jama.286.6.651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495600				2022-12-01	WOS:000170271500002
J	Day, M; Morris, RGM				Day, M; Morris, RGM			Memory consolidation and NMDA receptors: Discrepancy between genetic and pharmacological approaches	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; SELECTIVE IMPAIRMENT; ANTAGONIST; BLOCKADE; AP5		Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Day, M (corresponding author), Univ Edinburgh, Dept Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Morris, Richard G M/C-9982-2013					McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; 2001, SCIENCE, V291, P1902	10	24	27	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					U1	U1						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486056				2022-12-01	WOS:000170241000001
J	Salama, P; Assefa, F; Talley, L; Spiegel, P; van der Veen, A; Gotway, CA				Salama, P; Assefa, F; Talley, L; Spiegel, P; van der Veen, A; Gotway, CA			Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ENERGY DEFICIENCY; REFUGEE POPULATIONS; HEALTH; SITUATIONS; COMMUNITY; THAILAND; SOMALIA; KOSOVO; STATE; SUDAN	Context The World Food Programme estimated that 10 million people were at risk of starvation in Ethiopia in 2000 but later reported that a famine had been averted. However, no population-based data on mortality or nutrition existed for Gode district, at the epicenter of the famine in the Somali region of Ethiopia. Objectives To estimate mortality rates, determine the major causes of death, and estimate the prevalence of malnutrition among children and adults for the population of Gode district. Design and Setting Two-stage cluster survey conducted from July 27 through August 1, 2000, which included anthropometric measures and 8-month retrospective mortality data collection. Participants A total of 595 households comprising 4032 people living in Gode district of Ethiopia. Main Outcome Measures Crude mortality rates and mortality rates for children younger than 5 years, causes of death, weight for height of less than -2 z scores among children aged 6 months to 5 years, and body mass index of less than 18.5 kg/m(2) among adults and older persons. Results Of the 595 households, 346 (58.2%) were displaced from their usual places of residence. From December 1999 through July 2000, total of 293 deaths occurred in the sample population; 159 (54.3%) deaths were among children younger than 5 years and 72 (24.6%) were among children aged 5 to 14 years. The crude mortality rate was 3.2/ 10000 per day (95% confidence interval [CI], 2.4-3.8/10000 per day), which is 3 times the cutoff used to define an emergency. The mortality rate for children younger than 5 years was 6.8/10000 per day (95% CI, 5.4-8.2/10000 per day). Approximately 77% of deaths occurred before major relief interventions began in April/May 2000. Wasting contributed to 72.3% of all deaths among children younger than 5 years. Measles alone or in combination with wasting accounted for 35 (22.0%) of 159 deaths among children younger than 5 years and for 12 (16.7%) of 72 deaths among children aged 5 to 14 years. The prevalence rate for wasting (weight for height of <-2 z score) among children aged 6 months to 5 years was 29.1% (95% CI, 24.7%-33.4%). Using a method to adjust body mass index for body shape, the prevalence of undernutrition (body mass index <18.5 kg/m(2)) among adults aged 18 to 59 years was 22.7% (95% CI, 17.9%-27.5%). Conclusions To prevent unnecessary deaths, the humanitarian response to famine needs to be rapid, well coordinated, and based on sound epidemiological evidence. Public health interventions, such as mass measles vaccination campaigns with coverage extended to children aged 12 to 15 years should be implemented as the first priority. The prevalence of wasting and undernutrition among children and adults, respectively, should be assessed in all prolonged, severe famines.	CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA USA; CDCP, Int Emergency & Refugee Hlth Branch, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA USA; Save Children USA, Washington, DC USA; Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; WHO, Off Reg Humanitarian Coordinator, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Save the Children; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; World Health Organization	Salama, P (corresponding author), CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-48, Atlanta, GA 30341 USA.	psalama@cdc.gov						AABY P, 1988, REV INFECT DIS, V10, P478; AABY P, 1983, J INFECT DIS, V147, P693, DOI 10.1093/infdis/147.4.693; *ACT AG HUNG, 2000, RAP ASS NUTR SIT 5 C, P1; BERTINI C, 2000, FINDINGS RECOMMENDAT; BORREL A, 2001, ADDRESSING NUTR NEED; *CDCP, 1992, MMWR-MORBID MORTAL W, V41; COLLINS S, 1993, LANCET, V341, P1478; COLLINS S, 1993, JAMA-J AM MED ASSOC, V270, P637; COLLINS S, 2000, ASSESSMENT NUTR STAT, P1; Davis AP, 1996, LANCET, V348, P868, DOI 10.1016/S0140-6736(96)02134-4; DEAN AG, 1990, EPI INFO VERSION 6 W; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; *GOV ETH, 1999, 1994 POP HOUS CENS E, P1; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Kaartinen L, 1984, Lancet, V1, P39; KIDANE A, 1989, DEMOGRAPHY, V26, P515, DOI 10.2307/2061610; LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123; *MED SANS FRONT BE, 2000, NUTR SURV RETR MORT, P1; Morley D C, 1967, East Afr Med J, V44, P497; MURRAY MJ, 1976, LANCET, V1, P1283; NIEBURG P, 1988, DISASTERS, V12, P253, DOI 10.1111/j.1467-7717.1988.tb00674.x; NORGAN NG, 1994, AM J PHYS ANTHROPOL, V94, P229, DOI 10.1002/ajpa.1330940207; NORGAN NG, 1994, ANN HUM BIOL, V21, P79, DOI 10.1080/03014469400003092; Ronald C, 1999, BMJ, V318; Salama P, 2000, JAMA-J AM MED ASSOC, V284, P578, DOI 10.1001/jama.284.5.578; Salama P, 2001, LANCET, V357, P1430, DOI 10.1016/S0140-6736(00)04570-0; *SAVA CHILDR UK, 2000, ANTHR FOOD SEC ASS F, P1; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; *STEER COMM HUM RE, 1998, SPHERE PROJ HUM CHAR; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; *UN CHILDR FUND, 2000, STAT WORLDS CHILDR; *UN CHILDR FUND, 2000, SIT REP; *UN CHILDR FUND U, 2000, SUMM RES NUTR SURV C, P1; *UN CHILDR FUND WH, 2000, REP FOOD NUTR SIT GO, P1; UN. High Commission for Refugees, 1999, HDB EM; *US AG INT DEV, 2000, ETH DROUGHT FACT SHE, P1; VESPA J, 1995, BRIT MED J, V311, P652, DOI 10.1136/bmj.311.7006.652; *WHO, 1994, WKLY EPIDEMIOL REC, V69, P245; WHO, 1995, PHYS STAT US INT ANT; *WORLD FOOD PROGR, 1999, SUMM CONS AG REP EM	47	104	104	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					563	571		10.1001/jama.286.5.563	http://dx.doi.org/10.1001/jama.286.5.563			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476658	Bronze			2022-12-01	WOS:000170188300019
J	Cornelissen, JJLM; Donners, JJJM; de Gelder, R; Graswinckel, WS; Metselaar, GA; Rowan, AE; Sommerdijk, NAJM; Nolte, RJM				Cornelissen, JJLM; Donners, JJJM; de Gelder, R; Graswinckel, WS; Metselaar, GA; Rowan, AE; Sommerdijk, NAJM; Nolte, RJM			beta-helical polymers from isocyanopeptides	SCIENCE			English	Article							AQUEOUS-SOLUTION; SIDE-CHAINS; SHEET; POLYISOCYANIDES; PROTEIN; WATER; ACIDS	Polymerization of isocyanopeptides results in the formation of high molecular mass polymers that fold in a proteinlike fashion to give helical strands in which the peptide chains are arranged in beta -sheets. The beta -helical polymers retain their structure in water and unfold in a cooperative process at elevated temperatures. The peptide architecture in these polymers is a different form of the beta -helix motif found in proteins. Unlike their natural counterparts, which contain arrays of large beta -sheets stacked in a helical fashion, the isocyanopeptide polymers have a central helical core that acts as a director for the beta -sheet-like arrangement of the peptide side arms. The helical structure of these isocyanopeptide polymers has the potential to be controlled through tailoring of the side branches and the hydrogen-bonding network present in the beta -sheets.	Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands; Univ Nijmegen, Dept Inorgan Chem, NL-6525 ED Nijmegen, Netherlands; Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Eindhoven University of Technology	Nolte, RJM (corresponding author), Univ Nijmegen, Dept Organ Chem, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.		Nolte, Roeland/C-9930-2013; Rowan, Alan E/F-9702-2015; Sommerdijk, Nico A.J.M./B-7239-2013; de Gelder, René/D-4587-2012	Nolte, Roeland/0000-0002-5612-7815; Rowan, Alan E/0000-0003-0728-3851; Sommerdijk, Nico A.J.M./0000-0002-8956-195X; de Gelder, René/0000-0001-6152-640X				Baumeister B, 2000, CHEM COMMUN, P913, DOI 10.1039/b002113j; Branden C. I., 2012, INTRO PROTEIN STRUCT; Clericuzio M, 1997, J AM CHEM SOC, V119, P1059, DOI 10.1021/ja961692n; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GRANT DM, 1996, ENCY NUCL MAGNETIC R, V4; GREEN MM, 1988, MACROMOLECULES, V21, P1839, DOI 10.1021/ma00184a051; Griffiths-Jones SR, 2000, J AM CHEM SOC, V122, P8350, DOI 10.1021/ja000787t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Huang JT, 1997, J POLYM SCI POL CHEM, V35, P439; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Nesloney CL, 1996, J AM CHEM SOC, V118, P5836, DOI 10.1021/ja952472x; NOLTE RJM, 1974, J AM CHEM SOC, V96, P5932, DOI 10.1021/ja00825a038; NOLTE RJM, 1994, CHEM SOC REV, V23, P11, DOI 10.1039/cs9942300011; Nowick JS, 1999, ACCOUNTS CHEM RES, V32, P287, DOI 10.1021/ar970204t; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Pimentel G.C., 1960, HYDROGEN BOND; Prokhorova SA, 1998, MACROMOL RAPID COMM, V19, P359; Schenck HL, 1998, J AM CHEM SOC, V120, P4869, DOI 10.1021/ja973984+; Seebach D, 2000, HELV CHIM ACTA, V83, P2115, DOI 10.1002/1522-2675(20000906)83:9<2115::AID-HLCA2115>3.0.CO;2-E; SPEK AL, 1955, PLUTON PROGRAM PLOTT; TSANG KY, 1994, J AM CHEM SOC, V116, P3988, DOI 10.1021/ja00088a039; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	23	267	270	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					676	680		10.1126/science.1062224	http://dx.doi.org/10.1126/science.1062224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474106				2022-12-01	WOS:000170204600049
J	Robles-De-La-Torre, G; Hayward, V				Robles-De-La-Torre, G; Hayward, V			Force can overcome object geometry in the perception of shape through active touch	NATURE			English	Article							MOVEMENTS; FINGER; ELBOW	Haptic (touch) perception normally entails an active exploration of object surfaces over time. This is called active touch(1-3). When exploring the shape of an object, we experience both geometrical(4) and force cues. For example, when sliding a finger across a surface with a rigid bump on it, the finger moves over the bump while being opposed by a force whose direction and magnitude are related to the slope of the bump(5). The steeper the bump, the stronger the resistance. Geometrical and force cues are correlated, but it has been commonly assumed that shape perception relies on object geometry alone. Here we show that regardless of surface geometry, subjects identified and located shape features on the basis of force cues or their correlates. Using paradoxical stimuli, for example combining the force cues of a bump with the geometry of a hole, we found that subjects perceived a bump. Conversely, when combining the force cues of a hole with the geometry of a bump, subjects typically perceived a hole.	McGill Univ, Ctr Intelligent Machines, Montreal, PQ H3A 2A7, Canada	McGill University	Robles-De-La-Torre, G (corresponding author), McGill Univ, Ctr Intelligent Machines, Montreal, PQ H3A 2A7, Canada.		Hayward, Vincent/A-4646-2010	Hayward, Vincent/0000-0002-2102-1965				CLARK FJ, 1986, BRAIN, V109, P1195, DOI 10.1093/brain/109.6.1195; Coren S, 1992, LEFT HANDER SYNDROME; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GORDON IE, 1982, PERCEPT PSYCHOPHYS, V31, P446, DOI 10.3758/BF03204854; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Loomis JM, 1986, HDB PERCEPTION HUMAN, V2, p31/1; Minsky M. D. R, 1995, THESIS MIT; Pont SC, 1999, PERCEPT PSYCHOPHYS, V61, P874, DOI 10.3758/BF03206903; ROBLESDELATORRE G, 2000, P ASME DYN SYST CONT, V2, P1081; TAYLOR JL, 1992, J PHYSIOL-LONDON, V457, P503, DOI 10.1113/jphysiol.1992.sp019390	11	211	222	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					445	448		10.1038/35086588	http://dx.doi.org/10.1038/35086588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456DQ	11473320				2022-12-01	WOS:000170068200050
J	Melino, G				Melino, G			The Sirens' song	NATURE			English	Editorial Material							CELL-DEATH		Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, I-00133 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata	Melino, G (corresponding author), Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, I-00133 Rome, Italy.			MELINO, GERRY/0000-0001-9428-5972				Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; ARNEISEN JC, 1999, SCULPTURE VIVANT; Heemels MT, 2000, NATURE, V407, P769; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0	5	45	49	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					23	23		10.1038/35083653	http://dx.doi.org/10.1038/35083653			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452281				2022-12-01	WOS:000169644900020
J	Mack, V; Burnashev, N; Kaiser, KMM; Rozov, A; Jensen, V; Hvalby, O; Sakmann, B; Seeburg, PH; Sprengel, R				Mack, V; Burnashev, N; Kaiser, KMM; Rozov, A; Jensen, V; Hvalby, O; Sakmann, B; Seeburg, PH; Sprengel, R			Conditional restoration of hippocampal synaptic potentiation in GluR-A-deficient mice	SCIENCE			English	Article							GLUTAMATE RECEPTORS; AMPA RECEPTORS; EXPRESSION; CELLS; LTP; CAMKII	Plasticity of mature hippocampal CA1 synapses is dependent on L-alpha -amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors containing the glutamate receptor A (GLuR-A) subunit. In GLuR-A-deficient mice, plasticity could be restored by controlled expression of green fluorescent protein (GFP)-tagged GluRA, which contributes to channel formation and displayed the developmental redistribution of AMPA receptors in CA1 pyramidal neurons. Long-term potentiation (LTP) induced by pairing or tetanic stimulation was rescued in adult GluR-A(-/-) mice when (GFP)GluR-A expression was constitutive or induced in already fully developed pyramidal cells. This shows that GluR-A-independent forms of synaptic plasticity can mediate the establishment of mature hippocampal circuits that are prebuilt to express GluR-A-dependent LTP.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Univ Oslo, Inst Basic Med Sci, Dept Physiol, N-0462 Oslo, Norway	Max Planck Society; Max Planck Society; University of Oslo	Sprengel, R (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Burnashev, Nail/G-4056-2013; Rozov, Andrei/C-1997-2015					BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Chen HX, 1999, J NEUROPHYSIOL, V82, P526, DOI 10.1152/jn.1999.82.2.526; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JENSEN V, UNPUB; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	16	94	96	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2501	2504		10.1126/science.1059365	http://dx.doi.org/10.1126/science.1059365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431570				2022-12-01	WOS:000169658200045
J	Sun, ZYJ; Kim, HS; Wagner, G; Reinherz, EL				Sun, ZYJ; Kim, HS; Wagner, G; Reinherz, EL			Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimer	CELL			English	Article							CD3 GAMMA-CHAIN; TCR-ALPHA-BETA; MHC CLASS-II; ANTIGEN RECEPTOR; CRYSTAL-STRUCTURE; TCR/CD3 COMPLEX; SURFACE EXPRESSION; ZETA-CHAIN; T3-MOLECULAR COMPLEX; ACTIVATION MOTIFS	The T cell receptor (TCR) consists of genetically diverse disulfide-linked ru and beta chains in noncovalent association with the invariant CD3 subunits. CD3 epsilon and CD3 gamma are integral components of both the TCR and pre-TCR. Here, we present the solution structure of a heterodimeric CD3 epsilon gamma ectodomain complex. A unique side-to-side hydrophobic interface between the two C2-set immunoglobulin-like domains and parallel pairing of their respective C-terminal beta strands are revealed. Mutational analysis confirms the importance of the distinctive linkage as well as the membrane proximal stalk motif (RxCxxCxE) for domain-domain association. These biochemical and structural analyses offer insights into the modular pairwise association of CD3 invariant chains. More importantly, the findings suggest how the rigidified CD3 elements participate in TCR-based signal transduction.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	wagner@wagner.med.harvard.edu; ellis_reinherz@dfci.harvard.edu			NIAID NIH HHS [AI37581, AI19807] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019807, R56AI019807, R01AI037581, R01AI019807] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALARCON B, 1988, J BIOL CHEM, V263, P2953; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DELAHERA A, 1991, J EXP MED, V173, P7, DOI 10.1084/jem.173.1.7; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; EXLEY M, 1994, J BIOL CHEM, V269, P15140; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Gobel TWF, 2000, J IMMUNOL, V164, P879, DOI 10.4049/jimmunol.164.2.879; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Harrison PT, 1996, MOL MEMBR BIOL, V13, P67, DOI 10.3109/09687689609160579; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; KAPPES DJ, 1991, P NATL ACAD SCI USA, V88, P10619, DOI 10.1073/pnas.88.23.10619; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kim KS, 2000, J MOL BIOL, V302, P899, DOI 10.1006/jmbi.2000.4098; Klimov DK, 2000, P NATL ACAD SCI USA, V97, P7254, DOI 10.1073/pnas.97.13.7254; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Lin YX, 1999, J BIOMOL NMR, V15, P227, DOI 10.1023/A:1008343915382; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; Marrack P, 1986, Adv Immunol, V38, P1, DOI 10.1016/S0065-2776(08)60005-X; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; MEUER SC, 1983, NATURE, V303, P808, DOI 10.1038/303808a0; MEUER SC, 1983, J EXP MED, V157, P705, DOI 10.1084/jem.157.2.705; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; MYERS LC, 1993, BIOCHEMISTRY-US, V32, P14089, DOI 10.1021/bi00214a003; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; OHNO H, 1993, INT IMMUNOL, V5, P1403, DOI 10.1093/intimm/5.11.1403; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; REINHERZ EL, 1982, CELL, V30, P735, DOI 10.1016/0092-8674(82)90278-1; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; REINHERZ EL, 1983, IMMUNOL REV, V74, P83, DOI 10.1111/j.1600-065X.1983.tb01085.x; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAITO H, 1987, P NATL ACAD SCI USA, V84, P9131, DOI 10.1073/pnas.84.24.9131; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; SunderPlassmann R, 1997, EUR J IMMUNOL, V27, P2001, DOI 10.1002/eji.1830270826; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TUNNACLIFFE A, 1988, EUR J IMMUNOL, V18, P1639, DOI 10.1002/eji.1830181027; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; von Boehmer H, 1998, IMMUNOL REV, V165, P111; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Zidovetzki R, 1998, IMMUNOL LETT, V64, P97, DOI 10.1016/S0165-2478(98)00100-X	84	142	154	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2001	105	7					913	923		10.1016/S0092-8674(01)00395-6	http://dx.doi.org/10.1016/S0092-8674(01)00395-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439187	Bronze			2022-12-01	WOS:000169664300011
J	Buchbinder, R; Forbes, A; Hall, S; Dennett, X; Giles, G				Buchbinder, R; Forbes, A; Hall, S; Dennett, X; Giles, G			Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							INCLUSION-BODY MYOSITIS; POLYMYOSITIS-DERMATOMYOSITIS; ADULT DERMATOMYOSITIS; TEMPORAL ASSOCIATION; CELL CARCINOMA; CANCER; RISK; CLASSIFICATION	Background: The validity and magnitude of an association between myositis and malignant disease continue to be debated. Such issues as the legitimacy of a myositis diagnosis and distinction among myositis subgroups in previous population-based studies remain unresolved. Objective: To determine the risk for malignant disease in patients with biopsy-proven inflammatory myopathies. Design: Population-based, retrospective cohort study. Setting: Victoria, Australia. Patients: 537 patients in whom a biopsy-positive idiopathic inflammatory myopathy was first diagnosed from 1981 through 1995. Measurements: standardized incidence ratios were calculated to compare the incidence of malignant disease in patients with inflammatory myopathy and the general population. Results: A total of 116 cases of malignant disease were found in 104 patients. Seventy-four cases were identified concurrently with (within 7 days) or after diagnosis of myositis. The highest risk for malignant disease was associated with dermatomyositis (standardized incidence ratio, 6.2 [95% CI, 3.9 to 10.0]). The risk was also increased in polymyositis (standardized incidence ratio, 2.0 [CI, 1.4 to 2.7]), although the relative risk for malignant disease in dermatomyositis compared with polymyositis was 2.4 (CI, 1.3 to 4.2). An increased risk for malignant disease was also found in inclusion-body myositis (standardized incidence ratio, 2.4 [CI, 1.2 to 4.9]). The excess risk for malignant disease diminished with time (standardized incidence ratio, 4.4 [CI, 2.7 to 7.1] in the first year; 3.4 [Cl, 2.3 to 5.1] between 1 and 3 years; 2.2 [Cl, 1.3 to 3.9] between 3 and 5 years; and 1.6 [Cl, 1.0 to 2.6] beyond 5 years [P for trend, 0.002]). Conclusion: The risk for malignant disease is increased in biopsy-proven dermatomyositis and polymyositis and also appears to be increased in inclusion-body myositis.	Cabrini Med Ctr, Dept Clin Epidemiol, Malvern, Vic 3144, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia; Anti Canc Council Victoria, Canc Epidemiol Ctr, Canc Control Res Inst, Melbourne, Vic 3053, Australia	Cabrini Health; Monash University; Cancer Council Victoria	Buchbinder, R (corresponding author), Cabrini Med Ctr, Dept Clin Epidemiol, 183 Wattletree Rd,Suite 41, Malvern, Vic 3144, Australia.	rachelle.buchbinder@med.monash.edu.au	Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933; Giles, Graham/0000-0003-4946-9099; Forbes, Andrew/0000-0003-4269-914X				AIRIO A, 1995, J RHEUMATOL, V22, P1300; *ANT COUNC VICT CA, 1996, CANST CANC VICT 1993; BANKER BQ, 1986, MYOLOGY, P1385; BARNES BE, 1976, ANN INTERN MED, V84, P68, DOI 10.7326/0003-4819-84-1-68; BASSETSEGUIN N, 1990, ARCH DERMATOL, V126, P633, DOI 10.1001/archderm.126.5.633; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BONNETBLANC JM, 1990, DERMATOLOGICA, V180, P212, DOI 10.1159/000248032; Buchbinder R, 1996, AM J IND MED, V29, P171, DOI 10.1002/(SICI)1097-0274(199602)29:2<171::AID-AJIM7>3.0.CO;2-V; CALLEN JP, 1980, ARCH DERMATOL, V116, P295, DOI 10.1001/archderm.116.3.295; CHERKIN DC, 1992, SPINE, V17, P817, DOI 10.1097/00007632-199207000-00015; CHOW WH, 1995, CANCER CAUSE CONTROL, V6, P9, DOI 10.1007/BF00051675; COTE RA, 1980, SYSTEMATIZED NONENCL; COX NH, 1990, ARCH DERMATOL, V126, P61, DOI 10.1001/archderm.126.1.61; DAVIS W, 1987, STAT METHODS CANC RE, V2; DUNCAN AG, 1991, ACTA DERM-VENEREOL, V71, P312; HIDANO A, 1986, Journal of Dermatology (Tokyo), V13, P233; HILTONJONES D, 1992, NEW ENGL J MED, V327, P207; HOFFMAN GS, 1983, AM J MED, V75, P433, DOI 10.1016/0002-9343(83)90344-3; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Jensen ML, 1997, ARCH PHYS MED REHAB, V78, P327, DOI 10.1016/S0003-9993(97)90043-5; Kankeleit H., 1916, DTSCH ARCH KLIN MED, V120, P335; LAKHANPAL S, 1986, MAYO CLIN PROC, V61, P645, DOI 10.1016/S0025-6196(12)62030-8; Lipskie T L, 1998, Chronic Dis Can, V19, P112; LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727; LYON MG, 1989, J RHEUMATOL, V16, P1218; MANCHUL LA, 1985, ARCH INTERN MED, V145, P1835, DOI 10.1001/archinte.145.10.1835; Maoz CR, 1998, SEMIN ARTHRITIS RHEU, V27, P319, DOI 10.1016/S0049-0172(98)80052-8; MASI AT, 1988, MT SINAI J MED, V55, P471; Mautner GH, 1998, CUTIS, V61, P190; MEDSGER TA, 1970, AM J MED, V48, P715, DOI 10.1016/S0002-9343(70)80006-7; *NAT AC SCI, 1980, REL NAT HOSP DISCH S; O'Gradaigh D, 1998, BRIT J RHEUMATOL, V37, P914; ODDIS CV, 1990, J RHEUMATOL, V17, P1329; Patrick M, 1999, J RHEUMATOL, V26, P1094; Pautas E, 1999, AM J MED, V106, P122; SCHULMAN P, 1991, J RHEUMATOL, V18, P1689; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; STERTZ G, 1916, BERL KLIN WOCHENSCHR, V53, P488; WHITMORE SE, 1994, MEDICINE, V73, P153, DOI 10.1097/00005792-199405000-00004; World Health Organization, 1977, INT CLASS DIS; World Health Organization, 1976, INT CLASS DIS ONC; YTTERBERG SR, 1993, ARTHRITIS RHEUM, V36, P416, DOI 10.1002/art.1780360319; ZANTOS D, 1994, J RHEUMATOL, V21, P1855	43	275	293	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1087	1095		10.7326/0003-4819-134-12-200106190-00008	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412048				2022-12-01	WOS:000169313200001
J	Chadwick, D				Chadwick, D			Vagal-nerve stimulation for epilepsy	LANCET			English	Editorial Material							VAGUS NERVE; SEIZURES; CHILDREN; TRIAL		Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7IJ, Merseyside, England	University of Liverpool; Walton Centre	Chadwick, D (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7IJ, Merseyside, England.							Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Handforth A, 1998, NEUROLOGY, V51, P48, DOI 10.1212/WNL.51.1.48; Labar D, 2000, DEV MED CHILD NEUROL, V42, P496, DOI 10.1017/S001216220000092X; Marson AG, 2001, J NEUROL NEUROSUR PS, V70, P143, DOI 10.1136/jnnp.70.2.143; MCLACHLAN RS, 1993, EPILEPSIA, V34, P918, DOI 10.1111/j.1528-1157.1993.tb02112.x; Patwardhan RV, 2000, NEUROSURGERY, V47, P1353, DOI 10.1097/00006123-200012000-00016; Salinsky MC, 1996, ARCH NEUROL-CHICAGO, V53, P1176, DOI 10.1001/archneur.1996.00550110128021; Tatum WO, 1999, NEUROLOGY, V52, P1267, DOI 10.1212/WNL.52.6.1267; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x	12	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1726	1727		10.1016/S0140-6736(00)04933-3	http://dx.doi.org/10.1016/S0140-6736(00)04933-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403805				2022-12-01	WOS:000169156200006
J	Knight, SW; Bass, BL				Knight, SW; Bass, BL			A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENETIC INTERFERENCE; POLYMERASE; ARABIDOPSIS; NEUROSPORA; EXPRESSION; HELICASE; SEQUENCE; VIRUS	An early event in RNA interference (RNAi) is the cleavage of the initiating double-stranded RNA (dsRNA) to short pieces, 21 to 23 nucleotides in length. Here we describe a null mutation in dicer-1 (dcr-1), a gene proposed to encode the enzyme that generates these short RNAs. We find that dcr-1(-/-) animals have defects in RNAi under some, but not all, conditions. Mutant animals have germ line defects that lead to sterility, suggesting that cleavage of dsRNA to short pieces is a requisite event in normal development.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Dept Biochem, 50 N Med Dr,Room 211, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [R01 GM044073] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044073] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRENNER S, 1974, GENETICS, V77, P71; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Mello C, 1995, CAENORHABDITIS ELEGA, P451; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHEDL T, 1997, C ELEGANS, V2, P241; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Yochem J, 1998, GENETICS, V149, P1323; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	32	639	719	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2269	2271		10.1126/science.1062039	http://dx.doi.org/10.1126/science.1062039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11486053	Green Accepted			2022-12-01	WOS:000171139400048
J	Corma, A; Nemeth, LT; Renz, M; Valencia, S				Corma, A; Nemeth, LT; Renz, M; Valencia, S			Sn-zeolite beta as a heterogeneous chemoselective catalyst for Baeyer-Villiger oxidations	NATURE			English	Article							HYDROGEN-PEROXIDE; PLATINUM COMPLEXES; CYCLIC-KETONES	The Baeyer-Villiger oxidation, first reported more than 100 years ago(1), has evolved into a versatile reaction widely used(2) to convert ketones-readily available building blocks in organic chemistry-into more complex and valuable esters and lactones. Catalytic versions of the Baeyer-Villiger oxidation are particularly attractive for practical applications, because catalytic transformations simplify processing conditions while minimizing reactant use as well as waste production. Further benefits are expected from replacing peracids, the traditionally used oxidant, by cheaper and less polluting hydrogen peroxide(3). Dissolved platinum complexes(4) and solid acids, such as zeolites(5,6) or sulphonated resins(7), efficiently activate ketone oxidation by hydrogen peroxide. But these catalysts lack sufficient selectivity for the desired product if the starting material contains functional groups other than the ketone group; they perform especially poorly in the presence of carbon-carbon double bonds. Here we show that upon incorporation of 1.6 weight per cent tin into its framework, zeolite beta acts as an efficient and stable heterogeneous catalyst for the Baeyer-Villiger oxidation of saturated as well as unsaturated ketones by hydrogen peroxide, with the desired lactones forming more than 98% of the reaction products. We ascribe this high selectivity to direct activation of the ketone group, whereas other catalysts first activate hydrogen peroxide, which can then interact with the ketone group as well as other functional groups.	Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; Universal Oil Prod, UOP LLC, Des Plaines, IL 60017 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Universitat Politecnica de Valencia	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	CANOS, AVELINO CORMA/A-3040-2013; Renz, Michael/B-9361-2011; Valencia, Susana/I-4644-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; Renz, Michael/0000-0002-1101-9562; Valencia, Susana/0000-0001-7160-2795				Arends IWCE, 1997, ANGEW CHEM INT EDIT, V36, P1144, DOI 10.1002/anie.199711441; Baeyer A., 1899, CHEM BER, V32, P3625; Bhaumik A, 1996, CATAL LETT, V40, P47, DOI 10.1007/BF00807456; CAMBLOR MA, 1992, J CHEM SOC CHEM COMM, P589, DOI 10.1039/c39920000589; CHANG CD, 1996, Patent No. 4870192; Corma A., 1999, US Patent, Patent No. [5968473A, 5968473]; Fischer J, 1999, APPL CATAL A-GEN, V180, P435, DOI 10.1016/S0926-860X(98)00378-0; FRISONE MD, 1993, ORGANOMETALLICS, V12, P148; Gavagnin R, 1998, ORGANOMETALLICS, V17, P661, DOI 10.1021/om970756f; HERRMANN WA, 1994, J MOL CATAL, V94, P213, DOI 10.1016/S0304-5102(94)87043-8; HERRMANN WA, 1995, J ORGANOMET CHEM, V500, P149, DOI 10.1016/0022-328X(95)00518-U; HOELDERICH W, 1999, Patent No. 19745442; Huang HH, 2001, WATER RES, V35, P2291, DOI 10.1016/S0043-1354(00)00496-6; JACOBSON SE, 1978, J CHEM SOC CHEM COMM, P888, DOI 10.1039/c39780000888; Kelly D. R., 1998, BIOTRANSFORMATIONS A, V8a, P535; Palazzi C, 2000, J MOL CATAL A-CHEM, V151, P245, DOI 10.1016/S1381-1169(99)00249-6; Renz M, 1999, EUR J ORG CHEM, V1999, P737; SEN T, 1995, J CHEM SOC CHEM COMM, P207, DOI 10.1039/c39950000207; Shambayati S., 1991, COMPREHENSIVE ORGANI, V1, P283; Strukul G, 1998, ANGEW CHEM INT EDIT, V37, P1199, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1198::AID-ANIE1198>3.0.CO;2-Y	20	785	822	20	536	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					423	425		10.1038/35086546	http://dx.doi.org/10.1038/35086546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473313				2022-12-01	WOS:000170068200043
J	Volkman, SK; Barry, AE; Lyons, EJ; Nielsen, KM; Thomas, SM; Choi, M; Thakore, SS; Day, KP; Wirth, DF; Hartl, DL				Volkman, SK; Barry, AE; Lyons, EJ; Nielsen, KM; Thomas, SM; Choi, M; Thakore, SS; Day, KP; Wirth, DF; Hartl, DL			Recent origin of Plasmodium falciparum from a single progenitor	SCIENCE			English	Article							CHLOROQUINE RESISTANCE; POPULATION-STRUCTURE; ANTIGENIC VARIATION; MALARIA; GENE; ERYTHROCYTES; MUTATIONS; SEQUENCE; SURFACE; PROTEIN	Genetic variability of Plasmodium falciparum underlies its transmission success and thwarts efforts to control disease caused by this parasite. Genetic variation in antigenic, drug resistance, and pathogenesis determinants is abundant, consistent with an ancient origin of P. falciparum, whereas DNA variation at silent (synonymous) sites in coding sequences appears virtually absent, consistent with a recent origin of the parasite. To resolve this paradox, we analyzed introns and demonstrated that these are deficient in single-nucleotide polymorphisms, as are synonymous sites in coding regions. These data establish the recent origin of P. falciparum and further provide an explanation for the abundant diversity observed in antigen and other selected genes.	Harvard Univ, Sch Publ Hlth, Harvard Oxford Genome Divers Project, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Norwegian Univ Sci & Technol, Dept Bot, N-7491 Trondheim, Norway	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Norwegian University of Science & Technology (NTNU)	Wirth, DF (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Oxford Genome Divers Project, 665 Huntington Ave, Boston, MA 02115 USA.	dfwirth@hsph.harvard.edu	Nielsen, Kaare Magne/G-8107-2018; Day, Karen/F-3697-2015	Nielsen, Kaare Magne/0000-0002-7217-2114; Day, Karen/0000-0002-6115-6135; Barry, Alyssa/0000-0002-1189-2310				Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; Biswas S, 2000, TROP MED INT HEALTH, V5, P737, DOI 10.1046/j.1365-3156.2000.00632.x; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; BRUCECHWATT LJ, 1965, B WORLD HEALTH ORGAN, V32, P363; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hughes AL, 1998, GENETICS, V150, P511; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; JARCHO S, 1964, B HIST MED, V37, P1; KEMP DJ, 1990, ADV PARASIT, V29, P75; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Li W.H., 1997, MOL EVOLUTION; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; MCCUTCHAN TF, 1990, IMMUNOL LETT, V25, P23, DOI 10.1016/0165-2478(90)90085-5; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Rich SM, 1998, GENETICS, V150, P515; Rich SM, 1997, P NATL ACAD SCI USA, V94, P13040, DOI 10.1073/pnas.94.24.13040; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; 2000, WHO TECH REP SER, V892, P1	33	128	134	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					482	484		10.1126/science.1059878	http://dx.doi.org/10.1126/science.1059878			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463913				2022-12-01	WOS:000169966700044
J	Abrieu, A; Magnaghi-Jaulin, L; Kahana, JA; Peter, M; Castro, A; Vigneron, S; Lorca, T; Cleveland, DW; Labbe, JC				Abrieu, A; Magnaghi-Jaulin, L; Kahana, JA; Peter, M; Castro, A; Vigneron, S; Lorca, T; Cleveland, DW; Labbe, JC			Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; POLE BODY DUPLICATION; XENOPUS EGG EXTRACTS; DEPENDENT PROTEIN-KINASE; CENP-E; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; UNATTACHED KINETOCHORES; CHROMOSOME ALIGNMENT; ANAPHASE INITIATION	The mitotic checkpoint acts to inhibit entry into anaphase until all chromosomes have successfully attached to spindle microtubules. Unattached kinetochores are believed to release an activated form of Mad2 that inhibits APC/C-dependent ubiquitination and subsequent proteolysis of components needed for anaphase onset. Using Xenopus egg extracts, a vertebrate homolog of yeast Mps1p is shown here to be a kinetochore-associated kinase, whose activity is necessary to establish and maintain the checkpoint. Since high levels of Mad2 overcome checkpoint loss in Mps1-depleted extracts, Mps1 acts upstream of Mad2-mediated inhibition of APC/C. Mps1 is essential for the checkpoint because it is required for recruitment and retention of active CENP-E at kinetochores, which in turn is necessary for kinetochore association of Mad1 and Mad2.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; CNRS, UPR 1086, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.		labbe, jean-claude/B-2277-2009; Cleveland, Don/AAN-9783-2021; Peter, Marion/Y-5024-2019; Abrieu, Ariane/P-3307-2019; Abrieu, Ariane/G-6336-2013; CASTRO, ANNA/F-4350-2010	Peter, Marion/0000-0002-5720-4798; Abrieu, Ariane/0000-0002-0942-8877; CASTRO, ANNA/0000-0002-3655-1352; Lorca, Thierry/0000-0003-2007-8924; Cleveland, Don/0000-0002-1934-3682; Peter, Matthias/0000-0002-2160-6824				Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Brady DM, 2000, CURR BIOL, V10, P675, DOI 10.1016/S0960-9822(00)00515-7; Brown KD, 1996, J CELL SCI, V109, P961; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 1997, METHOD ENZYMOL, V283, P572; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HOGG D, 1994, ONCOGENE, V9, P89; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; LORCA T, 1994, BBA-MOL CELL RES, V1223, P325, DOI 10.1016/0167-4889(94)90091-4; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MILLS GB, 1992, J BIOL CHEM, V267, P16000; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MORIN N, 1994, EMBO J, V13, P4343, DOI 10.1002/j.1460-2075.1994.tb06754.x; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(00)00002-2; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	55	263	282	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					83	93		10.1016/S0092-8674(01)00410-X	http://dx.doi.org/10.1016/S0092-8674(01)00410-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461704	Bronze			2022-12-01	WOS:000169870300011
J	Grishok, A; Pasquinelli, AE; Conte, D; Li, N; Parrish, S; Ha, I; Baillie, DL; Fire, A; Ruvkun, G; Mello, CC				Grishok, A; Pasquinelli, AE; Conte, D; Li, N; Parrish, S; Ha, I; Baillie, DL; Fire, A; Ruvkun, G; Mello, CC			Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C-elegans developmental timing	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; MESSENGER-RNA; LIN-4 RNA; PROTEINS; TRANSCRIPTION; TRANSLATION; HELICASE; SEQUENCE	RNAi is a gene-silencing phenomenon triggered by double-stranded (ds) RNA and involves the generation of 21 to 26 nt RNA segments that guide mRNA destruction. In Caenorhabditis elegans, lin-4 and let-7 encode small temporal RNAs (stRNAs) of 22 nt that regulate stage-specific development. Here we show that inactivation of genes related to RNAi pathway genes, a homolog of Drosophila Dicer (dcr-1), and two homologs of rde-1 (alg-1 and alg-2), cause heterochronic phenotypes similar to lin-4 and let-7 mutations. Further we show that dcr-1, alg-1, and alg-2 are necessary for the maturation and activity of the lin-4 and let-7 stRNAs. Our findings suggest that a common processing machinery generates guide RNAs that mediate both RNAi and endogenous gene regulation.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Johns Hopkins Univ, Biol Grad Program, Baltimore, MD 21218 USA; Simon Fraser Univ, Inst Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Carnegie Inst Sci, Baltimore, MD 21210 USA; Hanwha Chem R&D Inst, Daejun 305345, South Korea	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Simon Fraser University; Carnegie Institution for Science	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Pillay, Nischalan/F-9536-2012	Grishok, Alla/0000-0001-8922-7575; Fire, Andrew/0000-0001-6217-8312	NIGMS NIH HHS [R01 GM037706, GM07321, GM37706, GM58800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Baulcombe D, 1999, ARCH VIROL, P189; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lynn K, 1999, DEVELOPMENT, V126, P469; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmidt A, 1999, GENETICS, V151, P749; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stewart HI, 1998, MOL GEN GENET, V260, P280, DOI 10.1007/s004380050896; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	42	1436	1633	5	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					23	34		10.1016/S0092-8674(01)00431-7	http://dx.doi.org/10.1016/S0092-8674(01)00431-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461699	Bronze			2022-12-01	WOS:000169870300006
J	Shimura, H; Schlossmacher, MC; Hattori, N; Frosch, MP; Trockenbacher, A; Schneider, R; Mizuno, Y; Kosik, KS; Selkoe, DJ				Shimura, H; Schlossmacher, MC; Hattori, N; Frosch, MP; Trockenbacher, A; Schneider, R; Mizuno, Y; Kosik, KS; Selkoe, DJ			Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease	SCIENCE			English	Article							RECESSIVE JUVENILE PARKINSONISM; PROTEIN LIGASE; SUBCELLULAR-LOCALIZATION; HIF-ALPHA; GENE; MUTATIONS; FIBRILLIZATION; HYDROXYLATION; FAMILIES; COMPLEX	Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha -synuclein and ubiquitin. Rare inherited forms of PD are caused by autosomal dominant mutations in alpha -synuclein or by autosomal recessive mutations in parkin, an E3 ubiquitin Ligase, We hypothesized that these two gene products interact functionally, namely, that parkin ubiquitinates alpha -synuclein normally and that this process is altered in autosomal recessive PD. We have now identified a protein complex in normal human brain that includes parkin as the E3 ubiquitin Ligase, UbcH7 as its associated E2 ubiquitin conjugating enzyme, and a new 22-kilodalton glycosylated form of alpha -synuclein (alpha Sp22) as its substrate. In contrast to normal parkin, mutant parkin associated with autosomal recessive PD failed to bind alpha Sp22. In an in vitro ubiquitination assay, alpha Sp22 Was modified by normal but not mutant parkin into polyubiquitinated, high molecular weight species. Accordingly, alpha Sp22 accumulated in a nonubiquitinated form in parkin-deficient PD brains. We conclude that alpha Sp22 is a substrate for parkin's ubiquitin Ligase activity in normal human brain and that Loss of parkin function causes pathological alpha Sp22 accumulation. These findings demonstrate a critical biochemical reaction between the two PD-Linked gene products and suggest that this reaction underlies the accumulation of ubiquitinated alpha -synuclein in conventional PD.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Juntendo University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Innsbruck	Schlossmacher, MC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	schloss@cnd.bwh.harvard.edu	shimura, hideki/AAA-2864-2020; Hattori, Nobutaka/ACR-0069-2022; Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861; Schlossmacher, Michael/0000-0002-0394-0300	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 38375, NS 02127] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hattori N, 2000, ADV RES NEURODEGENER, V8, P101; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Huynh DP, 2000, ANN NEUROL, V48, P737, DOI 10.1002/1531-8249(200011)48:5<737::AID-ANA7>3.3.CO;2-4; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mizuno Y, 1999, BIOMED PHARMACOTHER, V53, P109, DOI 10.1016/S0753-3322(99)80075-4; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHOSSMACHER MG, UNPUB; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Tanaka K, 1998, MOL CELLS, V8, P503; Terreni L, 2001, NEUROLOGY, V56, P463, DOI 10.1212/WNL.56.4.463; TROJANOWSKI JQ, 1999, CELL DEATH DIFFER, V5, P823; van de Warrenburg BPC, 2001, NEUROLOGY, V56, P555, DOI 10.1212/WNL.56.4.555; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	37	842	876	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					263	269		10.1126/science.1060627	http://dx.doi.org/10.1126/science.1060627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11431533				2022-12-01	WOS:000169875200048
J	Maas, R				Maas, R			Change of plasmid DNA structure, hypermethylation, and Lon-proteolysis as steps in a replicative cascade	CELL			English	Article							ESCHERICHIA-COLI; REPA1 PROTEIN; DAM METHYLTRANSFERASE; LEADER PEPTIDE; INITIATION; REPLICON; ORIR; RESOLUTION; INVITRO; BIOLOGY	I have defined conditions under which RepFIC plasmid DNA can be maintained in a state of lowered helical density. In exponentially growing cultures, the DNA of lowered helical density is present in small amounts but never totally absent, suggesting that it is; a normal variant of plasmid maintenance. It is fully methylated at frequent sites by dam-methyltransferase, some not previously recognized, further suggesting that the variant is a precursor of replication. The low-helical density plasmid is present in dam hosts, indicating that methylation is not essential for the change in helical density. The lowered helical density is stabilized in ion hosts, suggesting that Lon-protease may remove both the protein(s) that lower the helical density and the dam-methyltransferase after each round of replication.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Maas, R (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.				NIGMS NIH HHS [GM06048] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berger I, 1996, P NATL ACAD SCI USA, V93, P12116, DOI 10.1073/pnas.93.22.12116; BLOMBERG P, 1992, EMBO J, V11, P2675, DOI 10.1002/j.1460-2075.1992.tb05333.x; BOYE E, 1990, CELL, V62, P981, DOI 10.1016/0092-8674(90)90272-G; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Fu GK, 1997, J BIOL CHEM, V272, P534; JOHNSTON BH, 1985, CELL, V42, P713, DOI 10.1016/0092-8674(85)90268-5; Kornberg A., 1992, DNA REPLICATION; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Maas R, 1997, J BACTERIOL, V179, P3823, DOI 10.1128/jb.179.12.3823-3827.1997; MAAS R, 1991, MOL MICROBIOL, V5, P927, DOI 10.1111/j.1365-2958.1991.tb00767.x; MAAS R, 1989, MOL GEN GENET, V218, P190, DOI 10.1007/BF00331268; Maas R, 1997, J BACTERIOL, V179, P2163, DOI 10.1128/jb.179.7.2163-2168.1997; MASAI H, 1989, J BIOL CHEM, V264, P8082; MASAI H, 1988, NUCLEIC ACIDS RES, V16, P6493, DOI 10.1093/nar/16.14.6493; MASAI H, 1983, P NATL ACAD SCI-BIOL, V80, P6814, DOI 10.1073/pnas.80.22.6814; Maxam A M, 1980, Methods Enzymol, V65, P499; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; SAADI S, 1987, J BACTERIOL, V169, P1836, DOI 10.1128/jb.169.5.1836-1846.1987; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.mi.47.100193.003121; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; WAGNER BM, 1987, J DRUG DEV S2, V1, P7; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WU RP, 1992, J BACTERIOL, V174, P7620, DOI 10.1128/JB.174.23.7620-7628.1992	24	12	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					945	955		10.1016/S0092-8674(01)00402-0	http://dx.doi.org/10.1016/S0092-8674(01)00402-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439190	Bronze			2022-12-01	WOS:000169664300014
J	Coates, JD; Chakraborty, R; Lack, JG; O'Connor, SM; Cole, KA; Bender, KS; Achenbach, LA				Coates, JD; Chakraborty, R; Lack, JG; O'Connor, SM; Cole, KA; Bender, KS; Achenbach, LA			Anaerobic benzene oxidation coupled to nitrate reduction in pure culture by two strains of Dechloromonas	NATURE			English	Article							PETROLEUM-CONTAMINATED AQUIFER; POLYCYCLIC AROMATIC-HYDROCARBONS; SULFATE-REDUCING CONDITIONS; HARBOR SEDIMENTS; DEGRADATION; BIOREMEDIATION; TOLUENE; BIODEGRADATION; TRANSFORMATION; BACTERIUM	Benzene contamination is a significant problem. It is used in a wide range of manufacturing processes and is a primary component of petroleum-based fuels. Benzene is a hydrocarbon that is soluble, mobile, toxic and stable, especially in ground and surface waters. It is poorly biodegraded in the absence of oxygen. However, anaerobic benzene biodegradation has been documented under various conditions. Although benzene biomineralization has been demonstrated with nitrate(1), Fe(III)(2-5), sulphate(6,7) or CO28,9 as alternative electron acceptors, these studies were based on sediments or microbial enrichments. Until now there were no organisms in pure culture that degraded benzene anaerobically. Here we report two Dechloromonas strains, RCB and JJ, that can completely mineralize various mono-aromatic compounds including benzene to CO2 in the absence of O-2 with nitrate as the electron acceptor. This is the first example, to our knowledge, of an organism of any type that can oxidize benzene anaerobically, and we demonstrate the potential applicability of these organisms to the treatment of contaminated environments.	So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Coates, JD (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.		Chakraborty, Romy/D-9230-2015	Chakraborty, Romy/0000-0001-9326-554X; Bender, Kelly/0000-0002-0025-2166				Achenbach LA, 2000, ASM NEWS, V66, P714; Achenbach LA, 2001, INT J SYST EVOL MICR, V51, P527, DOI 10.1099/00207713-51-2-527; Anderson R.T., 1999, BIOREMEDIAT J, V3, P121, DOI DOI 10.1080/10889869991219271; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Anderson RT, 1998, ENVIRON SCI TECHNOL, V32, P1222, DOI 10.1021/es9704949; Anderson RT, 1997, ADV MICROB ECOL, V15, P289; Bruce RA, 1999, ENVIRON MICROBIOL, V1, P319, DOI 10.1046/j.1462-2920.1999.00042.x; Burland SM, 1999, APPL ENVIRON MICROB, V65, P529; CHRISTENSEN TH, 1994, CRIT REV ENV SCI TEC, V24, P119, DOI 10.1080/10643389409388463; Coates J. D., 1999, BIOREMEDIAT J, V3, P323, DOI [10.1080/10889869991219415, DOI 10.1080/10889869991219415]; Coates JD, 1999, APPL ENVIRON MICROB, V65, P5234; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1099, DOI 10.1128/AEM.62.3.1099-1101.1996; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1531, DOI 10.1128/AEM.62.5.1531-1536.1996; Coates JD, 1996, ENVIRON SCI TECHNOL, V30, P2784, DOI 10.1021/es9600441; Coates JD, 1998, NATURE, V396, P730, DOI 10.1038/25470; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; GRBICGALIC D, 1987, APPL ENVIRON MICROB, V53, P254; LOVLEY DR, 1994, NATURE, V370, P128, DOI 10.1038/370128a0; Lovley DR, 1997, J IND MICROBIOL BIOT, V18, P75, DOI 10.1038/sj.jim.2900246; Lovley DR, 1996, APPL ENVIRON MICROB, V62, P288, DOI 10.1128/AEM.62.1.288-291.1996; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P953, DOI 10.1128/AEM.61.3.953-958.1995; LOVLEY DR, 1990, APPL ENVIRON MICROB, V56, P1858, DOI 10.1128/AEM.56.6.1858-1864.1990; Lovley DR, 1999, ENVIRON MICROBIOL, V1, P89, DOI 10.1046/j.1462-2920.1999.00009.x; RABUS R, 1993, APPL ENVIRON MICROB, V59, P1444, DOI 10.1128/AEM.59.5.1444-1451.1993; RIDGWAY HF, 1990, APPL ENVIRON MICROB, V56, P3565, DOI 10.1128/AEM.56.11.3565-3575.1990; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; VOGEL TM, 1986, APPL ENVIRON MICROB, V52, P200, DOI 10.1128/AEM.52.1.200-202.1986; Weiner JM, 1998, APPL ENVIRON MICROB, V64, P1937; Weiner JM, 1998, APPL ENVIRON MICROB, V64, P775	30	380	419	5	154	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1039	1043		10.1038/35082545	http://dx.doi.org/10.1038/35082545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429602				2022-12-01	WOS:000169528500045
J	Cheng, YZ; Endo, K; Wu, K; Rodan, AR; Heberlein, U; Davis, RL				Cheng, YZ; Endo, K; Wu, K; Rodan, AR; Heberlein, U; Davis, RL			Drosophila fasciclinII is required for the formation of odor memories and for normal sensitivity to alcohol	CELL			English	Article							CELL-ADHESION MOLECULES; LONG-TERM-MEMORY; GROWTH CONE GUIDANCE; DEPENDENT PROTEIN-KINASE; CAMP-RESPONSIVE ELEMENT; MUSHROOM BODIES; SYNAPTIC PLASTICITY; IMMUNOGLOBULIN SUPERFAMILY; PHARMACOLOGICAL EVIDENCE; PREFERENTIAL EXPRESSION	Drosophila fasciclinII (fasII) mutants perform poorly after olfactory conditioning due to a defect in encoding, stabilizing, or retrieving short-term memories. Performance was rescued by inducing the expression of a normal transgene just before training and immediate testing. Induction after training but before testing failed to rescue performance, showing that Fas II does not have an exclusive role in memory retrieval processes. The stability of odor memories in fasII mutants are indistinguishable from control animals when initial performance is normalized. Like several other muta nts deficient in odor learning, fasII mutants exhibit a heightened sensitivity to ethanol vapors. A combination of behavioral and genetic strategies have therefore revealed a role for Fas II in the molecular operations of encoding short-term odor memories and conferring alcohol sensitivity. The preferential expression of Fas II in the axons of mushroom body neurons furthermore suggests that short-term odor memories are formed in these neurites.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608; Rodan, Aylin/0000-0001-9202-2378	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904] Funding Source: NIH RePORTER; NINDS NIH HHS [NS19904] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Beck CDO, 2000, J NEUROSCI, V20, P2944; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Byrne JH, 1996, J NEUROSCI, V16, P425; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DOYLE E, 1992, J NEUROCHEM, V59, P1570, DOI 10.1111/j.1471-4159.1992.tb08477.x; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; GARCIAALONSO L, 1995, P NATL ACAD SCI USA, V92, P10501, DOI 10.1073/pnas.92.23.10501; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SPRING HARB SYM, V55, P323; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; Holmes AL, 1999, DEVELOPMENT, V126, P261; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; Ito K, 1998, LEARN MEMORY, V5, P52; Lee T, 1999, DEVELOPMENT, V126, P4065; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mileusnic R, 1999, LEARN MEMORY, V6, P120; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Preat T, 1998, J NEUROSCI, V18, P8534; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; ROMAN G, 2001, IN PRESS BIOESSAYS; ROSE SPR, 1995, TRENDS NEUROSCI, V18, P502, DOI 10.1016/0166-2236(95)92774-K; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.0.CO;2-1; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wright JW, 1999, DEVELOPMENT, V126, P3217; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	53	105	108	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					757	768		10.1016/S0092-8674(01)00386-5	http://dx.doi.org/10.1016/S0092-8674(01)00386-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440718	Bronze			2022-12-01	WOS:000169375100009
J	Kadotani, H; Kadotani, T; Young, T; Peppard, PE; Finn, L; Colrain, IM; Murphy, GM; Mignot, E				Kadotani, H; Kadotani, T; Young, T; Peppard, PE; Finn, L; Colrain, IM; Murphy, GM; Mignot, E			Association between apolipoprotein E epsilon 4 and sleep-disordered breathing in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; APNEA SYNDROME; HYPERTENSION	Context Apolipoprotein E epsilon4 (ApoE epsilon4) is a well-known risk factor for Alzheimer disease and cardiovascular disease. Sleep-disordered breathing occurs in Alzheimer disease patients and increases risks for cardiovascular disease. Complex interactions among sleep, brain pathology, and cardiovascular disease may occur in ApoE epsilon4 carriers, Objective To study whether genetic variation at the level of ApoE is associated with sleep-disordered breathing or sleep abnormalities in the general population. Design, Setting, and Participants Ongoing longitudinal cohort study of sleep disorders at a US university beginning in 1989, providing a population-based probability sample of 791 middle-aged adults (mean [SD] age, 49 [8] years; range, 32-68 years). Main Outcome Measure Nocturnal polysomnography to evaluate apnea-hypopnea index. Results The probability of moderate-to-severe sleep-disordered breathing (apnea-hypopnea index greater than or equal to 15%) was significantly higher in participants with epsilon4, independent of age, sex, body mass index, and ethnicity (12.0% vs 7.0%; P=.003). Mean (SEM) apnea-hypopnea index was also significantly higher in participants with ApoE epsilon4 (6.5 [0.6] vs 4.8 [0.3]; P=.01). These effects increased with the number of ApoE epsilon4 alleles carried. Conclusions A significant portion of sleep-disordered breathing is associated with ApoE epsilon4 in the general population.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA; Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo 650, Japan; Univ Wisconsin, Dept Prevent Med, Madison, WI 53706 USA; Stanford Univ, Sleep Disorders Clin, Palo Alto, CA USA; Vet Affairs Sierra Pacific Mental Illness Res Edu, Palo Alto, CA USA	Stanford University; Kobe University; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Mignot, E (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA.		Kadotani, Hiroshi/A-7908-2015	Kadotani, Hiroshi/0000-0001-7474-3315	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014124, T32AG000164] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR03186] Funding Source: Medline; NHLBI NIH HHS [R01HL62252] Funding Source: Medline; NIA NIH HHS [R01 AG14124, T32 AG00164] Funding Source: Medline; NIMH NIH HHS [P30 MH40041] Funding Source: Medline; NINDS NIH HHS [P50 NS23724] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asada T, 2000, SLEEP, V23, P629; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Engleman HM, 2000, SLEEP, V23, pS102; GUILLEMINAULT C, 1995, CHEST, V107, P1545, DOI 10.1378/chest.107.6.1545; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MONTPLAISIR J, 1992, SLEEP, V15, pS17, DOI 10.1093/sleep/15.suppl_6.S17; Murphy GM, 1997, AM J PSYCHIAT, V154, P603; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PETIT D, 1993, NEUROBIOL AGING, V14, P141, DOI 10.1016/0197-4580(93)90089-T; PRINZ PN, 1982, J AM GERIATR SOC, V30, P86, DOI 10.1111/j.1532-5415.1982.tb01279.x; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; Saarelainen S, 1998, CLIN GENET, V53, P147; SIEST G, 1995, CLIN CHEM, V41, P1068; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2000, SLEEP, V23, pS122	19	173	182	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2888	2890		10.1001/jama.285.22.2888	http://dx.doi.org/10.1001/jama.285.22.2888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401610	Bronze			2022-12-01	WOS:000169156300028
J	Sandalow, DB; Bowles, IA				Sandalow, DB; Bowles, IA			Climate change - Fundamentals of treaty-making on climate change	SCIENCE			English	Article									World Resources Inst, Washington, DC 20002 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA	Harvard University; Conservation International	Sandalow, DB (corresponding author), World Resources Inst, 10 G St NE, Washington, DC 20002 USA.							AUSTIN D, 1998, CONTRIBUTIONS CLIMAT; CROWLEY T, 1991, SERIES GEOLOGY GEOPH, V18; *DOE, 2001, INT EN ANN 1999; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; HOUGHTON JT, 1990, SUMMARY POLICYMAKERS; *INT EN AG, 1998, EN STAT BAL OECD NON; IPCC, 2013, SUMM POL CLIM CHANG; ONEILL P, 1998, SPRING M AL ASS WASH; *UN, 1998, KYOT PROT UN FRAM CO; UN, 1992, FRAM CONV CLIM CHANG; United Nations, 2012, MONTREAL PROTOCOL SU, Vninth; US Department of Energy Energy Information Administration, 2001, INT EN OUTL 2001; Watson RT, 2000, LAND USE LAND USE CH	13	8	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1839	1840		10.1126/science.1062174	http://dx.doi.org/10.1126/science.1062174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397932				2022-12-01	WOS:000169200700025
J	Zhu, H; Bilgin, M; Bangham, R; Hall, D; Casamayor, A; Bertone, P; Lan, N; Jansen, R; Bidlingmaier, S; Houfek, T; Mitchell, T; Miller, P; Dean, RA; Gerstein, M; Snyder, M				Zhu, H; Bilgin, M; Bangham, R; Hall, D; Casamayor, A; Bertone, P; Lan, N; Jansen, R; Bidlingmaier, S; Houfek, T; Mitchell, T; Miller, P; Dean, RA; Gerstein, M; Snyder, M			Global analysis of protein activities using proteome chips	SCIENCE			English	Article							ASH1 MESSENGER-RNA; ARP2/3 COMPLEX; BUDDING YEAST; KINASES; CALMODULIN; SUBUNIT; GENOME; MOTOR	To facilitate studies of the yeast proteome, we cloned 5800 open reading frames and overexpressed and purified their corresponding proteins. The proteins were printed onto slides at high spatial density to form a yeast proteome microarray and screened for their ability to interact with proteins and phospholipids. We identified many new calmodulin- and phospholipid-interacting proteins; a common potential binding motif was identified for many of the calmodulin-binding proteins. Thus, microarrays of an entire eukaryotic proteome can be prepared and screened for diverse biochemical activities. The microarrays can also be used to screen protein-drug interactions and to detect posttranslational modifications.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; N Carolina State Univ, Fungal Genom Lab, Raleigh, NC 27695 USA; Yale Univ, Dept Anesthesiol, New Haven, CT 06520 USA	Yale University; Yale University; University of North Carolina; North Carolina State University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Casamayor, Antonio/A-3190-2012; Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019; Casamayor, Antonio/C-2509-2017	Casamayor, Antonio/0000-0003-2788-7329; Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Snyder, Michael/0000-0003-0784-7987				Ansari K, 1999, J BIOL CHEM, V274, P30052, DOI 10.1074/jbc.274.42.30052; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CAVEMAN A, 2000, J CELL SCI, V113, P3543; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fields S, 1999, P NATL ACAD SCI USA, V96, P8825, DOI 10.1073/pnas.96.16.8825; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gerstein M, 1998, PROTEINS, V33, P518, DOI 10.1002/(SICI)1097-0134(19981201)33:4<518::AID-PROT5>3.0.CO;2-J; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Guerra R, 2000, BIOSCIENCE REP, V20, P41, DOI 10.1023/A:1005583117296; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Li Y, 1999, MOL CELL BIOL, V19, P3588; MacBeath G, 2000, SCIENCE, V289, P1760; MARTIN TF, 2000, ANNU REV CELL DEV BI, V14, P231; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Menendez J, 1998, YEAST, V14, P647; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Pardo M, 1999, YEAST, V15, P459, DOI 10.1002/(SICI)1097-0061(199904)15:6<459::AID-YEA387>3.0.CO;2-L; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; STIRLING DA, 1994, EMBO J, V13, P4329, DOI 10.1002/j.1460-2075.1994.tb06753.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wera S, 2001, FEMS YEAST RES, V1, P9, DOI 10.1111/j.1567-1364.2001.tb00008.x; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, CURR OPIN CHEM BIOL, V5, P40, DOI 10.1016/S1367-5931(00)00170-8	37	1708	1862	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2101	2105		10.1126/science.1062191	http://dx.doi.org/10.1126/science.1062191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11474067	Green Submitted			2022-12-01	WOS:000171028700077
J	Wheeler, DA; Arathoon, EG; Pitts, M; Cedillos, RA; Bu, TE; Porras, GD; Herrera, G; Sosa, NR				Wheeler, DA; Arathoon, EG; Pitts, M; Cedillos, RA; Bu, TE; Porras, GD; Herrera, G; Sosa, NR			Availability of HIV care in Central America	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-1	Central America is an area with a growing human immunodeficiency virus (HIV) epidemic, but with marked limitations in its health care infrastructure. Estimated adult HIV infection rates range from 0.20% in Nicaragua to 2.01% in Belize. Hospitals and clinicians with experience in HIV care exist mainly, if not only, in capital cities and principal economic centers. Nationally sponsored social security systems in each country consistently offer a wider range of services than do ministry of health systems. Estimated access to the social security system ranges from 0% in Belize and 10% of the population in Honduras to 95% in Costa Rica. Combination antiretroviral therapy is not available through the ministries of health and zidovudine is only sporadically available for prevention of perinatal transmission. Combination therapy is available through the social security system in the countries of Guatemala, Panama, and Costa Rica only. A wide variety of antiretroviral agents are available through private pharmacies in all countries except Belize. With the exception of Costa Ricans, most people with HIV infection in Central America have limited access to HIV-specific health services and limited or no access to antiretroviral agents.	Infect Dis Physicians, Annandale, VA 22003 USA; Hosp San Juan Dios, Guatemala City, Guatemala; Natl AIDS Program, Belize City, Belize; Hosp Rosales, San Salvador, El Salvador; Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; Hosp Bautista, Managua, Nicaragua; Hosp Calderon Guardia, San Jose, Costa Rica; Complejo Hosp Metropolitano Arnulfo Arias Madrid, Panama City, Panama		Wheeler, DA (corresponding author), Infect Dis Physicians, 3289 Woodburn Rd,Suite 200, Annandale, VA 22003 USA.		Arathoon, Eduardo G./J-8751-2019	Arathoon, Eduardo G./0000-0002-6225-7413				AGUAIS J, 2000, 13 INT AIDS C JUL 13; Candal DH, 1997, AIDS RES HUM RETROV, V13, P1349, DOI 10.1089/aid.1997.13.1349; GONZALEZDIAZ E, 1999, INF DIS SOC AM ANN M; HASELTINE WA, 1998, ESTABLISHING PRIORIT; HERRERA G, 1999, 1 CENTR AM C SEX TRA; *J HOPK U AIDS SER, 1998, HOPK HIV REP S; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; Lara C, 1997, J CLIN MICROBIOL, V35, P783, DOI 10.1128/JCM.35.3.783-784.1997; *PAN AM HLTH ORG, 2000, AIDS SURV AM BIANN R; *PAN AM HLTH ORG W, 2000, BUILD BLOCKS GUID PR; QUATTRINI E, 2000, 13 INT AIDS C JUL 11; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; *U NAC AUT HOND, 1999, AN AC SIT NAC, P56; WEBER AE, 2000, 13 INT AIDS C JUL 10	14	12	13	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					853	860		10.1001/jama.286.7.853	http://dx.doi.org/10.1001/jama.286.7.853			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497545				2022-12-01	WOS:000170429600035
J	Ferguson-Smith, AC; Surani, MA				Ferguson-Smith, AC; Surani, MA			Imprinting and the epigenetic asymmetry between parental genomes	SCIENCE			English	Editorial Material							DNA METHYLATION; ANTISENSE RNA; IGF2R GENE; CPG ISLAND; HISTONE H3; GERM-LINE; LYSINE 9; EXPRESSION; CTCF; UPSTREAM	Genomic imprinting confers a developmental asymmetry on the parental genomes, through epigenetic modifications in the germ line and embryo. These heritable modifications regulate the monoallelic activity of parental alleles resulting in their functional differences during development. Specific cis-acting regulatory elements associated with imprinted genes carry modifications involving chromatin structural changes and DNA methylation. Some of these modifications are initiated in the germ tine. Comparative genomic analysis at imprinted domains is emerging as a powerful toot for the identification of conserved elements amenable to more detailed functional analysis, and for providing insight into the emergence of imprinting during the evolution of mammalian species. Genomic imprinting therefore provides a model system for the analysis of the epigenetic control of genome function.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge; University of Cambridge	Ferguson-Smith, AC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	afsmith@mole.bio.cam.ac.uk; as10021@mole.bio.cam.ac.uk	Ferguson-Smith, Anne C/G-7534-2011	Surani, Azim/0000-0002-8640-4318; Ferguson-Smith, Anne/0000-0002-7608-5894				ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Arney KL, 2001, INT J DEV BIOL, V45, P533; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BAYLIN S, IN PRESS SCIENCE; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Cranston MJ, 2001, GENOMICS, V73, P98, DOI 10.1006/geno.2001.6514; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Dean W, 2001, CURR BIOL, V11, pR527, DOI 10.1016/S0960-9822(01)00311-6; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Ferguson-Smith AC, 2000, CURR BIOL, V10, pR872, DOI 10.1016/S0960-9822(00)00817-4; Grandjean V, 2001, FEBS LETT, V488, P165, DOI 10.1016/S0014-5793(00)02349-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; JAENISCH R, IN PRESS SCIENCE; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kato Y, 1999, DEVELOPMENT, V126, P1823; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Loebel DAF, 1996, GENOME RES, V6, P114, DOI 10.1101/gr.6.2.114; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NEUMANN B, 1995, NAT GENET, V9, P451, DOI 10.1038/ng0495-451b; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; PAULSEN M, IN PRESS J PATHOL; PAULSEN M, UNPUB; Pickard B, 2001, MECH DEVELOP, V103, P35, DOI 10.1016/S0925-4773(01)00329-X; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Riesewijk AM, 1996, GENOMICS, V31, P158, DOI 10.1006/geno.1996.0027; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; SANFORD JP, 1987, GENE DEV, V1, P1039, DOI 10.1101/gad.1.10.1039; Schmidt JV, 2000, GENE DEV, V14, P1997; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; SURANI MA, 1993, PHILOS T R SOC B, V339, P165, DOI 10.1098/rstb.1993.0013; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; TAKADA S, UNPUB; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Werren JH, 2000, GENETICS, V155, P1469; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	63	306	334	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1086	1089		10.1126/science.1064020	http://dx.doi.org/10.1126/science.1064020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498578				2022-12-01	WOS:000170432600046
J	Noma, K; Allis, CD; Grewal, SIS				Noma, K; Allis, CD; Grewal, SIS			Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries	SCIENCE			English	Article							FISSION YEAST; PROTEIN; DIRECTIONALITY; EXPRESSION; CENTROMERE; REGION; LOCI	Eukaryotic genomes are organized into discrete structural and functional chromatin domains. Here, we show that distinct site-specific histone H3 methylation patterns define euchromatic and heterochromatic chromosomal domains within a 47-kilobase region of the mating-type locus in fission yeast. H3 methylated at lysine 9 (H3 Lys(9)), and its interacting Swi6 protein, are strictly localized to a 20-kilobase silent heterochromatic interval. In contrast, H3 methylated at lysine 4 (H3 LyS(4)) is specific to the surrounding euchromatic regions. Two inverted repeats flanking the silent interval serve as boundary elements to mark the borders between heterochromatin and euchromatin. Deletions of these boundary elements lead to spreading of H3 Lys(9) methylation and Swi6 into neighboring sequences. Furthermore, the H3 Lys(9) methylation and corresponding heterochromatin-associated complexes prevent H3 LyS(4) methylation in the silent domain.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM059772, R01GM053512] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53512, GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayoub N, 1999, GENETICS, V152, P495; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.3.CO;2-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NAKAYAMA J, UNPUB; Partridge JF, 2000, GENE DEV, V14, P783; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	25	577	600	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1150	1155		10.1126/science.1064150	http://dx.doi.org/10.1126/science.1064150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498594				2022-12-01	WOS:000170432600064
J	Pouille, F; Scanziani, M				Pouille, F; Scanziani, M			Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition	SCIENCE			English	Article							COINCIDENCE DETECTOR; CORTICAL NEURON; BRAIN-SLICES; INTERNEURONS; CA1; HIPPOCAMPUS; POTENTIALS; NOREPINEPHRINE; INTEGRATOR	The temporal resolution of neuronal integration depends on the time window within which excitatory inputs summate to reach the threshold for spike generation. Here, we show that in rat hippocampal pyramidal cells this window is very narrow (less than 2 milliseconds). This narrowness results from the short delay with which disynaptic feed-forward inhibition follows monosynaptic excitation. Simultaneous somatic and dendritic recordings indicate that feedforward inhibition is much stronger in the soma than in the dendrites, resulting in a broader integration window in the latter compartment. Thus, the subcellular partitioning of feed-forward inhibition enforces precise coincidence detection in the soma, while allowing dendrites to sum incoming activity over broader time windows.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Zurich	Scanziani, M (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Bergles DE, 1996, J NEUROSCI, V16, P572; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gordon S.., 1998, SYNAPTIC ORG BRAIN, V5; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; KNOWLES WD, 1981, J NEUROSCI, V1, P318; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAJOR G, 1994, J NEUROSCI, V14, P4613; McQuiston AR, 1999, J NEUROSCI, V19, P5693, DOI 10.1523/JNEUROSCI.19-14-05693.1999; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Seutin V, 1997, NEUROPHARMACOLOGY, V36, P1653, DOI 10.1016/S0028-3908(97)00147-0; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sturm AK, 2001, BIOL CYBERN, V84, P153, DOI 10.1007/s004220000209; TEITELBAUM H, 1975, Science (Washington D C), V188, P1114, DOI 10.1126/science.175440; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	23	797	807	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1159	1163		10.1126/science.1060342	http://dx.doi.org/10.1126/science.1060342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498596				2022-12-01	WOS:000170432600066
J	Smallman, HS; MacLeod, DIA; Doyle, P				Smallman, HS; MacLeod, DIA; Doyle, P			Vision: Realignment of cones after cataract removal	NATURE			English	Article									Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Pacific Sci & Engn Grp, San Diego, CA 92122 USA; Dartmouth Coll, Dept Math, Hanover, NH 03755 USA	University of California System; University of California San Diego; Dartmouth College	Smallman, HS (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.							APPLEGATE RA, 1993, J OPT SOC AM A, V10, P1611, DOI 10.1364/JOSAA.10.001611; APPLEGATE RA, 1981, INVEST OPHTH VIS SCI, V21, P869; BONDS AB, 1978, INVEST OPHTH VIS SCI, V17, P754; Dennison D., 1979, Encyclopedia of Plant Physiology, New Series, Volume 7. Physiology of movements [Haupt, W.; Feinleib, M.E. (Editors)]., P506; ENOCH J M, 1961, Optom Wkly, V8, P329; ENOCH JM, 1981, PHILOS T R SOC B, V291, P323, DOI 10.1098/rstb.1981.0002; ENOCH JM, 1991, VISUAL OPTICS INSTRU, P280; FINE I, IN PRESS VISION RES; Kono M, 2001, VISION RES, V41, P103, DOI 10.1016/S0042-6989(00)00228-5; LATIES AM, 1968, NATURE, V218, P172, DOI 10.1038/218172a0; Laties AM, 1979, MOTILITY CELL FUNCTI, P285; MACLEOD DIA, 1974, VISION RES, V14, P369, DOI 10.1016/0042-6989(74)90235-1; Stiles WS, 1933, P R SOC LOND B-CONTA, V112, P428, DOI 10.1098/rspb.1933.0020	13	21	21	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					604	605		10.1038/35088126	http://dx.doi.org/10.1038/35088126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493909				2022-12-01	WOS:000170318000029
J	Trembath, RC; Thomson, JR; Machado, RD; Morgan, NV; Atkinson, C; Winship, I; Simonneau, G; Galie, N; Loyd, JE; Humbert, M; Nichols, WC; Morrell, NW; Berg, J; Manes, A; McGaughran, J; Pauciulo, M; Wheeler, L				Trembath, RC; Thomson, JR; Machado, RD; Morgan, NV; Atkinson, C; Winship, I; Simonneau, G; Galie, N; Loyd, JE; Humbert, M; Nichols, WC; Morrell, NW; Berg, J; Manes, A; McGaughran, J; Pauciulo, M; Wheeler, L			Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIOVENOUS-MALFORMATIONS; GERMLINE MUTATIONS; PENDRED SYNDROME; KINASE-1 GENE; RECEPTOR; BETA; ENDOGLIN; TYPE-2; GROWTH; PPH1	Background: Most patients with familial primary pulmonary hypertension have defects in the gene for bone morphogenetic protein receptor II (BMPR2), a member of the transforming growth factor beta (TGF-beta) superfamily of receptors. Because patients with hereditary hemorrhagic telangiectasia may have lung disease that is indistinguishable from primary pulmonary hypertension, we investigated the genetic basis of lung disease in these patients. Methods: We evaluated members of five kindreds plus one individual patient with hereditary hemorrhagic telangiectasia and identified 10 cases of pulmonary hypertension. In the two largest families, we used microsatellite markers to test for linkage to genes encoding TGF-beta -receptor proteins, including endoglin and activin-receptor-like kinase 1 (ALK1), and BMPR2. In subjects with hereditary hemorrhagic telangiectasia and pulmonary hypertension, we also scanned ALK1 and BMPR2 for mutations. Results: We identified suggestive linkage of pulmonary hypertension with hereditary hemorrhagic telangiectasia on chromosome 12q13, a region that includes ALK1. We identified amino acid changes in activin-receptor-like kinase 1 that were inherited in subjects who had a disorder with clinical and histologic features indistinguishable from those of primary pulmonary hypertension. Immunohistochemical analysis in four subjects and one control showed pulmonary vascular endothelial expression of activin-receptor-like kinase 1 in normal and diseased pulmonary arteries. Conclusions: Pulmonary hypertension in association with hereditary hemorrhagic telangiectasia can involve mutations in ALK1. These mutations are associated with diverse effects, including the vascular dilatation characteristic of hereditary hemorrhagic telangiectasia and the occlusion of small pulmonary arteries that is typical of primary pulmonary hypertension.	Univ Leicester, Dept Med, Div Med Genet, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Genet, Div Med Genet, Leicester LE1 7RH, Leics, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Papworth Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand; Univ Paris Sud, Assistance Publ Hop Paris, Hop Antoine Beclere, Serv Pneumol, Clamart, France; Univ Bologna, Inst Cardiol, Bologna, Italy; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA	University of Leicester; University of Leicester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; University of Auckland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; University of Bologna; Vanderbilt University; Cincinnati Children's Hospital Medical Center	Trembath, RC (corresponding author), Univ Leicester, Dept Med, Div Med Genet, Adrian Bldg, Leicester LE1 7RH, Leics, England.		McGaughran, Julie/A-2563-2012; Galie, Nazzareno/F-7004-2014; Winship, Ingrid M/D-7204-2016; Machado, Rajiv D./AAD-7813-2019; Simonneau, Gerald/ABE-6614-2020; Morgan, Neil V/A-5475-2009	Galie, Nazzareno/0000-0003-4271-8670; Machado, Rajiv D./0000-0001-9247-0744; Morgan, Neil V/0000-0001-6433-5692; Morrell, Nicholas/0000-0001-5700-9792; McGaughran, Julie/0000-0002-0926-7858; Humbert, Marc/0000-0003-0703-2892; Loyd, James/0000-0002-5042-7390; Winship, Ingrid/0000-0001-8535-6003; Trembath, Richard/0000-0003-0550-3400	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048164, R01HL061997] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48164, HL61997] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cool CD, 1999, AM J PATHOL, V155, P411, DOI 10.1016/S0002-9440(10)65137-1; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Gausden E, 1997, J MED GENET, V34, P126, DOI 10.1136/jmg.34.2.126; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Klaus Daniel J., 1998, Human Mutation, V12, P137, DOI 10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU15>3.0.CO;2-M; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Machado RD, 2000, GENOMICS, V68, P220, DOI 10.1006/geno.2000.6291; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Makowski GS, 1998, ANN CLIN LAB SCI, V28, P254; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SAPRU RP, 1969, BRIT HEART J, V31, P559; Schulick AH, 1998, P NATL ACAD SCI USA, V95, P6983, DOI 10.1073/pnas.95.12.6983; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Thomson JR, 2000, J CLIN PATHOL, V53, P899, DOI 10.1136/jcp.53.12.899; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; TRELL E, 1972, AM J MED, V53, P50, DOI 10.1016/0002-9343(72)90115-5; WHYTE MKB, 1993, J APPL PHYSIOL, V75, P321, DOI 10.1152/jappl.1993.75.1.321	33	504	537	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					325	334		10.1056/NEJM200108023450503	http://dx.doi.org/10.1056/NEJM200108023450503			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484689	Green Accepted, Green Published			2022-12-01	WOS:000170193600003
J	Schwetz, BA				Schwetz, BA			New weight-reduction system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-01	WOS:000170188300005
J	Inchausti, P; Halley, J				Inchausti, P; Halley, J			Investigating long-term ecological variability using the global population dynamics database	SCIENCE			English	Editorial Material								The Global Population Dynamics Database (GPDD) is an important new source of information for ecologists, resource managers, and environmental scientists interested in the dynamics of natural populations. It comprises more than 4500 time series of population abundance for over 1800 animal species across many taxonomic groups and geographical locations. The GPDD offers great potential for asking comparative questions about the nature of population variability. We illustrate this by characterizing some critical features of ecological variability, variance growth, and spectral reddening.	Ecole Normale Super, Ecol Lab, F-75005 Paris, France; Aristotle Univ Thessaloniki, Sch Biol, Dept Ecol, GR-54006 Thessaloniki, Greece	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Aristotle University of Thessaloniki	Inchausti, P (corresponding author), Ecole Normale Super, Ecol Lab, 46 Rue Ulm, F-75005 Paris, France.	inchauss@biologie.ens.fr; jmax@bio.auth.gr	Halley, John M/AAP-3004-2020					Adler R., 1997, PRACTICAL GUIDE HEAV; ARINO A, 1995, EVOL ECOL, V9, P423; CYR H, 1996, OIKOS, V79, P54; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; HALLEY JW, UNPUB; Kendall BE, 1998, ECOL LETT, V1, P160; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; MACARDLE B, 1990, J ANIM ECOL, V59, P439; May R.M., 1975, P81; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Pimm S.L., 1991, BALANCE NATURE ECOLO; PIMM SL, 1988, NATURE, V334, P613, DOI 10.1038/334613a0; Royama T., 1992, ANAL POPULATION ECOL; STEELE J, 1986, NATURE, V313, P355; White A, 1996, NATURE, V381, P198, DOI 10.1038/381198a0	16	101	104	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					655	657		10.1126/science.293.5530.655	http://dx.doi.org/10.1126/science.293.5530.655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474102				2022-12-01	WOS:000170204600044
J	Padian, K; de Ricqles, AJ; Horner, JR				Padian, K; de Ricqles, AJ; Horner, JR			Dinosaurian growth rates and bird origins	NATURE			English	Article							BONE MICROSTRUCTURE; PERIOSTEAL BONE; SKELETOCHRONOLOGY; HISTOLOGY; ONTOGENY	Dinosaurs, like other tetrapods, grew more quickly just after hatching than later in life. However, they did not grow like most other non-avian reptiles, which grow slowly and gradually through life. Rather, microscopic analyses of the long-bone tissues show that dinosaurs grew to their adult size relatively quickly, much as large birds and mammals do today. The first birds reduced their adult body size by shortening the phase of rapid growth common to their larger theropod dinosaur relatives. These changes in timing were primarily related not to physiological differences but to differences in growth strategy.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Paris 07, CNRS, UMR 8570, Equipe Format Squelett, F-75251 Paris 05, France; Coll France, F-75231 Paris, France; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Montana State University System; Montana State University Bozeman	Padian, K (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kpadian@socrates.berkeley.edu						ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Amprino R., 1947, ARCH BIOL, V58, P315; [Anonymous], 1980, COLD LOOK WARM BLOOD; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Castanet J., 1993, BONE, P245; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; Chinsamy A, 1998, CRETACEOUS RES, V19, P225, DOI 10.1006/cres.1997.0102; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles Armand, 2000, Annee Biologique, V39, P69; DERICQLES A, 2001, IN PRESS PERSPECTIVE; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; KLEVEZAL G A, 1972, Zoologicheskii Zhurnal, V51, P1726; Klevezal GA., 1996, RECORDING STRUCTURES; Padian K, 1997, ENCY DINOSAURS, P288; Reid R.E.H., 1997, P449; Reid R.E.H., 1997, P403; Ricqlu┐s A., 1991, BONE, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Spotila J. R., 1980, COLD LOOK WARM BLOOD, P233; Starck J.M., 1998, AVIAN GROWTH DEV; van Soest R. W. M, 1971, Bijdragen tot de Dierkunde, V41, P61; Varricchio D. J., 1997, ENCY DINOSAURS, P282, DOI DOI 10.1016/J.CUB.2016.10.043; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhang Fucheng, 1998, Vertebrata Palasiatica, V36, P126	41	206	215	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					405	408		10.1038/35086500	http://dx.doi.org/10.1038/35086500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473307				2022-12-01	WOS:000170068200037
J	Knee, LBG; Brunt, CM				Knee, LBG; Brunt, CM			A massive cloud of cold atomic hydrogen in the outer Galaxy	NATURE			English	Article							H-I; MOLECULAR CLOUDS; MILKY-WAY; TEMPERATURES; SUPERSHELLS; SHELLS	A large fraction of the mass of the interstellar medium in our Galaxy is in the form of warm (10(3)-10(4) K) and cool (50-100 K) atomic hydrogen (H I) gas(1). Cold (10-30 K) regions are thought to be dominated by dense clouds of molecular hydrogen(2). Cold H I is difficult to observe, and therefore our knowledge of its abundance and distribution in the interstellar medium is poor. The few known clouds of cold H I are much smaller in size and mass than typical molecular clouds 3-5. Here we report the discovery that the H I supershell GSH139-03-69 is very cold (10 K). It is about 2 kiloparsecs in size and as massive as the largest molecular complexes(6). The existence of such an immense structure composed of cold atomic hydrogen in the interstellar medium runs counter to the prevailing view that cold gas resides almost exclusively in clouds dominated by molecular hydrogen.	Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Radio Astrophys Observ, Penticton, BC V2A 6K3, Canada; Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada	National Research Council Canada; University of Calgary	Knee, LBG (corresponding author), Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Radio Astrophys Observ, POB 248, Penticton, BC V2A 6K3, Canada.	lewis.knee@nrc.ca		Knee, Lewis/0000-0002-9342-9003				BLITZ L, 1991, NATO ADV SCI I C-MAT, V342, P3; Burton W. B., 1988, GALACTIC EXTRAGALACT, P295; CRUTCHER RM, 1974, ASTROPHYS J, V188, P481, DOI 10.1086/152738; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; DICKEY JM, 1990, ANNU REV ASTRON ASTR, V28, P215, DOI 10.1146/annurev.aa.28.090190.001243; Ehlerova S, 1997, ASTRON ASTROPHYS, V328, P121; ELMEGREEN BG, 1987, ASTROPHYS J, V320, P182, DOI 10.1086/165534; Gibson SJ, 2000, ASTROPHYS J, V540, P851, DOI 10.1086/309364; Hartmann D., 1997, ATLAS GALACTIC NEUTR; HEILES C, 1979, ASTROPHYS J, V229, P533, DOI 10.1086/156986; HEILES C, 1982, ASTROPHYS J, V262, P135, DOI 10.1086/160403; Heyer MH, 1998, ASTROPHYS J SUPPL S, V115, P241, DOI 10.1086/313086; Higgs LA, 2000, ASTRON J, V120, P2471, DOI 10.1086/316833; Higgs LA, 1999, ASTR SOC P, V168, P15; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023, DOI 10.1093/mnras/221.4.1023; Kulkarni S. R., INTERSTELLAR PROCESS, V134, P87, DOI [10.1007/978-94-009-3861-8_5, DOI 10.1007/978-94-009-3861-8_5]; KULKARNI SR, 1985, ASTROPHYS J, V291, P716, DOI 10.1086/163110; Landecker TL, 2000, ASTRON ASTROPHYS SUP, V145, P509, DOI 10.1051/aas:2000257; Perna R, 2000, ASTROPHYS J, V539, P706, DOI 10.1086/309282; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Spitzer L, 2008, JRASC; TAYLOR AR, UNPUB ASTRON J; TENORIOTAGLE G, 1988, ANNU REV ASTRON ASTR, V26, P145; TRAPERO J, 1995, ASTROPHYS J, V445, P231, DOI 10.1086/175690; VANDISHOECK EF, 1986, ASTROPHYS J SUPPL S, V62, P109, DOI 10.1086/191135; WANNIER PG, 1983, ASTROPHYS J, V268, P727, DOI 10.1086/160995	26	40	41	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					308	310		10.1038/35085519	http://dx.doi.org/10.1038/35085519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460155				2022-12-01	WOS:000169918200038
J	Meijers-Heijboer, H; van Geel, B; van Putten, WLJ; Henzen-Logmans, SC; Seynaeve, C; Menke-Pluymers, MBE; Bartels, CCM; Verhoog, LC; van den Ouweland, AMW; Niermeijer, MF; Brekelmans, CTM; Klijn, JGM				Meijers-Heijboer, H; van Geel, B; van Putten, WLJ; Henzen-Logmans, SC; Seynaeve, C; Menke-Pluymers, MBE; Bartels, CCM; Verhoog, LC; van den Ouweland, AMW; Niermeijer, MF; Brekelmans, CTM; Klijn, JGM			Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; HIGH-RISK; SURGERY; CARRIERS; SATISFACTION; TAMOXIFEN; SURVIVAL; FAMILIES	Background: Women with a BRCA1 or BRCA2 mutation have a high risk of breast cancer and may choose to undergo prophylactic bilateral total mastectomy. We investigated the efficacy of this procedure in such women. Methods: We conducted a prospective study of 139 women with a pathogenic BRCA1 or BRCA2 mutation who were enrolled in a breast-cancer surveillance program at the Rotterdam Family Cancer Clinic. At the time of enrollment, none of the women had a history of breast cancer. Seventy-six of these women eventually underwent prophylactic mastectomy, and the other 63 remained under regular surveillance. The effect of mastectomy on the incidence of breast cancer was analyzed by the Cox proportional-hazards method in which mastectomy was modeled as a time-dependent covariate. Results: No cases of breast cancer were observed after prophylactic mastectomy after a mean (+/-SE) follow-up of 2.9+/-1.4 years, whereas eight breast cancers developed in women under regular surveillance after a mean follow-up of 3.0+/-1.5 years (P=0.003; hazard ratio, 0; 95 percent confidence interval, 0 to 0.36). The actuarial mean five-year incidence of breast cancer among all women in the surveillance group was 17+/-7 percent. On the basis of an exponential model, the yearly incidence of breast cancer in this group was 2.5 percent. The observed number of breast cancers in the surveillance group was consistent with the expected number (ratio of observed to expected cases, 1.2; 95 percent confidence interval, 0.4 to 3.7; P=0.80). Conclusions: In women with a BRCA1 or BRCA2 mutation, prophylactic bilateral total mastectomy reduces the incidence of breast cancer at three years of follow-up. (N Engl J Med 2001;345:159-64.) Copyright (C) 2001 Massachusetts Medical Society.	Erasmus Univ, Med Ctr, Dr Daniel den Hoed Klin, Dept Med Oncol,Rotterdam Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Surg, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Stat, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Pathol, NL-3075 EA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Klijn, JGM (corresponding author), Erasmus Univ, Med Ctr, Dr Daniel den Hoed Klin, Dept Med Oncol,Rotterdam Family Canc Clin, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands.	bos@onch.azrl.nl						BERMAN L, 2000, LANCET, V356, P881; BILIMORIA MM, 1995, CA-CANCER J CLIN, V45, P263, DOI 10.3322/canjclin.45.5.263; Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HARTMANN LC, 2000, P AM ASSOC CANC RES, V41, P222; Hatcher MB, 2001, BRIT MED J, V322, P76, DOI 10.1136/bmj.322.7278.76; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Khurana KK, 2000, ARCH PATHOL LAB MED, V124, P378; Klijn JGM, 1997, EUR J CANCER, V33, P2149, DOI 10.1016/S0959-8049(97)00360-2; Kriege M., 2000, European Journal of Cancer, V36, pS137; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Meijers-Heijboer EJ, 2000, LANCET, V355, P2015, DOI 10.1016/S0140-6736(00)02347-3; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Peelen T, 2000, BRIT J CANCER, V82, P151, DOI 10.1054/bjoc.1999.0892; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; PetrijBosch A, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503a; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; SKOLNICK MH, 1990, SCIENCE, V250, P1715, DOI 10.1126/science.2270486; STEFANEK ME, 1995, PREV MED, V24, P412, DOI 10.1006/pmed.1995.1066; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 1999, J CLIN ONCOL, V17, P3396, DOI 10.1200/JCO.1999.17.11.3396; Whittemore AS, 1997, AM J HUM GENET, V60, P496; Wooster R, 1996, NATURE, V379, P749, DOI 10.1038/379749a0; ZION SM, 2000, PROG P AM SOC CLIN O, V19, pA441	34	669	688	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					159	164		10.1056/NEJM200107193450301	http://dx.doi.org/10.1056/NEJM200107193450301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463009	Green Published			2022-12-01	WOS:000169912800001
J	Reimold, AM; Iwakoshi, NN; Manis, J; Vallabhajosyula, P; Szomolanyi-Tsuda, E; Gravallese, EM; Friend, D; Grusby, MJ; Alt, F; Glimcher, LH				Reimold, AM; Iwakoshi, NN; Manis, J; Vallabhajosyula, P; Szomolanyi-Tsuda, E; Gravallese, EM; Friend, D; Grusby, MJ; Alt, F; Glimcher, LH			Plasma cell differentiation requires the transcription factor XBP-1	NATURE			English	Article							B-CELL; GERMINAL CENTER; T-CELL; TERMINAL DIFFERENTIATION; BLIMP-1 EXPRESSION; DEFICIENT MICE; IGM SECRETION; PROTEIN; LYMPHOCYTES; MEMORY	Considerable progress has been made in identifying the transcription factors involved in the early specification of the B-lymphocyte lineage. However, little is known about factors that control the transition of mature activated B cells to antibody-secreting plasma cells. Here we report that the transcription factor XBP-1 is required for the generation of plasma cells. XBP-1 transcripts were rapidly upregulated in vitro by stimuli that induce plasma-cell differentiation, and were found at high levels in plasma cells from rheumatoid synovium. When introduced into B-lineage cells, XBP-1 initiated plasma-cell differentiation. Mouse lymphoid chimaeras deficient in XBP-1 possessed normal numbers of activated B lymphocytes that proliferated, secreted cytokines and formed normal germinal centres. However, they secreted very little immunoglobulin of any isotype and failed to control infection with the B-cell-dependent polyoma virus, because plasma cells were markedly absent. XBP-1 is the only transcription factor known to be selectively and specifically required for the terminal differentiation of B lymphocytes to plasma cells.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.		Longo, Kenneth A/A-5631-2010					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altmeyer A, 1997, IMMUNITY, V7, P667, DOI 10.1016/S1074-7613(00)80387-8; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Bachmann MF, 1999, CURR OPIN IMMUNOL, V11, P332, DOI 10.1016/S0952-7915(99)80053-3; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BROOKS K, 1983, NATURE, V302, P825, DOI 10.1038/302825a0; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Choe J, 1998, EUR J IMMUNOL, V28, P508, DOI 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; GRAVALLESE EM, 1991, ARTHRITIS RHEUM-US, V34, P1076, DOI 10.1002/art.1780340903; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; ILLERA VA, 1993, J IMMUNOL, V151, P2965; Kim HJ, 1999, J IMMUNOL, V162, P3053; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu Y J, 1997, Semin Immunol, V9, P235, DOI 10.1006/smim.1997.0080; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Melchers F, 1997, CURR TOP MICROBIOL, V224, P19; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Oliver AM, 1997, J IMMUNOL, V158, P1108; RANDALL TD, 1993, MOL CELL BIOL, V13, P3929, DOI 10.1128/MCB.13.7.3929; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schwoon DR, 1997, EUR ADDICT RES, V3, P11, DOI 10.1159/000259142; Soro PG, 1999, J IMMUNOL, V163, P611; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SzomolanyiTsuda E, 1996, J EXP MED, V183, P403, DOI 10.1084/jem.183.2.403; SZOMOLANYITSUDA.E, J IMMUNOL, V164, P5877; Takatsu K, 1997, P SOC EXP BIOL MED, V215, P121; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wen XY, 1999, INT J ONCOL, V15, P173; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	49	957	1003	1	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					300	307		10.1038/35085509	http://dx.doi.org/10.1038/35085509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460154				2022-12-01	WOS:000169918200037
J	Baker, VR				Baker, VR			Water and the martian landscape	NATURE			English	Review							ORBITER LASER ALTIMETER; CHAOTIC OBLIQUITY; OUTFLOW CHANNELS; POLYGONAL TERRAIN; FLUVIAL VALLEYS; MARS; ICE; SURFACE; CRATER; CLIMATE	Over the past 30 years, the water-generated landforms and landscapes of Mars have been revealed in increasing detail by a succession of spacecraft missions. Recent data from the Mars Global Surveyor mission confirm the view that brief episodes of water-related activity, including glaciation, punctuated the geological history of Mars. The most recent of these episodes seems to have occurred within the past 10 million years. These new results are anomalous in regard to the prevailing view that the martian surface has been continuously extremely cold and dry, much as it is today, for the past 3.9 billion years. Interpretations of the new data are controversial, but explaining the anomalies in a consistent manner leads to potentially fruitful hypotheses for understanding the evolution of Mars in relation to Earth.	Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA	University of Arizona	Baker, VR (corresponding author), Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA.	baker@hwr.arizona.edu						Ackert RP, 1998, GEOGR ANN A, V80A, P267; ANDERSON RC, IN PRESS J GEOPHYS R; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1974, ICARUS, V23, P27, DOI 10.1016/0019-1035(74)90101-8; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Baker VR, 1996, GEOMORPHOLOGY, V16, P197, DOI 10.1016/S0169-555X(96)80001-8; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; BAKER VR, 1979, J GEOPHYS RES, V84, P7985, DOI 10.1029/JB084iB14p07985; Baker VR, 1996, BING SYMP G, P57; BAKER VR, FLOOD MEGAFLOOD DEPO; BAKER VR, 1993, RESOURCES NEAR EARTH, P765; Barlow NG, 2000, J GEOPHYS RES-PLANET, V105, P26733, DOI 10.1029/2000JE001258; Barsch D., 1996, ROCKGLACIERS; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; BURR D, IN PRESS INT ASS SCI; BURR DM, UNPUB GEOPHYS RE LET; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Cabrol NA, 2001, ICARUS, V149, P291, DOI 10.1006/icar.2000.6530; Cabrol NA, 1999, ICARUS, V139, P235, DOI 10.1006/icar.1999.6099; Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr M.H, 1996, WATER MARS; Carr MH, 1999, J GEOPHYS RES-PLANET, V104, P21897, DOI 10.1029/1999JE001048; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Carr MH, 1996, PLANET SPACE SCI, V44, P1411, DOI 10.1016/S0032-0633(96)00053-0; Carr MH, 2000, ASTRON GEOPHYS, V41, P20, DOI 10.1046/j.1468-4004.2000.00320.x; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAMBERLIN TC, 1904, POPULAR SCI MONTHLY, V66, P66; Chapman M.G., 2000, ENV EFFECTS VOLCANIC, P39, DOI DOI 10.1007/978-1-4615-4151-6_3; Clark DH, 1998, GEOGR ANN A, V80A, P175, DOI 10.1111/j.0435-3676.1998.00035.x; CLIFFORD SM, IN PRESS EVOLUTION M; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; Costard F, 2001, GEOMORPHOLOGY, V37, P289, DOI 10.1016/S0169-555X(00)00088-X; COSTARD F, LUN PLAN SCI C, V32; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; CROWELL JC, 1999, GEOL SOC AM MEMOIR, V192; Davis WM, 1926, SCIENCE, V63, P463, DOI 10.1126/science.63.1636.463; Dohm JM, 2000, GEOPHYS RES LETT, V27, P3559, DOI 10.1029/2000GL011728; FRENCH HM, 1996, PERIGLACIAL ENV, V2nd; Gilbert G K, 1896, Science, V3, P1, DOI 10.1126/science.3.53.1; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; Greeley R., 1992, MARS, P730; Gulick VC, 1997, ICARUS, V130, P68, DOI 10.1006/icar.1997.5802; GULICK VC, 1989, NATURE, V341, P514, DOI 10.1038/341514a0; Gulick VC, 1998, J GEOPHYS RES-PLANET, V103, P19365, DOI 10.1029/98JE01321; Gulick VC, 2001, GEOMORPHOLOGY, V37, P241, DOI 10.1016/S0169-555X(00)00086-6; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; HEAD JW, 2001, LUN PLAN SCI C, V32; HEAD JW, IN PRESS J GEOPHYS R; HEAD JW, 2001, LUNAR PLANET SCI, V32; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; HODGES CA, 1979, J GEOPHYS RES, V84, P8061, DOI 10.1029/JB084iB14p08061; Hoffman N, 2000, ICARUS, V146, P326, DOI 10.1006/icar.2000.6398; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, IN PRESS TERRA NOVA; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Ivanov MA, 2001, J GEOPHYS RES-PLANET, V106, P3275, DOI 10.1029/2000JE001257; Jakosky B. M., 1992, MARS, P969; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JONS HP, 1985, LUNAR PLANET SCI, V16, P414; KARGEL JS, 1995, J GEOPHYS RES-PLANET, V100, P5351, DOI 10.1029/94JE02447; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; KOMATSU G, LUN PLAN SCI C, V31; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; Lane MD, 2000, J GEOPHYS RES-PLANET, V105, P17617, DOI 10.1029/1999JE001197; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LUCCHITTA BK, 1986, J GEOPHYS RES-SOLID, V91, pE166, DOI 10.1029/JB091iB13p0E166; Lucchitta BK, 2001, GEOPHYS RES LETT, V28, P403, DOI 10.1029/2000GL011924; LUCCHITTA BK, 1982, J GEOPHYS RES, V87, P9951, DOI 10.1029/JB087iB12p09951; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; LUCCHITTA BK, 2001, LUNAR PLANET SCI, V32; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; MASURSKY H, 1973, J GEOPHYS RES, V78, P4009, DOI 10.1029/JB078i020p04009; Max MD, 2001, GEOPHYS RES LETT, V28, P1787, DOI 10.1029/2000GL011606; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; MOORE JG, 1989, J GEOPHYS RES-SOLID, V94, P17465, DOI 10.1029/JB094iB12p17465; MOUGINISMARK PJ, 1990, ICARUS, V84, P362, DOI 10.1016/0019-1035(90)90044-A; MOUGINISMARK PJ, 1993, LUNAR PLANET SCI, V24, P1021; Mulvaney R, 2000, GEOPHYS RES LETT, V27, P2673, DOI 10.1029/1999GL011254; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; Nelson DM, 1999, J GEOPHYS RES-PLANET, V104, P8653, DOI 10.1029/98JE01900; NUMMEDAL D, 1981, ICARUS, V45, P77, DOI 10.1016/0019-1035(81)90007-5; Nummedal D., 1978, CHANNELED SCABLAND; Ori GG, 2000, J GEOPHYS RES-PLANET, V105, P17629, DOI 10.1029/1999JE001219; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; PIERI DC, 1980, TM81979 NASA; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; SCHULTZ PH, 1979, J GEOPHYS RES, V84, P7669, DOI 10.1029/JB084iB13p07669; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; SLEEP NH, IN PRESS P NATL ACAD; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Squyres S. W., 1992, MARS, P523; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; Strom R.G., 1992, MARS, P383, DOI DOI 10.1016/S0032-0633(99)00016-1; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; Tanaka KL, 1999, J GEOPHYS RES-PLANET, V104, P8637, DOI 10.1029/98JE02552; TANAKA KL, 1990, J GEOPHYS RES-SOLID, V95, P14315, DOI 10.1029/JB095iB09p14315; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WEITZ CM, 2001, LUNAR PLANET SCI, V32; Whewell W., 1847, PHILOS INDUCTIVE SCI; WILLIAMS GE, 1993, EARTH-SCI REV, V34, P1, DOI 10.1016/0012-8252(93)90004-Q; WILSON L, 1969, REV GEOGR PHYS GEOL, V11, P303; [No title captured]	117	423	433	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					228	236		10.1038/35084172	http://dx.doi.org/10.1038/35084172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449284	Bronze			2022-12-01	WOS:000169778700062
J	Hoeppner, DJ; Hengartner, MO; Schnabel, R				Hoeppner, DJ; Hengartner, MO; Schnabel, R			Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; APOPTOSIS; PROTEIN; GENETICS; NEMATODE; CORPSES	Genetic studies have identified over a dozen genes that function in programmed cell death (apoptosis) in the nematode Caenorhabditis elegans(1-3). Although the ultimate effects on cell survival or engulfment of mutations in each cell death gene have been extensively described, much less is known about how these mutations affect the kinetics of death and engulfment, or the interactions between these two processes. We have used four-dimensional-Nomarski time-lapse video microscopy to follow in detail how cell death genes regulate the extent and kinetics of apoptotic cell death and removal in the early C. elegans embryo. Here we show that blocking engulfment enhances cell survival when cells are subjected to weak pro-apoptotic signals. Thus, genes that mediate corpse removal can also function to actively kill cells.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Grad Program Genet, Stony Brook, NY 11794 USA; Tech Univ Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Braunschweig University of Technology	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Hengartner, Michael O/A-7058-2008; Hengartner, Michael O/E-6235-2011	Hengartner, Michael/0000-0002-7584-596X				BRENNER S, 1974, GENETICS, V77, P71; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Duffield JS, 2000, J IMMUNOL, V164, P2110, DOI 10.4049/jimmunol.164.4.2110; ELLIS RE, 1991, GENETICS, V129, P79; GUMIENNY TL, IN PRESS CELL DEATH; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hodgkin J, 1997, C ELEGANS, P881; Knepper-Nicolai B, 1998, J BIOL CHEM, V273, P30530, DOI 10.1074/jbc.273.46.30530; LANG R, 1994, DEVELOPMENT, V120, P3395; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; [No title captured]	23	226	228	1	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					202	206		10.1038/35084103	http://dx.doi.org/10.1038/35084103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449279				2022-12-01	WOS:000169778700057
J	Super, H; Spekreijse, H; Lamme, VAF				Super, H; Spekreijse, H; Lamme, VAF			A neural correlate of working memory in the monkey primary visual cortex	SCIENCE			English	Article							PERSISTENCE; FIGURE; V1	The brain frequently needs to store information for short periods. In vision, this means that the perceptual correlate of a stimulus has to be maintained temporally once the stimulus has been removed from the visual scene. However, it is not known how the visual system transfers sensory information into a memory component. Here, we identify a neural correlate of working memory in the monkey primary visual cortex( V1). We propose that this component may Link sensory activity with memory activity.	Univ Amsterdam, Acad Med Ctr, Grad Sch Neurosci Amsterdam, Dept Visual Syst Anal, NL-1100 AA Amsterdam, Netherlands; Netherlands Ophthalm Res Inst, NL-1105 BA Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Super, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Grad Sch Neurosci Amsterdam, Dept Visual Syst Anal, POB 12011, NL-1100 AA Amsterdam, Netherlands.			Super, Hans/0000-0001-9328-0096				Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; DILOLLO V, 1984, J EXP PSYCHOL HUMAN, V10, P144, DOI 10.1037/0096-1523.10.1.144; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; GOLDMANRAKIC PS, 1990, PROGR BRAIN RES, P313; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Payne BR, 1996, TRENDS NEUROSCI, V19, P535, DOI 10.1016/S0166-2236(96)10061-8; SHIOIRI S, 1992, VISION RES, V32, P943, DOI 10.1016/0042-6989(92)90037-J; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170	12	190	191	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					120	124		10.1126/science.1060496	http://dx.doi.org/10.1126/science.1060496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441187	Green Published			2022-12-01	WOS:000169780300042
J	Pichot, C; Maataoui, M; Raddi, S; Raddi, P				Pichot, C; Maataoui, M; Raddi, S; Raddi, P			Surrogate mother for endangered Cupressus	NATURE			English	Article									INRA, Unite Rech Forestieres Mediterraneennes, F-84000 Avignon, France; Fac Sci, Dept Biol, UMR INRA UAPV Ecol Invertebres, F-84000 Avignon, France; Univ Florence, DISTAF, I-50145 Florence, Italy; CNR, Inst Forest Tree Pathol, I-50144 Florence, Italy	INRAE; Avignon Universite; INRAE; University of Florence; Consiglio Nazionale delle Ricerche (CNR)	Pichot, C (corresponding author), INRA, Unite Rech Forestieres Mediterraneennes, Ave Vivaldi, F-84000 Avignon, France.		Raddi, Sabrina/U-5640-2019	Raddi, Sabrina/0000-0002-9796-1515				BARRY J P, 1970, Bulletin de la Societe d'Histoire Naturelle de l'Afrique du Nord, V61, P95; Den Nijs A. P. M., 1993, V1, P229; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; GAUSSEN H., 1968, GYMNOSPERMES ACTUELL; Mogie M., 1992, EVOLUTION ASEXUAL RE; PAPAGEORGIOU AC, 1993, SILVAE GENET, V42, P109; Pichot C, 2000, ANN FOREST SCI, V57, P17; Pichot C, 2000, THEOR APPL GENET, V101, P574, DOI 10.1007/s001220051518; Pichot C, 1998, SEX PLANT REPROD, V11, P148, DOI 10.1007/s004970050132; Singh H., 1978, EMBRYOLOGY GYMNOSPER	10	59	66	2	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					39	39		10.1038/35083687	http://dx.doi.org/10.1038/35083687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452293	Bronze, Green Published			2022-12-01	WOS:000169644900030
J	Kleinert, S				Kleinert, S			Responding to the changing face of paediatric cardiology	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Kleinert, S (corresponding author), The Lancet, London WC1X 8RR, England.							BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189, DOI 10.1001/jama.1945.02860200029009; de Leval MR, 2000, J THORAC CARDIOV SUR, V119, P661, DOI 10.1016/S0022-5223(00)70006-7; Ramsay S, 1998, LANCET, V351, P1935, DOI 10.1016/S0140-6736(98)23026-1; Shumway NE, 1999, ANN THORAC SURG, V68, pS34, DOI 10.1016/S0003-4975(99)00814-0; Somerville J, 2001, THORAC CARDIOV SURG, V49, P21, DOI 10.1055/s-2001-9911	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2074	2074		10.1016/S0140-6736(00)05229-6	http://dx.doi.org/10.1016/S0140-6736(00)05229-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445098				2022-12-01	WOS:000169586600008
J	Shann, F				Shann, F			Bacterial pneumonia: commoner than perceived	LANCET			English	Editorial Material							ANTIBIOTIC USE; CHILDREN		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.		Shann, Frank/C-9510-2011					Bullowa JGM, 1935, J AMER MED ASSOC, V105, P1512; CATALANO M, 1990, REV INFECT DIS, V12, pS998; CUNNINGHAM DG, 1983, J PEDIATR-US, V103, P747, DOI 10.1016/S0022-3476(83)80473-9; Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; HORTAL M, 1990, REV INFECT DIS, V12, pS915; Liu YC, 1999, J CLIN EPIDEMIOL, V52, P539, DOI 10.1016/S0895-4356(99)00027-X; MIMICA I, 1971, AM J DIS CHILD, V122, P278, DOI 10.1001/archpedi.1971.02110040062002; NICHOL KP, 1967, NEW ENGL J MED, V277, P667, DOI 10.1056/NEJM196709282771301; Peters TR, 2000, J PEDIATR-US, V137, P416, DOI 10.1067/mpd.2000.109114; PUCZYNSKI MS, 1987, ANN EMERG MED, V16, P1359, DOI 10.1016/S0196-0644(87)80784-9; Shann F, 1999, LANCET, V354, P1488, DOI 10.1016/S0140-6736(99)00232-9; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Sombrero L, 1999, AM J TROP MED HYG, V60, P397, DOI 10.4269/ajtmh.1999.60.397; TAYLOR HG, 1988, EUR J CLIN PHARMACOL, V34, P84; TUPASI TE, 1990, REV INFECT DIS, V12, pS929; *WHO, 1994, WHOARI9434	17	24	27	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2070	2072		10.1016/S0140-6736(00)05226-0	http://dx.doi.org/10.1016/S0140-6736(00)05226-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445094				2022-12-01	WOS:000169586600005
J	Nestler, EJ				Nestler, EJ			Neurobiology - Total recall - The memory of addiction	SCIENCE			English	Editorial Material							NUCLEUS-ACCUMBENS; AMPHETAMINE; SYNAPSES		Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Bell K, 2000, NEUROPSYCHOPHARMACOL, V23, P335, DOI 10.1016/S0893-133X(00)00100-7; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Carlezon WA, 2000, J NEUROSCI, V20; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Robinson TE, 1997, J NEUROSCI, V17, P8491; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7	12	132	155	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2266	2267		10.1126/science.1063024	http://dx.doi.org/10.1126/science.1063024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423644				2022-12-01	WOS:000169455900038
J	Ango, F; Prezeau, L; Muller, T; Tu, JC; Xiao, B; Worley, PF; Pin, JP; Bockaert, J; Fagni, L				Ango, F; Prezeau, L; Muller, T; Tu, JC; Xiao, B; Worley, PF; Pin, JP; Bockaert, J; Fagni, L			Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer	NATURE			English	Article							CEREBELLAR GRANULE CELLS; CARBOXYL-TERMINAL DOMAIN; CONSTITUTIVE ACTIVITY; PHARMACOLOGICAL CHARACTERIZATION; PRIMARY CULTURES; SPLICE VARIANTS; K+ CHANNEL; GLUTAMATE-RECEPTOR-1; FAMILY; EXPRESSION	G-protein-coupled receptors (GPCRs) transduce signals from extracellular transmitters to the inside of the cell by activating G proteins. Mutation and overexpression of these receptors have revealed that they can reach their active state even in the absence of agonist, as a result of a natural shift in the equilibrium between their inactive and active conformations(1). Such agonist-independent (constitutive) activity has been observed for the glutamate GPCRs (the metabotropic glutamate receptors mGluR1a and mGluR5) when they are overexpressed in heterologous cells(2). Here we show that in neurons, the constitutive activity of these receptors is controlled by Homer proteins, which bind directly to the receptors' carboxy-terminal intracellular domains(3,4). Disruption of this interaction by mutagenesis or antisense strategies, or expression of endogenous Homer1a (H1a), induces constitutive activity in mGluR1a or mGluR5. Our results show that these glutamate GPCRs can be directly activated by intracellular proteins as well as by agonists.	CNRS, CCIPE, UPR 9023, F-34000 Montpellier, France; Bayer AG, Pharma Res, D-42096 Wuppertal, Germany; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); Bayer AG; Johns Hopkins University	Fagni, L (corresponding author), CNRS, CCIPE, UPR 9023, 141 Rue Cardonille, F-34000 Montpellier, France.		Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Ango, Fabrice/0000-0002-5548-209X; Xiao, Bo/0000-0002-6161-9478				Ango F, 2000, J NEUROSCI, V20, P8710; Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Chavis P, 1998, EUR J NEUROSCI, V10, P2322, DOI 10.1046/j.1460-9568.1998.00243.x; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Claeysen S, 2001, EMBO REP, V2, P61, DOI 10.1093/embo-reports/kve003; FAGNI L, 1991, EUR J NEUROSCI, V3, P778, DOI 10.1111/j.1460-9568.1991.tb01674.x; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Hasegawa H, 1996, J BIOL CHEM, V271, P1857, DOI 10.1074/jbc.271.4.1857; JOLY C, 1995, J NEUROSCI, V15, P3970; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P416, DOI 10.1016/S0165-6147(97)01127-9; Litschig S, 1999, MOL PHARMACOL, V55, P453; Mary S, 1998, J BIOL CHEM, V273, P425, DOI 10.1074/jbc.273.1.425; MATUSLEIBOVITCH N, 1995, J BIOL CHEM, V270, P1041, DOI 10.1074/jbc.270.3.1041; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; PARKER EM, 1991, J BIOL CHEM, V266, P9987; PREZEAU L, 1994, MOL PHARMACOL, V45, P570; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	27	331	340	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					962	965		10.1038/35082096	http://dx.doi.org/10.1038/35082096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418862				2022-12-01	WOS:000169386200048
J	Nash, D; Mostashari, F; Fine, A; Miller, J; O'Leary, D; Murray, K; Huang, A; Rosenberg, A; Greenberg, A; Sherman, M; Wong, S; Layton, M; Campbell, GL; Roehrig, JT; Gubler, DJ; Shieh, WJ; Zaki, S; Smith, P				Nash, D; Mostashari, F; Fine, A; Miller, J; O'Leary, D; Murray, K; Huang, A; Rosenberg, A; Greenberg, A; Sherman, M; Wong, S; Layton, M; Campbell, GL; Roehrig, JT; Gubler, DJ; Shieh, WJ; Zaki, S; Smith, P		1999 W Nile Outbreak Response Working	The outbreak of West Nile virus infection in the New York City area in 1999.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENCEPHALITIS EPIDEMIC; PATHOLOGY; COUNTY; FEVER	Background: In late August 1999, an unusual cluster of cases of meningoencephalitis associated with muscle weakness was reported to the New York City Department of Health. The initial epidemiologic and environmental investigations suggested an arboviral cause. Methods: Active surveillance was implemented to identify patients hospitalized with viral encephalitis and meningitis. Cerebrospinal fluid, serum, and tissue specimens from patients with suspected cases underwent serologic and viral testing for evidence of arboviral infection. Results: Outbreak surveillance identified 59 patients who were hospitalized with West Nile virus infection in the New York City area during August and September of 1999. The median age of these patients was 71 years (range, 5 to 90). The overall attack rate of clinical West Nile virus infection was at least 6.5 cases per million population, and it increased sharply with age. Most of the patients (63 percent) had clinical signs of encephalitis; seven patients died (12 percent). Muscle weakness was documented in 27 percent of the patients and flaccid paralysis in 10 percent; in all of the latter, nerve conduction studies indicated an axonal polyneuropathy. An age of 75 years or older was an independent risk factor for death (relative risk adjusted for the presence or absence of diabetes mellitus, 8.5; 95 percent confidence interval, 1.2 to 59.1), as was the presence of diabetes mellitus (age-adjusted relative risk, 5.1; 95 percent confidence interval, 1.5 to 17.3). Conclusions: This outbreak of West Nile meningoencephalitis in the New York City metropolitan area represents the first time this virus has been detected in the Western Hemisphere. Given the subsequent rapid spread of the virus, physicians along the eastern seaboard of the United States should consider West Nile virus infection in the differential diagnosis of encephalitis and viral meningitis during the summer months, especially in older patients and in those with muscle weakness. (N Engl J Med 2001;344:1807-14.) Copyright (C) 2001 Massachusetts Medical Society.	New York City Dept Hlth, Communicable Dis Program, New York, NY 10013 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Div Appl Publ Hlth Trainig,State Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bioterrorism Preparedness, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO USA; Westchester Cty Dept Hlth, New Rochelle, NY USA; Nassau Cty Dept Hlth, Mineola, NY USA; New York State Dept Hlth, Albany, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System	Nash, D (corresponding author), New York City Dept Hlth, HIV AIDS Surveillance Program, 346 Broadway,Rm 706, New York, NY 10013 USA.	dnash@health.nyc.gov	Nash, Denis/AFI-7485-2022	Roehrig, John/0000-0001-7581-0479; Nash, Denis/0000-0002-3280-5386	PHS HHS [U50/CCU212386-05] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144; Asnis DS, 2000, CLIN INFECT DIS, V30, P841; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; BENDER BS, 1986, J AM GERIATR SOC, V34, P649, DOI 10.1111/j.1532-5415.1986.tb04906.x; Briese T, 1999, LANCET, V354, P1650; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Komar N, 2000, REV SCI TECH OIE, V19, P166, DOI 10.20506/rst.19.1.1201; KOMAR N, IN PRESS EMERG INFEC; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Lvov D. K., 2000, Voprosy Virusologii, V45, P37; Lvov D. K., 2000, Voprosy Virusologii, V45, P4; Lvov DK, 2000, EMERG INFECT DIS, V6, P373, DOI 10.3201/eid0604.000408; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; MARFIN AA, 1993, AM J TROP MED HYG, V49, P30, DOI 10.4269/ajtmh.1993.49.30; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; MCINTOSH BM, 1994, CRC HDB SERIES ZOONO, P227; NASCI RS, IN PRESS EMERG INFEC; OLEJNIK E., 1952, Bulletin of the Research Council of Israel, V2, P210; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; Richman DD, 1997, CLIN VIROLOGY; SALTZMAN RL, 1987, REV INFECT DIS, V9, P1127; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; *SAS I, 1990, SAS LANG REF VERS 6; SAS Institute, 1990, SAS PROC GUID VERS 6; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Szilak I, 2000, NEW ENGL J MED, V342, P59, DOI 10.1056/NEJM200001063420113; TSAI TE, 1994, CRC HDB SERIES ZOO B; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; TSAI TF, 1988, J INFECT DIS, V157, P351, DOI 10.1093/infdis/157.2.351; WEISS D, IN PRESS EMERG INFEC; YOSHIKAWA TT, 1987, AGING CLIN PRACTICE; 1999, MMWR MORB MORTAL WKL, V48, P890; 2000, MMWR MORB MORTAL WKL, V49, P25; 1999, MMWR MORB MORTAL WKL, V48, P955; 1999, MMWR MORB MORTAL WKL, V48, P944; 2000, MMWR MORB MORTAL WKL, V49, P178	45	862	899	3	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2001	344	24					1807	1814		10.1056/NEJM200106143442401	http://dx.doi.org/10.1056/NEJM200106143442401			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441LC	11407341	Green Published			2022-12-01	WOS:000169231000001
J	Hannaford, P				Hannaford, P			Postmarketing surveillance study of Norplant in developing countries	LANCET			English	Editorial Material							IMPLANTS		Univ Aberdeen, Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland	University of Aberdeen	Hannaford, P (corresponding author), Univ Aberdeen, Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland.		Hannaford, Philip C/B-7867-2012					Boonstra H, 2000, CONTRACEPTION, V61, P9, DOI 10.1016/S0010-7824(99)00121-3; Du MK, 2000, INT J GYNECOL OBSTET, V68, P249, DOI 10.1016/S0020-7292(99)00214-3; Entwistle VA, 2000, LANCET, V355, P1633, DOI 10.1016/S0140-6736(00)02226-1; Fraser IS, 1998, CONTRACEPTION, V57, P1, DOI 10.1016/S0010-7824(97)00200-X; Meirik O, 2001, OBSTET GYNECOL, V97, P539, DOI 10.1016/S0029-7844(00)01220-5; Sivin I, 1997, CONTRACEPTION, V55, P73, DOI 10.1016/S0010-7824(96)00275-2; Sivin I, 1998, OBSTET GYNECOL, V92, P337, DOI 10.1016/S0029-7844(98)00219-1; SMITH R, 1993, BRIT MED J, V306, P1285, DOI 10.1136/bmj.306.6888.1285; 2000, WORLD POPULATION PRO	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 9	2001	357	9271					1815	1816		10.1016/S0140-6736(00)05007-8	http://dx.doi.org/10.1016/S0140-6736(00)05007-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440DN	11410183				2022-12-01	WOS:000169160800003
J	Schellenberg, JRMA; Abdulla, S; Nathan, R; Mukasa, O; Marchant, TJ; Kikumbih, N; Mushi, AK; Mponda, H; Minja, H; Mshinda, H; Tanner, M; Lengeler, C				Schellenberg, JRMA; Abdulla, S; Nathan, R; Mukasa, O; Marchant, TJ; Kikumbih, N; Mushi, AK; Mponda, H; Minja, H; Mshinda, H; Tanner, M; Lengeler, C			Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania	LANCET			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; MALARIA MORBIDITY; MORTALITY; AFRICA; LIMITATIONS; POPULATION; PROGRAM; HEALTH; AREA	Background Insecticide-treated nets have proven efficacy as a malaria-control tool in Africa. However, the transition from efficacy to effectiveness cannot be taken for granted. We assessed coverage and the effect on child survival of a large-scale social marketing programme for insecticide-treated nets in two rural districts of southern Tanzania with high perennial malaria transmission. Methods Socially marketed insecticide-treated nets were introduced stepwise over a 2-year period from May, 1997, in a population of 480 000 people. Cross-sectional coverage surveys were done at baseline and after 1, 2, and 3 years. A demographic surveillance system (DSS) was set up in an area of 60 000 people to record population, births, and deaths. Within the DSS area, the effect of insecticide-treated nets on child survival was assessed by a case-control approach. Cases were deaths in children aged between 1 month and 4 years. Four controls for each case were chosen from the DSS database. Use of insecticide-treated nets and potential confounding factors were assessed by questionnaire. Individual effectiveness estimates from the case-control study were combined with coverage to estimate community effectiveness. Findings Insecticide-treated net coverage of infants in the DSS area rose from less than 10% at baseline to more than 50% 3 years later. Insecticide-treated nets were associated with a 27% increase in survival in children aged 1 month to 4 years (95% CI 3-45). Coverage in such children was higher in areas with longer access to the programme. The modest average coverage achieved by 1999 in the two districts (18% in children younger than 5 years) suggests that insecticide-treated nets prevented 1 in 20 child deaths at that time. Interpretation Social marketing of insecticide-treated nets has great potential for effective malaria control in rural African settings.	Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; Swiss Trop Inst, CH-4002 Basel, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Schellenberg, JRMA (corresponding author), Orchard Ground Cottage, Cublington LU7 0LJ, Beds, England.	dajobelo@aol.com		Marchant, Tanya/0000-0002-4228-4334; Schellenberg, Joanna/0000-0002-0708-3676				Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; ANDREASEN AR, 1995, MARKETING SOCIAL CHA, P1; Binka FN, 1999, J BIOSOC SCI, V31, P375, DOI 10.1017/S0021932099003752; CHAVASSE D, 1999, INSECTICIDE TREATED, P1; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P639, DOI 10.1046/j.1365-3156.1999.00470.x; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hatz C, 1998, TROP MED INT HEALTH, V3, P498, DOI 10.1046/j.1365-3156.1998.00250.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325; Lengeler C, 1999, TROP MED INT HEALTH, V4, P409, DOI 10.1046/j.1365-3156.1999.00422.x; LENGELER C, 2001, COCHRANE LIB; *MAL CONS, 1999, 2 INT C INS TREAT NE; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; MINJA H, 2001, THESIS U BASEL BASEL; MOLINEAUX L, 1985, HLTH POLICY SOCIAL P, P13; *NAT BUR STAT TANZ, 2000, TANZ REPR CHILD HLTH; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Roll Back Malaria/WHO, 2000, AB DEC 192 TION PLAN; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SCHELLENBERG JRM, 2001, INDEPTH MONOGRAPH SE, V1; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; TANNER M, 1992, DIS MORTALITY SUBSAH, P286; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6	30	215	216	2	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1241	1247		10.1016/S0140-6736(00)04404-4	http://dx.doi.org/10.1016/S0140-6736(00)04404-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418148				2022-12-01	WOS:000168323300010
J	Hippisley-Cox, J; Pringle, M				Hippisley-Cox, J; Pringle, M			General practice workload implications of the national service framework for coronary heart disease: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283				Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Department of Health, 2000, NAT SERV FRAM COR AR; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; SMITH GD, 1993, BMJ-BRIT MED J, V306, P1367, DOI 10.1136/bmj.306.6889.1367	5	31	31	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					269	270		10.1136/bmj.323.7307.269	http://dx.doi.org/10.1136/bmj.323.7307.269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485958	Bronze, Green Published			2022-12-01	WOS:000170394300022
J	Alabadi, D; Oyama, T; Yanovsky, MJ; Harmon, FG; Mas, P; Kay, SA				Alabadi, D; Oyama, T; Yanovsky, MJ; Harmon, FG; Mas, P; Kay, SA			Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock	SCIENCE			English	Article							TRANSCRIPTION FACTOR; MOLECULAR-BASES; EXPRESSION; THALIANA; GENE; RHYTHMS; MUTANT	The interactive regulation between clock genes is central for oscillator function. Here, we show interactions between the Arabidopsis clock genes LATE ELONGATED HYPOCOTYL (LHY), CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), and TIMING OF CAB EXPRESSION 1 (TOC1). The MYB transcription factors LHY and CCA1 negatively regulate TOC1 expression. We show that both proteins bind to a region in the TOC1 promoter that is critical for its clock regulation. Conversely, TOC1 appears to participate in the positive regulation of LHY and CCA1 expression. Our results indicate that these interactions form a loop critical for clock function in Arabidopsis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.		Mas, Paloma/B-8215-2016; Rosa, Bruce/F-6393-2010; Alabadi, David/AAS-3408-2020; Kay, Steve A/F-6025-2011	Mas, Paloma/0000-0002-3780-8041; Alabadi, David/0000-0001-8492-6713; Kay, Steve A/0000-0002-0402-2878	NIGMS NIH HHS [GM56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALABADI D, UNPUB; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 1998, DEVELOPMENT, V125, P485; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	20	824	889	14	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					880	883		10.1126/science.1061320	http://dx.doi.org/10.1126/science.1061320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486091				2022-12-01	WOS:000170241000049
J	Sonenberg, N; Newgard, CB				Sonenberg, N; Newgard, CB			Protein synthesis - The perks of balancing glucose	SCIENCE			English	Editorial Material							TRANSLATIONAL CONTROL; KINASE; PEK		McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA	McGill University; McGill University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; RON D, COMMUNICATION; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shi YG, 1999, J BIOL CHEM, V274, P5723, DOI 10.1074/jbc.274.9.5723; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281	13	18	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					818	819		10.1126/science.1062937	http://dx.doi.org/10.1126/science.1062937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486079				2022-12-01	WOS:000170241000033
J	Petrie, M; Schwabl, H; Brande-Lavridsen, N; Burke, T				Petrie, M; Schwabl, H; Brande-Lavridsen, N; Burke, T			Maternal investment - Sex differences in avian yolk hormone levels	NATURE			English	Article							ATTRACTIVENESS; TESTOSTERONE; RATIOS; EGGS		Univ Newcastle Upon Tyne, Dept Psychol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Newcastle University - UK; Washington State University; University of Sheffield	Petrie, M (corresponding author), Univ Newcastle Upon Tyne, Dept Psychol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Burke, Terry/B-3196-2011; Petrie, Marion/AFM-9857-2022	Burke, Terry/0000-0003-3848-1244; Petrie, Marion/0000-0001-5754-6678; Russell, Andy/0000-0002-1299-8555				BOGART MH, 1987, J THEOR BIOL, V128, P349, DOI 10.1016/S0022-5193(87)80077-2; Bowden RM, 2000, P ROY SOC B-BIOL SCI, V267, P1745, DOI 10.1098/rspb.2000.1205; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; Crews D, 1996, GEN COMP ENDOCR, V102, P317, DOI 10.1006/gcen.1996.0075; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; HOYT DF, 1979, AUK, V96, P73; JENNINGS DH, IN PRESS AM ZOOL; KRACKOW S, 1999, JOHANNESBURG BIRD LI; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H., 1997, P3; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sturkie P.D., 1986, AVIAN PHYSIOL, DOI DOI 10.1007/978-1-4612-4862-0_5	13	137	139	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					498	498		10.1038/35087652	http://dx.doi.org/10.1038/35087652			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484039				2022-12-01	WOS:000170202900031
J	Orphan, VJ; House, CH; Hinrichs, KU; McKeegan, KD; DeLong, EF				Orphan, VJ; House, CH; Hinrichs, KU; McKeegan, KD; DeLong, EF			Methane-consuming archaea revealed by directly coupled isotopic and phylogenetic analysis	SCIENCE			English	Article							OXIDATION; SEDIMENTS; CONSORTIUM	Microorganisms Living in anoxic marine sediments consume more than 80% of the methane produced in the world's oceans. In addition to single-species aggregates, consortia of metabolically interdependent bacteria and archaea are found in methane-rich sediments. A combination of fluorescence in situ hybridization and secondary ion mass spectrometry shows that cells belonging to one specific archaeal group associated with the Methanosarcinales were all highly depleted in C-13 (to values of -96 parts per thousand). This depletion indicates assimilation of isotopically Light methane into specific archaeal cells. Additional microbial species apparently use other carbon sources, as indicated by significantly higher C-13/C-12 ratios in their cell carbon. Our results demonstrate the feasibility of simultaneous determination of the identity and the metabolic activity of naturally occurring microorganisms.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	Monterey Bay Aquarium Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Woods Hole Oceanographic Institution; University of California System; University of California Los Angeles	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Orphan, Victoria/AAS-5989-2020; Orphan, Victoria J/K-1002-2014; Hinrichs, Kai-Uwe/C-7675-2009; McKeegan, Kevin D/A-4107-2008	Orphan, Victoria/0000-0002-5374-6178; Orphan, Victoria J/0000-0002-5374-6178; Hinrichs, Kai-Uwe/0000-0002-0739-9291; McKeegan, Kevin D/0000-0002-1827-729X				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; BRUCHERT V, 1995, P ODP SCI RES 146 2, P219; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; HINRICHS KU, IN PRESS OCEAN MARGI; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; House CH, 2000, GEOLOGY, V28, P707, DOI 10.1130/0091-7613(2000)28<707:CICOIP>2.0.CO;2; MARTENS CS, 1977, LIMNOL OCEANOGR, V22, P10, DOI 10.4319/lo.1977.22.1.0010; MCKEEGAN KD, 1985, GEOCHIM COSMOCHIM AC, V49, P1971, DOI 10.1016/0016-7037(85)90091-2; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; PAULL CK, 2001, COMMUNICATION; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Summons RE, 1998, ORG GEOCHEM, V28, P465, DOI 10.1016/S0146-6380(98)00011-4; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x	18	732	799	10	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					484	487		10.1126/science.1061338	http://dx.doi.org/10.1126/science.1061338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463914				2022-12-01	WOS:000169966700045
J	Gu, HH; Saito, K; Klaman, LD; Shen, JQ; Fleming, T; Wang, YP; Pratt, JC; Lin, GS; Lim, B; Kinet, JP; Neel, BG				Gu, HH; Saito, K; Klaman, LD; Shen, JQ; Fleming, T; Wang, YP; Pratt, JC; Lin, GS; Lim, B; Kinet, JP; Neel, BG			Essential role for Gab2 in the allergic response	NATURE			English	Article							PHOSPHOLIPASE C-GAMMA; GROWTH-FACTOR RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MAST-CELLS; ACTIVATION; PROTEIN; KINASE; CYTOKINE; PATHWAY	Dos/Gab family scaffolding adapters (Dos, Gab1, Gab2) bind several signal relay molecules, including the protein-tyrosine phosphatase Shp-2 and phosphatidylinositol-3-OH kinase (PI(3)K); they are also implicated in growth factor, cytokine and antigen receptor signal transduction(1). Mice lacking Gab1 die during embryogenesis and show defective responses to several stimuli(2,3). Here we report that Gab2(-/-) mice are viable and generally healthy; however, the response (for example, degranulation and cytokine gene expression) of Gab2(-/-) mast cells to stimulation of the high affinity immunoglobulin-epsilon (IgE) receptor Fc epsilon RI is defective. Accordingly, allergic reactions such as passive cutaneous and systemic anaphylaxis are markedly impaired in Gab2(-/-) mice. Biochemical analyses reveal that signalling pathways dependent on PI(3)K, a critical component of Fc epsilon RI signalling, are defective in Gab2(-/-) mast cells. Our data identify Gab2 as the principal activator of PI(3)K in response to FceRI activation, thereby providing genetic evidence that Dos/Gab family scaffolds regulate the PI(3)K pathway in vivo. Gab2 and/or its associated signalling molecules may be new targets for developing drugs to treat allergy.	Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Expt Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Franklin W Olin Coll Engn, Needham, MA 02492 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Franklin W. Olin College of Engineering	Gu, HH (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA 02215 USA.	hgu@caregroup.harvard.edu						Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Barker SA, 1999, J LEUKOCYTE BIOL, V65, P321, DOI 10.1002/jlb.65.3.321; Barkley R., 1995, ADHD REPORT, V3, P5; Craddock BL, 1999, J BIOL CHEM, V274, P10633, DOI 10.1074/jbc.274.15.10633; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gommerman JL, 2000, J IMMUNOL, V165, P6915, DOI 10.4049/jimmunol.165.12.6915; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hibi M, 2000, LEUKEMIA LYMPHOMA, V37, P299, DOI 10.3109/10428190009089430; Ishizuka T, 1999, J IMMUNOL, V162, P2087; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; NAKANISHI S, 1995, CELL SIGNAL, V7, P545, DOI 10.1016/0898-6568(95)00033-L; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1	29	266	276	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					186	190		10.1038/35084076	http://dx.doi.org/10.1038/35084076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449275				2022-12-01	WOS:000169778700053
J	Haile-Selassie, Y				Haile-Selassie, Y			Late Miocene hominids from the Middle Awash, Ethiopia	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HOMINOIDS; LOTHAGAM; SEQUENCE; RIFT	Molecular studies suggest that the lineages leading to humans and chimpanzees diverged approximately 6.5-5.5 million years (Myr) ago, in the Late Miocene(1-3). Hominid fossils from this interval, however, are fragmentary and of uncertain phylogenetic status, age, or both(4-6). Here I report new hominid specimens from the Middle Awash area of Ethiopia that date to 5.2-5.8 Myr and are associated with a wooded palaeoenvironment(7). These Late Miocene fossils are assigned to the hominid genus Ardipithecus and represent the earliest definitive evidence of the hominid clade. Derived dental characters are shared exclusively with all younger hominids. This indicates that the fossils probably represent a hominid taxon that postdated the divergence of lineages leading to modern chimpanzees and humans. However, the persistence of primitive dental and postcranial characters in these new fossils indicates that Ardipithecus was phylogenetically close to the common ancestor of chimpanzees and humans. These new findings raise additional questions about the claimed hominid status of Orrorin tugenensis(8), recently described from Kenya and dated to similar to6 Myr(9).	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Human Evolut Studies Lab, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Haile-Selassie, Y (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3060 VLSB, Berkeley, CA 94720 USA.							Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; DAY MH, 1969, NATURE, V47, P230; Hill A., 1994, INTEGRATIVE PATHS PA, P123; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; McDougall I, 1999, J GEOL SOC LONDON, V156, P731, DOI 10.1144/gsjgs.156.4.0731; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058	15	278	290	3	64	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					178	181		10.1038/35084063	http://dx.doi.org/10.1038/35084063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451AJ	11449272				2022-12-01	WOS:000169778700050
J	Phillips, PS; Nolan, JP				Phillips, PS; Nolan, JP			Training in basic and advanced life support in UK medical schools: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							CARDIOPULMONARY RESUSCITATION		Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton SO16 6YD, Hants, England; Royal United Hosp, Dept Anaesthesia & Intens Care Med, Bath BA1 3NG, Avon, England	University of Southampton	Phillips, PS (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton SO16 6YD, Hants, England.		Nolan, Jerry P./ABF-2561-2020	Nolan, Jerry/0000-0003-3141-3812				CASEY WF, 1984, J ROY SOC MED, V77, P921, DOI 10.1177/014107688407701105; *GEN MED COUNC, 1997, NEW DOCT REC GEN CLI; Perkins GD, 1999, RESUSCITATION, V41, P19, DOI 10.1016/S0300-9572(99)00037-4; SKINNER DV, 1985, BRIT MED J, V290, P1549, DOI 10.1136/bmj.290.6481.1549; The Royal College of Physicians of London, 1987, J ROY COLL PHYS LOND, V21, P175	5	53	53	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2001	323	7303					22	23		10.1136/bmj.323.7303.22	http://dx.doi.org/10.1136/bmj.323.7303.22			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WA	11440938	Green Published, Bronze			2022-12-01	WOS:000169824300019
J	Pockley, P				Pockley, P			Gene screens for nuclear veterans	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					5	5		10.1038/35083721	http://dx.doi.org/10.1038/35083721			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452267	Bronze			2022-12-01	WOS:000169644900006
J	Schwartlander, B; Stover, J; Walker, N; Bollinger, L; Gutierrez, JP; McGreevey, M; Opuni, M; Forsythe, S; Kumaranayake, L; Watts, C; Bertozzi, S				Schwartlander, B; Stover, J; Walker, N; Bollinger, L; Gutierrez, JP; McGreevey, M; Opuni, M; Forsythe, S; Kumaranayake, L; Watts, C; Bertozzi, S			AIDS - Resource needs for HIV/AIDS	SCIENCE			English	Editorial Material									UNAIDS, Joint United Nations Programme HIV AIDS, Geneva, Switzerland; Futures Grp Int, Washington, DC 20036 USA; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England	UNAIDS; Instituto Nacional de Salud Publica; University of London; London School of Hygiene & Tropical Medicine	Schwartlander, B (corresponding author), UNAIDS, Joint United Nations Programme HIV AIDS, Geneva, Switzerland.		Forsythe, Steven/AAL-7558-2020; Gutierrez, Juan Pablo/A-4253-2010	Forsythe, Steven/0000-0002-4409-5991; Gutierrez, Juan Pablo/0000-0002-0557-5562; Opuni, Marjorie/0000-0002-0939-7695; Bertozzi, Stefano M/0000-0002-1723-7085				BOLLINGER L, UNIT COSTS HIV AIDS; Bonnel R, 2000, COSTS SCALING HIV PR; Cantor CH, 1997, ARCH SUICIDE RES, V3, P5, DOI 10.1023/A:1009699126206; FORSYTHE S, 2001, UNPUB CURRENT SPENDI; FOSTER S, 2000, FEDERAL HIV AIDS SPE; KUMARANAYAKE L, 2001, 5 WHO COMM MACR HLTH; Merson MH, 2000, AIDS, V14, pS68; *UNAIDS, 2000, REP GLOB HIV AIDS EP; World Bank, 2000, WORLD DEV REP 1999 2	9	116	118	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2434	2436		10.1126/science.1062876	http://dx.doi.org/10.1126/science.1062876			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11423619				2022-12-01	WOS:000169658200022
J	Weston, CR; Davis, RJ				Weston, CR; Davis, RJ			Signal transduction - Signaling specificity - a complex affair	SCIENCE			English	Editorial Material							GLYCOGEN-SYNTHASE KINASE-3; SUBSTRATE-SPECIFICITY; MAP KINASES; TRANSCRIPTION; INSULIN; 3-BETA; GSK3		Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Weston, CR (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	roger.davis@umassmed.edu						Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williams RSB, 2000, TRENDS PHARMACOL SCI, V21, P61, DOI 10.1016/S0165-6147(99)01428-5; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740	12	56	60	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2439	2440		10.1126/science.1063279	http://dx.doi.org/10.1126/science.1063279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431552				2022-12-01	WOS:000169658200024
J	Hirsh, AE; Fraser, HB				Hirsh, AE; Fraser, HB			Protein dispensability and rate of evolution	NATURE			English	Article							SUBSTITUTION RATE; GENES EVOLVE; GENOME; YEAST; CONSTRAINTS; REGION; SITES; TIME	If protein evolution is due in large part to slightly deleterious amino acid substitutions(1,2), then the rate of evolution should be greater in proteins that contribute less to individual fitness. The rationale for this prediction is that relatively dispensable proteins should be subject to weaker purifying selection, and should therefore accumulate mildly deleterious substitutions more rapidly. Although this argument was presented(3) over twenty years ago, and is fundamental to many applications of evolutionary theory(4), the prediction has proved difficult to confirm. In fact, a recent study showed that essential mouse genes do not evolve more slowly than non-essential ones(5). Thus, although a variety of factors influencing the rate of protein evolution have been supported by extensive sequence analysis(6-12), the relationship between protein dispensability and evolutionary rate has remained unconfirmed. Here we use the results from a highly parallel growth assay of single gene deletions in yeast(13) to assess protein dispensability, which we relate to evolutionary rate estimates that are based on comparisons of sequences drawn from twenty-one fully annotated genomes. Our analysis reveals a highly significant relationship between protein dispensability and evolutionary rate, and explains why this relationship is not detectable by categorical comparison of essential versus nonessential proteins. The relationship is highly conserved, so that protein dispensability in yeast is also predictive of evolutionary rate in a nematode worm.	Stanford Univ, Ctr Computat Genet & Biol Molding, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Hirsh, AE (corresponding author), Stanford Univ, Ctr Computat Genet & Biol Molding, Dept Biol Sci, Stanford, CA 94305 USA.							Ashburner M, 1999, GENETICS, V153, P179; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Ewens W.J., 1979, MATH POPULATION GENE; Feng DF, 1997, J MOL EVOL, V44, P361, DOI 10.1007/PL00006155; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GRISHIN NV, 1995, J MOL EVOL, V41, P675; Grishin NV, 2000, GENOME RES, V10, P991, DOI 10.1101/gr.10.7.991; Hughes AL, 1997, MOL BIOL EVOL, V14, P1, DOI 10.1093/oxfordjournals.molbev.a025694; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; KIMURA M, 1962, GENETICS, V47, P713; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; Makalowski W, 1998, J MOL EVOL, V47, P119, DOI 10.1007/PL00006367; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Robinson M, 1998, MOL BIOL EVOL, V15, P1091, DOI 10.1093/oxfordjournals.molbev.a026016; SARICH VM, 1973, SCIENCE, V179, P1144, DOI 10.1126/science.179.4078.1144; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Zhang JZ, 1998, GENETICS, V149, P1615	29	315	320	0	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1046	1049		10.1038/35082561	http://dx.doi.org/10.1038/35082561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429604				2022-12-01	WOS:000169528500047
J	Wilhelms, A; Larter, SR; Head, I; Farrimond, P; di-Primio, R; Zwach, C				Wilhelms, A; Larter, SR; Head, I; Farrimond, P; di-Primio, R; Zwach, C			Biodegradation of oil in uplifted basins prevented by deep-burial sterilization	NATURE			English	Article							NORTH-SEA; ARCHAEA; LIFE; BIOSPHERE; RATES; FIELD	Biodegradation of crude oil by bacterial activity-which has occurred in the majority of the Earth's oil reserves(1)-is known to reduce greatly the quality of petroleum in reservoirs(2). For economically successful prospecting for oil, it is therefore important to understand the processes and conditions in geological formations that lead to oil biodegradation. Although recent studies speculate that bacterial activity can potentially occur up to temperatures as high as 150 degreesC (refs 3, 4), it is generally accepted that effective petroleum biodegradation over geological timescales generally occurs in reservoirs with temperatures below 80 degreesC (ref. 2). This appears, however, to be at odds with the observation that non-degraded oils can still be found in reservoirs below this temperature. Here we compile data regarding the extent of oil biodegradation in several oil reservoirs, and rnd that the extensive occurrence of non-biodegraded oil in shallow, cool basins is restricted to those that have been uplifted from deeper, hotter regions of the Earth. We suggest that these petroleum reservoirs were sterilized by heating to a temperature around 80-90 degreesC during deep burial, inactivating hydrocarbon-degrading organisms that occur in the deep biosphere. Even when such reservoirs are subsequently uplifted to much cooler regions and filled with oil, degradation does not occur, implying that the sterilized sediments are not recolonized by hydrocarbon-degrading bacteria.	Univ Newcastle, Fossil Fuels & Environm Geochem Postgrad Inst, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Norsk Hydro AS, N-5020 Bergen, Norway	Newcastle University - UK; Norsk Hydro ASA	Larter, SR (corresponding author), Univ Newcastle, Fossil Fuels & Environm Geochem Postgrad Inst, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Steve.Larter@ncl.ac.uk	Abu Laban, Nidal/E-5809-2011	, Zeinab/0000-0001-7975-7943; Head, Ian/0000-0002-5373-162X; Larter, Stephen/0000-0001-7195-1477				BARNARD PC, 1991, GEOLOGICAL SOC SPECI, V59, P167; Blochl E, 1997, EXTREMOPHILES, V1, P14; Bray RJ, 1998, GEOL SOC SPEC PUBL, V133, P199, DOI 10.1144/GSL.SP.1998.133.01.09; Cannan J, 1984, ADV PETROLEUM GEOCHE, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; CHAPELLE FH, 1990, APPL ENVIRON MICROB, V56, P1865, DOI 10.1128/AEM.56.6.1865-1874.1990; CORNFORD C, 1988, ORG GEOCHEM, V13, P399, DOI 10.1016/0146-6380(88)90062-9; CORNFORD C, 1990, INTRO PETROLEUM GEOL, P294; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; Evans J, 1998, GEOL SOC SPEC PUBL, V133, P407, DOI 10.1144/GSL.SP.1998.133.01.22; FREDRICKSON JK, 1995, MOL ECOL, V4, P619, DOI 10.1111/j.1365-294X.1995.tb00262.x; Grassia GS, 1996, FEMS MICROBIOL ECOL, V21, P47; Horstad I, 1997, AAPG BULL, V81, P222; JOBSON A, 1972, APPL MICROBIOL, V23, P1082, DOI 10.1128/AEM.23.6.1082-1089.1972; LARTER SR, 2000, P GEOC 2000 CSPG GAC, P1; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; LINJORDET A, 1992, AAPG MEMOIR, V54, P349; Murphy EM, 1998, GEOCHIM COSMOCHIM AC, V62, P3395, DOI 10.1016/S0016-7037(98)00254-3; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P1793, DOI 10.1128/AEM.62.5.1793-1798.1996; ORPHAN VJ, 1999, APPL ENVIRON MICROB, V65, P700; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Roadifer R.E., 1987, AAPG STUDIES GEOLOGY, V23, P3; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; SCHROEDER FW, 1993, NPF SPECIAL PUBLICAT, V3, P469; STETTER KO, 1990, FEMS MICROBIOL LETT, V75, P117, DOI 10.1016/0378-1097(90)90526-V; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; Takahata Y, 2000, APPL ENVIRON MICROB, V66, P73, DOI 10.1128/AEM.66.1.73-79.2000; THEIS NJ, 1993, NPF SPECIAL PUBLICAT, V3, P433; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; ZOBELL CE, 1945, SCIENCE, V102, P364, DOI 10.1126/science.102.2650.364	31	219	236	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1034	1037		10.1038/35082535	http://dx.doi.org/10.1038/35082535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429600				2022-12-01	WOS:000169528500043
J	Jordan, P; Fromme, P; Witt, HT; Klukas, O; Saenger, W; Krauss, N				Jordan, P; Fromme, P; Witt, HT; Klukas, O; Saenger, W; Krauss, N			Three-dimensional structure of cyanobacterial photosystem I at 2.5 angstrom resolution	NATURE			English	Article							PHOTOSYNTHETIC REACTION CENTERS; ELECTRON-TRANSFER; SYNECHOCOCCUS SP; 4-ANGSTROM RESOLUTION; 2 PHYLLOQUINONES; CHLOROPHYLL-A; ACCEPTOR; COMPLEX; PROTEIN; MODEL	Life on Earth depends on photosynthesis, the conversion of light energy from the Sun to chemical energy. In plants, green algae and cyanobacteria, this process is driven by the cooperation of two large protein-cofactor complexes, photosystems I and II, which are located in the thylakoid photosynthetic membranes. The crystal structure of photosystem I from the thermophilic cyanobacterium Synechococcus elongatus described here provides a picture at atomic detail of 12 protein subunits and 127 cofactors comprising 96 chlorophylls, 2 phylloquinones, 3 Fe4S4 clusters, 22 carotenoids, 4 lipids, a putative Ca2+ ion and 201 water molecules. The structural information on the proteins and cofactors and their interactions provides a basis for understanding how the high efficiency of photosystem I in light capturing and electron transfer is achieved.	Tech Univ Berlin, Max Volmer Lab Biophys Chem, Inst Chem, Fak 2, D-10623 Berlin, Germany; Free Univ Berlin, Inst Chem Kristallog, D-14195 Berlin, Germany	Technical University of Berlin; Free University of Berlin	Fromme, P (corresponding author), Tech Univ Berlin, Max Volmer Lab Biophys Chem, Inst Chem, Fak 2, Str 17,Juni 135, D-10623 Berlin, Germany.			Fromme, Petra/0000-0003-0953-4909; Krauss, Norbert/0000-0002-7128-4632				ADMAN ET, 1973, J BIOL CHEM, V248, P3987; Artz K, 1997, P NATL ACAD SCI USA, V94, P13582, DOI 10.1073/pnas.94.25.13582; ASHIKAWA I, 1986, BIOCHEMISTRY-US, V25, P6154, DOI 10.1021/bi00368a049; Bittl R, 1997, BIOCHEMISTRY-US, V36, P12001, DOI 10.1021/bi971645n; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; CHAMOROVSKY SK, 1982, PHOTOBIOCH PHOTOBIOP, V4, P195; COGDELL RJ, 1985, PURE APPL CHEM, V57, P723, DOI 10.1351/pac198557050723; COUFAL J, 1989, PHOTOSYNTHETICA, V23, P603; DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097; FALZONE CJ, 1994, BIOCHEMISTRY-US, V33, P6052, DOI 10.1021/bi00186a004; FISH LE, 1985, J BIOL CHEM, V260, P1413; Fleming GR, 1997, CURR OPIN STRUC BIOL, V7, P738, DOI 10.1016/S0959-440X(97)80086-3; Foerster T., 1948, ANN PHYS, V2, P55; FROMME P, 1994, BBA-BIOENERGETICS, V1187, P99, DOI 10.1016/0005-2728(94)90092-2; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; Golbeck JH, 1999, PHOTOSYNTH RES, V61, P107, DOI 10.1023/A:1006281802710; GOLBECK JH, 1994, ADV PHOTOSYNTHESIS M, P319; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; Hippler M, 1999, J BIOL CHEM, V274, P4180, DOI 10.1074/jbc.274.7.4180; IKEUCHI M, 1991, FEBS LETT, V287, P5, DOI 10.1016/0014-5793(91)80003-L; IWAKI M, 1991, BIOCHEMISTRY-US, V30, P5347, DOI 10.1021/bi00236a004; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Kamlowski A, 1998, J PHYS CHEM B, V102, P8278, DOI 10.1021/jp9824611; Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6; Kass H, 2001, J PHYS CHEM B, V105, P1225, DOI 10.1021/jp0032311; Klukas O, 1999, J BIOL CHEM, V274, P7361, DOI 10.1074/jbc.274.11.7361; KOIKE H, 1989, FEBS LETT, V253, P257, DOI 10.1016/0014-5793(89)80971-8; KRATKY C, 1977, J MOL BIOL, V113, P431, DOI 10.1016/0022-2836(77)90151-6; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; Lancaster CRD, 2000, J BIOL CHEM, V275, P39364, DOI 10.1074/jbc.M008225200; Makewicz A, 1996, Z NATURFORSCH C, V51, P319; Makewicz Anja, 1995, P156; Mayer KL, 1999, BIOCHEMISTRY-US, V38, P13736, DOI 10.1021/bi9910373; MOSER CC, 1992, BIOCHIM BIOPHYS ACTA, V1101, P171, DOI 10.1016/S0005-2728(05)80012-X; Muhlenhoff U, 1996, EMBO J, V15, P488, DOI 10.1002/j.1460-2075.1996.tb00381.x; MUHLENHOFF U, 1993, GENE, V127, P71, DOI 10.1016/0378-1119(93)90618-D; NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D; Palsson LO, 1998, BIOPHYS J, V74, P2611, DOI 10.1016/S0006-3495(98)77967-6; Scheer H, 1991, CHLOROPHYLLS; Schlodder E, 1998, BIOCHEMISTRY-US, V37, P9466, DOI 10.1021/bi973182r; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Sun J, 1999, J BIOL CHEM, V274, P19048, DOI 10.1074/jbc.274.27.19048; VALKUNAS L, 1995, PHOTOSYNTH RES, V43, P149, DOI 10.1007/BF00042972; WATANABE T, 1985, FEBS LETT, V191, P252, DOI 10.1016/0014-5793(85)80019-3; Webber AN, 1996, BIOCHEMISTRY-US, V35, P12857, DOI 10.1021/bi961198w; XU QA, 1994, J BIOL CHEM, V269, P3205; Yang F, 1998, J PHYS CHEM B, V102, P8288, DOI 10.1021/jp981952i; ZHAO JD, 1992, BIOCHEMISTRY-US, V31, P5093, DOI 10.1021/bi00137a001; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	1964	2094	6	418	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					909	917		10.1038/35082000	http://dx.doi.org/10.1038/35082000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418848				2022-12-01	WOS:000169386200034
J	Lenhard, M; Bohnert, A; Jurgens, G; Laux, T				Lenhard, M; Bohnert, A; Jurgens, G; Laux, T			Termination of stem cell maintenance in Arabidopsis floral meristems by interactions between WUSCHEL and AGAMOUS	CELL			English	Article							HOMEOTIC GENE; FLOWER DEVELOPMENT; NEGATIVE REGULATION; ORGAN IDENTITY; EXPRESSION; SHOOT; ACTIVATION; THALIANA; PLANTS; SEPARATION	Floral meristems and shoot apical meristems (SAMs) are homologous, self-maintaining stem cell systems. Unlike SAMs, floral meristems are determinate, and stem cell maintenance is abolished once all floral organs are initiated. to investigate the underlying regulatory mechanisms, we analyzed the interactions between WUSCHEL (WUS), which specifies stem cell identity, and AGAMOUS (AG), which is required for floral determinacy. Our results show that repression of WUS by AG is essential for terminating the floral meristem and that WUS can induce AG expression in developing flowers. Together, this suggests that floral determinacy depends on a negative autoregulatory mechanism involving WUS and AG, which terminates stem cell maintenance.	Univ Tubingen, ZMBP Entwicklungsgenet, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Laux, T (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.		Lenhard, Michael/J-1554-2015					BARTON MK, 1993, DEVELOPMENT, V119, P823; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bowman J., 1994, ARABIDOPSIS ATLAS MO; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jack T, 1997, PLANT J, V11, P825, DOI 10.1046/j.1365-313X.1997.11040825.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Laux T, 1996, DEVELOPMENT, V122, P87; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MIZUKAMI Y, 1995, PLANT MOL BIOL, V28, P767, DOI 10.1007/BF00042064; Mizukami Y, 1997, PLANT CELL, V9, P393, DOI 10.1105/tpc.9.3.393; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Sieburth LE, 1998, DEVELOPMENT, V125, P4303; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; WEIGEL D, 1993, SCIENCE, V261, P1723, DOI 10.1126/science.261.5129.1723; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	32	404	442	5	75	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					805	814		10.1016/S0092-8674(01)00390-7	http://dx.doi.org/10.1016/S0092-8674(01)00390-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440722	Bronze			2022-12-01	WOS:000169375100013
J	BRAUN, HA; WISSING, H; SCHAFER, K; HIRSCH, MC				BRAUN, HA; WISSING, H; SCHAFER, K; HIRSCH, MC			OSCILLATION AND NOISE DETERMINE SIGNAL-TRANSDUCTION IN SHARK MULTIMODAL SENSORY CELLS	NATURE			English	Article							NEURONS; TRANSMISSION; INFORMATION	OSCILLATING membrane potentials that generate rhythmic impulse patterns are considered to be of particular significance for neuronal information processing1-4. In contrast, noise is usually seen as a disturbance which limits the accuracy of information transfer5-8. We show here, however, that noise in combination with intrinsic oscillations can provide neurons with particular encoding properties, a discovery we made when recording from single electro-sensory afferents of a fish. The temporal sequence of the impulse trains indicates oscillations that operate near the spike-triggering threshold. The oscillation frequency determines the basic rhythm of impulse generation, but whether or not an impulse is actually triggered essentially depends on superimposed noise. The probability of impulse generation can be altered considerably by minor modifications of oscillation baseline and amplitude, which may underlie the exquisite sensitivity of these receptors to thermal and electrical stimuli. Additionally, thermal, but not electrical, stimuli alter the oscillation frequency, allowing dual sensory messages to be conveyed in a single spike train. These findings demonstrate novel properties of sensory transduction which may be relevant for neuronal signalling in general.			BRAUN, HA (corresponding author), UNIV MARBURG,INST PHYSIOL,DEUTSCHHAUSSTR 2,D-35037 MARBURG,GERMANY.							Akoev G.N., 1981, Advances in Physiological Sciences, V31, P57; ALDENHOFF JB, 1989, PHARMACOPSYCHIATRY, V22, P227, DOI 10.1055/s-2007-1014606; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; BRAUN HA, 1990, THERMORECEPTION AND TEMPERATURE REGULATION, P19; BRAUN HA, 1984, SENSORY RECEPTOR MEC, P147; BRINK F, 1946, ANN NY ACAD SCI, V47, P457; BROMM B, 1975, EXPERIENTIA, V31, P615, DOI 10.1007/BF01932490; BULLER AJ, 1953, J PHYSIOL-LONDON, V122, P409, DOI 10.1113/jphysiol.1953.sp005011; BULLOCK TH, 1970, J GEN PHSL, V5, P565; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; DYKES RW, 1975, BRAIN RES, V98, P485, DOI 10.1016/0006-8993(75)90368-6; FITZHUGH R, 1958, J GEN PHYSIOL, V40, P675; FOHLMEISTER JF, 1974, J NEUROPHYSIOL, V37, P1213, DOI 10.1152/jn.1974.37.6.1213; HENSEL H, 1955, Z VERGL PHYSIOL, V37, P509, DOI 10.1007/BF00341377; IGGO A, 1969, J PYSL LOND, V200, P391; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; MADDOX J, 1991, NATURE, V325, P469; MCGORMICK DA, 1990, NEUROSCIENCE, V39, P103; SCHAFER K, 1990, EXPERIENTIA, V47, P47; SCHAFER K, 1991, PFLUGERS ARCH, V417, P91; SCHREINER RC, 1978, J NEUROPHYSIOL, V41, P338, DOI 10.1152/jn.1978.41.2.338; SOKABE M, 1993, J NEUROPHYSIOL, V70, P275, DOI 10.1152/jn.1993.70.1.275; WALTMAN BERNARD, 1966, ACTA PHYSIOL SCAND, V66, P1	30	340	359	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JAN 20	1994	367	6460					270	273		10.1038/367270a0	http://dx.doi.org/10.1038/367270a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MR494	11407413				2022-12-01	WOS:A1994MR49400056
J	Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS				Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS			Dysfunction of endothelial protein C activation in severe meningococcal sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; ADHESION MOLECULE EXPRESSION; COLI SEPTIC SHOCK; PURPURA FULMINANS; TISSUE FACTOR; NEISSERIA-MENINGITIDIS; PATHWAY INHIBITOR; ANTITHROMBIN-III; LIPOOLIGOSACCHARIDE STRUCTURE; SOLUBLE THROMBOMODULIN	Background: Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression of thrombomodulin and the endothelial protein C receptor in the dermal microvasculature of children with severe meningococcemia and purpuric or petechial lesions. Methods: We assessed the integrity of the endothelium and the expression of thrombomodulin and the endothelial protein C receptor in biopsy specimens of purpuric lesions from 21 children with meningococcal sepsis (median age, 41 months), as compared with control skin-biopsy specimens. Results: The expression of endothelial thrombomodulin and of the endothelial protein C receptor was lower in the patients with meningococcal sepsis than in the controls, both in vessels with thrombosis and in vessels without thrombosis. On electron microscopical examination, the endothelial cells were generally intact in both thrombosed and nonthrombosed vessels. Plasma thrombomodulin levels in the children with meningococcal sepsis (median, 6.4 ng per liter) were higher than those in the controls (median, 3.6 ng per liter; P=0.002). Plasma levels of protein C antigen, protein S antigen, and antithrombin antigen were lower than those in the controls. In two patients treated with unactivated protein C concentrate, activated protein C was undetectable at the time of admission, and plasma levels remained low. Conclusions: In severe meningococcal sepsis, protein C activation is impaired, a finding consistent with down-regulation of the endothelial thrombomodulin-endothelial protein C receptor pathway. (N Engl J Med 2001;345:408-16.) Copyright (C) 2001 Massachusetts Medical Society.	St Marys Hosp, Imperial Coll Sch med, Dept Paediat, London W2 1PG, England; St Marys Hosp, Imperial Coll Sch med, Dept Pathol, London W2 1PG, England; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK USA; Howard Hughes Med Inst, Oklahoma City, OK USA; Univ Bristol, Dept Pathol, Bristol, Avon, England; Univ Bristol, Dept Microbiol, Bristol, Avon, England	Imperial College London; Imperial College London; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute; University of Bristol; University of Bristol	Levin, M (corresponding author), St Marys Hosp, Imperial Coll Sch med, Dept Paediat, Norfolk Pl, London W2 1PG, England.		Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642; Levin, Michael/0000-0003-2767-6919; Goldin, Robert/0000-0001-5184-4519; Harrison, Odile/0000-0002-1623-0295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054804] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL54804] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Achtman M, 1995, MENINGOCOCCAL DIS, P159; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BRANDTZAEG P, 1990, THROMB RES, V57, P271, DOI 10.1016/0049-3848(90)90326-8; BRANDTZAEG P, 1989, THROMB RES, V55, P459, DOI 10.1016/0049-3848(89)90054-6; BRANDTZAEG P, 1995, MENINGOCOCCAL DIS, P71; CATTORETTI G, 1993, J PATHOL, V171, P83, DOI 10.1002/path.1711710205; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Jonge E, 1998, DRUGS, V55, P767, DOI 10.2165/00003495-199855060-00004; de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958; DEUTZTERLOUW PP, 1990, CLIN CHIM ACTA, V186, P321, DOI 10.1016/0009-8981(90)90318-M; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; DREYFUS M, 1991, NEW ENGL J MED, V325, P1565, DOI 10.1056/NEJM199111283252207; Duncan A, 1997, LANCET, V350, P1565, DOI 10.1016/S0140-6736(05)64007-X; EDGAR P, 1989, J CLIN PATHOL, V42, P985, DOI 10.1136/jcp.42.9.985; ELEY B, 2000, TXB PEDIAT DERMATOLO, V2, P1574; Esmon CT, 1999, THROMB HAEMOSTASIS, V82, P251; Esmon CT, 1997, THROMB HAEMOSTASIS, V78, P70; Faust SN, 2000, BEST PRACT RES CL HA, V13, P179, DOI 10.1053/beha.2000.0067; FOURRIER F, 1990, INTENS CARE MED, V16, P121, DOI 10.1007/BF01699858; FOURRIER F, 1993, CHEST, V104, P882, DOI 10.1378/chest.104.3.882; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Furuno T, 1997, INT ARCH ALLERGY IMM, V112, P262, DOI 10.1159/000237464; GRUBER A, 1992, BLOOD, V79, P2340; HARRIS OB, 2000, 12 INT PATH NEISS C, P18; Hazelzet JA, 1996, THROMB HAEMOSTASIS, V76, P932; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; HESSELVIK JF, 1991, THROMB HAEMOSTASIS, V65, P126; Heyderman RS, 1997, MICROB PATHOGENESIS, V22, P265, DOI 10.1006/mpat.1996.0112; HEYDERMAN RS, 1992, THROMB RES, V67, P677, DOI 10.1016/0049-3848(92)90071-H; HEYDERMAN RS, 2000, TXB PEDIAT DERMATOLO, V1, P384; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; IBA T, 1995, SURG TODAY, V25, P585, DOI 10.1007/BF00311430; Ikegami K, 1998, J TRAUMA, V44, P789, DOI 10.1097/00005373-199805000-00008; KLEIN NJ, 1992, J CELL SCI, V102, P821; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Krafte-Jacobs B, 1998, CRIT CARE MED, V26, P933, DOI 10.1097/00003246-199805000-00032; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Laszik Z, 1997, CIRCULATION, V96, P3633; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; LEVIN M, 1995, J PEDIATR-US, V127, P355, DOI 10.1016/S0022-3476(95)70063-3; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772; NADEL S, 1995, MENINGOCOCCAL DIS, P207; OSTERUD B, 1983, THROMB HAEMOSTASIS, V49, P5; PARAMO JA, 1990, THROMB HAEMOSTASIS, V64, P3; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; POWARS D, 1993, CLIN INFECT DIS, V17, P254, DOI 10.1093/clinids/17.2.254; Rintala E, 1998, CRIT CARE MED, V26, P965, DOI 10.1097/00003246-199805000-00038; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; SHETH SB, 1991, AM J HEMATOL, V36, P14, DOI 10.1002/ajh.2830360104; Shimura M, 1996, AM J HEMATOL, V52, P165; Smith OP, 1997, LANCET, V350, P1590, DOI 10.1016/S0140-6736(97)06356-3; SORIA J, 1985, THROMB HAEMOSTASIS, V53, P293; SOTTO MN, 1976, J INFECT DIS, V133, P506, DOI 10.1093/infdis/133.5.506; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010; VANDEUREN M, 1993, BMJ-BRIT MED J, V306, P1229, DOI 10.1136/bmj.306.6887.1229; White B, 2000, BLOOD, V96, P3719, DOI 10.1182/blood.V96.12.3719.h8003719_3719_3724; ZENZ W, 1995, PEDIATRICS, V96, P44	66	480	508	0	14	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					408	416		10.1056/NEJM200108093450603	http://dx.doi.org/10.1056/NEJM200108093450603			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496851				2022-12-01	WOS:000170295000003
J	Harvey, R; Lane, A; Murray, L; Harvey, I; Nair, P; Donovan, J				Harvey, R; Lane, A; Murray, L; Harvey, I; Nair, P; Donovan, J			Effect of Helicobacter pylori infection on blood pressure: a community based cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; ASSOCIATION		N Bristol NHS Trust, Frenchay Hosp, Bristol BS16 1LE, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	North Bristol NHS Trust; University of Bristol	Harvey, R (corresponding author), N Bristol NHS Trust, Frenchay Hosp, Bristol BS16 1LE, Avon, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARNES RJ, 1991, BRIT J GEN PRACT, V41, P286; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Lip GYH, 1996, BRIT MED J, V312, P250; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568	5	19	20	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					264	265		10.1136/bmj.323.7307.264	http://dx.doi.org/10.1136/bmj.323.7307.264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485956	Bronze, Green Published			2022-12-01	WOS:000170394300020
J	Catling, DC; Zahnle, KJ; McKay, CP				Catling, DC; Zahnle, KJ; McKay, CP			Biogenic methane, hydrogen escape, and the irreversible oxidation of early Earth	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; REDOX STATES; EVOLUTION; DOLOMITE; MANTLE; GA; PHOTOSYNTHESIS; GREENHOUSE; PALEOSOLS; ISOTOPES	The low O-2 content of the Archean atmosphere implies that methane should have been present at levels similar to 10(2) to 10(3) parts per million volume (ppmv) (compared with 1.7 ppmv today) given a plausible biogenic source. CH4 is favored as the greenhouse gas that countered the lower luminosity of the early Sun. But abundant CH4 implies that hydrogen escapes to space (up arrow space) orders of magnitude faster than today. Such reductant loss oxidizes the Earth. Photosynthesis splits water into O-2 and H, and methanogenesis transfers the H into CH4. Hydrogen escape after CH4 photolysis, therefore, causes a net gain of oxygen [CO2 + 2H(2)O CH4 --> 2O(2) --> CO2 + O-2 + 4H(up arrow space)]. Expected irreversible oxidation (similar to 10(12) to 10(13) moles oxygen per year) may help explain how Earth's surface environment became irreversibly oxidized.	NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; SETI Inst, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Catling, DC (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Mail Stop 245-3, Moffett Field, CA 94035 USA.	catling@humbabe.arc.nasa.gov	Catling, David C/D-2082-2009	Catling, David/0000-0001-5646-120X				Anbar AD, 2001, J GEOPHYS RES-PLANET, V106, P3219, DOI 10.1029/2000JE001272; BAHCALL JN, 1988, REV MOD PHYS, V60, P297, DOI 10.1103/RevModPhys.60.297; Bau M, 1999, EARTH PLANET SC LETT, V174, P43, DOI 10.1016/S0012-821X(99)00261-7; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUDYKO ML, 1985, HIST EARTHS ATMOSPHE; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; Canil D, 1999, GEOCHIM COSMOCHIM AC, V63, P557, DOI 10.1016/S0016-7037(98)00287-7; CHAMBERLAIN JW, 1987, THEORY PLANETARY ATM, P34; DELANO JW, IN PRESS ORIGIN LIFE; Des Marais DJ, 2000, SCIENCE, V289, P1703; DIX GR, 1995, PRECAMBRIAN RES, V70, P253, DOI 10.1016/0301-9268(94)00044-R; EUGSTER HP, 1972, P INT GEOL C, V24, P3; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Francois LM, 1986, PALEOCEANOGRAPHY, V1, P355, DOI 10.1029/PA001i004p00355; FYFE WS, 1978, FLUIDS EARTHS CRUST, pCH7; Green MG, 2000, TECTONOPHYSICS, V322, P69, DOI 10.1016/S0040-1951(00)00058-5; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; Holland H.D., 1978, CHEM ATMOSPHERE OCEA; Holland H. D., 1984, CHEM EVOLUTION ATMOS; Holland HD., 1999, GEOCHEM NEWS, V100, P20; HUNTEN DM, 1973, J ATMOS SCI, V30, P1481, DOI 10.1175/1520-0469(1973)030<1481:TEOLGF>2.0.CO;2; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; Lecuyer C, 1999, EARTH PLANET SC LETT, V165, P197, DOI 10.1016/S0012-821X(98)00267-2; Lecuyer C, 1998, CHEM GEOL, V145, P249, DOI 10.1016/S0009-2541(97)00146-0; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Melezhik VA, 1999, EARTH-SCI REV, V48, P71, DOI 10.1016/S0012-8252(99)00044-6; MELNIK YP, 1982, PRECAMBRIAN BANDED I, P68; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; PAVLOV AA, IN PRESS J GEOPHYS R; Prasad N, 1996, CATENA, V27, P105, DOI 10.1016/0341-8162(96)00003-3; Rye R, 2000, GEOLOGY, V28, P483, DOI 10.1130/0091-7613(2000)28<483:LAWAGE>2.0.CO;2; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; SCHIDLOWSKI M, 1987, ANNU REV EARTH PL SC, V15, P47, DOI 10.1146/annurev.ea.15.050187.000403; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Sleep NH, 2001, J GEOPHYS RES-PLANET, V106, P1373, DOI 10.1029/2000JE001247; Taylor H.P., 1977, J GEOLOGICAL SOC LON, V133, P509, DOI [DOI 10.1144/GSJGS.133.6.0509, 10.1144/gsjgs.133.6.0509]; VISCONTI G, 1975, J ATMOS SCI, V32, P1631, DOI 10.1175/1520-0469(1975)032<1631:TETOAP>2.0.CO;2; WALTER FM, 1991, SUN TIME, P633; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	46	307	329	10	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					839	843		10.1126/science.1061976	http://dx.doi.org/10.1126/science.1061976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486082				2022-12-01	WOS:000170241000038
J	Lange, RA; Hillis, LD				Lange, RA; Hillis, LD			Medical progress - Cardiovascular complications of cocaine use	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INDUCED CORONARY VASOCONSTRICTION; MYOCARDIAL-INFARCTION; CHEST-PAIN; ARTERY-DISEASE; COCAETHYLENE DEGRADATION; PROCAINAMIDE INHIBITION; INTRANASAL COCAINE; AORTIC DISSECTION; CLINICAL SAFETY; HUMAN PLATELETS		Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Room CS7-102,5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Lange, Richard/AAM-9594-2021					AMIN M, 1990, AM J CARDIOL, V66, P1434, DOI 10.1016/0002-9149(90)90529-A; Bailey DN, 1999, THER DRUG MONIT, V21, P301, DOI 10.1097/00007691-199906000-00008; Bailey DN, 1999, J ANAL TOXICOL, V23, P99, DOI 10.1093/jat/23.2.99; Bailey DN, 1999, J ANAL TOXICOL, V23, P173, DOI 10.1093/jat/23.3.173; Baumann BM, 2000, ACAD EMERG MED, V7, P878, DOI 10.1111/j.1553-2712.2000.tb02065.x; Baumgartner FJ, 1997, ANN THORAC SURG, V64, P1518, DOI 10.1016/S0003-4975(97)00988-0; BERTOLET BD, 1990, CLIN CARDIOL, V13, P323, DOI 10.1002/clc.4960130505; Besse S, 1997, EUR J PHARMACOL, V338, P123, DOI 10.1016/S0014-2999(97)81939-5; BILLMAN GE, 1993, J CARDIOVASC PHARM, V22, P869, DOI 10.1097/00005344-199312000-00015; BOEHRER JD, 1993, AM J MED, V94, P608, DOI 10.1016/0002-9343(93)90212-8; BRICKNER ME, 1991, CIRCULATION, V84, P1130, DOI 10.1161/01.CIR.84.3.1130; BRODY SL, 1990, AM J MED, V88, P325, DOI 10.1016/0002-9343(90)90484-U; BROGAN WC, 1992, ANN INTERN MED, V116, P556, DOI 10.7326/0003-4819-116-7-556; BROGAN WC, 1991, J AM COLL CARDIOL, V18, P581, DOI 10.1016/0735-1097(91)90617-I; CHAMBERS HF, 1987, ANN INTERN MED, V106, P833, DOI 10.7326/0003-4819-106-6-833; CHOKSHI SK, 1989, ANN INTERN MED, V111, P1039, DOI 10.7326/0003-4819-111-12-1039; COLEMAN DL, 1982, WESTERN J MED, V136, P444; DANIEL WC, 1995, AM J CARDIOL, V76, P398, DOI 10.1016/S0002-9149(99)80109-X; DARAS M, 1994, ACTA NEUROL SCAND, V90, P124; ESCOBEDO LG, 1991, ARCH PATHOL LAB MED, V115, P900; Fendrich M, 1999, AM J EPIDEMIOL, V149, P955; FLORES ED, 1990, J AM COLL CARDIOL, V16, P74, DOI 10.1016/0735-1097(90)90459-3; Gan XH, 1999, CLIN IMMUNOL, V91, P68, DOI 10.1006/clim.1998.4683; GITTER MJ, 1991, ANN INTERN MED, V115, P277, DOI 10.7326/0003-4819-115-4-277; GRANT BF, 1990, DRUG ALCOHOL DEPEN, V25, P97, DOI 10.1016/0376-8716(90)90147-7; HEARN WL, 1991, J NEUROCHEM, V56, P698, DOI 10.1111/j.1471-4159.1991.tb08205.x; HEARN WL, 1991, PHARM BIOCH BEHAV, P531; HENDERSON CE, 1988, AM J PERINAT, V5, P142, DOI 10.1055/s-2007-999673; Hoffman RS, 1996, AM J EMERG MED, V14, P693, DOI 10.1016/S0735-6757(96)90091-1; Hollander J E, 1994, Acad Emerg Med, V1, P330; HOLLANDER J E, 1992, Journal of Emergency Medicine, V10, P169, DOI 10.1016/0736-4679(92)90212-C; HOLLANDER JE, 1995, ARCH INTERN MED, V155, P1081, DOI 10.1001/archinte.155.10.1081; HOLLANDER JE, 1995, ANN EMERG MED, V26, P671, DOI 10.1016/S0196-0644(95)70035-8; HOLLANDER JE, 1995, CHEST, V107, P1237, DOI 10.1378/chest.107.5.1237; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P179, DOI 10.1111/j.1553-2712.1995.tb03191.x; Hollander JE, 1998, AM HEART J, V135, P245, DOI 10.1016/S0002-8703(98)70089-4; Hollander JE, 1997, VET HUM TOXICOL, V39, P276; HOLLANDER JE, 1992, NEW ENGL J MED, V327, P361; Huang L, 1997, AM J PHYSIOL-HEART C, V273, pH893, DOI 10.1152/ajpheart.1997.273.2.H893; INOUE H, 1988, J AM COLL CARDIOL, V11, P867, DOI 10.1016/0735-1097(88)90224-0; ISNER JM, 1986, NEW ENGL J MED, V315, P1438, DOI 10.1056/NEJM198612043152302; JEFFCOAT AR, 1989, DRUG METAB DISPOS, V17, P153; Kanani PM, 1998, J CARDIOVASC PHARM, V32, P42, DOI 10.1097/00005344-199807000-00007; Kerns William Ii, 1997, Journal of Emergency Medicine, V15, P321, DOI 10.1016/S0736-4679(97)00003-6; Kidwell DA, 1997, FORENSIC SCI INT, V84, P75, DOI 10.1016/S0379-0738(96)02051-8; Kolodgie FD, 1999, EXP MOL PATHOL, V66, P109, DOI 10.1006/exmp.1999.2253; KOLODGIE FD, 1991, J AM COLL CARDIOL, V17, P1553, DOI 10.1016/0735-1097(91)90646-Q; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; LANGE RA, 1990, ANN INTERN MED, V112, P897, DOI 10.7326/0003-4819-112-12-897; Madu EC, 1999, ANGIOLOGY, V50, P163, DOI 10.1177/000331979905000212; Mao JT, 1997, CELL IMMUNOL, V181, P38, DOI 10.1006/cimm.1997.1185; MINOR RL, 1991, ANN INTERN MED, V115, P797, DOI 10.7326/0003-4819-115-10-797; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; Mo W, 1998, AM J HYPERTENS, V11, P708, DOI 10.1016/S0895-7061(98)00041-7; MOLITERNO DJ, 1994, AM J MED, V96, P492, DOI 10.1016/0002-9343(94)90087-6; MOLITERNO DJ, 1994, NEW ENGL J MED, V330, P454, DOI 10.1056/NEJM199402173300702; NEGUS BH, 1994, AM J CARDIOL, V73, P510, DOI 10.1016/0002-9149(94)90684-X; Neiman J, 2000, EUR J NEUROL, V7, P595, DOI 10.1046/j.1468-1331.2000.00045.x; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; *OFF APPL STUD, 1999, DHHS PUBL; Parker RB, 1999, J CARDIOVASC PHARM, V34, P864, DOI 10.1097/00005344-199912000-00014; Perera R, 1997, J ELECTROCARDIOL, V30, P337, DOI 10.1016/S0022-0736(97)80047-7; Perreault C L, 1991, NIDA Res Monogr, V108, P139; PERREAULT CL, 1993, CARDIOVASC RES, V27, P262, DOI 10.1093/cvr/27.2.262; Perron AD, 1997, AM J EMERG MED, V15, P507, DOI 10.1016/S0735-6757(97)90196-0; PIRWITZ MJ, 1995, ARCH INTERN MED, V155, P1186, DOI 10.1001/archinte.155.11.1186; Pitts WR, 1997, PROG CARDIOVASC DIS, V40, P65, DOI 10.1016/S0033-0620(97)80023-0; Pitts WR, 1998, CIRCULATION, V97, P1270, DOI 10.1161/01.CIR.97.13.1270; RANDALL T, 1992, JAMA-J AM MED ASSOC, V267, P1043, DOI 10.1001/jama.267.8.1043; REZKALLA SH, 1993, AM J CARDIOL, V72, P243, DOI 10.1016/0002-9149(93)90173-A; RINDER HM, 1994, CIRCULATION, V90, P1162, DOI 10.1161/01.CIR.90.3.1162; SHIH RD, 1995, ANN EMERG MED, V26, P702, DOI 10.1016/S0196-0644(95)70041-2; Sofuoglu M, 2000, PHARMACOL BIOCHEM BE, V65, P255, DOI 10.1016/S0091-3057(99)00201-4; STENBERG RG, 1989, ARCH PATHOL LAB MED, V113, P521; *SUBST AB MENT HLT, 2000, DRUG AB WARN NETW AN; TAZELAAR HD, 1987, HUM PATHOL, V18, P195, DOI 10.1016/S0046-8177(87)80338-6; VIRMANI R, 1988, AM HEART J, V115, P1068, DOI 10.1016/0002-8703(88)90078-6; Wang RY, 1999, AM J EMERG MED, V17, P364, DOI 10.1016/S0735-6757(99)90088-8; WIENER RS, 1986, AM J MED, V81, P699, DOI 10.1016/0002-9343(86)90559-0; Wilbert-Lampen U, 1998, CIRCULATION, V98, P385, DOI 10.1161/01.CIR.98.5.385; WINNIFORD MD, 1986, CIRCULATION, V73, P662, DOI 10.1161/01.CIR.73.4.662; WIT AL, 1986, HEART CARDIOVASCULAR, V2, P1449; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; 2000, CIRCULATION S1, V102, P86; 2000, CIRCULATION S1, V102, P223	86	472	489	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					351	358		10.1056/NEJM200108023450507	http://dx.doi.org/10.1056/NEJM200108023450507			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484693				2022-12-01	WOS:000170193600008
J	Woodruff, PG; Fahy, JV				Woodruff, PG; Fahy, JV			Asthma: Prevalence, pathogenesis, and prospects for novel therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-IGE ANTIBODY; HOUSE-DUST MITE; CHILDHOOD ASTHMA; IMMUNOTHERAPY; PREGNANCY; MORTALITY; ALLERGENS; EXPOSURE; ATOPY; PHASE		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fahy, JV (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 505 Parnassus Ave,Box 0111, San Francisco, CA 94143 USA.	jfahy@itsa.ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056385, R01HL061662] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL-56385, R01 HL-61662, HL-07185] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Boulet LP, 1997, AM J RESP CRIT CARE, V155, P1835, DOI 10.1164/ajrccm.155.6.9196083; Boushey HA, 2000, LANCET, V356, P2114, DOI 10.1016/S0140-6736(00)03486-3; BOUSHEY HA, 2000, TXB RESP MED, P1247; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Campbell D, 2000, CLIN IMMUNOL, V97, P193, DOI 10.1006/clim.2000.4926; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Grant EN, 1999, J ALLERGY CLIN IMMUN, V104, pS1, DOI 10.1016/S0091-6749(99)70268-X; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Kim TS, 1997, J IMMUNOL, V158, P4137; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Litonjua AA, 2001, J ALLERGY CLIN IMMUN, V107, P41, DOI 10.1067/mai.2001.111143; Los H, 1999, EUR RESPIR J, V14, P1210, DOI 10.1183/09031936.99.14512109; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Martinez FD, 2001, RESPIR RES, V2, P129, DOI 10.1186/rr48; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Ronmark E, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e37; Sly RM, 2000, ANN ALLERG ASTHMA IM, V85, P121, DOI 10.1016/S1081-1206(10)62451-9; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wills-Karp M, 2000, IMMUNOPHARMACOLOGY, V48, P263, DOI 10.1016/S0162-3109(00)00223-X	37	36	44	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					395	398		10.1001/jama.286.4.395	http://dx.doi.org/10.1001/jama.286.4.395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466111				2022-12-01	WOS:000170069000001
J	Metz, JG; Roessler, P; Facciotti, D; Levering, C; Dittrich, F; Lassner, M; Valentine, R; Lardizabal, K; Domergue, F; Yamada, A; Yazawa, K; Knauf, V; Browse, J				Metz, JG; Roessler, P; Facciotti, D; Levering, C; Dittrich, F; Lassner, M; Valentine, R; Lardizabal, K; Domergue, F; Yamada, A; Yazawa, K; Knauf, V; Browse, J			Production of polyunsaturated fatty acids by polyketide synthases in both prokaryotes and eukaryotes	SCIENCE			English	Article							EICOSAPENTAENOIC ACID; ESCHERICHIA-COLI; BIOSYNTHESIS; DESATURATION; ELONGATION; BACTERIUM; MICROORGANISMS; ARABIDOPSIS; INITIATION; ENZYME	Polyunsaturated fatty acids (PUFAs) are essential membrane components in higher eukaryotes and are the precursors of many lipid-derived signaling molecules. Here, pathways for PUFA synthesis are described that do not require desaturation and elongation of saturated fatty acids. These pathways are catalyzed by polyketide synthases (PKSs) that are distinct from previously recognized PKSs in both structure and mechanism. Generation of cis double bonds probably involves position-specific isomerases; such enzymes might be useful in the production of new families of antibiotics. it is Likely that PUFA synthesis in cold marine ecosystems is accomplished in part by these PKS enzymes.	Omega Tech, Boulder, CO 80301 USA; Monsanto Co, Davis, CA 95616 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Sagami Chem Res Ctr, Kanagawa 229, Japan	Monsanto; Washington State University	Metz, JG (corresponding author), Omega Tech, 4909 Nautilus Court N, Boulder, CO 80301 USA.			Browse, John/0000-0002-2554-2821; Domergue, Frederic/0000-0002-0183-7000				Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARCLAY WR, 1994, J APPL PHYCOL, V6, P123, DOI 10.1007/BF02186066; Bentley R, 1999, ANNU REV MICROBIOL, V53, P411, DOI 10.1146/annurev.micro.53.1.411; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; GELLERMAN JL, 1979, BIOCHIM BIOPHYS ACTA, V573, P23, DOI 10.1016/0005-2760(79)90169-3; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McConn M, 1998, PLANT J, V15, P521, DOI 10.1046/j.1365-313X.1998.00229.x; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284; Pearson W R, 2000, Methods Mol Biol, V132, P185; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Sprecher H, 1999, Curr Opin Clin Nutr Metab Care, V2, P135, DOI 10.1097/00075197-199903000-00007; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Watanabe K, 1997, J BIOCHEM-TOKYO, V122, P467; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095	26	515	608	8	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					290	293		10.1126/science.1059593	http://dx.doi.org/10.1126/science.1059593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452122				2022-12-01	WOS:000169875200056
J	Jakosky, BM; Phillips, RJ				Jakosky, BM; Phillips, RJ			Mars' volatile and climate history	NATURE			English	Review							MARTIAN ATMOSPHERIC ARGON; ORBITER LASER ALTIMETER; CARBON-DIOXIDE CLOUDS; CHAOTIC OBLIQUITY; WATER RESERVOIRS; NORTHERN PLAINS; IMPACT EROSION; EVOLUTION; METEORITE; SURFACE	There is substantial evidence that the martian volatile inventory and climate have changed markedly throughout the planet's history. Clues come from areas as disparate as the history and properties of the deep interior, the composition of the crust and regolith, the morphology of the surface, composition of the present-day atmosphere, and the nature of the interactions between the upper atmosphere and the solar wind. We piece together the relevant observations into a coherent view of the evolution of the martian climate, focusing in particular on the observations that provide the strongest constraints.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Washington University (WUSTL)	Jakosky, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.	bruce.jakosky@lasp.colorado.edu; phillips@wustite.wustl.edu						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Aharonson O, 1998, GEOPHYS RES LETT, V25, P4413, DOI 10.1029/1998GL900057; ANDERSON RC, IN PRESS J GEOPHYS R; Ayres TR, 1997, J GEOPHYS RES-PLANET, V102, P1641, DOI 10.1029/96JE03306; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; Bjoraker G. L., 1989, B AM ASTRON SOC, V21, P991; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Carr M.H, 1996, WATER MARS; CARR MH, 1986, ICARUS, V68, P187, DOI 10.1016/0019-1035(86)90019-9; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CHRISTENSEN PR, IN PRESS J GEOPHYS R; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Craddock RA, 1997, J GEOPHYS RES-PLANET, V102, P13321, DOI 10.1029/97JE01084; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; DONAHUE TM, 1995, NATURE, V374, P432, DOI 10.1038/374432a0; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; FREY HV, 2001, LUN PLAN SCI C, V32; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOODING JL, 1988, GEOCHIM COSMOCHIM AC, V52, P909, DOI 10.1016/0016-7037(88)90361-4; GREELEY R, IN PRESS MARS EXPLOR; Haberle RM, 1998, J GEOPHYS RES-PLANET, V103, P28467, DOI 10.1029/98JE01396; HARRISON KP, LUN PLAN SCI C, V32; Hartmann W.K., 1981, BASALTIC VOLCANISM T, P1049; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HARTMANN WK, IN PRESS SPACE SCI R; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Head JW, 1998, GEOPHYS RES LETT, V25, P4401, DOI 10.1029/1998GL900116; HEAD JW, 2001, LUN PLAN SCI C, V32; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P11999, DOI 10.1029/1999JE001193; Hoffman N, 2000, ICARUS, V146, P326, DOI 10.1006/icar.2000.6398; Hutchins KS, 1996, J GEOPHYS RES-PLANET, V101, P14933, DOI 10.1029/96JE00860; Hutchins KS, 1997, J GEOPHYS RES-PLANET, V102, P9183, DOI 10.1029/96JE03838; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Jakosky B. M., 1992, MARS, P969; Jakosky BM, 1997, REV GEOPHYS, V35, P1, DOI 10.1029/96RG02903; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, AM GEOPH UN SPRING M; JAKOSKY BM, 2000, WATER MANY MYSTERIES; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Kieffer H. H., 1992, MARS, P1180; KOMAR PD, 1980, ICARUS, V42, P317, DOI 10.1016/0019-1035(80)90097-4; Krasnopolsky V, 2000, ICARUS, V148, P597, DOI 10.1006/icar.2000.6534; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Lane MD, 2000, J GEOPHYS RES-PLANET, V105, P17617, DOI 10.1029/1999JE001197; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; LIU SC, 1976, ICARUS, V28, P231, DOI 10.1016/0019-1035(76)90035-X; Lucchitta BK, 2001, GEOPHYS RES LETT, V28, P403, DOI 10.1029/2000GL011924; LUHMANN JG, 1992, GEOPHYS RES LETT, V19, P2151, DOI 10.1029/92GL02485; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Marti K, 2000, GEOPHYS RES LETT, V27, P1463, DOI 10.1029/1999GL011064; Mathew KJ, 2001, J GEOPHYS RES-PLANET, V106, P1401, DOI 10.1029/2000JE001255; MCELROY MB, 1976, PLANET SPACE SCI, V24, P1107, DOI 10.1016/0032-0633(76)90148-3; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; MELLON MT, IN PRESS J GEOPHYS R; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Mischna MA, 2000, ICARUS, V145, P546, DOI 10.1006/icar.2000.6380; MITCHELL DL, 2000, CRUSTAL MAGNETOCYLIN; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Owen T., 1992, MARS, P818; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PARKER TJ, 2000, LUN PLAN SCI C, V31; PECHMANN JC, 1980, ICARUS, V42, P185, DOI 10.1016/0019-1035(80)90071-8; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Purucker M, 2000, GEOPHYS RES LETT, V27, P2449, DOI 10.1029/2000GL000072; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; Schubert G, 2000, NATURE, V408, P666, DOI 10.1038/35047163; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; STEWART ST, UNPUB J GEOPHYS RES; Swindle TD, 2000, METEORIT PLANET SCI, V35, P107, DOI 10.1111/j.1945-5100.2000.tb01978.x; TANAKA K, 2000, GSA ABSTR PROGR, V32; Tanaka KL, 1999, J GEOPHYS RES-PLANET, V104, P8637, DOI 10.1029/98JE02552; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Tanaka KL, 1998, J GEOPHYS RES-PLANET, V103, P31407, DOI 10.1029/98JE01599; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; TREIMAN AH, 1993, METEORITICS, V28, P86, DOI 10.1111/j.1945-5100.1993.tb00251.x; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; WEISS BP, 2001, LUN PLAN SCI C, V32; Withers P, 2001, NATURE, V410, P651, DOI 10.1038/35070640; YUNG YL, 1988, ICARUS, V76, P146, DOI 10.1016/0019-1035(88)90147-9; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	106	320	323	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					237	244		10.1038/35084184	http://dx.doi.org/10.1038/35084184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449285	Bronze			2022-12-01	WOS:000169778700063
J	Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, MJ; Locht, C; Menozzi, FD				Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, MJ; Locht, C; Menozzi, FD			The heparin-binding haemagglutinin of M-tuberculosis is required for extrapulmonary dissemination	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HEMAGGLUTININ; GENE; IDENTIFICATION; MACROPHAGES; VIRULENCE; SURVIVAL; COMPLEX; ADHESIN; MICE	Tuberculosis remains the world's leading cause of death due to a single infectious agent, Mycobacterium tuberculosis, with 3 million deaths and 10 million new cases per year(1). The infection initiates in the lungs and can then spread rapidly to other tissues(2). The availability of the entire M. tuberculosis genome sequence(3) and advances in gene disruption technologies(4) have led to the identification of several mycobacterial determinants involved in virulence(5-8). However, no virulence factor specifically involved in the extrapulmonary dissemination of M. tuberculosis has been identified to date. Here we show that the disruption of the M. tuberculosis or Mycobacterium bovis Bacille Calmette-Guerin (BCG) hbhA gene encoding the heparin-binding haemagglutinin adhesin (HBHA) markedly affects mycobacterial interactions with epithelial cells, but not with macrophage-like cells. When nasally administered to mice, the mutant strains were severely impaired in spleen colonization, but not in lung colonization. Coating wild-type mycobacteria with anti-HBHA antibodies also impaired dissemination after intranasal infection. These results provide evidence that adhesins such as HBHA are required for extrapulmonary dissemination, and that interactions with non-phagocytic cells have an important role in the pathogenesis of tuberculosis. They also suggest that antibody responses to HBHA may add to immune protection against tuberculosis.	Inst Pasteur Lille, INSERM, U447, F-59019 Lille, France; US FDA, Ctr Biol Evaluat & Res, Lab Mycobacterial Dis, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; US Food & Drug Administration (FDA)	Locht, C (corresponding author), Inst Pasteur Lille, INSERM, U447, 1 Rue Prof Calmette, F-59019 Lille, France.		Biet, Franck/ABA-4151-2021; Locht, Camille/L-3516-2018; Delogu, Giovanni/I-3701-2012; Pethe, Kevin/D-4505-2011; Pethe, Kevin/F-9495-2015; Pethe, Kevin/L-1199-2013	Biet, Franck/0000-0001-8425-6158; Delogu, Giovanni/0000-0003-0182-8267; Pethe, Kevin/0000-0003-0297-0150; Pethe, Kevin/0000-0003-0916-8873				BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HENDERSON HJ, 1963, J IMMUNOL, V90, P553; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menozzi FD, 1998, P NATL ACAD SCI USA, V95, P12625, DOI 10.1073/pnas.95.21.12625; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Reddy VM, 2000, J INFECT DIS, V181, P1189, DOI 10.1086/315327; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000	20	347	370	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					190	194		10.1038/35084083	http://dx.doi.org/10.1038/35084083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449276				2022-12-01	WOS:000169778700054
J	Graef, IA; Chen, F; Chen, L; Kuo, A; Crabtree, GR				Graef, IA; Chen, F; Chen, L; Kuo, A; Crabtree, GR			Signals transduced by Ca2+/calcineurin and NFATc3/c4 pattern the developing vasculature	CELL			English	Article							BLOOD-VESSEL FORMATION; RECEPTOR TYROSINE KINASE; TRANSCRIPTION FACTOR MEF2C; CARDIAC DEVELOPMENT; CARDIOVASCULAR DEVELOPMENT; NEUREGULIN RECEPTOR; ENDOTHELIAL-CELLS; DEFICIENT MICE; CYCLOSPORINE-A; NF-ATC	Vascular development requires an orderly exchange of signals between growing vessels and their supporting tissues, but little is known of the intracellular signaling pathways underlying this communication. We find that mice with disruptions of both NFATc4 and the related NFATc3 genes die around E11 with generalized defects in vessel assembly as well as excessive and disorganized growth of vessels into the neural tube and somites. Since calcineurin is thought to control nuclear localization of NFATc proteins, we introduced a mutation into the calcineurin a gene that prevents phosphatase activation by Ca2+ signals. These CnB mutant mice exhibit vascular developmental abnormalities similar to the NFATc3/c4 null mice. We show that calcineurin function is transiently required between E7.5 and E8.5. Hence, early calcineurin/NFAT signaling initiates the later cross-talk between vessels and surrounding tissues that pattern the vasculature.	Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA.							Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; UMESS LD, 2000, NAT GENET, V26, P328; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang X, 1999, DEVELOPMENT, V126, P1571	45	341	364	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					863	875		10.1016/S0092-8674(01)00396-8	http://dx.doi.org/10.1016/S0092-8674(01)00396-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439183	Bronze			2022-12-01	WOS:000169664300007
J	Wang, DZ; Chang, PS; Wang, ZG; Sutherland, L; Richardson, JA; Small, E; Krieg, PA; Olson, EN				Wang, DZ; Chang, PS; Wang, ZG; Sutherland, L; Richardson, JA; Small, E; Krieg, PA; Olson, EN			Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor	CELL			English	Article							ALPHA-ACTIN GENE; TINMAN-RELATED GENES; C-FOS PROMOTER; TERNARY COMPLEX; SMOOTH-MUSCLE; ELEMENT; SKELETAL; CELLS; DNA; SM22-ALPHA	Serum response factor (SRF) regulates transcription of numerous muscle and growth factor-inducible genes. Because SRF is not muscle specific, It has been postulated to activate muscle genes by recruiting myogenic accessory factors. Using a bioinformatics-based screen for unknown cardiac-specific genes, we identified a novel and highly potent transcription factor, named myocardin, that is expressed in cardiac and smooth muscle cells. Myocardin belongs to the SAP domain family of nuclear proteins and activates cardiac muscle promoters by associating with SRF. Expression of a dominant negative mutant of myocardin in Xenopus embryos interferes with myocardial cell differentiation. Myocardin is the founding member of a class of muscle transcription factors and provides a mechanism whereby SRF can convey myogenic activity to cardiac muscle genes.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ 85724 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Arizona	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.		Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302	NHLBI NIH HHS [HL63926, R01 HL053351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL063926, R01HL053351] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Chen CY, 1996, MOL CELL BIOL, V16, P6372; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; Fu YC, 1998, DEVELOPMENT, V125, P4439; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; Grow MW, 1998, DEV BIOL, V204, P187, DOI 10.1006/dbio.1998.9080; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HAUSCHKA SD, 1994, MYOLOGY, P3; Hines WA, 1999, MOL CELL BIOL, V19, P1841; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Lien CL, 1999, DEVELOPMENT, V126, P75; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Mack CP, 1999, CIRC RES, V84, P852; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nieuwkoop P.D., 1994, SYSTEMATICAL CHRONOL, DOI 10.1201/9781003064565-29; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Paradis P, 1996, J BIOL CHEM, V271, P10827, DOI 10.1074/jbc.271.18.10827; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REECY J, 1998, HEART DEV, P273; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Wang DZ, 1999, DEVELOPMENT, V126, P1281; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	42	718	762	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					851	862		10.1016/S0092-8674(01)00404-4	http://dx.doi.org/10.1016/S0092-8674(01)00404-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439182	Bronze			2022-12-01	WOS:000169664300006
J	Myung, K; Chen, C; Kolodner, RD				Myung, K; Chen, C; Kolodner, RD			Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae	NATURE			English	Article							STRAND-BREAK REPAIR; CHROMOSOMAL REARRANGEMENTS; DNA HELICASE; YEAST; RECOMBINATION; MAINTENANCE; TELOMERASE; ENDS; REPLICATION; MUTANTS	Gross chromosome rearrangements (GCRs), such as translocations, deletion of a chromosome arm, interstitial deletions and inversions, are often observed in cancer cells(1-3). Spontaneous GCRs are rare in Saccharomyces cerevisiae; however, the existence of mutator mutants with increased genome instability suggests that GCRs are actively suppressed(4,5). Here we show by genetic analysis that these genome rearrangements probably result from DNA replication errors and are suppressed by at least three interacting pathways or groups of proteins: S-phase checkpoint functions 5, recombination proteins(4) and proteins that prevent de novo addition of telomeres at double-strand breaks (DSBs). Mutations that inactivate these pathways cause high rates of GCRs and show synergistic interactions, indicating that the pathways that suppress GCRs all compete for the same DNA substrates.	Univ Calif San Diego, Sch Med, Ctr Canc, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ctr Canc, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277				Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; HABER J E, 1992, Current Opinion in Cell Biology, V4, P401, DOI 10.1016/0955-0674(92)90005-W; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; MITELMAN F, 1991, CATALOG CHROMOSOME A; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Padilla-Nash HM, 1999, GENE CHROMOSOME CANC, V25, P53, DOI 10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Vessey CJ, 2000, PROG NUCLEIC ACID RE, V63, P189, DOI 10.1016/S0079-6603(08)60723-0; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	30	292	294	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1073	1076		10.1038/35082608	http://dx.doi.org/10.1038/35082608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429610				2022-12-01	WOS:000169528500053
J	Schulz, R; Beach, SR; Lind, B; Martire, LM; Zdaniuk, B; Hirsch, C; Jackson, S; Burton, L				Schulz, R; Beach, SR; Lind, B; Martire, LM; Zdaniuk, B; Hirsch, C; Jackson, S; Burton, L			Involvement in caregiving and adjustment to death of a spouse - Findings from the caregiver health effects study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEREAVEMENT; DEPRESSION; PREDICTORS	Context Most deaths in the United States occur among older persons who have 1 or more disabling conditions. As a result, many deaths are preceded by an extended period during which family members provide care to their disabled relative. Objective To better understand the effect of bereavement on family caregivers by examining predeath vs postdeath changes in self-reported and objective health outcomes among elderly persons providing varying levels of care prior to their spouse's death. Design and Setting Prospective, population-based cohort study conducted in 4 US communities between 1993 and 1998. Participants One hundred twenty-nine individuals aged 66 to 96 years whose spouse died during an average 4-year follow-up. Individuals were classified as noncaregivers (n=40), caregivers who reported no strain (n=37), or strained caregivers (n=52). Main Outcome Measures Changes in depression symptoms (assessed by the 10-item Center for Epidemiological Studies-Depression [CES-D] scale), antidepressant medication use, 6 health risk behaviors, and weight among the 3 groups of participants. Results Controlling for age, sex, race, education, prevalent cardiovascular disease at baseline, and interval between predeath and postdeath assessments, CES-D scores remained high but did not change among strained caregivers (9.44 vs 9.19; P=.76), while these scores increased for both noncaregivers (4.74 vs 8.25; F-1,F-116=14.33; P<.001) and nonstrained caregivers (4.94 vs 7.13; F-1,F-116=4.35; P= .04) Noncaregivers were significantly more likely to be using nontricyclic antidepressant medications following the death than the nonstrained caregiver group (odds ratio [OR], 12.85; 95% confidence interval [Cl], 1.02-162.13; P=.05). The strained caregiver group experienced significant improvement in health risk behaviors following the death of their spouse (1.47 vs 0.66 behaviors; F-1,F-118=20.23; P<.001), while the noncaregiver and nonstrained caregiver groups showed little change (0.27 vs 0.27 [P=.99] and 0.46 vs 0.27 [P=.39] behaviors, respectively). Noncaregivers experienced significant weight loss following the death (149.1 vs 145.3 lb [67.1 vs 65.4 kg]; F-1,F-101=8.12; P=.005), while the strained and nonstrained caregiving groups did not show significant weight change (156.2 vs 155.2 lb [70.3 vs 69.8 kg] [P= 41] and 156.2 vs 154.0 lb [70.3 vs 69.3 kg] [P=.12], respectively). Conclusions These data indicate that the impact of losing one's spouse among older persons Varies as a function of the caregiving experiences that precede the death. Among individuals who are already strained prior to the death of their spouse, the death itself does not increase their level of distress. Instead, they show reductions in health risk behaviors. Among noncaregivers, losing one's spouse results in increased depression and weight loss.	Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Univ Ctr Social & Urban Res, Pittsburgh, PA 15260 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Davis, Davis Med Ctr, Div Gen Med, Davis, CA USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Epidemiol Sect, Winston Salem, NC 27109 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Hlth Serv & Dev Ctr, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Wake Forest University; Johns Hopkins University	Schulz, R (corresponding author), Univ Pittsburgh, Dept Psychiat, 121 Univ Pl, Pittsburgh, PA 15260 USA.				NHLBI NIH HHS [HL65111, N01-HC-85086, N01-HC-85079, HL65112] Funding Source: Medline; NIA NIH HHS [AG01532, AG13305] Funding Source: Medline; NIMH NIH HHS [T32 MH19986, R01 MH52247, R01 MH46015] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC085079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL065111, P50HL065112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH052247, T32MH019986, R01MH046015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG013305] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BODNAR JC, 1994, PSYCHOL AGING, V9, P372; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Kurtz ME, 1997, SUPPORT CARE CANCER, V5, P53, DOI 10.1007/BF01681962; MCHORNEY CA, 1988, MED CARE, V26, P882, DOI 10.1097/00005650-198809000-00007; Park CL, 1997, J PERS, V65, P421, DOI 10.1111/j.1467-6494.1997.tb00960.x; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Schulz R, 1997, AGING MENT HEALTH, V1, P269, DOI 10.1080/13607869757173; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SHROUT PE, 1989, J CLIN EPIDEMIOL, V42, P69, DOI 10.1016/0895-4356(89)90027-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9	14	179	182	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2001	285	24					3123	3129		10.1001/jama.285.24.3123	http://dx.doi.org/10.1001/jama.285.24.3123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444FF	11427141				2022-12-01	WOS:000169388900026
J	Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Soininen, H; Tuomilehto, J; Nissien, A				Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Soininen, H; Tuomilehto, J; Nissien, A			Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							APOLIPOPROTEIN-E; BLOOD-PRESSURE; DEMENTIA; ATHEROSCLEROSIS; HYPERTENSION	Objective To examine the relation of midlife raised blood pressure and serum cholesterol concentrations to Alzheimer's disease in later life. Design Prospective, population based study. Setting Populations of Kuopio and Joensuu, eastern Finland. Participants Participants were derived from random, population based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average of 21 years' follow up, a total of 1449 (73%) participants aged 65-79 took part in the re-examination in 1998. Main outcome measures Midlife blood pressure and cholesterol concentrations and development of Alzheimer's disease in later life. Results People with raised systolic blood pressure (greater than or equal to 160 mm Hg) or high serum cholesterol concentration (greater than or equal to6.5 mmol/l) in midlife had a significantly higher risk of Alzheimer's disease in later life, even after adjustment for age, body mass index, education, vascular events, smoking status, and alcohol consumption, than those with normal systolic blood pressure (odds ratio 2.3, 95% confidence interval 1.0 to 5.5) or serum cholesterol (odds ratio 2.1, 1.0 to 4.4). Participants with both of these risk factors in midlife had a significantly higher risk of developing Alzheimer's disease than those with either of the risk factors alone (odds ratio 3.5, 1.6 to 7.9). Diastolic blood pressure in midlife had no significant effect on the risk of Alzheimer's disease. Conclusion Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life.	Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Dept Clin Radiol, Kuopio 70211, Finland; Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; N Karelia Cent Hosp, Joensuu 80210, Finland; Natl Publ Hlth Inst, SF-00300 Helsinki, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Univ Kuopio, Dept Neurol & Neurosci, POB 1627, FIN-70211 Kuopio, Finland.	miia.kivipelto@uku.fi	Laakso, Mikko/AHB-7022-2022; Kivipelto, Miia/AAS-3557-2021	Laakso, Mikko/0000-0003-1250-3425; Kivipelto, Miia/0000-0003-0992-3875				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; APPLEGATE WB, 1989, ANN INTERN MED, V110, P901, DOI 10.7326/0003-4819-110-11-901; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Klungel OH, 2000, STROKE, V31, P420, DOI 10.1161/01.STR.31.2.420; Kosunen O, 1996, ACTA NEUROPATHOL, V91, P185, DOI 10.1007/s004010050412; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; LAUNER LJ, 1994, AM J EPIDEMIOL, V139, P803, DOI 10.1093/oxfordjournals.aje.a117077; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Skoog I, 1999, ALZ DIS ASSOC DIS, V13, pS106, DOI 10.1097/00002093-199912003-00016; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495	17	1147	1189	1	63	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2001	322	7300					1447	1451		10.1136/bmj.322.7300.1447	http://dx.doi.org/10.1136/bmj.322.7300.1447			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408299	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000169389200022
J	Rowbotham, DJ				Rowbotham, DJ			Endogenous opioids, placebo response, and pain	LANCET			English	Editorial Material							ANALGESIA; MORPHINE; RECEPTOR; PHARMACOKINETICS; NOCICEPTIN		Leicester Royal Infirm, Leicester Warwick Med Sch, Dept Anaesthesia & Pain Management, Leicester LE1 5WW, Leics, England	University of Leicester	Rowbotham, DJ (corresponding author), Leicester Royal Infirm, Leicester Warwick Med Sch, Dept Anaesthesia & Pain Management, Leicester LE1 5WW, Leics, England.							Amanzio M, 2001, PAIN, V90, P205, DOI 10.1016/S0304-3959(00)00486-3; BAILLIE SP, 1989, AGE AGEING, V18, P258, DOI 10.1093/ageing/18.4.258; Calo' G, 2000, BRIT J PHARMACOL, V129, P1183, DOI 10.1038/sj.bjp.0703169; Calo G, 2000, BRIT J PHARMACOL, V129, P1261, DOI 10.1038/sj.bjp.0703219; Darland T, 1998, TRENDS NEUROSCI, V21, P215, DOI 10.1016/S0166-2236(97)01204-6; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; GLARE PA, 1991, THER DRUG MONIT, V13, P1, DOI 10.1097/00007691-199101000-00001; Horvath G, 2000, PHARMACOL THERAPEUT, V88, P437, DOI 10.1016/S0163-7258(00)00100-5; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; Picard PR, 1997, PAIN, V72, P309, DOI 10.1016/S0304-3959(97)00040-7; PLEUVRY BJ, 1991, BRIT J ANAESTH, V66, P370, DOI 10.1093/bja/66.3.370; PORTENOY RK, 1990, PAIN, V43, P273, DOI 10.1016/0304-3959(90)90025-9; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Stein C, 1997, PAIN, V71, P119, DOI 10.1097/00006396-199706000-00001; ter Riet G, 1998, PAIN, V76, P273, DOI 10.1016/S0304-3959(98)00057-8; YAKSH TL, 1978, PAIN, V4, P299, DOI 10.1016/0304-3959(77)90145-2; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	19	15	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2001	357	9272					1901	1902		10.1016/S0140-6736(00)05090-X	http://dx.doi.org/10.1016/S0140-6736(00)05090-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444YZ	11425407				2022-12-01	WOS:000169431000005
J	Ford, WCL				Ford, WCL			Biological mechanisms of male infertility	LANCET			English	Editorial Material							VITAMIN-E; IN-VITRO; SPERMATOZOA; MOTILITY; MEN		St Michaels Hosp, Univ Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England		Ford, WCL (corresponding author), St Michaels Hosp, Univ Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England.	chris.ford@bristol.ac.uk						AITKEN RJ, 1991, AM J OBSTET GYNECOL, V164, P542, DOI 10.1016/S0002-9378(11)80017-7; Bronson RA, 1999, J REPROD IMMUNOL, V45, P159; De Kretser DM, 2000, INT J ANDROL, V23, P30; LILFORD R, 1994, BMJ-BRIT MED J, V309, P570, DOI 10.1136/bmj.309.6954.570; Mallidis KMC, 2000, EUR J ENDOCRINOL, V142, P418, DOI 10.1530/eje.0.1420418; Oosterhuis GJE, 2000, FERTIL STERIL, V74, P245, DOI 10.1016/S0015-0282(00)00623-3; Rolf C, 1999, HUM REPROD, V14, P1028, DOI 10.1093/humrep/14.4.1028; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586; Sharma RK, 1999, HUM REPROD, V14, P2801, DOI 10.1093/humrep/14.11.2801; Shetty J, 1999, BIOL REPROD, V61, P61, DOI 10.1095/biolreprod61.1.61; SUKCHAROEN N, 1995, FERTIL STERIL, V63, P1293, DOI 10.1016/S0015-0282(16)57614-6; Suleiman SA, 1996, J ANDROL, V17, P530; Tesarik J, 1999, FERTIL STERIL, V72, P809, DOI 10.1016/S0015-0282(99)00379-9	14	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1223	1224		10.1016/S0140-6736(00)04452-4	http://dx.doi.org/10.1016/S0140-6736(00)04452-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418145				2022-12-01	WOS:000168323300007
J	Horton, R				Horton, R			Euthanasia and assisted suicide: what does the Dutch vote mean?	LANCET			English	Editorial Material							OF-LIFE CARE; END		Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.							Asch DA, 1997, SOC SCI MED, V45, P1661, DOI 10.1016/S0277-9536(97)00125-1; Bolmsjo I, 2000, J PALLIAT CARE, V16, P20, DOI 10.1177/082585970001600204; Carron A T, 1999, Ann Intern Med, V130, P82; Dworkin R, 1997, NEW YORK REV BOOKS, V44, P41; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Ganzini L, 2000, NEW ENGL J MED, V343, P151; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; HORTON R, 2000, NEW YORK REV    0810, P30; Kohlwes RJ, 2001, ARCH INTERN MED, V161, P657, DOI 10.1001/archinte.161.5.657; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Rabow MW, 2000, JAMA-J AM MED ASSOC, V283, P771, DOI 10.1001/jama.283.6.771; Roscoe LA, 2000, NEW ENGL J MED, V343, P1735, DOI 10.1056/NEJM200012073432315; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; Weber W, 2001, LANCET, V357, P1189, DOI 10.1016/S0140-6736(00)04400-7	16	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2001	357	9264					1221	1222		10.1016/S0140-6736(00)04450-0	http://dx.doi.org/10.1016/S0140-6736(00)04450-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425YY	11418143				2022-12-01	WOS:000168323300005
J	Doyle, Y				Doyle, Y			Equity in the new NHS: hard lessons from implementing a local healthcare policy on donepezil	BRITISH MEDICAL JOURNAL			English	Article									Merton Sutton & Wandsworth Hlth Author, London, England		Doyle, Y (corresponding author), The Wilson, Surrey CR4 4TP, England.							BIRKS J, 2000, COCHRANE DATABASE SY; *DEP HLTH, 2000, NHS PLAN; Melzer D, 1998, BMJ-BRIT MED J, V316, P762, DOI 10.1136/bmj.316.7133.762; *NAT I CLIN EXC, 2001, DON RIV GAL TREATM; Rosen R, 1998, HEALTH POLICY, V43, P103, DOI 10.1016/S0168-8510(97)00091-2; *STAND MED ADV COM, 1998, US DON ALZH DIS; 1998, DRUG THER B, V36, P60	7	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					222	224		10.1136/bmj.323.7306.222	http://dx.doi.org/10.1136/bmj.323.7306.222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473920	Green Published			2022-12-01	WOS:000170270200024
J	Edlin, BR; Seal, KH; Lorvick, J; Kral, AH; Ciccarone, DH; Moore, LD; Lo, B				Edlin, BR; Seal, KH; Lorvick, J; Kral, AH; Ciccarone, DH; Moore, LD; Lo, B			Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIRECTLY OBSERVED THERAPY; INTERFERON-ALPHA; ADHERENCE; TUBERCULOSIS; PROPHYLAXIS; COMBINATION; INFECTION; EQUIPMENT; EXCHANGE; SYRINGE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Edlin, BR (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, 3180 18th St,Suite 302, San Francisco, CA 94110 USA.	bredlin@itsa.ucsf.edu	Edlin, Brian R/F-2966-2018; Ciccarone, Daniel/I-5404-2013	Edlin, Brian R/0000-0001-8172-8797; Ciccarone, Daniel/0000-0002-2355-5477; Kral, Alex/0000-0002-9092-3671; Lorvick, Jennifer/0000-0002-2836-3028	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013245] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1998, MMWR Recomm Rep, V47, P43; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Bamberger JD, 2000, AM J PUBLIC HEALTH, V90, P699, DOI 10.2105/AJPH.90.5.699; Bangsberg DR, 1999, J GEN INTERN MED, V14, P446, DOI 10.1046/j.1525-1497.1999.05109.x; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V7; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121; Burris S, 2000, ANN INTERN MED, V133, P218, DOI 10.7326/0003-4819-133-3-200008010-00015; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; *EASL, 1999, J HEPATOL S1, V31, P3; Gerstein D., 1990, TREATING DRUG PROBLE; Gostin Lawrence O., 1999, HLTH HUMAN RIGHTS RE, P54; Gourevitch MN, 1996, J ADDICT DIS, V15, P93, DOI 10.1300/J069v15n01_07; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; HARRISON K, 1995, J ACQ IMMUN DEF SYND, V10, P386; Haynes RB, 1979, COMPLIANCE HLTH CARE; JANSSEN HLA, 1994, J HEPATOL, V21, P241, DOI 10.1016/S0168-8278(05)80402-7; King VL, 1999, METHADONE TREATMENT FOR OPIOID DEPENDENCE, P141; Lerner BH, 1998, ANN INTERN MED, V129, P573, DOI 10.7326/0003-4819-129-7-199810010-00012; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lorvick J, 1999, J URBAN HEALTH, V76, P461, DOI 10.1007/BF02351503; Lorvick J, 2001, AM J PUBLIC HEALTH, V91, P46, DOI 10.2105/AJPH.91.1.46; Maddrey WC, 1999, SEMIN LIVER DIS, V19, P67; Marco A, 1998, EUR RESPIR J, V12, P967, DOI 10.1183/09031936.98.12040967; Marlatt GA., 2012, HARM REDUCTION PRAGM, V2nd; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; *NIH, 1997, MAN HAP C, V15; *NIH, 1997, INT PREV HIV RISK BE, V15; NORMAND J, 1995, PREVENTING HIV TRANS; OCONNOR PG, 1994, NEW ENGL J MED, V331, P450, DOI 10.1056/NEJM199408183310707; *PAN CLIN PRACT TR, 2001, GUID US ANT AG HIV I; Pariante CM, 1999, LANCET, V354, P131, DOI 10.1016/S0140-6736(98)04793-X; *PUBL HLTH SERV, 1997, HIV PREV B MED ADV P; Quin JW, 1997, AUST NZ J MED, V27, P611, DOI 10.1111/j.1445-5994.1997.tb00985.x; RENAULT PF, 1987, ARCH INTERN MED, V147, P1577, DOI 10.1001/archinte.147.9.1577; ROBERTSON R, 1998, MANAGEMENT DRUG USER; Salomon N, 1997, INT J TUBERC LUNG D, V1, P397; Smirnoff M, 1998, INT J TUBERC LUNG D, V2, P134; Sorensen JL, 1998, AIDS CARE, V10, P297, DOI 10.1080/713612419; SYLVESTRE DL, 2000, ELIMINATING HLTH DIS, P422; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P591; Van Thiel DH, 1998, HEPATO-GASTROENTEROL, V45, P328; WARTENBERG AA, 1991, J GEN INTERN MED, V6, pS35, DOI 10.1007/BF02599256; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; Williams I., 1999, AM J MED, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	50	172	172	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					211	214		10.1056/NEJM200107193450311	http://dx.doi.org/10.1056/NEJM200107193450311			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453JM	11463019	Green Accepted			2022-12-01	WOS:000169912800011
J	Giese, B; Amaudrut, J; Kohler, AK; Spormann, M; Wessely, S				Giese, B; Amaudrut, J; Kohler, AK; Spormann, M; Wessely, S			Direct observation of hole transfer through DNA by hopping between adenine bases and by tunnelling	NATURE			English	Article							RANGE ELECTRON-TRANSFER; DISTANCE DEPENDENCE; CHARGE-TRANSPORT; AQUEOUS-SOLUTION; MECHANISM; MOLECULES; MIGRATION; TRAP	The function of DNA during oxidative stress(1) and its suitability as a potential building block for molecular devices(2-4) depend on long-distance transfer of electrons and holes through the molecule, yet many conflicting measurements of the efficiency of this process have been reported(5,6). It is accepted that charges are transported over long distances through a multistep hopping reaction(7-11); this 'G-hopping'(8) involves positive charges moving between guanines (Gs), the DNA bases with the lowest ionization potential. But the mechanism fails to explain the persistence of efficient charge transfer when the guanine sites are distant(7,12), where transfer rates do not, as expected, decrease rapidly with transfer distance. Here we show experimentally that the rate of charge transfer between two guanine bases decreases with increasing separation only if the guanines are separated by no more than three base pairs; if more bridging base pairs are present, the transfer rates exhibit only a weak distance dependence. We attribute this distinct change in the distance dependence of the rate of charge transfer through DNA to a shift from coherent superexchange charge transfer (tunnelling) at short distances to a process mediated by thermally induced hopping of charges between adenine bases (A-hopping) at long distances. Our results confirm theoretical predictions of this behaviour(13-17), emphasizing that seemingly contradictory observations of a strong(8,9) as well as a weak(7,12) influence of distance on DNA charge transfer are readily explained by a change in the transfer mechanism.	Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Giese, B (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.			Amaudrut, Jerome/0000-0003-0498-4089				Berlin YA, 2001, J AM CHEM SOC, V123, P260, DOI 10.1021/ja001496n; FELTS AK, 1995, J PHYS CHEM-US, V99, P2929, DOI 10.1021/j100009a057; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b; Giese B, 2000, CHEMPHYSCHEM, V1, P195, DOI 10.1002/1439-7641(20001215)1:4<195::AID-CPHC195>3.0.CO;2-B; Giese B, 1999, ANGEW CHEM INT EDIT, V38, P996, DOI 10.1002/(SICI)1521-3773(19990401)38:7<996::AID-ANIE996>3.0.CO;2-4; Grozema FC, 2000, J AM CHEM SOC, V122, P10903, DOI 10.1021/ja001497f; Heller A, 2000, FARADAY DISCUSS, V116, P1, DOI 10.1039/b006196o; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Kasumov AY, 2001, SCIENCE, V291, P280, DOI 10.1126/science.291.5502.280; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673; MURPHY CJ, 1993, SCIENCE, V262, P1025, DOI 10.1126/science.7802858; Okada A, 1998, J PHYS CHEM A, V102, P1241, DOI 10.1021/jp972918r; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Saito I, 1998, J AM CHEM SOC, V120, P12686, DOI 10.1021/ja981888i; Schuster GB, 2000, ACCOUNTS CHEM RES, V33, P253, DOI 10.1021/ar980059z; Segal D, 2000, J PHYS CHEM B, V104, P3817, DOI 10.1021/jp993260f; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Williams TT, 2000, J AM CHEM SOC, V122, P9048, DOI 10.1021/ja001552k	21	712	725	8	149	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					318	320		10.1038/35085542	http://dx.doi.org/10.1038/35085542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460159				2022-12-01	WOS:000169918200042
J	Hale, P				Hale, P			Mission now possible for AIDS fund - Adequate support by the G8 countries is needed to defeat this global killer.	NATURE			English	Editorial Material									Fac Med Necker Enfants Malad, Inst Necker, F-75015 Paris, France; MRC S Africa, Congella, South Africa; Yale Univ, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ist Super Sanita, Int AIDS Soc, I-00161 Rome, Italy; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Pasteur, Paris, France; UCL, London WC1E 6BT, England	UDICE-French Research Universities; Universite Paris Cite; Yale University; Johns Hopkins University; University of California System; University of California San Diego; Istituto Superiore di Sanita (ISS); Makerere University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Hale, P (corresponding author), Fac Med Necker Enfants Malad, Inst Necker, 156 Rue Vaugirard, F-75015 Paris, France.		VELLA, STEFANO/V-8440-2019	VELLA, STEFANO/0000-0003-2347-5984	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, ZIAAI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Sachs JD, 2001, NAT MED, V7, P521, DOI 10.1038/87830; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876	2	6	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					271	272		10.1038/35085650	http://dx.doi.org/10.1038/35085650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460133				2022-12-01	WOS:000169918200019
J	Kim, M; Canio, W; Kessler, S; Sinha, N				Kim, M; Canio, W; Kessler, S; Sinha, N			Developmental changes due to long-distance movement of a homeobox fusion transcript in tomato	SCIENCE			English	Article							MESSENGER-RNA; VIRAL MOVEMENT; GENE; TRAFFICKING; PROTEIN; LEAF; PLASMODESMATA; LOCALIZATION; TRANSPORT; PLANTS	Long-distance movement of RNA through the phloem is known to occur, but the functional importance of these transported RNAs has remained unclear. Crafting experiments with a naturally occurring dominant gain-of-function Leaf mutation in tomato were used to demonstrate long-distance movement of mutant messenger RNA (mRNA) into wild-type scions. The stock-specific pattern of mRNA expression was graft transmissible, indicating that the mRNA accumulation pattern is inherent to the transcript and not attributable to the promoter. The translocated mRNA caused changes in Leaf morphology of the wild-type scions, suggesting that the translocated RNA is functional.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Sinha, N (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.		Kessler, Sharon A/T-4784-2017	Kessler, Sharon A/0000-0002-7964-0451; Sinha, Neelima/0000-0002-1494-7065				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Gisel A, 1999, DEVELOPMENT, V126, P1879; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kuehn Christina, 1997, Science (Washington D C), V275, P1298; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; LUCAS WJ, 1994, ANNU REV PHYTOPATHOL, V32, P387, DOI 10.1146/annurev.py.32.090194.002131; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	17	295	319	8	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					287	289		10.1126/science.1059805	http://dx.doi.org/10.1126/science.1059805			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452121				2022-12-01	WOS:000169875200055
J	Paris, F; Fuks, Z; Kang, A; Capodieci, P; Juan, G; Ehleiter, D; Haimovitz-Friedman, A; Cordon-Cardo, C; Kolesnick, R				Paris, F; Fuks, Z; Kang, A; Capodieci, P; Juan, G; Ehleiter, D; Haimovitz-Friedman, A; Cordon-Cardo, C; Kolesnick, R			Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice	SCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; STEM-CELL SURVIVAL; SPHINGOMYELINASE; IRRADIATION; EXPRESSION; TISSUES	Gastrointestinal (GI) tract damage by chemotherapy or radiation Limits their efficacy in cancer treatment. Radiation has been postulated to target epithelial stem cells within the crypts of Lieberkuhn to initiate the Lethal CII syndrome. Here, we show in mouse models that microvascular endothelial apoptosis is the primary Lesion Leading to stem cell dysfunction. Radiation-induced crypt damage, organ failure, and death from the CI syndrome were prevented when endothelial apoptosis was inhibited pharmacologically by intravenous basic fibroblast growth factor (bFGF) or genetically by deletion of the acid sphingomyelinase gene. Endothelial but not crypt, cells express FGF receptor transcripts, suggesting that the endothelial Lesion occurs before crypt stem cell damage in the evolution of the GI syndrome. This study provides a basis for new approaches to prevent radiation damage to the bowel.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	NCI NIH HHS [CA85704, CA52462] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Bronckers ALJJ, 2000, HISTOCHEM CELL BIOL, V113, P293, DOI 10.1007/s004180000137; Capodieci P, 1998, DIAGN MOL PATHOL, V7, P69, DOI 10.1097/00019606-199804000-00002; CORDONCARDO C, 1990, LAB INVEST, V63, P832; CORDONCARDO C, UNPUB; Dobrowsky RT, 2000, METHOD ENZYMOL, V311, P184; Fahimi HD, 1999, J HISTOCHEM CYTOCHEM, V47, P1219, DOI 10.1177/002215549904701001; FUKS Z, 1992, EUR J CANCER, V28A, P725, DOI 10.1016/0959-8049(92)90104-A; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Merritt Anita J., 1996, P269; Okunieff P, 1996, BRIT J CANCER, V74, pS105; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PARIS F, UNPUB; Pena LA, 2000, CANCER RES, V60, P321; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; [No title captured]	29	980	1035	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2001	293	5528					293	297		10.1126/science.1060191	http://dx.doi.org/10.1126/science.1060191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452123				2022-12-01	WOS:000169875200057
J	Bradstock, K				Bradstock, K			Wanderings of the bone-marrow stem cell	LANCET			English	Editorial Material							HEMATOPOIETIC PROGENITOR CELLS; CHEMOKINE SDF-1; PERIPHERAL-BLOOD; CD34(+) CELLS; MOBILIZATION; ENGRAFTMENT; MIGRATION		Westmead Hosp, Dept Haematol, Blood & Marrow Transplant Serv, Westmead, NSW 2145, Australia	University of Sydney	Bradstock, K (corresponding author), Westmead Hosp, Dept Haematol, Blood & Marrow Transplant Serv, Westmead, NSW 2145, Australia.	bradstok@icpmr.wsahs.nsw.gov.au						Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Gupta P, 1998, BLOOD, V91, P3724, DOI 10.1182/blood.V91.10.3724.3724_3724_3733; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Levesque JP, 2000, BLOOD, V96, p221A; LORD BI, 1975, BLOOD, V46, P65; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5	12	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2001	358	9275					5	6		10.1016/S0140-6736(00)05298-3	http://dx.doi.org/10.1016/S0140-6736(00)05298-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454366				2022-12-01	WOS:000169710900005
J	Dehnhardt, G; Mauck, B; Hanke, W; Bleckmann, H				Dehnhardt, G; Mauck, B; Hanke, W; Bleckmann, H			Hydrodynamic trail-following in harbor seals (Phoca vitulina)	SCIENCE			English	Article							FISH; WAKE	Marine mammals often forage in dark or turbid waters. Whereas dolphins use echolocation under such conditions, pinnipeds apparently lack this sensory ability. For seals hunting in the dark, one source of sensory information may consist of fish-generated water movements, which seals can detect with their highly sensitive whiskers. Water movements in the wake of fishes persist for several minutes. Here we show that blindfolded seals can use their whiskers to detect and accurately follow hydrodynamic trails generated by a miniature submarine. This shows that hydrodynamic information can be used for Long-distance prey location.	Univ Bonn, Inst Zool, D-53115 Bonn, Germany; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Bonn; Ruhr University Bochum	Dehnhardt, G (corresponding author), Univ Bonn, Inst Zool, Poppelsdorfer Schloss, D-53115 Bonn, Germany.							ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fluid.23.1.261; Au W. W., 1993, SONAR DOLPHINS; Bell W.J, 1991, SEARCHING BEHAV; BLECKMANN H, 1991, J COMP PHYSIOL A, V168, P749; Bleckmann H, 1994, RECEPTION HYDRODYNAM; BLICKHAN R, 1992, NATURWISSENSCHAFTEN, V79, P220, DOI 10.1007/BF01227131; COOMBS S, 1989, MECHANOSENSORY LATER; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Hanke W, 2000, J EXP BIOL, V203, P1193; Levenson DH, 1999, MAR MAMMAL SCI, V15, P1303, DOI 10.1111/j.1748-7692.1999.tb00892.x; Muller UK, 1997, J EXP BIOL, V200, P2893; Videler J. J, 1993, FISH SWIMMING, P1; Weissburg MJ, 1998, PHILOS T R SOC B, V353, P701, DOI 10.1098/rstb.1998.0236	14	233	240	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					102	104		10.1126/science.1060514	http://dx.doi.org/10.1126/science.1060514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441183				2022-12-01	WOS:000169780300038
J	Changela, A; DiGate, RJ; Mondragon, A				Changela, A; DiGate, RJ; Mondragon, A			Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule	NATURE			English	Article							PROTEIN; DOMAIN; IDENTIFICATION; RESIDUES; INSIGHTS; PROGRAM; BINDING; TOPRIM	A variety of cellular processes, including DNA replication, transcription, and chromosome condensation, require enzymes that can regulate the ensuing topological changes occurring in DNA. Such enzymes-DNA topoisomerases-alter DNA topology by catalysing the cleavage of single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA), the passage of DNA through the resulting break, and the rejoining of the broken phosphodiester backbone(1). DNA topoisomerase III from Escherichia coli belongs to the type IA family of DNA topoisomerases, which transiently cleave ssDNA via formation of a covalent 5' phosphotyrosine intermediate. Here we report the crystal structure, at 2.05 Angstrom resolution, of an inactive mutant of E. coli DNA topoisomerase III in a non-covalent complex with an 8-base ssDNA molecule. The enzyme undergoes a conformational change that allows the oligonucleotide to bind within a groove leading to the active site. We note that the ssDNA molecule adopts a conformation like that of B-DNA while bound to the enzyme. The position of the DNA within the realigned active site provides insight into the role of several highly conserved residues during catalysis. These findings confirm various aspects of the type IA topoisomerase mechanism while suggesting functional implications for other topoisomerases and proteins that perform DNA rearrangements.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Maryland, Sch Med, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Northwestern University; University System of Maryland; University of Maryland Baltimore	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051350] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051350] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen SJ, 1998, J BIOL CHEM, V273, P6050, DOI 10.1074/jbc.273.11.6050; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fass D, 1999, NAT STRUCT BIOL, V6, P322; Harp JM, 1998, ACTA CRYSTALLOGR D, V54, P622, DOI 10.1107/S0907444997019008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li ZY, 2000, MOL MICROBIOL, V35, P888, DOI 10.1046/j.1365-2958.2000.01763.x; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mondragon A, 1999, STRUCTURE, V7, P1373, DOI 10.1016/S0969-2126(00)80027-1; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Sherratt DJ, 1998, CELL, V93, P149, DOI 10.1016/S0092-8674(00)81566-4; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; ZHANG HL, 1994, J BIOL CHEM, V269, P9052; ZHANG HL, 1995, J BIOL CHEM, V270, P23700, DOI 10.1074/jbc.270.40.23700; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	30	89	91	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1077	1081		10.1038/35082615	http://dx.doi.org/10.1038/35082615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429611				2022-12-01	WOS:000169528500054
J	Ferrari, G; Stornaiuolo, A; Mavilio, F				Ferrari, G; Stornaiuolo, A; Mavilio, F			Bone-marrow transplantation - Failure to correct murine muscular dystrophy	NATURE			English	Article							MUSCLE		H San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; GeneEra SpA, I-20132 Milan, Italy; Univ Modena, Sch Med, Dept Biomed Sci, I-41100 Modena, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Universita di Modena e Reggio Emilia	Ferrari, G (corresponding author), H San Raffaele Telethon Inst Gene Therapy, Via Olgettina 58, I-20132 Milan, Italy.		Ferrari, Giuliana/AAB-5546-2019	Ferrari, Giuliana/0000-0003-0790-3133; Mavilio, Fulvio/0000-0003-0459-4320	Telethon [TGT00D01, TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919	5	124	133	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1014	1015		10.1038/35082631	http://dx.doi.org/10.1038/35082631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429592				2022-12-01	WOS:000169528500035
J	Fang, JY; Chen, AP; Peng, CH; Zhao, SQ; Ci, L				Fang, JY; Chen, AP; Peng, CH; Zhao, SQ; Ci, L			Changes in forest biomass carbon storage in China between 1949 and 1998	SCIENCE			English	Article							UNITED-STATES; BUDGET; CLIMATE; CO2	The Location and mechanisms responsible for the carbon sink in northern mid-latitude Lands are uncertain. Here, we used an improved estimation method of forest biomass and a 50-year national forest resource inventory in China to estimate changes in the storage of Living biomass between 1949 and 1998. Our results suggest that Chinese forests released about 0.68 petagram of carbon between 1949 and 1980, for an annual emission rate of 0.022 petagram of carbon. Carbon storage increased significantly after the Late 1970s from 4.38 to 4.75 petagram of carbon by 1998, for a mean accumulation rate of 0.021 petagram of carbon per year, mainly due to forest expansion and regrowth. Since the mid-1970s, planted forests (afforestation and reforestation) have sequestered 0.45 petagram of carbon, and their average carbon density increased from 15.3 to 31.1 megagrams per hectare, while natural forests have Lost an additional 0.14 petagram of carbon, suggesting that carbon sequestration through forest management practices addressed in the Kyoto Protocol could help offset industrial carbon dioxide emissions.	Peking Univ, Minist Educ, Dept Urban & Environm Sci, Beijing 100871, Peoples R China; Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; Minist Nat Resources, Ontario Forest Res Inst, Sault Ste Marie, ON P6A 2E5, Canada; Lakehead Univ, Fac Forestry & Forest Environm, Thunder Bay, ON P7B 5E1, Canada; Chinese Acad Forestry, Inst Forest Ecol & Environm, Beijing 100091, Peoples R China	Peking University; Peking University; Ministry of Natural Resources & Forestry; Natural Resources Canada; Lakehead University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Fang, JY (corresponding author), Peking Univ, Minist Educ, Dept Urban & Environm Sci, Beijing 100871, Peoples R China.	jyfang@urban.pku.edu.cn	Peng, Changhui/G-8248-2012; Fang, Jingyun/A-4282-2009; Chen, Anping/H-9960-2014	Chen, Anping/0000-0003-2085-3863				BIRDSEY RA, 1995, RM228 USDA FOR SERV, P1; BROWN S, 1992, INTERCIENCIA, V17, P8; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; *CHIN MIN FOR, 1965, FOR RES STAT CHIN PE; *DEP FOR RES MAN C, 1996, FOR RES CHIN 1949 93; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; FANG JY, 2000, FOREST BIOMASS DATAB, P1; FANG JY, 1996, STUDIES EMISSIONS TH, P81; Field CB, 1999, SCIENCE, V285, P544, DOI 10.1126/science.285.5427.544; *FOR MIN CHIN, 1983, TECHN STAND FOR RES; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P125, DOI 10.1046/j.1365-2699.2000.00166.x; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; LI WH, 1996, RES FOREST RESOURCE; Peng CH, 1997, TELLUS B, V49, P393, DOI 10.1034/j.1600-0889.49.issue4.5.x; Potter S. C., 1999, SCIENCE, V283; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHLAMADINGER B, 2000, SPECIAL REPORT IPCC, P127; Schroeder P, 1997, FOREST SCI, V43, P424; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Steffen W, 1998, SCIENCE, V280, P1393; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	27	1016	1753	105	1073	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2320	2322		10.1126/science.1058629	http://dx.doi.org/10.1126/science.1058629			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423660				2022-12-01	WOS:000169455900055
J	Pybus, OG; Charleston, MA; Gupta, S; Rambaut, A; Holmes, EC; Harvey, PH				Pybus, OG; Charleston, MA; Gupta, S; Rambaut, A; Holmes, EC; Harvey, PH			The epidemic behavior of the hepatitis C virus	SCIENCE			English	Article							MOLECULAR EPIDEMIOLOGY; RELATIVE PREVALENCE; POPULATION HISTORY; INFECTION; GENOTYPES; DIVERSITY; SUBTYPES; TRANSMISSION; RECIPIENTS; SEQUENCES	Hepatitis C virus (HCV) is a leading worldwide cause of liver disease. Here, we use a new model of HCV spread to investigate the epidemic behavior of the virus and to estimate its basic reproductive number from gene sequence data. We find significant differences in epidemic behavior among HCV subtypes and suggest that these differences are largely the result of subtype-specific transmission patterns. Our model builds a bridge between the disciplines of population genetics and mathematical epidemiology by using pathogen gene sequences to infer the population dynamic history of an infectious disease.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	oliver.pybus@zoo.ox.ac.uk	Holmes, Edward/GVR-9499-2022; Rambaut, Andrew/B-2481-2009; Charleston, Michael A/O-4903-2017; Pybus, Oliver G/B-2640-2012	Rambaut, Andrew/0000-0003-4337-3707; Charleston, Michael A/0000-0001-8385-341X; Pybus, Oliver G/0000-0002-8797-2667; Holmes, Edward/0000-0001-9596-3552				ANDERSON R M, 1991; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, pRR19; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FORNS X, 1998, VIRAL HEPAT REV, V4, P1; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Kao JH, 2000, J GASTROEN HEPATOL, V15, pE91, DOI 10.1046/j.1440-1746.2000.02108.x; Kimura Y, 2000, J MED VIROL, V61, P37, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;37::AID-JMV6&gt;3.0.CO;2-E; Kingman J.F.C., 1982, J APPL PROB A, V19A, P27, DOI [10.2307/3213548, DOI 10.2307/3213548]; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; NEE S, 1995, PHILOS T ROY SOC B, V349, P25, DOI 10.1098/rstb.1995.0087; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; POL S, 1995, GASTROENTEROLOGY, V108, P581, DOI 10.1016/0016-5085(95)90088-8; POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7; Prescott LE, 1997, J MED VIROL, V53, P237, DOI 10.1002/(SICI)1096-9071(199711)53:3<237::AID-JMV10>3.3.CO;2-P; Prescott LE, 1996, J MED VIROL, V50, P168, DOI 10.1002/(SICI)1096-9071(199610)50:2&lt;168::AID-JMV10&gt;3.0.CO;2-I; Pybus OG, 1999, MOL BIOL EVOL, V16, P953, DOI 10.1093/oxfordjournals.molbev.a026184; Pybus OG, 2000, GENETICS, V155, P1429; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Rosen HR, 1999, AM J GASTROENTEROL, V94, P3015, DOI 10.1111/j.1572-0241.1999.01456.x; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; SHERLOCK S, 1993, VIRAL HEPATITIS, P1; Shobokshi OA, 1999, J MED VIROL, V58, P44, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;44::AID-JMV6&gt;3.0.CO;2-U; SILINI E, 1995, J HEPATOL, V22, P691, DOI 10.1016/0168-8278(95)80225-8; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Smith DB, 1997, J MOL EVOL, V45, P238, DOI 10.1007/PL00006226; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P65; Wong DA, 1998, EUR J EPIDEMIOL, V14, P421, DOI 10.1023/A:1007400304726	36	336	344	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2323	2325		10.1126/science.1058321	http://dx.doi.org/10.1126/science.1058321			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423661				2022-12-01	WOS:000169455900056
J	Rausher, MD				Rausher, MD			Co-evolution and plant resistance to natural enemies	NATURE			English	Review							HESSIAN FLY DIPTERA; BACILLUS-THURINGIENSIS; ARABIDOPSIS-THALIANA; EVOLUTIONARY ECOLOGY; PLUTELLA-XYLOSTELLA; FIELD POPULATIONS; IPOMOEA-PURPUREA; TRANSGENIC CROPS; MORNING GLORY; RNA EVOLUTION	Co-evolution between plants and their natural enemies is generally believed to have generated much of the Earth's biological diversity. A process analogous to co-evolution occurs in agricultural systems, in which natural enemies adapt to crop resistance introduced by breeding or genetic engineering. Because of this similarity, the investigation of resistance mechanisms in crops is helping to elucidate the workings of co-evolution in nature, while evolutionary principles, including those derived from investigation of co-evolution in nature, are being applied in the management of resistance in genetically engineered crops.	Duke Univ, Dept Biol, Evolut Ecol & Organismal Biol Grp, Durham, NC 27708 USA	Duke University	Rausher, MD (corresponding author), Duke Univ, Dept Biol, Evolut Ecol & Organismal Biol Grp, Durham, NC 27708 USA.	mrausher@duke.edu						Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; BERENBAUM M, 1983, EVOLUTION, V37, P163, DOI [10.2307/2408184, 10.1111/j.1558-5646.1983.tb05524.x]; Berenbaum M.R., 1988, P113; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; BERGELSON J, 1994, AM NAT, V143, P349, DOI 10.1086/285607; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Biere A, 1996, EVOLUTION, V50, P1098, DOI [10.2307/2410650, 10.1111/j.1558-5646.1996.tb02350.x]; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; CARROLL SP, 1987, ANN ENTOMOL SOC AM, V80, P373, DOI 10.1093/aesa/80.3.373; CASTILLOCHAVEZ C, 1988, EVOLUTION, V42, P986, DOI [10.2307/2408914, 10.1111/j.1558-5646.1988.tb02517.x]; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; COX TS, 1986, ENVIRON ENTOMOL, V15, P24, DOI 10.1093/ee/15.1.24; DeWit PJGM, 1997, TRENDS PLANT SCI, V2, P452, DOI 10.1016/S1360-1385(97)01139-4; DUSSOURD DE, 1987, SCIENCE, V237, P898, DOI 10.1126/science.3616620; EGGERSSCHUMACHER HA, 1983, ENTOMOL EXP APPL, V34, P301, DOI 10.1007/BF00186930; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.1111/j.1558-5646.1964.tb01674.x; Eubanks MD, 1997, OECOLOGIA, V109, P454, DOI 10.1007/s004420050105; Ewald P.W., 1994, EVOLUTION INFECT DIS; Fagerstrom T, 1987, FUNCT ECOL, V1, P73, DOI 10.2307/2389708; Feeny Paul, 1992, P1; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; FISCHHOFF DA, 1992, P 1992 BELTW COTT PR, P751; Fischhoff David A., 1996, V15, P214; FOSTER JE, 1991, ENVIRON ENTOMOL, V20, P964, DOI 10.1093/ee/20.4.964; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FRY JD, 1990, AM NAT, V136, P569, DOI 10.1086/285116; FUTUYMA DJ, 1979, ECOL MONOGR, V49, P33, DOI 10.2307/1942571; GALLUN RL, 1977, ANN NY ACAD SCI, V287, P223, DOI 10.1111/j.1749-6632.1977.tb34241.x; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, AM SCI, V79, P496; Gould F., 1988, P13; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; HAMMA H, 1992, APPL ENTOMOL ZOOL, V27, P355; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hartl D. L., 1989, PRINCIPLES POPULATIO; HATCHETT JH, 1968, ANN ENTOMOL SOC AM, V61, P1446, DOI 10.1093/aesa/61.6.1446; HAUGHN GW, 1988, MOL GEN GENET, V211, P266, DOI 10.1007/BF00330603; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Heino M, 1998, CAN J FISH AQUAT SCI, V55, P1971, DOI 10.1139/cjfas-55-8-1971; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; International Conference on Harmonization, 1997, FED REG, V62, P27463; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; Jermy T., 1976, Symposia Biologica Hungarica, V16, P109; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Landweber LF, 1999, TRENDS ECOL EVOL, V14, P353, DOI 10.1016/S0169-5347(99)01680-8; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Li W.H., 1997, MOL EVOLUTION; Liu YB, 1997, P ROY SOC B-BIOL SCI, V264, P605, DOI 10.1098/rspb.1997.0086; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; MEFFE G. K., 1997, PRINCIPLES CONSERVAT; Meyers BC, 1998, PLANT CELL, V10, P1833, DOI 10.1105/tpc.10.11.1833; MULLER CH, 1969, SCIENCE, V164, P197, DOI 10.1126/science.164.3876.197; Murphy EJ, 1999, EVOL ECOL, V13, P517, DOI 10.1023/A:1006783902331; PAIGE KN, 1994, AM NAT, V143, P739, DOI 10.1086/285630; Painter RH, 1951, INSECT RESISTANCE CR; Parker JE, 1997, TRENDS BIOCHEM SCI, V22, P291, DOI 10.1016/S0968-0004(97)01089-X; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Perez CJ, 1997, J ECON ENTOMOL, V90, P1462, DOI 10.1093/jee/90.6.1462; PRYOR T, 1987, TRENDS GENET, V3, P157, DOI 10.1016/0168-9525(87)90217-4; Purrington CB, 1999, AM NAT, V154, pS82, DOI 10.1086/303285; RATHCKE BJ, 1975, SCIENCE, V187, P175, DOI 10.1126/science.187.4172.175; Rausher Mark D., 1993, P259; Rausher MD, 1996, TRENDS GENET, V12, P212, DOI 10.1016/0168-9525(96)10020-2; ROBINSON T, 1974, SCIENCE, V184, P430, DOI 10.1126/science.184.4135.430; ROSENTHAL GA, 1976, SCIENCE, V192, P256, DOI 10.1126/science.1257764; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Roush R. T., 1997, ADV INSECT CONTROL R, P271; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; ROUSH RT, 1982, J ECON ENTOMOL, V75, P708, DOI 10.1093/jee/75.4.708; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; SEIGLER D, 1976, AM NAT, V110, P101, DOI 10.1086/283050; SEIGLER DS, BIOCH SYSTEM ECOL, V5, P195; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Shirley BW, 1996, TRENDS PLANT SCI, V1, P377, DOI 10.1016/S1360-1385(96)80312-8; Shonle I, 2000, EVOLUTION, V54, P778, DOI 10.1111/j.0014-3820.2000.tb00079.x; Simms E. L., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P392; SIMMS EL, 1989, EVOLUTION, V43, P573, DOI 10.1111/j.1558-5646.1989.tb04253.x; SIMMS EL, 1987, AM NAT, V130, P70; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strong D.R., 1984, COMMUNITY PATTERNS M; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; Thompson J.N., 1982, INTERACTION COEVOLUT; Thompson J.N., 1994, COEVOLUTIONARY PROCE; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; Van EMDEN H. F., 1966, WORLD REV PEST CONTR, V5, P115; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; Wood R. J., 1981, GENETIC CONSEQUENCES, P53; 1999, BIOSYSTEMS, V52; [No title captured]	103	311	350	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					857	864		10.1038/35081193	http://dx.doi.org/10.1038/35081193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459070				2022-12-01	WOS:000169246400064
J	Todd, WTA				Todd, WTA			Prospects for the prevention of haemolytic-uraemic syndrome	LANCET			English	Editorial Material							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI O157-H7; INFECTIONS; ANTIBODIES; STOOLS; TOXIN		Monklands Hosp, Lanarkshire Area Infect Dis Unit, Airdale ML6 0JS, Lanark, Scotland	Monklands Hospital	Todd, WTA (corresponding author), Monklands Hosp, Lanarkshire Area Infect Dis Unit, Airdale ML6 0JS, Lanark, Scotland.							CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; FITZPATRICK MM, 1991, BMJ-BRIT MED J, V303, P489, DOI 10.1136/bmj.303.6801.489; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kimmitt PT, 1999, LANCET, V353, P1588, DOI 10.1016/S0140-6736(99)00621-2; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Louie M, 1998, J CLIN MICROBIOL, V36, P3375, DOI 10.1128/JCM.36.11.3375-3377.1998; Manjarrez-Hernandez HA, 2000, INFECT IMMUN, V68, P5030, DOI 10.1128/IAI.68.9.5030-5036.2000; Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549; MONNENS L, 2000, INT S WORKSH SHIG TO; Nakao H, 1999, INFECT IMMUN, V67, P5717, DOI 10.1128/IAI.67.11.5717-5722.1999; Obrig Tom G., 1997, Frontiers in Bioscience, V2, pD635; PROULX F, 1992, J PEDIATR-US, V121, P299, DOI 10.1016/S0022-3476(05)81209-0; Takeda T, 1998, ESCHERICHIA COLI O15, P385; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2001	357	9269					1636	1638		10.1016/S0140-6736(00)04859-5	http://dx.doi.org/10.1016/S0140-6736(00)04859-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425363				2022-12-01	WOS:000168901600004
J	King, SL				King, SL			The most primitive sense	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					766	766		10.1001/jama.286.7.766	http://dx.doi.org/10.1001/jama.286.7.766			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497512				2022-12-01	WOS:000170429600001
J	Harrison, LH; Pass, MA; Mendelsohn, AB; Egri, M; Rosenstein, NE; Bustamante, A; Razeq, J; Roche, JC				Harrison, LH; Pass, MA; Mendelsohn, AB; Egri, M; Rosenstein, NE; Bustamante, A; Razeq, J; Roche, JC			Invasive meningococcal disease in adolescents and young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; UNITED-STATES; VACCINE; PREVENTION; INFECTION; RISK	Context Incidence of invasive meningococcal disease has increased recently in persons aged 15 through 24 years. Objective To characterize meningococcal infection in adolescents and young adults in Maryland during the 1990s. Design and Setting Population-based surveillance study for meningococcal disease from January 1, 1990, through December 31, 1999, in Maryland. Patients Maryland residents diagnosed as having invasive meningococcal disease. Main Outcome Measure Invasive meningococcal infection. Results Of 295 total cases, 71 (24.1%) occurred among persons aged 15 through 24 years. Sixteen (22.5%) of these cases were fatal. The annual incidence rate increased from 0.9 to 2.1 cases per 100000 among 15 through 24 year olds (P=.01). The proportion of all disease increased from 16.0% to 28.9% (P=.03). The incidence and proportion of cases subsequently decreased to 1.0 and 16.4% in 1998 through 1999, respectively. Infection in 15 through 24 year olds was more likely to be fatal than infection in those younger than age 15 years (22.5% vs 4.6%; P=.001). Infection in 15 through 24 year olds, compared with those aged 25 years or older, was more likely to be associated with male sex (66.2% vs 34.8%; P<.001) and serogroup C infection (46.9% vs 20.2%; P<.001), respectively. Infections were potentially preventable with the licensed meningococcal vaccine in 82.8% of 15 through 24 year olds, 68.1% of those younger than 15 years, and 76.8% of adults aged 25 years or older. Conclusions Incidence of meningococcal infection in 15 through 24 year olds in Maryland increased and then declined during the 1990s. Infection in this age group was associated with an unusually high case-fatality ratio, and the vast majority of cases were potentially vaccine preventable.	Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Ctr Dis Control & Prevent, Meningitis & Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA USA; Maryland Dept Hlth & Mental Hyg, Labs Adm, Baltimore, MD USA; Maryland Dept Hlth & Mental Hyg, Epidemiol & Dis Control Program, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Maryland Department of Health & Mental Hygiene	Harrison, LH (corresponding author), Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, 521 Parran Hall,130 DeSoto St, Pittsburgh, PA 15261 USA.	lharriso@edc.gsph.pitt.edu		Mendelsohn, Aaron/0000-0002-0560-1177				Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P13; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P229; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; Barquet N, 1999, ARCH INTERN MED, V159, P2329, DOI 10.1001/archinte.159.19.2329; Carrol ED, 2000, ARCH DIS CHILD, V83, P271, DOI 10.1136/adc.83.3.271; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; FINN R, IN PRESS SO MED J; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; FISCHER M, 1998, 36 ANN M INF DIS SOC; Froeschle JE, 1999, CLIN INFECT DIS, V29, P215, DOI 10.1086/520166; GOLD R, 1971, B WORLD HEALTH ORGAN, V45, P279; HARRISON LH, 1995, JAMA-J AM MED ASSOC, V273, P419, DOI 10.1001/jama.273.5.419; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HARRISON LH, 1987, EVOLUTION MENINGOCOC, V1, P27; HUDSON PJ, 1986, PEDIATR INFECT DIS J, V5, P213, DOI 10.1097/00006454-198603000-00011; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Knapp JS, 1999, MANUAL CLIN MICROBIO, P586; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; PELTOLA H, 1982, LANCET, V2, P595; Rosenstein N, 1998, JAMA-J AM MED ASSOC, V279, P435, DOI 10.1001/jama.279.6.435; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; SAEZNIETO JA, 1982, J HYG-CAMBRIDGE, V89, P139, DOI 10.1017/S0022172400070637; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; WOODS CW, 1998, 36 ANN M INF DIS SOC; 2001, FACT SHEET YOUTH RIS; 2000, MOR MORTAL WKLY REP, V49, P1	36	99	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					694	699		10.1001/jama.286.6.694	http://dx.doi.org/10.1001/jama.286.6.694			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495619	Bronze			2022-12-01	WOS:000170271500025
J	Temple, LKF; McLeod, RS; Gallinger, S; Wright, JG				Temple, LKF; McLeod, RS; Gallinger, S; Wright, JG			Defining disease in the genomics era	SCIENCE			English	Editorial Material									Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON M5G 1X5, Canada; Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Publ Hlth Sci, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Temple, LKF (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON M5G 1X5, Canada.		McLeod, Robin/K-1476-2013; Gallinger, Steven/E-4575-2013						0	50	51	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					807	808		10.1126/science.1062938	http://dx.doi.org/10.1126/science.1062938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486074				2022-12-01	WOS:000170241000026
J	Rexrode, KM; Buring, JE; Glynn, RJ; Stampfer, MJ; Youngman, LD; Gaziano, JM				Rexrode, KM; Buring, JE; Glynn, RJ; Stampfer, MJ; Youngman, LD; Gaziano, JM			Analgesic use and renal function in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NONNARCOTIC ANALGESICS; COLORECTAL-CANCER; FAILURE; DISEASE; RISK; ASPIRIN; ACETAMINOPHEN; ABUSE	Context Several case-control studies suggest an association between analgesic use and increased risk of chronic renal disease, but few cohort studies have examined this association. Objective To determine whether analgesic use is associated with risk of renal dysfunction. Design and Setting Cohort study of analgesic use data from the Physicians' Health Study, which lasted 14 years from September 1982 to December 1995 with annual follow-up. Participants A total of 11 032 initially healthy men who provided blood samples and self-report of analgesic use. Main Outcome Measures Elevated creatinine level defined as 1.5 mg/dL (133 mu mol/L) or higher and a reduced creatinine clearance defined as 55 mL/min (0.9 mL/s) or less, and self-reported use of acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (never [<12 pills]; 12-1499 pills; 1500-2499 pills; and <greater than or equal to>2500 pills). Results PI total of 460 men had elevated creatinine levels (4.2%) and 1258 had reduced creatinine clearance (11.4%). Mean creatinine levels and creatinine clearances were similar among men who did not use analgesics and those who did, even at total intakes of 2500 or more pills. In multivariable analyses adjusted for age; body mass index; history of hypertension, elevated cholesterol, and diabetes; occurrence of cardiovascular disease; physical activity; and use of other analgesics, the relative risks of elevated creatinine level associated with intake of 2500 or more pills were 0.83 (95% confidence interval [CI], 0.50-1.39, P for trend =.05) for acetaminophen, 0.98 (95% CI, 0.53-1.81; P for trend =.96) for aspirin, and 1.07 (95% CI, 0.71-1.64; P for trend =.86) for other nonsteroidal anti-inflammatory drugs. Ho association was observed be tween analgesic use and reduced creatinine clearance. Conclusions Moderate analgesic use in this cohort study of initially healthy men was not associated with increased risk of renal dysfunction.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; US FDA, Res Off, Laurel, MD USA; Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, Channing Lab, 900 Commonwealth Ave, Boston, MA 02215 USA.		Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429	NCI NIH HHS [CA-40360, CA-34944] Funding Source: Medline; NHLBI NIH HHS [HL-26490, HL-34595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAKELY P, 1995, J AM SOC NEPHROL, V6, P48; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAgati V, 1996, AM J KIDNEY DIS, V28, pS24, DOI 10.1016/S0272-6386(96)90565-X; Delzell E, 1998, MEDICINE, V77, P102, DOI 10.1097/00005792-199803000-00003; DUBACH UC, 1991, NEW ENGL J MED, V324, P155, DOI 10.1056/NEJM199101173240304; ELSEVIERS MM, 1995, KIDNEY INT, V48, P1912, DOI 10.1038/ki.1995.491; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; Gutthann SP, 1996, ARCH INTERN MED, V156, P2433, DOI 10.1001/archinte.1996.00440200041005; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; MCCREDIE M, 1988, NEPHRON, V49, P26; McLaughlin JK, 1998, KIDNEY INT, V54, P679, DOI 10.1046/j.1523-1755.1998.00043.x; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; POMMER W, 1989, AM J NEPHROL, V9, P403, DOI 10.1159/000168002; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SANDLER DP, 1991, ANN INTERN MED, V115, P165, DOI 10.7326/0003-4819-115-3-165; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; SPUHLER O, 1953, Z KLIN MED, V151, P1; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; YOUNGMAN LD, 1993, FASEB J, V1, P377; 1988, N ENGL J MED, V318, P262; 1983, FED REG         1005, V48, P45466	27	78	80	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					315	321		10.1001/jama.286.3.315	http://dx.doi.org/10.1001/jama.286.3.315			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466097	Bronze			2022-12-01	WOS:000169869200022
J	Chan, SY; Empig, CJ; Welte, FJ; Speck, RF; Schmaljohn, A; Kreisberg, JF; Goldsmith, MA				Chan, SY; Empig, CJ; Welte, FJ; Speck, RF; Schmaljohn, A; Kreisberg, JF; Goldsmith, MA			Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses	CELL			English	Article							BINDING-PROTEIN; GLYCOPROTEIN; MEMBRANE; IDENTIFICATION; SEQUESTRATION; INFECTIONS	Human infections by Marburg (MBG) and Ebola (EBO) viruses result in lethal hemorrhagic fever. To identify cellular entry factors employed by MBG virus, noninfectible cells transduced with an expression library were challenged with a selectable pseudotype virus packaged by MBG glycoproteins (GP). A cDNA encoding the folate receptor-alpha (FR-alpha) was recovered from cells exhibiting reconstitution of viral entry. A FR-alpha cDNA was recovered in a similar strategy employing EBO pseudotypes. FR-alpha expression in Jurkat cells facilitated MBG or EBO entry, and FR-blocking reagents inhibited infection by MBG or EBO. Finally, FR-alpha bound cells expressing MBG or EBO GP and mediated syncytia formation triggered by MBG GP. Thus, FR-alpha is a significant cofactor for cellular entry for MBG and EBO viruses.	Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94141 USA; USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Goldsmith, MA (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	mgoldsmith@gladstone.ucsf.edu	Speck, Roberto F/O-2433-2016	Kreisberg, Jason/0000-0002-3616-079X; Speck, Roberto/0000-0002-8453-1137				Allan VJ, 2000, PRACT APPROACH SER, V218, P1; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Chan SY, 2000, J VIROL, V74, P4933, DOI 10.1128/JVI.74.10.4933-4937.2000; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Da Costa M, 2000, AM J PHYSIOL-CELL PH, V278, pC812, DOI 10.1152/ajpcell.2000.278.4.C812; FRA AM, 1994, J BIOL CHEM, V269, P30745; FRANKLIN WA, 1994, INT J CANCER, P89; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; Hevey M, 1997, VIROLOGY, V239, P206, DOI 10.1006/viro.1997.8883; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Maziarz KM, 1999, J BIOL CHEM, V274, P11086, DOI 10.1074/jbc.274.16.11086; Peters C.J., 1996, FIELDS VIROLOGY, P1161; Rijnboutt S, 1996, J CELL BIOL, V132, P35, DOI 10.1083/jcb.132.1.35; Ross JF, 1999, CANCER-AM CANCER SOC, V85, P348, DOI 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; SCHMALJOHN AL, 1995, VIROLOGY, V206, P963, DOI 10.1006/viro.1995.1019; SVENDSEN IB, 1982, CARLSBERG RES COMMUN, V47, P371, DOI 10.1007/BF02907775; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; VEY M, 1992, VIROLOGY, V188, P408, DOI 10.1016/0042-6822(92)90775-K; Villanueva J, 1998, AM J PHYSIOL-REG I, V275, pR1503, DOI 10.1152/ajpregu.1998.275.5.R1503; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WEITMAN SD, 1992, CANCER RES, V52, P3396; WEITMAN SD, 1992, CANCER RES, V52, P6708; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	40	165	178	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					117	126		10.1016/S0092-8674(01)00418-4	http://dx.doi.org/10.1016/S0092-8674(01)00418-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461707	Bronze			2022-12-01	WOS:000169870300014
J	Reddien, PW; Cameron, S; Horvitz, HR				Reddien, PW; Cameron, S; Horvitz, HR			Phagocytosis promotes programmed cell death in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; PROTEIN CED-9; GENE; ENGULFMENT; ENCODES; NEMATODE; MACROPHAGES; ACTIVATION; MIGRATION	In the nematode Caenorhabditis elegans programmed cell death requires the killer genes egl-1, ced-4 and ced-3 (refs 1 and 2), and the engulfment of dying cells requires the genes ced-1, ced-2, ced-5, ced-6, ced-7, ced-10 and ced-12 (refs 3-5). Here we show that engulfment promotes programmed cell death. Mutations that cause partial loss of function of killer genes allow the survival of some cells that are programmed to die, and mutations in engulfment genes enhance the frequency of this cell survival. Furthermore, mutations in engulfment genes alone allow the survival and differentiation of some cells that would normally die. Engulfment genes probably act in engulfing cells to promote death, as the expression in engulfing cells of ced-1, which encodes a receptor that recognizes cell corpses(6), rescues the cell-killing defects of ced-1 mutants. We propose that engulfing cells act to ensure that cells triggered to undergo programmed cell death by the CED-3 caspase(7) die rather than recover after the initial stages of death.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 68-425,77 Massachusetts Ave, Cambridge, MA 02139 USA.							Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CLARK SG, 1994, GENETICS, V137, P987; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LITTLE GH, 1993, COMP BIOCHEM PHYS A, V105, P79, DOI 10.1016/0300-9629(93)90176-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	30	268	285	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					198	202		10.1038/35084096	http://dx.doi.org/10.1038/35084096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449278				2022-12-01	WOS:000169778700056
J	Herbert, TD; Schuffert, JD; Andreasen, D; Heusser, L; Lyle, M; Mix, A; Ravelo, AC; Stott, LD; Herguera, JC				Herbert, TD; Schuffert, JD; Andreasen, D; Heusser, L; Lyle, M; Mix, A; Ravelo, AC; Stott, LD; Herguera, JC			Collapse of the California Current during glacial maxima linked to climate change on land	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; DEVILS-HOLE; PACIFIC-OCEAN; ATLANTIC; RECORD; CALIBRATION; INDICATORS; BARBADOS; CALCITE; MARGIN	Time series of alkenone unsaturation indices gathered along the California margin reveal Large (4 degrees to 8 degreesC) glacial-interglacial changes in sea surface temperature (SST) over the past 550,000 years. Interglacial times with SSTs equal to or exceeding that of the Holocene contain peak abundances in the pollen of redwood, the distinctive component of the temperate rainforest of the northwest coast of California. In the region now dominated by the California Current, SSTs warmed 10,000 to 15,000 years in advance of deglaciation at each of the past five glacial maxima. SSTs did not rise in advance of deglaciation south of the modern California Current front. Glacial warming along the California margin therefore is a regional signal of the weakening of the California Current during times when large ice sheets reorganized wind systems over the North Pacific. Both the timing and magnitude of the SST estimates suggest that the Devils Hole (Nevada) calcite record represents regional but not global paleotemperatures, and hence does not pose a fundamental challenge to the orbital ("Milankovitch") theory of the Ice Ages.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Boise State Univ, Ctr Geophys Invest Shallow Subsurface, Boise, ID 83725 USA; Oregon State Univ, Corvallis, OR 97331 USA; Univ So Calif, Los Angeles, CA 90089 USA; Ctr Invest Cient & Educ Super Ensenada, Ensenada 22860, Baja California, Mexico	Brown University; University of California System; University of California Santa Cruz; Columbia University; Idaho; Boise State University; Oregon State University; University of Southern California; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Herbert, TD (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Herguera, Juan Carlos/B-7812-2016	Herguera, Juan Carlos/0000-0001-8335-2607; Ravelo, Ana Christina/0000-0003-3929-677X				BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BENSON LV, 1990, PALAEOGEOGR PALAEOCL, V78, P241, DOI 10.1016/0031-0182(90)90217-U; CROWLEY TJ, 1994, PALEOCEANOGRAPHY, V9, P1, DOI 10.1029/93PA02558; Dean WE, 1997, GEOCHIM COSMOCHIM AC, V61, P4507, DOI 10.1016/S0016-7037(97)00237-8; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; ELY LL, 1994, J CLIMATE, V7, P977, DOI 10.1175/1520-0442(1994)007<0977:ANPACA>2.0.CO;2; EMERY WJ, 1985, J GEOPHYS RES-OCEANS, V90, P857, DOI 10.1029/JC090iC01p00857; FAIRBANKS RG, 1978, QUATERNARY RES, V10, P181, DOI 10.1016/0033-5894(78)90100-X; GRIGGS GB, 1969, J SEDIMENT PETROL, V39, P1142; Grootes P. M., 1993, CLIMATE CHANGE CONTI, V78, P37; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Herbert T.D., 1995, PROC OCEAN DRILL SCI, V146, P257; Herbert TD, 1998, PALEOCEANOGRAPHY, V13, P263, DOI 10.1029/98PA00069; Heusser L.E., 1995, PROC OCEAN DRILL SCI, V146, P265; HEUSSER LE, 1979, SCIENCE, V204, P837, DOI 10.1126/science.204.4395.837; HEUSSER LE, 2000, P OC DRILL PROGR SCI, V167, P217; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; IMBRIE J, 1993, NATURE, V363, P531, DOI 10.1038/363531a0; Imbrie J., 1984, MILANKOVITCH CLIMA 1, P269; Kennett James P., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V146, P281; KENT D, 1971, GEOL SOC AM BULL, V82, P2741, DOI 10.1130/0016-7606(1971)82[2741:CCITNP]2.0.CO;2; KUTZBACH JE, 1985, QUATERNARY SCI REV, V4, P147, DOI 10.1016/0277-3791(85)90024-1; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; LYLE M, UNPUB; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Mortyn PG, 1996, PALEOCEANOGRAPHY, V11, P415, DOI 10.1029/96PA01236; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Ortiz J, 1997, PALEOCEANOGRAPHY, V12, P191, DOI 10.1029/96PA03165; PISIAS NG, IN PRESS QUAT SCI RE; PRAHL FG, 1995, PALEOCEANOGRAPHY, V10, P763, DOI 10.1029/95PA01394; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Reimers CE, 1992, GLOBAL BIOGEOCHEM CY, V6, P199, DOI 10.1029/92GB00105; ROSANSKI KL, 1993, CLIMAT CHANGE CONTIN, P1; RUDDIMAN WF, 1984, GEOL SOC AM BULL, V95, P381, DOI 10.1130/0016-7606(1984)95<381:ITRACR>2.0.CO;2; Sabin AL, 1996, QUATERNARY RES, V46, P48, DOI 10.1006/qres.1996.0043; SANCETTA C, 1992, QUATERNARY RES, V38, P359, DOI 10.1016/0033-5894(92)90044-J; Schneider R.R., 1995, S ATLANTIC PRESENT P, P527; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Schuffert JD, 1998, MAR GEOL, V146, P21, DOI 10.1016/S0025-3227(97)00122-9; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; SIMPSON JJ, 1983, GEOPHYS RES LETT, V10, P937, DOI 10.1029/GL010i010p00937; Stott LD, 2000, PALEOCEANOGRAPHY, V15, P161, DOI 10.1029/1999PA000375; THOMPSON PR, 1980, NATURE, V287, P829, DOI 10.1038/287829a0; Villanueva J, 1998, GEOCHIM COSMOCHIM AC, V62, P2421, DOI 10.1016/S0016-7037(98)00180-X; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; WINOGRAD IJ, 1996, EOS T AM GEOPHYS UN, V77, pS169	49	216	223	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					71	76		10.1126/science.1059209	http://dx.doi.org/10.1126/science.1059209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441174				2022-12-01	WOS:000169780300029
J	Lydon-Rochelle, M; Holt, VL; Easterling, TR; Martin, DP				Lydon-Rochelle, M; Holt, VL; Easterling, TR; Martin, DP			Risk of uterine rupture during labor among women with a prior cesarean delivery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VAGINAL BIRTH; TRIAL; MISOPROSTOL; SECTION	Background: Each year in the United States, approximately 60 percent of women with a prior cesarean delivery who become pregnant again attempt labor. Concern persists that a trial of labor may increase the risk of uterine rupture, an uncommon but serious obstetrical complication. Methods: We conducted a population-based, retrospective cohort analysis using data from all primiparous women who gave birth to live singleton infants by cesarean section in civilian hospitals in Washington State from 1987 through 1996 and who delivered a second singleton child during the same period (a total of 20,095 women). We assessed the risk of uterine rupture for deliveries with spontaneous onset of labor, those with labor induced by prostaglandins, and those in which labor was induced by other means; these three groups of deliveries were compared with repeated cesarean delivery without labor. Results: Uterine rupture occurred at a rate of 1.6 per 1000 among women with repeated cesarean delivery without labor (11 women), 5.2 per 1000 among women with spontaneous onset of labor (56 women), 7.7 per 1000 among women whose labor was induced without prostaglandins (15 women), and 24.5 per 1000 among women with prostaglandin-induced labor (9 women). As compared with the risk in women with repeated cesarean delivery without labor, uterine rupture was more likely among women with spontaneous onset of labor (relative risk, 3.3; 95 percent confidence interval, 1.8 to 6.0), induction of labor without prostaglandins (relative risk, 4.9; 95 percent confidence interval, 2.4 to 9.7), and induction with prostaglandins (relative risk, 15.6; 95 percent confidence interval, 8.1 to 30.0). Conclusions: For women with one prior cesarean delivery, the risk of uterine rupture is higher among those whose labor is induced than among those with repeated cesarean delivery without labor. Labor induced with a prostaglandin confers the highest risk. (N Engl J Med 2001;345:3-8.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Washington, Ctr Womens Hlth Res, Dept Family & Child Nursing, Sch Nursing, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lydon-Rochelle, M (corresponding author), Univ Washington, Ctr Womens Hlth Res, Dept Family & Child Nursing, Sch Nursing, Mailstop 357262, Seattle, WA 98195 USA.				AHRQ HHS [5 T32 HS00034] Funding Source: Medline; NINR NIH HHS [T32 NR07039] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR007039] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		*AM COLL OBST GYN, 1999, 228 ACOG, P1; Caughey AB, 1999, AM J OBSTET GYNECOL, V181, P872, DOI 10.1016/S0002-9378(99)70317-0; FLAMM BL, 1994, OBSTET GYNECOL, V83, P927, DOI 10.1097/00006250-199406000-00005; Gregory KD, 1999, OBSTET GYNECOL, V94, P985, DOI 10.1016/S0029-7844(99)00422-6; LEUNG AS, 1993, AM J OBSTET GYNECOL, V169, P945, DOI 10.1016/0002-9378(93)90032-E; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; PARRISH KM, 1993, AM J EPIDEMIOL, V138, P119, DOI 10.1093/oxfordjournals.aje.a116834; Plaut MM, 1999, AM J OBSTET GYNECOL, V180, P1535, DOI 10.1016/S0002-9378(99)70049-9; Rageth JC, 1999, OBSTET GYNECOL, V93, P332, DOI 10.1016/S0029-7844(98)00446-3; Raskin KS, 1999, J REPROD MED, V44, P571; SAS Institute, 1990, SAS STAT US GUID VER; Stalnaker BL, 1997, AM J OBSTET GYNECOL, V177, P268, DOI 10.1016/S0002-9378(97)70186-8; VENTURA SJ, 2000, NATL VITAL STAT REP, V48, P13; Wing DA, 1998, OBSTET GYNECOL, V91, P828, DOI 10.1016/S0029-7844(97)00553-X; 1998, ICD 9 CM, V1	15	566	593	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2001	345	1					3	8		10.1056/NEJM200107053450101	http://dx.doi.org/10.1056/NEJM200107053450101			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449QJ	11439945	Bronze			2022-12-01	WOS:000169697600001
J	Imai, Y; Soda, M; Inoue, H; Hattori, N; Mizuno, Y; Takahashi, R				Imai, Y; Soda, M; Inoue, H; Hattori, N; Mizuno, Y; Takahashi, R			An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; RECESSIVE JUVENILE PARKINSONISM; ALPHA-SYNUCLEIN; LEWY BODIES; DEGRADATION; DISEASE; ER; RECEPTOR; AGGREGATION; PROTEASOME	A putative G protein-coupled transmembrane polypeptide, named Pael receptor, was identified as an interacting protein with Parkin, a gene product responsible for autosomal recessive juvenile Parkinsonism (AR-JP). When overexpressed in cells, this receptor tends to become unfolded, insoluble, and ubiquitinated in vivo. The insoluble Pael receptor leads to unfolded protein-induced cell death. Parkin specifically ubiquitinates this receptor in the presence of ubiquitin-conjugating enzymes resident in the endoplasmic reticulum and promotes the degradation of insoluble Pael receptor, resulting in suppression of the cell death induced by Pael receptor overexpression. Moreover, the insoluble form of Pael receptor accumulates in the brains of AR-JP patients. Here, we show that the unfolded Pael receptor is a substrate of Parkin, the accumulation of which may cause selective neuronal death in AR-JP.	RIKEN, BSI, Lab Motor Syst Neurodegenerat, Saitama 3510198, Japan; Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; Juntendo University	Takahashi, R (corresponding author), RIKEN, BSI, Lab Motor Syst Neurodegenerat, Saitama 3510198, Japan.		Hattori, Nobutaka/ACR-0069-2022; Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Inoue, Haruhisa/0000-0003-4736-9537				Baba M, 1998, AM J PATHOL, V152, P879; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Donohue PJ, 1998, MOL BRAIN RES, V54, P152, DOI 10.1016/S0169-328X(97)00336-7; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Mizuno Y, 1998, J NEUROCHEM, V71, P893; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valdenaire O, 1998, FEBS LETT, V424, P193, DOI 10.1016/S0014-5793(98)00170-7; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V233, P559, DOI 10.1006/bbrc.1997.6408; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zuscik MJ, 2000, NAT MED, V6, P1388, DOI 10.1038/82207	40	851	899	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					891	902		10.1016/S0092-8674(01)00407-X	http://dx.doi.org/10.1016/S0092-8674(01)00407-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439185	Bronze			2022-12-01	WOS:000169664300009
J	Lee, SH; Oe, T; Blair, IA				Lee, SH; Oe, T; Blair, IA			Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins	SCIENCE			English	Article							DNA-ADDUCTS; IN-VIVO; PEROXIDATION; PRODUCT; DAMAGE; ACID; SUBSTRATE; ASCORBATE; APOPTOSIS; RADICALS	Epidemiological data suggest that dietary antioxidants play a protective role against cancer. This has led to the proposal that dietary supplementation with antioxidants such as vitamin C (vit C) may be useful in disease prevention. However, vit C has proved to be ineffective in cancer chemoprevention studies. In addition, concerns have been raised over potentially deleterious transition metal ion-mediated pro-oxidant effects. We have now determined that vit C induces lipid hydroperoxide decomposition to the DNA-reactive bifunctional electrophiles 4-oxo-2-nonenal, 4,5-epoxy-2(E)-decenal, and 4-hydroxy-2-non-enal, The compound 4,5-Epoxy-2(E)-decenal is a precursor of etheno-2'-deoxyadenosine, a highly mutagenic lesion found in human DNA. Vitamin C-mediated formation of genotoxins from lipid hydroperoxides in the absence of transition metal ions could help explain its lack of efficacy as a cancer chemoprevention agent.	Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Blair, IA (corresponding author), Univ Penn, Ctr Canc Pharmacol, 1254 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Oe, Tomoyuki/AAE-1514-2019; Blair, Ian A/B-3320-2010	Oe, Tomoyuki/0000-0002-3893-0815; Lee, Seon Hwa/0000-0003-1095-5516	NCI NIH HHS [CA16520, CA65878] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016520, R01CA065878] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Burcham PC, 1998, MUTAGENESIS, V13, P287, DOI 10.1093/mutage/13.3.287; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Doerge DR, 2000, CHEM RES TOXICOL, V13, P1259, DOI 10.1021/tx0001575; Gardner HW, 1998, PLANT PHYSIOL, V116, P1359, DOI 10.1104/pp.116.4.1359; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kamitani H, 1998, J BIOL CHEM, V273, P21569, DOI 10.1074/jbc.273.34.21569; KURNAGAI T, 2000, BIOCHEM BIOPH RES CO, V273, P437; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LAUDICINA DC, 1990, ARCH BIOCHEM BIOPHYS, V278, P73, DOI 10.1016/0003-9861(90)90233-O; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine RL, 2000, CANCER RES, V60, P4098; Lin JM, 1999, LIPIDS, V34, P1117, DOI 10.1007/s11745-999-0463-8; Linn S, 1998, DRUG METAB REV, V30, P313, DOI 10.3109/03602539808996315; Lippman SM, 1998, JNCI-J NATL CANCER I, V90, P1514, DOI 10.1093/jnci/90.20.1514; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Proteggente AR, 2000, BIOCHEM BIOPH RES CO, V277, P535, DOI 10.1006/bbrc.2000.3711; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Williams C, 1999, ANN NY ACAD SCI, V889, P72, DOI 10.1111/j.1749-6632.1999.tb08725.x	30	357	388	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2083	2086		10.1126/science.1059501	http://dx.doi.org/10.1126/science.1059501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408659				2022-12-01	WOS:000169284700050
J	Balter, M				Balter, M			Canser research - Transatlantic war over BRCA1 patent	SCIENCE			English	News Item																			0	6	6	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1818	1818		10.1126/science.292.5523.1818	http://dx.doi.org/10.1126/science.292.5523.1818			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397923				2022-12-01	WOS:000169200700010
J	Mack, TM				Mack, TM			The new pan-asian paan problem	LANCET			English	Editorial Material							RISK-FACTOR; BETEL QUID; TOBACCO		Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California	Mack, TM (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	tmack@hsc.usc.edu						Chen CL, 1999, CARCINOGENESIS, V20, P2331, DOI 10.1093/carcin/20.12.2331; Chen JW, 1996, J ORAL PATHOL MED, V25, P140, DOI 10.1111/j.1600-0714.1996.tb00209.x; GUPTA P, 1990, 7 WORLD C TOB HLTH P; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; HUANG WT, 1990, EC STUDY BETEL NUTS; *IARC, 1972, MON EV CARC RISK CHE, V1, P169; *IARC, 1985, MON EV CARC RISK CHE, V37, P141; Liu CJ, 2000, CAN MED ASSOC J, V162, P359; Merchant A, 2000, INT J CANCER, V86, P128, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;128::AID-IJC20&gt;3.0.CO;2-M; Norton SA, 1998, J AM ACAD DERMATOL, V38, P81, DOI 10.1016/S0190-9622(98)70543-2; PINDBORG JJ, 1984, COMMUNITY DENT ORAL, V12, P195, DOI 10.1111/j.1600-0528.1984.tb01438.x; Reichart P A, 1999, Eur J Dent Educ, V3, P126, DOI 10.1111/j.1600-0579.1999.tb00078.x; SARMA AB, 1992, FOOD CHEM TOXICOL, V30, P161, DOI 10.1016/0278-6915(92)90152-B; Tang JG, 1997, COMMUNITY DENT ORAL, V25, P177, DOI 10.1111/j.1600-0528.1997.tb00918.x; Tsai JF, 2001, BRIT J CANCER, V84, P709, DOI 10.1054/bjoc.1999.1597	15	30	31	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1638	1639		10.1016/S0140-6736(00)04860-1	http://dx.doi.org/10.1016/S0140-6736(00)04860-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425364				2022-12-01	WOS:000168901600005
J	Walker, JR; Corpina, RA; Goldberg, J				Walker, JR; Corpina, RA; Goldberg, J			Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; KU80-DEFICIENT CELLS; END; COMPLEX; BINDING; SUBUNIT; RECOMBINATION; ASSOCIATION; STABILITY; PATHWAY	The Ku heterodimer (Ku70 and Ku80 subunits) contributes to genomic integrity through its ability to bind DNA double-strand breaks and facilitate repair by the non-homologous end-joining pathway. The crystal structure of the human Ku heterodimer was determined both alone and bound to a 55-nucleotide DNA element at 2.7 and 2.5 Angstrom resolution, respectively. Ku70 and Ku80 share a common topology and form a dyad-symmetrical molecule with a preformed ring that encircles duplex DNA. The binding site can cradle two full turns of DNA while encircling only the central 3-4 base pairs (bp). Ku makes no contacts with DNA bases and few with the sugar-phosphate backbone, but it fits sterically to major and minor groove contours so as to position the DNA helix in a defined path through the protein ring. These features seem well designed to structurally support broken DNA ends and to bring the DNA helix into phase across the junction during end processing and ligation.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org		/0000-0002-5255-895X				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calsou P, 1999, J BIOL CHEM, V274, P7848, DOI 10.1074/jbc.274.12.7848; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; CHOU CH, 1992, J EXP MED, V175, P1677, DOI 10.1084/jem.175.6.1677; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Liang F, 1996, J BIOL CHEM, V271, P14405, DOI 10.1074/jbc.271.24.14405; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAILLARD S, 1993, PROTEINS, V15, P330, DOI 10.1002/prot.340150310; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034; Zhao JK, 1999, BIOCHEMISTRY-US, V38, P2152, DOI 10.1021/bi9825246; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	44	828	868	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					607	614		10.1038/35088000	http://dx.doi.org/10.1038/35088000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493912				2022-12-01	WOS:000170318000032
J	Annas, GJ				Annas, GJ			The limits of state laws to protect genetic information	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ABELSON R, 2001, NY TIMES        0610, P1; Andrews L. B., 2001, FUTURE PERFECT CONFR; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; CUMMINGS J, 2001, WALL STREET J   0625, pB2; Fedder RS, 2000, J LEGAL MED, V21, P557, DOI 10.1080/019476400455807; Greely H T, 2000, Jurimetrics, V40, P153; JAGUTIS MA, 1999, MARQ L REV, V82, P429; LASALANDRA M, 2001, BOSTON HERALD   0225, P3; Laurie GT, 2001, J LEGAL MED, V22, P1, DOI 10.1080/019476401750171115; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; MURRAY TH, 1997, GENETIC SECRETS PROT, P60; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; Nelkin D, 2001, NAT REV GENET, V2, P555, DOI 10.1038/35080583; Roche PA, 2001, NAT REV GENET, V2, P392, DOI 10.1038/35072029; ROCHE PA, 1996, JURIMETICS, V31, P1; SIXEL LM, 2001, HOUSTON CHRONIC 0216, pB1; SWAZEY JP, 1992, GENE MAPPING USING L, P45; 2000, FDCH POLITICAL  0602, P20; 2000, NY TIMES        0627, pF8	19	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					385	388		10.1056/NEJM200108023450523	http://dx.doi.org/10.1056/NEJM200108023450523			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484711	Green Published			2022-12-01	WOS:000170193600030
J	Krause, DW				Krause, DW			Fossil molar from a Madagascan marsupial - The discovery of a tiny tooth from the Late Cretaceous period has sizeable implications.	NATURE			English	Article									SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Krause, DW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.							Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; CIFELLI RL, 1987, NATURE, V325, P520, DOI 10.1038/325520a0; CIFELLI RL, 1993, P NATL ACAD SCI USA, V90, P9413, DOI 10.1073/pnas.90.20.9413; Clemens W.A., 1986, CONTRIBUTIONS GEOLOG, V3, P55, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; FOX RC, 1975, CAN J EARTH SCI, V12, P412, DOI 10.1139/e75-037; Fox Richard C., 1995, P247; Krause D.W., 1999, GSA TODAY, V9, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Masters JC, 1995, CREATURES OF THE DARK, P31; PRASAD GVR, 1988, NATURE, V332, P638, DOI 10.1038/332638a0; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; SLAUGHTER BH, 1968, SCIENCE, V162, P254, DOI 10.1126/science.162.3850.254; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359; [No title captured]	15	55	58	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					497	498		10.1038/35087649	http://dx.doi.org/10.1038/35087649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484038				2022-12-01	WOS:000170202900030
J	Wittmann, CW; Wszolek, MF; Shulman, JM; Salvaterra, PM; Lewis, J; Hutton, M; Feany, MB				Wittmann, CW; Wszolek, MF; Shulman, JM; Salvaterra, PM; Lewis, J; Hutton, M; Feany, MB			Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; HUMAN TAU; ALZHEIMERS-DISEASE; BRAIN DEGENERATION; GENE-EXPRESSION; MUTANT; PHOSPHORYLATION; DEMENTIA; PROTEINS; NEURONS	The microtubule-binding protein tau has been implicated in the pathogenesis of Alzheimer's disease and related disorders. However, the mechanisms underlying tau-mediated neurotoxicity remain unclear. We created a genetic model of tau-related neurodegenerative disease by expressing wild-type and mutant forms of human tau in the fruit fly Drosophila melanogaster. Transgenic flies showed key features of the human disorders: adult onset, progressive neurodegeneration, early death, enhanced toxicity of mutant tau, accumulation of abnormal tau, and relative anatomic selectivity. However, neurodegeneration occurred without the neurofibrillary tangle formation that is seen in human disease and some rodent tauopathy models. This fly model may allow a genetic analysis of the cellular mechanisms underlying tau neurotoxicity.	Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosci, Duarte, CA 91010 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; City of Hope; Beckman Research Institute of City of Hope; Mayo Clinic	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, 221 Longwood Ave,Room 514, Boston, MA 02115 USA.			Feany, Mel/0000-0003-0315-7970				Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; Feany MB, 2000, J NEUROPATH EXP NEUR, V59, P847, DOI 10.1093/jnen/59.10.847; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GEDDES JF, 1993, BRAIN, V116, P281, DOI 10.1093/brain/116.1.281; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	25	662	685	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					711	714		10.1126/science.1062382	http://dx.doi.org/10.1126/science.1062382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11408621				2022-12-01	WOS:000170204600059
J	Reick, M; Garcia, JA; Dudley, C; McKnight, SL				Reick, M; Garcia, JA; Dudley, C; McKnight, SL			NPAS2: An analog of clock operative in the mammalian forebrain	SCIENCE			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; DOUBLE-TIME; PROTEIN; MPER1; RHYTHMICITY; ORTHOLOG; CLONING; LOOP	Neuronal PAS domain protein 2 (NPAS2) is a transcription factor expressed primarily in the mammalian forebrain. NPAS2 is highly related in primary amino acid sequence to Clock, a transcription factor expressed in the suprachiasmatic nucleus that heterodimerizes with BMAL1 and regulates circadian rhythm. To investigate the biological role of NPAS2, we prepared a neuroblastoma cell Line capable of conditional induction of the NPAS2:BMAL1 heterodimer and identified putative target genes by representational difference analysis, DNA microarrays, and Northern blotting. Coinduction of NPAS2 and BMAL1 activated transcription of the endogenous Per1, Per2, and Cry1 genes, which encode negatively activating components of the circadian regulatory apparatus, and repressed transcription of the endogenous BMAL1 gene. Analysis of the frontal cortex of wild-type mice kept in a 24-hour Light-dark cycle revealed that Per1, Per2, and Cry1 mRNA Levels were elevated during darkness and reduced during Light, whereas BMAL1 mRNA displayed the opposite pattern. In situ hybridization assays of mice kept in constant darkness revealed that Per2 mRNA abundance did not oscillate as a function of the circadian cycle in NPAS2-deficient mice. Thus, NPAS2 likely functions as part of a molecular clock operative in the mammalian forebrain.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Garcia, Joseph/0000-0002-5621-7538	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388] Funding Source: NIH RePORTER; NIMH NIH HHS [1RO1MH59388] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BIEDLER JL, 1988, ADV NEUROBLASTOMA RE, V2, P265; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; DECOURSEY PJ, 1989, BRAIN RES, V500, P263, DOI 10.1016/0006-8993(89)90322-3; DRUCKERCOLIN R, 1984, BRAIN RES, V311, P353, DOI 10.1016/0006-8993(84)90099-4; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; REICK M, UNPUB; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	29	434	451	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					506	509		10.1126/science.1060699	http://dx.doi.org/10.1126/science.1060699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11441147				2022-12-01	WOS:000169966700050
J	Roux, AVD; Merkin, SS; Arnett, D; Chambless, L; Massing, M; Nieto, FJ; Sorlie, P; Szklo, M; Tyroler, HA; Watson, RL				Roux, AVD; Merkin, SS; Arnett, D; Chambless, L; Massing, M; Nieto, FJ; Sorlie, P; Szklo, M; Tyroler, HA; Watson, RL			Neighborhood of residence and incidence of coronary heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALAMEDA-COUNTY; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; PHYSICAL-ACTIVITY; UNITED-STATES; SOCIAL-CLASS; HEALTH; MORTALITY	Background: Where a person lives is not usually thought of as an independent predictor of his or her health, although physical and social features of places of residence may affect health and health-related behavior. Methods: Using data from the Atherosclerosis Risk in Communities Study, we examined the relation between characteristics of neighborhoods and the incidence of coronary heart disease. Participants were 45 to 64 years of age at base line and were sampled from four study sites in the United States: Forsyth County, North Carolina; Jackson, Mississippi; the northwestern suburbs of Minneapolis; and Washington County, Maryland. As proxies for neighborhoods, we used block groups containing an average of 1000 people, as defined by the U.S. Census. We constructed a summary score for the socioeconomic environment of each neighborhood that included information about wealth and income, education, and occupation. Results: During a median of 9.1 years of follow-up, 615 coronary events occurred in 13,009 participants. Residents of disadvantaged neighborhoods (those with lower summary scores) had a higher risk of disease than residents of advantaged neighborhoods, even after we controlled for personal income, education, and occupation. Hazard ratios for coronary heart disease among low-income persons living in the most disadvantaged neighborhoods, as compared with high-income persons in the most advantaged neighborhoods, were 3.1 among whites (95 percent confidence interval, 2.1 to 4.8) and 2.5 among blacks (95 percent confidence interval, 1.4 to 4.5). These associations remained unchanged after adjustment for established risk factors for coronary heart disease. Conclusions: Even after controlling for personal income, education, and occupation, we found that living in a disadvantaged neighborhood is associated with an increased incidence of coronary heart disease. (N Engl J Med 2001;345:99-106.) Copyright (C) 2001 Massachusetts Medical Society.	Columbia Univ, Columbia Coll Phys & Surg, Div Gen Med, New York, NY USA; Columbia Univ, Joseph T Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Univ N Carolina, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA	Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Mississippi; University of Mississippi Medical Center	Roux, AVD (corresponding author), Columbia Presbyterian Med Ctr, Div Gen Med, 622 W 168th St,PH9 E,Rm 105, New York, NY 10032 USA.			Szklo, Moyses/0000-0001-9433-6266	NHLBI NIH HHS [R29 HL59386, N01-HC-55016, N01-HC-55015] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055016] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059386] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON JT, 1979, PREV MED, V8, P525, DOI 10.1016/0091-7435(79)90328-1; Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; [Anonymous], THIN RED LINE POOR S; [Anonymous], [No title captured]; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; *BUR CENS, 1982, 1980 CENS POP; CHEADLE A, 1991, PREV MED, V20, P250, DOI 10.1016/0091-7435(91)90024-X; COX DR, 1972, J R STAT SOC B, V34, P187; Diez-Roux AV, 1999, J EPIDEMIOL COMMUN H, V53, P55, DOI 10.1136/jech.53.1.55; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Duncan C, 1999, SOC SCI MED, V48, P497, DOI 10.1016/S0277-9536(98)00360-8; ELFORD J, 1989, LANCET, V1, P343; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; GREEN M, 1991, POOR PAY MORE LESS 1; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; HACKBARTH DP, 1995, J PUBLIC HEALTH POL, V16, P213, DOI 10.2307/3342593; Hart C, 1997, SOC SCI MED, V45, P893, DOI 10.1016/S0277-9536(96)00431-5; HENRY JP, 1986, POSTGRAD MED J, V62, P687, DOI 10.1136/pgmj.62.729.687; Jargowsky PA, 1996, AM SOCIOL REV, V61, P984, DOI 10.2307/2096304; Kahn HA., 1989, STAT METHODS EPIDEMI; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaplan GA, 1996, INT J HEALTH SERV, V26, P507, DOI 10.2190/4CUU-7B3G-G4XR-0K0B; KING AC, 1992, MED SCI SPORTS EXERC, V24, P221; Kleinschmidt I, 1995, J EPIDEMIOL COMMUN H, V49, pS72, DOI 10.1136/jech.49.Suppl_2.S72; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Massey DS, 1996, DEMOGRAPHY, V33, P395, DOI 10.2307/2061773; Mooney C., 1990, Journal of Human Nutrition and Dietetics, V3, P111, DOI 10.1111/j.1365-277X.1990.tb00058.x; Pucci LG, 1998, AM J PREV MED, V15, P155, DOI 10.1016/S0749-3797(98)00034-8; RAUTAHARJU PM, 1981, CIRCULATION, V64, P249, DOI 10.1161/01.CIR.64.2.249; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Robert SA, 1998, J HEALTH SOC BEHAV, V39, P18, DOI 10.2307/2676387; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; SHAH BV, 1997, SUDAAN USERS MANUAL; Shumaker SA, 1994, SOCIAL SUPPORT CARDI; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; SZKKO M, 2000, EPIDEMIOLOGY BASICS; Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P1122; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WING S, 1987, LANCET, V2, P1067; WING S, 1988, AM J PUBLIC HEALTH, V78, P923, DOI 10.2105/AJPH.78.8.923; Yen IH, 1998, AM J PUBLIC HEALTH, V88, P1709, DOI 10.2105/AJPH.88.11.1709; Yen IH, 1999, AM J EPIDEMIOL, V149, P898; 1999, MMWR MORB MORTAL WKL, V48, P143	44	1252	1265	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					99	106		10.1056/NEJM200107123450205	http://dx.doi.org/10.1056/NEJM200107123450205			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451AH	11450679	Green Published			2022-12-01	WOS:000169776900005
J	Richter, JD; Theurkauf, WE				Richter, JD; Theurkauf, WE			Development - The message is in the translation	SCIENCE			English	Editorial Material							MESSENGER-RNA; NANOS; DROSOPHILA; PUMILIO; PHOSPHORYLATION; RECRUITMENT; INTERACTS; CPEB		Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA.	joel.richter@umassmed.edu; william.theurkauf@umassmed.edu		Theurkauf, William/0000-0001-7342-1912				Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; DALBY B, 1993, EMBO J, V12, P1219, DOI 10.1002/j.1460-2075.1993.tb05763.x; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; RICHTER JD, 2000, TRANSLATIONAL CONTRO, pCH27; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Wreden C, 1997, DEVELOPMENT, V124, P3015	12	31	32	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					60	62		10.1126/science.1062237	http://dx.doi.org/10.1126/science.1062237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441171				2022-12-01	WOS:000169780300026
J	Knight, J				Knight, J			Meet the Herod bug	NATURE			English	News Item							MALE-KILLING WOLBACHIA; ARMADILLIDIUM-VULGARE LATR; CYTOPLASMIC INCOMPATIBILITY; MOLECULAR-IDENTIFICATION; DROSOPHILA; ENDOSYMBIONT; HYMENOPTERA; SEQUENCES; SEX											Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BROWER JH, 1976, ANN ENTOMOL SOC AM, V69, P1011, DOI 10.1093/aesa/69.6.1011; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hoffmann AA, 1998, GENETICS, V148, P221; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst GDD, 2000, GENETICS, V156, P699; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1123, DOI 10.1098/rspb.2001.1632; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; RICHARDSON PM, 1987, J INVERTEBR PATHOL, V50, P176, DOI 10.1016/0022-2011(87)90080-2; RIGAUD T, 1993, GENETICS, V133, P247; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Stouthamer R, 2001, P ROY SOC B-BIOL SCI, V268, P617, DOI 10.1098/rspb.2000.1404; Taylor MJ, 2000, PARASITOL TODAY, V16, P179, DOI 10.1016/S0169-4758(00)01661-6; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; WADE MJ, 1985, SCIENCE, V227, P527, DOI 10.1126/science.3966160; Werren J.H., 1995, P ROY SOC LOND B BIO, V262, P147; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0	24	13	14	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					12	14		10.1038/35083744	http://dx.doi.org/10.1038/35083744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452274	Bronze			2022-12-01	WOS:000169644900012
J	Sutcliffe, AG; Taylor, B; Saunders, K; Thornton, S; Lieberman, BA; Grudzinskas, JG				Sutcliffe, AG; Taylor, B; Saunders, K; Thornton, S; Lieberman, BA; Grudzinskas, JG			Outcome in the second year of life after in-vitro fertilisation by intracytoplasmic sperm injection: a UK case-control study	LANCET			English	Article							CHILDREN BORN; FOLLOW-UP; PREGNANCIES; DISEASES; RISK	Background There have been reports suggesting that children born after in-vitro fertilisation by intracytoplasmic sperm injection (ICSI) are at increased risk of neurodevelopmental delay. We have undertaken a case-control study of this issue. Methods We studied 208 singleton children conceived by ICSI and a control group of 221 normally conceived singleton children. Children were recruited from 22 fertility centres and local nurseries throughout the UK. Controls were selected to match cases as closely as possible for social class, maternal educational attainment, region, sex, and race. The primary outcome measure was neurodevelopmental scoring; secondary measures were perinatal outcomes, postnatal health, and congenital abnormalities. A single examiner assessed all the children. Findings A follow-up rate of 90% for the ICSI group was achieved at a mean age of 17 months. No difference between the study children and controls was found in mean neurodevelopmental scores (98.08 [SD 10.93] vs 98.69 [9.99]) or any subscales on the Griffiths' scales of mental development. Perinatal outcome was similar apart from a higher rate of caesarean section (73 [35.1%] vs 53 [24.0%], p=0.015) and a lower mean birthweight (3163 [SD 642] vs 3341 [606] g, p=0.013) in the study group. Rates of major congenital abnormality were also similar overall (ten [4.8%] study vs ten [4.5%] control), although there were significantly more congenital anomalies among children born to fathers with oligozoospermia than in other children. Interpretation This population study did not show any significant difference between children conceived after ICSI and their naturally conceived peers in terms of physical health and development.	UCL Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, London NW3 2PF, England; Monash Univ, Monash Med Ctr, Dept Paediat, Melbourne, Vic 3004, Australia; Pk Hosp, CARE, Nottingham, England; St Marys Hosp, Dept Reprod Med, Manchester M13 0JH, Lancs, England; BUPA Hosp, Manchester Fertil Serv, Manchester, Lancs, England; St Bartholomews & Royal London Sch Med & Dent, Dept Obstet & Gynaecol, London, England	University of London; University College London; UCL Medical School; Monash University; University of Manchester; University of London; Queen Mary University London	Sutcliffe, AG (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, Royal Free Campus, London NW3 2PF, England.	icsi@rfc.ucl.ac.uk		Sutcliffe, Alastair/0000-0001-8542-6155				Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Bonduelle M, 1999, HUM REPROD, V14, P243, DOI 10.1093/humrep/14.suppl_1.243; Bonduelle M, 1998, LANCET, V351, P1553, DOI 10.1016/S0140-6736(98)24021-9; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; Hawkins MM, 1999, LANCET, V354, P1906, DOI 10.1016/S0140-6736(05)76874-4; Kent-First MG, 1996, MOL HUM REPROD, V2, P943, DOI 10.1093/molehr/2.12.943; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; Loft A, 1999, HUM REPROD, V14, P2143, DOI 10.1093/humrep/14.8.2143; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Palermo GD, 1996, JAMA-J AM MED ASSOC, V276, P1893, DOI 10.1001/jama.276.23.1893; Stuppia L, 1998, HUM GENET, V102, P566, DOI 10.1007/s004390050741; Sutcliffe AG, 1999, BMJ-BRIT MED J, V318, P704; Sutcliffe AG, 1998, LANCET, V352, P578, DOI 10.1016/S0140-6736(05)79291-6; SUTCLIFFE AG, 2001, INT COLLABORATIVE ST; Vogt PH, 1999, LANCET, V354, P611, DOI 10.1016/S0140-6736(99)80147-0; Wennerholm UB, 1996, HUM REPROD, V11, P1113; Wennerholm UB, 2000, HUM REPROD, V15, P944, DOI 10.1093/humrep/15.4.944; World Health Organization, 2010, LAB MAN EX HUM SEM S	18	179	185	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2001	357	9274					2080	2084		10.1016/S0140-6736(00)05180-1	http://dx.doi.org/10.1016/S0140-6736(00)05180-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445100				2022-12-01	WOS:000169586600010
J	Mungai, M; Tegtmeier, G; Chamberland, M; Parise, M				Mungai, M; Tegtmeier, G; Chamberland, M; Parise, M			Transfusion-transmitted malaria in the United States from 1963 through 1999	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-DONOR SELECTION; COLLECTION; COMPONENTS; TRANSMISSION	Background: Transfusion-transmitted malaria is uncommon in the United States. After the report of three cases of complicated Plasmodium falciparum infection acquired by transfusion, we reviewed all cases of transfusion-transmitted malaria reported to the Centers for Disease Control and Prevention (CDC) from 1963 through 1999. Methods: Information on the patients was from surveillance reports sent to the CDC. Information about the implicated blood donors came from the National Malaria Surveillance System. To determine whether donors should have been excluded from donating blood, we compared their characteristics with the exclusion guidelines of the Food and Drug Administration and the American Association of Blood Banks. Results: Of 93 cases of transfusion-transmitted malaria reported in 28 states, 33 (35 percent) were due to P. falciparum, 25 (27 percent) were due to P. vivax, 25 (27 percent) were due to P. malariae, 5 (5 percent) were due to P. ovale, 3 (3 percent) were mixed infections, and 2 (2 percent) were due to unidentified species. Ten of the 93 patients (11 percent) died. There were potentially 91 donors (in two cases, two patients received blood from the same donor), 67 of whom (74 percent) could be identified as infective. Of 64 implicated donors whose country of origin was reported, 38 (59 percent) were foreign born. Among those for whom complete information was available, 37 of 60 donors (62 percent) would have been excluded from donating according to current guidelines (in place since 1994), and 30 of 48 donors (62 percent) should have been excluded under the guidelines in place at the time of donation. Conclusions: Careful screening of donors according to the recommended exclusion guidelines remains the best way to prevent transfusion-transmitted malaria. (N Engl J Med 2001;344:1973-8.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; Publ Hlth Serv, US Dept HHS, Washington, DC USA; Community Blood Ctr Greater Kansas City, Kansas City, MO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Public Health Service	Parise, M (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Mailstop F-22,4770 Buford Hwy, Atlanta, GA 30341 USA.	mcp0@cdc.gov						*AM ASS BLOOD BANK, 1999, ASS B, V9910; *AM ASS BLOOD BANK, 1999, STAND BLOOD BANKS TR; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; BESSON P, 1976, REV FR TRANSFUS IMMU, V19, P369, DOI 10.1016/S0338-4535(76)80076-1; BRASSEUR P, 1981, HEMATOLOGIE, V24, P597; BRUCECHW.LJ, 1974, B WORLD HEALTH ORGAN, V50, P337; Busch MP, 2000, VOX SANG, V78, P253; Chiodini PL, 1997, VOX SANG, V73, P143, DOI 10.1046/j.1423-0410.1997.7330143.x; CHWATT LJB, 1982, TROP DIS B, V79, P827; *GEN ACC OFF, 1997, GAOPEMD972; Gilles HM, 1993, ESSENTIAL MALARIOLOG, P124; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; GUERRERO IC, 1983, ANN INTERN MED, V99, P221, DOI 10.7326/0003-4819-99-2-221; HANG VTT, 1995, T ROY SOC TROP MED H, V89, P44, DOI 10.1016/0035-9203(95)90652-5; KACHUR SP, 1998, LAST PUBLIC HLTH PRE, P313; Linden JV, 2000, TRANSFUSION, V40, P285, DOI 10.1046/j.1537-2995.2000.40030285.x; LOPEZ CE, 1977, J INFECT DIS, V135, P875, DOI 10.1093/infdis/135.5.875; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; MILLER LH, 1975, TRANSMISSIBLE DISEAS, P241; NAHLEN BL, 1991, TRANSFUSION, V31, P798, DOI 10.1046/j.1537-2995.1991.31992094665.x; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; SHULMAN IA, 1994, ARCH PATHOL LAB MED, V118, P366; SULZER AJ, 1971, B WORLD HEALTH ORGAN, V45, P375; SURGENOR DM, 1990, NEW ENGL J MED, V322, P1646, DOI 10.1056/NEJM199006073222306; Talib V H, 1996, Indian J Pathol Microbiol, V39, P493; TURC JM, 1990, EMERGING GLOBAL PATTERNS IN TRANSFUSION-TRANSMITTED INFECTIONS, P31; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Wallace EL, 1998, TRANSFUSION, V38, P625, DOI 10.1046/j.1537-2995.1998.38798346630.x; WALLACE EL, 1995, TRANSFUSION, V35, P802, DOI 10.1046/j.1537-2995.1995.351096026360.x; WALLACE EL, 1993, TRANSFUSION, V33, P139, DOI 10.1046/j.1537-2995.1993.33293158046.x; Williamson W. C., 1848, ANN MAG NAT HIST, V1, P1, DOI 10.1080/03745485809494465; Zoon K, 1994, RECOMMENDATIONS DEFE, P64; 2000, FED REG, V65, P36452; 1999, MMWR MORB MORTAL WKL, V48, P253	34	179	196	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2001	344	26					1973	1978		10.1056/NEJM200106283442603	http://dx.doi.org/10.1056/NEJM200106283442603			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446HQ	11430326				2022-12-01	WOS:000169508200003
J	Roelofs, J; Van Haastert, PJM				Roelofs, J; Van Haastert, PJM			Genomics - Genes lost during evolution	NATURE			English	Article									Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	Roelofs, J (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	p.j.m.van.haastert@chem.rug.nl	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465				Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Kay RR, 1999, TRENDS GENET, V15, P294, DOI 10.1016/S0168-9525(99)01770-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Roelofs J, 2001, BIOCHEM J, V354, P697, DOI 10.1042/0264-6021:3540697	4	58	59	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1013	1014		10.1038/35082627	http://dx.doi.org/10.1038/35082627			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429590	Green Published, Green Submitted			2022-12-01	WOS:000169528500034
J	Moulin, L; Munive, A; Dreyfus, B; Boivin-Masson, C				Moulin, L; Munive, A; Dreyfus, B; Boivin-Masson, C			Nodulation of legumes by members of the beta-subclass of Proteobacteria	NATURE			English	Article							HOST-SPECIFICITY	Members of the Leguminosae form the largest plant family on Earth, with around 18,000 species. The success of legumes can largely be attributed to their ability to form a nitrogen-fixing symbiosis with specific bacteria known as rhizobia, manifested by the development of nodules on the plant roots in which the bacteria rx atmospheric nitrogen, a major contributor to the global nitrogen cycle. Rhizobia described so far belong exclusively to the a-subclass of Proteobacteria, where they are distributed in four distinct phylogenetic branches(1,2). Although nitrogen-fixing bacteria exist in other proteobacterial subclasses, for example Herbaspirillum and Azoarcus from the phylogenetically distant beta -subclass, none has been found to harbour the nod genes essential for establishing rhizobial symbiosis(3,4). Here we report the identification of proteobacteria from the b-subclass that nodulate legumes. This finding shows that the ability to establish a symbiosis with legumes is more widespread in bacteria than anticipated to date.	IRD INRA CIRAD ENSAM Baillarguet, Lab Symbioses Trop & Mediterraneennes, F-34398 Montpellier 5, France	Arts et Metiers Institute of Technology; CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boivin-Masson, C (corresponding author), IRD INRA CIRAD ENSAM Baillarguet, Lab Symbioses Trop & Mediterraneennes, PB 5035, F-34398 Montpellier 5, France.	Catherine.Boivin@mpl.ird.fr	Munive, José-Antonio/P-4379-2018; Moulin, Lionel/C-2921-2008	Munive, José-Antonio/0000-0003-4509-6563; Moulin, Lionel/0000-0001-9068-6912				Boone CM, 1999, CARBOHYD RES, V317, P155, DOI 10.1016/S0008-6215(99)00083-X; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; DESCHODT C C, 1976, Phytophylactica, V8, P103; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Polhill R.M., 1981, ADV LEGUME SYSTEMATI, P191; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Sy A, 2001, J BACTERIOL, V183, P214, DOI 10.1128/JB.183.1.214-220.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Berkum P, 1998, RHIZOBIACEAE MOL BIO, P124; Young JPW, 1996, NEW PHYTOL, V133, P87, DOI 10.1111/j.1469-8137.1996.tb04344.x; Zhang XX, 2000, APPL ENVIRON MICROB, V66, P2988, DOI 10.1128/AEM.66.7.2988-2995.2000	15	470	508	0	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					948	950		10.1038/35082070	http://dx.doi.org/10.1038/35082070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418858				2022-12-01	WOS:000169386200044
J	Chyba, CF; Hand, KP				Chyba, CF; Hand, KP			Planetary science - Life without photosynthesis	SCIENCE			English	Editorial Material							EUROPA; OCEAN; EARTH; MARS; ICE		SETI Inst, Ctr Study Life Universe, Mt View, CA 94404 USA; Stanford Univ, Ctr Int Secur & Cooperat, Stanford, CA 94305 USA; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chyba, CF (corresponding author), SETI Inst, Ctr Study Life Universe, Mt View, CA 94404 USA.		Hand, Kevin Peter/I-8246-2018	Hand, Kevin Peter/0000-0002-3225-9426				Chyba CF, 2001, P NATL ACAD SCI USA, V98, P801, DOI 10.1073/pnas.98.3.801; COLBURN DS, 1985, ICARUS, V63, P39, DOI 10.1016/0019-1035(85)90019-3; Cooper JF, 2001, ICARUS, V149, P133, DOI 10.1006/icar.2000.6498; DRAGANIC IG, 1991, PRECAMBRIAN RES, V52, P337, DOI 10.1016/0301-9268(91)90087-Q; FREDRIKSSON K, 1988, METEORITICS, V23, P35, DOI 10.1111/j.1945-5100.1988.tb00894.x; Gaidos EJ, 1999, SCIENCE, V284, P1631, DOI 10.1126/science.284.5420.1631; Jakosky BM, 1998, J GEOPHYS RES-PLANET, V103, P19359, DOI 10.1029/98JE01892; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; McCollom TM, 1999, J GEOPHYS RES-PLANET, V104, P30729, DOI 10.1029/1999JE001126; McCord TB, 1999, J GEOPHYS RES-PLANET, V104, P11827, DOI 10.1029/1999JE900005; MOORE JC, 1994, J GEOPHYS RES-OCEANS, V99, P5171, DOI 10.1029/93JC02832; Nealson KH, 1997, J GEOPHYS RES-PLANET, V102, P23675, DOI 10.1029/97JE01996; WALKER JCG, 1977, EVOLUTION ATMOSPHERE, P93; ZOLOTOV MY, 2000, LUNAR PLANET SCI, V31	15	72	73	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2026	2027		10.1126/science.1060081	http://dx.doi.org/10.1126/science.1060081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408649				2022-12-01	WOS:000169284700036
J	Wainger, BJ; DeGennaro, M; Santoro, B; Siegelbaum, SA; Tibbs, GR				Wainger, BJ; DeGennaro, M; Santoro, B; Siegelbaum, SA; Tibbs, GR			Molecular mechanism of cAMP modulation of HCN pacemaker channels	NATURE			English	Article							K+ CHANNEL; T1 DOMAIN; C-LINKER; LIGAND; IDENTIFICATION; ACTIVATION; SUBUNIT; BINDING; FAMILY	Hyperpolarization-activated cation channels of the HCN gene family(1-6) contribute to spontaneous rhythmic activity in both heart(7) and brain(5,6,8). All four family members contain both a core transmembrane segment domain, homologous to the S1-S6 regions of voltage-gated K+ channels, and a carboxy-terminal 120 amino-acid cyclic nucleotide-binding domain (CNBD) motif. Homologous CNBDs are responsible for the direct activation of cyclic nucleotide-gated channels and for modulation of the HERG voltage-gated K+ channel-important for visual and olfactory signalling(9) and for cardiac repolarization(10), respectively. The direct binding of cyclic AMP to the cytoplasmic site on HCN channels permits the channels to open more rapidly and completely after repolarization of the action potential(1,2,11), thereby accelerating rhythmogenesis(6-8). However, the mechanism by which cAMP binding modulates HCN channel gating and the basis for functional differences between HCN isoforms remain unknown. Here we demonstrate by constructing truncation mutants that the CNBD inhibits activation of the core transmembrane domain. cAMP binding relieves this inhibition. Differences in activation gating and extent of cAMP modulation between the HCN1 and HCN2 isoforms result largely from differences in the efficacy of CNBD inhibition.	Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Tibbs, GR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	grt1@columbia.edu	Wainger, Brian/L-7553-2017; DeGennaro, Matthew/H-4975-2015	DeGennaro, Matthew/0000-0003-3837-4430; Santoro, Bina/0000-0002-4277-1992				Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; CHEN S, 2000, SOC NEUR ABSTR, V26, P2139; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.ph.55.030193.002323; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	28	365	380	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					805	810		10.1038/35081088	http://dx.doi.org/10.1038/35081088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459060				2022-12-01	WOS:000169246400051
J	Kuehni, CE; Davis, A; Brooke, AM; Silverman, M				Kuehni, CE; Davis, A; Brooke, AM; Silverman, M			Are all wheezing disorders in very young: (preschool) children increasing in prevalence?	LANCET			English	Article							RESPIRATORY SYMPTOMS; NATURAL-HISTORY; ASTHMA; CHILDHOOD; RISK; ADULTS; TRENDS; ATOPY	Background Distinct wheezing disorders co-exist in young (preschool) children, some of which (early transient wheeze and viral wheeze) are thought to be unrelated to atopy. Investigation of changes in prevalence of wheezing disorders in preschool children could provide important clues about underlying mechanisms responsible for increasing prevalence of asthma in schoolchildren. Methods Repeated population surveys of the prevalence of respiratory symptoms were done by parent-completed postal questionnaires in random samples of 1650 (1990) and 2600 (1998) caucasian children aged 1-5 years living in the county of Leicestershire, UK. Findings The response rates were 86% (1422 of 1650) in 1990 and 84% (2127 of 2522) in 1998. Between 1990 and 1998, there was a significant increase in the prevalence of reported wheeze ever (16% to 29%, p<0.0001), current wheeze (12% to 26%, p<0.0001), diagnosis of asthma (11% to 19%, p<0.0001), treatment for wheeze (15% to 26%, p<0.0001), and admission for wheeze or other chest trouble (6% to 10%, p<0.0001). The increase occurred both in children with viral wheeze (9% to 19%) and in those with the classic asthma pattern of wheezing with multiple triggers (6% to 10%). There was also an increase in transient early wheezers (3% to 5%), persistent wheezers (5% to 13%), and late-onset wheezers (6% to 8%), and in all severity groups. The increase could not be accounted for by putative household risk factors because these declined between the 2 years. Interpretation The fact that all preschool wheezing disorders increased (including viral wheeze) makes it probable that factors unrelated to atopy are implicated in the changing epidemiology of wheeze in childhood.	Univ Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland; Univ Leicester, Leicester Royal Infirm, Dept Child Hlth, Leicester, Leics, England; Leicestershire & Rutland Healthcare Trust, Childrens Directorate, Leicester LE1 7RG, Leics, England	University of Bern; University Hospital of Bern; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland.	claudia.kuehni@insel.ch		Kuehni, Claudia E./0000-0001-8957-2002				ANDERSON HR, 1994, BRIT MED J, V308, P1600, DOI 10.1136/bmj.308.6944.1600; ANDERSON HR, 1986, J EPIDEMIOL COMMUN H, V40, P121, DOI 10.1136/jech.40.2.121; BROOKE AM, 1995, AM J RESP CRIT CARE, V152, P1872, DOI 10.1164/ajrccm.152.6.8520749; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Fleming DM, 2000, THORAX, V55, P657, DOI 10.1136/thorax.55.8.657; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; Kuehni CE, 2000, EUR RESPIR J, V16, P81, DOI 10.1034/j.1399-3003.2000.16a14.x; *LUNG ASTHM INF AG, 1996, 962 STGE HOSP MED SC; LUYT DK, 1994, ARCH DIS CHILD, V71, P24, DOI 10.1136/adc.71.1.24; LUYT DK, 1993, BMJ-BRIT MED J, V306, P1386, DOI 10.1136/bmj.306.6889.1386; LUYT DK, 1995, EUR RESPIR J, V8, P1736, DOI 10.1183/09031936.95.08101736; Magnus P, 1997, BRIT MED J, V314, P1795, DOI 10.1136/bmj.314.7097.1795; Martinez FD, 1998, EUR RESPIR J, V12, p3S; NINAN TK, 1992, BRIT MED J, V304, P873, DOI 10.1136/bmj.304.6831.873; Nystad W, 1998, EUR J EPIDEMIOL, V14, P247, DOI 10.1023/A:1007453322547; PARK ES, 1986, ARCH DIS CHILD, V61, P642, DOI 10.1136/adc.61.7.642; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; PEAT JK, 1994, BMJ-BRIT MED J, V308, P1591, DOI 10.1136/bmj.308.6944.1591; Rusconi F, 1999, AM J RESP CRIT CARE, V160, P1617, DOI 10.1164/ajrccm.160.5.9811002; Russell G, 1997, BRIT MED J, V315, P1014, DOI 10.1136/bmj.315.7114.1014; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; SILVERMAN M, 1993, THORAX, V48, P1200, DOI 10.1136/thx.48.12.1200; Silverman M, 1997, ARCH DIS CHILD, V77, P62, DOI 10.1136/adc.77.1.62; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Weiss ST, 1997, CIBA F SYMP, V206, P244	26	190	192	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2001	357	9271					1821	1825		10.1016/S0140-6736(00)04958-8	http://dx.doi.org/10.1016/S0140-6736(00)04958-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440DN	11410189				2022-12-01	WOS:000169160800009
J	Iborra, FJ; Jackson, DA; Cook, PR				Iborra, FJ; Jackson, DA; Cook, PR			Coupled transcription and translation within nuclei of mammalian cells	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; TRANSFER-RNAS; VISUALIZATION; POLYPEPTIDE; PROTEIN; EXPORT; DECAY; SITES	It is widely assumed that the vital processes of transcription and translation are spatially separated in eukaryotes and that no translation occurs in nuclei. We localized translation sites by incubating permeabilized mammalian cells with [H-3]lysine or lysyl-transfer RNA tagged with biotin or BODIPY; although most nascent polypeptides were cytoplasmic, some were found in discrete nuclear sites known as transcription "factories." Some of this nuclear translation also depends on concurrent transcription by RNA polymerase II. This coupling is simply explained if nuclear ribosomes translate nascent transcripts as those transcripts emerge from still-engaged RNA polymerases, much as they do in bacteria.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England	University of Oxford; University of Manchester	Cook, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		Iborra, Francisco J/A-2943-2009; iborra, francisco j/K-9313-2015	iborra, francisco j/0000-0002-0692-3696; Cook, Peter/0000-0002-6639-188X				Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; CHATTERJEE NK, 1977, ARCH BIOCHEM BIOPHYS, V183, P228, DOI 10.1016/0003-9861(77)90436-2; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; EISINGER DP, 1997, MOL CELL BIOL, V17, P5135; ETCHISON D, 1987, J VIROL, V61, P2702, DOI 10.1128/JVI.61.9.2702-2710.1987; GOIDL JA, 1978, TRENDS BIOCHEM SCI, V3, pN225; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hollinshead M, 1997, J HISTOCHEM CYTOCHEM, V45, P1053, DOI 10.1177/002215549704500803; IBORRA FJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1865, DOI 10.1177/40.12.1453005; Iborra FJ, 1998, J CELL SCI, V111, P2269; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; RAY MK, 1993, BIOCHEMISTRY-US, V32, P5151, DOI 10.1021/bi00070a026; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303	22	301	311	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1139	1142		10.1126/science.1061216	http://dx.doi.org/10.1126/science.1061216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11423616				2022-12-01	WOS:000170432600061
J	Lopes, M; Cotta-Ramusino, C; Pellicioli, A; Liberi, G; Plevani, P; Muzi-Falconi, M; Newlon, CS; Foiani, M				Lopes, M; Cotta-Ramusino, C; Pellicioli, A; Liberi, G; Plevani, P; Muzi-Falconi, M; Newlon, CS; Foiani, M			The DNA replication checkpoint response stabilizes stalled replication forks	NATURE			English	Article							S-PHASE; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINTS; ORIGINS; PROGRESSION; PROTEIN; PHOSPHORYLATION; RECOMBINATION; ACTIVATION; PLASMIDS	In response to DNA damage and blocks to replication, eukaryotes activate the checkpoint pathways that prevent genomic instability and cancer by coordinating cell cycle progression with DNA repair(1-5). In budding yeast, the checkpoint response requires the Mec1-dependent activation of the Rad53 protein kinase(3,4,6). Active Rad53 slows DNA synthesis when DNA is damaged(7) and prevents firing of late origins of replication(8,9). Further, rad53 mutants are unable to recover from a replication block 10. Mec1 and Rad53 also modulate the phosphorylation state of different DNA replication and repair enzymes(6,11-13). Little is known of the mechanisms by which checkpoint pathways interact with the replication apparatus when DNA is damaged or replication blocked. We used the two-dimensional gel technique(14) to examine replication intermediates in response to hydroxyurea-induced replication blocks. Here we show that hydroxyurea-treated rad53 mutants accumulate unusual DNA structures at replication forks. The persistence of these abnormal molecules during recovery from the hydroxyurea block correlates with the inability to dephosphorylate Rad53. Further, Rad53 is required to properly maintain stable replication forks during the block. We propose that Rad53 prevents collapse of the fork when replication pauses.	Ist FIRC Oncol Mol, I-20141 Milan, Italy; Univ Milan, Dipartimento Genet & Biol Microorganismi, I-20133 Milan, Italy; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	IFOM - FIRC Institute of Molecular Oncology; University of Milan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Foiani, M (corresponding author), Ist FIRC Oncol Mol, Via Serio 21, I-20141 Milan, Italy.		Pellicioli, Achille/B-8765-2017; Lopes, Massimo/G-4300-2013; Muzi-Falconi, Marco/A-6035-2012; Foiani, Marco/M-8234-2014; LIBERI, GIORDANO/AAY-7273-2020	Pellicioli, Achille/0000-0002-1528-9009; Muzi-Falconi, Marco/0000-0001-7046-6090; Foiani, Marco/0000-0003-4795-834X; LIBERI, GIORDANO/0000-0003-3160-2242; PLEVANI, PAOLO/0000-0003-1869-2626; Lopes, Massimo/0000-0003-3847-8133	Telethon [E.1108] Funding Source: Medline	Telethon(Fondazione Telethon)		Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FOIANI M, 2000, MUTAT RES, V21, P286; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rothstein R, 2000, GENE DEV, V14, P1; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Weinert T, 1997, CANCER SURV, V29, P109; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	29	607	620	1	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					557	561		10.1038/35087613	http://dx.doi.org/10.1038/35087613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484058				2022-12-01	WOS:000170202900050
J	Nielsen, SJ; Schneider, R; Bauer, UM; Bannister, AJ; Morrison, A; O'Carroll, D; Firestein, R; Cleary, M; Jenuwein, T; Herrera, RE; Kouzarides, T				Nielsen, SJ; Schneider, R; Bauer, UM; Bannister, AJ; Morrison, A; O'Carroll, D; Firestein, R; Cleary, M; Jenuwein, T; Herrera, RE; Kouzarides, T			Rb targets histone H3 methylation and HP1 to promoters	NATURE			English	Article							RETINOBLASTOMA PROTEIN; CHROMATIN-STRUCTURE; IN-VIVO; DEACETYLASE; EXPRESSION; DOMAIN	In eukaryotic cells the histone methylase SUV39H1 and the methyl-lysine binding protein HP1 functionally interact to repress transcription at heterochromatic sites(1). Lysine 9 of histone H3 is methylated by SUV39H1 (ref. 2), creating a binding site for the chromo domain of HP1 (refs 3, 4). Here we show that SUV39H1 and HP1 are both involved in the repressive functions of the retinoblastoma (Rb) protein. Rb associates with SUV39H1 and HP1 in vivo by means of its pocket domain. SUV39H1 cooperates with Rb to repress the cyclin E promoter, and in fibroblasts that are disrupted for SUV39, the activity of the cyclin E and cyclin A2 genes are specifically elevated. Chromatin immunoprecipitations show that Rb is necessary to direct methylation of histone H3, and is necessary for binding of HP1 to the cyclin E promoter. These results indicate that the SUV39H1-HP1 complex is not only involved in heterochromatic silencing but also has a role in repression of euchromatic genes by Rb and perhaps other co-repressor proteins.	Wellcome CRC Inst, Cambridge CB2 1QR, England; Dept Pathol, Cambridge CB2 1QR, England; Baylor Coll Med, Dept Mol & Cellular Biol, Breast Ctr, Houston, TX 77030 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA	Baylor College of Medicine; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Stanford University	Kouzarides, T (corresponding author), Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	tk106@mole.bio.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162; Morrison, Ashby/0000-0003-1228-5093; O'Carroll, Donal/0000-0002-8626-2217; Bannister, Andrew/0000-0002-6312-4436	NIGMS NIH HHS [R25 GM056929] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Korner K, 2000, J BIOL CHEM, V275, P18676, DOI 10.1074/jbc.M001110200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8	19	703	740	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					561	565		10.1038/35087620	http://dx.doi.org/10.1038/35087620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484059				2022-12-01	WOS:000170202900051
J	Clark, JS; Carpenter, SR; Barber, M; Collins, S; Dobson, A; Foley, JA; Lodge, DM; Pascual, M; Pielke, R; Pizer, W; Pringle, C; Reid, WV; Rose, KA; Sala, O; Schlesinger, WH; Wall, DH; Wear, D				Clark, JS; Carpenter, SR; Barber, M; Collins, S; Dobson, A; Foley, JA; Lodge, DM; Pascual, M; Pielke, R; Pizer, W; Pringle, C; Reid, WV; Rose, KA; Sala, O; Schlesinger, WH; Wall, DH; Wear, D			Ecological forecasts: An emerging imperative	SCIENCE			English	Editorial Material							SPREAD; AGRICULTURE; INVASION; MALARIA; MODELS; CARBON; CO2	Planning and decision-making can be improved by access to reliable forecasts of ecosystem state, ecosystem services, and natural capital. Availability of new data sets, together with progress in computation and statistics, will increase our ability to forecast ecosystem change. An agenda that would lead toward a capacity to produce, evaluate, and communicate forecasts of critical ecosystem services requires a process that engages scientists and decision-makers. interdisciplinary linkages are necessary because of the climate and societal controls on ecosystems, the feedbacks involving social change, and the decision-making relevance of forecasts.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Ecol Soc Amer, Washington, DC 20006 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Natl Ctr Atmospher Res, Environm & Societal Impacts Grp, Boulder, CO 80301 USA; Resources Future Inc, Washington, DC 20036 USA; Univ Georgia, Dept Ecol, Athens, GA 30602 USA; Millennium Ecosyst Assessment, Seattle, WA 98103 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Univ Buenos Aires, CONICET, Fac Agron, IFEVA,Dept Ecol, RA-1417 Buenos Aires, DF, Argentina; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; US Forest Serv, USDA, Res Triangle Pk, NC 27709 USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; Kansas State University; Princeton University; University of Wisconsin System; University of Wisconsin Madison; University of Notre Dame; University of Michigan System; University of Michigan; National Center Atmospheric Research (NCAR) - USA; Resources for the Future; University System of Georgia; University of Georgia; Louisiana State University System; Louisiana State University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Duke University; Colorado State University; United States Department of Agriculture (USDA); United States Forest Service	Clark, JS (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jimclark@duke.edu	Lodge, David Michael/AAX-1781-2021; Rose, Kenneth/AAA-3534-2022; Pringle, Catherine M/I-1841-2012; Collins, Scott L/P-7742-2014; Carpenter, Stephen/AAQ-6404-2020; Wall, Diana H/F-5491-2011; Clark, James S./G-6331-2011; Foley, Jonathan A/GRS-5522-2022	Rose, Kenneth/0000-0002-9310-8410; Collins, Scott L/0000-0002-0193-2892; Sala, Osvaldo/0000-0003-0142-9450				Benstead JP, 1999, ECOL APPL, V9, P656, DOI 10.1890/1051-0761(1999)009[0656:EOALHD]2.0.CO;2; *BIO SERV, 1981, PRES IMPL FOR ORG SH, V2; *BIO SERV, 1981, PRES IMPL FOR ORG SH, V1; Brabets T. P, 1996, 964001 US GEOL SURV; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Clark J., UNPUB; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Dye C, 2000, SCIENCE, V289, P1697; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; HARRISON S, 1993, CONSERV BIOL, V7, P950, DOI 10.1046/j.1523-1739.1993.740950.x; JUDGE GG, 1982, THEORY PRACTICE ECON; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.2307/176998; Nakicenovic N., 2000, SPECIAL REPORT EMISS, V1, P595; Nalepa TF, 1995, J GREAT LAKES RES, V21, P411, DOI 10.1016/S0380-1330(95)71055-3; *NAT AC SCI, 2001, UND WEATH CLIM EC IN; *NAT AC SCI, 2000, GRAND CHALL ENV SCI; National Research Council, 1999, MAK CLIM FOR MATT; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; RASKIN P, 2000, 8 STOCKH ENV I POL S; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Richards J.F., 1990, EARTH TRANSFORMED HU, P163; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; SAREWITZ D, 2000, PREDICTION SCI POLIC; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Shugart H.H., 1984, THEORY FOREST DYNAMI; Stokstad E, 1999, SCIENCE, V285, P1199, DOI 10.1126/science.285.5431.1199; Strayer DL, 1999, J N AM BENTHOL SOC, V18, P74, DOI 10.2307/1468010; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Wear DN, 1998, ECOSYSTEMS, V1, P575, DOI 10.1007/s100219900052; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Wikle CK, 2001, J AM STAT ASSOC, V96, P382, DOI 10.1198/016214501753168109	45	622	658	7	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					657	660		10.1126/science.293.5530.657	http://dx.doi.org/10.1126/science.293.5530.657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474103				2022-12-01	WOS:000170204600045
J	Fernandez-Lopez, S; Kim, HS; Choi, EC; Delgado, M; Granja, JR; Khasanov, A; Kraehenbuehl, K; Long, G; Weinberger, DA; Wilcoxen, KM; Ghadiri, MR				Fernandez-Lopez, S; Kim, HS; Choi, EC; Delgado, M; Granja, JR; Khasanov, A; Kraehenbuehl, K; Long, G; Weinberger, DA; Wilcoxen, KM; Ghadiri, MR			Antibacterial agents based on the cyclic D,L-alpha-peptide architecture	NATURE			English	Article							TRANSMEMBRANE ION CHANNELS; ANTIMICROBIAL PEPTIDES; NANOTUBES; MEMBRANES; CELLS; DYES	The rapid emergence of bacterial infections that are resistant to many drugs underscores the need for new therapeutic agents(1-3). Here we report that six- and eight-residue cyclic D,L-alpha -peptides act preferentially on Gram-positive and/or Gram-negative bacterial membranes compared to mammalian cells, increase membrane permeability, collapse transmembrane ion potentials, and cause rapid cell death. The effectiveness of this class of materials as selective antibacterial agents is highlighted by the high efficacy observed against lethal methicillin-resistant Staphylococcus aureus infections in mice. Cyclic D,L-alpha -peptides are proteolytically stable, easy to synthesize, and can be derived from a potentially vast membrane-active sequence space. The unique abiotic structure of the cyclic peptides and their quick bactericidal action may also contribute to limit temporal acquirement of drug resistant bacteria. The low molecular weight D,L-alpha -peptides offer an attractive complement to the current arsenal of naturally derived antibiotics, and hold considerable potential in combating a variety of existing and emerging infectious diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu	Abrams, William R/A-5782-2008; Long, Georgina V/C-1771-2013; Granja, Juan R/P-7646-2014	Long, Georgina V/0000-0001-8894-3545; Granja, Juan R/0000-0002-5842-7504				AMSTERDAM D, 1991, ANTIBIOTICS LAB MED, P53; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Clark TD, 1998, J AM CHEM SOC, V120, P651, DOI 10.1021/ja972786f; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; GRANJA JR, 1994, J AM CHEM SOC, V116, P10785, DOI 10.1021/ja00102a054; Khurshid MA, 1999, MMWR-MORBID MORTAL W, V48, P1165; Kim HS, 1998, J AM CHEM SOC, V120, P4417, DOI 10.1021/ja9735315; KIM HS, 1999, SELF ASSEMBLING CYCL, pCH3; Koplan J. P, 1998, PREVENTING EMERGING; LOEW LM, 1994, ADV CHEM SER, V235, P151; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Oren Z, 1998, BIOPOLYMERS, V47, P451; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Seebach D, 1997, HELV CHIM ACTA, V80, P173, DOI 10.1002/hlca.19970800116; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403	22	788	821	3	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					452	455		10.1038/35086601	http://dx.doi.org/10.1038/35086601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473322				2022-12-01	WOS:000170068200052
J	Crespo-Facorro, B; Paradiso, S; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD				Crespo-Facorro, B; Paradiso, S; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD			Neural mechanisms of anhedonia in schizophrenia - A PET study of response to unpleasant and pleasant odors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL BLOOD-FLOW; NUCLEUS-ACCUMBENS; BRAIN ACTIVITY; COGNITIVE DYSMETRIA; FUNCTIONAL-ANATOMY; FACIAL EXPRESSIONS; OLFACTORY FUNCTION; <O-15>WATER PET; CEREBELLAR	Context Loss of the capacity to experience pleasure (anhedonia) is a core clinical feature of schizophrenia. Although functional imaging techniques have been successful in identifying the neural basis of cognitive impairments in schizophrenia, no attempts to date have been made to investigate neural systems underlying emotional disturbances. Objective To study the neural basis of emotional processing in schizophrenia by exploring the pattern of brain responses to olfactory stimuli in patients and healthy volunteers. Design Positron emission tomographic study of patients with schizophrenia and healthy volunteers, Positron emission tomographic data were collected between July 21, 1995, and September 11, 1997, and data analyses were conducted in 1999-2001. Setting The Mental Health Clinical Research Center at the University of Iowa, Iowa City. Participants Sixteen healthy volunteers with a mean age of 29.5; years and 18 patients with schizophrenia and a mean age of 30.0 years. Main Outcome Measure Areas of relative increase or decrease in regional cerebral blood flow, measured using positron emission tomography and the [O-15]water method while participants performed an emotion-induction olfactory task to determine response to pleasant (vanillin) and unpleasant (4-methylvaleric acid) odors, compared between patients and healthy volunteers. Results Patients with schizophrenia subjectively experienced unpleasant odors in a manner similar to healthy volunteers but showed impairment in the experience of pleasant odors. The analysis of the regional cerebral blood flow revealed that patients failed to activate limbic/paralimbic regions (eg, insular cortex, nucleus accumbens, and parahippocampal gyrus) during the experience of unpleasant odors, recruiting a compensatory set of frontal cortical regions instead. Conclusion Abnormalities in the complex functional interactions between mesolimbic and frontal regions may underlie emotional disturbances in schizophrenia.	Univ Iowa Hosp & Clin, Mental Hlth Clin Res Ctr, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Hosp Univ Marques de Valdecilla, Santander, Spain; Univ Iowa Hosp & Clin, Dept Radiol, Positron Emiss Tomog Imaging Ctr, Iowa City, IA 52242 USA	University of Iowa; Hospital Universitario Marques de Valdecilla (HUMV); University of Iowa	Andreasen, NC (corresponding author), Univ Iowa Hosp & Clin, Mental Hlth Clin Res Ctr, Coll Med, Dept Psychiat, Room 2911 JPP,200 Hawkins Dr, Iowa City, IA 52242 USA.		Crespo-Facorro, BENEDICTO/AAY-2238-2021; Paradiso, Sergio/H-9052-2012; Crespo-Facorro, BENEDICTO/GXZ-9830-2022	Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Andreasen, Nancy/0000-0001-5730-9744; O'Leary, Daniel/0000-0003-1959-6521; Ponto, Laura/0000-0003-1197-6714	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043271, P50MH043271, T32MH019113, R01MH060990] Funding Source: NIH RePORTER; NIMH NIH HHS [MH19113, MH60990, MHCRC43271] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Andreasen NC, 1999, BIOL PSYCHIAT, V46, P908, DOI 10.1016/S0006-3223(99)00152-3; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Andreasen NC, 1996, J CEREBR BLOOD F MET, V16, P804, DOI 10.1097/00004647-199609000-00005; ANDREASEN NC, 1992, J NEUROPSYCH CLIN N, V4, P125; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; ANDREASEN NC, 1993, J NEUROPSYCH CLIN N, V5, P121; ANDREASEN NC, 1995, P NATL ACAD SCI USA, V92, P5111, DOI 10.1073/pnas.92.11.5111; Andreasen NC, 1995, NEUROIMAGE, V2, P296, DOI 10.1006/nimg.1995.1037; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P754; Arndt S, 1996, J CEREBR BLOOD F MET, V16, P1271, DOI 10.1097/00004647-199611000-00023; Arnold SE, 1996, ACTA NEUROPATHOL, V92, P217, DOI 10.1007/s004010050512; BERENBAUM H, 1990, PSYCHOL MED, V20, P367, DOI 10.1017/S0033291700017682; BERTOLUCCIDANGIO M, 1990, J NEUROCHEM, V55, P1208, DOI 10.1111/j.1471-4159.1990.tb03126.x; Blanchard JJ, 1998, SCHIZOPHRENIA BULL, V24, P413, DOI 10.1093/oxfordjournals.schbul.a033336; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BROWN SL, 1979, J NERV MENT DIS, V167, P410, DOI 10.1097/00005053-197907000-00003; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; CIZADLO T, 1994, SPIE INT SOC OPTICAL, V2168, P423; CLARK DC, 1987, ANHEDONIA AFFECT DEF; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; CROW TJ, 1977, PSYCHOL MED, V7, P213, DOI 10.1017/S0033291700029287; Curtis VA, 1998, AM J PSYCHIAT, V155, P1056, DOI 10.1176/ajp.155.8.1056; Davis M, 1998, J CLIN NEUROPHYSIOL, V15, P378, DOI 10.1097/00004691-199809000-00002; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Epstein J, 1999, ANN NY ACAD SCI, V877, P562, DOI 10.1111/j.1749-6632.1999.tb09289.x; Fulbright RK, 1998, AM J NEURORADIOL, V19, P1721; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; GRAY JA, 1995, NEUROPSYCHOLOGIA, V33, P1143, DOI 10.1016/0028-3932(95)00054-7; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; HURTIG RR, 1994, J CEREBR BLOOD F MET, V14, P423, DOI 10.1038/jcbfm.1994.53; ITO M, 1993, TRENDS NEUROSCI, V16, P448, DOI 10.1016/0166-2236(93)90073-U; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kopala LC, 1998, AM J PSYCHIAT, V155, P134, DOI 10.1176/ajp.155.1.134; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; Kraepelin E., 1971, DEMENTIA PRAECOX PAR; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; LEINER HC, 1989, BEHAV NEUROSCI, V103, P998, DOI 10.1037/0735-7044.103.5.998; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Moberg PJ, 1997, AM J PSYCHIAT, V154, P1016; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Paradiso S, 1997, AM J PSYCHIAT, V154, P384; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Parent A, 1996, CARPENTERS HUMAN NEU; Qureshy A, 2000, J NEUROPHYSIOL, V84, P1656, DOI 10.1152/jn.2000.84.3.1656; RAICHLE ME, 1983, J NUCL MED, V24, P790; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; SERBY MJ, 1992, SCI OLFACTION, P410; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wollenweber SD, 1997, IEEE T NUCL SCI, V44, P1613, DOI 10.1109/23.632741; Wright IC, 1999, SCHIZOPHR RES, V35, P1, DOI 10.1016/S0920-9964(98)00094-2; YAKOVLEV PI, 1948, J NERV MENT DIS, V107, P313, DOI 10.1097/00005053-194810740-00001; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021	80	184	185	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					427	435		10.1001/jama.286.4.427	http://dx.doi.org/10.1001/jama.286.4.427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456DZ	11466121	Bronze			2022-12-01	WOS:000170069000014
J	Tishkoff, SA; Varkonyi, R; Cahinhinan, N; Abbes, S; Argyropoulos, G; Destro-Bisol, G; Drousiotou, A; Dangerfield, B; Lefranc, G; Loiselet, J; Piro, A; Stoneking, M; Tagarelli, A; Tagarelli, G; Touma, EH; Williams, SM; Clark, AG				Tishkoff, SA; Varkonyi, R; Cahinhinan, N; Abbes, S; Argyropoulos, G; Destro-Bisol, G; Drousiotou, A; Dangerfield, B; Lefranc, G; Loiselet, J; Piro, A; Stoneking, M; Tagarelli, A; Tagarelli, G; Touma, EH; Williams, SM; Clark, AG			Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance	SCIENCE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; LOCUS; POPULATION; EVOLUTION; GENE; POLYMORPHISM; SEQUENCE; SAMPLES; AFRICA	The frequencies of Low-activity alleles of glucose-6-phosphate dehydrogenase in humans are highly correlated with the prevalence of malaria. These "deficiency" alleles are thought to provide reduced risk from infection by the Plasmodium parasite and are maintained at high frequency despite the hemopathologies that they cause. Haplotype analysis of "A-" and "Med" mutations at this Locus indicates that they have evolved independently and have increased in frequency at a rate that is too rapid to be explained by random genetic drift. Statistical modeling indicates that the A- allele arose within the past 3840 to 11,760 years and the Med allele arose within the past 1600 to 6640 years. These results support the hypothesis that malaria has had a major impact on humans only since the introduction of agriculture within the past 10,000 years and provide a striking example of the signature of selection on the human genome.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Penn State Univ, Dept Biol, Inst Evolutionary Genet, University Pk, PA 16802 USA; Fac Med, Tunis, Tunisia; Inst Pasteur, Tunis, Tunisia; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Roma La Sapienza, Dept Human & Anim Biol, Rome, Italy; Cyprus Inst Neurol & Genet, Dept Biochem Genet, Nicosia, Cyprus; Univ Witwatersrand, S African Inst Med Res, Dept Human Genet, Johannesburg, South Africa; Univ Sci, Montpellier, France; CNRS, Montpellier, France; Univ St Joseph, Beirut, Lebanon; CNR, Ist Med Sperimentale & Biotecnol, Mangone, Cosenza, Italy; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; Meharry Med Coll, Dept Microbiol, Nashville, TN 37208 USA	University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sapienza University Rome; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); Saint Joseph University Beirut; Consiglio Nazionale delle Ricerche (CNR); Max Planck Society; Meharry Medical College	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, Biol Psychol Bldg, College Pk, MD 20742 USA.	st130@umail.umd.edu	Tagarelli, Giuseppe/N-8140-2015; Williams, Scott/B-9491-2012; Williams, Scott/Q-4812-2019	Tagarelli, Giuseppe/0000-0002-4792-023X; Williams, Scott/0000-0002-4835-9544; Clark, Andrew/0000-0001-7159-8511; Destro Bisol, Giovanni/0000-0002-4232-9715	FOGARTY INTERNATIONAL CENTER [T37TW000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032] Funding Source: NIH RePORTER; FIC NIH HHS [T37-TW00043] Funding Source: Medline; NCRR NIH HHS [G12-RR03032] Funding Source: Medline; NHLBI NIH HHS [HL03321] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; BEUTLER E, 1977, BLOOD, V49, P467; Brooks A., COMMUNICATION; Brooks A. S., 1990, WORLD 18000 BP, V2, P121; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; DURANDO F, 1997, ANCIENT GREECE DAWN; FILOSA S, 1993, GENOMICS, V17, P6, DOI 10.1006/geno.1993.1276; *GENB, X55448 GENB; Gillespie JH, 2000, GENETICS, V155, P909; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Luzzatto L, 2001, HEMATOLOGYONCOLOGY C, P4517, DOI [10.1016/j.hoc.2015.11.006, DOI 10.1016/J.HOC.2015.11.006]; Neuhauser C, 1997, GENETICS, V145, P519; PLATO CC, 1964, AM J HUM GENET, V16, P267; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SAUNDERS M, UNPUB; Sherman Irwin W., 1998, P3; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Spedini G, 1999, AM J PHYS ANTHROPOL, V110, P143, DOI 10.1002/(SICI)1096-8644(199910)110:2<143::AID-AJPA3>3.3.CO;2-A; STONEKING M, 1990, GENETICS, V124, P717; Tagarelli A, 2000, FEBS LETT, V466, P139, DOI 10.1016/S0014-5793(99)01776-7; Tagarelli A, 1991, Gene Geogr, V5, P141; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TOUMA E, 1997, 7 INT C INB ERR MET, P26; Verra F, 2000, MOL BIOCHEM PARASIT, V105, P149, DOI 10.1016/S0166-6851(99)00162-0; VERRELLI BC, UNPUB; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90080-N; VULLIAMY TJ, 1991, P NATL ACAD SCI USA, V88, P8568, DOI 10.1073/pnas.88.19.8568; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134; Williams SM, 2000, HYPERTENSION, V36, P2, DOI 10.1161/01.HYP.36.1.2; Yellen J.E., 1998, AFR ARCHAEOL REV, V15, P173, DOI [DOI 10.1023/, DOI 10.1023/A:1021659928822]	45	938	956	5	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					455	462		10.1126/science.1061573	http://dx.doi.org/10.1126/science.1061573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11423617				2022-12-01	WOS:000169966700037
J	Hoehler, TM; Bebout, BM; Des Marais, DJ				Hoehler, TM; Bebout, BM; Des Marais, DJ			The role of microbial mats in the production of reduced gases on the early Earth	NATURE			English	Article							OXYGEN; CYANOBACTERIA; FERMENTATION	The advent of oxygenic photosynthesis on Earth may have increased global biological productivity by a factor of 100-1,000 (ref. 1), profoundly affecting both geochemical and biological evolution. Much of this new productivity probably occurred in microbial mats, which incorporate a range of photosynthetic and anaerobic microorganisms in extremely close physical proximity(2,3). The potential contribution of these systems to global biogeochemical change would have depended on the nature of the interactions among these mat microorganisms. Here we report that in modern, cyanobacteria-dominated mats from hypersaline environments in Guerrero Negro, Mexico, photosynthetic microorganisms generate H-2 and CO-gases that provide a basis for direct chemical interactions with neighbouring chemotrophic and heterotrophic microbes(4). We also observe an unexpected flux of CH4, which is probably related to H-2-based alteration of the redox potential within the mats. These fluxes would have been most important during the nearly 2-billion-year period during which photosynthetic mats contributed substantially to biological productivity(5) -and hence, to biogeochemistry-on Earth. In particular, the large fluxes of H-2 that we observe could, with subsequent escape to space, represent a potentially important mechanism for oxidation of the primitive oceans and atmosphere.	NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Hoehler, TM (corresponding author), NASA, Ames Res Ctr, Exobiol Branch, MS 239-4, Moffett Field, CA 94035 USA.	thoehler@mail.arc.nasa.gov						Bebout B.M., 1994, MICROBIAL MATS STRUC, P265; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; COHEN Y, 1984, ANCIENT STROMATOLITE; CONRAD R, 1988, ADV MICROB ECOL, V10, P231; Des Marais D.J., 1995, ADV MICROBIAL ECOL P, P251; DesMarais DJ, 1997, REV MINERAL, V35, P429; Dolfing J., 1988, BIOL ANAEROBIC MICRO, P417; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holland H. D., 1984, CHEM EVOLUTION ATMOS; IANNOTTI EL, 1973, J BACTERIOL, V114, P1231, DOI 10.1128/JB.114.3.1231-1240.1973; LOVLEY DR, 1983, APPL ENVIRON MICROB, V45, P187, DOI 10.1128/AEM.45.1.187-192.1983; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; NEWTON W, 1977, RECENT DEV NITROGEN; Nisbet EG, 1999, P ROY SOC B-BIOL SCI, V266, P2375, DOI 10.1098/rspb.1999.0934; Schink B., 1988, BIOL ANAEROBIC MICRO, P771; Skyring G. W., 1989, MICROBIAL MATS PHYSL, P170; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; Stal LJ, 1994, MICROBIAL MATS STRUC; Walker J. C. G., 1977, EVOLUTION ATMOSPHERE; Walter M.R., 1976, STROMATOLITES; Wolin M.J., 1982, ASM NEWS, V48, P561; [No title captured]	27	175	186	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					324	327		10.1038/35085554	http://dx.doi.org/10.1038/35085554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460161				2022-12-01	WOS:000169918200044
J	Kamada, K; Shu, F; Chen, H; Malik, S; Stelzer, G; Roeder, RG; Meisterernst, M; Burley, SK				Kamada, K; Shu, F; Chen, H; Malik, S; Stelzer, G; Roeder, RG; Meisterernst, M; Burley, SK			Crystal structure of Negative Cofactor 2 recognizing the TBP-DNA transcription complex	CELL			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; YEAST TFIIA/TBP/DNA COMPLEX; HISTONE FOLD; IN-VIVO; PREINITIATION COMPLEX; GENE-TRANSCRIPTION; REPRESSOR COMPLEX; MINOR-GROOVE; BOX	The X-ray structure of a ternary complex of Negative Cofactor 2 (NC2), the TATA box binding protein (TBP), and DNA has been determined at 2.6 Angstrom resolution. The N termini of NC2 alpha and beta resemble histones H2A and H2B, respectively, and form a heterodimer that binds to the bent DNA double helix on the underside of the preformed TBP-DNA complex via electrostatic interactions. NC2 beta contributes to inhibition of TATA-dependent transcription through interactions of its C-terminal or helix with a conserved hydrophobic feature on the upper surface of TBP, which in turn positions the penultimate a helix of NC2 beta to block recognition of the TBP-DNA complex by transcription factor IIB. Further regulatory implications of the NC2 heterodimer structure are discussed.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Natl Res Ctr Environm & Hlth, Inst Immunol, Dept Gene Express, D-81377 Munich, Germany; Univ Munich, Mol Biol Lab, D-81377 Munich, Germany	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Munich; University of Munich	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.		Kamada, Katsuhiko/M-3666-2017	Kamada, Katsuhiko/0000-0001-8523-3417; Burley, Stephen/0000-0002-2487-9713				ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; DeDecker BS, 1996, J MOL BIOL, V264, P1072, DOI 10.1006/jmbi.1996.0697; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; INOSTROZA JA, 1992, CELL, V70, P477; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kaiser K, 1996, TRENDS BIOCHEM SCI, V21, P342, DOI 10.1016/0968-0004(96)10043-8; Kim J, 1996, J BIOL CHEM, V271, P18405, DOI 10.1074/jbc.271.31.18405; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; NIKOLOV DB, 1996, P NATL ACAD SCI USA, V93, P4956; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36	55	118	123	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					71	81		10.1016/S0092-8674(01)00417-2	http://dx.doi.org/10.1016/S0092-8674(01)00417-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461703	Bronze			2022-12-01	WOS:000169870300010
J	Grimm, JW; Hope, BT; Wise, RA; Shaham, Y				Grimm, JW; Hope, BT; Wise, RA; Shaham, Y			Neuroadaptation - Incubation of cocaine craving after withdrawal	NATURE			English	Article							RELAPSE; SENSITIZATION; ABSTINENCE; ADDICTION; STRESS		NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Grimm, JW (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.		shaham, yavin/G-1306-2014; Hope, Bruce T/A-9223-2010; Wise, Roy A/A-6465-2012	Hope, Bruce T/0000-0001-5804-7061; 	Intramural NIH HHS [Z01 DA000434-08] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000434] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; deWit H, 1996, EXP CLIN PSYCHOPHARM, V4, P5, DOI 10.1037/1064-1297.4.1.5; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SARNYAI Z, IN PRESS PHARM REV; SATEL SL, 1991, AM J PSYCHIAT, V148, P1712; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; STEWART J, 1983, PROG NEURO-PSYCHOPH, V7, P591, DOI 10.1016/0278-5846(83)90030-1; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6	13	695	706	3	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					141	142		10.1038/35084134	http://dx.doi.org/10.1038/35084134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449260	Green Accepted			2022-12-01	WOS:000169778700038
J	Schoener, TW; Spiller, DA; Losos, JB				Schoener, TW; Spiller, DA; Losos, JB			Predators increase the risk of catastrophic extinction of prey populations	NATURE			English	Article							TROPHIC CASCADES; COMPETITION; DIVERSITY	There has been considerable research on both top-down effects(1,2) and on disturbances(3-5) in ecological communities; however, the interaction between the two, when the disturbance is catastrophic, has rarely been examined(6). Predators may increase the probability of prey extinction resulting from a catastrophic disturbance both by reducing prey population size(7,8) and by changing ecological traits of prey individuals such as habitat characteristics(8,9) in a way that increases the vulnerability of prey species to extinction. We show that a major hurricane in the Bahamas led to the extinction of lizard populations on most islands onto which a predator had been experimentally introduced, whereas no populations became extinct on control islands. Before the hurricane, the predator had reduced prey populations to about half of those on control islands. Two months after the hurricane, we found only recently hatched individuals-apparently lizards survived the inundating storm surge only as eggs. On predator-introduction islands, those hatchling populations were a smaller fraction of pre-hurricane populations than on control islands. Egg survival allowed rapid recovery of prey populations to pre-hurricane levels on all control islands but on only a third of predator-introduction islands-the other two-thirds lost their prey populations. Thus climatic disturbance compounded by predation brought prey populations to extinction.	Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Davis; Washington University (WUSTL)	Schoener, TW (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	twschoener@ucdavis.edu						Abrams PA, 1996, AM NAT, V148, P211, DOI 10.1086/285920; Ackerman J., 2000, NAT GEOGR MAG    OCT, V198, P86; Andrewartha H.G., 1954, DISTRIBUTION ABUNDAN; Diamond J.M., 1986, COMMUNITY ECOLOGY; DUNSON WA, 1991, AM NAT, V101, P97; EVANS EW, 1982, J NEW YORK ENTOMOL S, V90, P241; FIENBERG SE, 1972, BIOMETRIKA, V59, P591, DOI 10.2307/2334810; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; HECKEL DG, 1979, ECOLOGY, V60, P966, DOI 10.2307/1936865; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Kareiva P.M., 1993, BIOTIC INTERACTIONS; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pickett S.T., 2013, ECOLOGY NATURAL DIST; Power Mary E., 1996, P286; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schoener T.W., 1987, P8; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; SCHOENER TW, 1982, OECOLOGIA, V53, P160, DOI 10.1007/BF00545659; SCHOENER TW, UNPUB ECOL MONOGR; SCHWARTZ A, 1991, AMPHIBIANS REPTILES, P424; Siegel S., 1988, NONPARAMETRIC STAT B, P128; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; WIENS JA, 1977, AM SCI, V65, P590	29	75	81	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					183	186		10.1038/35084071	http://dx.doi.org/10.1038/35084071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449274				2022-12-01	WOS:000169778700052
J	Kuypers, MMM; Blokker, P; Erbacher, J; Kinkel, H; Pancost, RD; Schouten, S; Damste, JSS				Kuypers, MMM; Blokker, P; Erbacher, J; Kinkel, H; Pancost, RD; Schouten, S; Damste, JSS			Massive expansion of marine archaea during a mid-Cretaceous oceanic anoxic event	SCIENCE			English	Article							ORGANIC-CARBON; ETHER LIPIDS; SEDIMENTS; PRODUCTS; BIOMASS; EARTH; SEA	Biogeochemical and stable carbon isotopic analysis of black-share sequences deposited during an Albian oceanic anoxic event (similar to 112 million years ago) indicate that up to 80 weight percent of sedimentary organic carbon is derived from marine, nonthermophilic archaea, The carbon-13 content of archaeal molecular fossils indicates that these archaea were Living chemoautotrophically. Their massive expansion may have been a response to the strong stratification of the ocean during this anoxic event. Indeed, the sedimentary record of archaeal membrane lipids suggests that this anoxic event marks a time in Earth history at which certain hyperthermophilic archaea adapted to low-temperature environments.	Netherlands Inst Sea Res, Dept Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Bundesanstalt Geowissensch & Rohstoffe, D-30655 Hannover, Germany	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Damste, JSS (corresponding author), Netherlands Inst Sea Res, Dept Biogeochem & Toxicol, POB 59, NL-1790 AB Den Burg, Netherlands.		Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; Pancost, Richard/0000-0003-0298-4026; Erbacher, Jochen/0000-0003-2793-0307				ARTHUR MA, 1985, NATURE, V315, P216, DOI 10.1038/315216a0; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; ARTHUR MA, 1985, AM GEOPHYS UNION MON, V32, P504; Bralower TJ, 1997, GEOL SOC AM BULL, V109, P1421, DOI 10.1130/0016-7606(1997)109<1421:MCSISO>2.3.CO;2; BRALOWER TJ, 1987, GEOL SOC LOND SPEC P, V26, P345; Damste JSS, 1997, ORG GEOCHEM, V26, P517, DOI 10.1016/S0146-6380(97)00039-9; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; Erbacher J, 2001, NATURE, V409, P325, DOI 10.1038/35053041; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Hoefs MJL, 1997, APPL ENVIRON MICROB, V63, P3090, DOI 10.1128/AEM.63.8.3090-3095.1997; Hold IM, 1998, ORG GEOCHEM, V28, P179, DOI 10.1016/S0146-6380(97)00130-7; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.0.CO;2-N; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; KUYPERS MMM, UNPUB; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; OURISSON G, 1992, ACCOUNTS CHEM RES, V25, P398, DOI 10.1021/ar00021a003; PEARSON A, 2001, GEOCHIM COSMOCHIM AC, V196, P67; SCHLANGER S O, 1976, Geologie en Mijnbouw, V55, P179; Schouten S, 1997, ORG GEOCHEM, V26, P409, DOI 10.1016/S0146-6380(97)00011-9; Schouten S, 2000, P NATL ACAD SCI USA, V97, P14421, DOI 10.1073/pnas.97.26.14421; SCHOUTEN S, UNPUB; STETTER KO, 1998, EXTREMOPHILES MICROB, pCH1; VANDERMEER MTJ, IN PRESS FEMS MICROB; Vink A, 1998, GEOCHIM COSMOCHIM AC, V62, P965, DOI 10.1016/S0016-7037(98)00034-9; VOLKMAN JK, 1986, ORG GEOCHEM, V9, P83, DOI 10.1016/0146-6380(86)90089-6	27	187	209	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					92	94		10.1126/science.1058424	http://dx.doi.org/10.1126/science.1058424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441180				2022-12-01	WOS:000169780300035
J	Lalvani, A; Pathan, AA; Durkan, H; Wilkinson, KA; Whelan, A; Deeks, JJ; Reece, WHH; Latif, M; Pasvol, G; Hill, AVS				Lalvani, A; Pathan, AA; Durkan, H; Wilkinson, KA; Whelan, A; Deeks, JJ; Reece, WHH; Latif, M; Pasvol, G; Hill, AVS			Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells	LANCET			English	Article							ESAT-6 ANTIGEN; RESPONSES; EPIDEMIOLOGY; PROTEIN; DIAGNOSIS; BOVIS; BCG	Background Identification of individuals latently infected with Mycobacterium tuberculosis is an important part of tuberculosis control. The current method, the tuberculin shin test (TST), has poor specificity because of the antigenic cross-reactivity of purified protein derivative (PPD) with M bovis BCG vaccine and environmental mycobacteria. ESAT-6 is a secreted antigen that is highly specific for M tuberculosis complex, but is absent from M bovis BCG. With an enzyme-linked immunospot (ELISPOT) assay for interferon gamma, we have identified ESAT-6-specific T cells as an accurate marker of M tuberculosis infection. Methods We did a prospective, masked study of 50 healthy contacts, with varying but well defined degrees of exposure to M tuberculosis, who attended an urban contact-tracing clinic. We assessed and compared the efficacy of our assay and TST for detection of symptomless infected individuals by correlation of test results with the degree of exposure to an infectious index case. Findings The ESAT-6 ELISPOT assay results had a strong positive relation with increasing intensity of exposure (odds ratio=9.0 per unit increase in level of exposure [95% CI 2.6-31.6], p=0.001), whereas TST results had a weaker relation with exposure (1.9 [1.0-3.5], p=0.05). By contrast, ELISPOT results were not correlated with BCG vaccination status (p=0.7), whereas TST results were significantly more likely to be positive in BCG-vaccinated contacts (12.1 [1.3-115.7], p=0.03). Interpretation This new antigen-specific T cell-based assay could allow more accurate identification of symptom-free individuals recently exposed to M tuberculosis, and thereby help to improve tuberculosis control.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Northwick Pk Hosp & Clin Res Ctr, Imperial Coll Sch Med, Wellcome Ctr Clin Trop Med, Harrow HA1 3UJ, Middx, England; Northwick Pk Hosp & Clin Res Ctr, TB Contact Tracing Clin, Harrow HA1 3UJ, Middx, England; Vet Labs Agcy, Dept Bacterial Dis, TB Res Grp, Weybridge, Surrey, England; Inst Hlth Sci, Ctr Stat Med, Oxford, England	University of Oxford; Imperial College London; Imperial College London; Veterinary Laboratories Agency; University of Oxford	Lalvani, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	ajit.lalvani@ndm.ox.ac.uk	Pasvol, Geoffrey/B-7113-2009; Whelan, Adam O/C-9497-2011; Wilkinson, Katalin/AAQ-7713-2021; Deeks, Jon/AAV-5745-2020; HILL, Adrian V>S>/C-1306-2008; Wilkinson, Katalin/AAF-6805-2020	Wilkinson, Katalin/0000-0002-9796-2040; Deeks, Jon/0000-0002-8850-1971; Lalvani, Ajit/0000-0002-2396-246X				Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brandt L, 1996, J IMMUNOL, V157, P3527; COMSTOCK GW, 1975, AM J EPIDEMIOL, V101, P363, DOI 10.1093/oxfordjournals.aje.a112105; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HMSO, 1996, IMM INF DIS; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; KWAMANGA DO, 1995, E AFR MED J, V72, P222; LAIVANI A, 2001, J INFECT DIS, V183, P469; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Ormerod P, 2000, THORAX, V55, P887; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; STEAD WW, 1978, JAMA-J AM MED ASSOC, V240, P2544, DOI 10.1001/jama.240.23.2544; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000	30	315	333	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2001	357	9273					2017	2021		10.1016/S0140-6736(00)05115-1	http://dx.doi.org/10.1016/S0140-6736(00)05115-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438135				2022-12-01	WOS:000169509200012
J	Cassell, EJ; Leon, AC; Kaufman, SG				Cassell, EJ; Leon, AC; Kaufman, SG			Preliminary evidence of impaired thinking in sick patients	ANNALS OF INTERNAL MEDICINE			English	Article							MINI-MENTAL-STATE	Background: Earlier anecdotal observations suggested to us that certain aspects of judgment in sick adults approximate the thinking of children. Objective: To describe changes in judgment associated with serious illness in otherwise competent adults. Design: Cohort study. Setting: Urban acute-care hospital and senior citizen center. Participants: sicker (Karnofsky score less than or equal to 50; n = 24) and less sick (Karnofsky score > 50; n = 39) hospitalized patients were compared with controls (n = 28). Normal performance on the Mini-Mental State Examination (score greater than or equal to 24) was required for study entrance. Measurements: Seven Piagetian tasks of judgment designed to study childhood cognitive development. Degree of sickness was determined by using the Karnofsky scale of physical function. Results: Patients with Karnofsky scores of 50 or less responded correctly to fewer Piagetian tasks than controls (mean [+/- SD], 1.8 +/- 2.6 vs. 5.9 +/- 1.6; P < 0.001). Furthermore, a smaller proportion of sicker patients responded correctly to each of the seven tasks. Patients with Karnofsky scores greater than 50 did not perform differently than controls, Conclusion: In sicker hospitalized patients, performance on seven Piagetian tasks of judgment was similar to that among children younger than 10 years of age. This evidence of cognitive impairment warrants further investigation.	Cornell Univ, Joan & Sanford I Weill Coll Med, New York, NY USA; Lynbrook Publ Sch Syst, Lynbrook, NY USA	Cornell University	Cassell, EJ (corresponding author), 28 Old Fulton St, Brooklyn, NY 11201 USA.	ecassell@email.msn.com						Bond T. G, 1997, PIAGET VYGOTSKY, P167; Burchenal J.H., 1949, EVALUATION CHEMOTHER; BURKE LE, 1991, CHILD DEV; CASSELL EJ, 1985, HEALERS ART, P38; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GINSBURG H, 1969, PIAGETS THEORY INTEL, P168; Piaget J., 1967, CHILDS CONCEPTION SP; Piaget J., 2008, PSYCHOL CHILD; Piaget J., 1950, PSYCHOL INTELLIGENCE	10	83	85	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1120	1123		10.7326/0003-4819-134-12-200106190-00012	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412052				2022-12-01	WOS:000169313200005
J	Martinek, S; Inonog, S; Manoukian, AS; Young, MW				Martinek, S; Inonog, S; Manoukian, AS; Young, MW			A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; KINASE-I-EPSILON; BEHAVIORAL RHYTHMS; PERIOD GENE; TEMPORAL EXPRESSION; WINGLESS SIGNAL; NERVOUS-SYSTEM; DOUBLE-TIME; PROTEIN; LIGHT	Tissue-specific overexpression of the glycogen synthase kinase-3 (GSK-3) ortholog shaggy (sgg) shortens the period of the Drosophila circadian locomotor activity cycle. The short period phenotype was attributed to premature nuclear translocation of the PERIOD/TIMELESS heterodimer. Reducing SGG/GSK-3 activity lengthens period, demonstrating an intrinsic role for the kinase in circadian rhythmicity. Lowered sgg activity decreased TIMELESS phosphorylation, and it was found that GSK-3 beta specifically phosphorylates TIMELESS in vitro. Overexpression of sgg in vivo converts hypophosphorylated TIMELESS to a hyperphosphorylated protein whose electrophoretic mobility, and light and phosphatase sensitivity, are indistinguishable from the rhythmically produced hyperphosphorylated TIMELESS of wild-type flies. Our results indicate a role for SGG/GSK-3 in TIMELESS phosphorylation and in the regulated nuclear translocation of the PERIOD/TIMELESS heterodimer.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn, Sci & Technol Ctr Biol Timing, New York, NY 10021 USA; Ontario Canc Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M9, Canada	Rockefeller University; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, New York, NY 10021 USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM054339] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 54339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASCHOFF J, 1965, CIRCADIAN CLOCKS, P94; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BOUROUIS M, 1990, EMBO J, V9, P2877, DOI 10.1002/j.1460-2075.1990.tb07477.x; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Giebultowicz JM, 2000, ANNU REV ENTOMOL, V45, P769, DOI 10.1146/annurev.ento.45.1.769; Hall JC, 2000, CURR OPIN NEUROBIOL, V10, P456, DOI 10.1016/S0959-4388(00)00117-3; Hardin PE, 1999, SCIENCE, V286, P2460, DOI 10.1126/science.286.5449.2460; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kaneko M, 1997, J NEUROSCI, V17, P6745; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KLOSS B, 2001, IN PRESS NEURON; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Li C, 1999, MOL CELL, V3, P77, DOI 10.1016/S1097-2765(00)80176-8; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NEWBY LM, 1993, GENETICS, V135, P1077; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2000, J BIOL RHYTHM, V15, P357, DOI 10.1177/074873000129001459; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rothenfluh A, 2000, GENETICS, V156, P665; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stanewsky R, 1997, J NEUROSCI, V17, P676; Suri V, 2000, J NEUROSCI, V20, P7547; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	61	433	445	1	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					769	779		10.1016/S0092-8674(01)00383-X	http://dx.doi.org/10.1016/S0092-8674(01)00383-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440719	Bronze			2022-12-01	WOS:000169375100010
J	Wenger, NS; Kanouse, DE; Collins, RL; Liu, HH; Schuster, MA; Gifford, AL; Bozzette, SA; Shapiro, MF				Wenger, NS; Kanouse, DE; Collins, RL; Liu, HH; Schuster, MA; Gifford, AL; Bozzette, SA; Shapiro, MF			End-of-life discussions and preferences among persons with HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; NATIONAL PROBABILITY SAMPLES; LOW-PREVALENCE DISEASES; ADVANCE DIRECTIVES; HOMOSEXUAL-MEN; CARE; COMMUNICATION; AIDS; ATTITUDES; BARRIERS	Context Deficits in advance care planning leave many patients and their physicians unprepared for decisions about end-of-life care. Even though the prognosis has im; proved for many persons with human immunodeficiency virus (HIV) infection, a need for planning remains. Objective To evaluate prevalence of end-of-life discussions, use of advance directives, and preferences concerning end-of-life care and their relationship with patient demographics, clinical status, psychosocial variables, and practitioner characteristics among HIV-infected persons. Design, Setting, and Patients Cross-sectional survey of a US probability sample of 2864, which represents 231 400 adults receiving care for HIV, conducted from January 1996 to April 1997. Main Outcome Measures Communication with physician regarding end-of-life issues, completion of an advance directive, preference for aggressiveness of care,and willingness to tolerate future permanent adverse health states. Results A total of 1432 patients (50%) discussed some aspect of end-of-life care with their practitioner and 1088 (38%) completed an advance directive. Patients were more likely to complete an advance directive after a physician discussion (odds ratio [OR], 5.82; 95% confidence interval [CI], 4.50-7.52). Practitioners discussed end-of-life care less with blacks (OR, 0.57; 95% CI, 0.39-0.83) and Latinos (OR, 0.74; 95% CI, 0.55-0.98) than with whites. Women (OR, 1.39; 95% CI, 1.05-1.84) and patients with children in the household (OR, 1.53; 95% CI, 1.12-2.10) communicated the most with practitioners about end-of-life issues. Patients infected with HIV via injection drug use (OR, 0.64; 95% CI, 0.45-0.89) and those with less education communicated the least with physicians about end-of-life issues. Less denial, greater trust in one's practitioner, and longer patient-practitioner relationship were associated with more advance care planning. Conclusions: Half of all persons infected with HIV are at risk of making end-of-life decisions without prior discussions with their health care practitioners. Blacks, Latinos, intravenous drug users, and less educated individuals need advance care planning interventions in clinical HIV programs.	Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA 90095 USA; RAND Hlth, Santa Monica, CA USA; San Diego VA Healthcare Syst, Dept Med, La Jolla, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Wenger, NS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, GIM HSR,911 Broxton Plaza, Los Angeles, CA 90095 USA.	nwenger@mednet.ucla.edu	Gifford, Allen L/D-9329-2016	Gifford, Allen L/0000-0001-6442-1128	AHRQ HHS [U-01HS08578] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BERRY SH, 1999, MR1090AHCPR RAND; Bindels PJE, 1996, LANCET, V347, P499, DOI 10.1016/S0140-6736(96)91138-1; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; COULTON CJ, 1990, J CLIN EPIDEMIOL, V43, pS51, DOI 10.1016/0895-4356(90)90219-F; Curtis JR, 1997, J GEN INTERN MED, V12, P736, DOI 10.1046/j.1525-1497.1997.07158.x; Curtis JR, 1999, AIDS, V13, P1123, DOI 10.1097/00002030-199906180-00017; Curtis JR, 2000, ARCH INTERN MED, V160, P1690, DOI 10.1001/archinte.160.11.1690; DUAN N, 1999, MR1060AHCPR RAND; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; EMANUEL LL, 1995, J AM GERIATR SOC, V43, P440, DOI 10.1111/j.1532-5415.1995.tb05821.x; FOWLER FJ, 1995, MED DECIS MAKING, V15, P195, DOI 10.1177/0272989X9501500301; Frankel MR, 1999, HEALTH SERV RES, V34, P969; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; HAAS JS, 1993, ARCH INTERN MED, V153, P1241, DOI 10.1001/archinte.153.10.1241; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Kaldjian LC, 1998, AIDS, V12, P103, DOI 10.1097/00002030-199801000-00012; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Littrell J, 1996, SOC WORK HEALTH CARE, V23, P43, DOI 10.1300/J010v23n02_03; Loue S, 1995, J LEGAL MED, V16, P461, DOI 10.1080/01947649509510990; Shapiro MF, 1999, HEALTH SERV RES, V34, P951; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SLOME L, 1992, J ACQ IMMUN DEF SYND, V5, P712; Slome LR, 1997, NEW ENGL J MED, V336, P417, DOI 10.1056/NEJM199702063360606; STEINBROOK R, 1986, NEW ENGL J MED, V314, P457, DOI 10.1056/NEJM198602133140730; TENO J, 1990, J GEN INTERN MED, V5, P490, DOI 10.1007/BF02600877; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1046/j.1525-1497.2001.00215.x; WACHTER RM, 1993, CRIT CARE CLIN, V9, P125, DOI 10.1016/S0749-0704(18)30212-4; Wilson IB, 1997, J GEN INTERN MED, V12, P784, DOI 10.1046/j.1525-1497.1997.07166.x	30	53	54	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2880	2887		10.1001/jama.285.22.2880	http://dx.doi.org/10.1001/jama.285.22.2880			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440BP	11401609				2022-12-01	WOS:000169156300027
J	Fischereder, M; Luckow, B; Hocher, B; Wuthrich, RP; Rothenpieler, U; Schneeberger, H; Panzer, U; Stahl, RAK; Hauser, IA; Budde, K; Neumayer, HH; Kramer, BK; Land, W; Schlondorff, D				Fischereder, M; Luckow, B; Hocher, B; Wuthrich, RP; Rothenpieler, U; Schneeberger, H; Panzer, U; Stahl, RAK; Hauser, IA; Budde, K; Neumayer, HH; Kramer, BK; Land, W; Schlondorff, D			CC chemokine receptor 5 and renal-transplant survival	LANCET			English	Article							HIV-1 INFECTION; FUNCTIONAL EXPRESSION; ALLOGRAFT-REJECTION; MOLECULAR-CLONING; DELETION ALLELE; RANTES; GENE; RESISTANCE; MIP-1-ALPHA; INDIVIDUALS	Background About 1% of white populations are homozygous carriers of an allele of the gene for the CC chemokine receptor 5 (CCR5) with a 32 bp deletion (CCR5 Delta 32), which leads to an inactive receptor. During acute and chronic transplant rejection, ligands for CCR5 are upregulated, and the graft is infiltrated by CCR5-positive mononuclear cells. We therefore investigated the influence of CCR5 Delta 32 on renal-transplant survival Methods Genomic DNA from peripheral-blood leucocytes of 1227 renal-transplant recipients was screened by PCR for the presence of CCR5 Delta 32. Demographic and clinical data were extracted from hospital records. Complete follow-up data were available for 576 recipients of first renal transplants. Graft survival was analysed by Fisher's exact test and Kaplan-Meier plots compared with a log-rank test. Findings PCR identified 21 patients homozygous for CCR5 Delta 32 (frequency 1.7%). One patient died with a functioning graft. Only one of the remaining patients lost transplant function during follow-up (median 7.2 years) compared with 78 of the 555 patients with a homozygous wild-type or heterozygous CCR5 Delta 32 genotype. Graft survival was significantly longer in the homozygous CCR5 Delta 32 group than in the control group (log-rank p=0.033; hazard ratio 0.367 [95% CI 0.157-0.859]). Interpretation Patients homozygous for CCR5 Delta 32; show longer survival of renal transplants than those with: other genotypes, suggesting a pathophysiological role for CCR5 in transplant Loss. This receptor may be a useful target for the prevention of transplant loss.	Univ Munchen Klinikum, Med Poliklin, D-80336 Munich, Germany; Humboldt Univ, Univ Klinikum, Charite, Berlin, Germany; Univ Spital Zurich, Zurich, Switzerland; Univ Munich, Klinikum Grosshadern, Abt Transplantat Chirurg, D-8000 Munich, Germany; Univ Hamburg, Med Klin & Poliklin, Abt Nephrol Osteol, Hamburg, Germany; Univ Regensburg Klinikum, Klin & Poliklin Innere Med 2, Regensburg, Germany; Univ Erlangen Nurnberg, Med Klin 4, Erlangen, Germany; Univ Frankfurt Klin, Med Klin 4, Funkt Bereich Nephrol, Frankfurt, Germany	University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University Zurich Hospital; University of Munich; University of Hamburg; University of Regensburg; University of Erlangen Nuremberg; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Schlondorff, D (corresponding author), Univ Munchen Klinikum, Med Poliklin, Pettenkoferstr 8A, D-80336 Munich, Germany.		Budde, Klemens/AAD-2170-2020; Hocher, Berthold/AAC-3510-2020	Budde, Klemens/0000-0002-7929-5942; Hocher, Berthold/0000-0001-8143-0579; Land, Walter Gottlieb/0000-0002-0090-0629				Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Belperio JA, 2000, J IMMUNOL, V165, P461, DOI 10.4049/jimmunol.165.1.461; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Blanpain C, 1999, BLOOD, V94, P1899; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dekel B, 1999, INT IMMUNOL, V11, P1673, DOI 10.1093/intimm/11.10.1673; Fischereder M, 1998, TRANSPLANTATION, V65, P936, DOI 10.1097/00007890-199804150-00013; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Garred P, 1998, J RHEUMATOL, V25, P1462; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Grone HJ, 1999, FASEB J, V13, P1371, DOI 10.1096/fasebj.13.11.1371; Hall IP, 1999, LANCET, V354, P1264, DOI 10.1016/S0140-6736(99)03425-X; Heidenreich S, 1998, J AM SOC NEPHROL, V9, P1309; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Murphy PM, 2000, PHARMACOL REV, V52, P145; NADEAU KC, 1995, P NATL ACAD SCI USA, V92, P8729, DOI 10.1073/pnas.92.19.8729; PATTISON J, 1994, LANCET, V343, P209, DOI 10.1016/S0140-6736(94)90992-X; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Robertson H, 1998, HISTOCHEM CELL BIOL, V110, P207, DOI 10.1007/s004180050283; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Segerer S, 1999, KIDNEY INT, V56, P52, DOI 10.1046/j.1523-1755.1999.00544.x; Sellebjerg F, 2000, J NEUROIMMUNOL, V102, P98, DOI 10.1016/S0165-5728(99)00166-6; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867	29	250	268	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1758	1761		10.1016/S0140-6736(00)04898-4	http://dx.doi.org/10.1016/S0140-6736(00)04898-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403814				2022-12-01	WOS:000169156200015
J	Strom, BL; Schinnar, R; Ziegler, EE; Barnhart, KT; Sammel, MD; Macones, GA; Stallings, VA; Drulis, JM; Nelson, SE; Hanson, SA				Strom, BL; Schinnar, R; Ziegler, EE; Barnhart, KT; Sammel, MD; Macones, GA; Stallings, VA; Drulis, JM; Nelson, SE; Hanson, SA			Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYTO-ESTROGENS; PHYTOESTROGENS; ISOFLAVONES; PROTEIN; BINDING; RELEVANCE; RECEPTORS; AFFINITY; DISEASE; CANCER	Context A large body of evidence documents the role of phytoestrogens in influencing hormone-dependent states. Infants fed soy formula receive high levels of phytoestrogens, in the form of soy isoflavones, during a stage of development at which permanent effects are theoretically possible. However, a paucity of data exists on the long-term effects of infant soy formulas. Objective To examine the association between infant exposure to soy formula and health in young adulthood, with an emphasis on reproductive health. Design, Setting, and Participants Retrospective cohort study conducted from March to August 1999 among adults aged 20 to 34 years who, as infants, participated during 1965-1978 in controlled feeding studies conducted at the University of Iowa, Iowa City (248 were fed soy formula and 563 were fed cow milk formula during infancy). Main Outcome Measures Self-reported pubertal maturation, menstrual and reproductive history, height and usual weight, and current health, compared based on type of formula exposure during infancy. Results No statistically significant differences were observed between groups in either women or men for more than 30 outcomes. However, women who had been fed soy formula reported slightly longer duration of menstrual bleeding (adjusted mean difference, 0.37 days; 95% confidence interval [CI], 0.06-0.68), with no difference in severity of menstrual flow. They also reported greater discomfort with menstruation (unadjusted relative risk for extreme discomfort vs no or mild pain, 1.77; 95% CI, 1.04-3.00). Conclusions Exposure to soy formula does not appear to lead to different general health or reproductive outcomes than exposure to cow milk formula. Although the few positive findings should be explored in future studies, our findings are reassuring about the safety of infant soy formula.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Childrens Hosp, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Iowa, Dept Pediat, Fomon Infant Nutr Unit, Iowa City, IA 52242 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Iowa	Strom, BL (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 824 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	bstrom@cceb.med.upenn.edu		Sammel, Mary/0000-0003-1248-4199	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083279] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acacio BD, 2000, FERTIL STERIL, V73, P595, DOI 10.1016/S0015-0282(99)00591-9; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.1289/ehp.95103s7103; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; CARTER MW, 1953, P SOC EXP BIOL MED, V84, P506, DOI 10.3181/00379727-84-20693; CASSIDY A, 1994, AM J CLIN NUTR, V60, P333, DOI 10.1093/ajcn/60.3.333; CHENG E, 1953, SCIENCE, V118, P164, DOI 10.1126/science.118.3058.164; DRANE H, 1975, FOOD COSMET TOXICOL, V13, P491, DOI 10.1016/S0015-6264(75)80216-1; DRANE HM, 1980, FOOD COSMET TOXICOL, V18, P425, DOI 10.1016/0015-6264(80)90201-1; FOLMAN Y, 1966, J ENDOCRINOL, V34, P215, DOI 10.1677/joe.0.0340215; FOMON SJ, 1984, PEDIATR RES, V18, P1233, DOI 10.1203/00006450-198412000-00001; FOMON SJ, 1986, J NUTR, V116, P1405, DOI 10.1093/jn/116.8.1405; FOMON SJ, 1971, ACTA PAEDIATR SCAND, P1; GAVALER JS, 1995, P SOC EXP BIOL MED, V208, P98; GREENLAND S, 1988, J CLIN EPIDEMIOL, V41, P1167, DOI 10.1016/0895-4356(88)90020-0; Huggett AC, 1997, LANCET, V350, P815, DOI 10.1016/S0140-6736(05)62613-X; Humfrey Charles D. N., 1998, Natural Toxins, V6, P51, DOI [10.1002/(SICI)1522-7189(199804)6:2<51::AID-NT11>3.3.CO;2-0, 10.1002/(SICI)1522-7189(199804)6:2<51::AID-NT11>3.0.CO;2-9]; Ingram D, 1997, LANCET, V350, P990, DOI 10.1016/S0140-6736(97)01339-1; Irvine CHG, 1998, P SOC EXP BIOL MED, V217, P247; IRVING C, 1995, NEW ZEAL MED J, V108, P208; KATZENELLENBOGEN BS, 1977, ENDOCRINOLOGY, V100, P1252, DOI 10.1210/endo-100-5-1252; Klein KO, 1998, NUTR REV, V56, P193, DOI 10.1111/j.1753-4887.1998.tb01748.x; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR, P1; Knight DC, 1996, OBSTET GYNECOL, V87, P897; McCullagh P, 2019, GEN LINEAR MODELS; MEHTA CR, 1992, AM STAT, V46, P146, DOI 10.2307/2684185; Miller R, 1981, SIMULTANEOUS STAT IN, DOI [10.1007/978-1-4613-8122-8_1, DOI 10.1007/978-1-4613-8122-8]; MOULE G. R., 1963, Anim. Breed. Abstr., V31, P139; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; North K, 2000, BJU INT, V85, P107, DOI 10.1046/j.1464-410x.2000.00436.x; ROSENBLUM ER, 1992, ALCOHOL CLIN EXP RES, V16, P843, DOI 10.1111/j.1530-0277.1992.tb01879.x; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; SETCHELL KDR, 1987, GASTROENTEROLOGY, V93, P225, DOI 10.1016/0016-5085(87)91006-7; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Sheehan DM, 1998, P SOC EXP BIOL MED, V217, P379, DOI 10.3181/00379727-217-44248; SHEMESH M, 1972, J REPROD FERTIL, V29, P1; SHUTT DA, 1972, J ENDOCRINOL, V52, P299, DOI 10.1677/joe.0.0520299; SHUTT DA, 1976, ENDEAVOUR, V35, P110, DOI 10.1016/0160-9327(76)90004-1; Siegel S., 1988, NONPARAMETRIC STAT B, V2nd; SUTHERLAND RL, 1980, NATURE, V288, P273, DOI 10.1038/288273a0; TANG BY, 1980, J ENDOCRINOL, V85, P291, DOI 10.1677/joe.0.0850291; WHITTEN PL, 1995, P SOC EXP BIOL MED, V208, P82; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	49	223	233	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					807	814		10.1001/jama.286.7.807	http://dx.doi.org/10.1001/jama.286.7.807			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497534	Bronze			2022-12-01	WOS:000170429600028
J	Heckman, DS; Geiser, DM; Eidell, BR; Stauffer, RL; Kardos, NL; Hedges, SB				Heckman, DS; Geiser, DM; Eidell, BR; Stauffer, RL; Kardos, NL; Hedges, SB			Molecular evidence for the early colonization of land by fungi and plants	SCIENCE			English	Article							DETERMINING DIVERGENCE TIMES; EARLY EVOLUTION; ORIGIN; DIVERSIFICATION; CLOCK; LIFE	The colonization of land by eukaryotes probably was facilitated by a partnership (symbiosis) between a photosynthesizing organism (phototroph) and a fungus. However, the time when colonization occurred remains speculative. The first fossil land plants and fungi appeared 480 to 460 million years ago (Ma), whereas molecular clock estimates suggest an earlier colonization of land, about 600 Ma. Our protein sequence analyses indicate that green algae and major lineages of fungi were present 1000 Ma and that land plants appeared by 700 Ma, possibly affecting Earth's atmosphere, climate, and evolution of animals in the Precambrian.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Astrobiol Res Ctr, University Pk, PA 16802 USA; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hedges, SB (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sbh1@psu.edu	Geiser, David/J-9950-2013					Alexopoulos C. J., 1996; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; Berbee ML, 2001, MYCOTA, V7, P229; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; Goremykin VV, 1997, PLANT SYST EVOL, V206, P337, DOI 10.1007/BF00987956; GRAY J, 1992, AM SCI, V80, P444; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kroken SB, 1996, AM J BOT, V83, P1241, DOI 10.2307/2446108; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kumar S., 1996, PHYLTEST PROGRAM TES; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Schwartzman D., 1999, LIFE TEMPERATURE EAR; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Watanabe Y, 2000, NATURE, V408, P574, DOI 10.1038/35046052; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	37	671	712	8	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1129	1133		10.1126/science.1061457	http://dx.doi.org/10.1126/science.1061457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498589				2022-12-01	WOS:000170432600058
J	Matzke, M; Matzke, AJM; Kooter, JM				Matzke, M; Matzke, AJM; Kooter, JM			RNA: Guiding gene silencing	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; DNA METHYLTRANSFERASES; MESSENGER-RNA; EVOLUTION; PLANTS; ARABIDOPSIS; METHYLATION; MECHANISMS; DISRUPTION; TRANSGENE	In diverse organisms, small RNAs derived from cleavage of double-stranded RNA can trigger epigenetic gene silencing in the cytoplasm and at the genome level. Small RNAs can guide posttranscriptional degradation of complementary messenger RNAs and, in plants, transcriptional gene silencing by methylation of homologous DNA sequences. RNA silencing is a potent means to counteract foreign sequences and could play an important role in plant and animal development.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Vrije Univ Amsterdam, Dept Dev Genet, Amsterdam, Netherlands	Austrian Academy of Sciences; Vrije Universiteit Amsterdam	Matzke, M (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.		Matzke, Antonius/H-8698-2015					Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Barstead R, 2001, CURR OPIN CHEM BIOL, V5, P63, DOI 10.1016/S1367-5931(00)00173-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; DAVIDSON EH, 1979, SCIENCE, V204, P1051; Doudna JA, 2000, NAT STRUCT BIOL, V7, P954, DOI 10.1038/80729; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erdmann VA, 2001, NUCLEIC ACIDS RES, V29, P189, DOI 10.1093/nar/29.1.189; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HAMMOND SM, IN PRESS SCIENCE; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; TSUCHI T, 2001, CHEMBIOCHEM, V2, P239; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	53	259	358	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1080	1083		10.1126/science.1063051	http://dx.doi.org/10.1126/science.1063051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498576				2022-12-01	WOS:000170432600044
J	Wilson, FH; Disse-Nicodeme, S; Choate, KA; Ishikawa, K; Nelson-Willams, C; Desitter, I; Gunel, M; Milford, DV; Lipkin, GW; Achard, JM; Feely, MP; Dussol, B; Berland, Y; Unwin, RJ; Mayan, H; Simon, DB; Farfel, Z; Jeunemaitre, X; Lifton, RP				Wilson, FH; Disse-Nicodeme, S; Choate, KA; Ishikawa, K; Nelson-Willams, C; Desitter, I; Gunel, M; Milford, DV; Lipkin, GW; Achard, JM; Feely, MP; Dussol, B; Berland, Y; Unwin, RJ; Mayan, H; Simon, DB; Farfel, Z; Jeunemaitre, X; Lifton, RP			Human hypertension caused by mutations in WNK kinases	SCIENCE			English	Article							PSEUDOHYPOALDOSTERONISM TYPE-II; FAMILIAL HYPERKALEMIA; CHLORIDE REABSORPTION; MULTILOCUS LINKAGE; BLOOD-PRESSURE; DEFECT; LOCUS	Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K+, and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of anti hypertensive drugs.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Coll France, INSERM, U36, F-75005 Paris, France; Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England; Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TT, W Midlands, England; Hop Amiens Sud, Serv Nephrol, Amiens, France; Gen Infirm, Unit Mol Vasc Med, Leeds LS1 3EX, W Yorkshire, England; Hop St Marguerite, Serv Nephrol & Hemodialyse, Marseille, France; UCL, Dept Nephrol, London W1W 7EY, England; UCL, Dept Physiol, London W1W 7EY, England; Tel Aviv Univ, Sheba Med Ctr, Fac Med, Dept Med E, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sheba Med Ctr, Fac Med, Biochem Pharmacol Lab, IL-52621 Tel Hashomer, Israel	Howard Hughes Medical Institute; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Birmingham; University of Birmingham; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Leeds General Infirmary; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of London; University College London; University of London; University College London; Chaim Sheba Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.	richard.ltifton@yale.edu	achard, jean-michel/A-3392-2017; JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X; Wilson, Frederick/0000-0002-5019-0186				Baima J, 1999, HYPERTENSION, V34, P4, DOI 10.1161/01.HYP.34.1.4; BAZ M, 1990, PRESSE MED, V19, P1981; Disse-Nicodeme S, 2000, AM J HUM GENET, V67, P302, DOI 10.1086/303020; FARFEL Z, 1978, ARCH INTERN MED, V138, P1828, DOI 10.1001/archinte.138.12.1828; Gordon Richard D., 1995, P2111; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE MR, 1980, LANCET, V1, P879; LEE MR, 1979, Q J MED, V48, P245; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; PAVER W K, 1964, Med J Aust, V2, P305; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; SCHUSTER VL, 1987, AM J PHYSIOL, V253, pF203, DOI 10.1152/ajprenal.1987.253.2.F203; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; TAKE C, 1991, NEW ENGL J MED, V324, P472, DOI 10.1056/NEJM199102143240707; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795	21	1082	1132	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1107	1112		10.1126/science.1062844	http://dx.doi.org/10.1126/science.1062844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498583				2022-12-01	WOS:000170432600051
J	Liquori, CL; Ricker, K; Moseley, ML; Jacobsen, JF; Kress, W; Naylor, SL; Day, JW; Ranum, LPW				Liquori, CL; Ricker, K; Moseley, ML; Jacobsen, JF; Kress, W; Naylor, SL; Day, JW; Ranum, LPW			Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9	SCIENCE			English	Article							TRINUCLEOTIDE REPEAT EXPANSION; BINDING-PROTEIN BINDS; FRAGILE-X-SYNDROME; REDUCES EXPRESSION; MESSENGER-RNA; CHROMOSOME 3Q; CTG REPEAT; MYOPATHY; LINKAGE; GENE	Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation on either chromosome 19q13 (DM1) or 3q21 (DM2/PROMM). DM1 is caused by a CTG expansion in the 3' untranslated region of the dystrophia myotonica-protein kinase gene (DMPK). Several mechanisms have been invoked to explain how this mutation, which does not alter the protein-coding portion of a gene, causes the specific constellation of clinical features characteristic of DM. We now report that DM2 is caused by a CCTG expansion (mean similar to 5000 repeats) located in intron 1 of the zinc finger protein 9 (ZNF9) gene. Parallels between these mutations indicate that microsatellite expansions in RNA can be pathogenic and cause the multisystemic features of DM1 and DM2.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol MMC 206, Minneapolis, MN 55455 USA; Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; Univ Wurzburg, Inst Human Genet, D-97070 Wurzburg, Germany; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wurzburg; University of Wurzburg; University of Texas System; University of Texas Health San Antonio	Ranum, LPW (corresponding author), Univ Minnesota, Inst Human Genet, 420 Delaware St SE, Minneapolis, MN 55455 USA.			Day, John/0000-0002-0086-9529	NCI NIH HHS [CA56266] Funding Source: Medline; NHGRI NIH HHS [HG002051] Funding Source: Medline; NINDS NIH HHS [NS35870] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alwazzan M, 1999, HUM MOL GENET, V8, P1491, DOI 10.1093/hmg/8.8.1491; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; DEMUNAIN AL, 1994, ANN NEUROL, V35, P374, DOI 10.1002/ana.410350323; FLINK IL, 1995, GENE, V163, P279, DOI 10.1016/0378-1119(95)00421-2; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; *GENB, AC022944 GENB; *GENB, M28372 GENB; *GENB, AC023598 GENB; *GENB, AF388525 GENB; *GENB, AF388526 GENB; *GENB, AF389886 GENB; *GENB, AC022993 GENB; *GENB, AF389887 GENB; Groenen P, 1998, BIOESSAYS, V20, P901, DOI 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0; Harper P.S., 1989, MYOTONIC DYSTROPHY; Helderman-van den Enden ATJM, 1999, J MED GENET, V36, P253; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moutou C, 1997, HUM MOL GENET, V6, P971, DOI 10.1093/hmg/6.7.971; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; RANUM LPW, UNPUB; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ricker K, 1999, NEUROLOGY, V52, P170, DOI 10.1212/WNL.52.1.170; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; Schneider C, 2000, NEUROLOGY, V55, P383, DOI 10.1212/WNL.55.3.383; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Steinert H., 1909, DTSCH Z NERVENHEILKU, V37, P58, DOI [10.1007/BF01671719, DOI 10.1007/BF01671719]; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WONG LJC, 1995, AM J HUM GENET, V56, P114	49	846	895	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					864	867		10.1126/science.1062125	http://dx.doi.org/10.1126/science.1062125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486088				2022-12-01	WOS:000170241000045
J	Budd, G				Budd, G			Climbing life's tree	NATURE			English	Editorial Material									Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden	Uppsala University	Budd, G (corresponding author), Uppsala Univ, Dept Earth Sci, Norbyvagen 22, SE-75236 Uppsala, Sweden.			Budd, Graham/0000-0001-9007-4369				Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Smith A.B., 1994, SYSTEMATICS FOSSIL R	2	18	19	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					487	487		10.1038/35087679	http://dx.doi.org/10.1038/35087679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484029				2022-12-01	WOS:000170202900023
J	Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B				Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B		Natl Israel Ovarian Canc Study Grp	Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; DETERMINANTS; POPULATION; OVULATION; ISRAEL; WOMEN	Background Multiparity and the use of oral contraceptives reduce the risk of ovarian cancer, but their effects on this risk in women with a BRCA1 or BRCA2 mutation are unclear. Methods We conducted a population-based case control study of ovarian cancer among Jewish women in Israel. Women were tested for the two founder mutations in BRCA1 and the one founder mutation in BRCA2 that are known to be common among Jews. We estimated the effects of parity and oral-contraceptive use on the risk of ovarian cancer in carriers and noncarriers in separate analyses that included all control women, who did not have ovarian cancer. Results Of 751 controls who underwent mutation analysis, 13 (1.7 percent) had a BRCA1 or BRCA2 mutation, whereas 244 of 840 women with ovarian cancer (29.0 percent) had a BRCA1 or BRCA2 mutation. Overall, each additional birth and each additional year of use of oral contraceptives were found to lower the risk of ovarian cancer, as expected. Additional births were protective in separate analyses of carriers and non-carriers, but oral-contraceptive use appeared to reduce the risk only in noncarriers; among carriers, the reduction in the odds of ovarian cancer was 12 percent per birth (95 percent confidence interval, 2.3 to 21 percent) and 0..2 percent per year of oral-contraceptive use (-4.9 to 5.0 percent). Conclusions The risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation decreases with each birth but not with increased duration of use of oral contraceptives. These data suggest that it is premature to use oral contraceptives for the chemoprevention of ovarian cancer in carriers of such mutations. (N Engl J Med 2001;345:235-40.) Copyright (C) 2001 Massachusetts Medical Society.	Chaim Sheba Med Ctr, Dept Clin Epidemiol, IL-52621 Tel Hashomer, Israel; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Shaare Zedek Med Ctr, Jerusalem, Israel; Sapir Med Ctr, Kefar Sava, Israel; Edith Wolfson Med Ctr, Holon, Israel	Chaim Sheba Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Modan, B (corresponding author), Chaim Sheba Med Ctr, Dept Clin Epidemiol, IL-52621 Tel Hashomer, Israel.	BModan@gcrtner.hcalth.gov.il	Struewing, Jeffery P/I-7502-2013; Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; 	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP010171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA61126-01-03, N02-CP-91026, MS N02-CP-81005, N02-CP-60534] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; ALBERT P, IN PRESS AM J EPIDEM; BOOTH M, 1989, BRIT J CANCER, V60, P592, DOI 10.1038/bjc.1989.320; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; Eeles RA, 2000, BRIT J CANCER, V83, P25; FATHALLA MF, 1971, LANCET, V2, P163; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; Godard B, 1998, AM J OBSTET GYNECOL, V179, P403, DOI 10.1016/S0002-9378(98)70372-2; GWINN ML, 1990, J CLIN EPIDEMIOL, V43, P559, DOI 10.1016/0895-4356(90)90160-Q; HARTGE P, 1989, AM J OBSTET GYNECOL, V161, P10, DOI 10.1016/0002-9378(89)90221-4; HARTGE P, 1995, BRIT J CANCER, V71, P642, DOI 10.1038/bjc.1995.126; MCGOWAN L, 1988, European Journal of Gynaecological Oncology, V9, P195; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Modan B, 1998, AM J EPIDEMIOL, V147, P1038; MORI M, 1988, AM J EPIDEMIOL, V128, P771, DOI 10.1093/oxfordjournals.aje.a115030; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; PARAZZINI F, 1991, EUR J CANCER, V27, P594, DOI 10.1016/0277-5379(91)90226-4; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Riman T, 1998, CLIN ENDOCRINOL, V49, P695, DOI 10.1046/j.1365-2265.1998.00577.x; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Salazar-Martinez E, 1999, CANCER RES, V59, P3658; Schildkraut Joellen M., 2001, Gynecologic Oncology, V80, P275; Struewing JP, 1999, AM J HUM GENET, V65, P1800, DOI 10.1086/302678; Ursin G, 1997, CANCER RES, V57, P3678; WEISS NS, 1981, INT J CANCER, V28, P669, DOI 10.1002/ijc.2910280602; WEISS NS, 1988, AM J EPIDEMIOL, V128, P451, DOI 10.1093/oxfordjournals.aje.a114993; WU ML, 1988, AM J EPIDEMIOL, V128, P1216, DOI 10.1093/oxfordjournals.aje.a115076	29	261	264	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					235	240		10.1056/NEJM200107263450401	http://dx.doi.org/10.1056/NEJM200107263450401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474660	Bronze			2022-12-01	WOS:000170054200001
J	Shelton, JD; Johnston, B				Shelton, JD; Johnston, B			Condom gap in Africa: evidence from donor agencies and key informants	BRITISH MEDICAL JOURNAL			English	Article									US Agcy Int Dev, Ctr Populat Hlth & Nutr, Washington, DC 20523 USA; Futures Grp Int, Populat Hlth & Nutr Informat Project, Washington, DC 20005 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Ctr Populat Hlth & Nutr, Washington, DC 20523 USA.							Gardner R, 1999, POPULATION REPORTS H, V9; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Sidley P, 2001, BRIT MED J, V322, P635, DOI 10.1136/bmj.322.7287.635	3	35	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					139	139		10.1136/bmj.323.7305.139	http://dx.doi.org/10.1136/bmj.323.7305.139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463681	Bronze, Green Published			2022-12-01	WOS:000170106200015
J	Ellis, DA; Mabury, SA; Martin, JW; Muir, DCG				Ellis, DA; Mabury, SA; Martin, JW; Muir, DCG			Thermolysis of fluoropolymers as a potential source of halogenated organic acids in the environment	NATURE			English	Article							TRIFLUOROACETIC-ACID; SURFACE WATERS; PRECIPITATION; RADICALS; DEGRADATION; MECHANISM; PYROLYSIS; KINETICS; OZONE; RAIN	Following the introduction of hydrochlorofluorocarbon (HCFCs) and hydrofluorocarbon (HFCs) gases as replacements for the ozone-destroying chlorofluorocarbons (CFCs), it has been discovered that HCFCs/HFCs can degrade in the atmosphere to produce trifluoroacetic acid(1), a compound with no known loss mechanisms in the environment(2,3), and higher concentrations in natural waters(4) have been shown to be mildly phytotoxic(5). Present environmental levels of trifluooracetic acid are not accounted by HCFC/HFC degradation alone(8-10). Here we report that thermolysis of fluorinated polymers, such as the commercial polymers Teflon and Kel-F, can also produce trifluoroacetate and the similar compound chlorodifluoroacetate. This can occur either directly, or indirectly via products that are known to degrade to these haloacetates in the atmosphere(11). The environmental significance of these findings is confirmed by modelling, which indicates that the thermolysis of fluoropolymers in industrial and consumer high-temperature applications (ovens, nonstick cooking utensils and combustion engines) is likely to be a significant source of trifluoroacetate in urban rain water (similar to 25 ng l(-1), as estimated for Toronto). Thermolysis also leads to longer chain polyfluoro- and/or polychlorofluoro- (C3-C14) carboxylic acids which may be equally persistent. Some of these products have recently been linked with possible adverse health(6) and environmental impacts and are being phased out of the US market(7). Furthermore, we detected CFCs and fluorocarbons- groups that can destroy ozone and act as greenhouse gases, respectively-among the other thermal degradation products, suggesting that continued use of fluoropolymers may also exacerbate stratospheric ozone-depletion and global warming.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada; Environm Canada, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada	University of Toronto; University of Guelph; Environment & Climate Change Canada; National Water Research Institute	Mabury, SA (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.		Muir, Derek/AAD-7526-2021; Martin, Jonathan W/J-3824-2013	Martin, Jonathan W/0000-0001-6265-4294; Muir, Derek/0000-0001-6631-9776				Acerboni G, 1999, CHEM PHYS LETT, V309, P364, DOI 10.1016/S0009-2614(99)00698-3; ARITO H, 1977, Annals of Occupational Hygiene, V20, P247, DOI 10.1093/annhyg/20.3.247; ATKINSON B, 1957, J CHEM SOC, P2086, DOI 10.1039/jr9570002086; Berends AG, 1999, ENVIRON TOXICOL CHEM, V18, P1053, DOI [10.1002/etc.5620180533, 10.1897/1551-5028(1999)018&lt;1053:TOTTAO&gt;2.3.CO;2]; Berg M, 2000, ENVIRON SCI TECHNOL, V34, P2675, DOI 10.1021/es990855f; Boutonnet JC, 1999, HUM ECOL RISK ASSESS, V5, P59, DOI 10.1080/10807039991289644; BROWN D, 2000, WASH POST       0517; Buravtsev NN, 1999, J FLUORINE CHEM, V96, P35, DOI 10.1016/S0022-1139(98)00325-X; Cahill TM, 2000, ENVIRON SCI TECHNOL, V34, P2909, DOI 10.1021/es991435t; Cahill TM, 2001, ENVIRON SCI TECHNOL, V35, P820, DOI 10.1021/es0013982; Ellis DA, 2000, ENVIRON SCI TECHNOL, V34, P632, DOI 10.1021/es990422c; FEIRING AE, 1994, ORGANOFLUORINE CHEM, P348; FRANKLIN J, 1993, CHEMOSPHERE, V27, P1565, DOI 10.1016/0045-6535(93)90251-Y; Holloway JH, 2000, J FLUORINE CHEM, V104, P3, DOI 10.1016/S0022-1139(00)00222-0; Hynes RG, 1999, J PHYS CHEM A, V103, P5967, DOI 10.1021/jp991065v; Imbalzano J.F, 1991, CHEM ENG PROG, V30, P69; Johns K, 2000, J FLUORINE CHEM, V104, P5, DOI 10.1016/S0022-1139(00)00251-7; Jordan A, 1999, ENVIRON SCI TECHNOL, V33, P522, DOI 10.1021/es980674y; Lemieux PM, 2000, ENVIRON SCI TECHNOL, V34, P377, DOI 10.1021/es990465t; Martin JW, 2000, ENVIRON SCI TECHNOL, V34, P274, DOI 10.1021/es990935j; Mashino M, 2000, J PHYS CHEM A, V104, P7255, DOI 10.1021/jp000498r; Paleta O, 1997, J FLUORINE CHEM, V86, P155, DOI 10.1016/S0022-1139(97)00083-3; RAVISHANKARA AR, 1993, SCIENCE, V259, P194, DOI 10.1126/science.259.5092.194; Rizvi M, 1995, J THERM ANAL, V45, P1597, DOI 10.1007/BF02547453; Schneider WF, 1996, J PHYS CHEM-US, V100, P6097, DOI 10.1021/jp952703m; Scott BF, 2000, ENVIRON SCI TECHNOL, V34, P4266, DOI 10.1021/es9908523; Simon CM, 1998, POLYM DEGRAD STABIL, V62, P1, DOI 10.1016/S0141-3910(97)00097-9; Teruel MA, 1999, INT J CHEM KINET, V31, P867, DOI 10.1002/(SICI)1097-4601(1999)31:12<867::AID-KIN5>3.0.CO;2-R; Upham BL, 1998, INT J CANCER, V78, P491, DOI 10.1002/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9; Von Sydow LM, 2000, ENVIRON SCI TECHNOL, V34, P3115, DOI 10.1021/es9913683; Wujcik CE, 1999, ENVIRON SCI TECHNOL, V33, P1747, DOI 10.1021/es980697c	31	223	232	7	118	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					321	324		10.1038/35085548	http://dx.doi.org/10.1038/35085548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460160				2022-12-01	WOS:000169918200043
J	Wang, C; Deng, L; Hong, M; Akkaraju, GR; Inoue, J; Chen, ZJJ				Wang, C; Deng, L; Hong, M; Akkaraju, GR; Inoue, J; Chen, ZJJ			TAK1 is a ubiquitin-dependent kinase of MKK and IKK	NATURE			English	Article							I-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; DEFECTIVE INTERLEUKIN-1; ACTIVATION; PROTEIN; TRAF6; INDUCTION; ALPHA; IL-1; JNK	TRAF6 is a signal transducer that activates I kappaB kinase (IKK) and Jun amino-terminal kinase (JNK) in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and lipopolysaccharides (LPS)(1-4). IKK activation by TRAF6 requires two intermediary factors, TRAF6-regulated IKK activator 1 (TRIKA1) and TRIKA2 (ref. 5). TRIKA1 is a dimeric ubiquitin-conjugating enzyme complex composed of Ubc13 and Uev1A (or the functionally equivalent Mms2). This Ubc complex, together with TRAF6, catalyses the formation of a Lys 63 (K63)-linked polyubiquitin chain that mediates IKK activation through a unique proteasome-independent mechanism(5). Here we report the purification and identification of TRIKA2, which is composed of TAK1, TAB1 and TAB2, a protein kinase complex previously implicated in IKK activation through an unknown mechanism(6,7). We find that the TAK1 kinase complex phosphorylates and activates IKK in a manner that depends on TRAF6 and Ubc13-Uev1A. Moreover, the activity of TAK1 to phosphorylate MKK6, which activates the JNK-p38 kinase pathway, is directly regulated by K63-linked polyubiquitination. We also provide evidence that TRAF6 is conjugated by the K63 polyubiquitin chains. These results indicate that ubiquitination has an important regulatory role in stress response pathways, including those of IKK and JNK.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Keio Univ, Dept Appl Chem, Kouhoku Ku, Kanagawa 2238522, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Keio University	Chen, ZJJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Akkaraju, Giridhar/0000-0003-2977-2744				Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	24	1558	1641	4	128	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					346	351		10.1038/35085597	http://dx.doi.org/10.1038/35085597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460167				2022-12-01	WOS:000169918200050
J	Humphries, SE; Talmud, PJ; Hawe, E; Bolla, M; Day, INM; Miller, GJ				Humphries, SE; Talmud, PJ; Hawe, E; Bolla, M; Day, INM; Miller, GJ			Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study	LANCET			English	Article							DIAGONAL GEL-ELECTROPHORESIS; APOE-DEFICIENT MICE; ALZHEIMERS-DISEASE; E POLYMORPHISM; MYOCARDIAL-INFARCTION; RISK; LIPOPROTEIN; ATHEROSCLEROSIS; AUTOANTIBODIES; ACTIVATION	Background The common isoforms of apolipoprotein E (apoE), E2, E3, and E4, are important determinants of plasma lipid concentrations, and the epsilon4 allele is associated with raised risk of coronary heart disease. We investigated whether the effect of smoking on coronary heart disease risk is affected by APOE genotype. Methods We enrolled 3052 middle-aged men who were free of coronary heart disease for prospective cardiovascular surveillance in the second Northwick Park Heart Study (NPHSII). Smoking habit was ascertained at baseline and yearly by questionnaire. APOE genotype was identified by PCR and restriction enzyme digestion. Endpoints were fatal coronary heart disease, non-fatal myocardial infarction, and coronary artery surgery and silent myocardial infarction at follow-up. Findings During 18 836 person years of surveillance, 96 men had an acute myocardial infarction, 26 needed coronary artery surgery, and 14 had silent myocardial infarctions. Compared with never-smokers, risk of coronary heart disease in ex-smokers was 1.34 (95% CI 0.86-2.08) and in smokers it was 1.94 (1.25-3.01). This risk was independent of other classic risk factors. In never-smokers, risk was closely similar in men with different genotypes. Risk in men homozygous for the epsilon3 allele was 1.74 (1.10-2.77) in ex-smokers and 1.68 (1.01-2.83) in smokers, whereas in men carrying the epsilon4 allele risk was 0.84 (0.40-1.75) and 3.17 (1.82-5.50), respectively, with no significant differences in risk in the epsilon2 carriers. For the epsilon3 group, the genotype effect on risk was no longer significant after adjustment for classic risk factors (including plasma lipids). However. even after adjustment. smokers who were carriers of the epsilon4 allele, showed significantly raised risk of coronary heart disease compared with the non-smoking group (2.79, 1.59-4.91, epsilon4-smoking interaction p=0.007). Interpretation Smoking increases the risk of coronary heart disease in men of all genotypes but particularly in men carrying the epsilon4 allele.	Royal Free & UCL, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England; St Bartholomews Hosp, Coll Med, Wolfson Inst Prevent Med, MRC Epidemiol & Med Care Unit, London, England; Southampton Univ Hosp NHS Trust & Sch Med, Human Genet Res Div, Southampton, Hants, England	University of London; King's College London; University College London; UCL Medical School; University of London; Queen Mary University London; University of Southampton	Humphries, SE (corresponding author), Royal Free & UCL, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England.	rmhaseh@ucl.ac.uk	Talmud, Philippa J/C-4402-2008; Humphries, Stephen E/C-5075-2008	Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547	NHLBI NIH HHS [HL 33014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN DR, 1988, J VASC SURG, V7, P139, DOI 10.1067/mva.1988.avs0070139; BLANN AD, 1992, ATHEROSCLEROSIS, V96, P249, DOI 10.1016/0021-9150(92)90072-O; BOLLA MK, 1995, CLIN CHEM, V41, P1599; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DALMON J, 1993, MOL CELL BIOL, V13, P1183, DOI 10.1128/MCB.13.2.1183; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAY INM, 1994, ANAL BIOCHEM, V222, P389, DOI 10.1006/abio.1994.1507; Desurmont C, 2000, ARTERIOSCL THROM VAS, V20, P435, DOI 10.1161/01.ATV.20.2.435; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; DOLL RICHARD, 1966, NAT CANCER INST MONOGR, V19, P205; Eliasson B, 1997, ATHEROSCLEROSIS, V129, P79, DOI 10.1016/S0021-9150(96)06028-5; Fickl H, 1996, ATHEROSCLEROSIS, V124, P75, DOI 10.1016/0021-9150(96)05820-0; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Haffer S., 1996, ARTERIOSCLER THROMB, V58, P585; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Kessler C, 1997, ARTERIOSCL THROM VAS, V17, P2880, DOI 10.1161/01.ATV.17.11.2880; Lowe Gordon D. O., 1993, Current Opinion in Lipidology, V4, P283, DOI 10.1097/00041433-199308000-00004; MILLER GJ, 1995, THROMB HAEMOSTASIS, V73, P82; Miller GJ, 1996, THROMB HAEMOSTASIS, V75, P767; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; *MRC COMM RES CHRO, 1976, QUEST RESP SYMPT; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Prineas R.J., 1982, MINNESOTA CODE MANUA; Seed M, 2001, AM J MED, V110, P22, DOI 10.1016/S0002-9343(00)00652-5; Smith JD, 1998, INT J CLIN LAB RES, V28, P116, DOI 10.1007/s005990050030; Stengard JH, 1999, CLIN GENET, V56, P367; Talmud PJ, 2000, ATHEROSCLEROSIS, V149, P75, DOI 10.1016/S0021-9150(99)00309-3; Terry JG, 1996, STROKE, V27, P1755, DOI 10.1161/01.STR.27.10.1755; *WHO REG OFF EUR, 1976, MYOC INF COMM REG; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	36	197	211	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					115	119		10.1016/S0140-6736(01)05330-2	http://dx.doi.org/10.1016/S0140-6736(01)05330-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463413				2022-12-01	WOS:000169837700012
J	Humpherys, D; Eggan, K; Akutsu, H; Hochedlinger, K; Rideout, WM; Biniszkiewicz, D; Yanagimachi, R; Jaenisch, R				Humpherys, D; Eggan, K; Akutsu, H; Hochedlinger, K; Rideout, WM; Biniszkiewicz, D; Yanagimachi, R; Jaenisch, R			Epigenetic instability in ES cells and cloned mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; SOMATIC-CELLS; H19 GENE; ADULT; METHYLATION; CLONING; MOUSE; FETAL; EXPRESSION	Cloning by nuclear transfer (NT) is an inefficient process in which most clones die before birth and survivors often display growth abnormalities. In an effort to correlate gene expression with survival and fetal overgrowth, we have examined imprinted gene expression in both mice cloned by nuclear transfer and in the embryonic stem (ES) cell donor populations from which they were derived. The epigenetic state of the ES cell genome was found to be extremely unstable. Similarly, variation in imprinted gene expression was observed in most cloned mice, even in those derived from ES cells of the same subclone. Many of the animals survived to adulthood despite widespread gene dysregulation, indicating that mammalian development may be rather tolerant to epigenetic aberrations of the genome. These data imply that even apparently normal cloned animals may have subtle abnormalities in gene expression.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Hawaii, John A Burns Sch Med, Dept Anat & Reprod Biol, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Hawaii System	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Eggan, Kevin/P-7119-2018		NCI NIH HHS [5-R35-CA44339, R01-CA84198] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084198, R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Dean W, 1998, DEVELOPMENT, V125, P2273; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kono T, 1998, REPROD FERT DEVELOP, V10, P593, DOI 10.1071/RD98056; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Young LE, 2000, THERIOGENOLOGY, V53, P627, DOI 10.1016/S0093-691X(99)00263-0; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	24	558	612	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					95	97		10.1126/science.1061402	http://dx.doi.org/10.1126/science.1061402			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441181				2022-12-01	WOS:000169780300036
J	Bicknell, AB; Lomthaisong, K; Woods, RJ; Hutchinson, EG; Bennett, HPJ; Gladwell, RT; Lowry, PJ				Bicknell, AB; Lomthaisong, K; Woods, RJ; Hutchinson, EG; Bennett, HPJ; Gladwell, RT; Lowry, PJ			Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth	CELL			English	Article							PANCREATIC TRYPSIN-INHIBITOR; PROOPIOMELANOCORTIN PEPTIDES; UNILATERAL ADRENALECTOMY; CRYSTAL-STRUCTURE; RAT; EXPRESSION; CORTEX; ADRENOCORTICOTROPIN; DEXAMETHASONE; HYPERTROPHY	The adrenal gland requires stimuli from peptides derived from the ACTH precursor, pro-opiomelanocortin (POMC), to maintain its tonic state. Studies have proposed that a specific postsecretional cleavage of the nonmitogenic N-terminal 16 kDa fragment, also known as pro-gamma -melanotropin (pro-gamma -MSH), is required, releasing shorter fragments that promote adrenal growth. Here, we provide evidence for this hypothesis by the cloning and characterization of a serine protease that is upregulated during growth of the adrenal cortex. It is expressed exclusively in the outer adrenal cortex, the site of cell proliferation, and in the Y1 adrenal cell line. We also show that it is required for growth of Y1 cells, remains bound to the cell surface, and cleaves its substrate, pro-gamma -MSH, at a specific bond.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; McGill Univ, Montreal, PQ, Canada	University of Reading; McGill University	Bicknell, AB (corresponding author), Univ Reading, Sch Anim & Microbial Sci, POB 228, Reading RG6 6AJ, Berks, England.	a.b.bicknell@rdg.ac.uk		Lomthaisong, Khomsorn/0000-0002-0645-5757				Bicknell AB, 2000, J NEUROENDOCRINOL, V12, P977, DOI 10.1046/j.1365-2826.2000.00543.x; BODE W, 1984, EUR J BIOCHEM, V144, P185, DOI 10.1111/j.1432-1033.1984.tb08447.x; BRANSOME ED, 1968, ENDOCRINOLOGY, V83, P956, DOI 10.1210/endo-83-5-956; BROWN JR, 1966, BIOCHEM J, V101, P933; DALLMAN MF, 1980, ENDOCRINOLOGY, V107, P1397, DOI 10.1210/endo-107-5-1397; DALLMAN MF, 1976, AM J PHYSIOL, V231, P408, DOI 10.1152/ajplegacy.1976.231.2.408; DUNLAP NE, 1984, ENDOCRINOLOGY, V114, P1490, DOI 10.1210/endo-114-5-1490; ESTIVARIZ FE, 1982, NATURE, V297, P419, DOI 10.1038/297419a0; ESTIVARIZ FE, 1992, ADRENAL GLAND, P43; HOLZWARTH M, 1988, INT CONGR SER, V799, P841; HORNSBY P J, 1984, Endocrine Research, V10, P259; JAMES S, 1985, J CHROMATOGR, V326, P329, DOI 10.1016/S0021-9673(01)87458-6; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRISTENSEN P, 1986, HISTOCHEMISTRY, V85, P431, DOI 10.1007/BF00982674; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; LIPSCOMB HS, 1968, EXCERPTA MED, V222, P79; LOWRY PJ, 1983, NATURE, V306, P70, DOI 10.1038/306070a0; MIN HY, 1986, NUCLEIC ACIDS RES, V14, P8879; Morley SD, 1996, MOL ENDOCRINOL, V10, P585, DOI 10.1210/me.10.5.585; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; PELLEGRINO C, 1963, EXP CELL RES, V31, P167, DOI 10.1016/0014-4827(63)90165-4; RAO AJ, 1978, ENDOCRINOLOGY, V102, P371, DOI 10.1210/endo-102-2-371; Ross JT, 2000, ENDOCRINOLOGY, V141, P2153, DOI 10.1210/en.141.6.2153; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; SAPHIER PW, 1993, ENDOCRINOLOGY, V133, P1459, DOI 10.1210/en.133.3.1459; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; VINSON GP, 1985, CELL BIOCHEM FUNCT, V3, P235, DOI 10.1002/cbf.290030402; WRIGHT NA, 1974, J ENDOCRINOL, V62, P527, DOI 10.1677/joe.0.0620527; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	31	103	105	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					903	912		10.1016/S0092-8674(01)00403-2	http://dx.doi.org/10.1016/S0092-8674(01)00403-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439186	Bronze			2022-12-01	WOS:000169664300010
J	Mayfield, JA; Fiebig, A; Johnstone, SE; Preuss, D				Mayfield, JA; Fiebig, A; Johnstone, SE; Preuss, D			Gene families from the Arabidopsis thaliana pollen coat proteome	SCIENCE			English	Article							INTRAGENIC RECOMBINATION; STIGMA INTERACTIONS; ALLELIC DIVERSITY; RAPID EVOLUTION; SELECTION; LOCUS; RESISTANCE; PROTEINS; REVEALS; GENOME	The pollen extracellular matrix contains proteins mediating species specificity and components needed for efficient pollination. We identified all proteins >10 kilodaltons in the Arabidopsis pollen coating and showed that most of the corresponding genes reside in two genomic clusters. One cluster encodes six Lipases, whereas the other contains six lipid-binding oleosin genes, including GRP17, a gene that promotes efficient pollination. Individual oleosins exhibit extensive divergence between eco types, but the entire cluster remains intact. Analysis of the syntenic region in Brassica oleracea revealed even greater divergence, but a similar clustering of the genes. Such allelic flexibility may promote speciation in plants.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Preuss, D (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	dpreuss@midway.uchicago.edu		Mayfield, Jacob/0000-0002-5762-6755; Fiebig, Aretha/0000-0002-0612-5029				Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; DEOLIVEIRA DE, 1993, PLANT J, V3, P495, DOI 10.1046/j.1365-313X.1993.03040495.x; Dickinson HG, 2000, TRENDS GENET, V16, P373, DOI 10.1016/S0168-9525(00)02083-7; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Kasahara M, 1997, TRENDS GENET, V13, P90, DOI 10.1016/S0168-9525(97)01065-2; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Richman AD, 1996, SCIENCE, V273, P1212, DOI 10.1126/science.273.5279.1212; Ruiter RK, 1997, PLANT CELL, V9, P1621, DOI 10.1105/tpc.9.9.1621; SommerKnudsen J, 1997, SEX PLANT REPROD, V10, P253, DOI 10.1007/s004970050095; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wang X, 2001, PLANT PHYSIOL, V125, P1012, DOI 10.1104/pp.125.2.1012; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zinkl GM, 2000, ANN BOT-LONDON, V85, P15, DOI 10.1006/anbo.1999.1066	22	163	194	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2482	2485		10.1126/science.1060972	http://dx.doi.org/10.1126/science.1060972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431566				2022-12-01	WOS:000169658200039
J	Trimmer, BA; Aprille, JR; Dudzinski, DM; Lagace, CJ; Lewis, SM; Michel, T; Qazi, S; Zayas, RM				Trimmer, BA; Aprille, JR; Dudzinski, DM; Lagace, CJ; Lewis, SM; Michel, T; Qazi, S; Zayas, RM			Nitric oxide and the control of firefly flashing	SCIENCE			English	Article							MITOCHONDRIAL RESPIRATION; MANDUCA-SEXTA; OCTOPAMINE; DROSOPHILA; NEURONS; INHIBITION; SYNTHASE; OXYGEN	Bioluminescent flashing is essential for firefly reproduction, yet the specific molecular mechanisms that control Light production are not well understood. We report that Light production by fireflies can be stimulated by nitric oxide (NO) gas in the presence of oxygen and that NO scavengers block bioluminescence induced by the neurotransmitter octopamine, NO synthase is robustly expressed in the firefly Lantern in cells interposed between nerve endings and the light-producing photocytes, These results suggest that NO synthesis is a key determinant of flash control in fireflies.	Tufts Univ, Dept Biol, Medford, MA 02155 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA	Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Trimmer, BA (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.			Zayas, Ricardo M./0000-0002-6272-0519; Trimmer, Barry/0000-0003-1782-7373				Achenbach H, 1997, NEUROREPORT, V8, P3737, DOI 10.1097/00001756-199712010-00016; Bicker G, 1998, TRENDS NEUROSCI, V21, P349, DOI 10.1016/S0166-2236(98)01236-3; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Branham MA, 1996, NATURE, V381, P745, DOI 10.1038/381745b0; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; BUCK JB, 1948, ANN NY ACAD SCI, V49, P397, DOI 10.1111/j.1749-6632.1948.tb30944.x; Case J.F., 1978, P331; CHRISTENSEN TA, 1983, NEUROSCIENCE, V9, P183, DOI 10.1016/0306-4522(83)90055-6; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1999, P NATL ACAD SCI USA, V96, P1559, DOI 10.1073/pnas.96.4.1559; COPE FW, 1976, PHYSIOL CHEM PHYS M, V8, P343; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P363; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Grueber WB, 1999, J COMP NEUROL, V404, P127, DOI 10.1002/(SICI)1096-9861(19990201)404:1<127::AID-CNE10>3.0.CO;2-M; HASEMZADEH H, 1985, LIFE SCI, V37, P433; Lloyd J.E., 1979, P293; MULLER U, 1994, EUR J NEUROSCI, V6, P1362, DOI 10.1111/j.1460-9568.1994.tb00327.x; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; SMITH DS, 1963, J CELL BIOL, V16, P323, DOI 10.1083/jcb.16.2.323; VAUGHN M, 1998, AM J PHYSIOL, V274, P1705; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Zayas RM, 2000, J COMP NEUROL, V419, P422	25	103	111	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2486	2488		10.1126/science.1059833	http://dx.doi.org/10.1126/science.1059833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11431567				2022-12-01	WOS:000169658200040
J	Yeh, JC; Hiraoka, N; Petryniak, B; Nakayama, J; Ellies, LG; Rabuka, D; Hindsgaul, O; Marth, JD; Lowe, JB; Fukuda, M				Yeh, JC; Hiraoka, N; Petryniak, B; Nakayama, J; Ellies, LG; Rabuka, D; Hindsgaul, O; Marth, JD; Lowe, JB; Fukuda, M			Novel sulfated lymphocyte homing receptors and their control by a core1 extension beta 1,3-N-acetylglucosaminyltransferase	CELL			English	Article							POLY-N-ACETYLLACTOSAMINE; HIGH ENDOTHELIAL VENULES; L-SELECTIN; MOLECULAR-CLONING; HEPARAN-SULFATE; FUNCTIONAL-CHARACTERIZATION; SULFOTRANSFERASE GENE; LEUKOCYTE TRAFFICKING; MONOCLONAL-ANTIBODY; EXPRESSION CLONING	L-selectin mediates lymphocyte homing by facilitating lymphocyte adhesion to addressins expressed in the high endothelial venules (HEV) of secondary lymphoid organs. Peripheral node addressin recognized by the MECA-79 antibody is apparently part of the L-selectin ligand, but its chemical nature has been undefined. We now identify a sulfated extended core1 mucin-type O-glycan, Gal beta1-->4(sulfo-->6)GlcNAc beta1-->3Gal beta1--> 3GalNAc, as the MECA-79 epitope. Molecular cloning of a HEV-expressed core1-beta1,3-N-acetylglucosaminyltransferase (Core1-beta 3GlcNAcT) enabled the construction of the 6-sulfo sialyl Lewis x on extended core1 O-glycans, recapitulating the potent L-selectin-mediated, shear-dependent adhesion observed with novel L-selectin ligands derived from core2 beta1,6-N-acetylglucosaminyltransferase-I null mice. These results identify Core1-beta 3GlcNAcT and its cognate extended core1 O-glycans as essential participants in the expression of the MECA-79-positive, HEV-specific L-selectin ligands required for lymphocyte homing.	Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Dept Pathol, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan; Univ Calif San Diego, Howard Hughes Med Inst, Div Cellular & Mol Med, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Shinshu University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Fukuda, M (corresponding author), Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [R01CA048737, F32CA079130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NCI NIH HHS [F32CA79130, P01CA79132, CA48737] Funding Source: Medline; NIDDK NIH HHS [DK48247] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; IMAI Y, 1993, NATURE, V361, P555; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kumamoto K, 1998, BIOCHEM BIOPH RES CO, V247, P514, DOI 10.1006/bbrc.1998.8824; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; LEE N, 1990, J BIOL CHEM, V265, P20476; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Misra AK, 2000, BIOORG MED CHEM LETT, V10, P1505, DOI 10.1016/S0960-894X(00)00207-9; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; SCHACHTER H, 1994, MOL GLYCOBIOLOGY, P88; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Ujita M, 2000, J BIOL CHEM, V275, P15868, DOI 10.1074/jbc.M001034200; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; WATANABE K, 1979, J BIOL CHEM, V254, P3221; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zhou DP, 1999, P NATL ACAD SCI USA, V96, P406, DOI 10.1073/pnas.96.2.406	51	283	297	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					957	969		10.1016/S0092-8674(01)00394-4	http://dx.doi.org/10.1016/S0092-8674(01)00394-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439191	Bronze			2022-12-01	WOS:000169664300015
J	Brookfield, JFY				Brookfield, JFY			Predicting the future	NATURE			English	Editorial Material									Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England	University of Nottingham	Brookfield, JFY (corresponding author), Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England.							Maynard Smith, 1998, EVOL GENET	1	6	6	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					999	999		10.1038/35082701	http://dx.doi.org/10.1038/35082701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429579				2022-12-01	WOS:000169528500024
J	Oliver, D; He, DZZ; Klocker, N; Ludwig, J; Schulte, U; Waldegger, S; Ruppersberg, JP; Dallos, P; Fakler, B				Oliver, D; He, DZZ; Klocker, N; Ludwig, J; Schulte, U; Waldegger, S; Ruppersberg, JP; Dallos, P; Fakler, B			Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein	SCIENCE			English	Article							CHANNELS; MOTILITY; CAPACITANCE; SALICYLATE; MECHANISM; COCHLEA	Outer hair cells (OHCs) of the mammalian cochlea actively change their cell Length in response to changes in membrane potential. This electromotility, thought to be the basis of cochlear amplification, is mediated by a voltage-sensitive motor molecule recently identified as the membrane protein prestin. Here, we show that voltage sensitivity is conferred to prestin by the intracellular anions chloride and bicarbonate. Removal of these anions abolished fast voltage-dependent motility, as well as the characteristic nonlinear charge movement ("gating currents") driving the underlying structural rearrangements of the protein. The results support a model in which anions act as extrinsic voltage sensors, which bind to the prestin molecule and thus trigger the conformational changes required for motility of OHCs.	Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Univ Marburg, Ctr Pediat, D-35037 Marburg, Germany; Northwestern Univ, Dept Neurobiol & Physiol, Auditory Physiol Lab, Evanston, IL 60208 USA	Eberhard Karls University of Tubingen; Boys Town National Research Hospital; Philipps University Marburg; Northwestern University	Fakler, B (corresponding author), Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany.		Oliver, Dominik/F-5845-2013; Dallos, Peter/Q-9360-2019; Ludwig, Jost/K-3446-2017	Oliver, Dominik/0000-0002-8368-0923; Dallos, Peter/0000-0002-9731-6591; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIDCD NIH HHS [DC00089] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J. F., 1989, MECH HEARING, P107; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DALLOS P, 1992, J NEUROSCI, V12, P4575; Fahlke C, 1997, J GEN PHYSIOL, V110, P551, DOI 10.1085/jgp.110.5.551; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; HE D, UNPUB; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; HERRINGTON JD, 1995, PULSE CONTROL V4 7; IWASA KH, 1994, J ACOUST SOC AM, V96, P2216, DOI 10.1121/1.410094; Kakehata S, 1996, J NEUROSCI, V16, P4881; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Klocker N, 2001, MOL CELL NEUROSCI, V17, P514, DOI 10.1006/mcne.2000.0956; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; OLIVER D, UNPUB; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Waldegger S, 2001, GENOMICS, V72, P43, DOI 10.1006/geno.2000.6445; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	26	344	359	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2340	2343		10.1126/science.1060939	http://dx.doi.org/10.1126/science.1060939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423665				2022-12-01	WOS:000169455900061
J	VanDemark, AP; Hofmann, RM; Tsui, C; Pickart, CM; Wolberger, C				VanDemark, AP; Hofmann, RM; Tsui, C; Pickart, CM; Wolberger, C			Molecular insights into polyubiquitin chain assembly: Crystal structure of the Mms2/Ubc13 heterodimer	CELL			English	Article							UBIQUITIN-CONJUGATING-ENZYME; RING FINGER PROTEINS; DNA-REPAIR; MULTIUBIQUITIN CHAIN; PROTEOLYSIS; COMPLEX; RAD6; GENE; INHIBITION; PROGRAM	While the signaling properties of ubiquitin depend on the topology of polyubiquitin chains, little is known concerning the molecular basis of specificity in chain assembly and recognition. UEV/Ubc complexes have been implicated in the assembly of Lys63-linked polyubiquitin chains that act as a novel signal in postreplicative DNA repair and I kappaB alpha kinase activation. The crystal structure of the Mms2/Ubc13 heterodimer shows the active site of Ubc13 at the intersection of two channels that are potential binding sites for the two substrate ubiquitins. Mutations that destabilize the heterodimer interface confer a marked UV sensitivity, providing direct evidence that the intact heterodimer is necessary for DNA repair. Selective mutations in the channels suggest a molecular model for specificity in the assembly of Lys63-linked polyubiquitin signals.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		VanDemark, Andrew/0000-0003-3424-4831; Wolberger, Cynthia/0000-0001-8578-2969	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060372] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60372] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; COOK WJ, 1992, J BIOL CHEM, V267, P15116; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Jiang F, 1999, BIOCHEMISTRY-US, V38, P6471, DOI 10.1021/bi9901329; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thomson TM, 1998, FEBS LETT, V423, P49, DOI 10.1016/S0014-5793(98)00060-X; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Worthylake DR, 1998, J BIOL CHEM, V273, P6271, DOI 10.1074/jbc.273.11.6271; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908; Xiao W, 2000, GENETICS, V155, P1633; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	253	264	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					711	720		10.1016/S0092-8674(01)00387-7	http://dx.doi.org/10.1016/S0092-8674(01)00387-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440714	Bronze			2022-12-01	WOS:000169375100005
J	Hogberg, P; Nordgren, A; Buchmann, N; Taylor, AFS; Ekblad, A; Hogberg, MN; Nyberg, G; Ottosson-Lofvenius, M; Read, DJ				Hogberg, P; Nordgren, A; Buchmann, N; Taylor, AFS; Ekblad, A; Hogberg, MN; Nyberg, G; Ottosson-Lofvenius, M; Read, DJ			Large-scale forest girdling shows that current photosynthesis drives soil respiration	NATURE			English	Article							CARBON BALANCE; TEMPERATURE SENSITIVITY; ROOTS	The respiratory activities of plant roots, of their mycorrhizal fungi and of the free-living microbial heterotrophs (decomposers) in soils are significant components of the global carbon balance, but their relative contributions remain uncertain(1,2). To separate mycorrhizal root respiration from heterotrophic respiration in a boreal pine forest, we conducted a large-scale tree-girdling experiment, comprising 9 plots each containing about 120 trees. Tree-girdling involves stripping the stem bark to the depth of the current xylem at breast height terminating the supply of current photosynthates to roots and their mycorrhizal fungi without physically disturbing the delicate root-microbe-soil system. Here we report that girdling reduced soil respiration within 1-2 months by about 54% relative to respiration on ungirdled control plots, and that decreases of up to 37% were detected within 5 days. These values clearly show that the flux of current assimilates to roots is a key driver of soil respiration; they are conservative estimates of root respiration, however, because girdling increased the use of starch reserves in the roots. Our results indicate that models of soil respiration should incorporate measures of photosynthesis and of seasonal patterns of photosynthate allocation to roots.	SLU, Depr Forest Ecol, Sect Soil Sci, SE-90183 Umea, Sweden; Max Planck Inst Biogeochem, D-07701 Jena, Germany; SLU, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Swedish University of Agricultural Sciences; Max Planck Society; Swedish University of Agricultural Sciences; University of Sheffield	Hogberg, P (corresponding author), SLU, Depr Forest Ecol, Sect Soil Sci, SE-90183 Umea, Sweden.		Högberg, Peter/B-2916-2012; Högberg, Mona N./L-9635-2014; Read, David/C-2454-2013; Buchmann, Nina/E-6095-2011; Ekblad, Alf/AAG-2632-2019	Högberg, Peter/0000-0002-2849-2719; Högberg, Mona N./0000-0003-1258-7630; Buchmann, Nina/0000-0003-0826-2980; Nyberg, Gert/0000-0003-1979-8772				Agren G. I., 1980, Ecological Bulletins, V32, P307; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Craine JM, 1999, PLANT SOIL, V207, P77, DOI 10.1023/A:1004417419288; EDWARDS NT, 1979, OECOLOGIA, V40, P247, DOI 10.1007/BF00345322; Ericsson A., 1980, Ecological Bulletins, V32, P239; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hansen J., 1997, P97; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hogberg P, 1996, SOIL BIOL BIOCHEM, V28, P1131, DOI 10.1016/0038-0717(96)00124-1; Lindroth A, 1998, GLOBAL CHANGE BIOL, V4, P443, DOI 10.1046/j.1365-2486.1998.00165.x; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Plamboeck AH, 1999, OECOLOGIA, V119, P452, DOI 10.1007/s004420050807; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Smith SE, 1997, MYCORRHIZAL SYMBIOSE; SODERSTROM B, 1987, SOIL BIOL BIOCHEM, V19, P231, DOI 10.1016/0038-0717(87)90002-2; STEEN E, 1986, NEW PHYTOL, V104, P339, DOI 10.1111/j.1469-8137.1986.tb02901.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	18	1391	1536	21	692	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					789	792		10.1038/35081058	http://dx.doi.org/10.1038/35081058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459055				2022-12-01	WOS:000169246400046
J	Litt, MD; Simpson, M; Gaszner, M; Allis, CD; Felsenfeld, G				Litt, MD; Simpson, M; Gaszner, M; Allis, CD; Felsenfeld, G			Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus	SCIENCE			English	Article							ENHANCER-BLOCKING ACTIVITY; INSULATOR; EXPRESSION; GENE	Methylation of histories at specific residues plays an important role in transcriptional regulation. Chromatin immunoprecipitation of dimethytated lysine 9 on histone H3 across 53 kilobases of the chicken beta -globin locus during erythropoiesis shows an almost complete anticorrelation between regions of elevated lysine 9 methylation and acetylation. Lysine 9 is methylated most over constitutive condensed chromatin and developmentally inactive globin genes. In contrast, lysine 4 methylation of histone H3 correlates with H3 acetylation. These results lead us to propose a mechanism by which the insulator in the beta -globin locus can protect the globin genes from being silenced by adjacent condensed chromatin.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	gxf@vger.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLIS CD, COMMUNICATION; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Davie JR, 1999, J CELL BIOCHEM, P141; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; FELSENFELD G, 1993, GENE, V135, P119, DOI 10.1016/0378-1119(93)90056-9; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; RECILLASTARGA F, COMMUNICATION; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X	21	497	516	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2453	2455		10.1126/science.1064413	http://dx.doi.org/10.1126/science.1064413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11498546	Green Submitted			2022-12-01	WOS:000171237200047
J	Salghetti, SE; Caudy, AA; Chenoweth, JG; Tansey, WP				Salghetti, SE; Caudy, AA; Chenoweth, JG; Tansey, WP			Regulation of transcriptional activation domain function by ubiquitin	SCIENCE			English	Article							MEDIATED PROTEOLYSIS; DNA-REPLICATION; DEGRADATION; PROTEASOME; PROTEINS; COMPLEX; SIGNAL; CHAIN; MET4	The ability of transcriptional activation domains (TADs) to signal ubiquitin-mediated proteolysis suggests an involvement of the ubiquitin-proteasome pathway in transcription. To probe this involvement, we asked how ubiquitylation regulates the activity of a transcription factor containing the VP16 TAD. We show that the VP16 TAD signals ubiquitylation through the Met30 ubiquitin-ligase and that Met30 is also required for the VP16 TAD to activate transcription. The requirement for Met30 in transcription is circumvented by fusion of ubiquitin to the VP16 activator, demonstrating that activator ubiquitylation is essential for transcriptional activation. We propose that ubiquitylation regulates TAD function by serving as a dual signal for activation and activator destruction.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Tansey, WP (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd,POB 100, Cold Spring Harbor, NY 11724 USA.			Caudy, Amy/0000-0001-6307-8137	NCI NIH HHS [CA45508, CA-13106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015	18	311	318	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1651	1653		10.1126/science.1062079	http://dx.doi.org/10.1126/science.1062079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11463878				2022-12-01	WOS:000170802900061
J	McGuire, SE; Le, PT; Davis, RL				McGuire, SE; Le, PT; Davis, RL			The role of Drosophila mushroom body signaling in olfactory memory	SCIENCE			English	Article							SYNAPTIC VESICLE MEMBRANE; MUTANT DROSOPHILA; SHIBIRE; BODIES; DYNAMIN; MELANOGASTER; SENSITIVITY; EXPRESSION; DEFICIENT; MUTATIONS	The mushroom bodies of the Drosophila brain are important for olfactory learning and memory. To investigate the requirement for mushroom body signaling during the different phases of memory processing, we transiently inactivated neurotransmission through this region of the brain by expressing a temperature-sensitive allele of the shibire dynamin guanosine triphosphatase, which is required for synaptic transmission. Inactivation of mushroom body signaling through alpha/beta neurons during different phases of memory processing revealed a requirement for mushroom body signaling during memory retrieval, but not during acquisition or consolidation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013; Oka, Yoshitaka/C-9670-2010	Davis, Ronald/0000-0002-5986-7608; Oka, Yoshitaka/0000-0002-3482-3051	NINDS NIH HHS [NS19904] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong JD, 1998, LEARN MEMORY, V5, P102; Beck CDO, 2000, J NEUROSCI, V20, P2944; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Grant D, 1998, GENETICS, V149, P1019; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Ito K, 1998, LEARN MEMORY, V5, P52; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lee T, 1999, DEVELOPMENT, V126, P4065; MCGUIRE SE, UNPUB; ROMAN G, IN PRESS BIOESSAYS; Sokal R.R., 1981, BIOMETRY; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	28	333	342	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1330	1333		10.1126/science.1062622	http://dx.doi.org/10.1126/science.1062622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11397912				2022-12-01	WOS:000170492600044
J	Fiorillo, L; Zucker, M; Sawyer, D; Lin, AN				Fiorillo, L; Zucker, M; Sawyer, D; Lin, AN			The pseudomonas hot-foot syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	6th Congress of the European-Society-for-Pediatric-Dermatology	SEP 13-18, 1999	CATHOLIC UNIV OF THE SACRED HEART, ROME, ITALY	European Soc Pediat Dermatol	CATHOLIC UNIV OF THE SACRED HEART		IDIOPATHIC PALMOPLANTAR HIDRADENITIS; PLANTAR HIDRADENITIS; ECCRINE HIDRADENITIS; CHILDREN; AERUGINOSA; EXPOSURE; WET	Background: Between March and May 1998, there was an outbreak of a clinically distinct skin eruption on the soles of the feet of children who used a community wading pool. Methods: We reviewed the medical records of 40 children in whom this syndrome developed during this time. We treated 17 children and advised the attending physicians on the care of the other 23. Follow-up data were obtained for up to one year. Results: Exquisitely painful erythematous plantar nodules developed in 40 children (age, 2 to 15 years) within 40 hours after they had used a wading pool whose floor was coated with abrasive grit. Culture of the plantar pustules from one child yielded Pseudomonas aeruginosa with a pattern on pulsed-field gel electrophoresis that was identical to that of a strain of P. aeruginosa cultured from the pool water. A skin-biopsy specimen from this patient showed a perivascular and perieccrine neutrophilic infiltrate, and a specimen from another patient showed a dermal microabscess. Thirty-seven patients were treated symptomatically; three others were treated with cephalexin. All patients recovered within 14 days, but three children had recurrences of the painful plantar nodules within 24 hours after using the pool again. Folliculitis developed in one patient. Conclusions: The "pseudomonas hot-foot syndrome'' is characterized by the acute onset in children of exquisitely tender plantar nodules and a benign, self-limited course. This community outbreak developed after exposure to pool water containing high concentrations of P. aeruginosa.	Univ Alberta, Div Dermatol & Cutaneous Sci, Edmonton, AB T6G 2G3, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Pathol, Calgary, AB T2N 1N4, Canada	University of Alberta; University of Calgary; University of Calgary	Lin, AN (corresponding author), Univ Alberta, Div Dermatol & Cutaneous Sci, 2-104 Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.							Aleman CT, 1999, CUTIS, V63, P161; Bartolo E, 1998, J EUR ACAD DERMATOL, V10, P257; BLAUVELT A, 1992, J AM ACAD DERMATOL, V27, P111, DOI 10.1016/S0190-9622(08)80819-5; Buezo GF, 1996, AM J DERMATOPATH, V18, P413, DOI 10.1097/00000372-199608000-00015; HAY RJ, 1998, ROOK WILKINSON EBLIN, V2, P1097; HERN AE, 1992, J AM ACAD DERMATOL, V26, P259, DOI 10.1016/S0190-9622(08)80304-0; KOSATSKY T, 1985, AM J MED, V79, P10, DOI 10.1016/0002-9343(85)90539-X; Landau M, 1998, PEDIATR DERMATOL, V15, P97, DOI 10.1046/j.1525-1470.1998.1998015097.x; METZKER A, 1988, J AM ACAD DERMATOL, V18, P144, DOI 10.1016/S0190-9622(88)80055-0; Naimer SA, 2000, PEDIATR EMERG CARE, V16, P182, DOI 10.1097/00006565-200006000-00013; Pique E, 1997, DERMATOLOGY, V195, P379, DOI 10.1159/000245992; RABINOWITZ LG, 1995, ARCH DERMATOL, V131, P817, DOI 10.1001/archderm.131.7.817; RASMUSSEN JE, 1982, AM J DIS CHILD, V136, P553, DOI 10.1001/archpedi.1982.03970420077018; REED RK, 1976, J PEDIATR-US, V88, P977, DOI 10.1016/S0022-3476(76)81054-2; Simon M, 1998, ARCH DERMATOL, V134, P76, DOI 10.1001/archderm.134.1.76; STAHR BJ, 1994, J CUTAN PATHOL, V21, P289, DOI 10.1111/j.1600-0560.1994.tb00702.x; Weigl L, 2000, BRIT J DERMATOL, V142, P1048, DOI 10.1046/j.1365-2133.2000.03497.x	17	49	52	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					335	338		10.1056/NEJM200108023450504	http://dx.doi.org/10.1056/NEJM200108023450504			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484690				2022-12-01	WOS:000170193600004
J	Marie, Y; Sanson, M; Mokhtari, K; Leuraud, P; Kujas, M; Delattre, JY; Poirier, J; Zalc, B; Khe, HX				Marie, Y; Sanson, M; Mokhtari, K; Leuraud, P; Kujas, M; Delattre, JY; Poirier, J; Zalc, B; Khe, HX			OLIG2 as a specific marker of oligodendroglial tumour cells	LANCET			English	Article								OLIG2 is a recently Identified transcription factor involved In the specification of cells In the oligodendroglial lineage. We Investigated the expression of OLIG2 by In-situ hybridisation In 21 brain tumours: nine grade II and III oligodendrogliomas, three grade II oligoastrocytomas, and nine non-oligodendroglial tumours (four grade IV astrocytomas, two meningiomas, a dysembryoplastic neuroepithelial tumour, and two metastases). OLIG2-positive cells corresponding to neoplastic oligodendrocytes were present in all oligodendrogliomas and oligoastrocytomas. By contrast, OLIG2 expression was not detected in the non-oligodendroglial tumours. Thus, oligodendroglioma probably arise from oligodendrocyte precursor cells. OLIG2 should prove a useful marker for the diagnosis of oligodendroglial tumours.	Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris 13, France; INSERM, U495, Lab Biol Interact Neurone Glie, Paris, France; UPMC, Paris, France; Grp Hosp Pitie Salpetriere, Lab Histoembryol Cytogenet, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Khe, HX (corresponding author), Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris 13, France.		Messier, Claude/A-2322-2008; Hoang-Xuan, Khe/O-7527-2017	Messier, Claude/0000-0002-4791-1763; 				Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Fortin D, 1999, NEUROSURGERY, V45, P1279, DOI 10.1097/00006123-199912000-00001; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; REIFENBERGER J, 1994, AM J PATHOL, V145, P1175; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	5	122	129	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					298	300		10.1016/S0140-6736(01)05499-X	http://dx.doi.org/10.1016/S0140-6736(01)05499-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498220				2022-12-01	WOS:000170114400017
J	Chinsamy, A; Elzanowski, A				Chinsamy, A; Elzanowski, A			Bone histology - Evolution of growth pattern in birds	NATURE			English	Article									Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; S African Museum, ZA-8000 Cape Town, South Africa; Univ Wroclaw, Inst Zool, PL-50335 Wroclaw, Poland	University of Cape Town; University of Wroclaw	Chinsamy, A (corresponding author), Univ Cape Town, Dept Zool, Private Bag, ZA-7700 Rondebosch, South Africa.		Elzanowski, Andrzej/ABD-5511-2020	Chinsamy-Turan, Anusuya/0000-0002-9786-5080				CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; ELZANOWSKI A, 1981, PALAEONTOL POLON, V42, P147; HOUDE P, 1987, AUK, V104, P125, DOI 10.2307/4087243; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Reid R.E.H., 1993, Modern Geology, V18, P391; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Sanz JL, 1997, SCIENCE, V276, P1543, DOI 10.1126/science.276.5318.1543; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P247; STARCK JM, 1994, J MORPHOL, V222, P113, DOI 10.1002/jmor.1052220202; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; [No title captured]	13	66	69	1	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					402	403		10.1038/35086650	http://dx.doi.org/10.1038/35086650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473304				2022-12-01	WOS:000170068200034
J	Lockey, D; Davies, G; Coats, T				Lockey, D; Davies, G; Coats, T			Survival of trauma patients who have prehospital tracheal intubation without anaesthesia or muscle relaxants: observational study	BRITISH MEDICAL JOURNAL			English	Article							ESOPHAGEAL		Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Lockey, D (corresponding author), Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England.		Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784				Blostein PA, 1998, J TRAUMA, V44, P534, DOI 10.1097/00005373-199803000-00021; Cooke MW, 1999, BRIT MED J, V319, P1150, DOI 10.1136/bmj.319.7218.1150; GULY UM, 1995, BRIT MED J, V310, P1091, DOI 10.1136/bmj.310.6987.1091; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Pelucio M, 1997, ACAD EMERG MED, V4, P563, DOI 10.1111/j.1553-2712.1997.tb03579.x	5	52	54	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					141	141		10.1136/bmj.323.7305.141	http://dx.doi.org/10.1136/bmj.323.7305.141			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463683	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000170106200017
J	Baudouin-Cornu, P; Surdin-Kerjan, Y; Marliere, P; Thomas, D				Baudouin-Cornu, P; Surdin-Kerjan, Y; Marliere, P; Thomas, D			Molecular evolution of protein atomic composition	SCIENCE			English	Article							AMINO-ACID-COMPOSITION; SACCHAROMYCES-CEREVISIAE; METABOLISM; CYSTEINE	Living organisms encounter various growth conditions in their habitats, raising the question of whether ecological fluctuations could alter biological macromolecules. The advent of complete genome sequences and the characterization of whole metabolic pathways allowed us to search for such ecological imprints. Significant correlations between atomic composition and metabolic function were found in sulfur- and carbon-assimilatory enzymes, which appear depleted in sulfur and carbon, respectively, in both the bacterium Escherichia coli and the eukaryote Saccharomyces cerevisiae, In addition to genetic instructions, genomic data thus also provide paleontological records of environmental nutrient availability and of metabolic costs.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Evol SA, F-91000 Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thomas, D (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.			Baudouin-Cornu, Peggy/0000-0001-7296-099X				CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Creighton TE, 1983, PROTEINS STRUCTURES; Fraenkel D., 1996, ESCHERICHIA COLI SAL, P189; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; JOHNSTON M, 1992, MOL CELLULAR BIOL YE, P193; KARLIN S, 1992, PROTEIN ENG, V5, P729, DOI 10.1093/protein/5.8.729; KARLIN S, 1992, SCIENCE, V257, P39, DOI 10.1126/science.1621093; Kimura M., 1983, NEUTRAL THEORY MOL E; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P419; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; LEYH TS, 1992, J BIOL CHEM, V267, P542; LI WH, 1997, MOL EVOLUTOIN; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Nei M., 1987, MOL EVOLUTIONARY GEN; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SUEKOA N, 1961, COLD SPRING HARB SYM, V26, P35; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344	19	102	108	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2001	293	5528					297	300		10.1126/science.1061052	http://dx.doi.org/10.1126/science.1061052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452TK	11452124				2022-12-01	WOS:000169875200058
J	Richardson, JE; Weitz, FM; Fay, MF; Cronk, QCB; Linder, HP; Reeves, G; Chase, MW				Richardson, JE; Weitz, FM; Fay, MF; Cronk, QCB; Linder, HP; Reeves, G; Chase, MW			Rapid and recent origin of species richness in the Cape flora of South Africa	NATURE			English	Article							DNA; EVOLUTION	The Cape flora of South Africa grows in a continental area with many diverse and endemic species(1-4). We need to understand the evolutionary origins and ages of such 'hotspots' to conserve them effectively(5). In volcanic islands the timing of diversification can be precisely measured with potassium-argon dating. In contrast, the history of these continental species is based upon an incomplete fossil record and relatively imprecise isotopic palaeotemperature signatures. Here we use molecular phylogenetics and precise dating of two island species within the same clade as the continental taxa to show recent speciation in a species-rich genus characteristic of the Cape flora. The results indicate that diversification began approximately(7-8) Myr ago, coincident with extensive aridification caused by changes in ocean currents. The recent origin of endemic species diversity in the Cape flora shows that large continental bursts of speciation can occur rapidly over timescales comparable to those previously associated with oceanic island radiations(6,7).	Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; Univ Western Cape, Dept Bot, ZA-7535 Bellville, Cape Province, South Africa; Univ Cape Town, Bolus Herbarium, Dept Bot, ZA-7700 Rondebosch, South Africa; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Royal Bot Garden, Edinburgh EH3 5LR, Midlothian, Scotland	Royal Botanic Gardens, Kew; University of the Western Cape; University of Cape Town; University of Edinburgh	Richardson, JE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolut Biol, Santa Cruz, CA 95064 USA.	jamesr@darwin.ucsc.edu	Fay, Michael/AAU-5861-2021; Chase, Mark W/A-6642-2011; Linder, Hans Peter/F-5316-2010; Richardson, James-Edward/L-2768-2016; Fay, Michael F/G-4741-2010	Richardson, James-Edward/0000-0001-9014-4865; Fay, Michael F/0000-0003-3491-9093; Cronk, Quentin/0000-0002-4027-7368				Axelrod D. I., 1978, Biogeography and ecology of Southern Africa. Vol.1., P77; Baldwin Bruce G., 1995, P259; COETZEE J A, 1983, Bothalia, V14, P345; Coetzee J. A., 1978, ANTARCTIC GLACIAL HI, P115; CRONK QCB, 2000, ENDEMIC FLORA ST HEL, P23; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Givnish Thomas J., 1995, P288; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; GOOD R, 1974, GEOGRAPHY FLOWERING, P190; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; Johnson SD, 1996, TAXON, V45, P59, DOI 10.2307/1222585; KENNETT JP, 1980, PALAEOGEOGR PALAEOCL, V31, P123, DOI 10.1016/0031-0182(80)90017-6; Linder HP, 1998, BOT J LINN SOC, V128, P319; LINDER HP, 1985, TRANSVAAL MUSEUM MON, V4, P53; Linder R., 1992, ECOLOGY FYNBOS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SWOFFORD DL, 1998, PAUPSTAR4 0 B2 PHYLO; TAKHTAJAN A, 1986, FLORISTIC REGIONS WO, P263; Wojciechowski MF, 1999, SYST BOT, V24, P409, DOI 10.2307/2419698	24	213	218	2	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					181	183		10.1038/35084067	http://dx.doi.org/10.1038/35084067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449273				2022-12-01	WOS:000169778700051
J	WoldeGabriel, G; Haile-Selassie, Y; Renne, PR; Hart, WK; Ambrose, SH; Asfaw, B; Heiken, G; White, T				WoldeGabriel, G; Haile-Selassie, Y; Renne, PR; Hart, WK; Ambrose, SH; Asfaw, B; Heiken, G; White, T			Geology and palaeontology of the Late Miocene Middle Awash valley, Afar rift, Ethiopia	NATURE			English	Article							EARLY HOMINID; AUSTRALOPITHECUS; CLIMATE; CARBON; AFRICA; ARAMIS	The Middle Awash study area of Ethiopia's Afar rift has yielded abundant vertebrate fossils (approximate to 10,000), including several hominid taxa(1-4). The study area contains a long sedimentary record spanning Late Miocene (5.3-11.2 Myr ago) to Holocene times. Exposed in a unique tectonic and volcanic transition zone between the main Ethiopian rift (MER) and the Afar rift, sediments along the western Afar rift margin in the Middle Awash provide a unique window on the Late Miocene of Ethiopia. These deposits have now yielded the earliest hominids, described in an accompanying paper(5) and dated here to between 5.54 and 5.77 Myr. These geological and palaeobiological data from the Middle Awash provide fresh perspectives on hominid origins and early evolution. Here we show that these earliest hominids derive from relatively wet and wooded environments that were modulated by tectonic, volcanic, climatic and geomorphic processes. A similar wooded habitat also has been suggested for the 6.0 Myr hominoid fossils recently recovered from Lukeino, Kenya(6). These findings require fundamental reassessment of models that invoke a significant role for global climatic change and/or savannah habitat in the origin of hominids.	Univ Calif Los Alamos Natl Lab, Inst Geophys & Planetary Phys, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Human Evolut Studies Lab, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94709 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Miami Univ, Dept Geol, Oxford, OH 45056 USA; Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; Rift Valley Res Serv, Addis Ababa, Ethiopia	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Berkeley Geochronolgy Center; University System of Ohio; Miami University; University of Illinois System; University of Illinois Urbana-Champaign	WoldeGabriel, G (corresponding author), Univ Calif Los Alamos Natl Lab, Inst Geophys & Planetary Phys, EES-6-MS D462, Los Alamos, NM 87545 USA.			Renne, Paul/0000-0003-1769-5235				Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CERLING TE, 1989, NATURE, V341, P138, DOI 10.1038/341138a0; CONROY GC, 1978, NATURE, V275, P67; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Griffin DL, 1999, J GEOL SOC LONDON, V156, P817, DOI 10.1144/gsjgs.156.4.0817; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Harland W.B., 1990, GEOLOGIC TIME SCALE; HEDBERG HD, 1976, INT STRATIGRAPHIC GU; Kalb J.E., 1982, Newsletters on Stratigraphy, V11, P95; KALB JE, 1993, NEWSL STRATIGR, V29, P21; KINGDOM J, 1974, E AFRICAN MAMMALS B, V2; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; MOHR P, 1983, TECTONOPHYSICS, V94, P509, DOI 10.1016/0040-1951(83)90032-X; MORLEY CK, 1990, AAPG BULL, V74, P1234; MORTON WH, 1975, AFAR DEPRESSION ETHI, P55; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; QUADE J, 1989, GEOL SOC AM BULL, V101, P464, DOI 10.1130/0016-7606(1989)101&lt;0464:SVITCA&gt;2.3.CO;2; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Ruddiman W. F., 1989, P OCEAN DRILLING PG, V108, P463, DOI DOI 10.2973/0DP.PR0C.SR.108.173.1989; TIERCELIN JJ, 1980, ACCAD NAZ LINCEI ROM, V47, P491; Van Campo E., 1991, P OCEAN DRILLING PRO, V117, P277; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	26	141	147	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					175	178		10.1038/35084058	http://dx.doi.org/10.1038/35084058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449271				2022-12-01	WOS:000169778700049
J	Langer, R				Langer, R			Perspectives: Drug delivery - Drugs on target	SCIENCE			English	Editorial Material									MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Affleck DG, 2001, GENE THER, V8, P349, DOI 10.1038/sj.gt.3301395; Carino GP, 1999, ADV DRUG DELIVER REV, V35, P249, DOI 10.1016/S0169-409X(98)00075-1; Daugherty AL, 1999, PHARM SCI TECHNOL TO, V2, P144, DOI 10.1016/S1461-5347(99)00142-X; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; EDWARDS DA, 1999, ENCY CONTROLLED DRUG, V2, P936; Hwang SJ, 2001, CURR OPIN MOL THER, V3, P183; Hwang SJ, 2001, BIOCONJUGATE CHEM, V12, P280, DOI 10.1021/bc0001084; Langer R, 1998, NATURE, V392, P5; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; SANTINI JT, 2000, ANGEW CHEM INT EDIT, V39, P2396	10	477	514	1	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					58	59		10.1126/science.1063273	http://dx.doi.org/10.1126/science.1063273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441170				2022-12-01	WOS:000169780300024
J	White, LE; Coppola, DM; Fitzpatrick, D				White, LE; Coppola, DM; Fitzpatrick, D			The contribution of sensory experience to the maturation of orientation selectivity in ferret visual cortex	NATURE			English	Article							SHREW STRIATE CORTEX; DARK-REARED KITTENS; HORIZONTAL CONNECTIONS; CORTICOCORTICAL CONNECTIONS; CAT; MAPS; SPECIFICITY; ARRANGEMENT; DEPRIVATION; PREFERENCE	Sensory experience begins when neural circuits in the cerebral cortex are still immature; however, the contribution of experience to cortical maturation remains unclear. In the visual cortex, the selectivity of neurons for oriented stimuli at the time of eye opening is poor(1-5) and increases dramatically after the onset of visual experience(3-8). Here we investigate whether visual experience has a significant role in the maturation of orientation selectivity and underlying cortical circuits(9-12) using two forms of deprivation: dark rearing, which completely eliminates experience, and binocular lid suture, which alters the pattern of sensory driven activity(13). Orientation maps were present in dark-reared ferrets, but fully mature levels of tuning were never attained. In contrast, only rudimentary levels of orientation selectivity were observed in lid-sutured ferrets. Despite these differences, horizontal connections in both groups were less extensive and less clustered than normal, suggesting that long-range cortical processing is not essential for the expression of orientation selectivity, but may be needed for the full maturation of tuning. Thus, experience is beneficial or highly detrimental to cortical maturation, depending on the pattern of sensory driven activity.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Div Phys Therapy, Durham, NC 27710 USA; Centenary Coll Louisiana, Dept Biol, Shreveport, LA 71134 USA	Duke University; Duke University	White, LE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	white033@mc.duke.edu						BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Bonhoeffer Tobias, 1996, P55; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 1996, J NEUROSCI, V16, P6443; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW N, 1995, VISUAL DEV; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; LUBKE J, 1992, J COMP NEUROL, V323, P42, DOI 10.1002/cne.903230105; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; Shouval HZ, 2000, J NEUROSCI, V20, P1119, DOI 10.1523/JNEUROSCI.20-03-01119.2000; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Zufferey PD, 1999, EUR J NEUROSCI, V11, P2669, DOI 10.1046/j.1460-9568.1999.00683.x	29	161	163	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2001	411	6841					1049	1052		10.1038/35082568	http://dx.doi.org/10.1038/35082568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429605				2022-12-01	WOS:000169528500048
J	Brady, AJB; Oliver, MA; Pittard, JB				Brady, AJB; Oliver, MA; Pittard, JB			Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Merck Sharp & Dohme Ltd, Hoddesdon EN11 9BU, Herts, England; Staines & Thameside Med, Staines TW18 3JH, Surrey, England	University of Glasgow; Merck & Company	Brady, AJB (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.	a.j.brady@clinmed.gla.ac.uk						Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Flanagan DEH, 1999, QJM-INT J MED, V92, P245, DOI 10.1093/qjmed/92.5.245	4	57	57	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2001	322	7300					1463	1463		10.1136/bmj.322.7300.1463	http://dx.doi.org/10.1136/bmj.322.7300.1463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444FJ	11408303	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-01	WOS:000169389200030
J	Adams, H; Ashworth, E; Breault, GA; Guo, J; Hunter, CA; Mayers, PC				Adams, H; Ashworth, E; Breault, GA; Guo, J; Hunter, CA; Mayers, PC			Knot tied around an octahedral metal centre	NATURE			English	Article							MOLECULAR TREFOIL KNOT; TOPOLOGY		Univ Sheffield, Dept Chem, Krebs Inst Biomolec Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; AstraZeneca, Macclesfield SK10 4TG, Cheshire, England	University of Sheffield; AstraZeneca	Adams, H (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst Biomolec Sci, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.		Hunter, Christopher Alexander/AFS-7239-2022	Hunter, Christopher Alexander/0000-0002-5182-1859				Arai Y, 1999, NATURE, V399, P446, DOI 10.1038/20894; Ashton PR, 1997, LIEBIGS ANN-RECL, P2485; Breault GA, 1999, TETRAHEDRON, V55, P5265, DOI 10.1016/S0040-4020(99)00282-3; Breault GA, 1998, J AM CHEM SOC, V120, P3402, DOI 10.1021/ja973938+; Carina RF, 1996, J AM CHEM SOC, V118, P9110, DOI 10.1021/ja961459p; Dietrich-Buchecker C., 1999, MOL CATENANES ROTAXA, P107; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; Safarowsky O, 2000, ANGEW CHEM INT EDIT, V39, P1616, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1616::AID-ANIE1616>3.0.CO;2-Y; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Sokolov V. I., 1973, RUSS CHEM REV, V42, P452, DOI DOI 10.1070/RC1973V042N06ABEH002636; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477	11	89	89	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					763	763		10.1038/35081143	http://dx.doi.org/10.1038/35081143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459044				2022-12-01	WOS:000169246400033
J	Woodman, CBJ; Collins, S; Winter, H; Bailey, A; Ellis, J; Prior, P; Yates, M; Rollason, TP; Young, LS				Woodman, CBJ; Collins, S; Winter, H; Bailey, A; Ellis, J; Prior, P; Yates, M; Rollason, TP; Young, LS			Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study	LANCET			English	Article							INTRAEPITHELIAL NEOPLASIA; HIGH-GRADE; RISK-FACTOR; LESIONS; TYPE-16; PROGRESSION; SMEARS; DNA	Background Laboratory and epidemiological research suggests an association between human papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN). We studied the natural history of incident cervical HPV infection and its relation to the development of CIN. Methods We recruited 2011 women aged 15-19 years who had recently become sexually active. We took a cervical smear every 6 months and stored samples for virological analysis. We immediately referred all women with any cytological abnormality for colposcopic assessment, out postponed treatment until there was histological evidence of progression to high-grade CIN. Findings IN 1075 women who were cytologically normal and HPV negative at recruitment, the cumulative risk at 3 years of any HPV infection was 44% (95% CI 40-48): HPV 16 was the most common type. The cumulative risk at 3 years of detecting an HPV type not present in the first positive sample was 26% (20-32). 246 women had an abnormal smear during follow-up, of whom 28 progressed to high-grade CIN. The risk of high-grade CIN was greatest in women who tested positive for HPV 16 (risk ratio 8.5 [3.7-19.2]); this risk was maximum 6-12 months after first detection of HPV 16. All HPV types under consideration were associated with cytologically abnormal smears. Although abnormality was significantly less likely to be associated with low-viral-load samples, the cumulative risk at 3 years of a high-viral-load sample after a low-viral-load sample was 45% (95% CI 35-56). Five women who progressed to high-grade CIN consistently tested negative for HPV. Interpretation Our findings suggest that attempts to exploit the association between cervical neoplasia and HPV infection to improve effectiveness of cervical screening programmes might be undermined by the limited inferences that can be drawn from the characterisation of a woman's HPV status at a single point in time, and the short lead time gained by its detection.	Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England; Cent Manchester Healthcare Trust, Dept Clin Virol, Manchester, Lancs, England; Univ Birmingham, Dept Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, Dept Pathol, Birmingham, W Midlands, England; Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham, W Midlands, England	University of Manchester; University of Birmingham; University of Birmingham; Birmingham Women's Hospital; Birmingham Women's Hospital	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.	ciaran.woodman@cce.man.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298				Bauer HM, 1992, DIAGNOSTIC MOL PATHO, P131; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Burger MPM, 1996, BRIT J CANCER, V73, P831, DOI 10.1038/bjc.1996.146; Chenoy R, 1996, BRIT J OBSTET GYNAEC, V103, P457, DOI 10.1111/j.1471-0528.1996.tb09773.x; DOWNEY GP, 1994, LANCET, V344, P432, DOI 10.1016/S0140-6736(94)91768-X; FLANNELLY G, 1995, J MED VIROL, V47, P6, DOI 10.1002/jmv.1890470103; Herrington CS, 1999, J PATHOL, V189, P1; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HIPPELAINEN MI, 1994, SEX TRANSM DIS, V21, P76, DOI 10.1097/00007435-199403000-00004; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, INT J CANCER, V78, P594, DOI 10.1002/(SICI)1097-0215(19981123)78:5&lt;594::AID-IJC11&gt;3.0.CO;2-B; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Kjellberg L, 1999, J GEN VIROL, V80, P391, DOI 10.1099/0022-1317-80-2-391; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kruger-Kjaer S, 1998, INT J CANCER, V76, P613, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;613::AID-IJC1&gt;3.0.CO;2-T; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Luostarinen T, 1999, INT J CANCER, V80, P818, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;818::AID-IJC4&gt;3.0.CO;2-T; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Park JJ, 1998, GYNECOL ONCOL, V70, P386, DOI 10.1006/gyno.1998.5100; RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0; RICHART RM, 1969, AM J OBSTET GYNECOL, V105, P386, DOI 10.1016/0002-9378(69)90268-3; Shah KV, 1996, INT J GYNECOL PATHOL, V15, P127, DOI 10.1097/00004347-199604000-00006; Silins I, 1999, J GEN VIROL, V80, P2931, DOI 10.1099/0022-1317-80-11-2931; SOLER C, 1991, J VIROL METHODS, V35, P143, DOI 10.1016/0166-0934(91)90130-R; Swan DC, 1999, J CLIN MICROBIOL, V37, P1030, DOI 10.1128/JCM.37.4.1030-1034.1999; Tabrizi SN, 1999, BRIT J OBSTET GYNAEC, V106, P252, DOI 10.1111/j.1471-0528.1999.tb08239.x; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; VANDENVELDE C, 1992, J MED VIROL, V36, P279, DOI 10.1002/jmv.1890360409; Vonka V, 1999, INT J CANCER, V80, P365, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;365::AID-IJC5&gt;3.0.CO;2-C; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wideroff L, 1999, J INFECT DIS, V180, P1424, DOI 10.1086/315055; 1997, REVISED GUIDELINES C; 1995, HUMAN PAPILLOMAVIRUS, V64	34	590	649	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2001	357	9271					1831	1836		10.1016/S0140-6736(00)04956-4	http://dx.doi.org/10.1016/S0140-6736(00)04956-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440DN	11410191				2022-12-01	WOS:000169160800011
J	Breiling, A; Turner, BM; Bianchi, ME; Orlando, V				Breiling, A; Turner, BM; Bianchi, ME; Orlando, V			General transcription factors bind promoters repressed by Polycomb group proteins	NATURE			English	Article							DROSOPHILA-MELANOGASTER; IN-VIVO; CHROMATIN; COMPLEX; INTERACTS; TRITHORAX	To maintain cell identity during development and differentiation, mechanisms of cellular memory have evolved that preserve transcription patterns in an epigenetic manner. The proteins of the Polycomb group (PcG) are part of such a mechanism, maintaining gene silencing. They act as repressive multiprotein complexes that may render target genes inaccessible to the transcriptional machinery(1,2), inhibit chromatin remodelling(3,4), influence chromosome domain topology(5) and recruit histone deacetylases (HDACs)(6). PcG proteins have also been found to bind to core promoter regions(7), but the mechanism by which they regulate transcription remains unknown. To address this, we used formaldehyde-crosslinked chromatin immunoprecipitation (X-ChIP) to map TATA-binding protein (TBP), transcription initiation factor IIB (TFIIB) and IIF (TFIIF), and dHDAC1 (RPD3) across several Drosophila promoter regions. Here we show that binding of PcG proteins to repressed promoters does not exclude general transcription factors (GTFs) and that depletion of PcG proteins by double-stranded RNA interference leads to de-repression of developmentally regulated genes. We further show that PcG proteins interact in vitro with GTFs. We suggest that PcG complexes maintain silencing by inhibiting GTF-mediated activation of transcription.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Birmingham, Sch Med, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Orlando, V (corresponding author), San Raffaele Sci Inst, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.		Bianchi, Marco Emilio/K-3417-2018	Bianchi, Marco Emilio/0000-0002-5329-6445; Breiling, Achim/0000-0002-7928-299X				Barlow AL, 2001, EXP CELL RES, V265, P90, DOI 10.1006/excr.2001.5162; Beuchle D, 2001, DEVELOPMENT, V128, P993; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CHINWALLA V, 1995, EMBO J, V14, P2056, DOI 10.1002/j.1460-2075.1995.tb07197.x; GREGORY RI, IN PRESS MOL CELL BI; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Johnson CA, 2001, J BIOL CHEM, V276, P4539, DOI 10.1074/jbc.C000824200; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; PARO R, 1992, MECH DEVELOP, V40, P37; Paro R., 1996, EPIGENETIC MECH GENE, P507; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Wei Q, 2000, DEV BIOL, V228, P239, DOI 10.1006/dbio.2000.9938; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878	28	201	203	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					651	655		10.1038/35088090	http://dx.doi.org/10.1038/35088090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493924				2022-12-01	WOS:000170318000044
J	Tod, AM; Read, C; Lacey, A; Abbott, J				Tod, AM; Read, C; Lacey, A; Abbott, J			Barriers to uptake of services for coronary heart disease: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							PREVENTION; ANGINA	Objectives To identify factors within the South Yorkshire coalfields that influence use of health services by people with angina. Design Qualitative study using semistructured individual and group interviews. Setting General practice and community settings in Barnsley and Rotherham health authorities. Participants 14 patients with stable angina and nine primary care staff had individual interviews plus five community groups and one group of general practitioners. Main outcome measures Barriers to accessing health services. Results A complex web of factors was identified that prevented, delayed, or facilitated referral to secondary care. Delay, denial, and self management by patients meant that the Rill extent of symptoms often remained hidden from general practitioners, resulting in a delayed or missed referral. Barriers identified fell into six categories: structural personal, social and cultural, past experience and expectations, diagnostic confusion, and knowledge and awareness. Conclusions Many of the factors influencing referral operate before general practitioners become involved. Community development could be one way of tackling inequalities and promoting sustainable change. Structural changes are needed to improve access and increase the acceptability of general practice services. Primary care staff should be educated to detect under-reporting of symptoms and promote appropriate referral.	Rotherham Hlth Author, Rotherham S60 3AQ, S Yorkshire, England; Sheffield Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Tod, AM (corresponding author), Rotherham Hlth Author, Bevan House, Rotherham S60 3AQ, S Yorkshire, England.		Tod, Angela M/P-2330-2015	Tod, Angela M/0000-0001-6336-3747				Blaxter M., 1990, HLTH LIFESTYLES; Bowling A., 2009, RES METHODS HLTH; *BRIT HEART FDN, 1999, COR HEART DIS STAT; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; DAVISON C, 1992, SOC SCI MED, V34, P675, DOI 10.1016/0277-9536(92)90195-V; Fisher B, 1999, BRIT MED J, V318, P749, DOI 10.1136/bmj.318.7186.749; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Glaser B. G., 1978, THEORETICAL SENSITIV; Goddard M, 1998, EQUITY ACCESS HLTH C; GORDON D, 2000, INEQUALITIES HLTH EV; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Lincon YS., 1985, NATURALISTIC INQUIRY; Maggs-Rapport F, 2000, J ADV NURS, V31, P219, DOI 10.1046/j.1365-2648.2000.01243.x; Mays N, 1996, QUALITATIVE RES HLTH; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; Ritchie J., 2002, ANAL QUALITATIVE DAT, V1, P187; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; *ROTH HLTH AUTH, 1998, HLTH ROTH PEOPL 1998; Ruston A, 1998, BRIT MED J, V316, P1060; SORRELL JM, 1995, J ADV NURS, V21, P117; Strauss A., 1998, BASICS QUALITATIVE R; Wiles R, 1998, SOC SCI MED, V46, P1477, DOI 10.1016/S0277-9536(97)10140-X	22	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					214	217		10.1136/bmj.323.7306.214	http://dx.doi.org/10.1136/bmj.323.7306.214			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459UQ	11473916	Bronze, Green Published			2022-12-01	WOS:000170270200022
J	Wilson, PA; Norris, RD				Wilson, PA; Norris, RD			Warm tropical ocean surface and global anoxia during the mid-Cretaceous period	NATURE			English	Article							PLANKTONIC-FORAMINIFERA; NORTH-ATLANTIC; TEMPERATURES; EVOLUTION; CLIMATE; EVENTS; ORIGIN; OXYGEN; MODEL; ROCKS	The middle of the Cretaceous period (about 120 to 80 Myr ago) was a time of unusually warm polar temperatures(1), repeated reef-drowning in the tropics(2) and a series of oceanic anoxic events (OAEs) that promoted both the widespread deposition of organic carbon-rich marine sediments and high biological turnover(3-8). The cause of the warm temperatures is unproven but widely attributed to high levels of atmospheric greenhouse gases such as carbon dioxide(7-12). In contrast, there is no consensus on the climatic causes and effects of the OAEs, with both high biological productivity and ocean `stagnation' being invoked as the cause of ocean anoxia(3-8). Here we show, using stable isotope records from multiple species of well-preserved foraminifera, that the thermal structure of surface waters in the western tropical Atlantic Ocean underwent pronounced variability about 100 Myr ago, with maximum sea surface temperatures 3-5 degreesC warmer than today. This variability culminated in a collapse of upper-ocean stratification during OAE-1d (the `Breistroffer' event), a globally significant period of organic-carbon burial that we show to have fundamental, stratigraphically valuable, geochemical similarities to the main OAEs of the Mesozoic era. Our records are consistent with greenhouse forcing being responsible for the warm temperatures, but are inconsistent both with explanations for OAEs based on ocean stagnation, and with the traditional view (reviewed in ref. 12) that past warm periods were more stable than today's climate.	Southampton Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	NERC National Oceanography Centre; University of Southampton; Woods Hole Oceanographic Institution	Wilson, PA (corresponding author), Southampton Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	paw1@soc.soton.ac.uk		Wilson, Paul/0000-0001-6425-8906				[Anonymous], 1982, CLIMATE EARTH HIST, DOI DOI 10.17226/11798; ARTHUR MA, 1990, NATO ADV SCI I C-MAT, V304, P75; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Arthur MA, 1985, GEOPHYS MONOGR SER, P504, DOI [DOI 10.1029/GM032P0504, 10.1159/000020165]; Barron E. J, 1985, CARBON CYCLE ATMOSPH, P546, DOI [10.1029/GM032p0546, DOI 10.1029/GM032P0546]; Barron EJ, 1995, STUDIES GEOPHYSICS, P108; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Crowley TJ, 1991, PALEOCEANOGRAPHY, V6, P387, DOI 10.1029/91PA00432; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; Erba E, 1999, J FORAMIN RES, V29, P371; Erbacher J, 1997, MAR MICROPALEONTOL, V30, P139, DOI 10.1016/S0377-8398(96)00023-0; Erbacher J, 2001, NATURE, V409, P325, DOI 10.1038/35053041; Gale AS, 1996, CRETACEOUS RES, V17, P515, DOI 10.1006/cres.1996.0032; HERBERT TD, 1986, NATURE, V321, P739, DOI 10.1038/321739a0; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hofmann P, 2000, PALAEOGEOGR PALAEOCL, V163, P97, DOI 10.1016/S0031-0182(00)00147-4; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; JENKYNS HC, 1980, J GEOL SOC LONDON, V137, P171, DOI 10.1144/gsjgs.137.2.0171; MANABE S, 1985, J GEOPHYS RES-OCEANS, V90, P1689, DOI 10.1029/JC090iC06p11689; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; OPDYKE BN, 1999, EOS, V80, pF486; Poulsen CJ, 1999, PALEOCEANOGRAPHY, V14, P679, DOI 10.1029/1999PA900034; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; SCHLANGER SO, 1981, EARTH PLANET SC LETT, V52, P435, DOI 10.1016/0012-821X(81)90196-5; *SHIPB SCI PART, 1995, P ODP INIT REP, V144, P20; Smith A. G., 1994, ATLAS MESOZOIC CENOZ; Stoll HM, 2000, GEOL SOC AM BULL, V112, P308, DOI 10.1130/0016-7606(2000)112<308:HSIRFT>2.0.CO;2; Wilson PA, 1998, NATURE, V392, P889, DOI 10.1038/31865; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2; Wolff T, 1999, PALEOCEANOGRAPHY, V14, P374, DOI 10.1029/1999PA900011	30	314	326	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					425	429		10.1038/35086553	http://dx.doi.org/10.1038/35086553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473314				2022-12-01	WOS:000170068200044
J	Rutter, J; Reick, M; Wu, LC; McKnight, SL				Rutter, J; Reick, M; Wu, LC; McKnight, SL			Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors	SCIENCE			English	Article							NICOTINAMIDE-ADENINE DINUCLEOTIDE; SUPRACHIASMATIC NUCLEUS; CIRCADIAN CLOCK; ANTICIPATORY ACTIVITY; AEROBIC GLYCOLYSIS; EXPRESSION; LACTATE; BRAIN; ORGANIZATION; ENTRAINMENT	Clock:BMAL1 and NPAS2:BMAL1 are heterodimeric transcription factors that control gene expression as a function of the Light-dark cycle. Although built to fluctuate at or near a 24-hour cycle, the clock can be entrained by Light, activity, or food. Here we show that the DNA-binding activity of the Clock:BMAL1 and NPAS2:BMAL1 heterodimers is regulated by the redox state of nicotinamide adenine dinucleotide (NAD) cofactors in a purified system. The reduced forms of the redox cofactors, NAD(H) and NADP(H), strongly enhance DNA binding of the Clock:BMAL1 and NPAS2:BMAL1 heterodimers, whereas the oxidized forms inhibit. These observations raise the possibility that food, neuronal activity, or both may entrain the circadian clock by direct modulation of cellular redox state.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388] Funding Source: NIH RePORTER; NIGMS NIH HHS [NIH5-T32-GM08-291-12] Funding Source: Medline; NIMH NIH HHS [1RO1MH59388] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe H, 1998, NEUROSCI LETT, V258, P93, DOI 10.1016/S0304-3940(98)00877-5; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V4; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; GAROFALO O, 1988, J NEUROCHEM, V51, P172, DOI 10.1111/j.1471-4159.1988.tb04851.x; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kopperschlager G, 1996, J CHROMATOGR B, V684, P25, DOI 10.1016/0378-4347(96)00133-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; MAGISTRETTI PJ, COMMUNICATION; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOORE RY, 1995, CIBA F SYMP, V183, P88; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pellerin L, 1996, DEV NEUROSCI-BASEL, V18, P336, DOI 10.1159/000111426; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peters A., 1978, FINE STRUCTURE NERVO, V4, P588; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; REICK M, UNPUB; RUTTER J, UNPUB; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; TAKAHASHI S, 1995, P NATL ACAD SCI USA, V92, P4616, DOI 10.1073/pnas.92.10.4616; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	42	717	741	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					510	514		10.1126/science.1060698	http://dx.doi.org/10.1126/science.1060698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11441146				2022-12-01	WOS:000169966700051
J	Zuccato, C; Ciammola, A; Rigamonti, D; Leavitt, BR; Goffredo, D; Conti, L; MacDonald, ME; Friedlander, RM; Silani, V; Hayden, MR; Timmusk, T; Sipione, S; Cattaneo, E				Zuccato, C; Ciammola, A; Rigamonti, D; Leavitt, BR; Goffredo, D; Conti, L; MacDonald, ME; Friedlander, RM; Silani, V; Hayden, MR; Timmusk, T; Sipione, S; Cattaneo, E			Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease	SCIENCE			English	Article							NEUROTROPHIC FACTOR; MOUSE MODEL; CELLULAR-LOCALIZATION; TARGETED DISRUPTION; GABAERGIC NEURONS; TRANSGENIC MICE; MESSENGER-RNA; RAT-BRAIN; IN-VITRO; EXPRESSION	Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, Loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is Lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This Leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.	Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellance Neurodegenerat Dis, I-20133 Milan, Italy; Univ Milan, IRCCS Osped Maggiore, Sch Med, Ctr Dino Ferrari,Dept Neurol Sci, I-20133 Milan, Italy; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Univ Helsinki, Inst Biotechnol, Program Mol Neurosci, Helsinki, Finland; Uppsala Univ, Ctr Biomed, Dept Dev Neurosci, Uppsala, Sweden	University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of British Columbia; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Helsinki; Uppsala University	Cattaneo, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.cattaneo@unimi.it	Conti, Luciano/H-4184-2012; Hayden, Michael R/D-8581-2011; Leavitt, Blair R/G-1934-2012; Friedlander, Robert M/A-2845-2016; Silani, Vincenzo/P-4421-2017; Timmusk, Tonis/H-4889-2015	Conti, Luciano/0000-0002-2050-9846; Hayden, Michael R/0000-0001-5159-1419; Friedlander, Robert M/0000-0003-4423-9219; Silani, Vincenzo/0000-0002-7698-3854; ZUCCATO, CHIARA/0000-0003-1771-3392; CATTANEO, ELENA/0000-0002-0755-4917; leavitt, Blair/0000-0002-4532-766X; Timmusk, Tonis/0000-0002-1015-3348	Telethon [E.0840] Funding Source: Medline	Telethon(Fondazione Telethon)		Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Canals JM, 2001, J NEUROSCI, V21, P117, DOI 10.1523/JNEUROSCI.21-01-00117.2001; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Conner JM, 1997, J NEUROSCI, V17, P2295; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Fusco FR, 1999, J NEUROSCI, V19, P1189; HARPER PS, 1996, HUNTINGTONS DIS, P317; HAYDEN MR, 1981, HUNTINGTONS CHOREA, P140; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; LIU ZQ, 1995, CHEM RES CHINESE U, V11, P155; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1994, NEUROSCIENCE, V60, P287, DOI 10.1016/0306-4522(94)90242-9; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404	37	954	993	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					493	498		10.1126/science.1059581	http://dx.doi.org/10.1126/science.1059581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11408619				2022-12-01	WOS:000169966700048
J	Fisk, HA; Winey, M				Fisk, HA; Winey, M			The mouse Mps1p-like kinase regulates centrosome duplication	CELL			English	Article							POLE BODY DUPLICATION; CYCLIN-DEPENDENT KINASES; HAMSTER OVARY CELLS; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; MITOTIC CHECKPOINT; BUDDING YEAST; DNA-SYNTHESIS; GENE MPS1; REPRODUCTION	The yeast Mps1p protein kinase acts in centrosome duplication and the spindle assembly checkpoint. We demonstrate here that a mouse Mps1p ortholog (esk, which we designate mMps1p) regulates centrosome duplication. Endogenous mMps1p and overexpressed GFP-mMps1p localize to centrosomes and kinetochores in mouse cells. Overexpression of GFP-mMps1p causes reduplication of centrosomes during S phase arrest. In contrast, a kinase-deficient mutant blocks centrosome duplication altogether. Control of centrosome duplication by mMps1p requires a known regulator of the process, Cdk2. Inhibition of Cdk2 prevents centrosome reduplication and destabilizes mMps1p, causing its subsequent loss from centrosomes, suggesting that Cdk2 promotes mMps1p's centrosome duplication function by regulating its stability during S phase. Thus, mMps1p, an in vitro Cdk2 substrate, regulates centrosome duplication jointly with Cdk2.	Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Winey, M (corresponding author), Univ Colorado, UCB 347, Boulder, CO 80309 USA.				NIGMS NIH HHS [GM51312] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hartley RS, 1997, DEV BIOL, V188, P312, DOI 10.1006/dbio.1997.8647; HE X, 1997, J CELL SCI, V111, P1635; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOGG D, 1994, ONCOGENE, V9, P89; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KURIYAMA R, 1986, CELL MOTIL CYTOSKEL, V6, P355, DOI 10.1002/cm.970060402; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LINDBERG RA, 1993, ONCOGENE, V8, P351; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 1997, METHOD ENZYMOL, V283, P113; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schnackenberg BJ, 1999, BIOL CELL, V91, P429, DOI 10.1016/S0248-4900(99)80084-7; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; STEIN GS, 1994, CELL BIOL LAB HDB, P282; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1	44	180	187	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					95	104		10.1016/S0092-8674(01)00411-1	http://dx.doi.org/10.1016/S0092-8674(01)00411-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461705	Green Published, Bronze			2022-12-01	WOS:000169870300012
J	Pardini, AT; Jones, CS; Noble, LR; Kreiser, B; Malcolm, H; Bruce, BD; Stevens, JD; Cliff, G; Scholl, MC; Francis, M; Duffy, CAJ; Martin, AP				Pardini, AT; Jones, CS; Noble, LR; Kreiser, B; Malcolm, H; Bruce, BD; Stevens, JD; Cliff, G; Scholl, MC; Francis, M; Duffy, CAJ; Martin, AP			Sex-biased dispersal of great white sharks - In some respects, these sharks behave more like whales and dolphins than other fish.	NATURE			English	Article							MITOCHONDRIAL		Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland; Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA; CSIRO, Marine Res Labs, Hobart, Tas 7000, Australia; Natal Sharks Board, ZA-4320 Umhlanga Rocks, South Africa; Natl Inst Water & Atmospher Res, Wellington, New Zealand	University of Aberdeen; University of Southern Mississippi; University of Colorado System; University of Colorado Boulder; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Pardini, AT (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.	am@stripe.colorado.edu	Scholl, Michael Christoph/ABF-5665-2021	Noble, leslie/0000-0003-3076-0759; Cliff, Geremy/0000-0003-1790-6055				BASS J, 1978, SENSORY BIOL SHARKS, P545; Cliff G, 1996, GREAT WHITE SHARKS, P393, DOI 10.1016/B978-012415031-7/50037-9; Compagno LJV, 1997, ENVIRON BIOL FISH, V50, P61, DOI 10.1023/A:1007308406137; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	13	236	242	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					139	140		10.1038/35084125	http://dx.doi.org/10.1038/35084125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449258				2022-12-01	WOS:000169778700036
J	Sjogren, M				Sjogren, M			EDRF transcripts and diagnosis of variant Creutzfeldt-Jakob disease	LANCET			English	Editorial Material									Univ Gothenburg, Inst Clin Neurosci, SE-43180 Molndal, Sweden	University of Gothenburg	Sjogren, M (corresponding author), Univ Gothenburg, Inst Clin Neurosci, SE-43180 Molndal, Sweden.		Sjogren, Magnus/M-2668-2015	Sjogren, Magnus/0000-0003-2060-1914				Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; Miele G, 2001, NAT MED, V7, P361, DOI 10.1038/85515; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2069	2070		10.1016/S0140-6736(00)05224-7	http://dx.doi.org/10.1016/S0140-6736(00)05224-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445093				2022-12-01	WOS:000169586600003
J	Allen, GJ; Chu, SP; Harrington, CL; Schumacher, K; Hoffman, T; Tang, YY; Grill, E; Schroeder, JI				Allen, GJ; Chu, SP; Harrington, CL; Schumacher, K; Hoffman, T; Tang, YY; Grill, E; Schroeder, JI			A defined range of guard cell calcium oscillation parameters encodes stomatal movements	NATURE			English	Article							CYTOSOLIC-FREE CALCIUM; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ANION CHANNELS; ARABIDOPSIS; FREQUENCY; GROWTH; SPECIFICITY; INCREASES	Oscillations in cytosolic calcium concentration ([Ca2+](cyt)) are central regulators of signal transduction cascades(1), although the roles of individual [Ca2+](cyt) oscillation parameters in regulating downstream physiological responses remain largely unknown. In plants, guard cells integrate environmental and endogenous signals to regulate the aperture of stomatal pores(2) and [Ca2+](cyt) oscillations are a fundamental component of stomatal closure(3,4). Here we systematically vary [Ca2+](cyt) oscillation parameters in Arabidopsis guard cells using a 'calcium clamp'(3,5-7) and show that [Ca2+](cyt) controls stomatal closure by two mechanisms. Shortterm 'calcium-reactive' closure occurred rapidly when [Ca2+](cyt) was elevated, whereas the degree of long-term steady-state closure was 'calcium programmed' by [Ca2+](cyt) oscillations within a defined range of frequency, transient number, duration and amplitude. Furthermore, in guard cells of the gca2 mutant(8), [Ca2+](cyt) oscillations induced by abscisic acid and extracellular calcium had increased frequencies and reduced transient duration, and steady-state stomatal closure was abolished. Experimentally imposing [Ca2+](cyt) oscillations with parameters that elicited closure in the wild type restored long-term closure in gca2 stomata. These data show that a defined window of guard cell [Ca2+](cyt) oscillation parameters programs changes in steady-state stomatal aperture.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Univ Tubingen, ZMBP Pflanzenphysiol, D-72076 Tubingen, Germany; Tech Univ, Lehrstuhl Bot, D-85350 Freising Weihenstephan, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Eberhard Karls University of Tubingen	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.		Schumacher, Karin/E-8500-2014	Schumacher, Karin/0000-0001-6484-8105				Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Blatt MR, 2000, CURR OPIN PLANT BIOL, V3, P196, DOI 10.1016/S1369-5266(00)00064-9; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hamilton DWA, 2000, P NATL ACAD SCI USA, V97, P4967, DOI 10.1073/pnas.080068897; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; MacRobbie EAC, 1997, J EXP BOT, V48, P515, DOI 10.1093/jxb/48.Special_Issue.515; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Trewavas AJ, 1998, CURR OPIN PLANT BIOL, V1, P428, DOI 10.1016/S1369-5266(98)80268-9	30	411	455	6	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1053	1057		10.1038/35082575	http://dx.doi.org/10.1038/35082575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429606				2022-12-01	WOS:000169528500049
J	Jones, PL				Jones, PL			Extracellular matrix and tenascin-C in pathogenesis of breast cancer	LANCET			English	Editorial Material							MALIGNANT GLIOMAS; PHASE-I; CARCINOGENESIS; EXPRESSION; INVASION; RECEPTOR; 81C6		Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Jones, PL (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA.			Jones, Peter Lloyd/0000-0003-1445-4081				Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BIGNER DD, 1995, J NEURO-ONCOL, V24, P109, DOI 10.1007/BF01052668; Cokgor I, 2000, J CLIN ONCOL, V18, P3862, DOI 10.1200/JCO.2000.18.22.3862; Goepel C, 2000, GYNECOL ONCOL, V79, P372, DOI 10.1006/gyno.2000.5978; Hansen RK, 2000, ENDOCR-RELAT CANCER, V7, P95, DOI 10.1677/erc.0.0070095; Jahkola T, 1998, BRIT J CANCER, V78, P1507, DOI 10.1038/bjc.1998.714; Jahkola T, 1998, EUR J CANCER, V34, P1687, DOI 10.1016/S0959-8049(98)00215-9; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.0.CO;2-G; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; LEMAISTRE CF, 1994, BREAST CANCER RES TR, V32, P97, DOI 10.1007/BF00666210; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Woodward TL, 2000, ENDOCRINOLOGY, V141, P2814, DOI 10.1210/en.141.8.2814	15	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					1992	1994		10.1016/S0140-6736(00)05133-3	http://dx.doi.org/10.1016/S0140-6736(00)05133-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438127				2022-12-01	WOS:000169509200004
J	Gopfert, MC; Robert, D				Gopfert, MC; Robert, D			Turning the key on Drosophila audition	NATURE			English	Article							MECHANOSENSORY TRANSDUCTION; MUTATIONS		Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Zurich	Gopfert, MC (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Gopfert, Martin/0000-0001-8201-5334				BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; *RYB CONS, 1999, NUCLEIC ACIDS RES, V28, P85; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	10	77	80	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					908	908		10.1038/35082144	http://dx.doi.org/10.1038/35082144			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418847	Bronze			2022-12-01	WOS:000169386200033
J	May, R				May, R			Risk and uncertainty	NATURE			English	Editorial Material									Royal Soc, London SW1Y 5AG, England		May, R (corresponding author), Royal Soc, Carlton House Terrace, London SW1Y 5AG, England.								0	13	13	2	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					891	891		10.1038/35082158	http://dx.doi.org/10.1038/35082158			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418834	Bronze			2022-12-01	WOS:000169386200022
J	Zhang, CY; Baffy, G; Perret, P; Krauss, S; Peroni, O; Grujic, D; Hagen, T; Vidal-Puig, AJ; Boss, O; Kim, YB; Zheng, XX; Wheeler, MB; Shulman, GI; Chan, CB; Lowell, BB				Zhang, CY; Baffy, G; Perret, P; Krauss, S; Peroni, O; Grujic, D; Hagen, T; Vidal-Puig, AJ; Boss, O; Kim, YB; Zheng, XX; Wheeler, MB; Shulman, GI; Chan, CB; Lowell, BB			Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes	CELL			English	Article							SENSITIVE K+ CHANNELS; BROWN ADIPOSE-TISSUE; FATTY-ACIDS; CARBOHYDRATE-METABOLISM; PANCREATIC-ISLETS; THYROID-HORMONE; RECEPTOR GENE; KNOCKOUT MICE; NORMAL MEN; EXPRESSION	B cells sense glucose through its metabolism and the resulting increase in ATP, which subsequently stimulates insulin secretion. Uncoupling protein-2 (UCP2) mediates mitochondrial proton leak, decreasing ATP production. In the present study, we assessed UCP2's role in regulating insulin secretion. UCP2-deficient mice had higher islet ATP levels and increased glucose-stimulated insulin secretion, establishing that UCP2 negatively regulates insulin secretion. Of pathophysiologic significance, UCP2 was markedly upregulated in islets of ob/ob mice, a model of obesity-induced diabetes. Importantly, ob/ob mice lacking UCP2 had restored first-phase insulin secretion, increased serum insulin levels, and greatly decreased levels of glycemia. These results establish UCP2 as a key component of beta cell glucose sensing, and as a critical link between obesity, B cell dysfunction, and type 2 diabetes.	Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Toronto, Fac Med, Dept Med & Physiol, Toronto, ON M5F 1A8, Canada; Univ Prince Edward Isl, Atlantic Vet Coll, Dept Anat & Physiol, Charlottetown, PE C1A 4P3, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; Howard Hughes Medical Institute; Yale University; University of Toronto; University of Prince Edward Island	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.	blowell@caregroup.harvard.edu	Shulman, Gerald I./P-7176-2019; Chan, Catherine/C-1162-2011; Perret, pascale/O-7382-2019; Baffy, Gyorgy/P-7986-2018; Perret, Pascale/M-3911-2014	Shulman, Gerald I./0000-0003-1529-5668; Chan, Catherine/0000-0003-3882-0592; Perret, pascale/0000-0003-0804-8247; Baffy, Gyorgy/0000-0002-8334-0400; Perret, Pascale/0000-0003-0804-8247; Wheeler, Michael B./0000-0002-7480-7267; Vidal-Puig, Antonio/0000-0003-4220-9577	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053477, T32DK007533, R01DK040936, P30DK046200, R37DK053477, P30DK057521] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK040936, DK57521, T32 DK07533, DK46200, R01-DK53477, R37 DK053477] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; BELOFFCHAIN A, 1975, HORM METAB RES, V7, P374, DOI 10.1055/s-0028-1093730; BODEN G, 1991, DIABETES, V40, P686, DOI 10.2337/diabetes.40.6.686; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRICHARD SM, 1990, DIABETES, V39, P1326, DOI 10.2337/diabetes.39.11.1326; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; CAWTHORN EG, 1991, MOL CELL ENDOCRINOL, V75, P197, DOI 10.1016/0303-7207(91)90161-K; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; CHAN CB, 2001, IN PRESS DIABETES; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chung WK, 1997, OBES RES, V5, P183, DOI 10.1002/j.1550-8528.1997.tb00291.x; COLEMAN DL, 1982, DIABETES, V31, P1; Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; GEMBAL M, 1993, J CLIN INVEST, V91, P871, DOI 10.1172/JCI116308; GEPTS W, 1960, DIABETES, V9, P63, DOI 10.2337/diab.9.1.63; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; HELLMAN B, 1961, ACTA ENDOCRINOL-COP, V36, P606; HIMMSHAGEN J, 1989, PROG LIPID RES, V28, P67, DOI 10.1016/0163-7827(89)90009-X; Hinz W, 1999, FEBS LETT, V448, P57, DOI 10.1016/S0014-5793(99)00331-2; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Kahn Steven E., 2000, American Journal of Medicine, V108, p2S, DOI 10.1016/S0002-9343(00)00336-3; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; LI E, 1993, P NATL ACAD SCI USA, V90, P1590, DOI 10.1073/pnas.90.4.1590; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Poitout V, 1996, ANNU REV MED, V47, P69; Reilly JM, 2000, BIOCHEM BIOPH RES CO, V277, P541, DOI 10.1006/bbrc.2000.3705; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Ronner P, 1999, ANAL BIOCHEM, V275, P208, DOI 10.1006/abio.1999.4317; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Schaff er I. E., 1999, MITOCHONDRIA, P141; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Wang MY, 1999, DIABETES, V48, P1020, DOI 10.2337/diabetes.48.5.1020; ZAVARONI I, 1987, J CLIN ENDOCR METAB, V65, P494, DOI 10.1210/jcem-65-3-494; Zhang CY, 1999, FEBS LETT, V449, P129, DOI 10.1016/S0014-5793(99)00441-X; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	56	717	749	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2001	105	6					745	755		10.1016/S0092-8674(01)00378-6	http://dx.doi.org/10.1016/S0092-8674(01)00378-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440717	Bronze			2022-12-01	WOS:000169375100008
J	Allison, TJ; Winter, CC; Fournie, JJ; Bonneville, M; Garboczi, DN				Allison, TJ; Winter, CC; Fournie, JJ; Bonneville, M; Garboczi, DN			Structure of a human gamma delta T-cell antigen receptor	NATURE			English	Article							NONPEPTIDIC MYCOBACTERIAL LIGANDS; RECOGNITION; STIMULATION; CRYSTALLOGRAPHY; PYROPHOSPHATE; SUBSET; SUITE	T-cell antigen receptors composed of gamma and delta polypeptide chains (gamma delta TCRs) can directly recognize antigens in the form of intact proteins or non-peptide compounds, unlike alpha beta TCRs, which recognize antigens bound to major histocompatibility complex molecules (MHC). About 5% of peripheral blood T cells bear gamma delta TCRs, most of which recognize non-peptide phosphorylated antigens(1,2). Here we describe the 3.1 Angstrom resolution structure of a human gamma delta TCR from a T-cell clone(3) that is phosphoantigen-reactive. The orientation of the variable (V) and constant (C) regions of the gamma delta TCR is unique when compared with alpha beta TCRs or antibodies, and results from an unusually small angle between the V gamma and C gamma domains. The complementarity-determining regions (CDRs) of the V domains exhibit a chemically reasonable binding site for phosphorylated antigens, providing a possible explanation for the canonical usage of the V gamma9 and V delta2 gene segments by phosphoantigen-reactive receptors. Although the gamma delta TCR V domains are similar in overall structure to those of alpha beta TCRs, gamma delta TCR C domains are markedly different. Structural differences in C gamma and C delta, and in the location of the disulphide bond between them, may enable gamma delta TCRs to form different recognition/signalling complexes than alpha beta TCRs.	NIAID, Struct Biol Sect, Immunogenet Lab, Rockville, MD 20852 USA; CHU Purpan, INSERM, U395, F-31024 Toulouse, France; Inst Biol, INSERM, U463, F-44035 Nantes, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Allison, TJ (corresponding author), NIAID, Struct Biol Sect, Immunogenet Lab, 12441 Parklawn Dr, Rockville, MD 20852 USA.		Fournie, Jean-Jacques/J-7805-2013	Fournie, Jean-Jacques/0000-0001-6542-6908	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000835] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; DAVODEAU F, 1993, EUR J IMMUNOL, V23, P804, DOI 10.1002/eji.1830230405; DAVODEAU F, 1993, J BIOL CHEM, V268, P15455; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Fournie JJ, 1996, RES IMMUNOL, V147, P338, DOI 10.1016/0923-2494(96)89648-9; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Kunzmann V, 2000, BLOOD, V96, P384; LANG F, 1995, J IMMUNOL, V154, P5986; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; LOH EY, 1994, J IMMUNOL, V152, P3324; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 2001, IMMUNITY, V14, P331, DOI 10.1016/S1074-7613(01)00113-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SCIAMMAS R, 1994, J IMMUNOL, V152, P5392; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10	30	196	206	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					820	824		10.1038/35081115	http://dx.doi.org/10.1038/35081115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459064	Green Published			2022-12-01	WOS:000169246400055
J	Wohlgemuth, S; Ronacher, B; Wehner, R				Wohlgemuth, S; Ronacher, B; Wehner, R			Ant odometry in the third dimension	NATURE			English	Article							PATH-INTEGRATION; CATAGLYPHIS-FORTIS; DESERT ANTS; HONEYBEE NAVIGATION; DISTANCE ESTIMATION; OPTIC FLOW; ORIENTATION; GOAL	Desert ants (Cataglyphis) are renowned for their ability to perform large-scale foraging excursions and then return to the nest by path integration. They do so by integrating courses steered and the distances travelled into a continually updated home vector(1). Whereas the angular orientation is based on skylight cues(2), how the ants gauge the distances travelled has remained largely unclear(3,4). Furthermore, almost all studies on path integration in Cataglyphis(5,6), as well as in spiders(7,8), rodents(9), and humans(10,11), have aimed at understanding how the animals compute home-bound courses in the horizontal plane. Here, we investigate for the first time how an animal's odometer operates when a path integration task has to be accomplished that includes a vertical component. We trained Cataglyphis ants within arrays of uphill and downhill channels, and later tested them on flat terrain, or vice versa. In all these cases, the ants indicated homing distances that corresponded not to the distances actually travelled but to the ground distances; that is, to the sum of the horizontal projections of the uphill and downhill segments of the ants' paths.	Univ Zurich, Dept Zool, CH-8057 Zurich, Switzerland; Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	University of Zurich; Humboldt University of Berlin	Ronacher, B (corresponding author), Univ Zurich, Dept Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernhard.ronacher@rz.hu-berlin.de						Bardunias PM, 2000, NATURWISSENSCHAFTEN, V87, P532, DOI 10.1007/s001140050772; Esch HE, 1996, J EXP BIOL, V199, P155; Etienne AS, 1996, J EXP BIOL, V199, P201; Gorner P., 1985, P275; HERAN H, 1956, Z VERGL PHYSIOL, V38, P168, DOI 10.1007/BF00338625; HILL DE, 1979, BEHAV ECOL SOCIOBIOL, V5, P301, DOI 10.1007/BF00293678; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; MARKL H, 1962, Z VERGL PHYSIOL, V45, P475, DOI 10.1007/BF00342998; Mittelstaedt H., 1973, FORTSCHR ZOOL, V21, P46; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Ronacher B, 2000, J EXP BIOL, V203, P1113; RONACHER B, 1995, J COMP PHYSIOL A, V177, P21; SAUVE JP, 1989, THESIS U AIX MARSEIL; Schafer M, 1993, VERH DTSCH ZOOL GES, V86, P270; SEYFARTH EA, 1982, BEHAV ECOL SOCIOBIOL, V11, P139, DOI 10.1007/BF00300103; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Srinivasan MV, 1997, J EXP BIOL, V200, P2513; TAYLOR CR, 1972, SCIENCE, V178, P1096, DOI 10.1126/science.178.4065.1096; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WEHNER R, 1994, FORTS ZOOL, V39, P103; WEHNER R, 1990, ETHOL ECOL EVOL, V2, P27, DOI 10.1080/08927014.1990.9525492; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; WEHNER R, 1997, ORIENTATION COMMUNIC, P145	25	99	99	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					795	798		10.1038/35081069	http://dx.doi.org/10.1038/35081069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459057				2022-12-01	WOS:000169246400048
J	Niemann, T; Nielsen, TT; Thorsgaard, N; Lous, J				Niemann, T; Nielsen, TT; Thorsgaard, N; Lous, J			Differences in therapeutic consequences of exercise testing between a rural and an urban Danish county: population based study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY ANGIOGRAPHY		Med Res Unit Ringkobing, DK-6950 Ringkobing, Denmark; Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; Herning Cent Hosp, Dept Med, DK-7400 Herning, Denmark; Aarhus Univ, Inst Gen Practice, DK-8000 Aarhus C, Denmark; Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Niemann, T (corresponding author), Finsensgade 26, DK-7400 Herning, Denmark.							EVERY NR, 1993, NEW ENGL J MED, V329, P546, DOI 10.1056/NEJM199308193290807; GRAY D, 1994, BRIT HEART J, V71, P474; Niemann T, 2000, SCAND CARDIOVASC J, V34, P286, DOI 10.1080/713783124; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907	4	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2001	322	7299					1394	1395		10.1136/bmj.322.7299.1394	http://dx.doi.org/10.1136/bmj.322.7299.1394			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442KN	11397744	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000169284600017
J	McConnell, JR; Emery, J; Eshed, Y; Bao, N; Bowman, J; Barton, MK				McConnell, JR; Emery, J; Eshed, Y; Bao, N; Bowman, J; Barton, MK			Role of PHABULOSA and PHAVOLUTA in determining radial patterning in shoots	NATURE			English	Article							HD-ZIP; GENE; ARABIDOPSIS; MERISTEM; ENCODES; MEMBERS; LEAVES	The upper side of the angiosperm leaf is specialized for efficient capture of sunlight whereas the lower side is specialized for gas exchange. In Arabidopsis, the establishment of polarity in the leaf probably requires the generation and perception of positional information along the radial (adaxial versus abaxial or central versus peripheral) dimension of the plant. This is because the future upper (adaxial) side of the leaf develops from cells closer to the centre of the shoot, whereas the future under (abaxial) side develops from cells located more peripherally. Here we implicate the Arabidopsis PHABULOSA and PHAVOLUTA genes in the perception of radial positional information in the leaf primordium. Dominant phabulosa (phb)(1) and phavoluta (phv) mutations cause a dramatic transformation of abaxial leaf fates into adaxial leaf fates. They do so by altering the predicted sterol/lipid-binding domains of ATHB14 and ATHB9, proteins of previously unknown function that also contain DNA-binding motifs. This change probably renders the protein constitutively active, implicating this domain as a central regulator of protein function and the PHB and PHV proteins as receptors for an adaxializing signal.	Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Program Plant Breeding & Plant Genet, Madison, WI 53706 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Barton, MK (corresponding author), Univ Wisconsin, Dept Genet, 445 Henry Mall, Madison, WI 53706 USA.	mkbarton@facstaff.wisc.edu		Bowman, John/0000-0001-7347-3691; Eshed, Yuval/0000-0001-8290-0018				BENFEY PN, 1990, EMBO J, V9, P1677, DOI 10.1002/j.1460-2075.1990.tb08291.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Lynn K, 1999, DEVELOPMENT, V126, P469; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Ratcliffe OJ, 2000, PLANT CELL, V12, P315, DOI 10.1105/tpc.12.3.315; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SNOW M, 1959, NEW PHYTOL, V8, P188; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; WAITES R, 1995, DEVELOPMENT, V121, P2143; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139	15	827	1055	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					709	713		10.1038/35079635	http://dx.doi.org/10.1038/35079635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395776				2022-12-01	WOS:000169112500050
J	Gupta, R; Kim, JY; Espinal, MA; Caudron, JM; Pecoul, B; Farmer, PE; Raviglione, MC				Gupta, R; Kim, JY; Espinal, MA; Caudron, JM; Pecoul, B; Farmer, PE; Raviglione, MC			Public health - Responding to market failures in tuberculosis control	SCIENCE			English	Editorial Material							RESISTANT TUBERCULOSIS; COUNTRIES		WHO, Stop TB Dept, Geneva, Switzerland; Harvard Univ, Sch Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; Med Sans Frontieres, B-1090 Brussels, Belgium; MSF, Access Essential Med, CH-1211 Geneva 6, Switzerland	World Health Organization; Harvard University; Harvard Medical School; Doctors Without Borders; Doctors Without Borders	Gupta, R (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, Geneva, Switzerland.	guptara@who.int		RAVIGLIONE, Mario/0000-0002-9331-2067; Gupta, Rajesh/0000-0002-3307-6541				Baleta A, 2001, LANCET, V357, P775, DOI 10.1016/S0140-6736(00)04158-1; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; CROFTON J, 1960, BRIT MED J, V17, P679; DIMASI JA, 1991, J HEALTH ECON, V10, P107, DOI 10.1016/0167-6296(91)90001-4; DYE C, UNPUB; ENARSON DA, 2000, MANGEMENT TUBERCULOS; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Farmer P., 2000, INFECT INEQUALITIES; GUPTA R, 2001, GUIDELINES ESTABLISH; GUPTA R, 2000, P PROC 2 LIN ANT DRU; Harvard Medical School and Open Society Institute, 1999, GLOB IMP DRUG RES TU; ISEMAN MD, 1993, NEW ENGL J MED, V328, P576, DOI 10.1056/NEJM199302253280811; Kim J., 2000, DYING GROWTH; *MED SANS FRONT, 1999, CAMP ACC ESSMED PRIC; MIGLIORI GB, 1999, B WORLD HEALTH ORGAN, V76, P475; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; SUAREZ PG, IN PRESS J INFECT DI; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; WHO, 1997, GUID MAN DRUG RES TU; World Health Organization (WHO), 2001, HUM RIGHTS APPR TUB	23	114	114	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1049	1051		10.1126/science.1061861	http://dx.doi.org/10.1126/science.1061861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11463877				2022-12-01	WOS:000170432600028
J	Digicaylioglu, M; Lipton, SA				Digicaylioglu, M; Lipton, SA			Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signalling cascades	NATURE			English	Article							NITRIC-OXIDE; TRANSCRIPTION FACTOR; CYTOKINE RECEPTORS; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; ACTIVATION; INHIBITION; HIPPOCAMPAL	Erythropoietin, a kidney cytokine regulating haematopoiesis (the production of blood cells), is also produced in the brain after oxidative or nitrosative stress(1,2). The transcription factor hypoxia-inducible factor-1 (HIF-1) upregulates EPO following hypoxic stimuli(3,4). Here we show that preconditioning with EPO protects neurons in models of ischaemic and degenerative damage due to excitotoxins(4,5) and consequent generation of free radicals, including nitric oxide (NO). Activation of neuronal EPO receptors (EPORs) prevents apoptosis induced by NMDA (N-methyl-D-aspartate) or NO by triggering cross-talk between the signalling pathways of Janus kinase-2 (Jak2) and nuclear factor-kappaB (NF-kappaB). We show that EPOR-mediated activation of Jak2 leads to phosphorylation of the inhibitor of NF-kappaB (I kappaB), subsequent nuclear translocation of the transcription factor NF-kappaB, and NF-kappaB-dependent transcription of neuroprotective genes. Transfection of cerebrocortical neurons with a dominant interfering form of Jak2 or an I kappaB alpha super-repressor blocks EPO-mediated prevention of neuronal apoptosis. Thus neuronal EPORs activate a neuroprotective pathway that is distinct from previously well characterized Jak and NF-kappaB functions. Moreover, this EPO effect may underlie neuroprotection mediated by hypoxic-schaemic preconditioning.	Burnham Inst, Ctr Neurosci & Aging Res, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp,Program Neurosci, Cerebrovasc & NeuroSci Res Inst, Boston, MA 02115 USA	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Digicaylioglu, Murat H/D-3302-2009	Lipton, Stuart/0000-0002-3490-1259				ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bonfoco E, 1996, NEUROREPORT, V8, P273, DOI 10.1097/00001756-199612200-00054; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Gage AT, 1996, BRAIN RES, V719, P172, DOI 10.1016/0006-8993(96)00092-3; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Schmidt H.H.H.W., 1996, METHODS NITRIC OXIDE, P491; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; ZHUANG HM, 1994, J BIOL CHEM, V269, P21411	30	776	857	0	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					641	647		10.1038/35088074	http://dx.doi.org/10.1038/35088074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493922				2022-12-01	WOS:000170318000042
J	Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR				Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR			Induction of apoptosis by a secreted lipocatin that is transcriptionally regulated by IL-3 deprivation	SCIENCE			English	Article							ACUTE-PHASE PROTEIN; CELL-DEATH; HEMATOPOIETIC-CELLS; INDUCED EXPRESSION; GENE; SURVIVAL; ENDONUCLEASE; ACTIVATION; WITHDRAWAL; LINES	Many hematopoietic cells undergo apoptosis when deprived of specific cytokines, and this process requires de novo RNA/protein synthesis. Using DNA microarrays to analyze interleukin-3 (IL-3)- dependent murine FL5.12 pro-B cells, we found that the gene undergoing maximal transcriptional induction after cytokine withdrawal is 24p3, which encodes a secreted lipocalin. Conditioned medium from IL-3-deprived FL5.12 cells contained 24p3 and induced apoptosis in naive FL5.12 cells even when IL-3 was present. 24p3 also induced apoptosis in a wide variety of leukocytes but not other cell types. Apoptotic sensitivity correlated with the presence of a putative 24p3 cell surface receptor. We conclude that IL-3 deprivation activates 24p3 transcription, leading to synthesis and secretion of 24p3, which induces apoptosis through an autocrine pathway.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, 373 Plantat St, Worcester, MA 01605 USA.		Teodoro, Joe/AFT-2440-2022	Teodoro, Joe/0000-0002-3713-6839				Blalock WL, 1999, LEUKEMIA, V13, P1109, DOI 10.1038/sj.leu.2401493; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chu ST, 1996, BIOCHEM J, V316, P545, DOI 10.1042/bj3160545; COHEN JJ, 1984, J IMMUNOL, V132, P38; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; Flower DR, 1996, BIOCHEM J, V318, P1; GALILI U, 1982, CANCER RES, V42, P1433; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JOHNSON DE, 1998, FRONT BIOSCI, V3, P313; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Liu QS, 1997, MOL REPROD DEV, V46, P507, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;507::AID-MRD9&gt;3.0.CO;2-S; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; MCCUBREY J, 1989, ONCOGENE RES, V4, P97; MISHIZAWA M, 1992, FEBS LETT, V299, P36; NIELSEN BS, 1996, GUT, V38, P41; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	31	312	333	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					829	834		10.1126/science.1061075	http://dx.doi.org/10.1126/science.1061075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486081				2022-12-01	WOS:000170241000036
J	Bae, SH; Bae, KH; Kim, JA; Seo, YS				Bae, SH; Bae, KH; Kim, JA; Seo, YS			RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes	NATURE			English	Article							REPLICATION PROTEIN-A; DNA-BINDING-PROTEIN; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; STRANDED-DNA; POLYMERASE-DELTA; SV40 ORIGIN; YEAST; GENE; METABOLISM	Extensive work on the maturation of lagging strands during the replication of simian virus 40 DNA suggests that the initiator RNA primers of Okazaki fragments are removed by the combined action of two nucleases, RNase HI and Fen1, before the Okazaki fragments join(1-5). Despite the well established in vitro roles of these two enzymes(6), genetic analyses in yeast revealed that null mutants of RNase HI and/or Fen1 are not lethal(7-9), suggesting that an additional enzymatic activity may be required for the removal of RNA. One such enzyme is the Saccharomyces cerevisiae Dna2 helicase(10-12)/endonuclease(12), which is essential for cell viability(13,14) and is well suited to removing RNA primers of Okazaki fragments(15). In addition, Dna2 interacts genetically and physically with several proteins involved in the elongation or maturation of Okazaki fragments(10,16). Here we show that the endonucleases Dna2 and Fen1 act sequentially to facilitate the complete removal of the primer RNA. The sequential action of these enzymes is governed by a single-stranded DNA-binding protein, replication protein-A (RPA). Our results demonstrate that the processing of Okazaki fragments in eukaryotes differs significantly from, and is more complicated than, that occurring in prokaryotes. We propose a novel biochemical mechanism for the maturation of eukaryotic Okazaki fragments.	Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Natl Creat Res Initiat Ctr Cell Cycle Control, Suwon 440746, South Korea	Sungkyunkwan University (SKKU)	Seo, YS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Natl Creat Res Initiat Ctr Cell Cycle Control, 300 Chunchun Dong, Suwon 440746, South Korea.	ysseo@med.skku.ac.kr	Seo, Yeonsoo/C-1605-2011	Bae, Kwang-Hee/0000-0002-5868-2556				Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2000, J BIOCHEM MOL BIOL, V33, P155; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; Frank P, 1998, FEBS LETT, V421, P23, DOI 10.1016/S0014-5793(97)01528-7; Gary R, 1999, MOL CELL BIOL, V19, P5373; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Iftode C, 1997, MOL CELL BIOL, V17, P3876, DOI 10.1128/MCB.17.7.3876; Kang HY, 2000, GENETICS, V155, P1055; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Mass G, 1998, MOL CELL BIOL, V18, P6399, DOI 10.1128/MCB.18.11.6399; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	30	273	277	1	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					456	461		10.1038/35086609	http://dx.doi.org/10.1038/35086609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473323				2022-12-01	WOS:000170068200053
J	Shortle, D; Ackerman, MS				Shortle, D; Ackerman, MS			Persistence of native-like topology in a denatured protein in 8 M urea	SCIENCE			English	Article							RESIDUAL DIPOLAR COUPLINGS; STAPHYLOCOCCAL NUCLEASE; 131-RESIDUE FRAGMENT; BACKBONE DYNAMICS; NMR; RESTRAINTS; ALIGNMENT; STATE; COMPACT; GELS	Experimental methods have demonstrated that when a protein unfolds, not all of its structure is Lost. Here we report measurement of residual dipolar couplings in denatured forms of the small protein staphylococcal nuclease oriented in strained polyacrylamide gels. A highly significant correlation among the dipolar couplings for individual residues suggests that a native-like spatial positioning and orientation of chain segments (topology) persists to concentrations of at least 8 molar urea. These data demonstrate that long-range ordering can occur well before a folding protein attains a compact conformation, a conclusion not anticipated by any of the standard models of protein folding.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Shortle, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM34171] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034171] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Bonneau R, 2001, PROTEINS, V43, P1, DOI 10.1002/1097-0134(20010401)43:1<1::AID-PROT1012>3.0.CO;2-A; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; GILLESPIE JH, UNPUB; Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Sinclair JF, 1999, PROTEIN SCI, V8, P991, DOI 10.1110/ps.8.5.991; Skrynnikov NR, 2000, J BIOMOL NMR, V18, P239, DOI 10.1023/A:1026501101716; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; TJANDRA N, 1999, STRUCT FOLD DES, V9, pR205; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q	20	525	532	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					487	489		10.1126/science.1060438	http://dx.doi.org/10.1126/science.1060438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463915				2022-12-01	WOS:000169966700046
J	Parnell, RJ; Buchanan-Smith, HM				Parnell, RJ; Buchanan-Smith, HM			Animal behaviour - An unusual social display by gorillas	NATURE			English	Article									Univ Stirling, Dept Psychol, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland; New York Zool Soc, Wildlife Conservat Soc, Bronx, NY 10460 USA	University of Stirling; Wildlife Conservation Society	Parnell, RJ (corresponding author), Univ Stirling, Dept Psychol, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland.		Buchanan-Smith, Hannah M/A-5350-2009	Buchanan-Smith, Hannah M/0000-0002-2516-7734				Beck B.B., 1980, ANIMAL TOOL BEHAV US; Byrne Richard W., 1996, P111; WILLIAMSON EA, 1990, AM J PRIMATOL, V21, P265, DOI 10.1002/ajp.1350210403	3	21	23	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					294	294		10.1038/35085631	http://dx.doi.org/10.1038/35085631			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460152				2022-12-01	WOS:000169918200035
J	Schwetz, BA				Schwetz, BA			New treatment for chronic myelogenous leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.							Stephenson J, 2001, JAMA-J AM MED ASSOC, V285, P2841, DOI 10.1001/jama.285.22.2841	1	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2001	286	1					35	35		10.1001/jama.286.1.35	http://dx.doi.org/10.1001/jama.286.1.35			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449GR	11434814				2022-12-01	WOS:000169676400005
J	Sheng, M; Lee, SH				Sheng, M; Lee, SH			AMPA receptor trafficking and the control of synaptic transmission	CELL			English	Review							LONG-TERM POTENTIATION; PLASTICITY; SYNAPSES; MEMBRANE; LTP		Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MIT, Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sheng, Morgan/0000-0002-8703-5366				Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	20	160	163	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2001	105	7					825	828		10.1016/S0092-8674(01)00406-8	http://dx.doi.org/10.1016/S0092-8674(01)00406-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439178	Bronze			2022-12-01	WOS:000169664300003
J	Stanhope, MJ; Lupas, A; Italia, MJ; Koretke, KK; Volker, C; Brown, JR				Stanhope, MJ; Lupas, A; Italia, MJ; Koretke, KK; Volker, C; Brown, JR			Phylogenetic analyses do not support horizontal gene transfers from bacteria to vertebrates	NATURE			English	Article							MONOAMINE-OXIDASE; GENOME SEQUENCE; BEHAVIOR; ARCHAEA	Horizontal gene transfer (HGT) has long been recognized as a principal force in the evolution of genomes(1). Genome sequences of Archaea and Bacteria have revealed the existence of genes whose similarity to loci in distantly related organisms is explained most parsimoniously by HGT events(2-4). In most multicellular organisms, such genetic fixation can occur only in the germ line. Therefore, it is notable that the publication of the human genome reports 113 incidents of direct HGT between bacteria and vertebrates(5), without any apparent occurrence in evolutionary intermediates, that is, non-vertebrate eukaryotes. Phylogenetic analysis arguably provides the most objective approach for determining the occurrence and directionality of HGT(6,7). Here we report a phylogenetic analysis of 28 proposed HGT genes, whose presence in the human genome had been confirmed by polymerase chain reaction (PCR)(5). The results indicate that most putative HGT genes are present in more anciently derived eukaryotes (many such sequences available in non-vertebrate EST databases) and can be explained in terms of descent through common ancestry. They are, therefore, unlikely to be examples of direct HGT from bacteria to vertebrates.	GlaxoSmithKline Inc, Bioinformat, Collegeville, PA 19426 USA	GlaxoSmithKline	Stanhope, MJ (corresponding author), GlaxoSmithKline Inc, Bioinformat, 1250 S Collegeville Rd,UP1345, Collegeville, PA 19426 USA.	Michael_J_Stanhope@sbphrd.com; James_R_Brown@sbphrd.com		Italia, Michael/0000-0002-6941-6181				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FELSENSTEIN J, 2000, PHYLIP PHYLOGENY INT; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Kyrpides NC, 1999, TRENDS GENET, V15, P298, DOI 10.1016/S0168-9525(99)01811-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Logsdon JM, 1999, CURR BIOL, V9, pR747, DOI 10.1016/S0960-9822(99)80474-6; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; SMITH MW, 1992, TRENDS BIOCHEM SCI, V17, P489, DOI 10.1016/0968-0004(92)90335-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	16	157	164	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					940	944		10.1038/35082058	http://dx.doi.org/10.1038/35082058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418856				2022-12-01	WOS:000169386200042
J	Lamont, EB; Christakis, NA				Lamont, EB; Christakis, NA			Prognostic disclosure to patients with cancer near the end of life	ANNALS OF INTERNAL MEDICINE			English	Article							INFORMATION NEEDS; ODDS RATIOS; SURVIVAL; PREFERENCES; PREDICTIONS; ATTITUDES; SUPPORT	Background: Patients' understanding of their prognosis informs numerous medical and nonmedical decisions, but patients with cancer and their physicians often have disparate prognostic expectations. Objective: To determine whether physician behavior might contribute to the disparity between patients' and physicians' prognostic expectations. Design: Prospective cohort study. Setting: Five hospices in Chicago, Illinois. Patients: 326 patients with cancer. Intervention: Physicians formulated survival estimates and also indicated the survival estimates that they would communicate to their patients if the patients insisted. Measurements: Comparison of the formulated and communicated prognoses. Results: For 300 of 311 evaluable patients (96.5%), physicians were able to formulate prognoses. Physicians reported that they would not communicate any survival estimate 22.7% (95% CI, 17.9% to 27.4%) of the time, would communicate the same survival estimate they formulated 37% (CI, 31.5% to 42.5%) of the time, and would communicate a survival estimate different from the one they formulated 40.3% (CI, 34.8% to 45.9%) of the time. Of the discrepant survival estimates, most (70.2%) were optimistically discrepant. Multivariate analysis revealed that older patients were more likely to receive frank survival estimates, that the most experienced physicians and the physicians who were least confident about their prognoses were more likely to favor no disclosure over frank disclosure, and that female physicians were less likely to favor frank disclosure over pessimistically discrepant disclosure. Conclusions: Physicians reported that even if patients with cancer requested survival estimates, they would provide a frank estimate only 37% of the time and would provide no estimate, a conscious overestimate, or a conscious underestimate most of the time (63%). This pattern may contribute to the observed disparities between physicians' and patients' estimates of survival.	Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Christakis, NA (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	nchrista@medicine.bsd.uchicago.edu	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008	Lamont, Elizabeth/0000-0001-6604-678X	NIA NIH HHS [K12 AG-0048-09] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGRESTI A, 1990, CATEGORICAL DATA ANA, P125; Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BILLINGS JA, 1985, OUTPATIENT MANAGEMEN; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; Buckman R., 1992, BREAK BAD NEWS GUIDE; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 2000, MED CARE, V38, P528, DOI 10.1097/00005650-200005000-00009; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; CONNORS AF, 1992, MED DECIS MAKING, V12, P336; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Davison B J, 1995, Oncol Nurs Forum, V22, P1401; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; EVANS C, 1985, LANCET, V1, P1204; FIREBAUGH G, 1985, AM SOCIOL REV, V50, P713, DOI 10.2307/2095384; FITTS WT, 1953, JAMA-J AM MED ASSOC, V153, P901, DOI 10.1001/jama.1953.02940270007002; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; Hobcraft J., 1985, COHORT ANAL SOCIAL R, P89; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Kutner JS, 1999, SOC SCI MED, V48, P1341, DOI 10.1016/S0277-9536(98)00453-5; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; MCCULLAGH P, 1999, GEN LINEAR MODELS, P125; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.1979.03290350017012; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; POSES RM, 1990, ARCH INTERN MED, V150, P1874, DOI 10.1001/archinte.150.9.1874; STEIHAUSER KE, 2000, ANN INTERN MED, V132, P5825; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zubrod CG, 1960, J CHRON DIS, V11, P7	36	363	367	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1096	1105		10.7326/0003-4819-134-12-200106190-00009	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412049				2022-12-01	WOS:000169313200002
J	Gollob, MH; Green, MS; Tang, ASL; Gollob, T; Karibe, A; Roberts, R; Ahmad, F; Lozado, R; Shah, G; Fananapazir, L; Bachinski, LL; Roberts, R; Tapscott, T; Gonzales, O; Begley, D; Mohiddin, S				Gollob, MH; Green, MS; Tang, ASL; Gollob, T; Karibe, A; Roberts, R; Ahmad, F; Lozado, R; Shah, G; Fananapazir, L; Bachinski, LL; Roberts, R; Tapscott, T; Gonzales, O; Begley, D; Mohiddin, S			Identification of a gene responsible for familial Wolff-Parkinson-White syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	22nd Annual Meeting of the North-American-Society-of-Pacing-and-Electrophysiology	MAY 02-05, 2001	BOSTON, MA	N Amer Soc Pacing & Electrophysiol			ACTIVATED PROTEIN-KINASE; ATRIAL-FIBRILLATION; CARDIAC-ARREST; PATTERNS; SUBUNIT; YOUNG	Background The Wolff Parkinson White syndrome, with a prevalence in Western countries of 1.5 to 3.1 per 1000 persons, causes considerable morbidity and may cause sudden death. We identified two families in which the Wolff Parkinson White syndrome segregated as an autosomal dominant disorder. Methods We studied 70 members of the two families (57 in Family 1 and 13 in Family 2). The subjects underwent 12-lead electrocardiography and two-dimensional echocardiography. Genotyping mapped the gene responsible to 7q34-q36, a locus previously identified to be responsible for an inherited form of Wolff Parkinson White syndrome. Candidate genes were identified, sequenced, and analyzed in normal and affected family members to identify the disease-causing gene. Results A total of 31 members (23 from Family 1 and 8 from Family 2) had the Wolff Parkinson White syndrome. Affected members of both families had ventricular preexcitation with conduction abnormalities and cardiac hypertrophy. The maximal combined two-point lod score was 9.82 at a distance of 5 cM from marker D7S636, which confirmed the linkage of the gene in both families to 7q34-q36. Haplotype analysis indicated that there were no alleles in common in the two families at this locus, suggesting that the two families do not have a common founder. We identified a missense mutation in the gene that encodes the gamma2 regulatory subunit of AMP-activated protein kinase (PRKAG2). The mutation results in the substitution of glutamine for arginine at residue 302 in the protein. Conclusions The identification of this genetic defect has important implications for elucidating the pathogenesis of ventricular preexcitation. Further understanding of how this molecular defect leads to supraventricular arrhythmias could influence the development of specific therapies for other forms of supraventricular arrhythmia. (N Engl J Med 2001;344:1823-31.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; NHLBI, Inherited Heart Dis Sect, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; University of Ottawa; University of Ottawa Heart Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roberts, R (corresponding author), Baylor Coll Med, Dept Med, Cardiol Sect, 6550 Fannin,MS SM 677, Houston, TX 77030 USA.	rroberts@bcm.tmc.edu	Tang, Anthony S/E-6203-2014	Ahmad, Ferhaan/0000-0003-2877-4641; Gollob, Michael/0000-0003-0242-5208	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005058] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Khatib SM, 1999, AM HEART J, V138, P403, DOI 10.1016/S0002-8703(99)70140-7; Aliot E, 1998, EUR HEART J, V19, pE25; BAUERNFEIND RA, 1981, AM J CARDIOL, V47, P562, DOI 10.1016/0002-9149(81)90539-7; BENSON DW, 1983, AM J CARDIOL, V52, P65, DOI 10.1016/0002-9149(83)90070-X; CAMPBELL RWF, 1977, AM J CARDIOL, V40, P514, DOI 10.1016/0002-9149(77)90065-0; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; COOPER DN, 1990, HUM GENET, V85, P55; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dunnigan A., 1986, CARDIAC PREEXCITATIO, P21; FURLANELLO F, 1992, PACE, V15, P1403; GUIZE L, 1985, ANN MED INTERNE, V136, P474; HEJTMANCIK MR, 1957, AM HEART J, V54, P708, DOI 10.1016/0002-8703(57)90425-8; JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301; Kastor J A, 1974, Cardiovasc Clin, V6, P111; KLEIN GJ, 1988, J AM COLL CARDIOL, V11, P1035, DOI 10.1016/S0735-1097(98)90063-8; Leclerc I, 1998, FEBS LETT, V431, P180, DOI 10.1016/S0014-5793(98)00745-5; MACRAE CA, 1995, J CLIN INVEST, V96, P1216, DOI 10.1172/JCI118154; Moule SK, 1998, FEBS LETT, V439, P287, DOI 10.1016/S0014-5793(98)01392-1; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Ott J., 1991, ANAL HUMAN GENETIC L; PACKARD JM, 1954, CIRCULATION, V10, P384, DOI 10.1161/01.CIR.10.3.384; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Thompson MW, 1991, THOMPSON THOMPSON GE; TOPAZ O, 1989, AM HEART J, V118, P281, DOI 10.1016/0002-8703(89)90186-5; WAN Q, 1992, CHINESE MED J-PEKING, V105, P284; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282	27	423	448	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2001	344	24					1823	1831		10.1056/NEJM200106143442403	http://dx.doi.org/10.1056/NEJM200106143442403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	441LC	11407343	Bronze			2022-12-01	WOS:000169231000003
J	Ziv, E; Cauley, J; Morin, PA; Saiz, R; Browner, WS				Ziv, E; Cauley, J; Morin, PA; Saiz, R; Browner, WS			Association between the T29 -> C polymorphism in the transforming growth factor beta 1 gene and breast cancer among elderly white women the study of osteoporotic fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; GROWTH-FACTOR-BETA-1 GENE; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; RISK; SUSCEPTIBILITY; FREQUENCY; CYP17; BRCA1	Context Transgenic animal experiments suggest that increased expression of transforming growth factor beta1 (TGF-beta1) is protective against early tumor development, particularly in breast cancer. A T -->C (thymine to cytosine) transition in the 29th nucleotide in the coding sequence results in a leucine to proline substitution at the 10th amino acid and is associated with increased serum levels of TGF-beta1. Objective To determine whether an association exists between this TGF-beta1 polymorphism and breast cancer risk. Design, Setting, and Participants The Study of Osteoporotic Fractures, a prospective cohort study of white, community-dwelling women aged 65 years or older who were recruited at 4 US centers between 1986 and 1988. Three thousand seventy-five women who provided sufficient clinical information, buffy coat samples, and adequate consent for genotyping are included in this analysis. Main Outcome Measure Breast cancer cases during a mean (SD) follow-up of 9.3 (1.9) years, verified by medical chart review and compared by genotype. Results Risk of breast cancer was similar in the 1124 women with the T/T genotype (56 cases; 5.4 per 1000 person-years) and the 1493 women with the T/C genotype (80 cases; 5.8 per 1000 person-years) but was significantly lower (P=.01) in the 458 women with the C/C genotype (10 cases; 2.3 per 1000 person-years). In analyses that adjusted for age, age at menarche, age at menopause, estrogen use, parity, body mass index, and bone mineral density, women with the C/C genotype had a significantly lower risk of developing breast cancer compared with women with the T/T or T/C genotype (hazard ratio [HR], 0.36; 95% confidence interval [CI], 0.17-0.75). There was no significant difference between the risk for women with the T/C genotype compared with women with the T/T genotype (adjusted HR, 1.04; 95% CI, 0.73-1.48). Conclusions Our findings suggest that TGF-beta1 genotype is associated with risk of breast cancer in white women aged 65 years or older. Because the T allele is the common variant and confers an increased risk, it may be associated with a large proportion of breast cancer cases.	Vet Affairs Med Ctr, Div Gen Internal Med, San Francisco, CA 94122 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Axys Pharmaceut Inc, La Jolla, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ziv, E (corresponding author), Vet Affairs Med Ctr, Div Gen Internal Med, Box 111-A1,4150 Clement St, San Francisco, CA 94122 USA.	eziv@itsa.ucsf.edu	Morin, Phillip A/E-9515-2010; Cauley, Jane A/N-4836-2015; Ziv, Elad/L-5396-2014	Cauley, Jane A/0000-0003-0752-4408; Morin, Phillip/0000-0002-3279-1519	NIAMS NIH HHS [AR35582, AR355833, AR35584] Funding Source: Medline; NIA NIH HHS [AG05349, AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582, R01AR035584] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ambrosone CB, 1996, JAMA-J AM MED ASSOC, V276, P1494, DOI 10.1001/jama.276.18.1494; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Arteaga CL, 1996, BREAST CANCER RES TR, V38, P49, DOI 10.1007/BF01803783; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Coughlin SS, 1999, CANCER EPIDEM BIOMAR, V8, P1023; Dunning AM, 1998, BRIT J CANCER, V77, P2045, DOI 10.1038/bjc.1998.340; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Feigelson HS, 1997, CANCER RES, V57, P1063; FORD D, 1995, AM J HUM GENET, V57, P1457; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Morin PA, 1999, BIOTECHNIQUES, V27, P538, DOI 10.2144/99273rr02; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Pasche B, 1999, CANCER RES, V59, P5678; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Rebbeck TR, 1999, CANCER-AM CANCER SOC, V86, P2493, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2493::AID-CNCR6>3.0.CO;2-Z; Reiss M, 1997, BREAST CANCER RES TR, V45, P81, DOI 10.1023/A:1005865812918; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Yamada Y, 1999, AM J MED, V106, P477, DOI 10.1016/S0002-9343(99)00043-1; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	24	105	112	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2001	285	22					2859	2863		10.1001/jama.285.22.2859	http://dx.doi.org/10.1001/jama.285.22.2859			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BP	11401606	Bronze			2022-12-01	WOS:000169156300024
J	Zhang, YP; Xiong, Y				Zhang, YP; Xiong, Y			A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation	SCIENCE			English	Article							RING-FINGER DOMAIN; STABILIZES P53; MDM2; DEGRADATION; PROTEIN; HDM2; TRANSACTIVATION; LOCALIZATION; PROMOTES; PATHWAY	The p53 protein is present in low amounts in normally growing cells and is activated in response to physiological insults. MDM2 regulates p53 either through inhibiting p53's transactivating function in the nucleus or by targeting p53 degradation in the cytoplasm. We identified a previously unknown nuclear export signal (NES) in the amino terminus of p53, spanning residues 11 to 27 and containing two serine residues phosphorylated after DNA damage, which was required for p53 nuclear export in colloboration with the carboxyl-terminal NES, Serine-15-phosphorylated p53 induced by ultraviolet irradiation was not exported. Thus, DNA damage-induced phosphorylation may achieve optimal p53 activation by inhibiting both MDM2 binding to, and the nuclear export of, p53.	Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.			Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA065572, K01CA087580] Funding Source: NIH RePORTER; NCI NIH HHS [CA65572, K01 CA087580] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Chehab NH, 2000, GENE DEV, V14, P278; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	28	300	311	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1910	1915		10.1126/science.1058637	http://dx.doi.org/10.1126/science.1058637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397945				2022-12-01	WOS:000169200700049
J	Geijsen, N; Uings, IJ; Pals, C; Armstrong, J; McKinnon, M; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ				Geijsen, N; Uings, IJ; Pals, C; Armstrong, J; McKinnon, M; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ			Cytokine-specific transcriptional regulation through an IL-5R alpha interacting protein	SCIENCE			English	Article							INTERLEUKIN-5 RECEPTOR; IL-5 RECEPTOR; ALPHA-CHAIN; CELL; PDZ; MICE; DIFFERENTIATION; RECOGNITION; EXPRESSION; ACTIVATOR	Cytokine receptors consist of multiple subunits, which are often shared between different receptors, resulting in the functional redundancy sometimes observed between cytokines. The interleukin 5 (IL-5) receptor consists of an IL-5-specific alpha -subunit (IL-5R alpha) and a signal-transducing beta -subunit (betac) shared with the IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors. In this study, we sought to find a rote for the cytoplasmic domain of IL-5R alpha. We show that syntenin, a protein containing PSD-95/Discs large/zO-1 (PDZ) domains, associates with the cytoplasmic tail of the IL-5R alpha. Syntenin was found to directly associate with the transcription factor Sox4. Association of syntenin with IL-5R alpha was required for IL-5-mediated activation of Sox4. These studies identify a mechanism of transcriptional activation by cytokine-specific receptor subunits.	Univ Utrecht, Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, NL-3584 CX Utrecht, Netherlands; Glaxo Wellcome Med Res Ctr, Cell Biol Unit, Stevenage SG1 2NY, Herts, England	Utrecht University; Utrecht University Medical Center; GlaxoSmithKline	Coffer, PJ (corresponding author), Univ Utrecht, Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, G03-550,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.		Coffer, Paul J/A-5769-2009; Coffer, Paul/AAF-7970-2020; Koenderman, Leo/AAE-7870-2020	Koenderman, Leo/0000-0002-5636-6453				Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hiroi T, 1999, J IMMUNOL, V162, P821; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Moon BG, 2001, IMMUNOLOGY, V102, P289, DOI 10.1046/j.1365-2567.2001.01196.x; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Takatsu K, 1998, CYTOKINE GROWTH F R, V9, P25, DOI 10.1016/S1359-6101(97)00034-8; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	18	100	109	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1136	1138		10.1126/science.1059157	http://dx.doi.org/10.1126/science.1059157			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498591				2022-12-01	WOS:000170432600060
J	deVeber, G; Andrew, M; Adams, C; Bjornson, B; Booth, F; Buckley, DJ; Camfield, CS; David, M; Humphreys, P; Langevin, P; MacDonald, EA; Gillett, J				deVeber, G; Andrew, M; Adams, C; Bjornson, B; Booth, F; Buckley, DJ; Camfield, CS; David, M; Humphreys, P; Langevin, P; MacDonald, EA; Gillett, J		Canadian Pediat Ischemic Stroke St	Cerebral sinovenous thrombosis in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAGITTAL SINUS THROMBOSIS; ARTERIAL ISCHEMIC STROKE; FACTOR-V LEIDEN; VENOUS THROMBOSIS; VEIN-THROMBOSIS; INFANTS; CHILDHOOD; ANGIOGRAPHY; DEFICIENCY; DISORDERS	Background: Cerebral sinovenous thrombosis in children is a serious disorder, and information is needed about its prevention and treatment. Methods: The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. Children (newborn to 18 years of age) with symptoms and radiographic confirmation of sinovenous thrombosis were included. Results: During the first six years of the registry, 160 consecutive children with sinovenous thrombosis were enrolled, and the incidence of the disorder was 0.67 case per 100,000 children per year. Neonates were most commonly affected. Fifty-eight percent of the children had seizures, 76 percent had diffuse neurologic signs, and 42 percent had focal neurologic signs. Risk factors included head and neck disorders (in 29 percent), acute systemic illnesses (in 54 percent), chronic systemic diseases (in 36 percent), and prothrombotic states (in 41 percent). Venous infarcts occurred in 41 percent of the children. Fifty-three percent of the children received antithrombotic agents. Neurologic deficits were present in 38 percent of the children, and 8 percent died; half the deaths were due to sinovenous thrombosis. Predictors of adverse neurologic outcomes were seizures at presentation and venous infarcts. Conclusions: Sinovenous thrombosis in children affects primarily neonates and results in neurologic impairment or death in approximately half the cases. The occurrence of venous infarcts or seizures portends a poor outcome. (N Engl J Med 2001;345:417-23.) Copyright (C) 2001 Massachusetts Medical Society.	Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Populat Hlth Sci Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; Mem Univ Newfoundland, Dept Pediat, St Johns, NF A1C 5S7, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Univ Montreal, Dept Hematol Oncol, Montreal, PQ, Canada; Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; CHU Laval, Dept Pediat Neurol, St Foy, PQ, Canada; Queens Univ, Dept Pediat, Kingston, ON K7L 3N6, Canada; Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; Univ Western Ontario, Dept Clin Neurosci, London, ON N6A 3K7, Canada; McMaster Univ, Dept Pediat, Hamilton, ON, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; Univ Alberta, Dept Pediat, Edmonton, AB, Canada; Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of British Columbia; University of Manitoba; Memorial University Newfoundland; Dalhousie University; Universite de Montreal; University of Ottawa; Laval University; Queens University - Canada; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University; McGill University; McGill University; McGill University; University of Alberta; University of Saskatchewan	deVeber, G (corresponding author), Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Bjornson, Bruce Hal/A-8616-2010	Bjornson, Bruce Hal/0000-0002-1465-6196; /0000-0002-9584-0576				BARAM TZ, 1988, ANN NEUROL, V24, P792, DOI 10.1002/ana.410240617; BARRON TF, 1992, PEDIATR NEUROL, V8, P112, DOI 10.1016/0887-8994(92)90030-3; BEZINQUE SL, 1995, PEDIATR RADIOL, V25, P175, DOI 10.1007/BF02021526; Bonduel M, 1999, ARCH NEUROL-CHICAGO, V56, P967, DOI 10.1001/archneur.56.8.967; Bousser MG, 1997, MAJOR PROBLEMS NEURO, V33; BROWN MT, 1991, NEUROLOGY, V41, P455, DOI 10.1212/WNL.41.3.455; *CANSIM, STAT CAN; CANTU C, 1993, STROKE, V24, P1880, DOI 10.1161/01.STR.24.12.1880; Casey SO, 1996, RADIOLOGY, V198, P163, DOI 10.1148/radiology.198.1.8539371; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; Deschiens MA, 1996, STROKE, V27, P1724, DOI 10.1161/01.STR.27.10.1724; deVeber G, 1998, ARCH NEUROL-CHICAGO, V55, P1539, DOI 10.1001/archneur.55.12.1539; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; DINDAR F, 1974, CAN MED ASSOC J, V111, P545; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Einhaupl KM, 1990, CEREBRAL SINUS THROM, P149, DOI 10.1007/978- 1-4684-8199-0_14; HICKEY WF, 1982, AM J MED, V73, P740; JUSTICH E, 1984, EUR J RADIOL, V4, P294; LEE BCP, 1984, AM J NEURORADIOL, V5, P281; LUDWIG B, 1980, NEURORADIOLOGY, V20, P145, DOI 10.1007/BF00341779; Maiti B., 1997, Journal of the Neurological Sciences, V150, pS147, DOI 10.1016/S0022-510X(97)85563-3; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; Nagaraja D, 1999, NEUROL INDIA, V47, P43; *PRACT MAN INF, 1997, INT CLASS DIS 9 REV; PRATS JM, 1992, NEUROLOGY, V42, P2303, DOI 10.1212/WNL.42.12.2303-a; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; *SAS I, 1998, STATV VERS 5 1; SCOTTI LN, 1974, RADIOLOGY, V112, P393, DOI 10.1148/112.2.393; SHEVELL MI, 1989, PEDIATR NEUROL, V5, P161, DOI 10.1016/0887-8994(89)90065-9; UZIEL Y, 1995, J PEDIATR-US, V126, P722, DOI 10.1016/S0022-3476(95)70399-3; VANKUIJCK MAP, 1994, NEUROPEDIATRICS, V25, P16, DOI 10.1055/s-2008-1071575; vonScheven E, 1996, J PEDIATR-US, V129, P339, DOI 10.1016/S0022-3476(96)70064-1; YUH WTC, 1994, AM J NEURORADIOL, V15, P309; Zuber M, 1996, STROKE, V27, P1721, DOI 10.1161/01.STR.27.10.1721	36	709	741	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					417	423		10.1056/NEJM200108093450604	http://dx.doi.org/10.1056/NEJM200108093450604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496852				2022-12-01	WOS:000170295000004
J	Kuroda, A; Nomura, K; Ohtomo, R; Kato, J; Ikeda, T; Takiguchi, N; Ohtake, H; Kornberg, A				Kuroda, A; Nomura, K; Ohtomo, R; Kato, J; Ikeda, T; Takiguchi, N; Ohtake, H; Kornberg, A			Role of inorganic polyphosphate in promoting ribosomal, protein degradation by the ion protease in E-coli	SCIENCE			English	Article							ESCHERICHIA-COLI; LON PROTEASE; SULA; PURIFICATION; SYSTEM	Inorganic polyphosphate (polyp), a polymer of hundreds of phosphate (P-i) residues, accumulates in Escherichia coli in response to stresses, including amino acid starvation. Here we show that the adenosine 5'-triphosphate-dependent protease Lon formed a complex with polyp and degraded most of the ribosomal proteins, including S2, L9, and L13. Purified S2 also bound to polyp and formed a complex with Lon in the presence of polyP. Thus, polyP may promote ribosomal. protein degradation by the Lon protease, thereby supplying the amino acids needed to respond to starvation.	Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398527, Japan; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Hiroshima University; Stanford University	Kuroda, A (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.		Takiguchi, Noboru/F-3419-2014; Kato, Junichi/S-1469-2018	Takiguchi, Noboru/0000-0001-7266-0276; Kato, Junichi/0000-0003-0279-8813				Ault-Riche D, 1998, J BACTERIOL, V180, P1841; CACHIA C, 1991, J CHROMATOGR, V539, P343, DOI 10.1016/S0021-9673(01)83943-1; CHUNG CH, 1982, P NATL ACAD SCI-BIOL, V79, P795, DOI 10.1073/pnas.79.3.795; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Kanemori M, 1999, J BACTERIOL, V181, P3674, DOI 10.1128/JB.181.12.3674-3680.1999; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 1999, P NATL ACAD SCI USA, V96, P14264, DOI 10.1073/pnas.96.25.14264; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Miller C. G., 1996, ESCHERICHIA COLI SAL, P938; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; NISHI K, 1988, MOL GEN GENET, V212, P177, DOI 10.1007/BF00322462; SONEZAKI S, 1994, APPL MICROBIOL BIOT, V42, P313; ULBRICH B, 1975, EUR J BIOCHEM, V57, P49, DOI 10.1111/j.1432-1033.1975.tb02275.x; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	17	286	295	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					705	708		10.1126/science.1061315	http://dx.doi.org/10.1126/science.1061315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474114				2022-12-01	WOS:000170204600057
J	Ruiz, J				Ruiz, J			The stability against freezing of an internal liquid-water ocean in Callisto	NATURE			English	Article							GALILEAN SATELLITES; SUBSURFACE OCEANS; ICY SATELLITES; OUTER PLANETS; EVOLUTION; CONVECTION; GANYMEDE; EUROPA; MODELS; SHELL	The discovery of the induced magnetic field of Callisto-one of Jupiter's moons-has been interpreted(1,2) as evidence for a subsurface ocean, even though the presence of such an ocean is difficult to understand in the context of existing theoretical models(3-5). Tidal heating should not be significant for Callisto, and, in the absence of such heating, it is difficult to see how this internal ocean could have survived until today without freezing(1,6). Previous work(3,4) indicated that an outer ice layer on the ocean would be unstable against solid-state convection, which once begun would lead to total freezing of liquid water in about 10(8) years. Here I show that when a methodology(7) for more physically reasonable water ice viscosities (that is, stress-dependent non-newtonian viscosities, rather than the stress-independent newtonian viscosities considered previously) is adopted, the outer ice shell becomes stable against convection. This implies that a subsurface ocean could have survived up to the present, without the need for invoking antifreeze substances or other special conditions.	Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam, E-28040 Madrid, Spain; Univ Complutense Madrid, Seminar Planetary Sci, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Ruiz, J (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam, E-28040 Madrid, Spain.	jaruiz@eucmax.sim.ucm.es	Ruiz, Javier/P-3975-2015	Ruiz, Javier/0000-0002-3937-8380				Anderson JD, 1998, SCIENCE, V280, P1573, DOI 10.1126/science.280.5369.1573; CASSEN PM, 1982, SATELLITES JUPITER, P93; CONSOLMAGNO GJ, 1978, ICARUS, V34, P280, DOI 10.1016/0019-1035(78)90168-9; Davies ME, 1998, ICARUS, V135, P372, DOI 10.1006/icar.1998.5982; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; DURHAM WB, IN PRESS J GEOPHYS; Goldsby DL, 1997, SCRIPTA MATER, V37, P1399, DOI 10.1016/S1359-6462(97)00246-7; GOLDSBY DL, IN PRESS J GEOPHYS; GOLDSBY DL, 1997, LUNAR PLANET SCI, V28, P429; Kamb B., 1972, FLOW FRACTURE ROCKS, P211, DOI [10.1029/GM016p0211, DOI 10.1029/GM016P0211]; KARGEL JS, 1992, ICARUS, V100, P556, DOI 10.1016/0019-1035(92)90118-Q; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; KIRK RL, 1987, ICARUS, V69, P91, DOI 10.1016/0019-1035(87)90009-1; KLINGER J, 1980, SCIENCE, V209, P271, DOI 10.1126/science.209.4453.271; LEWIS JS, 1971, SCIENCE, V172, P1127, DOI 10.1126/science.172.3988.1127; LUPO MJ, 1979, ICARUS, V40, P157, DOI 10.1016/0019-1035(79)90061-7; McKinnon WB, 1999, GEOPHYS RES LETT, V26, P951, DOI 10.1029/1999GL900125; McKinnon WB, 1998, ASTROPHYS SPACE SC L, V227, P525, DOI 10.1007/978-94-011-5252-5_22; MUELLER S, 1988, ICARUS, V76, P437, DOI 10.1016/0019-1035(88)90014-0; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; REYNOLDS RT, 1979, GEOPHYS RES LETT, V6, P121, DOI 10.1029/GL006i002p00121; Schubert G., 1986, SATELLITES, P224; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Showman AP, 1997, ICARUS, V127, P93, DOI 10.1006/icar.1996.5669; Solomatov VS, 1996, J GEOPHYS RES-PLANET, V101, P4737, DOI 10.1029/95JE03361; SOLOMATOV VS, 1995, PHYS FLUIDS, V7, P266, DOI 10.1063/1.868624; Sotin C, 1998, ASTROPHYS SPACE SC L, V227, P79, DOI 10.1007/978-94-011-5252-5_4; STEVENSON DJ, 1998, EOS T AGU S, V79, pF535; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	30	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					409	411		10.1038/35086506	http://dx.doi.org/10.1038/35086506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473308	Green Accepted			2022-12-01	WOS:000170068200038
J	Otsuka, R; Watanabe, H; Hirata, K; Tokai, K; Muro, T; Yoshiyama, M; Takeuchi, K; Yoshikawa, J				Otsuka, R; Watanabe, H; Hirata, K; Tokai, K; Muro, T; Yoshiyama, M; Takeuchi, K; Yoshikawa, J			Acute effects of passive smoking on the coronary circulation in healthy young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON EMISSION TOMOGRAPHY; BLOOD-FLOW VELOCITY; ENVIRONMENTAL TOBACCO-SMOKE; AMERICAN-HEART-ASSOCIATION; DOPPLER-ECHOCARDIOGRAPHY; CIGARETTE-SMOKING; ARTERY STENOSIS; DISEASE; RESERVE; RISK	Context Recent studies have shown that passive smoking is a risk factor for ischemic heart disease and may be associated with vascular endothelial dysfunction, The acute effects of passive smoking on coronary circulation in nonsmokers are not known. Objective To determine the acute effects of passive smoking on coronary circulation using coronary flow velocity reserve (CFVR), assessed by noninvasive transthoracic Doppler echocardiography. Design, Setting, and Participants Cross-sectional study conducted from-September 2000 to November 2000 among 30 Japanese men (mean age, 27 years; 15 healthy nonsmokers and 15 asymptomatic active smokers) without history of hypertension, diabetes mellitus, or hyperlipidemia. Main Outcome Measures Coronary flow velocity reserve, calculated as the ratio of hyperemic to basal coronary flow velocity induced by intravenous infusion of adenosine triphosphate and measured in each participant before and after a 30-min ute exposure to environmental tobacco smoke. Results Heart rate and blood pressure responses to adenosine triphosphate infusion were not affected by passive smoking exposure in either group. Passive smoking exposure had no effect on basal coronary flow velocity in either group. Mean (SD) CFVR in nonsmokers was significantly higher than that in active smokers before passive smoking exposure (4.4 [0.91] vs 3.6 [0.88], respectively; P=.02), while CFVR after passive smoking exposure did not differ between groups (P=.83). Passive smoking exposure significantly reduced mean (SD) CFVR in nonsmokers (4.4 [0.91] vs 3.4 [0.73], respectively; P<.001). Conclusions Passive smoking substantially reduced CFVR in healthy nonsmokers. This finding provides direct evidence that passive smoking may cause endothelial dysfunction of the coronary circulation in nonsmokers.	Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University	Watanabe, H (corresponding author), Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.							ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102; CAMICI P, 1989, AM J PHYSIOL, V257, pE309, DOI 10.1152/ajpendo.1989.257.3.E309; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; DAYANIKLI F, 1994, CIRCULATION, V90, P808, DOI 10.1161/01.CIR.90.2.808; DESILVA R, 1994, CARDIOVASC RES, V28, P1595; FOLKOW B, 1990, HYPERTENSION, V16, P89, DOI 10.1161/01.HYP.16.1.89; Frielingsdorf J, 1996, CIRCULATION, V93, P1380, DOI 10.1161/01.CIR.93.7.1380; FUSEJIMA K, 1987, J AM COLL CARDIOL, V10, P1024, DOI 10.1016/S0735-1097(87)80342-X; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; GOULD KL, 1974, AM J CARDIOL, V33, P87, DOI 10.1016/0002-9149(74)90743-7; HOLBROOK JH, 1984, CIRCULATION, V70, P1114; Hozumi T, 1998, CIRCULATION, V97, P1557, DOI 10.1161/01.CIR.97.16.1557; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; KENNY A, 1994, BRIT HEART J, V71, P57; KENNY A, 1992, AM J CARDIOL, V69, P1265, DOI 10.1016/0002-9149(92)91218-S; KENNY A, 1994, AM J CARDIOL, V73, P1021, DOI 10.1016/0002-9149(94)90164-3; KRITZ H, 1995, ARCH INTERN MED, V155, P1942, DOI 10.1001/archinte.155.18.1942; Miller DD, 1996, CIRCULATION, V94, P2447, DOI 10.1161/01.CIR.94.10.2447; Nagamachi S, 1996, J NUCL MED, V37, P1626; NITENBERG A, 1993, DIABETES, V42, P1017, DOI 10.2337/diabetes.42.7.1017; PENN A, 1993, CIRCULATION, V88, P1820, DOI 10.1161/01.CIR.88.4.1820; PENN A, 1994, CIRCULATION, V90, P1363, DOI 10.1161/01.CIR.90.3.1363; RAIJ L, 1994, CIRCULATION, V90, P575; ROSS JJ, 1990, J AM COLL CARDIOL, V15, P373, DOI 10.1016/S0735-1097(10)80065-8; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SEILER C, 1993, CIRCULATION, V88, P2139, DOI 10.1161/01.CIR.88.5.2139; Sonoda S, 1998, AM HEART J, V135, P621, DOI 10.1016/S0002-8703(98)70277-7; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; STEENLAND K, 1992, JAMA-J AM MED ASSOC, V267, P94, DOI 10.1001/jama.267.1.94; Sumida H, 1998, J AM COLL CARDIOL, V31, P811, DOI 10.1016/S0735-1097(98)00010-2; Tanaka T, 1998, AM J CARDIOL, V82, P1275, DOI 10.1016/S0002-9149(98)00614-6; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Valkonen M, 1998, CIRCULATION, V97, P2012, DOI 10.1161/01.CIR.97.20.2012; Verberne HJ, 1999, HEART, V82, P509, DOI 10.1136/hrt.82.4.509; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; WELLS AJ, 1988, ENVIRON INT, V14, P249; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094; ZHU BQ, 1993, J AM COLL CARDIOL, V21, P225, DOI 10.1016/0735-1097(93)90741-I	41	258	270	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					436	441		10.1001/jama.286.4.436	http://dx.doi.org/10.1001/jama.286.4.436			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466122	Bronze			2022-12-01	WOS:000170069000015
J	Cha, BJ; Koppetsch, BS; Theurkauf, WE				Cha, BJ; Koppetsch, BS; Theurkauf, WE			In vivo analysis of Drosophila bicoid mRNA localization reveals a novel microtubule-dependent axis specification pathway	CELL			English	Article							MESSENGER-RNA LOCALIZATION; ALPHA-LIKE PROTEIN; ANTEROPOSTERIOR POLARITY; SPATIAL-DISTRIBUTION; ANTERIOR POLE; OOGENESIS; OOCYTES; POSTERIOR; TRANSPORT; CYTOSKELETON	Drosophila bicoid mRNA is synthesized in the nurse cells and transported to the oocyte where microtubules and Exuperantia protein mediate localization to the anterior pole. Fluorescent bicoid mRNA injected into the oocyte displays nonpolar microtubule-dependent transport to the closest cortical surface, and the oocyte microtubule cytoskeleton lacks clear axial asymmetry. Nonetheless, bicoid mRNA injected into the nurse cell cytoplasm, withdrawn, and injected into a second oocyte shows microtubule-dependent transport to the anterior cortex. Nurse cells require microtubules and Exuperantia to support anterior transport of bicoid mRNA, and microtubules are required for bicoid mRNA-Exuperantia particle coassembly. We propose that microtubule-dependent Exuperantia-bicoid mRNA complex formation in the nurse cell cytoplasm allows anterior-specific transport on a grossly nonpolar oocyte microtubule network.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.			Theurkauf, William/0000-0001-7342-1912				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CHAO YC, 1991, DEV GENET, V12, P333, DOI 10.1002/dvg.1020120502; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grieder NC, 2000, DEVELOPMENT, V127, P4253; HAY B, 1990, DEVELOPMENT, V109, P425; Hays T, 2000, NAT CELL BIOL, V2, pE60, DOI 10.1038/35008687; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; King RC., 1970, OVARIAN DEV DROSOPHI; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Pokrywka NJ, 1995, CURR TOP DEV BIOL, V31, P139; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Spradling Allan C., 1993, P1; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; WANG SX, 1994, NATURE, V369, P400, DOI 10.1038/369400a0; Waters JC, 1997, CURR OPIN CELL BIOL, V9, P37, DOI 10.1016/S0955-0674(97)80149-4; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427	41	153	155	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					35	46		10.1016/S0092-8674(01)00419-6	http://dx.doi.org/10.1016/S0092-8674(01)00419-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461700	Bronze			2022-12-01	WOS:000169870300007
J	Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN				Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN			Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein	LANCET			English	Article							P COMPONENT SCINTIGRAPHY; JUVENILE RHEUMATOID-ARTHRITIS; C-REACTIVE PROTEIN; SYSTEMIC AMYLOIDOSIS; LIVER-TRANSPLANTATION; ALZHEIMER-DISEASE; REGRESSION; DEPOSITS; IMMUNOASSAY; TURNOVER	Background Reactive systemic (AA, secondary) amyloidosis occurs in chronic inflammatory diseases, and most patients present with nephropathy. The amyloid fibrils are derived from the circulating acute-phase reactant serum amyloid A protein (SAA), but the relation between production of fib,il precursor protein, amyloid load, and clinical outcome in AA and other types of amyloidosis is unclear. Methods We studied amyloidotic organ function and survival prospectively for 12-117 months in 80 patients with systemic AA amyloidosis in whom serum SAA concentration was measured monthly and visceral amyloid deposits were assessed annually by serum amyloid P component scintigraphy. Underlying inflammatory diseases were treated as vigorously as possible. Findings Amyloid deposits regressed in 25 of 42 patients whose median SAA values were within the reference range (<10 mg/L) throughout follow-up, and amyloidotic organ function stabilised or improved in 39 of these cases. Outcome varied substantially among patients whose median SAA concentration exceeded 10 mg/L, but amyloid load increased and organ function deteriorated in most of those whose SAA was persistently above 50 mg/L, Estimated survival at 10 years was 90% in patients whose median SAA was under 10 mg/L, and 40% among those whose median SAA exceeded this value (p=0.0009). Interpretation Although isolated amyloid fibrils are stable in vitro, AA amyloid deposits exist in a state of dynamic turnover, and outcome is favourable in AA amyloidosis when the SAA concentration is maintained below 10 mg/L. The potential for amyloid to regress and for the function of amyloidotic organs to recover support therapeutic strategies to decrease the supply of amyloid fibril precursor proteins in amyloidosis generally.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of London; University College London; UCL Medical School	Gillmore, JD (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Royal Free Campus, London NW3 2PF, England.	j.gillmore@rfc.ucl.ac.uk	Lovat, Laurence/C-1986-2009; Hawkins, Philip N/C-5573-2008	Lovat, Laurence/0000-0003-4542-3915; 				Akpolat T, 2000, AM J NEPHROL, V20, P68, DOI 10.1159/000013559; Baum J, 1977, ARTHRITIS RHEUM, V20, P253; BERGLUND K, 1993, J RHEUMATOL, V20, P2051; GERTZ MA, 1991, MEDICINE, V70, P246, DOI 10.1097/00005792-199107000-00002; Gillmore JD, 2000, QJM-INT J MED, V93, P269, DOI 10.1093/qjmed/93.5.269; Goldsmith DJA, 1996, NEPHRON, V74, P572, DOI 10.1159/000189454; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HAWKINS PN, 1993, ARTHRITIS RHEUM, V36, P842, DOI 10.1002/art.1780360616; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; HAWKINS PN, 1988, LANCET, V1, P1413; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HAWKINS PN, 1995, MYELOMA, P477; HAZENBERG BPC, 1994, BAILLIERE CLIN RHEUM, V8, P661, DOI 10.1016/S0950-3579(05)80121-9; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Husby G, 1998, SCAND J RHEUMATOL, V27, P161, DOI 10.1080/030097498440750; HUTCHINSON WL, 1994, J CLIN INVEST, V94, P1390, DOI 10.1172/JCI117474; Jager PL, 1998, J NUCL MED, V39, P699; Kraul D., 1997, Clinical Chemistry, V43, pS150; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Lovat LB, 1998, GUT, V42, P727, DOI 10.1136/gut.42.5.727; MORONI G, 1992, CLIN NEPHROL, V38, P81; Pepys MB, 1999, HORIZONS MED, P397; PEPYS MB, 1996, OXFORD TXB MED, P1512; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; Rydh A, 1998, EUR J NUCL MED, V25, P709; SAVOLAINEN HA, 1993, J RHEUMATOL, V20, P1201; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schnitzer T J, 1977, Arthritis Rheum, V20, P245; Tan SY, 1996, KIDNEY INT, V50, P282, DOI 10.1038/ki.1996.313; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; VIGUSHIN DM, 1994, AMYLOID AMYLOIDOSIS, P685; WILKINS J, 1994, CLIN CHEM, V40, P1284; YAMADA T, 1993, ANN CLIN BIOCHEM, V30, P72, DOI 10.1177/000456329303000112	36	405	430	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					24	29		10.1016/S0140-6736(00)05252-1	http://dx.doi.org/10.1016/S0140-6736(00)05252-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11454373				2022-12-01	WOS:000169710900012
J	Weiss, R				Weiss, R			AIDS: unbeatable 20 years on	LANCET			English	Editorial Material									UCL, Dept Viral Oncol Immunol & Mol Pathol, London W1T 4JF, England	University of London; University College London	Weiss, R (corresponding author), UCL, Dept Viral Oncol Immunol & Mol Pathol, London W1T 4JF, England.	r.weiss@ucl.ac.uk						BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P305; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P250; Cohen Jon, 2001, SHOTS DARK WAYWARD S; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639	6	6	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2001	357	9274					2073	2074		10.1016/S0140-6736(00)05228-4	http://dx.doi.org/10.1016/S0140-6736(00)05228-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445097				2022-12-01	WOS:000169586600007
J	Brennan, J; Lu, CC; Norris, DP; Rodriguez, TA; Beddington, RSP; Robertson, EJ				Brennan, J; Lu, CC; Norris, DP; Rodriguez, TA; Beddington, RSP; Robertson, EJ			Nodal signalling in the epiblast patterns the early mouse embryo	NATURE			English	Article							ANTERIOR PRIMITIVE ENDODERM; RIGHT ASYMMETRIC EXPRESSION; VISCERAL ENDODERM; TRANSCRIPTION FACTOR; POSTERIOR POLARITY; NEURAL PLATE; GASTRULATION; AXIS; SPECIFICATION; REQUIREMENT	Shortly after implantation the mouse embryo comprises three tissue layers. The founder tissue of the embryo proper, the epiblast, forms a radially symmetric cup of epithelial cells that grows in close apposition to the extra-embryonic ectoderm and the visceral endoderm. This simple cylindrical structure exhibits a distinct molecular pattern along its proximal-distal axis(1). The anterior-posterior axis of the embryo is positioned later by coordinated cell movements that rotate the pre-existing proximal-distal axis(2-5). The transforming growth factor-beta family member Nodal is known to be required for formation of the anterior-posterior axis(6). Here we show that signals from the epiblast are responsible for the initiation of proximal-distal polarity. Nodal acts to promote posterior cell fates in the epiblast and to maintain molecular pattern in the adjacent extra-embryonic ectoderm. Both of these functions are independent of Smad2. Moreover, Nodal signals from the epiblast also pattern the visceral endoderm by activating the Smad2-dependent pathway required for specification of anterior identity in overlying epiblast cells. Our experiments show that proximal-distal and subsequent anterior-posterior polarity of the pregastrulation embryo result from reciprocal cell-cell interactions between the epiblast and the two extra-embryonic tissues.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Natl Inst Med Res, Div Mammalian Dev, London NW7 1AA, England	Harvard University; MRC National Institute for Medical Research	Robertson, EJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Brennan, Jane/0000-0003-3222-5485; Rodriguez, Tristan/0000-0002-3415-8493				Acampora D, 1998, DEVELOPMENT, V125, P5091; Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; ANG SL, 1994, DEVELOPMENT, V120, P2979; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; POIRIER F, 1992, DEVELOPMENT, V115, P143; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Rhinn M, 1998, DEVELOPMENT, V125, P845; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Varlet I, 1997, DEVELOPMENT, V124, P1033; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	30	381	398	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					965	969		10.1038/35082103	http://dx.doi.org/10.1038/35082103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418863				2022-12-01	WOS:000169386200049
J	Smetacek, V				Smetacek, V			A watery arms race	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Dawkins R., 1982, pi; MARGULI SL, 2000, ENV EVOLUTION; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277	4	147	157	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					745	745		10.1038/35081210	http://dx.doi.org/10.1038/35081210			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459035	Bronze			2022-12-01	WOS:000169246400024
J	Grupe, A; Germer, S; Usuka, J; Aud, D; Belknap, JK; Klein, RF; Ahluwalia, MK; Higuchi, R; Peltz, G				Grupe, A; Germer, S; Usuka, J; Aud, D; Belknap, JK; Klein, RF; Ahluwalia, MK; Higuchi, R; Peltz, G			In silico mapping of complex disease-related traits in mice	SCIENCE			English	Article							ALCOHOL PREFERENCE; ALLERGIC-ASTHMA; INBRED MICE; LOCI; MOUSE; GENES; IDENTIFICATION; DISCOVERY; DRINKING; MODELS	Experimental murine genetic models of complex human disease show great potential for understanding human disease pathogenesis. To reduce the time required for analysis of such models from many months down to milliseconds, a computational method for predicting chromosomal regions regulating phenotypic traits and a murine database of single nucleotide polymorphisms were developed. After entry of phenotypic information obtained from inbred mouse strains, the phenotypic and genotypic information is analyzed in silico to predict the chromosomal regions regulating the phenotypic trait.	Roche Biosci, Dept Genet & Genome, Palo Alto, CA 94303 USA; Roche Mol Syst, Alameda, CA 94501 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Portland Vet Affairs Med Ctr, Portland, OR 97201 USA	Roche Holding; Roche Holding; Stanford University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System	Peltz, G (corresponding author), Roche Biosci, Dept Genet & Genome, Palo Alto, CA 94303 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG002322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32HG-00044, 1 R01 HG02322-01] Funding Source: Medline; NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NIAMS NIH HHS [R01 AR044659-07, R01 AR044659] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; Belknap JK, 1997, BEHAV GENET, V27, P55, DOI 10.1023/A:1025615409383; Buck KJ, 1997, J NEUROSCI, V17, P3946; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Dwyer-Nield LD, 2000, AM J PHYSIOL-LUNG C, V279, pL326, DOI 10.1152/ajplung.2000.279.2.L326; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; KLEIN RF, IN PRESS J BONE MINE; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; MUCENSKI ML, 1986, MOL CELL BIOL, V6, P4236, DOI 10.1128/MCB.6.12.4236; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Phillips TJ, 1998, MAMM GENOME, V9, P936; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Tarantino LM, 1998, ALCOHOL CLIN EXP RES, V22, P1099; Wielowieyski A, 1999, MAMM GENOME, V10, P623, DOI 10.1007/s003359901057; Williams RW, 1998, J NEUROSCI, V18, P138; Zhang YM, 1999, HUM MOL GENET, V8, P601, DOI 10.1093/hmg/8.4.601; Zhou G, 1999, INVEST OPHTH VIS SCI, V40, P817; 1998, JAX NOTES, V475	22	232	247	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1915	1918		10.1126/science.1058889	http://dx.doi.org/10.1126/science.1058889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397946				2022-12-01	WOS:000169200700050
J	Berkley, JA; Mwangi, I; Ngetsa, CJ; Mwarumba, S; Lowe, BS; Marsh, K; Newton, CRJC				Berkley, JA; Mwangi, I; Ngetsa, CJ; Mwarumba, S; Lowe, BS; Marsh, K; Newton, CRJC			Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa	LANCET			English	Article							CEREBRAL MALARIA; REAGENT STRIPS	Background The diagnosis of acute bacterial meningitis in children is difficult in sub-Saharan Africa, because the clinical features overlap with those of other common diseases, and laboratory facilities are inadequate in many areas. We have assessed the value of non-laboratory tests and incomplete laboratory data in diagnosing childhood acute bacterial meningitis in this setting. Methods We prospectively studied 905 children undergoing lumbar puncture at a rural district hospital in Kenya over 1 year. We related microbiological findings and cerebrospinal-fluid (CSF) laboratory measurements to tests that would typically be available at such a hospital. Findings Acute bacterial meningitis was proven in 45 children (5.0% [95% CI 3.7-6.6]) and probable in 26 (2.9% [1.9-4.2]). 21 of the 71 cases of proven or probable acute bacterial meningitis had neither neck stiffness nor turbid CSF. In eight of 45 children with proven disease the CSF leucocyte count was less than 10x10(6)/L or leucocyte counting was not possible because of blood-staining. The presence of either a leucocyte count of 50x10(6)/L or more or a CSF/blood glucose ratio of 0.10 or less detected all but two of the 45 children with proven acute bacterial meningitis; these two samples were grossly blood-stained. Interpretation The diagnosis of childhood acute bacterial meningitis is likely to be missed in a third of cases at district hospitals in sub-Saharan Africa without adequate and reliable laboratory resources. CSF culture facilities are expensive and difficult to maintain, and greater gains could be achieved with facilities for accurate leucocyte counting and glucose measurement.	Ctr GEog Med Res Coast, Kilifi, Kenya; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 9DU, England; Inst Child Hlth, Neurosci Unit, London, England	University of Oxford; University of London; University College London	Berkley, JA (corresponding author), Ctr GEog Med Res Coast, POB 230, Kilifi, Kenya.		Newton, Charles/C-6222-2009; Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Berkley, James/0000-0002-1236-849X				Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P423, DOI 10.1097/00006454-199206000-00001; Bonev V, 1997, LANCET, V349, P287, DOI 10.1016/S0140-6736(05)64902-1; COMMEY JOO, 1994, E AFR MED J, V71, P113; FELGENHAUER K, 1985, J NEUROL, V232, P157, DOI 10.1007/BF00313892; FISHMAN RA, 1992, CEREBROSPINAL FLUID, P183; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Molyneux E, 1996, LANCET, V348, P1170, DOI 10.1016/S0140-6736(05)65304-4; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; MOOSA AA, 1995, LANCET, V345, P1290, DOI 10.1016/S0140-6736(95)90931-1; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; SCHIMDLEY JW, 1981, ANN NEUROL, V9, P81; Snow Robert W., 1994, Afr J Health Sci, V1, P71; *WHO, 1997, WHOCHD986; WRIGHT PW, 1993, PEDIATR INFECT DIS J, V12, P37, DOI 10.1097/00006454-199301000-00009	16	73	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2001	357	9270					1753	1757		10.1016/S0140-6736(00)04897-2	http://dx.doi.org/10.1016/S0140-6736(00)04897-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440BN	11403812				2022-12-01	WOS:000169156200013
J	Rizki, A; Lundblad, V				Rizki, A; Lundblad, V			Defects in mismatch repair promote telomerase-independent proliferation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HUMAN CANCER; RECOMBINATION; YEAST; MAINTENANCE; SENESCENCE; MUTATIONS; SEQUENCES; REMOVAL; HOMOLOG	Mismatch repair has a central role in maintaining genomic stability by repairing DNA replication errors and inhibiting recombination between non-identical (homeologous) sequences(1,2). Defects in mismatch repair have been linked to certain human cancers, including hereditary non-polyposis colorectal cancer (HNPCC) and sporadic tumours(3-5). A crucial requirement for tumour cell proliferation is the maintenance of telomere length(6), and most tumours achieve this by reactivating telomerase(7). In both yeast and human cells, however, telomerase-independent telomere maintenance can occur as a result of recombination-dependent exchanges between often imperfectly matched telomeric sequences(8-12). Here we show that loss of mismatch-repair function promotes cellular proliferation in the absence of telomerase. Defects in mismatch repair, including mutations that correspond to the same amino-acid changes recovered from HNPCC tumours(13), enhance telomerase-independent survival in both Saccharomyces cerevisiae and a related budding yeast with a degree of telomere sequence homology that is similar to human telomeres. These results indicate that enhanced telomeric recombination in human cells with mismatch-repair defects may contribute to cell immortalization and hence tumorigenesis.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nicholson A, 2000, GENETICS, V154, P133; RAYSSIGUIER C, 1989, NATURE, V342, P389; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Studamire B, 1999, MOL CELL BIOL, V19, P7558; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tran HT, 1999, MOL CELL BIOL, V19, P2000	23	106	107	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					713	716		10.1038/35079641	http://dx.doi.org/10.1038/35079641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395777				2022-12-01	WOS:000169112500051
J	Betran, AP; de Onis, M; Lauer, JA; Villar, J				Betran, AP; de Onis, M; Lauer, JA; Villar, J			Ecological study of effect of breast feeding on infant mortality in Latin America	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POTENTIAL INTERVENTIONS; DEVELOPING-COUNTRIES; CHILDHOOD PNEUMONIA; PROMOTION PROGRAM; DIARRHEAL; DISEASES; CHILDREN; RISK; PREVENTION	Objective To estimate the effect of exclusive breast feeding and partial breast feeding on infant mortality from diarrhoeal disease and acute respiratory infections in Latin America. Design Attributable fraction analysis of national data on infant mortality arid breast feeding. Setting Latin America and the Caribbean. Main outcome measures Mortality from diarrhoeal disease and acute respiratory infections and nationally representative breastfeeding rates. Results 55% of infant deaths from diarrhoeal disease and acute respiratory infections in Latin America are preventable by exclusive breast feeding among infants aged 0-3 months and partial breast feeding throughout the remainder of infancy. Among infants aged 0-3 months, 66% of deaths from these causes are preventable by exclusive breast feeding; among infants aged 4-11 months, 32% of such deaths are preventable by partial breast feeding. 13.9% of infant deaths from all causes are preventable by these breastfeeding patterns. The annual number of preventable deaths is about 52 000 for the region. Conclusions Exclusive breastfeeding of infants aged 0-3 months and partial breastfeeding throughout the remainder of infancy could substantially reduce infant mortality in Latin America. Interventions to promote breast feeding should target younger infants.	WHO, Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Nutr Hlth & Dev, CH-1211 Geneva, Switzerland; WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva, Switzerland; Univ Zaragoza, Fac Med, Dept Prevent Med & Publ Hlth, Zaragoza, Spain	World Health Organization; World Health Organization; World Health Organization; University of Zaragoza	Betran, AP (corresponding author), WHO, Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	betrana@who.int	Betrán, Ana Pilar/G-2023-2010	Lauer, Jeremy A/0000-0003-0652-0691				Albernaz E, 1998, J Hum Lact, V14, P283, DOI 10.1177/089033449801400402; Amador Manuel, 1992, Food and Nutrition Bulletin, V14, P101; BARROS FC, 1986, PEDIATRICS, V78, P656; BROWN KH, 1989, PEDIATRICS, V83, P31; Carnes BA, 1996, POPUL DEV REV, V22, P231, DOI 10.2307/2137434; Castillo C, 1996, Bull Pan Am Health Organ, V30, P125; COLE P, 1971, BRIT J PREV SOC MED, V25, P242; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P271; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; Golding J, 1997, EARLY HUM DEV, V49, pS143, DOI 10.1016/S0378-3782(97)00060-1; Heligman L., 1980, J I ACTUARIES, V107, P49, DOI DOI 10.1017/S0020268100040257; HUFFMAN S, 1991, BREASTFEEDING SAVES; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; Lopez A., 2000, 9 WHO GPE; MARTINES JC, 1994, J NUTR, V124, P1189, DOI 10.1093/jn/124.8.1189; Monteiro C., 1990, Health Policy and Planning, V5, P23, DOI 10.1093/heapol/5.1.23; Murray C., 1996, GLOBAL BURDEN DIS IN, V2; OUELLET BL, 1979, AM J EPIDEMIOL, V109, P451, DOI 10.1093/oxfordjournals.aje.a112703; *POP COUNC, 1990, STUD FAMILY PLANN, V21, P181; POPKIN BM, 1991, J BIOSOC SCI, V23, P5, DOI 10.1017/S0021932000019027; PUFFER RR, 1973, PATTERNS MORTALITY C; SACHDEV HPS, 1991, J PEDIATR GASTR NUTR, V12, P76, DOI 10.1097/00005176-199101000-00016; United Nations, 1995, WORLD POP PROSP; VALDES V, 1993, J TROP PEDIATRICS, V39, P142, DOI 10.1093/tropej/39.3.142; Victora Cesar G., 1996, Food and Nutrition Bulletin, V17, P390; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; VICTORA CG, 1992, ACTA PAEDIATR, V81, P7, DOI 10.1111/j.1651-2227.1992.tb12364.x; VICTORA CG, 1987, LANCET, V2, P319; Victora CG, 1999, AM J CLIN NUTR, V70, P309; VILLAR J, 1981, LANCET, V2, P621; WHO, 1996, WHONUT961; WHO UNICEF, 1989, PROT PROM SUPP BREAS; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692	33	69	80	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2001	323	7308					303	306		10.1136/bmj.323.7308.303	http://dx.doi.org/10.1136/bmj.323.7308.303			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498485	Green Published, Bronze			2022-12-01	WOS:000170470900016
J	Cohen, JE; Gurtler, RE				Cohen, JE; Gurtler, RE			Modeling household transmission of American trypanosomiasis	SCIENCE			English	Article							NORTH-WEST ARGENTINA; TRIATOMA-INFESTANS HEMIPTERA; CHAGAS-DISEASE TRANSMISSION; CRUZI; PREVALENCE; INFECTION; VECTOR; SEROPOSITIVITY; POPULATIONS; REDUVIIDAE	American trypanosomiasis, or Chagas disease, caused by the protozoan parasite Trypanosoma cruzi and transmitted by blood-feeding triatomine bugs, is a chronic, frequently fatal infection that is common in Latin America. Neither adequate drugs nor a vaccine is available. A mathematical model calibrated to detailed household data from three villages in northwest Argentina shows that householders could greatly reduce the risk of human infection by excluding domestic animals, especially infected dogs, from bedrooms; removing potential refuges for bugs from waits and ceilings; and using domestically applied insecticides. Low-cost, locally practicable environmental management combined with intermittent use of insecticides can sustainably control transmission of T. cruzi to humans in rural Argentina and probably elsewhere.	Rockefeller Univ, Lab Populat, New York, NY 10021 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Ecol Gen, Buenos Aires, DF, Argentina	Rockefeller University; University of Buenos Aires	Cohen, JE (corresponding author), Rockefeller Univ, Lab Populat, 1230 York Ave,Box 20, New York, NY 10021 USA.	cohen@rockefeller.edu						AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35; BUSENBERG SN, 1991, LECT NOTES PURE APPL, V131, P283; CANALS M, 1992, REV MED CHILE, V120, P1359; Castanera M. B., 1999, THESIS U BUENOS AIRE; CATALA S, 1991, MED VET ENTOMOL, V5, P325, DOI 10.1111/j.1365-2915.1991.tb00558.x; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Cecere MC, 1998, B WORLD HEALTH ORGAN, V76, P373; da Silva G R, 1969, Rev Saude Publica, V3, P23, DOI 10.1590/S0034-89101969000100004; GIOJALAS LC, 1990, T ROY SOC TROP MED H, V84, P439, DOI 10.1016/0035-9203(90)90355-I; Gurtler RE, 1996, J MED ENTOMOL, V33, P15, DOI 10.1093/jmedent/33.1.15; GURTLER RE, 1993, T ROY SOC TROP MED H, V87, P12, DOI 10.1016/0035-9203(93)90400-K; Gurtler RE, 1998, AM J TROP MED HYG, V59, P741; Gurtler RE, 1997, J APPL ECOL, V34, P699, DOI 10.2307/2404917; GURTLER RE, 1991, T ROY SOC TROP MED H, V85, P741, DOI 10.1016/0035-9203(91)90440-A; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Himschoot P. H, 1993, THESIS U BUENOS AIRE; KITRON U, 1989, REV INFECT DIS, V11, P391; LEHANE MJ, 1992, ACTA TROP, V52, P27, DOI 10.1016/0001-706X(92)90004-H; MINTER DM, 1976, PAN AM HLTH ORG SCI, V318, P330; Moncayo Alvaro, 1997, World Health Statistics Quarterly, V50, P195; RABINOVICH JE, 1990, B WORLD HEALTH ORGAN, V68, P737; RABINOVICH JE, 1990, ECOL MODEL, V52, P249, DOI 10.1016/0304-3800(90)90019-D; RABINOVICH JE, 1987, CHAGAS DIS VECTORS, V1, P119; Schmunis GA, 1996, LANCET, V348, P1171, DOI 10.1016/S0140-6736(05)65305-6; Schofield C. J., 1990, Appropriate technology in vector control., P187; Segura EL, 2000, AM J TROP MED HYG, V62, P353, DOI 10.4269/ajtmh.2000.62.353; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; VELASCOHERNANDEZ JX, 1994, THEOR POPUL BIOL, V46, P1, DOI 10.1006/tpbi.1994.1017; *WHO, 1999, SPEC PROGR RES TRAIN	30	187	194	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					694	698		10.1126/science.1060638	http://dx.doi.org/10.1126/science.1060638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474111	Green Submitted			2022-12-01	WOS:000170204600054
J	Kearon, C; Ginsberg, JS; Douketis, J; Crowther, M; Brill-Edwards, P; Weitz, JI; Hirsh, J				Kearon, C; Ginsberg, JS; Douketis, J; Crowther, M; Brill-Edwards, P; Weitz, JI; Hirsh, J			Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing	ANNALS OF INTERNAL MEDICINE			English	Article							WHOLE-BLOOD ASSAY; SIMPLIRED-D-DIMER; VEIN THROMBOSIS; PULMONARY-EMBOLISM; NONINVASIVE DIAGNOSIS; THROMBOEMBOLISM; SCORE; MODEL	Background: When deep venous thrombosis is suspected, objective testing is required to confirm or refute the diagnosis. Objective: To determine whether the combination of a low clinical suspicion and a normal D-dimer result rules out deep venous thrombosis. Design: Prospective cohort study. Setting: Three tertiary care hospitals in Canada. Patients: 445 outpatients with a suspected first episode of deep venous thrombosis. Interventions: Patients were categorized as having low, moderate, or high pretest probability of thrombosis and underwent whole-blood D-dimer testing. Patients with a low pretest probability and a negative result on the D-dimer test had no further diagnostic testing and received no anticoagulant therapy. Additional diagnostic testing was done in all other patients. Measurements: Venous thromboembolic events during 3-month follow-up. Results: 177 (40%) patients had both a low pretest probability and a negative D-dimer result. One of these patients had deep venous thrombosis during follow-up (negative predictive value, 99.4% [95% CI, 96.9% to 100%]). Conclusion: The combination of a low pretest probability of deep venous thrombosis and a negative result on a whole-blood D-dimer test rules out deep venous thrombosis in a large proportion of symptomatic outpatients.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Kearon, C (corresponding author), McMaster Univ, Henderson Gen Hosp, Room 401,711 Concess St, Hamilton, ON L8V 1C3, Canada.		Weitz, Jeffrey/AAD-1929-2019; Douketis, James/AAO-5659-2021; ginsberg, jeffrey s/ABC-1065-2020	Weitz, Jeffrey/0000-0002-1092-7550; 				Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; Bigaroni A, 2000, THROMB HAEMOSTASIS, V83, P788, DOI 10.1055/s-0037-1613912; BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1; Ginsberg JS, 1997, ARCH INTERN MED, V157, P1077, DOI 10.1001/archinte.157.10.1077; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; JOHN MA, 1990, THROMB RES, V58, P273, DOI 10.1016/0049-3848(90)90097-V; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; KEARON C, 1995, HAEMOSTASIS, V25, P72; Lee AYY, 1998, BAILLIERE CLIN HAEM, V11, P587, DOI 10.1016/S0950-3536(98)80084-X; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Wells PS, 1998, J INTERN MED, V243, P15; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; Wells PS, 1998, LANCET, V351, P1405, DOI 10.1016/S0140-6736(05)79444-7	18	149	155	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2001	135	2					108	111		10.7326/0003-4819-135-2-200107170-00011	http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452DR	11453710				2022-12-01	WOS:000169842300004
J	Reizes, O; Lincecum, J; Wang, ZH; Goldberger, O; Huang, L; Kaksonen, M; Ahima, R; Hinkes, MT; Barsh, GS; Rauvala, H; Bernfield, M				Reizes, O; Lincecum, J; Wang, ZH; Goldberger, O; Huang, L; Kaksonen, M; Ahima, R; Hinkes, MT; Barsh, GS; Rauvala, H; Bernfield, M			Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AGOUTI-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; CELL-SURFACE; MELANOCORTIN RECEPTORS; FIBROBLAST GROWTH; FOOD-INTAKE; N-SYNDECAN; IN-VIVO; OBESITY	Transgenic expression in the hypothalamus of syndecan-1, a cell surface heparan sulfate proteoglycan (HSPG) and modulator of ligand-receptor encounters, produces mice with hyperphagia and maturity-onset obesity resembling mice with reduced action of alpha melanocyte stimulating hormone (alpha MSH). Via their HS chains, syndecans potentiate the action of agouti-related protein and agouti signaling protein, endogenous inhibitors of alpha MSH. In wild-type mice, syndecan-3, the predominantly neural syndecan, is expressed in hypothalamic regions that control energy balance. Food deprivation increases hypothalamic syndecan-3 levels several-fold. Syndecan-3 null mice, otherwise apparently normal, respond to food deprivation with markedly reduced reflex hyperphagia. We propose that oscillation of hypothalamic syndecan-3 levels physiologically modulates feeding behavior.	Harvard Univ, Sch Med, Dept Pediat & Cell Biol, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Div Endocrinol, Boston, MA 02115 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, Helsinki 00014, Finland; Univ Helsinki, Dept Biosci, Helsinki 00014, Finland	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Helsinki; University of Helsinki	Bernfield, M (corresponding author), Harvard Univ, Sch Med, Dept Pediat & Cell Biol, Div Newborn Med, 300 Longwood Ave, Boston, MA 02115 USA.		Reizes, Ofer/ABA-4179-2021; Ahima, Rexford/W-1394-2019	Reizes, Ofer/0000-0003-0075-6871; Kaksonen, Marko/0000-0003-3645-7689; Rauvala, Heikki/0000-0001-7809-9811	NICHD NIH HHS [HD18655, HD06763] Funding Source: Medline; NIDDK NIH HHS [DK28506] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD006763, R37HD006763] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bagnol D, 1999, J NEUROSCI, V19; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Carey DJ, 1997, J BIOL CHEM, V272, P2873, DOI 10.1074/jbc.272.5.2873; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Conrad H. E., 1998, HEPARIN BINDING PROT; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Hagan MM, 2000, AM J PHYSIOL-REG I, V279, pR47, DOI 10.1152/ajpregu.2000.279.1.R47; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kiefer LL, 1998, BIOCHEMISTRY-US, V37, P991, DOI 10.1021/bi971913h; Lauri SE, 1999, J NEUROSCI, V19, P1226; Loeb JA, 1999, DEVELOPMENT, V126, P781; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Paxinos G., 2018, RAT NERVOUS SYSTEM; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RAULO E, 1994, J BIOL CHEM, V269, P12999; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666	45	170	176	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					105	116		10.1016/S0092-8674(01)00415-9	http://dx.doi.org/10.1016/S0092-8674(01)00415-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461706	Bronze			2022-12-01	WOS:000169870300013
J	Grimm, PC; Nickerson, P; Jeffery, J; Savani, RC; Gough, J; McKenna, RM; Stern, E; Rush, DN				Grimm, PC; Nickerson, P; Jeffery, J; Savani, RC; Gough, J; McKenna, RM; Stern, E; Rush, DN			Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOOTH-MUSCLE CELLS; CHRONIC TRANSPLANT REJECTION; INTERNATIONAL STANDARDIZATION; MYOFIBROBLAST INVOLVEMENT; SUBCLINICAL REJECTION; HISTOLOGIC DIAGNOSIS; INJURY; HYALURONAN; DIFFERENTIATION; VASCULOPATHY	Background: Tissue remodeling depends on mesenchymal cells (fibroblasts and myofibroblasts) and is a prominent feature of chronic renal-transplant rejection. It is not known whether the mesenchymal cells that participate in remodeling originate locally or from circulating precursor cells. Methods: We obtained biopsy specimens of renal allografts from six male recipients of an allograft from a female donor, four female recipients of an allograft from a male donor, two male recipients of an allograft from a male donor, and two female recipients of an allograft from a female donor. All the allografts were undergoing chronic rejection. We used immunohistochemical methods to identify mesenchymal cells with smooth-muscle alpha- actin and in situ hybridization to identify mesenchymal cells with Y-chromosome DNA. Results: No Y-chromosome bodies were identified in the case of the two renal-allograft specimens in which both the donor and the recipient were female. In the case of the two renal-allograft specimens in which both the donor and the recipient were male, approximately 40 percent of mesenchymal cells contained a Y-chromosome body. In the case of the six specimens in which the donor was female and the recipient was male, a mean (+/-SD) of 34+/-16 percent of mesenchymal cells in the neointima, 38+/-12 percent of such cells in the adventitia, and 30+/-7 percent of such cells in the interstitium contained the Y-chromosomal marker, indicating that they originated from the recipient rather than the donor. In the case of the four renal-allograft specimens in which the donor was male and the recipient was female, the respective values were 24+/-15 percent, 33+/-9 percent, and 23+/-8 percent, indicating a persistent population of donor mesenchymal cells. Conclusions: The presence of mesenchymal cells of host origin in the vascular and interstitial compartments of renal allografts undergoing chronic rejection provides evidence that a circulating mesenchymal precursor cell has the potential to migrate to areas of inflammation. (N Engl J Med 2001;345:93-7.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of Manitoba; University of Manitoba; University of Pennsylvania	Grimm, PC (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,MC 0831, La Jolla, CA 92093 USA.		Rashmin C. Savani, MBChB/AAG-2041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Grimm, Paul/0000-0001-7870-8592; Nickerson, Peter/0000-0002-7393-7799	NIAID NIH HHS [R01-AI43655-02] Funding Source: Medline; NIDDK NIH HHS [R21 DK53610-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK053610] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akyurek LM, 1996, TRANSPLANTATION, V62, P1526; ANDERSEN CB, 1991, APMIS, V99, P645, DOI 10.1111/j.1699-0463.1991.tb01240.x; Brazelton T. R., 1997, Journal of Heart and Lung Transplantation, V16, P72; Brazelton TR, 1999, INFLAMM RES, V48, pS134; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Geraghty JG, 1996, TRANSPLANTATION, V62, P502, DOI 10.1097/00007890-199608270-00013; Gizycki MJ, 1997, AM J RESP CELL MOL, V16, P664, DOI 10.1165/ajrcmb.16.6.9191468; GRIMM PC, 1995, TRANSPLANTATION, V59, P579; Grimm PC, 1999, J AM SOC NEPHROL, V10, P1582; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Katoh Y, 1996, TRENDS CARDIOVAS MED, V6, P100, DOI 10.1016/1050-1738(96)00014-X; LI J, 1995, EXP HEMATOL, V23, P133; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; Pedagogos E, 1997, TRANSPLANTATION, V64, P1192, DOI 10.1097/00007890-199710270-00019; Pethig K, 1998, AM HEART J, V135, P628, DOI 10.1016/S0002-8703(98)70278-9; PLISSONNIER D, 1995, TRANSPLANTATION, V60, P414, DOI 10.1097/00007890-199509000-00003; Routledge MW, 1997, TRANSPLANT P, V29, P2603, DOI 10.1016/S0041-1345(97)00525-3; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; SALOMON RN, 1991, AM J PATHOL, V138, P791; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; Shi Y, 1996, CIRCULATION, V93, P340, DOI 10.1161/01.CIR.93.2.340; SKALLI O, 1987, DIFFERENTIATION, V33, P232, DOI 10.1111/j.1432-0436.1987.tb01562.x; SOLEZ K, 1994, CLIN TRANSPLANT, V8, P345; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259	30	215	225	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2001	345	2					93	97		10.1056/NEJM200107123450203	http://dx.doi.org/10.1056/NEJM200107123450203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451AH	11450677	Bronze			2022-12-01	WOS:000169776900003
J	Leovy, C				Leovy, C			Weather and climate on Mars	NATURE			English	Review							THERMAL INFRARED PROPERTIES; MARTIAN ATMOSPHERE; INTERANNUAL VARIABILITY; DUST STORMS; TEMPERATURES; SIMULATION; TIDES; TES	Imagine a planet very much like the Earth, with similar size, rotation rate and inclination of rotation axis, possessing an atmosphere and a solid surface, but lacking oceans and dense clouds of liquid water. We might expect such a desert planet to be dominated by large variations in day-night and winter-summer weather. Dust storms would be common. Observations and simulations of martian climate confirm these expectations and provide a wealth of detail that can help resolve problems of climate evolution.	Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Leovy, C (corresponding author), Univ Washington, Dept Atmospher Sci, Box 351640, Seattle, WA 98195 USA.	conway@atmos.washington.edu						ANDERSON E, 1978, J ATMOS SCI, V35, P723, DOI 10.1175/1520-0469(1978)035<0723:MTLOOD>2.0.CO;2; Anderson FS, 1999, J GEOPHYS RES-PLANET, V104, P18991, DOI 10.1029/1999JE900024; ARVIDSON RE, 1983, SCIENCE, V222, P463, DOI 10.1126/science.222.4623.463; BARNES JR, 1984, J ATMOS SCI, V41, P1536, DOI 10.1175/1520-0469(1984)041<1536:LBIITM>2.0.CO;2; BARNES JR, 1981, J ATMOS SCI, V38, P225, DOI 10.1175/1520-0469(1981)038<0225:MDITMA>2.0.CO;2; BRIGGS G, 1972, B AM METEOROL SOC, V55, P278; CANTOR B, IN PRESS J GEOPHYS R, V106; Clancy RT, 2000, J GEOPHYS RES-PLANET, V105, P9553, DOI 10.1029/1999JE001089; CONRATH B, 1999, J GEOPHYS RES, V104, P9509; CONRATH BJ, 1981, ICARUS, V48, P246, DOI 10.1016/0019-1035(81)90107-X; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; GIERASCH P, 1979, GEOPHYS RES LETT, V6, P405, DOI 10.1029/GL006i005p00405; GIERASCH PJ, 1972, J ATMOS SCI, V29, P400, DOI 10.1175/1520-0469(1972)029<0400:TEODOT>2.0.CO;2; GREELEY R, 1993, J GEOPHYS RES-PLANET, V98, P3183, DOI 10.1029/92JE02580; GREELEY R, 1992, MARS, P835; HABERLE RM, 1986, SCIENCE, V234, P459, DOI 10.1126/science.234.4775.459; Haberle RM, 1997, J GEOPHYS RES-PLANET, V102, P13301, DOI 10.1029/97JE01334; Hartmann DL, 1994, GLOBAL PHYSICAL CLIM, P140; HINSON D, IN PRESS J GEOPHYS R, V106; Hinson DP, 1999, J GEOPHYS RES-PLANET, V104, P26997, DOI 10.1029/1999JE001069; Hollingsworth JL, 1996, J ATMOS SCI, V53, P428, DOI 10.1175/1520-0469(1996)053<0428:FSPWIM>2.0.CO;2; Hollingsworth JL, 1996, NATURE, V380, P413, DOI 10.1038/380413a0; James P.B., 1992, MARS, P934; James PB, 1999, ICARUS, V138, P64, DOI 10.1006/icar.1998.6060; JOSHI MM, 1994, NATURE, V367, P548, DOI 10.1038/367548a0; Kahn R. A., 1992, MARS, P1017; KEATING G, 2000, B AM ASTRON SOC, V32; Leovy C. B., 1985, Recent Advances in Planetary Meteorology. Seymour Hess Memorial Symposium at the 1983 IUGG General Assembly, P69; LEOVY CB, 1973, J ATMOS SCI, V30, P749, DOI 10.1175/1520-0469(1973)030<0749:MFMDS>2.0.CO;2; Lewis SR, 1999, J GEOPHYS RES-PLANET, V104, P24177, DOI 10.1029/1999JE001024; MARTIN TZ, 1979, J GEOPHYS RES, V84, P2843, DOI 10.1029/JB084iB06p02843; Murphy JR, 1995, J GEOPHYS RES-PLANET, V100, P26357, DOI 10.1029/95JE02984; MURPHY JR, 1990, J GEOPHYS RES-SOLID, V95, P14555, DOI 10.1029/JB095iB09p14555; PETERFREUND AR, 1979, J GEOPHYS RES, V84, P2853, DOI 10.1029/JB084iB06p02853; RYAN JA, 1970, J GEOPHYS RES, V75, P531, DOI 10.1029/JC075i003p00531; RYAN JA, 1981, GEOPHYS RES LETT, V8, P899, DOI 10.1029/GL008i008p00899; SANTEE M, 1993, J GEOPHYS RES-PLANET, V98, P3261, DOI 10.1029/92JE01896; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Seiff A., 1977, Journal of Geophysical Research, V82, P4364, DOI 10.1029/JS082i028p04364; SMITH M, IN PRESS J GEOPHYS R, V106; Smith MD, 2000, J GEOPHYS RES-PLANET, V105, P9539, DOI 10.1029/1999JE001097; THOMAS P, 1985, SCIENCE, V230, P175, DOI 10.1126/science.230.4722.175; THOMAS PG, 1984, ICARUS, V58, P396, DOI 10.1016/0019-1035(84)90085-X; TILLMAN JE, 1988, J GEOPHYS RES-ATMOS, V93, P9433, DOI 10.1029/JD093iD08p09433; TILLMAN JE, 1993, J GEOPHYS RES-PLANET, V98, P10963, DOI 10.1029/93JE01084; Wilson RJ, 2000, ICARUS, V145, P555, DOI 10.1006/icar.2000.6378; Wilson RJ, 1996, J ATMOS SCI, V53, P1290, DOI 10.1175/1520-0469(1996)053<1290:CMSOTT>2.0.CO;2; Zurek R.W., 1992, MARS, P835; ZUREK RW, 1981, SCIENCE, V213, P437, DOI 10.1126/science.213.4506.437; ZUREK RW, 1976, J ATMOS SCI, V33, P321, DOI 10.1175/1520-0469(1976)033<0321:DTITMA>2.0.CO;2; ZUREK RW, 1993, J GEOPHYS RES-PLANET, V98, P3247, DOI 10.1029/92JE02936; ZUREK RW, 1988, J ATMOS SCI, V45, P2469, DOI 10.1175/1520-0469(1988)045<2469:ZSRTAT>2.0.CO;2; [No title captured]	53	87	89	5	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2001	412	6843					245	249		10.1038/35084192	http://dx.doi.org/10.1038/35084192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449286				2022-12-01	WOS:000169778700064
J	Johnston, AM; Raven, JA; Beardall, J; Leegood, RC				Johnston, AM; Raven, JA; Beardall, J; Leegood, RC			Carbon fixation - Photosynthesis in a marine diatom	NATURE			English	Article							INORGANIC CARBON; ACQUISITION		Scottish Crop Res Inst, Dundee DD2 5DA, Scotland; Univ Dundee, Inst Biol Sci, Dundee DD1 4HN, Scotland; Monash Univ, Dept Biol Sci, Clayton, Vic 3800, Australia; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	James Hutton Institute; University of Dundee; Monash University; University of Sheffield	Johnston, AM (corresponding author), Scottish Crop Res Inst, Dundee DD2 5DA, Scotland.	ajohn@scri.sari.ac.uk	Beardall, John/L-5262-2019; Beardall, John/A-1250-2008	Beardall, John/0000-0001-7684-446X; Beardall, John/0000-0001-7684-446X				Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; BEARDALL J, 1976, J PHYCOL, V12, P409; BEARDALL J, 1989, AQUAT BOT, V34, P105, DOI 10.1016/0304-3770(89)90052-1; JOHNSTON AM, 1991, CAN J BOT, V69, P1123, DOI 10.1139/b91-144; JOHNSTON AM, 1987, PHYCOLOGIA, V26, P159, DOI 10.2216/i0031-8884-26-2-159.1; JOHNSTON AM, 1992, MARINE ECOL PROG SER, V87, P517; Raven JA, 1997, ADV BOT RES, V27, P85; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Riebesell U, 2000, NATURE, V407, P959, DOI 10.1038/35039665; Sage R. F., 1999, C4 PLANT BIOL, P596	10	35	38	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2001	412	6842					40	41		10.1038/35083694	http://dx.doi.org/10.1038/35083694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452295				2022-12-01	WOS:000169644900032
J	Grodstein, F; Manson, JE; Stampfer, MJ				Grodstein, F; Manson, JE; Stampfer, MJ			Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study - A prospective, observational study	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN REPLACEMENT THERAPY; ARTERY-DISEASE; HEART-DISEASE; WOMEN; RISK; REPRODUCIBILITY; PROGESTIN; MORTALITY; VALIDITY; TRIAL	Background: The Heart and Estrogen/progestin Replacement Study (HERS) was the first randomized clinical trial of combined hormone therapy and secondary prevention of coronary events. The trial had overall null results but reported an unexpected increased risk for recurrent events in the initial year, followed by a decrease during the final years. Objective: To provide additional data on a time trend in risk for recurrent heart disease. Design: A prospective, observational cohort study of secondary prevention of coronary heart disease. Setting: Nurses' Health Study. Patients: 2489 postmenopausal women with previous myocardial infarction or documented atherosclerosis; 213 cases of recurrent nonfatal myocardial infarction or coronary death were identified from 1976 through 1996. Measurements: Information on hormone status and on recurrent disease was collected by using biennial questionnaires. Multi-variable-adjusted relative risks and 95% CIs were calculated from logistic regression models. Results: A trend of decreasing risk for recurrent major coronary heart disease events with increasing duration of hormone use was observed (P for trend = 0.002). For short-term current users, the multivariate-adjusted relative risk for major coronary heart disease was 1.25 (95% CI, 0.78 to 2.00) compared with never-users. However, after longer-term hormone use, the rate of second events was lower in current users than in never-users (relative risk, 0.38 [CI, 0.22 to 0.66]). No clear differences emerged between users of estrogen alone and users of estrogen combined with progestin. Overall, with up to 20 years of follow-up, the relative risk for a second event among current users of hormone therapy was 0.65 (CI, 0.45 to 0.95) compared with never-users. Conclusions: The risk for recurrent major coronary events seems to increase among short-term hormone users with previous coronary disease but to decrease with longer-term use.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Grodstein, F (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG013482] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL34594] Funding Source: Medline; NIA NIH HHS [AG13482] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; GREENLAND S, 1985, AM J EPIDEMIOL, V122, P495, DOI 10.1093/oxfordjournals.aje.a114131; GRODSTEIN F, 1994, OBSTET GYNECOL, V83, P5; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 1999, ANN INTERN MED, V131, P463, DOI 10.7326/0003-4819-131-6-199909210-00012; Hodis HN, 2000, CIRCULATION, V102, P837; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Khan MA, 2000, AM J CARDIOL, V86, P330, DOI 10.1016/S0002-9149(00)00926-7; KIM SC, 1995, CIRCULATION S1, V92, P674; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; NEWTON KM, 1997, AM J EPIDEMIOL, V145, P69; OKeefe JH, 1997, J AM COLL CARDIOL, V29, P1; *ORG WH, 1971, ID REG REP 5 WORK GR; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; ROSANO GMC, 1993, LANCET, V342, P133, DOI 10.1016/0140-6736(93)91343-K; Rothman KJ, 1979, NIH PUBLICATION, V79-1649, P31; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; SULLIVAN JM, 1990, ARCH INTERN MED, V150, P2557, DOI 10.1001/archinte.150.12.2557; SULLIVAN JM, 1994, J AM COLL CARDIOL, V23, pA49; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	32	218	232	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2001	135	1					1	8		10.7326/0003-4819-135-1-200107030-00003	http://dx.doi.org/10.7326/0003-4819-135-1-200107030-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449JC	11434726	Green Published, Green Submitted			2022-12-01	WOS:000169680500001
J	Boughman, JW				Boughman, JW			Divergent sexual selection enhances reproductive isolation in sticklebacks	NATURE			English	Article							SYMPATRIC STICKLEBACKS; INTRASPECIFIC VARIATION; GASTEROSTEUS-ACULEATUS; NATURAL-SELECTION; BRITISH-COLUMBIA; SPECIES-PAIR; SPECIATION; EVOLUTION; TRAITS; COMPETITION	Sexual selection may facilitate speciation because it can cause rapid evolutionary diversification of male mating signals and female preferences. Divergence in these traits can then contribute to reproductive isolation(1-3). The sensory drive hypothesis predicts that three mechanisms underlie divergence in sexually selected traits(4): (1) habitat-specific transmission of male signals(5-7); (2) adaptation of female perceptual sensitivity to local ecological conditions(8); and (3) matching of male signals to female perceptual sensitivity(4,9). I test these mechanisms in threespine sticklebacks (Gasterosteus spp.) that live in different light environments. Here I show that female perceptual sensitivity to red light varies with the extent of redshift in the light environment, and contributes to divergent preferences. Male nuptial colour varies with environment and is tuned to female perceptual sensitivity. The extent of divergence among populations in both male signal colour and female preference for red is correlated with the extent of reproductive isolation in these recently diverged species. These results demonstrate that divergent sexual selection generated by sensory drive contributes to speciation.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Boughman, JW (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.			Boughman, Janette/0000-0002-5731-7389				CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Endler J. A., 1992, AM NAT, V139, pS125; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; Fisher R.A., 1930, GENETICAL THEORY NAT; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; KLUMP GM, 1995, METHODS COMP PSYCHOA; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1988, J THEOR BIOL, V133, P85, DOI 10.1016/S0022-5193(88)80026-2; LEVINE JS, 1979, SENS PROCESS, V3, P95; LUTHGOSE JN, 1979, ECOLOGY VISION; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MCDONALD CG, 1995, J COMP PHYSIOL A, V176, P255; MCFARLAND WN, 1975, VISION RES, V15, P1071, DOI 10.1016/0042-6989(75)90003-6; McPhail J.D., 1994, P399; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; REIMCHEN TE, 1989, EVOLUTION, V43, P450, DOI 10.1111/j.1558-5646.1989.tb04239.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; RYAN M.J., 1990, OXFORD SURV EVOL BIO, V7, P156; RYAN MJ, 1991, BIOL J LINN SOC, V44, P249, DOI 10.1111/j.1095-8312.1991.tb00619.x; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D, 1998, ENDLESS FORMS, P114; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; TAYLOR EB, 2000, GASTROSTEUS P R SO B, V267, P2375, DOI DOI 10.1098/RSPB.2000.1294; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	30	513	520	1	215	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2001	411	6840					944	948		10.1038/35082064	http://dx.doi.org/10.1038/35082064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418857				2022-12-01	WOS:000169386200043
J	Beja, O; Spudich, EN; Spudich, JL; Leclerc, M; DeLong, EF				Beja, O; Spudich, EN; Spudich, JL; Leclerc, M; DeLong, EF			Proteorhodopsin phototrophy in the ocean	NATURE			English	Article							SENSORY RHODOPSIN-II; HALOBACTERIUM-HALOBIUM; PURPLE MEMBRANE; PROCHLOROCOCCUS; PHOBORHODOPSIN; CYANOBACTERIA; COMMUNITY; BACTERIA; ATLANTIC; PROTEIN	Proteorhodopsin(1), a retinal-containing integral membrane protein that functions as a light-driven proton pump, was discovered in the genome of an uncultivated marine bacterium; however, the prevalence, expression and genetic variability of this protein in native marine microbial populations remain unknown. Here we report that photoactive proteorhodopsin is present in oceanic surface waters. We also provide evidence of an extensive family of globally distributed proteorhodopsin variants. The protein pigments comprising this rhodopsin family seem to be spectrally tuned to different habitats-absorbing light at different wavelengths in accordance with light available in the environment. Together, our data suggest that proteorhodopsin-based phototrophy is a globally significant oceanic microbial process.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Monterey Bay Aquarium Research Institute; University of Texas System	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Leclerc, Marion/AAZ-3950-2021	Leclerc, Marion/0000-0001-8684-2847				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Bowmaker James K., 1999, Novartis Foundation Symposium, V224, P21, DOI 10.1002/9780470515693.ch3; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; KIRK JTO, 1983, LIGHT PHOTOSYNTHESIS, P104; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; MICHEL H, 1980, BIOCHEMISTRY-US, V19, P4607, DOI 10.1021/bi00561a011; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; NEUGEBAUER DC, 1983, METHOD ENZYMOL, V97, P218; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Sasaki J, 1998, BIOPHYS J, V75, P2435, DOI 10.1016/S0006-3495(98)77687-8; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294	25	577	612	8	126	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					786	789		10.1038/35081051	http://dx.doi.org/10.1038/35081051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459054				2022-12-01	WOS:000169246400045
J	Gilbert, IR; Jarvis, PG; Smith, H				Gilbert, IR; Jarvis, PG; Smith, H			Proximity signal and shade avoidance differences between early and late successional trees	NATURE			English	Article							NATURAL-ENVIRONMENT; LIGHT QUALITY; PHYTOCHROME; PLANTS; PERCEPTION; CANOPIES; GROWTH	Competitive interactions between plants determine the success of individuals and species. In developing forests, competition for light is the predominant factor. Shade tolerators acclimate photo-synthetically to low light(1-3) and are capable of long-term survival under the shade cast by others, whereas shade avoiders rapidly dominate gaps but are overtaken in due course by shade-tolerant, later successional species. Shade avoidance(4-6) results from the phytochrome-mediated perception of far-red radiation (700- 800 nm) scattered from the leaves of neighbours, provides early warning of shading(7), and induces developmental responses that, when successful, result in the overgrowth of those neighbours(8). Shade tolerators cast a deep shade, whereas less-tolerant species cast light shade(9), and saplings tend to have high survivorship in shade cast by conspecific adults, but high rates of mortality when shaded by more-tolerant species(9). Here we report a parallel relationship in which the shade-avoidance responses of three tree species are inversely proportional to proximity signals generated by those species. On this basis, early successional species generate small proximity signals but react strongly to them, whereas late successional species react weakly but generate strong signals.	Univ Nottingham, Div Plant Sci, Loughborough LE12 5RD, Leics, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland	University of Nottingham; University of Edinburgh; University of Edinburgh	Smith, H (corresponding author), Univ Nottingham, Div Plant Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	Harry.Smith@Nottingham.ac.uk						BALLARE CL, 1990, SCIENCE, V247, P329, DOI 10.1126/science.247.4940.329; Bjorkman O., 1981, ENCYCL PLANT PHYSIOL, V12, P57; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; CANHAM CD, 1994, CAN J FOREST RES, V24, P337, DOI 10.1139/x94-046; CASAL JJ, 1989, PLANT CELL ENVIRON, V12, P855, DOI 10.1111/j.1365-3040.1989.tb01966.x; CHILD R, 1981, NEW PHYTOL, V89, P545, DOI 10.1111/j.1469-8137.1981.tb02334.x; GILBERT IR, 1995, PLANT CELL ENVIRON, V18, P475, DOI 10.1111/j.1365-3040.1995.tb00549.x; HAYWARD PM, 1984, TECHNIQUES PHOTOMORP, P159; Kull O, 1998, FUNCT ECOL, V12, P472, DOI 10.1046/j.1365-2435.1998.00214.x; Lei TT, 1998, ANN BOT-LONDON, V82, P9, DOI 10.1006/anbo.1998.0644; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; MORGAN DC, 1976, NATURE, V262, P210, DOI 10.1038/262210a0; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SMITH H, 1977, PHOTOCHEM PHOTOBIOL, V25, P547; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445	16	90	97	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					792	795		10.1038/35081062	http://dx.doi.org/10.1038/35081062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459056	Green Published			2022-12-01	WOS:000169246400047
J	McDonald, JJ; Teder-Salejarvi, WA; Ward, LM				McDonald, JJ; Teder-Salejarvi, WA; Ward, LM			Multisensory integration and crossmodal attention effects in the human brain	SCIENCE			English	Editorial Material							SPATIAL ATTENTION; AUDITORY-CORTEX; SPEECH		Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada	Simon Fraser University; University of California System; University of California San Diego; University of British Columbia	McDonald, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jmcd@sfu.ca; wat@sdepl.ucsd.edu; lward@cortex.psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015				Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bertelson P., 1999, COGNITIVE CONTRIBUTI, P347, DOI DOI 10.1016/S0166-4115(99)80034-X; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; de Gelder B, 2000, SCIENCE, V289, P1148; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037//0096-1523.18.4.1030; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; KENNETT S, IN PRESS J COGNIT NE; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MCDONALD JJ, 1999, THESIS U BRIT COLUMB; MEREDITH MA, 1987, J NEUROSCI, V7, P3125; RICHARD C, 1999, THESIS U BRIT COLUMB; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Stein BE., 1993, MERGING SENSES; TASSINARI G, 1994, VISION RES, V34, P179, DOI 10.1016/0042-6989(94)90330-1; VROOMEN J, IN PRESS PERCEPT PSY; Ward LM, 2000, PERCEPT PSYCHOPHYS, V62, P1258, DOI 10.3758/BF03212127; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, pCH25	20	71	73	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11397913				2022-12-01	WOS:000169200700051
J	Kerstetter, RA; Bollman, K; Taylor, RA; Bomblies, K; Poethig, RS				Kerstetter, RA; Bollman, K; Taylor, RA; Bomblies, K; Poethig, RS			KANADI regulates organ polarity in Arabidopsis	NATURE			English	Article							RESPONSE REGULATORS; NUCLEAR-LOCALIZATION; ASP PHOSPHORELAY; THALIANA; PROTEIN; GENE; LEAF; MERISTEM; EXPRESSION; ENCODES	Leaves and floral organs are polarized along their adaxial-abaxial (dorsal-ventral) axis. In Arabidopsis, this difference is particularly obvious in the first two rosette leaves, which possess trichomes (leaf hairs) on their adaxial surface but not their abaxial surface(1-3). Mutant alleles of KANADI (KAN) were identified in a screen for mutants that produce abaxial trichomes on these first two leaves. kan mutations were originally identified as enhancers of the mutant floral phenotype of crabs claw (crc), a gene that specifies abaxial identity in carpels(4,5). Here we show that KAN is required for abaxial identity in both leaves and carpels, and encodes a nuclear-localized protein in the GARP family of putative transcription factors. The expression pattern of KAN messenger RNA and the effect of ectopically expressing KAN under the regulation of the cauliflower mosaic virus (CAMV) 35S promoter indicate that KAN may also specify peripheral identity in the developing embryo.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.		Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Bomblies, Kirsten/0000-0002-2434-3863				BARTON MK, 1993, DEVELOPMENT, V119, P823; Behringer FJ, 1992, PLANT MOL BIOL REP, V10, P190, DOI 10.1007/BF02668346; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Hall LN, 1998, PLANT CELL, V10, P925, DOI 10.1105/tpc.10.6.925; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Lohrmann J, 1999, PLANT BIOLOGY, V1, P495, DOI 10.1111/j.1438-8677.1999.tb00775.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Roberts C, 1997, PCAMBIA VECTOR RELEA; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Telfer A, 1997, DEVELOPMENT, V124, P645; Telfer A., 1994, ARABIDOPSIS, P379, DOI DOI 10.1083/JCB.201205114; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Wykoff DD, 1999, P NATL ACAD SCI USA, V96, P15336, DOI 10.1073/pnas.96.26.15336	25	443	469	4	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					706	709		10.1038/35079629	http://dx.doi.org/10.1038/35079629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395775				2022-12-01	WOS:000169112500049
J	Ourednik, V; Ourednik, J; Flax, JD; Zawada, WM; Hutt, C; Yang, CH; Park, KI; Kim, SU; Sidman, RL; Freed, CR; Snyder, EY				Ourednik, V; Ourednik, J; Flax, JD; Zawada, WM; Hutt, C; Yang, CH; Park, KI; Kim, SU; Sidman, RL; Freed, CR; Snyder, EY			Segregation of human neural stem cells in the developing primate forebrain	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING CEREBRAL-CORTEX; ADULT HUMAN HIPPOCAMPUS; MAMMALIAN BRAIN; NEUROGENESIS; NEOCORTEX; MIGRATION; NEURONS; TRANSPLANTATION; PROGENITORS	Many central nervous system regions at all stages of Life contain neural stem cells (NSCs). We explored how these disparate NSC pools might emerge. A traceable clone of human NSCs was implanted intraventricularly to allow its integration into cerebral germinal zones of Old World monkey fetuses. The NSCs distributed into two subpopulations: One contributed to corticogenesis by migrating along radial glia to temporally appropriate layers of the cortical plate and differentiating into lamina-appropriate neurons or glia; the other remained undifferentiated and contributed to a secondary germinal zone (the subventricular zone) with occasional members interspersed throughout brain parenchyma. An early neurogenetic program allocates the progeny of NSCs either immediately for organogenesis or to undifferentiated pools for later use in the "postdevelopmental" brain.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Colorado, Sch Med, Dept Med & Pharmacol, Denver, CO 80220 USA; Univ Colorado, Sch Med, Neurosci Program, Denver, CO 80220 USA; Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; Univ British Columbia, Dept Neurol, Vancouver, BC V6T 2B5, Canada; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,LMRC, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Yonsei University; Yonsei University Health System; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ourednik, V (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, 855 Harvard Inst Med,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vouredni@caregroup.harvard.edu; esnyder1@caregroup.harvard.edu						AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BAYER SA, 1994, NEUROIMAGE, V1, P296, DOI 10.1006/nimg.1994.1014; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; Goldman-Rakic P S, 1982, Neurosci Res Program Bull, V20, P520; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRANGER B, 1995, J COMP NEUROL, V360, P363, DOI 10.1002/cne.903600212; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lacorazza HD, 1996, NAT MED, V2, P424, DOI 10.1038/nm0496-424; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mehler MF, 1999, BRAIN PATHOL, V9, P515, DOI 10.1111/j.1750-3639.1999.tb00539.x; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ourednik J, 1998, J COMP NEUROL, V395, P91, DOI 10.1002/(SICI)1096-9861(19980525)395:1<91::AID-CNE7>3.0.CO;2-C; Ourednik V, 1999, CLIN GENET, V56, P267, DOI 10.1034/j.1399-0004.1999.560403.x; Palmer TD, 1999, J NEUROSCI, V19, P8487; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Park K. I., 1998, Society for Neuroscience Abstracts, V24, P1310; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0	44	164	174	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1820	1824		10.1126/science.1060580	http://dx.doi.org/10.1126/science.1060580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11474066				2022-12-01	WOS:000170894400044
J	Jones, PA; Takai, D				Jones, PA; Takai, D			The role of DNA methylation in mammalian epigenetics	SCIENCE			English	Editorial Material							DE-NOVO METHYLATION; CPG ISLAND; METHYLTRANSFERASE GENE; HISTONE DEACETYLASE; DENOVO METHYLATION; CELL-LINES; BINDING; TRANSCRIPTION; CHROMOSOME; COMPLEX	Genes constitute only a small proportion of the total mammalian genome, and the precise control of their expression in the presence of an overwhelming background of noncoding DNA presents a substantial problem for their regulation. Noncoding DNA, containing introns, repetitive elements, and potentially active transposable elements, requires effective mechanisms for its tong-term silencing. Mammals appear to have taken advantage of the possibilities afforded by cytosine methylation to provide a heritable mechanism for altering DNA-protein interactions to assist in such silencing. Genes can be transcribed from methylation-free promoters even though adjacent transcribed and nontranscribed regions are extensively methylated. Gene promoters can be used and regulated white keeping noncoding DNA, including transposable elements, suppressed. Methylation is also used for Long-term epigenetic silencing of X-linked and imprinted genes and can either increase or decrease the level of transcription, depending on whether the methylation inactivates a positive or negative regulatory element.	Univ So Calif, Keck Sch Med, Dept Biochem, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Jones, PA (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem, USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave,MS 8302L, Los Angeles, CA 90089 USA.	jones_p@ccnt.hsc.usc.edu	jia, xu/A-8386-2016		NATIONAL CANCER INSTITUTE [R01CA082422] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA82422] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baylin SB, 1998, ADV CANCER RES, V72, P141; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Carotti D, 1998, BIOCHEMISTRY-US, V37, P1101, DOI 10.1021/bi971031i; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHRISTMAN JK, 1995, P NATL ACAD SCI USA, V92, P7347, DOI 10.1073/pnas.92.16.7347; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gonzalgo ML, 1998, CANCER RES, V58, P1245; GRIGG G, 1994, BIOESSAYS, V16, P431, DOI 10.1002/bies.950160612; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Han L, 2001, MOL CELL BIOL, V21, P3416, DOI 10.1128/MCB.21.10.3416-3424.2001; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; HENDRIKS RW, 1992, GENOMICS, V14, P598, DOI 10.1016/S0888-7543(05)80157-0; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; JAHNER D, 1985, NATURE, V315, P594, DOI 10.1038/315594a0; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; TAKAI D, UNPUB; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yeivin A, 1993, EXS, V64, P523; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	47	1409	1533	5	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1068	1070		10.1126/science.1063852	http://dx.doi.org/10.1126/science.1063852			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498573				2022-12-01	WOS:000170432600041
J	Park, Y; Kuroda, MI				Park, Y; Kuroda, MI			Epigenetic aspects of X-chromosome dosage compensation	SCIENCE			English	Editorial Material							INACTIVATION CENTER; ACETYL TRANSFERASE; MALE DROSOPHILA; MSL COMPLEX; HISTONE H3; RNA PAINTS; CHROMATIN; EVOLUTION; SEX; GENES	The X chromosomes of mammals and fruit flies exhibit unusual properties that have evolved to deal with the different dosages of X-linked genes in mates (XY) and females (XX). The X chromosome dosage-compensation mechanisms discovered in these species are evolutionarily unrelated, but exhibit surprising parallels in their regulatory strategies. These features include the importance of noncoding RNAs, and epigenetic spreading of chromatin-modifying activities.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute	Park, Y (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.							Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bone JR, 1996, GENETICS, V144, P705; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 2000, CURR OPIN GENET DEV, V10, P555, DOI 10.1016/S0959-437X(00)00127-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KRIVSHENKO J, 1959, GENETICS, V44, P1027; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MARIN I, 1996, NATURE, V383; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASMUSSEN TP, 2001, CHROMOSOMA      0720; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Sado T, 2001, DEVELOPMENT, V128, P1275; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Solter D, 1997, GENE DEV, V11, P153, DOI 10.1101/gad.11.2.153; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	47	83	88	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1083	1085		10.1126/science.1063073	http://dx.doi.org/10.1126/science.1063073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498577				2022-12-01	WOS:000170432600045
J	Hutvagner, G; McLachlan, J; Pasquinelli, AE; Balint, E; Tuschl, T; Zamore, PD				Hutvagner, G; McLachlan, J; Pasquinelli, AE; Balint, E; Tuschl, T; Zamore, PD			A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; REGULATORY RNA; MESSENGER-RNA; GENE; LIN-14; ARABIDOPSIS; DROSOPHILA; SEQUENCE	The 21-nucleotide small temporal RNA (stRNA) let-7 regulates developmental timing in Caenorhabditis elegans and probably in other bilateral animals. We present in vivo and in vitro evidence that in Drosophila melanogaster a developmentally regulated precursor RNA is cleaved by an RNA interference-like mechanism to produce mature let-7 stRNA. Targeted destruction in cultured human cells of the messenger RNA encoding the enzyme Dicer, which acts in the RNA interference pathway, leads to accumulation of the let-7 precursor. Thus, the RNA interference and stRNA pathways intersect. Both pathways require the RNA-processing enzyme Dicer to produce the active small-RNA component that represses gene expression.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society	Hutvagner, G (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618; Hutvagner, Gyorgy/0000-0002-7231-9446	NIGMS NIH HHS [GM62862-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM062862] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alefelder S, 1998, NUCLEIC ACIDS RES, V26, P4983, DOI 10.1093/nar/26.21.4983; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; CHELLADURAI B, 1993, BIOCHEMISTRY-US, V32, P7549, DOI 10.1021/bi00080a029; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1490, P163, DOI 10.1016/S0167-4781(99)00221-3; Moss EG, 2000, CURR BIOL, V10, pR436, DOI 10.1016/S0960-9822(00)00528-5; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1111/j.1574-6976.1999.tb00405.x; NYKANEN A, UNPUB; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PASQUINELLI AE, UNPUB; Ray A, 1996, DEVELOPMENT, V122, P2631; Ray S, 1996, DEV BIOL, V180, P365, DOI 10.1006/dbio.1996.0309; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUVKUN G, 1991, DEVELOPMENT, P47; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZUKER M, 1999, PRACTICAL GUIDE RNA	36	2043	2329	6	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					834	838		10.1126/science.1062961	http://dx.doi.org/10.1126/science.1062961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11452083				2022-12-01	WOS:000170241000037
J	Newman, JH; Wheeler, L; Lane, KB; Loyd, E; Gaddipati, R; Phillips, JA; Loyd, JE				Newman, JH; Wheeler, L; Lane, KB; Loyd, E; Gaddipati, R; Phillips, JA; Loyd, JE			Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GERMLINE MUTATIONS	Background: Most patients with primary pulmonary hypertension are thought to have sporadic, not inherited, disease. Because clinical disease develops in only 10 to 20 percent of persons carrying the gene for familial primary pulmonary hypertension, we hypothesized that many patients with apparently sporadic primary pulmonary hypertension may actually have familial primary pulmonary hypertension. Methods: In a study conducted over 20 years, we developed a registry of 67 families affected by familial primary pulmonary hypertension. Through patient referrals, extensive family histories, and correlation of family pedigrees, we discovered shared ancestry among five subfamilies. We assessed some family members for mutations in the gene encoding bone morphogenetic protein receptor II (BMPR2), which has recently been found to cause familial primary pulmonary hypertension. Results: We linked five separately identified subfamilies that included 394 known members spanning seven generations, which were traced back to a founding couple in the mid-1800s. Familial primary pulmonary hypertension has been diagnosed in 18 family members, 12 of whom were first thought to have sporadic disease. The conditions of 7 of the 18 were initially misdiagnosed as other cardiopulmonary diseases. Six members affected with familial primary pulmonary hypertension and 6 of 10 at risk for carriage have undergone genotype analysis, and they have the same mutation in BMPR2, a transversion of thymine to guanine at position 354 in exon 3. Conclusions: Many cases of apparently sporadic primary pulmonary hypertension may be familial. The recent discovery of mutations in BMPR2 should make it possible to identify those with susceptibility to the disease.	Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med,Ctr Lung Res, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Div Med Genet, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Newman, JH (corresponding author), Vanderbilt Univ, Med Ctr N, Allergy Pulm & Crit Care Div, T-1218, Nashville, TN 37232 USA.			Loyd, James/0000-0002-5042-7390	NCRR NIH HHS [RR 00095] Funding Source: Medline; PHS HHS [R0I 48164-06] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; DRESDALE DT, 1954, B NEW YORK ACAD MED, V30, P195; DRESDALE DT, 1951, AM J MED, V11, P686, DOI 10.1016/0002-9343(51)90020-4; ELLIOTT G, 1995, CHEST, V108, P973, DOI 10.1378/chest.108.4.973; KINGDON HS, 1966, ARCH INTERN MED, V118, P422, DOI 10.1001/archinte.118.5.422; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RICH S, 1998, WORLD S PRIM PULM HY; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Zhou SB, 1999, NEW ENGL J MED, V341, P1144, DOI 10.1056/NEJM199910073411510	15	246	263	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					319	324		10.1056/NEJM200108023450502	http://dx.doi.org/10.1056/NEJM200108023450502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484688				2022-12-01	WOS:000170193600002
J	DiAntonio, A; Haghighi, AP; Portman, SL; Lee, JD; Amaranto, AM; Goodman, CS				DiAntonio, A; Haghighi, AP; Portman, SL; Lee, JD; Amaranto, AM; Goodman, CS			Ubiquitination-dependent mechanisms regulate synaptic growth and function	NATURE			English	Article							FAT-FACETS GENE; DROSOPHILA; EXPRESSION; SYSTEM; LIGASE	The covalent attachment of ubiquitin to cellular proteins is a powerful mechanism for controlling protein activity and localization(1). Ubiquitination is a reversible modification promoted by ubiquitin ligases and antagonized by deubiquitinating proteases(2). Ubiquitin-dependent mechanisms regulate many important processes including cell-cycle progression, apoptosis and transcriptional regulation(3). Here we show that ubiquitin-dependent mechanisms regulate synaptic development at the Drosophila neuromuscular junction (NMJ). Neuronal overexpression of the deubiquitinating protease fat facets(4) leads to a profound disruption of synaptic growth control; there is a large increase in the number of synaptic boutons, an elaboration of the synaptic branching pattern, and a disruption of synaptic function. Antagonizing the ubiquitination pathway in neurons by expression of the yeast deubiquitinating protease UBP2 (ref. 5) also produces synaptic overgrowth and dysfunction. Genetic interactions between fat facets and highwire(6), a negative regulator of synaptic growth that has structural homology to a family of ubiquitin ligases, suggest that synaptic development may be controlled by the balance between positive and negative regulators of ubiquitination.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Washington University (WUSTL); University of California System; University of California Berkeley	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid,Campus Box 8103, St Louis, MO 63110 USA.			DiAntonio, Aaron/0000-0002-7262-0968				[Anonymous], COMPREHENSIVE MENTAL; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; Chen X, 2000, GENETICS, V156, P1829; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SERDAROGLU P, 1992, NEUROPATH APPL NEURO, V18, P232, DOI 10.1111/j.1365-2990.1992.tb00785.x; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; YAO KM, 1994, J NEUROCHEM, V63, P41; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	23	315	325	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					449	452		10.1038/35086595	http://dx.doi.org/10.1038/35086595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473321				2022-12-01	WOS:000170068200051
J	Stevens, RC; Wilson, IA				Stevens, RC; Wilson, IA			Industrializing structural biology	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; PROTEIN-PRODUCTION; TECHNOLOGY; AUTOMATION; RIBOSOME; MODEL; CORE; RNA		Scripps Res Inst, Joint Ctr Struct Genom, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stevens, RC (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, Dept Mol Biol, La Jolla, CA 92037 USA.		Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062411] Funding Source: NIH RePORTER; NIGMS NIH HHS [1P50 GM062411] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abola E, 2000, NAT STRUCT BIOL, V7, P973, DOI 10.1038/80754; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bernal JD, 1934, NATURE, V133, P794, DOI 10.1038/133794b0; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Diller DJ, 1999, ACTA CRYSTALLOGR D, V55, P656, DOI 10.1107/S0907444998014589; Ealick SE, 2000, CURR OPIN CHEM BIOL, V4, P495, DOI 10.1016/S1367-5931(00)00122-8; Edwards AM, 2000, NAT STRUCT BIOL, V7, P970, DOI 10.1038/80751; Georgalis Yannis, 1999, Science Progress, V82, P271; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Lamzin VS, 2000, NAT STRUCT BIOL, V7, P978, DOI 10.1038/80763; Lorber B, 1999, PRACT APPROACH SER, P17; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McPherson A., 1999, CRYSTALLIZATION BIOL; Muchmore SW, 2000, STRUCTURE, V8, pR243, DOI 10.1016/S0969-2126(00)00535-9; Mueller U, 2001, J BIOTECHNOL, V85, P7, DOI 10.1016/S0168-1656(00)00349-7; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ramakrishnan V, 2001, CURR OPIN STRUC BIOL, V11, P144, DOI 10.1016/S0959-440X(00)00184-6; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; ROENTGEN WC, 1895, WURZBURG PHYSICAL ME; Service RF, 2001, SCIENCE, V292, P187; Stevens RC, 2000, CURR OPIN STRUC BIOL, V10, P558, DOI 10.1016/S0959-440X(00)00131-7; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; Sweet RM, 1998, NAT STRUCT BIOL, V5, P654, DOI 10.1038/1344; Thornton JM, 2001, SCIENCE, V292, P2095, DOI 10.1126/science.292.5524.2095; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	31	33	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					519	520		10.1126/science.293.5529.519	http://dx.doi.org/10.1126/science.293.5529.519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463918				2022-12-01	WOS:000169966700053
J	Li, J; Stein, D; McMullan, C; Branton, D; Aziz, MJ; Golovchenko, JA				Li, J; Stein, D; McMullan, C; Branton, D; Aziz, MJ; Golovchenko, JA			Ion-beam sculpting at nanometre length scales	NATURE			English	Article							POLYNUCLEOTIDE MOLECULES; BOMBARDED SI(001); DISCRIMINATION; CHANNEL; SIO2	Manipulating matter at the nanometre scale is important for many electronic, chemical and biological advances(1-3), but present solid-state fabrication methods do not reproducibly achieve dimensional control at the nanometre scale. Here we report a means of fashioning matter at these dimensions that uses low-energy ion beams and reveals surprising atomic transport phenomena that occur in a variety of materials and geometries. The method is implemented in a feedback-controlled sputtering system that provides fine control over ion beam exposure and sample temperature. We call the method "ion-beam sculpting'', and apply it to the problem of fabricating a molecular-scale hole, or nanopore, in a thin insulating solid-state membrane. Such pores can serve to localize molecular-scale electrical junctions and switches(4-6) and function as masks(7) to create other small-scale structures. Nanopores also function as membrane channels in all living systems, where they serve as extremely sensitive electro-mechanical devices that regulate electric potential, ionic flow, and molecular transport across cellular membranes(8). We show that ion-beam sculpting can be used to fashion an analogous solid-state device: a robust electronic detector consisting of a single nanopore in a Si(3)N(4) membrane, capable of registering single DNA molecules in aqueous solution.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	golovchenko@physics.harvard.edu	Aziz, Michael/AAK-4866-2020; Stein, Derek/AAV-4959-2020	Aziz, Michael/0000-0001-9657-9456; Stein, Derek/0000-0001-5917-4986				Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; Brongersma ML, 2000, J APPL PHYS, V88, P59, DOI 10.1063/1.373624; Carter G, 1997, SURF INTERFACE ANAL, V25, P952, DOI 10.1002/(SICI)1096-9918(199711)25:12<952::AID-SIA333>3.0.CO;2-F; Deshmukh MM, 1999, APPL PHYS LETT, V75, P1631, DOI 10.1063/1.124777; Erlebacher J, 1999, PHYS REV LETT, V82, P2330, DOI 10.1103/PhysRevLett.82.2330; Erlebacher J, 2000, J VAC SCI TECHNOL A, V18, P115, DOI 10.1116/1.582127; GNASET H, 1999, ION IRRADIATION SOLI; Gu LQ, 1999, NATURE, V398, P686, DOI 10.1038/19491; HAMMILL OP, 1981, PFLUGERS ARCH, V391, P85; Hille B., 1992, IONIC CHANNELS EXCIT; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; JOHNSON RE, 1993, KONG DANSK VIDENSK, P403; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; MAYER TM, 1994, J APPL PHYS, V76, P1633, DOI 10.1063/1.357748; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; NENADOVIC T, 1990, NUCL INSTRUM METH B, V48, P538, DOI 10.1016/0168-583X(90)90178-W; RAICHOUDHURY P, 1997, HDB MICROLITHOGRAPHY, P41; RALLS KS, 1989, APPL PHYS LETT, V55, P2459, DOI 10.1063/1.102001; RALPH DC, 1995, PHYS REV LETT, V74, P3241, DOI 10.1103/PhysRevLett.74.3241; Reed MA, 1998, ANN NY ACAD SCI, V852, P133, DOI 10.1111/j.1749-6632.1998.tb09868.x; SIGMUND P, 1993, DANSKE VIDENSK SELSK, V43, P7; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; WOLF S, 2000, SILICON PROCESSING V, P149; Zhou C, 1997, APPL PHYS LETT, V71, P611, DOI 10.1063/1.120195	27	1375	1534	29	541	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					166	169		10.1038/35084037	http://dx.doi.org/10.1038/35084037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449268	Green Submitted			2022-12-01	WOS:000169778700046
J	Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK				Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK			Prevalence and predictive value of intermittent viremia with combination HIV therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR THERAPY; TRIPLE-DRUG THERAPY; VIROLOGICAL RESPONSE; VIRAL REPLICATION; INDUCTION THERAPY; GENETIC-VARIATION; PERIPHERAL-BLOOD; IN-VIVO	Context In HIV-infected patients having virologic suppression (plasma HIV RNA <50 copies/mL) with antiretroviral therapy, intermittent episodes of low-level viremia have been correlated with slower decay rates of latently infected cells and increased levels of viral evolution, but the clinical significance of these episodes is unknown. Objective To determine if HIV-infected patients with intermittent viremia have a higher risk of virologic failure (confirmed HIV RNA >200 copies/mL). Design and Setting Retrospective analysis of subjects in well-characterized cohorts, the AIDS Clinical Trials Group (ACTG) 343 trial of induction-maintenance therapy (August 1997 to November 1998) and the Merck 035 trial (ongoing since March 1995). Patients Two hundred forty-one ACTG 343 patients, of whom 101 received triple-drug therapy throughout the study, and a small group of 13 patients from Merck 035 having virologic suppression after 6 months of indinavir-zidovudine-lamivudine. Main Outcome Measures Association of intermittent viremia (plasma HIV RNA >50 copies/mL) with a subsequent measure (50 copies/mL) with virologic failure (2 consecutive plasma HIV RNA measures >200 copies/mL) in both study groups; evidence of drug resistance in 7 patients from the small (n=13) study group with long-term follow-up. Results Intermittent viremia occurred in 96 (40%) of the 241 ACTG 343 patients of whom 32 (13%) had 2 consecutive HIV RNA values >50 copies/mL. during the median 84 weeks of observation (median duration of observation after first intermittent viremia episode was 46 weeks). Of the 101 individuals receiving triple-drug therapy throughout, 29% had intermittent viremia; the proportion of episodes occurring during the maintenance period was 64% for the entire cohort and 68% for the group not receiving triple-drug therapy throughout vs 55% for those who did (P=.25), Intermittent viremia did not predict virologic failure: 10 (10.4%) of 96 patients with and 20 (13.8%) of 145 patients without intermittent viremia had virologic failure (relative risk, 0.76; 95% confidence interval [CI], 0.29-1.72). In a Cox proportional hazards model, the risk for virologic failure was not significantly greater in the ACTG 343 patients with intermittent viremia (hazard ratio, 1.28; 95% CI, 0.59-2.79). Median Viral load in 10 ACTG 343 patients assessed between 24 and 60 weeks of therapy using an ultrasensitive 2.5-copies/mL detection level assay was 23 copies/mL in those with intermittent viremia vs <2.5 copies/mL in those without (P=.15). intermittent viremia occurred in 6 of 13 patients from the small study group assessed after 76 to 260 weeks of therapy (using the 2.5-copies/mL detection level assay) and was associated with a higher steady state of viral replication (P=.03), but not virologic failure over 4.5 years of observation. Viral DNA sequences from 7 patients did not show evolution of drug resistance. Conclusions Intermittent viremia occurred frequently and was associated with higher levels of replication (Merck 035), but was not associated with virologic failure in patients receiving initial combination therapy of indinavir-zidovudine-lamivudine (ACTG 343 and Merck 035). In this population, treatment changes may not be necessary to maintain long-term virologic suppression with low-level or intermittent viremia.	Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; San Diego VA Healthcare Syst, San Diego, CA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Dept Med, Infect Dis Unit, Boston, MA 02115 USA; Washington Univ, Dept Internal Med, St Louis, MO USA; Univ Washington, Sch Med, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; Merck Res Lab, W Point, PA USA; Univ Zurich, Dept Med, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Washington University (WUSTL); University of Washington; University of Washington Seattle; Merck & Company; University of Zurich	Havlir, DV (corresponding author), Univ Calif San Diego, Dept Med, 150 W Washington,Suite 100, San Diego, CA 92103 USA.		Tebas, Pablo/A-7061-2008; gunthard, huldrych f/F-1724-2011	gunthard, huldrych f/0000-0002-1142-6723; Tebas, Pablo/0000-0001-5345-7942	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027670, U01AI038858, R37AI029164, R01AI043752, R01AI029164, P30AI036214, U01AI038855] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29164, AI38858, AI38855, AI43752, AI27670, AI36214] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACOSTA EP, 2000, 7 C RETR OPP INF SAN, P162; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CLAVEL F, 1989, J VIROL, V63, P1455, DOI 10.1128/JVI.63.3.1455-1459.1989; COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Drusano GL, 1998, J INFECT DIS, V178, P360, DOI 10.1086/515631; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Grabar S, 2000, AIDS, V14, P141, DOI 10.1097/00002030-200001280-00009; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 1998, P NATL ACAD SCI USA, V95, P6314, DOI 10.1073/pnas.95.11.6314; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 1999, J VIROL, V73, P9404; Haslett PAJ, 2000, J INFECT DIS, V181, P1264, DOI 10.1086/315381; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; OBRIEN WA, 1995, BLOOD, V86, P1082; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Paris D, 1999, AIDS RES HUM RETROV, V15, P1631, DOI 10.1089/088922299309676; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Pilcher CD, 1999, AIDS, V13, P1337, DOI 10.1097/00002030-199907300-00010; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Raboud JM, 1999, J INFECT DIS, V180, P1347, DOI 10.1086/314998; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; US Department of Health and Human Services, 2001, GUID US ANT AG HIV I; Wit FWNM, 1999, J INFECT DIS, V179, P790, DOI 10.1086/314675; Yerly S, 2000, AIDS, V14, P243, DOI 10.1097/00002030-200002180-00006; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	37	288	289	1	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2001	286	2					171	179		10.1001/jama.286.2.171	http://dx.doi.org/10.1001/jama.286.2.171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451JJ	11448280	Bronze			2022-12-01	WOS:000169798700022
J	Wadman, M				Wadman, M			US blood ban underlines CJD fears	NATURE			English	News Item																		Wadman M, 2001, NATURE, V409, P441, DOI 10.1038/35054193	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					7	7		10.1038/35083730	http://dx.doi.org/10.1038/35083730			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452271	Bronze			2022-12-01	WOS:000169644900010
J	Mochizuki, N; Yamashita, S; Kurokawa, K; Ohba, Y; Nagai, T; Miyawaki, A; Matsuda, M				Mochizuki, N; Yamashita, S; Kurokawa, K; Ohba, Y; Nagai, T; Miyawaki, A; Matsuda, M			Spatio-temporal images of growth-factor-induced activation of Ras and Rap1	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SIGNAL-REGULATED KINASE; DEPENDENT ACTIVATION; MOLECULAR SWITCH; PHOSPHORYLATION; PATHWAYS; GENE; CREB	G proteins of the Ras family function as molecular switches in many signalling cascades(1-3); however, little is known about where they become activated in living cells. Here we use FRET (fluorescent resonance energy transfer)-based sensors to report on the spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Epidermal growth factor activated Ras at the peripheral plasma membrane and Rap1 at the intracellular perinuclear region of COS-1 cells. In PC12 cells, nerve growth factor-induced activation of Ras was initiated at the plasma membrane and transmitted to the whole cell body. After three hours, high Ras activity was observed at the extending neurites. By using the FRAP (fluorescence recovery after photobleaching) technique, we found that Ras at the neurites turned over rapidly; therefore, the sustained Ras activity at neurites was due to high GTP/GDP exchange rate and/or low GTPase activity, but not to the retention of the active Ras. These observations may resolve long-standing questions as to how Ras and Rap1 induce different cellular responses(4) and how the signals for differentiation and survival are distinguished by neuronal cells(5).	Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Suita, Osaka 5658565, Japan; Int Med Ctr Japan, Res Inst, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan; Osaka Univ, Inst Microbial Dis, Dept Tumor Virol, Suita, Osaka 5650871, Japan; RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan	National Cerebral & Cardiovascular Center - Japan; National Center for Global Health & Medicine - Japan; Osaka University; RIKEN	Matsuda, M (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.		Kurokawa, Kazuo/E-9130-2013; Miyawaki, Atsushi/K-3569-2014; Ohba, Yusuke/E-7944-2011	Kurokawa, Kazuo/0000-0003-3549-4795; Miyawaki, Atsushi/0000-0002-2329-3235; Nagai, Takeharu/0000-0003-2650-9895; Matsuda, Michiyuki/0000-0002-5876-9969				BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; HOSHINO M, 1988, MOL CELL BIOL, V8, P4169, DOI 10.1128/MCB.8.10.4169; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Lippincott-Schwartz J, 1999, METHOD CELL BIOL, V58, P261; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SATOH T, 1992, J BIOL CHEM, V267, P24149; SCHELL DL, 1994, J SOC GYNECOL INVEST, V1, P269, DOI 10.1177/107155769400100405; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	25	473	494	1	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2001	411	6841					1065	1068		10.1038/35082594	http://dx.doi.org/10.1038/35082594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446TF	11429608				2022-12-01	WOS:000169528500051
J	Watkins, RE; Wisely, GB; Moore, LB; Collins, JL; Lambert, MH; Williams, SP; Willson, TM; Kliewer, SA; Redinbo, MR				Watkins, RE; Wisely, GB; Moore, LB; Collins, JL; Lambert, MH; Williams, SP; Willson, TM; Kliewer, SA; Redinbo, MR			The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity	SCIENCE			English	Article							PREGNANE-X-RECEPTOR; LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; JOHNS-WORT; SIGNALING PATHWAY; MOLECULAR-BASIS; CHOLESTEROL; COACTIVATOR; ANTAGONISM; ACTIVATION	The human nuclear pregnane X receptor (hPXR) activates cytochrome P450-3A expression in response to a wide variety of xenobiotics and plays a critical role in mediating dangerous drug-drug interactions. We present the crystal structures of the ligand-binding domain of hPXR both alone and in complex with the cholesterol-lowering drug SR12813 at resolutions of 2.5 and 2.75 angstroms, respectively. The hydrophobic ligand-binding cavity of hPXR contains a small number of polar residues, permitting SR12813 to bind in three distinct orientations. The position and nature of these polar residues were found to be critical for establishing the precise pharmacologic activation profile of PXR. Our findings provide important insights into how hPXR detects xenobiotics and may prove useful in predicting and avoiding drug-drug interactions.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.		feinstein, doug/M-9414-2019	Williams, Shawn/0000-0001-8311-2638				Berkhout TA, 1996, J BIOL CHEM, V271, P14376, DOI 10.1074/jbc.271.24.14376; Berkhout TA, 1997, ATHEROSCLEROSIS, V133, P203, DOI 10.1016/S0021-9150(97)00131-7; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; MAUREL P, 1996, CYTOCHROMES P450 MET, P241; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; ONATE SA, 1995, SCIENCE, V270, P1354; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7; Savas U, 2000, DRUG METAB DISPOS, V28, P529; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Wentworth JM, 2000, J ENDOCRINOL, V166, pR11, DOI 10.1677/joe.0.166R011; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116	35	634	660	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2329	2333		10.1126/science.1060762	http://dx.doi.org/10.1126/science.1060762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11408620				2022-12-01	WOS:000169455900058
J	Chuang, HH; Prescott, ED; Kong, HY; Shields, S; Jordt, SE; Basbaum, AI; Chao, MV; Julius, D				Chuang, HH; Prescott, ED; Kong, HY; Shields, S; Jordt, SE; Basbaum, AI; Chao, MV; Julius, D			Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P-2-mediated inhibition	NATURE			English	Article							SENSORY NEURONS; SIGNALING COMPLEX; DIRECT ACTIVATION; MICE LACKING; PAIN; HYPERALGESIA; CHANNELS; PHOTOTRANSDUCTION; SENSITIZATION; RESPONSES	Tissue injury generates endogenous factors that heighten our sense of pain by increasing the response of sensory nerve endings to noxious stimuli(1,2). Bradykinin and nerve growth factor (NGF) are two such pro-algesic agents that activate G-protein-coupled (BK2) and tyrosine kinase (TrkA) receptors, respectively, to stimulate phospholipase C (PLC) signalling pathways in primary afferent neurons(3,4). How these actions produce sensitization to physical or chemical stimuli has not been elucidated at the molecular level. Here, we show that bradykinin- or NGF-mediated potentiation of thermal sensitivity in vivo requires expression of VR1, a heat-activated ion channel on sensory neurons. Diminution of plasma membrane phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2) levels through antibody sequestration or PLC-mediated hydrolysis mimics the potentiating effects of bradykinin or NGF at the cellular level. Moreover, recruitment of PLC-gamma to TrkA is essential for NGF-mediated potentiation of channel activity, and biochemical studies suggest that VR1 associates with this complex. These studies delineate a biochemical mechanism through which bradykinin and NGF produce hypersensitivity and might explain how the activation of PLC signalling systems regulates other members of the TRP channel family.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; NYU, Sch Med, Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY 10016 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@socrates.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Shields, Shannon/0000-0002-8006-7103; Chao, Moses/0000-0002-6969-3744				Bergmann I, 1998, NEUROSCI LETT, V255, P87, DOI 10.1016/S0304-3940(98)00713-7; Bevan S., 1999, TXB PAIN, P85; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Koltzenburg M, 1999, PAIN, pS93, DOI 10.1016/S0304-3959(99)00142-6; Koltzenburg M, 1999, EUR J NEUROSCI, V11, P1698, DOI 10.1046/j.1460-9568.1999.00590.x; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MCMAHON SB, 1999, TXB PAIN, P105; Nicholas RS, 1999, NEUROSCIENCE, V91, P1425, DOI 10.1016/S0306-4522(98)00706-4; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Womack KB, 2000, J NEUROSCI, V20, P2792; Woolf CJ, 1996, PHILOS T ROY SOC B, V351, P441, DOI 10.1098/rstb.1996.0040; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; ZHANG Z, 1983, CHINESE ANN MATH B, V4, P1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	30	943	1005	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2001	411	6840					957	962		10.1038/35082088	http://dx.doi.org/10.1038/35082088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444EN	11418861				2022-12-01	WOS:000169386200047
J	Joshipura, KJ; Hu, FB; Manson, JE; Stampfer, MJ; Rimm, EB; Speizer, FE; Colditz, G; Ascherio, A; Rosner, B; Spiegelman, D; Willett, WC				Joshipura, KJ; Hu, FB; Manson, JE; Stampfer, MJ; Rimm, EB; Speizer, FE; Colditz, G; Ascherio, A; Rosner, B; Spiegelman, D; Willett, WC			The effect of fruit and vegetable intake on risk for coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; VITAMIN-E CONSUMPTION; DIETARY PATTERNS; CLINICAL-TRIAL; MEN; MORTALITY; WOMEN; STROKE; HEALTH; FIBER	Background: Many constituents of fruits and vegetables may reduce the risk for coronary heart disease, but data on the relationship between fruit and vegetable consumption and risk for coronary heart disease are sparse. Objective: To evaluate the association of fruit and vegetable consumption with risk for coronary heart disease. Design: Prospective cohort study. Setting: The Nurses' Health Study and the Health Professionals' Follow-Up Study. Participants: 84 251 women 34 to 59 years of age who were followed for 14 years and 42 148 men 40 to 75 years who were followed for 8 years. All were free of diagnosed cardiovascular disease, cancer, and diabetes at baseline. Measurements: The main outcome measure was incidence of nonfatal myocardial infarction or fatal coronary heart disease (1127 cases in women and 1063 cases in men). Diet was assessed by using food-frequency questionnaires. Results: After adjustment for standard cardiovascular risk factors, persons in the highest quintile of fruit and vegetable intake had a relative risk for coronary heart disease of 0.80 (95% CI, 0.69 to 0.93) compared with those in the lowest quintile of intake. Each 1-serving/d increase in intake of fruits or vegetables was associated with a 4% lower risk for coronary heart disease (relative risk, 0.96 [CI, 0.94 to 0.99]; P = 0.01, test for trend). Green leafy vegetables (relative risk with 1-serving/d increase, 0.77 [CI, 0.64 to 0.93]), and vitamin C-rich fruits and vegetables (relative risk with 1-serving/d increase, 0.94 [CI, 0.88 to 0.99]) contributed most to the apparent protective effect of total fruit and vegetable intake. Conclusions: Consumption of fruits and vegetables, particularly green leafy vegetables and vitamin C-rich fruits and vegetables, appears to have a protective effect against coronary heart disease.	Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Joshipura, KJ (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, 188 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009; Joshipura, Kaumudi J/AAA-3852-2020; Hu, Frank/C-1919-2013	Colditz, Graham/0000-0002-7307-0291; Joshipura, Kaumudi/0000-0003-1964-7579	NCI NIH HHS [CA40356, CA55075] Funding Source: Medline; NHLBI NIH HHS [HL34595, HL35464] Funding Source: Medline; NIDCR NIH HHS [DE12102] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595, R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; CAAN B, 1991, EPIDEMIOLOGY, V2, P430, DOI 10.1097/00001648-199111000-00007; Chatellier G, 1996, BRIT MED J, V312, P426; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; GILLMAN MW, 1995, JAMA-J AM MED ASSOC, V273, P1113, DOI 10.1001/jama.273.14.1113; Hirayama T, 1986, Prog Clin Biol Res, V206, P299; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KHAW KT, 1987, AM J EPIDEMIOL, V126, P1093, DOI 10.1093/oxfordjournals.aje.a114748; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; KNEKT P, 1994, AM J EPIDEMIOL, V139, P1180, DOI 10.1093/oxfordjournals.aje.a116964; Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; Miller ER, 1998, CIRCULATION, V98, P2390, DOI 10.1161/01.CIR.98.22.2390; MORRIS JN, 1977, BMJ-BRIT MED J, V2, P1307, DOI 10.1136/bmj.2.6098.1307; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rose GA., 1982, WHO MONOGRAPH SERIES, V58; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STEINMETZ KA, 1993, CANCER RES, V53, P536; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd	34	979	1025	0	128	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2001	134	12					1106	1114		10.7326/0003-4819-134-12-200106190-00010	http://dx.doi.org/10.7326/0003-4819-134-12-200106190-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442YU	11412050	Green Published			2022-12-01	WOS:000169313200003
J	Kalir, S; McClure, J; Pabbaraju, K; Southward, C; Ronen, M; Leibler, S; Surette, MG; Alon, U				Kalir, S; McClure, J; Pabbaraju, K; Southward, C; Ronen, M; Leibler, S; Surette, MG; Alon, U			Ordering genes in a flagella pathway by analysis of expression kinetics from living bacteria	SCIENCE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SALMONELLA-TYPHIMURIUM; MUTANTS; REGULON; UNITS	The recent advances in large-scale monitoring of gene expression raise the challenge of mapping systems on the basis of kinetic expression data in living cells. To address this, we measured promoter activity in the flagellar system of Escherichia coli at high accuracy and temporal resolution by means of reporter plasmids. The genes in the pathway were ordered by analysis algorithms without dependence on mutant strains. The observed temporal program of transcription was much more detailed than was previously thought and was associated with multiple steps of flagella assembly.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Calgary; Howard Hughes Medical Institute; Princeton University; Princeton University	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Surette, Michael G/AAE-8825-2020; Rosa, Bruce/F-6393-2010	McClure, JoAnn/0000-0003-4165-744X				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dimster-Denk D, 1999, J LIPID RES, V40, P850; Duda R.O., 1973, PATTERN CLASSIFICATI, VXVII, P482; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; KOMEDA Y, 1980, GENETICS, V94, P277; KOMEDA Y, 1982, J BACTERIOL, V150, P16, DOI 10.1128/JB.150.1.16-26.1982; KOMEDA Y, 1986, J BACTERIOL, V168, P1315, DOI 10.1128/jb.168.3.1315-1318.1986; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Pruss BM, 1997, J BACTERIOL, V179, P5602; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Zhao RB, 2000, GENE DEV, V14, P981	27	270	276	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2080	2083		10.1126/science.1058758	http://dx.doi.org/10.1126/science.1058758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11408658				2022-12-01	WOS:000169284700049
J	Staessen, JA; Nawrot, T; Den Hond, E; Thijs, L; Fagard, R; Hoppenbrouwers, K; Koppen, G; Nelen, V; Schoeters, G; Vanderschueren, D; Van Hecke, E; Verschaeve, L; Vlietinck, R; Roels, HA				Staessen, JA; Nawrot, T; Den Hond, E; Thijs, L; Fagard, R; Hoppenbrouwers, K; Koppen, G; Nelen, V; Schoeters, G; Vanderschueren, D; Van Hecke, E; Verschaeve, L; Vlietinck, R; Roels, HA		Environm Hlth Study Grp	Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers	LANCET			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; GENERAL-POPULATION; PUBERTAL CHANGES; TOBACCO-SMOKE; LEAD SMELTER; EXPOSURE; HEALTH; CHILDREN; DIOXIN; PCBS	Background Human exposure to chemicals is normally monitored by measurement of environmental pollutants in external media. We investigated whether biomarkers in adolescents can show exposure to, and health effects of, common environmental pollutants. Methods We recruited 200 17-year-old adolescents (120 girls) from a rural control area and from two suburbs polluted by a lead smelter and two waste incinerators. We measured biomarkers of exposure and of effect in blood and urine samples, and obtained questionnaire data. School doctors measured testicular volume and staged sexual maturation. Findings Internal exposure was mostly within current standards, Concentrations of lead and cadmium in blood, PCBs (polychlorinated biphenyls) and dioxin-like compounds In serum samples, and metabolites of VOCs (volatile organic compounds) in urine were higher in one or both suburbs than in the control area, Children who lived near the waste incinerators matured sexually at an older age than others, and testicular volume was smaller in boys from the suburbs than in controls. Biomarkers of glomerular or tubular renal dysfunction in individuals were positively correlated with blood lead. Biomarkers of DNA damage were positively correlated with urinary metabolites of PAHs (polycyclic aromatic hydrocarbons) and VOCs, Interpretation Biomarkers can be used to detect environmental exposure to pollutants and measure their biological effects before overt disease develops. Our findings suggest that current environmental standards are insufficient to avoid measurable biological effects.	Katholieke Univ Leuven, Studiecoordinatiectr Hypertensie & Cardiovasc Rev, Dept Mol & Cardiovasc Onderzoek, Louvain, Belgium; Katholieke Univ Leuven, Dienst Jeugdgezondheidszorg, Dept Maatschappelijke Gezondheidszorg, Louvain, Belgium; Katholieke Univ Leuven, Afdeling Expt Geneeskunde, Dept Ontwikkelingsbiol, Louvain, Belgium; Katholieke Univ Leuven, Inst Sociale & Econ Geog, Louvain, Belgium; Katholieke Univ Leuven, Afdeling Genet Epidemiol, Ctr Menselijke Erfelijkheid, Dept Med Celbiol, Louvain, Belgium; Vlaamse Instelling Technol Onderzoek, Afdeling Leefmillieu, Onderzoekseenheid Milieutoxicol, Mol, Belgium; Prov Inst Hyg, Antwerp, Belgium; Catholic Univ Louvain, Unite Toxicol Ind & Med Travail, B-1200 Brussels, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; VITO; Universite Catholique Louvain	Staessen, JA (corresponding author), Studiecoordinatiectr, Lab Hypertensie, Campus Gasthuisberg,Gebouw Onderwijs Navorsing,He, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.ac.be	Nawrot, Tim/AAA-4531-2019; Koppen, Gudrun/Q-4011-2018; Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356; Schoeters, Greta/0000-0002-6556-4814; vanderschueren, dirk/0000-0003-1395-0104; Nawrot, Tim/0000-0002-3583-3593				ABDULLA M, 1990, BIOL TRACE ELEM RES, V23, P25, DOI 10.1007/BF02917176; AELVOET W, 1997, GEZONDHEIDSINDICATOR, P130; AERTS JMM, 1996, ORGANOHALOGEN COMP, V27, P285; [Anonymous], [No title captured]; Arai T, 1998, INT J FERTIL WOMEN M, V43, P40; Bernard A, 1999, NATURE, V401, P231, DOI 10.1038/45717; BERNARD AM, 1995, ENVIRON RES, V68, P91, DOI 10.1006/enrs.1995.1012; Bertazzi PA, 1998, ENVIRON HEALTH PERSP, V106, P625, DOI 10.2307/3433813; Bokenkamp A, 1998, PEDIATRICS, V101, P875, DOI 10.1542/peds.101.5.875; BREEDVELD BC, 1996, NEDERLANDSE VOEDINGS; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; BROUWER A, 1995, EUR J PHARM-ENVIRON, V293, P1; BUCHET JP, 1990, LANCET, V336, P699, DOI 10.1016/0140-6736(90)92201-R; CLAEYS F, 1992, CADMIUM HUMAN ENV TO, P83; Clapp R, 2000, LANCET, V355, P1838, DOI 10.1016/S0140-6736(00)02280-7; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; DORNBERGER V, 1987, ANDROLOGIA, V19, P487; Duarte-Davidson R, 2001, OCCUP ENVIRON MED, V58, P2, DOI 10.1136/oem.58.1.2; Elinder CG., 1985, CADMIUM HLTH TOXICOL, P23; Faustman EM, 2000, ENVIRON HEALTH PERSP, V108, P13, DOI 10.2307/3454629; FLOYD RA, 1990, CARCINOGENESIS, V11, P1147; Golub MS, 2000, ENVIRON HEALTH PERSP, V108, P355, DOI 10.2307/3454355; Hagmar L, 1998, CANCER RES, V58, P4117; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Hotz P, 1997, INT ARCH OCC ENV HEA, V70, P29, DOI 10.1007/s004200050183; KIMBROUGH RD, 1995, CRIT REV TOXICOL, V25, P133, DOI 10.3109/10408449509021611; KOOPMANESSEBOOM C, 1994, CHEMOSPHERE, V28, P1721, DOI 10.1016/0045-6535(94)90428-6; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Pauwels A, 2000, ENVIRON HEALTH PERSP, V108, P553, DOI 10.1289/ehp.00108553; Persons DL, 1998, CANCER GENET CYTOGEN, V106, P11, DOI 10.1016/S0165-4608(98)00036-3; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Pierce CH, 1998, INT ARCH OCC ENV HEA, V71, P433, DOI 10.1007/s004200050303; ROELS HA, 1980, ENVIRON RES, V22, P81, DOI 10.1016/0013-9351(80)90121-8; ROELS HA, 1978, ENVIRON RES, V15, P290, DOI 10.1016/0013-9351(78)90105-6; SCHOETERS G, 1998, 1998TOXR0097 DEP GEZ; SCHWARTZ GG, 1990, BIOL MARKERS EPIDEMI, P147; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Siegel S., 1988, NONPARAMETRIC STAT B, P284; Staessen J A, 1996, J Cardiovasc Risk, V3, P26, DOI 10.1097/00043798-199602000-00005; STAESSEN JA, 1994, AM J HYPERTENS, V7, P685, DOI 10.1093/ajh/7.8.685; STAESSEN JA, 1992, NEW ENGL J MED, V327, P151, DOI 10.1056/NEJM199207163270303; Tagesson C, 1993, Pol J Occup Med Environ Health, V6, P357; Timbrell J.A., 1996, BIOMARKERS, V1, P1; van Zeeland AA, 1999, MUTAT RES-GEN TOX EN, V439, P249, DOI 10.1016/S1383-5718(98)00192-2; VanGoethem F, 1997, MUTAT RES-GEN TOX EN, V392, P31, DOI 10.1016/S0165-1218(97)00043-8; VANHUMMELEN P, 1993, MUTAT RES, V300, P231, DOI 10.1016/0165-1218(93)90055-I; VANROOIJ JGM, 1994, INT ARCH OCC ENV HEA, V66, P55, DOI 10.1007/BF00386580; *VLAAMS MIL, 2000, STAT NIEUWS MEETR DI; *WOLT ATL PROD, 1997, WOLT KLEIN WER, P1	53	168	171	3	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2001	357	9269					1660	1669		10.1016/S0140-6736(00)04822-4	http://dx.doi.org/10.1016/S0140-6736(00)04822-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UY	11425371				2022-12-01	WOS:000168901600012
J	Amidzic, O; Riehle, HJ; Fehr, T; Wienbruch, C; Elbert, T				Amidzic, O; Riehle, HJ; Fehr, T; Wienbruch, C; Elbert, T			Pattern of focal gamma-bursts in chess players - Grandmasters call on regions of the brain not used so much by less skilled amateurs.	NATURE			English	Article							MEMORY		Univ Konstanz, D-78457 Constance, Germany	University of Konstanz	Amidzic, O (corresponding author), Univ Konstanz, Univ Str 10,Fac D30, D-78457 Constance, Germany.		Fehr, Thorsten/P-5058-2018; Elbert, Thomas/C-8556-2009	Fehr, Thorsten/0000-0002-2224-1740; Elbert, Thomas/0000-0003-1332-4939				Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Elo Arpad E, 1978, RATING CHESSPLAYERS; Gobet F, 1998, COGNITION, V66, P115, DOI 10.1016/S0010-0277(98)00020-1; Pulvermuller F, 1999, TRENDS COGN SCI, V3, P250, DOI 10.1016/S1364-6613(99)01344-3; Singer W, 1997, TRENDS COGN SCI, V1, P252, DOI 10.1016/S1364-6613(97)01079-6; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195	6	55	57	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					603	603		10.1038/35088119	http://dx.doi.org/10.1038/35088119			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	460PP	11493907	Green Published			2022-12-01	WOS:000170318000027
J	Ridker, PM; Danesh, J; Youngman, L; Collins, R; Stampfer, MJ; Peto, R; Hennekens, CH				Ridker, PM; Danesh, J; Youngman, L; Collins, R; Stampfer, MJ; Peto, R; Hennekens, CH			A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar US men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CHLAMYDIA-PNEUMONIAE; CARDIOVASCULAR RISK; INFECTION; INFLAMMATION; MORTALITY	Background: The role of Helicobacter pylori as a determinant of cardiovascular disease is controversial. Objective: To determine whether previous exposure to H. pylori is associated with an increased risk for myocardial infarction. Design: Prospective case-control study. Setting: Physicians' Health Study. Participants: Initially healthy U.S. men. Measurements: Titers of IgG antibody against H. pylori and several inflammatory markers were measured in baseline blood samples obtained from 445 men who subsequently had a myocardial infarction (case-patients) and 445 men matched for age and smoking status who remained free of vascular disease (controls) during a mean follow-up of 8.9 years. Results: Baseline seropositivity was similar among case-patients and controls (43.4% vs. 44.3%; rate ratio, 0.96 [95% Cl, 0.7 to 1.3]). Minimal evidence of association was found between magnitude of seropositivity and subsequent risk and between seropositivity and levels of the inflammatory biomarkers. Conclusion: in a socioeconomically homogeneous population, we found limited evidence of association between H. pylori exposure and risk for future myocardial infarction.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Leducq Ctr Mol & Genet Epidemiol Cardiovasc Dis, Ctr Cardiovasc Dis Prevent, Boston, MA USA; Univ Miami, Miami, FL 33152 USA; Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Miami; Radcliffe Infirmary; University of Oxford	Ridker, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org			NHLBI NIH HHS [HL58755] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aromaa A., 1996, Gut, V39, pA91; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Folsom AR, 1998, CIRCULATION, V98, P845, DOI 10.1161/01.CIR.98.9.845; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MURRAY LJ, 1995, BRIT HEART J, V74, P497; Ossewaarde JM, 1998, EPIDEMIOL INFECT, V120, P93, DOI 10.1017/S0950268897008303; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Ridker PM, 1999, ANN INTERN MED, V131, P573, DOI 10.7326/0003-4819-131-8-199910190-00004; Ridker PM, 1998, CIRCULATION, V97, P1671, DOI 10.1161/01.CIR.97.17.1671; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 1999, AM J MED, V106, P376; Strachan DP, 1998, CIRCULATION, V98, P1286, DOI 10.1161/01.CIR.98.13.1286; Strandberg TE, 1997, BRIT MED J, V314, P1317, DOI 10.1136/bmj.314.7090.1317; Wald NJ, 1997, BMJ-BRIT MED J, V315, P1199, DOI 10.1136/bmj.315.7117.1199; Whincup P, 2000, CIRCULATION, V101, P1647; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568; Witherell H, 1999, GASTROENTEROLOGY, V116, pA355	20	60	62	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					184	188		10.7326/0003-4819-135-3-200108070-00010	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487485				2022-12-01	WOS:000170298500004
J	Evans, J; Heron, J; Francomb, H; Oke, S; Golding, O				Evans, J; Heron, J; Francomb, H; Oke, S; Golding, O		Avon Longitudinal Study Parents	Cohort study of depressed mood during pregnancy and after childbirth	BRITISH MEDICAL JOURNAL			English	Article							POSTNATAL DEPRESSION; PSYCHIATRIC-DISORDER; ASSOCIATION; PREVALENCE; WOMEN	Objective To follow mothers' mood through pregnancy and after childbirth and compare reported symptoms of depression at each stage. Design Longitudinal cohort study. Setting Avon. Participants Pregnant women resident within Avon with an expected date of delivery between 1 April 1991 and 31 December 1992. Main outcome measures Symptom scores from the Edinburgh postnatal depression scale at 18 and 32 weeks of pregnancy and 8 weeks and 8 months postpartum. Proportion of women above a threshold indicating probable depressive disorder. Results Depression scores were higher at 32 weeks of pregnancy than 8 weeks postpartum (difference in means 0.88, 95% confidence interval 0.79 to 0.97). There was no difference in the distribution of total scores or scores for individual items at the four time points. 1222 (13.5%) women scored above threshold for probable depression at 32 weeks of pregnancy, 821 (9.1%) at 8 weeks postpartum, and 147 (1.6%) throughout. More mothers moved above the threshold for depression between 18 weeks and 32 weeks of pregnancy than between 32 weeks of pregnancy and 8 weeks postpartum. Conclusions Symptoms of depression are not more common or severe after childbirth than during pregnancy. Research and clinical efforts need to be moved towards understanding, recognising, and treating antenatal depression.	Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Div Child Hlth, Bristol BS8 1TQ, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Dept Womens Hlth & Care Newborn, Bristol BS10 5NB, Avon, England; Barrow Hosp, Mother & Baby Unit, Bristol BS48 3SG, Avon, England	University of Bristol; University of Bristol; North Bristol NHS Trust; Southmead Hospital	Evans, J (corresponding author), Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England.		Heron, Jon/D-5884-2011	Heron, Jon/0000-0001-6199-5644; Evans, Jonathan/0000-0003-3171-640X; Golding, Jean/0000-0003-2826-3307	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; COOPER PJ, 1988, BRIT J PSYCHIAT, V152, P799, DOI 10.1192/bjp.152.6.799; COX JL, 1982, BRIT J PSYCHIAT, V140, P111, DOI 10.1192/bjp.140.2.111; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crown S, 1979, MANUAL CROWN CRISP E; Fergusson DM, 1996, PAEDIATR PERINAT EP, V10, P279, DOI 10.1111/j.1365-3016.1996.tb00051.x; GREEN JM, 1991, BRIT J PSYCHIAT, V158, P865, DOI 10.1192/bjp.158.6.865a; GREEN JM, 1990, J REPROD INFANT PSYC, V0008; HARRIS B, 1992, BMJ-BRIT MED J, V305, P152, DOI 10.1136/bmj.305.6846.152; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; KENDELL RE, 1976, PSYCHOL MED, V6, P297, DOI 10.1017/S0033291700013854; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; OHARA MW, 1984, J ABNORM PSYCHOL, V93, P158, DOI 10.1037/0021-843X.93.2.158; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; PAGEL MD, 1990, SOC SCI MED, V30, P597, DOI 10.1016/0277-9536(90)90158-O; PITT B, 1968, BRIT J PSYCHIAT, V114, P1325, DOI 10.1192/bjp.114.516.1325; Sinclair D, 1998, BRIT J PSYCHIAT, V172, P58, DOI 10.1192/bjp.172.1.58; Spinelli MG, 1997, AM J PSYCHIAT, V154, P1028; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; Thorpe K., 1993, J REPROD INFANT PSYC, V11, P119, DOI [10.1080/02646839308403204, DOI 10.1080/02646839308403204]; WATSON JP, 1984, BRIT J PSYCHIAT, V144, P453, DOI 10.1192/bjp.144.5.453	24	866	886	0	70	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					257	260		10.1136/bmj.323.7307.257	http://dx.doi.org/10.1136/bmj.323.7307.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461ZT	11485953	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000170394300017
J	Mustard, JF; Cooper, CD; Rifkin, MK				Mustard, JF; Cooper, CD; Rifkin, MK			Evidence for recent climate change on Mars from the identification of youthful near-surface ground ice	NATURE			English	Article							GLOBAL SURVEYOR; ORBITER CAMERA; WATER; BEHAVIOR; MODEL; VIEWS	Ground ice in the crust and soil may be one of the largest reservoirs of water on Mars(1-3). Near-surface ground ice is predicted to be stable at latitudes higher than 40 degrees (ref. 4), where a number of geomorphologic features indicative of viscous creep and hence ground ice have been observed(5). Mid-latitude soils have also been implicated as a water-ice reservoir(6), the capacity of which is predicted to vary on a 100,000-year timescale owing to orbitally driven variations in climate(7). It is uncertain, however, whether near-surface ground ice currently exists at these latitudes, and how it is changing with time. Here we report observational evidence for a mid-latitude reservoir of near-surface water ice occupying the pore space of soils. The thickness of the ice-occupied soil reservoir (1-10 m) and its distribution in the 30 degrees to 60 degrees latitude bands indicate a reservoir of (1.5-6.0) x 10(4) km(3), equivalent to a global layer of water 10-40 cm thick. We infer that the reservoir was created during the last phase of high orbital obliquity less than 100,000 years ago, and is now being diminished.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Mustard, JF (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.							Carr M.H, 1996, WATER MARS; Christensen P., 1992, MARS SPACE SCI SERIE, P686; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; COOPER CD, 2000, LUNAR PLANET SCI, V31, P1747; Edgett KS, 2000, J GEOPHYS RES-PLANET, V105, P1623, DOI 10.1029/1999JE001152; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Haberle RM, 1997, J GEOPHYS RES-PLANET, V102, P9051, DOI 10.1029/97JE00383; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; Houben H, 1997, J GEOPHYS RES-PLANET, V102, P9069, DOI 10.1029/97JE00046; Johnson JB, 2000, GEOPHYS RES LETT, V27, P2769, DOI 10.1029/1999GL011077; Kreslavsky MA, 2000, J GEOPHYS RES-PLANET, V105, P26695, DOI 10.1029/2000JE001259; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Metzger SM, 1999, GEOPHYS RES LETT, V26, P2781, DOI 10.1029/1999GL008341; MUSTARD JF, 2001, LUNAR PLANET SCI, V32, P1988; Renno NO, 2000, J GEOPHYS RES-PLANET, V105, P1859, DOI 10.1029/1999JE001037; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; SQURYES SW, 1986, SCIENCE, V231, P249; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; STORRS AD, 1988, ICARUS, V76, P493, DOI 10.1016/0019-1035(88)90017-6	20	424	428	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					411	414		10.1038/35086515	http://dx.doi.org/10.1038/35086515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473309				2022-12-01	WOS:000170068200039
J	Folkers, GK; Fauci, AS				Folkers, GK; Fauci, AS			The AIDS research model - Implications for other infectious diseases of global health importance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHALLENGES; PREVENTION; HIV/AIDS		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Bldg 31,Room 7A03,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	afauci@nih.gov						[Anonymous], WHO REP INF DIS REM; [Anonymous], 2001, NIAID GLOB HLTH RES; Auerbach JD, 2000, AM J PUBLIC HEALTH, V90, P1029, DOI 10.2105/AJPH.90.7.1029; Binswanger HP, 2001, SCIENCE, V292, P221, DOI 10.1126/science.1057504; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P250; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; Fauci AS, 1998, EMERG INFECT DIS, V4, P374, DOI 10.3201/eid0403.980308; GALLO RC, 1987, NATURE, V326, P435; Gellman Barton, 2000, WASH POST, pA01; GREENE WC, 1991, NEW ENGL J MED, V324, P308, DOI 10.1056/NEJM199101313240506; *I GLOB HLTH, 2000, GLOB HLTH FOR, V1; Institute of Medicine, 1997, AM VIT INT GLOB HLTH; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWRENCE C, 2001, HLTH FUNDING UPDATE; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; National Intelligence Council, 2000, GLOB INF DIS THREAT; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SELIK RM, 1993, TRANSFUSION, V33, P890, DOI 10.1046/j.1537-2995.1993.331194082377.x; Shorter E, 1987, HLTH CENTURY; *UN GEN ASS SPEC S, 2001, GLOB CRIS GLOB ACT; *UNAIDS, 2000, REP GLOB HIV AIDS EP; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WACHTER RM, 1992, NEW ENGL J MED, V326, P128, DOI 10.1056/NEJM199201093260209; World Health Organization, 2000, WORLD HLTH REP 2000; 1998, MMWR MORB MORTAL WKL, V47, P43; 2000, HIV AIDS SURVEILLANC, V12, P1	28	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					458	461		10.1001/jama.286.4.458	http://dx.doi.org/10.1001/jama.286.4.458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466126				2022-12-01	WOS:000170069000019
J	Saitoe, M; Schwarz, TL; Umbach, JA; Gundersen, CB; Kidokoro, Y				Saitoe, M; Schwarz, TL; Umbach, JA; Gundersen, CB; Kidokoro, Y			Absence of junctional glutamate receptor clusters in Drosophila mutants lacking spontaneous transmitter release	SCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; NEURONAL-SYNAPTOBREVIN; EMBRYOS; SYNAPSE; NEUROTRANSMITTER; MELANOGASTER; MUTATIONS; SYNTAXIN; LARVAE; CSP	Little is known about the functional significance of spontaneous miniature synaptic potentials, which are the result of vesicular exocytosis at nerve terminals. Here, by using Drosophila mutants with specific defects in presynaptic function, we found that glutamate receptors clustered normally at neuromuscular junctions of mutants that retained spontaneous transmitter secretion but had Lost the ability to release transmitter in response to action potential. In contrast, receptor clustering was defective in mutants in which both spontaneous and evoked vesicle exocytosis were absent. Thus, spontaneous vesicle exocytosis appears to be tightly Linked to the clustering of glutamate receptors during development.	Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan; Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; Stanford Univ, Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Gunma University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saitoe, M (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan.			Gundersen, Cameron/0000-0002-1552-6086; Saitoe, Minoru/0000-0001-9731-4214				ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; MCMAHAN UJ, 1990, COLD SH Q B, V55, P407; MORR J, COMMUNICATION; Nishikawa K, 1995, J NEUROSCI, V15, P7905; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; PESTRONK A, 1976, NATURE, V264, P787, DOI 10.1038/264787a0; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schulze KL, 1996, GENETICS, V144, P1713; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Yoshihara M, 1999, J NEUROSCI, V19, P2432	25	92	94	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					514	517		10.1126/science.1061270	http://dx.doi.org/10.1126/science.1061270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463917				2022-12-01	WOS:000169966700052
J	Turk, D; McPhaden, MJ; Busalacchi, AJ; Lewis, MR				Turk, D; McPhaden, MJ; Busalacchi, AJ; Lewis, MR			Remotely sensed biological production in the equatorial Pacific	SCIENCE			English	Article							1997-98 EL-NINO; ATMOSPHERIC CO2; OCEAN; CARBON; EXPORT; MODEL; CYCLE	A combination of ship, buoy, and satellite observations in the tropical Pacific during the period from 1992 to 2000 provides a basin-scale perspective on the net effects of El Nino and La Nina on biogeochemical cycles. New biological production during the 1997-99 El Nino/La Nina period varied by more than a factor of 2, The resulting interannual changes in global carbon sequestration associated with the El Nino/La Nina cycle contributed to the Largest known natural perturbation of the global carbon cycle over these time scales.	Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA	Dalhousie University; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park	Turk, D (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada.		McPhaden, Michael J/D-9799-2016	McPhaden, Michael J/0000-0002-8423-5805				BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; BARBER RT, 1989, GLOBAL ECOLOGICAL CO, P21; BATTISTI DS, 1988, J ATMOS SCI, V45, P2889, DOI 10.1175/1520-0469(1988)045<2889:DATOAW>2.0.CO;2; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; CHAVEZ FP, 1987, DEEP-SEA RES, V34, P1229, DOI 10.1016/0198-0149(87)90073-2; Cullen JJ, 1995, LIMNOL OCEANOGR, V40, P1336, DOI 10.4319/lo.1995.40.7.1336; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; Hackert EC, 2001, J GEOPHYS RES-OCEANS, V106, P2345, DOI 10.1029/1999JC000055; Leonard CL, 1996, INT J REMOTE SENS, V17, P721, DOI 10.1080/01431169608949040; McCarthy JJ, 1996, DEEP-SEA RES PT II, V43, P1065, DOI 10.1016/0967-0645(96)00022-7; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Meinen CS, 2001, J PHYS OCEANOGR, V31, P1324, DOI 10.1175/1520-0485(2001)031<1324:IVIWWV>2.0.CO;2; MURRAY JW, 1989, DEEP-SEA RES, V36, P1471, DOI 10.1016/0198-0149(89)90052-6; MURRAY JW, 1994, SCIENCE, V266, P58, DOI 10.1126/science.266.5182.58; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; PENA MA, 1992, MAR ECOL PROG SER, V80, P265, DOI 10.3354/meps080265; PICAUT J, IN PRESS RADAR ALTIM; Raimbault P, 1999, J GEOPHYS RES-OCEANS, V104, P3341, DOI 10.1029/1998JC900004; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Rodier M, 1997, DEEP-SEA RES PT II, V44, P2085, DOI 10.1016/S0967-0645(97)00092-1; SCHOPF PS, 1988, J ATMOS SCI, V45, P549, DOI 10.1175/1520-0469(1988)045<0549:VIACOM>2.0.CO;2; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Turk D, 2001, J GEOPHYS RES-OCEANS, V106, P4501, DOI 10.1029/1999JC000058; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; WHEELER P, UNPUB JOINT GLOBAL O; WILKERSON FP, 1992, J GEOPHYS RES-OCEANS, V97, P669, DOI 10.1029/91JC01534	31	58	73	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					471	474		10.1126/science.1056449	http://dx.doi.org/10.1126/science.1056449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463910				2022-12-01	WOS:000169966700041
J	Goodman, S				Goodman, S			Battle to save beleaguered beluga	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					108	108		10.1038/35084355	http://dx.doi.org/10.1038/35084355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449227	Bronze			2022-12-01	WOS:000169778700009
J	Logothetis, NK; Pauls, J; Augath, M; Trinath, T; Oeltermann, A				Logothetis, NK; Pauls, J; Augath, M; Trinath, T; Oeltermann, A			Neurophysiological investigation of the basis of the fMRI signal	NATURE			English	Article							VISUAL-CORTEX; HUMAN BRAIN; NEURONAL-ACTIVITY; GLUCOSE-METABOLISM; BLOOD OXYGENATION; TEMPORAL BINDING; EEG; ACTIVATION; OSCILLATIONS; STIMULATION	Functional magnetic resonance imaging (fMRI) is widely used to study the operational organization of the human brain, but the exact relationship between the measured fMRI signal and the underlying neural activity is unclear. Here we present simultaneous intracortical recordings of neural signals and fMRI responses. We compared local field potentials (LFPs), single- and multi-unit spiking activity with highly spatio-temporally resolved blood-oxygen-level-dependent (BOLD) fMRI responses from the visual cortex of monkeys. The largest magnitude changes were observed in LFPs, which at recording sites characterized by transient responses were the only signal that significantly correlated with the haemodynamic response. Linear systems analysis on a trial-by-trial basis showed that the impulse response of the neurovascular system is both animal- and site-specific, and that LFPs yield a better estimate of BOLD responses than the multi-unit responses. These findings suggest that the BOLD contrast mechanism reflects the input and intracortical processing of a given area rather than its spiking output.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Mandelkow, Hendrik/AAQ-2583-2021; Logothetis, Nikos/U-9282-2019; anand, amit/A-7222-2009	Mandelkow, Hendrik/0000-0003-0274-3599; 				BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bonhoeffer Tobias, 1996, P55; Bonmassar G, 1999, NEUROREPORT, V10, P1893, DOI 10.1097/00001756-199906230-00018; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Carandini M, 1997, J NEUROSCI, V17, P8621; Clarke DD, 1989, BASIC NEUROCHEMISTRY, P565; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; FRAHM J, 1992, JMRI-J MAGN RESON IM, V2, P501, DOI 10.1002/jmri.1880020505; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; Freeman WJ, 1975, MASS ACTION NERVOUS; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hess A, 2000, J NEUROSCI, V20, P3328, DOI 10.1523/JNEUROSCI.20-09-03328.2000; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Juergens E, 1999, EXP BRAIN RES, V129, P247, DOI 10.1007/s002210050895; Krakow K, 1999, BRAIN, V122, P1679, DOI 10.1093/brain/122.9.1679; Krakow K, 2000, HUM BRAIN MAPP, V10, P10, DOI 10.1002/(SICI)1097-0193(200005)10:1<10::AID-HBM20>3.0.CO;2-T; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEGATT AD, 1980, J NEUROSCI METH, V2, P203, DOI 10.1016/0165-0270(80)90061-8; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mansfield P., 1977, J PHYS C SOLID STATE, V10, P55, DOI 10.1088/0022-3719/10/3/004; MENON RS, 1992, INVEST RADIOL S, V27, P53; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Pan JW, 2000, MAGNET RESON MED, V44, P673, DOI 10.1002/1522-2594(200011)44:5<673::AID-MRM3>3.0.CO;2-L; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Schmitt F., 1998, ECHO PLANAR IMAGING; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shulman RG, 1998, P NATL ACAD SCI USA, V95, P11993, DOI 10.1073/pnas.95.20.11993; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.ph.55.030193.002025; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; TAKAHASHI S, 1995, P NATL ACAD SCI USA, V92, P4616, DOI 10.1073/pnas.92.10.4616; TallonBaudry C, 1997, NEUROREPORT, V8, P1103, DOI 10.1097/00001756-199703240-00008; [No title captured]; [No title captured]	50	4296	4385	16	591	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2001	412	6843					150	157		10.1038/35084005	http://dx.doi.org/10.1038/35084005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451AJ	11449264				2022-12-01	WOS:000169778700042
J	Zeki, S				Zeki, S			Artistic creativity and the Brain	SCIENCE			English	Article									UCL, Dept Cognit Neurol, London WC1E 6BT, England; Wellcome Dept Cognit Neurol, London, England	University of London; University College London; University of London; University College London	Zeki, S (corresponding author), UCL, Dept Cognit Neurol, Mortimer St, London WC1E 6BT, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020						0	97	104	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2001	293	5527					51	52		10.1126/science.1062331	http://dx.doi.org/10.1126/science.1062331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11441167				2022-12-01	WOS:000169780300019
J	Schiermeier, Q				Schiermeier, Q			Imported stem cells deepen Germany's ethical divide	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					4	4		10.1038/35083712	http://dx.doi.org/10.1038/35083712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11452264	Bronze			2022-12-01	WOS:000169644900004
J	Spelman, D				Spelman, D			Prevention of overwhelming sepsis in asplenic patients: could do better	LANCET			English	Editorial Material									Monash Univ, Alfred Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Spelman, D (corresponding author), Monash Univ, Alfred Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic 3181, Australia.	d.spelman@alfred.org.au						Cavill I, 1996, BRIT MED J, V312, P430; Hegarty P K, 2000, Hematol J, V1, P357, DOI 10.1038/sj.thj.6200056; Sarangi J, 1997, J PUBLIC HEALTH MED, V19, P208, DOI 10.1093/oxfordjournals.pubmed.a024611; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214	4	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2001	357	9274					2072	2072		10.1016/S0140-6736(00)05227-2	http://dx.doi.org/10.1016/S0140-6736(00)05227-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RQ	11445096				2022-12-01	WOS:000169586600006
J	Young, BA; Anthony, LC; Gruber, TM; Arthur, TM; Heyduk, E; Lu, CZ; Sharp, MM; Heyduk, T; Burgess, RR; Gross, CA				Young, BA; Anthony, LC; Gruber, TM; Arthur, TM; Heyduk, E; Lu, CZ; Sharp, MM; Heyduk, T; Burgess, RR; Gross, CA			A coiled-coil from the RNA polymerase beta ' subunit allosterically induces selective nontemplate strand binding by sigma(70)	CELL			English	Article							PROMOTER RECOGNITION; CRYSTAL-STRUCTURE; AMINO-ACIDS; DNA; SEQUENCE; REGION; SITE; ORGANIZATION; MUTANT; DOMAIN	For transcription to initiate, RNA polymerase must recognize and melt promoters. Selective binding to the nontemplate strand of the -10 region of the promoter is central to this process. We show that a 48 amino acid (aa) coiled-coil from the beta' subunit (aa 262-309) induces sigma (70) to perform this function almost as efficiently as core RNA polymerase itself. We provide evidence that interaction between the beta' coiled-coil and region 2.2 of sigma (70) promotes an allosteric transition that allows om to selectively recognize the nontemplate strand. As the beta' 262-309 peptide can function with the previously crystallized portion of sigma (70), nontemplate recognition can be reconstituted with only 47 kDa, or 1/10 of holoenzyme.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Oncol, Madison, WI 53706 USA; St Louis Univ, Sch Med, EA Doisy Dept Biochem & Mol Biol, St Louis, MO 63128 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Saint Louis University	Gross, CA (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.	cgross@cgl.ucsf.edu		Arthur, Terrance/0000-0001-9035-0474; Burgess, Richard/0000-0001-9545-3165	NIGMS NIH HHS [GM50514, GM28575, GM30477] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050514, R01GM028575, R21GM050514] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; DANIELS D, 1990, P NATL ACAD SCI USA, V87, P8075, DOI 10.1073/pnas.87.20.8075; Dombroski AJ, 1997, J BIOL CHEM, V272, P3487; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fedoriw AM, 1998, BIOCHEMISTRY-US, V37, P11971, DOI 10.1021/bi980980o; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; GRUBER TM, 2001, IN PRESS MOL CELL; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Heyduk E, 1999, J BIOL CHEM, V274, P3315, DOI 10.1074/jbc.274.6.3315; Huang H, 1997, PHYS WORLD, V10, P25; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; KENNEY TJ, 1989, P NATL ACAD SCI USA, V86, P9109, DOI 10.1073/pnas.86.23.9109; Ko DC, 1998, GENE DEV, V12, P3276, DOI 10.1101/gad.12.20.3276; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; RING BZ, 1994, CELL, V78, P317, DOI 10.1016/0092-8674(94)90300-X; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; SENTENAC A, 1992, TRANSCRIPTIONAL REGU, P27; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; SEVERINOV K, 1992, J BIOL CHEM, V267, P12813; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Waldspurger J.-L., 1990, FESTSCHRIFT HONOR PI, V2, P267; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.bi.60.070191.003353; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	43	81	81	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2001	105	7					935	944		10.1016/S0092-8674(01)00398-1	http://dx.doi.org/10.1016/S0092-8674(01)00398-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	449BK	11439189	Bronze			2022-12-01	WOS:000169664300013
J	Szulc, P; Meunier, PJ				Szulc, P; Meunier, PJ			Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease?	LANCET			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; SERUM UNDERCARBOXYLATED OSTEOCALCIN; BONE-MINERAL DENSITY; ELDERLY WOMEN; HIP FRACTURE; MENATETRENONE; RESORPTION		Hop Edouard Herriot, INSERM, U403, F-69437 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Meunier, PJ (corresponding author), Hop Edouard Herriot, INSERM, U403, F-69437 Lyon, France.		Szulc, Pawel/N-5238-2018	Szulc, Pawel/0000-0003-4168-6697				Bjarnason I, 1997, GUT, V40, P228, DOI 10.1136/gut.40.2.228; Caraballo PJ, 1999, ARCH INTERN MED, V159, P1750, DOI 10.1001/archinte.159.15.1750; CROUCHER PI, 1993, OSTEOPOROSIS INT, V3, P236, DOI 10.1007/BF01623826; HARA K, 1993, J BONE MINER RES, V8, P535; HARA K, 1995, BONE, V16, P179, DOI 10.1016/8756-3282(94)00027-W; HODGES SJ, 1993, J BONE MINER RES, V8, P1005; HODGES SJ, 1993, J BONE MINER RES, V8, P1241; MOTLEY RJ, 1993, BONE MINER, V23, P95, DOI 10.1016/S0169-6009(08)80046-3; NOTOYA K, 1995, BONE, V16, pS349, DOI 10.1016/8756-3282(94)00046-3; ROUX C, 1995, OSTEOPOROSIS INT, V5, P156, DOI 10.1007/BF02106094; Schoon EJ, 2001, GUT, V48, P473, DOI 10.1136/gut.48.4.473; Schulte CMS, 2000, GASTROENTEROLOGY, V119, P909, DOI 10.1053/gast.2000.18158; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515; Sokoll LJ, 1996, AM J CLIN NUTR, V63, P566, DOI 10.1093/ajcn/63.4.566; Stone KL, 1999, J BONE MINER RES, V14, pS263; SZULC P, 1994, J BONE MINER RES, V9, P1591; SZULC P, 1993, J CLIN INVEST, V91, P1769, DOI 10.1172/JCI116387	18	17	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2001	357	9273					1995	1996		10.1016/S0140-6736(00)05135-7	http://dx.doi.org/10.1016/S0140-6736(00)05135-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JB	11438129				2022-12-01	WOS:000169509200006
J	Barker, PA; Street-Perrott, FA; Leng, MJ; Greenwood, PB; Swain, DL; Perrott, RA; Telford, RJ; Ficken, KJ				Barker, PA; Street-Perrott, FA; Leng, MJ; Greenwood, PB; Swain, DL; Perrott, RA; Telford, RJ; Ficken, KJ			A 14,000-year oxygen isotope record from diatom silica in two alpine lakes on Mt. Kenya	SCIENCE			English	Article							ATLANTIC-OCEAN; EAST-AFRICA; ICE; CLIMATE; FLUCTUATIONS; QUELCCAYA; EVENTS; IMPACT; BP	Oxygen isotopes are sensitive tracers of climate change in tropical regions. Abrupt shifts of up to 18 per mil in the oxygen isotope ratio of diatom silica have been found in a 14,000-year record from two alpine Lakes on Mt. Kenya. Interpretation of tropical-montane isotope records is controversial, especially concerning the relative roles of precipitation and temperature. Here, we argue that Holocene variations in delta O-18 are better explained by Lake moisture balance than by temperature-induced fractionation. Episodes of heavy convective precipitation dated similar to 11,100 to 8600, 6700 to 5600, 2900 to 1900, and <1300 years before the present were linked to enhanced soil erosion, neoglacial ice advances, and forest expansion on Mt. Kenya.	Univ Lancaster, Dept Geog, HYSED, Lancaster LA1 4YB, England; Univ Wales, Dept Geog, Trop Palaeoenvironm Res Grp, Swansea SA2 8PP, W Glam, Wales; NERC, Isotope Geosci Lab, Nottingham NG12 5GG, England	Lancaster University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Barker, PA (corresponding author), Univ Lancaster, Dept Geog, HYSED, Lancaster LA1 4YB, England.		Telford, Richard/C-1668-2008; Barker, Philip/J-5938-2012; Telford, Richard/AAD-2249-2019	Telford, Richard/0000-0001-9826-3076; Telford, Richard/0000-0001-9826-3076; Barker, Philip/0000-0002-5334-9201; Leng, Melanie/0000-0003-1115-5166				Brandriss ME, 1998, GEOCHIM COSMOCHIM AC, V62, P1119, DOI 10.1016/S0016-7037(98)00054-4; Darling W.G., 1996, THESIS OPEN U; DUPLESSY JC, 1980, NATURE, V286, P479, DOI 10.1038/286479a0; Flohn H., 1987, PALAEOECOL AFR, V18, P3; FONTES JC, 1993, ISOTOPE TECHNIQUES S, P231; GASSE F, 1994, EARTH PLANET SC LETT, V126, P435, DOI 10.1016/0012-821X(94)90123-6; Gatebe CK, 1999, J GEOPHYS RES-ATMOS, V104, P14237, DOI 10.1029/1998JD200103; GROOTES PM, 1989, J GEOPHYS RES-ATMOS, V94, P1187, DOI 10.1029/JD094iD01p01187; HASTENRATH S, 1981, GLACIERS EQUATORIAL; Hoffmann G, 1997, QUATERN INT, V37, P115, DOI 10.1016/1040-6182(96)00004-3; Jouzel J, 2000, QUATERNARY SCI REV, V19, P363, DOI 10.1016/S0277-3791(99)00069-4; Karlen W, 1999, AMBIO, V28, P409; KRISHNAMURTHY RV, 1985, NATURE, V317, P160, DOI 10.1038/317160a0; Ngecu WM, 1999, ENVIRON GEOL, V38, P277, DOI 10.1007/s002540050425; Nicholson S.E., 1996, LIMNOLOGY CLIMATOLOG, DOI DOI 10.1201/9780203748978-2; Njitchoua R, 1999, J HYDROL, V223, P17, DOI 10.1016/S0022-1694(99)00087-6; Peyron O, 2000, QUATERNARY RES, V54, P90, DOI 10.1006/qres.2000.2136; Rietti-Shati M, 1998, SCIENCE, V281, P980, DOI 10.1126/science.281.5379.980; ROZANSKI K, 1996, LIMNOLOGY CLIMATOLOG, P79; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Schmidt M, 2001, GEOCHIM COSMOCHIM AC, V65, P201, DOI 10.1016/S0016-7037(00)00534-2; Sonzogni C, 1998, QUATERNARY SCI REV, V17, P1185, DOI 10.1016/S0277-3791(97)00099-1; Stager JC, 1997, SCIENCE, V276, P1834, DOI 10.1126/science.276.5320.1834; STREETPERROTT FA, 1990, NATURE, V343, P607, DOI 10.1038/343607a0; StreetPerrott FA, 1997, SCIENCE, V278, P1422, DOI 10.1126/science.278.5342.1422; SWAIN DL, 1999, THESIS U WALES SWANS; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1979, SCIENCE, V203, P1240, DOI 10.1126/science.203.4386.1240; Thompson LG, 2000, J QUATERNARY SCI, V15, P377, DOI 10.1002/1099-1417(200005)15:4<377::AID-JQS542>3.0.CO;2-L; THOMPSON LG, 1979, SEA LEVEL ICE CLIMAT, V131, P55; VYVERMAN W, 1995, J PALEOLIMNOL, V13, P65, DOI 10.1007/BF00678111	31	121	124	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2001	292	5525					2307	2310		10.1126/science.1059612	http://dx.doi.org/10.1126/science.1059612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423656				2022-12-01	WOS:000169455900051
J	Pacala, SW; Hurtt, GC; Baker, D; Peylin, P; Houghton, RA; Birdsey, RA; Heath, L; Sundquist, ET; Stallard, RF; Ciais, P; Moorcroft, P; Caspersen, JP; Shevliakova, E; Moore, B; Kohlmaier, G; Holland, E; Gloor, M; Harmon, ME; Fan, SM; Sarmiento, JL; Goodale, CL; Schimel, D; Field, CB				Pacala, SW; Hurtt, GC; Baker, D; Peylin, P; Houghton, RA; Birdsey, RA; Heath, L; Sundquist, ET; Stallard, RF; Ciais, P; Moorcroft, P; Caspersen, JP; Shevliakova, E; Moore, B; Kohlmaier, G; Holland, E; Gloor, M; Harmon, ME; Fan, SM; Sarmiento, JL; Goodale, CL; Schimel, D; Field, CB			Consistent land- and atmosphere-based US carbon sink estimates	SCIENCE			English	Article							WOOD PRODUCTS; UNITED-STATES; MODEL; CO2; STORAGE; TRANSPORT; FORESTS; FLUXES; BUDGET	For the period 1980-89, we estimate a carbon sink in the coterminous United States between 0.30 and 0.58 petagrams of carbon per year (petagrams of carbon = 10(15) grams of carbon). The net carbon flux from the atmosphere to the Land was higher, 0.37 to 0.71 petagrams of carbon per year, because a net flux of 0.07 to 0.13 petagrams of carbon per year was exported by rivers and commerce and returned to the atmosphere elsewhere. These Land-based estimates are Larger than those from previous studies (0.08 to 0.35 petagrams of carbon per year) because of the inclusion of additional processes and revised estimates of some component fluxes. Although component estimates are uncertain, about one-half of the total is outside the forest sector. We also estimated the sink using atmospheric models and the atmospheric concentration of carbon dioxide (the tracer-transport inversion method). The range of results from the atmosphere-based inversions contains the Land-based estimates. Atmosphere- and land-based estimates are thus consistent, within the Large ranges of uncertainty for both methods. Atmosphere-based results for 1980-89 are similar to those for 1985-89 and 1990-94, indicating a relatively stable U.S. sink throughout the period.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Complex Syst Res Ctr, Durham, NH 03824 USA; Woods Hole Res Ctr, Woods Hole, MA 02543 USA; UPMC, Biogeochim Isotop Lab, CNRS, INRA, Paris, France; US Forest Serv, USDA, Newtown Sq, PA 19073 USA; US Geol Survey, Woods Hole, MA 02543 USA; US Geol Survey, Div Water Resources, Boulder, CO 80303 USA; CEA Saclay, LSCE, F-91191 Gif Sur Yvette, France; Goethe Univ Frankfurt, Zentrum Umweltforsch, D-60325 Frankfurt, Germany; Max Planck Inst Biogeochem, D-07745 Jena, Germany; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University System Of New Hampshire; University of New Hampshire; Woods Hole Research Center; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Goethe University Frankfurt; Max Planck Society; Oregon State University; Carnegie Institution for Science	Pacala, SW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	Pacala@princeton.edu	Shevliakova, Elena/J-5770-2014; Noojipady, Praveen/B-2511-2010; Fan, Song-Miao/A-8004-2008; Hurtt, George/A-8450-2012; Stallard, Robert F/H-2649-2013; Ciais, Philippe M/A-6840-2011	Fan, Song-Miao/0000-0001-8352-8035; Hurtt, George/0000-0001-7278-202X; Stallard, Robert F/0000-0001-8209-7608; Ciais, Philippe M/0000-0001-8560-4943; Goodale, Christine/0000-0003-4317-3983; Peylin, Philippe/0000-0001-9335-6994; Holland, Elisabeth Ann/0000-0002-3570-621X				[Anonymous], GLOBAL ATMOSPHERIC T; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Birdsey RA, 1992, WO59 USDA FOR SERV G; BIRDSEY RA, 1995, PRODUCTIVITY AM FORE, P56; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; *FED EM MAN AG ARM, 1993, WAT CONTR INFR NAT I; Gloor M, 1999, J GEOPHYS RES-ATMOS, V104, P14245, DOI 10.1029/1999JD900132; HEATH LS, 1993, WATER AIR SOIL POLL, V70, P279, DOI 10.1007/BF01105002; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P125, DOI 10.1046/j.1365-2699.2000.00166.x; Kaminski T, 1999, J GEOPHYS RES-ATMOS, V104, P18555, DOI 10.1029/1999JD900146; MAHLMAN JD, 1978, J ATMOS SCI, V35, P1340, DOI 10.1175/1520-0469(1978)035<1340:TSUAGG>2.0.CO;2; MELILLO J, UNPUB; MOORCROFT P, IN PRESS ECOL MONOGR; Peylin P, 2000, GEOPH MONOG SERIES, V114, P295; PEYLIN P, UNPUB; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Skog KE, 1998, FOREST PROD J, V48, P75; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; Winjum JK, 1998, FOREST SCI, V44, P272	25	634	721	12	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2001	292	5525					2316	2320		10.1126/science.1057320	http://dx.doi.org/10.1126/science.1057320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	11423659	Green Submitted			2022-12-01	WOS:000169455900054
J	Beltrami, AP; Urbanek, K; Kajstura, J; Yan, SM; Finato, N; Bussani, R; Nadal-Ginard, B; Silvestri, F; Leri, A; Beltrami, CA; Anversa, P				Beltrami, AP; Urbanek, K; Kajstura, J; Yan, SM; Finato, N; Bussani, R; Nadal-Ginard, B; Silvestri, F; Leri, A; Beltrami, CA; Anversa, P			Evidence that human cardiac myocytes divide after myocardial infarction (Publication with Expression of Concern. See vol. 379, pg. 1870, 2018)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Publication with Expression of Concern							HEMATOPOIETIC STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; HEART-FAILURE; PROLIFERATION; DIFFERENTIATION; TRANSPLANTATION; HYPERTROPHY; INDUCTION; DIVISION	Background The scarring of the heart that results from myocardial infarction has been interpreted as evidence that the heart is composed of myocytes that are unable to divide. However, recent observations have provided evidence of proliferation of myocytes in the adult heart. Therefore, we studied the extent of mitosis among myocytes after myocardial infarction in humans. Methods Samples from the border of the infarct and from areas of the myocardium distant from the infarct were obtained from 13 patients who had died 4 to 12 days after infarction. Ten normal hearts were used as controls. Myocytes that had entered the cell cycle in preparation for cell division were measured by labeling of the nuclear antigen Ki-67, which is associated with cell division. The fraction of myocyte nuclei that were undergoing mitosis was determined, and the mitotic index (the ratio of the number of nuclei undergoing mitosis to the number not undergoing mitosis) was calculated. The presence of mitotic spindles, contractile rings, karyokinesis, and cytokinesis was also recorded. Results In the infarcted hearts, Ki-67 expression was detected in 4 percent of myocyte nuclei in the regions adjacent to the infarcts and in 1 percent of those in regions distant from the infarcts. The reentry of myocytes into the cell cycle resulted in mitotic indexes of 0.08 percent and 0.33 percent, respectively, in the zones adjacent to and distant from the infarcts. Events characteristic of cell division - the formation of the mitotic spindles, the formation of contractile rings, karyokinesis, and cytokinesis - were identified; these features demonstrated that there was myocyte proliferation after myocardial infarction. Conclusions Our results challenge the dogma that the adult heart is a postmitotic organ and raise the possibility that the regeneration of myocytes may contribute to the increase in muscle mass of the myocardium. (N Engl J Med 2001;344:1750-7.) Copyright (C) 2001 Massachusetts Medical Society.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; Univ Udine, Dept Pathol, I-33100 Udine, Italy; Univ Trieste, Dept Pathol, Trieste, Italy	New York Medical College; University of Udine; University of Trieste	Anversa, P (corresponding author), New York Med Coll, Dept Med, Vosburgh Pavil,Rm 302, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu	Beltrami, Antonio/C-5291-2008; Finato, Nicoletta/A-7351-2010; beltrami, carlo a/A-8026-2008	Beltrami, Antonio/0000-0002-0679-2710; Yan, Shaomin/0000-0001-7642-3972; Bussani, Rossana/0000-0001-8241-9726	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039902, P01HL043023, R01HL038132] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-43023, HL-39902, HL-38132] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; ANVERSA P, 1990, PROG CARDIOVASC DIS, V33, P49, DOI 10.1016/0033-0620(90)90039-5; Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; BODINE DM, 1994, BLOOD, V84, P1482; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; HALL PA, 1990, J CLIN PATHOL, V43, P184, DOI 10.1136/jcp.43.3.184; HALL PA, 1993, ONCOGENE, V8, P203; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; KAJSTURA J, 1995, CIRCULATION, V92, P2306, DOI 10.1161/01.CIR.92.8.2306; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Leor J, 1996, CIRCULATION, V94, P332; LINZBACH AJ, 1960, AM J CARDIOL, V5, P370, DOI 10.1016/0002-9149(60)90084-9; LOUD AV, 1984, LAB INVEST, V50, P250; MacCallum DE, 2000, J PATHOL, V191, P286; MacCallum DE, 2000, J PATHOL, V190, P537; Moreau V, 1999, CURR OPIN CELL BIOL, V11, P152, DOI 10.1016/S0955-0674(99)80019-2; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Orlic D, 1998, BLOOD, V91, P3247, DOI 10.1182/blood.V91.9.3247.3247_3247_3254; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; PARODI O, 1993, CIRCULATION, V88, P509, DOI 10.1161/01.CIR.88.2.509; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SKALLI O, 1988, AM J PATHOL, V130, P515; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wolf WA, 1999, CELL MOL LIFE SCI, V55, P108, DOI 10.1007/s000180050274; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	40	1043	1246	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2001	344	23					1750	1757		10.1056/NEJM200106073442303	http://dx.doi.org/10.1056/NEJM200106073442303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	439TL	11396441	Bronze			2022-12-01	WOS:000169133600003
J	CHARIOT, P				CHARIOT, P			ZIDOVUDINE MYOPATHY	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											CHARIOT, P (corresponding author), HOP HENRI MONDOR,F-94000 CRETEIL,FRANCE.		Chariot, Patrick/H-6384-2019	Chariot, Patrick/0000-0001-5556-8814					0	3	3	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	1993	328	23					1675	1675						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF054	11407398				2022-12-01	WOS:A1993LF05400005
J	Zhang, XM; Ramalho-Santos, M; McMahon, AP				Zhang, XM; Ramalho-Santos, M; McMahon, AP			Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node	CELL			English	Article							LEFT-RIGHT AXIS; SONIC-HEDGEHOG; SCLEROTOME INDUCTION; INDIAN HEDGEHOG; CARTILAGE DIFFERENTIATION; VERTEBRATE DEVELOPMENT; MAMMALIAN TOOTH; GENE; EXPRESSION; PROLIFERATION	Genetic analyses in Drosophila have demonstrated that the multipass membrane protein Smoothened (Smo) is essential for all Hedgehog signaling. We show that Smo acts epistatic to Ptc1 to mediate Shh and Ihh signaling in the early mouse embryo. Smo and Shh/Ihh compound mutants have identical phenotypes: embryos fail to turn, arresting at somite stages with a small, linear heart tube, an open gut and cyclopia. The absence of visible left/right (L/R) asymmetry led us to examine the pathways controlling L/R situs. We present evidence consistent with a model in which Hedgehog signaling within the node is required for activation of Gdf1, and induction of left-side determinants. Further, we demonstrate an absolute requirement for Hedgehog signaling in sclerotomal development and a role in cardiac morphogenesis.	Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Harvard University	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.		Ramalho-Santos, Miguel/L-9092-2018; McMahon, Andrew P/ABE-7520-2020	Ramalho-Santos, Miguel/0000-0003-0177-5556; 	NINDS NIH HHS [NS33642] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama H, 1997, BIOCHEM BIOPH RES CO, V235, P142, DOI 10.1006/bbrc.1997.6750; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1998, DEVELOPMENT, V125, P777; Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dockter JL, 2000, CURR TOP DEV BIOL, V48, P77; Dutton R, 1999, J NEUROSCI, V19, P2601; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kos L, 1998, MECH DEVELOP, V70, P25, DOI 10.1016/S0925-4773(97)00168-8; Lassar AB, 1996, CURR OPIN NEUROBIOL, V6, P57, DOI 10.1016/S0959-4388(96)80009-2; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lyons GE, 1996, CURR OPIN GENET DEV, V6, P454, DOI 10.1016/S0959-437X(96)80067-0; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Marcelle C, 1999, DEV BIOL, V214, P277, DOI 10.1006/dbio.1999.9389; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Quirk J, 1997, COLD SPRING HARB SYM, V62, P217; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sarkar L, 2000, P NATL ACAD SCI USA, V97, P4520, DOI 10.1073/pnas.97.9.4520; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	78	457	471	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					781	792		10.1016/S0092-8674(01)00385-3	http://dx.doi.org/10.1016/S0092-8674(01)00385-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11517919	Bronze			2022-12-01	WOS:000169375100011
